10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 10-Q

(Mark One)

 

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
	OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

OR

 

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
	OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER: 1-33901

Oaktree Specialty Lending Corporation

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

 

Delaware (State or jurisdiction of incorporation or organization)	26-1219283 (I.R.S. Employer Identification No.)
333 South Grand Avenue, 28th Floor Los Angeles, CA (Address of principal executive office)	90071 (Zip Code)

REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:

(213) 830-6300

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share	OCSL	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   þ     No   ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes   þ   No   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer  þ	Accelerated filer  ¨	Non-accelerated filer  ¨	Smaller reporting company  ¨
Emerging growth company  ¨	If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes  ¨     No  þ

The registrant had 77,079,811 shares of common stock outstanding as of August 1, 2023.

OAKTREE SPECIALTY LENDING CORPORATION

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2023

TABLE OF CONTENTS

		PART I — FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements:
		Consolidated Statements of Assets and Liabilities as of June 30, 2023 (unaudited) and September 30, 2022	2
		Consolidated Statements of Operations (unaudited) for the three and nine months ended June 30, 2023 and 2022	3
		Consolidated Statements of Changes in Net Assets (unaudited) for the three and nine months ended June 30, 2023 and 2022	4
		Consolidated Statements of Cash Flows (unaudited) for the nine months ended June 30, 2023 and 2022	5
		Consolidated Schedule of Investments (unaudited) as of June 30, 2023	6
		Consolidated Schedule of Investments as of September 30, 2022	17
		Notes to Consolidated Financial Statements (unaudited)	26
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations		82
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		101
Item 4.	Controls and Procedures		103
		PART II — OTHER INFORMATION
Item 1.	Legal Proceedings		103
Item 1A.	Risk Factors		103
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		103
Item 3.	Defaults Upon Senior Securities		103
Item 4.	Mine Safety Disclosures		103
Item 5.	Other Information		103
Item 6.	Exhibits		104
Signatures			105

1

PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements.

Oaktree Specialty Lending Corporation

Consolidated Statements of Assets and Liabilities

(in thousands, except per share amounts)

	June 30, 2023 (unaudited)		September 30, 2022
ASSETS
Investments at fair value:
Control investments (cost June 30, 2023: $285,236; cost September 30, 2022: $260,305)	$	238,196	$	214,165
Affiliate investments (cost June 30, 2023: $25,370; cost September 30, 2022: $27,353)	23,911		26,196
Non-control/Non-affiliate investments (cost June 30, 2023: $2,985,679; cost September 30, 2022: $2,330,096)	2,873,512		2,253,750
Total investments at fair value (cost June 30, 2023: $3,296,285; cost September 30, 2022: $2,617,754)	3,135,619		2,494,111
Cash and cash equivalents	59,704		23,528
Restricted cash	12,956		2,836
Interest, dividends and fees receivable	29,457		35,598
Due from portfolio companies	2,080		22,495
Receivables from unsettled transactions	39,261		4,692
Due from broker	39,990		45,530
Deferred financing costs	13,284		7,350
Deferred offering costs	186		32
Deferred tax asset, net	2,695		1,687
Derivative assets at fair value	49		6,789
Other assets	693		1,665
Total assets	$	3,335,974	$	2,646,313
LIABILITIES AND NET ASSETS
Liabilities:
Accounts payable, accrued expenses and other liabilities	$	3,412	$	3,701
Base management fee and incentive fee payable	20,072		15,940
Due to affiliate	7,724		3,180
Interest payable	12,907		7,936
Payables from unsettled transactions	2,785		26,981
Derivative liability at fair value	39,567		41,969
Credit facilities payable	1,135,000		700,000
Unsecured notes payable (net of $3,909 and $5,020 of unamortized financing costs as of June 30, 2023 and September 30, 2022, respectively)	605,066		601,043
Total liabilities	1,826,533		1,400,750
Commitments and contingencies (Note 13)
Net assets:
Common stock, $0.01 par value per share, 250,000 shares authorized; 77,080 and 61,125 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively (1)	771		611
Additional paid-in-capital	2,163,528		1,827,721
Accumulated overdistributed earnings	(654,858)		(582,769)
Total net assets (equivalent to $19.58 and $20.38 per common share as of June 30, 2023 and September 30, 2022, respectively) (Note 11) (1)	1,509,441		1,245,563
Total liabilities and net assets	$	3,335,974	$	2,646,313

 __________

(1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.

See notes to Consolidated Financial Statements.

2

Oaktree Specialty Lending Corporation

Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Interest income:
Control investments	$	5,568	$	3,400	$	15,326	$	10,214
Affiliate investments	681		470		1,970		1,170
Non-control/Non-affiliate investments	88,069		50,707		234,516		155,656
Interest on cash and cash equivalents	992		151		2,221		157
Total interest income	95,310		54,728		254,033		167,197
PIK interest income:
Non-control/Non-affiliate investments	3,967		5,178		14,220		14,515
Total PIK interest income	3,967		5,178		14,220		14,515
Fee income:
Control investments	13		12		38		38
Affiliate investments	5		5		15		15
Non-control/Non-affiliate investments	1,555		2,258		5,921		5,039
Total fee income	1,573		2,275		5,974		5,092
Dividend income:
Control investments	1,050		875		3,150		5,491
Non-control/Non-affiliate investments	—		81		4		81
Total dividend income	1,050		956		3,154		5,572
Total investment income	101,900		63,137		277,381		192,376
Expenses:
Base management fee	11,983		9,819		33,383		29,853
Part I incentive fee	9,590		6,497		26,300		19,658
Part II incentive fee	—		(6,796)		—		(8,791)
Professional fees	1,387		885		4,962		3,029
Directors fees	160		160		480		443
Interest expense	30,793		11,870		79,316		31,178
Administrator expense	322		271		935		968
General and administrative expenses	752		811		2,753		2,217
Total expenses	54,987		23,517		148,129		78,555
Fees waived	(1,500)		(750)		(4,025)		(2,250)
Net expenses	53,487		22,767		144,104		76,305
Net investment income before taxes	48,413		40,370		133,277		116,071
(Provision) benefit for taxes on net investment income	—		—		—		(3,308)
Excise tax	—		—		(78)		—
Net investment income	48,413		40,370		133,199		112,763
Unrealized appreciation (depreciation):
Control investments	734		(16,991)		(900)		(26,552)
Affiliate investments	149		(328)		(302)		(716)
Non-control/Non-affiliate investments	(6,497)		(67,806)		(36,296)		(90,333)
Foreign currency forward contracts	4,575		(1,630)		(4,802)		(778)
Net unrealized appreciation (depreciation)	(1,039)		(86,755)		(42,300)		(118,379)
Realized gains (losses):
Control investments	—		—		—		1,868
Non-control/Non-affiliate investments	(4,294)		416		(14,404)		5,888
Foreign currency forward contracts	(6,309)		8,796		(5,513)		12,179
Net realized gains (losses)	(10,603)		9,212		(19,917)		19,935
(Provision) benefit for taxes on realized and unrealized gains (losses)	(86)		(661)		397		1,696
Net realized and unrealized gains (losses), net of taxes	(11,728)		(78,204)		(61,820)		(96,748)
Net increase (decrease) in net assets resulting from operations	$	36,685	$	(37,834)	$	71,379	$	16,015
Net investment income per common share — basic and diluted (1)	$	0.63	$	0.66	$	1.89	$	1.86
Earnings (loss) per common share — basic and diluted (Note 5) (1)	$	0.48	$	(0.62)	$	1.01	$	0.26
Weighted average common shares outstanding — basic and diluted (1)	77,080		61,123		70,431		60,593

__________

(1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

See notes to Consolidated Financial Statements.

3

Oaktree Specialty Lending Corporation

Consolidated Statements of Changes in Net Assets

(in thousands, except per share amounts)

(unaudited)

	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Operations:
Net investment income	$	48,413	$	40,370	$	133,199	$	112,763
Net unrealized appreciation (depreciation)	(1,039)		(86,755)		(42,300)		(118,379)
Net realized gains (losses)	(10,603)		9,212		(19,917)		19,935
(Provision) benefit for taxes on realized and unrealized gains (losses)	(86)		(661)		397		1,696
Net increase (decrease) in net assets resulting from operations	36,685		(37,834)		71,379		16,015
Stockholder transactions:
Distributions to stockholders	(42,394)		(30,256)		(143,468)		(87,483)
Net increase (decrease) in net assets from stockholder transactions	(42,394)		(30,256)		(143,468)		(87,483)
Capital share transactions:
Issuance of common stock in connection with the OSI2 Merger	—		—		334,034		—
Issuance of common stock under dividend reinvestment plan	1,123		874		4,351		2,426
Repurchase of common stock under dividend reinvestment plan	(1,123)		(874)		(2,418)		(874)
Issuance of common stock in connection with the "at the market" offering	—		1,243		—		20,622
Net increase (decrease) in net assets from capital share transactions	—		1,243		335,967		22,174
Total increase (decrease) in net assets	(5,709)		(66,847)		263,878		(49,294)
Net assets at beginning of period	1,515,150		1,330,376		1,245,563		1,312,823
Net assets at end of period	$	1,509,441	$	1,263,529	$	1,509,441	$	1,263,529
Net asset value per common share (1)	$	19.58	$	20.67	$	19.58	$	20.67
Common shares outstanding at end of period (1)	77,080		61,125		77,080		61,125

__________

(1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

See notes to Consolidated Financial Statements.

4

Oaktree Specialty Lending Corporation

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

	Nine months ended June 30, 2023		Nine months ended June 30, 2022
Operating activities:
Net increase (decrease) in net assets resulting from operations	$	71,379	$	16,015
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation	42,300		118,379
Net realized (gains) losses	19,917		(19,935)
PIK interest income	(14,220)		(14,515)
Accretion of original issue discount on investments	(15,554)		(22,707)
Accretion of original issue discount on unsecured notes payable	509		509
Amortization of deferred financing costs	3,407		2,801
Deferred taxes	(1,030)		(984)
Purchases of investments	(597,662)		(620,843)
Proceeds from the sales and repayments of investments	521,163		554,933
Cash received in the OSI2 Merger	22,317		—
Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable	12,866		(9,456)
(Increase) decrease in due from portfolio companies	20,520		(4,891)
(Increase) decrease in receivables from unsettled transactions	(34,562)		4,876
(Increase) decrease in due from broker	5,540		(34,700)
(Increase) decrease in other assets	(548)		1,017
Increase (decrease) in accounts payable, accrued expenses and other liabilities	(52,290)		(700)
Increase (decrease) in base management fee and incentive fee payable	37		(17,086)
Increase (decrease) in due to affiliate	3,823		(817)
Increase (decrease) in interest payable	1,278		3,759
Increase (decrease) in payables from unsettled transactions	(24,196)		470
Increase (decrease) in director fees payable	(9)		38
Net cash provided by (used in) operating activities	(15,015)		(43,837)
Financing activities:
Distributions paid in cash	(139,117)		(85,057)
Borrowings under credit facilities	572,000		290,000
Repayments of borrowings under credit facilities	(362,000)		(175,000)
Shares issued under the "at the market" offering	—		20,839
Repurchases of common stock under dividend reinvestment plan	(2,418)		(874)
Deferred financing costs paid	(7,314)		(334)
Offering costs paid	(186)		(215)
Net cash provided by (used in) financing activities	60,965		49,359
Effect of exchange rate changes on foreign currency	346		(842)
Net increase (decrease) in cash and cash equivalents and restricted cash	46,296		4,680
Cash and cash equivalents and restricted cash, beginning of period	26,364		31,635
Cash and cash equivalents and restricted cash, end of period	$	72,660	$	36,315
Supplemental information:
Cash paid for interest	$	70,429	$	24,109
Non-cash financing activities:
Issuance of shares of common stock under dividend reinvestment plan	1,933		$	2,426
Deferred Financing costs	125		—
Issuance of shares in connection with the OSI2 Merger	334,034		—
Reconciliation to the Consolidated Statements of Assets and Liabilities	June 30, 2023		September 30, 2022
Cash and cash equivalents	$	59,704	$	23,528
Restricted cash	12,956		2,836
Total cash and cash equivalents and restricted cash	$	72,660	$	26,364

See notes to Consolidated Financial Statements.

5

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares		Principal (7)		Cost		Fair Value		Notes
Control Investments																(8)(9)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						829				$	—	$	—	(15)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						34,984,460				34,984		27,638		(15)
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.39%		8/28/2025			$	14,102	14,102		14,102		(6)(15)
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00%			8/28/2025			—		—		—		(6)(15)(19)
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	SOFR+	5.00%	10.24%		8/28/2025			3,484		3,484		3,484		(6)(15)(19)
Dominion Diagnostics, LLC	Health Care Services	Common Stock						30,031				15,222		2,711		(15)
OCSI Glick JV LLC	Multi-Sector Holdings	Subordinated Debt	L+	4.50%	9.36%		10/20/2028			58,349		49,997		49,632		(6)(11)(14)(15)(19)
OCSI Glick JV LLC	Multi-Sector Holdings	Membership Interest						87.5	%			—		—		(11)(14)(16)(19)
Senior Loan Fund JV I, LLC	Multi-Sector Holdings	Subordinated Debt	L+	7.00%	11.86%		12/29/2028			112,656		112,656		112,656		(6)(11)(14)(15)(19)
Senior Loan Fund JV I, LLC	Multi-Sector Holdings	Membership Interest						87.5	%			54,791		27,973		(11)(12)(14)(16)(19)
Total Control Investments (15.8% of net assets)												$	285,236	$	238,196
Affiliate Investments																(17)
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver	L+	6.75%	12.29%		10/17/2023			$	22,304	$	22,327	$	22,186	(6)(15)(19)
Assembled Brands Capital LLC	Specialized Finance	Common Stock						1,783,332				804		—		(15)
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity						1,129,453				1,159		1,412		(15)
Assembled Brands Capital LLC	Specialized Finance	Warrants						78,045				—		—		(15)
Caregiver Services, Inc.	Health Care Services	Preferred Equity						1,080,399				1,080		313		(15)
Total Affiliate Investments (1.6% of net assets)												$	25,370	$	23,911
Non-Control/Non-Affiliate Investments																(18)
107-109 Beech OAK22 LLC	Real Estate Development	First Lien Revolver			11.00%		2/27/2026			$	14,916	$	14,770	$	14,489	(15)(19)
107 Fair Street LLC	Real Estate Development	First Lien Term Loan			12.50%		5/31/2024			1,174		1,133		1,112		(10)(15)(19)
112-126 Van Houten Real22 LLC	Real Estate Development	First Lien Term Loan			12.00%		5/4/2024			3,710		3,664		3,645		(10)(15)(19)
A.T. Holdings II Ltd.	Biotechnology	First Lien Term Loan			14.25%		9/13/2029			21,434		21,620		21,434		(11)(15)(22)
A.T. Holdings II SÀRL	Biotechnology	First Lien Term Loan				20.00%	2/6/2024			5,576		5,561		5,464		(11)(15)
Access CIG, LLC	Diversified Support Services	Second Lien Term Loan	L+	7.75%	12.94%		2/27/2026			20,000		19,943		18,883		(6)(15)
Accupac, Inc.	Personal Care Products	First Lien Term Loan	SOFR+	5.50%	10.86%		1/16/2026			20,286		20,193		20,246		(6)(15)
Accupac, Inc.	Personal Care Products	First Lien Term Loan	SOFR+	5.50%			1/16/2026			—		(2)		(8)		(6)(15)(19)
Accupac, Inc.	Personal Care Products	First Lien Revolver	SOFR+	5.50%	10.86%		1/16/2026			2,033		2,011		2,027		(6)(15)(19)
Acquia Inc.	Application Software	First Lien Term Loan	L+	7.00%	12.34%		10/31/2025			6,400		6,327		6,374		(6)(15)
Acquia Inc.	Application Software	First Lien Term Loan	L+	7.00%	12.34%		10/31/2025			25,332		25,283		25,230		(6)(15)
Acquia Inc.	Application Software	First Lien Revolver	L+	7.00%	12.05%		10/31/2025			2,113		2,101		2,102		(6)(15)(19)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025			3,520		3,480		3,455		(6)(15)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025			18,271		18,091		17,935		(6)(15)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.66%		12/18/2025			1,000		983		982		(6)(15)
ADC Therapeutics SA	Biotechnology	First Lien Term Loan	SOFR+	7.50%	12.89%		8/15/2029			6,589		6,292		6,267		(6)(11)(15)
ADC Therapeutics SA	Biotechnology	First Lien Term Loan	SOFR+	7.50%			8/15/2029			—		(38)		(38)		(6)(11)(15)(19)
ADC Therapeutics SA	Biotechnology	Warrants						28,948				174		18		(11)(15)

6

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
AI Sirona (Luxembourg) Acquisition S.a.r.l.	Pharmaceuticals	Second Lien Term Loan	E+	7.25%	10.67%		9/28/2026		€	29,985	$	33,119	$	32,128	(6)(11)(15)
AIP RD Buyer Corp.	Distributors	Second Lien Term Loan	SOFR+	7.75%	12.95%		12/21/2029		$	17,873	17,646		17,533		(6)(15)
AIP RD Buyer Corp.	Distributors	Common Stock						17,870			1,733		2,578		(15)
AirStrip Technologies, Inc.	Application Software	Warrants						5,715			90		—		(15)
All Web Leads, Inc.	Advertising	First Lien Term Loan	SOFR+	8.50%			12/29/2023		23,562		22,795		16,880		(6)(15)(20)
Altice France S.A.	Integrated Telecommunication Services	Fixed Rate Bond			5.50%		10/15/2029		4,050		3,561		2,900		(11)
Alto Pharmacy Holdings, Inc.	Health Care Technology	First Lien Term Loan	SOFR+	8.00%	13.34%	3.50%	10/14/2027		8,794		8,132		8,011		(6)(15)
Alto Pharmacy Holdings, Inc.	Health Care Technology	Warrants						166,414			642		518		(15)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.89%		6/30/2025		17,280		17,197		16,503		(6)(15)
Alvotech Holdings S.A.	Biotechnology	Fixed Rate Bond			8.50%	3.50%	11/16/2026		28,464		28,363		27,682		(11)(15)
Alvotech Holdings S.A.	Biotechnology	Fixed Rate Bond			8.50%	3.50%	11/16/2026		2,121		1,945		2,063		(11)(15)
Alvotech Holdings S.A.	Biotechnology	Fixed Rate Bond			8.50%	3.50%	11/16/2026		27,692		27,612		26,930		(11)(15)
Alvotech Holdings S.A.	Biotechnology	Fixed Rate Bond			8.50%	3.50%	11/16/2026		2,064		1,891		2,007		(11)(15)
Alvotech Holdings S.A.	Biotechnology	Common Stock						824,197			2,426		6,379		(11)
Alvotech Holdings S.A.	Biotechnology	Common Stock						141,640			566		339		(11)(13)(15)
American Auto Auction Group, LLC	Consumer Finance	Second Lien Term Loan	SOFR+	8.75%	13.99%		1/2/2029		17,048		16,411		12,616		(6)(15)
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.49%		10/20/2028		19,163		18,289		16,718		(6)
Amplify Finco Pty Ltd.	Movies & Entertainment	Second Lien Term Loan	SOFR+	8.00%	13.39%		11/26/2027		12,500		12,188		11,865		(6)(11)(15)
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.25%		8/11/2025		3,710		3,075		2,863		(6)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	5.00%	10.20%		1/10/2025		9,280		9,189		9,280		(6)(15)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	5.00%	10.20%		1/10/2025		32,308		31,999		32,308		(6)(15)
Apptio, Inc.	Application Software	First Lien Revolver	L+	5.00%	10.20%		1/10/2025		808		792		808		(6)(15)(19)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	E+	7.25%	10.07%		7/14/2026		€	3,017	3,341		3,321		(6)(11)(15)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	SOFR+	6.00%	11.25%		7/14/2026		$	10,519	10,389		10,614		(6)(11)(15)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	SONIA+	7.25%	12.18%		7/14/2026		£	4,949	6,364		6,348		(6)(11)(15)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	SONIA+	7.25%	12.45%		7/14/2026		£	23,675	28,939		30,370		(6)(11)(15)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	SONIA+	5.75%	8.57%		7/14/2026		£	3,649	3,927		4,027		(6)(11)(15)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.31%		12/29/2027		$	3,284	3,276		3,120		(6)(11)(15)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027		—		(14)		(20)		(6)(11)(15)(19)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	10.44%		10/25/2028		8,490		8,153		5,983		(6)
athenahealth Group Inc.	Health Care Technology	Preferred Equity						21,523			20,789		18,821		(15)
Athenex, Inc.	Pharmaceuticals	First Lien Term Loan			11.00%		6/19/2026		1,338		1,257		1,257		(11)(15)(20)
Athenex, Inc.	Pharmaceuticals	First Lien Term Loan			11.00%		6/19/2026		1,338		1,241		1,257		(11)(15)(20)
Athenex, Inc.	Pharmaceuticals	First Lien Term Loan			11.00%		6/19/2026		5,350		4,951		5,029		(11)(15)(20)
Athenex, Inc.	Pharmaceuticals	Warrants						10,634	—		488		—		(11)(15)
Athenex, Inc.	Pharmaceuticals	Warrants						10,634			488		—		(11)(15)
ATNX SPV, LLC	Pharmaceuticals	First Lien Term Loan					5/31/2031		11,683		11,723		11,274		(11)(15)(22)
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	11.27%		12/24/2026		29,509		29,137		28,299		(6)(11)(15)

7

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
Avalara, Inc.	Application Software	First Lien Term Loan	SOFR+	7.25%	12.49%		10/19/2028		$	50,470	$	49,639	$	49,461	(6)(15)
Avalara, Inc.	Application Software	First Lien Revolver	SOFR+	7.25%			10/19/2028		—		(113)		(101)		(6)(15)(19)
The Avery	Real Estate Operating Companies	First Lien Term Loan	L+	7.30%			2/17/2023		19,163		19,163		18,286		(6)(15)(20)
The Avery	Real Estate Operating Companies	Subordinated Debt Term Loan	L+	12.50%			2/17/2023		4,641		4,641		4,164		(6)(15)(20)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027		3,258		3,227		3,173		(6)(15)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027		1,264		1,273		1,232		(6)(15)
BAART Programs, Inc.	Health Care Services	Second Lien Term Loan	SOFR+	8.50%	14.00%		6/11/2028		8,920		8,819		8,661		(6)(15)
BAART Programs, Inc.	Health Care Services	Second Lien Term Loan	SOFR+	8.50%	14.00%		6/11/2028		2,091		2,067		2,030		(6)(15)
BAART Programs, Inc.	Health Care Services	Second Lien Term Loan	SOFR+	8.50%	14.00%		6/11/2028		4,361		4,296		4,235		(6)(15)
Berner Food & Beverage, LLC	Soft Drinks & Non-alcoholic Beverages	First Lien Term Loan	SOFR+	5.50%	10.70%		7/30/2027		40,764		40,529		40,316		(6)(15)
Berner Food & Beverage, LLC	Soft Drinks & Non-alcoholic Beverages	First Lien Revolver	PRIME+	4.50%	12.50%		7/30/2026		2,528		2,492		2,482		(6)(15)(19)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan			8.00%	2.25%	4/19/2027		6,719		6,508		6,282		(11)(15)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan					9/30/2032		3,210		3,230		3,130		(11)(15)(22)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan			8.00%	2.25%	4/19/2027		—		—		—		(11)(15)(19)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan			8.00%	2.25%	4/19/2027		—		—		—		(11)(15)(19)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan					9/30/2032		—		—		—		(11)(15)(19)(22)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan					9/30/2032		—		—		—		(11)(15)(19)(22)
BioXcel Therapeutics, Inc.	Pharmaceuticals	Warrants						26,131			225		34		(11)(15)
Blackhawk Network Holdings, Inc.	Data Processing & Outsourced Services	Second Lien Term Loan	L+	7.00%	12.25%		6/15/2026		30,625		30,346		29,385		(6)
Blumenthal Temecula, LLC	Automotive Retail	First Lien Term Loan			9.00%		9/24/2023		4,994		5,006		4,969		(15)
Blumenthal Temecula, LLC	Automotive Retail	Preferred Equity						1,708,618			1,711		2,085		(15)
Blumenthal Temecula, LLC	Automotive Retail	Preferred Equity						394,297			395		481		(15)
Blumenthal Temecula, LLC	Automotive Retail	Common Stock						394,297			424		355		(15)
Cadence Aerospace, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	6.50%	11.91%	2.00%	11/14/2024		13		13		13		(6)(15)
Cadence Aerospace, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	6.50%	11.91%	2.00%	11/14/2024		3,031		2,971		3,031		(6)(15)
Cadence Aerospace, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	6.50%	11.91%	2.00%	11/14/2024		1,557		1,526		1,557		(6)(15)
Cadence Aerospace, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	6.50%	11.91%	2.00%	11/14/2024		1,024		1,002		1,024		(6)(15)
CircusTrix Holdings, LLC	Leisure Facilities	First Lien Term Loan	SOFR+	5.50%	10.70%		7/14/2023		130		130		130		(6)(15)
CircusTrix Holdings, LLC	Leisure Facilities	First Lien Term Loan	SOFR+	5.50%	10.70%		7/14/2023		129		129		129		(6)(15)
CircusTrix Holdings, LLC	Leisure Facilities	First Lien Term Loan	SOFR+	5.50%	10.70%		1/16/2024		1,084		1,103		1,084		(6)(15)
CircusTrix Holdings, LLC	Leisure Facilities	First Lien Term Loan	SOFR+	5.50%	10.70%		1/16/2024		9,002		9,003		9,002		(6)(15)
Clear Channel Outdoor Holdings, Inc.	Advertising	Fixed Rate Bond			7.50%		6/1/2029		2,632		2,632		1,951		(11)
Clear Channel Outdoor Holdings, Inc.	Advertising	Fixed Rate Bond			7.75%		4/15/2028		176		170		138		(11)
Condor Merger Sub Inc.	Systems Software	Fixed Rate Bond			7.38%		2/15/2030		8,420		8,257		7,330
Continental Intermodal Group LP	Oil & Gas Storage & Transportation	First Lien Term Loan	L+	8.50%	13.69%		1/28/2025		24,350		23,525		21,506		(6)(15)
Continental Intermodal Group LP	Oil & Gas Storage & Transportation	Warrants									706		154		(15)

8

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
Convergeone Holdings, Inc.	IT Consulting & Other Services	First Lien Term Loan	L+	5.00%	10.37%		1/4/2026		$	17,506	$	15,434	$	11,176	(6)
Conviva Inc.	Application Software	Preferred Equity						417,851			605		894		(15)
CorEvitas, LLC	Health Care Technology	First Lien Term Loan	SOFR+	6.13%	11.33%		12/13/2025		13,671		13,633		13,408		(6)(15)
CorEvitas, LLC	Health Care Technology	First Lien Term Loan	SOFR+	6.13%	11.33%		12/13/2025		4,903		4,853		4,809		(6)(15)
CorEvitas, LLC	Health Care Technology	First Lien Revolver	PRIME+	5.75%	14.00%		12/13/2025		1,250		1,226		1,202		(6)(15)(19)
CorEvitas, LLC	Health Care Technology	Common Stock						1,500			1,574		3,299		(15)
Coupa Holdings, LLC	Application Software	First Lien Term Loan	SOFR+	7.50%	12.60%		2/27/2030		13,157		12,843		12,852		(6)(15)
Coupa Holdings, LLC	Application Software	First Lien Term Loan	SOFR+	7.50%			2/27/2030		—		(15)		(14)		(6)(15)(19)
Coupa Holdings, LLC	Application Software	First Lien Revolver	SOFR+	7.50%			2/27/2029		—		(21)		(21)		(6)(15)(19)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.24%		10/13/2029		14,787		14,186		13,807		(6)
Coyote Buyer, LLC	Specialty Chemicals	First Lien Term Loan	L+	6.00%	11.10%		2/6/2026		18,060		17,715		17,706		(6)(15)
Coyote Buyer, LLC	Specialty Chemicals	First Lien Revolver	SOFR+	6.00%	11.20%		2/6/2025		533		520		507		(6)(15)(19)
CPC Acquisition Corp.	Specialty Chemicals	Second Lien Term Loan	SOFR+	7.75%			12/29/2028		727		462		325		(6)(15)(20)
Delta Leasing SPV II LLC	Specialized Finance	Subordinated Debt Term Loan			3.00%	7.00%	8/31/2029		13,043		13,043		13,043		(11)(15)(19)
Delta Leasing SPV II LLC	Specialized Finance	Preferred Equity						419			419		419		(11)(15)
Delta Leasing SPV II LLC	Specialized Finance	Common Stock						2			2		2		(11)(15)
Delta Leasing SPV II LLC	Specialized Finance	Warrants						31			—		—		(11)(15)
Dialyze Holdings, LLC	Health Care Equipment	First Lien Term Loan	SOFR+	9.00%	14.42%		8/4/2026		20,757		20,092		20,705		(6)(15)
Dialyze Holdings, LLC	Health Care Equipment	Subordinated Debt Term Loan				8.00%	9/30/2027		641		640		611		(15)
Dialyze Holdings, LLC	Health Care Equipment	Warrants						6,397,254			1,642		1,215		(15)
Digital.AI Software Holdings, Inc.	Application Software	First Lien Term Loan	SOFR+	7.00%	12.34%		2/10/2027		12,418		12,226		12,120		(6)(15)
Digital.AI Software Holdings, Inc.	Application Software	First Lien Revolver	SOFR+	6.75%	12.09%		2/10/2027		204		184		172		(6)(15)(19)
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.22%		8/2/2027		4,769		4,687		4,672		(6)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.80%		4/26/2029		4,963		4,879		4,632		(6)
Eagleview Technology Corporation	Application Software	Second Lien Term Loan	L+	7.50%	13.04%		8/14/2026		8,974		8,884		7,359		(6)(15)
EOS Fitness Opco Holdings, LLC	Leisure Facilities	Preferred Equity						488			488		1,160		(15)
EOS Fitness Opco Holdings, LLC	Leisure Facilities	Common Stock						12,500			—		—		(15)
Establishment Labs Holdings Inc.	Health Care Technology	First Lien Term Loan			3.00%	6.00%	4/21/2027		10,899		10,779		10,463		(11)(15)
Establishment Labs Holdings Inc.	Health Care Technology	First Lien Term Loan			3.00%	6.00%	4/21/2027		1,746		1,720		1,676		(11)(15)
Establishment Labs Holdings Inc.	Health Care Technology	First Lien Term Loan			3.00%	6.00%	4/21/2027		—		1		—		(11)(15)(19)
Establishment Labs Holdings Inc.	Health Care Technology	First Lien Term Loan			3.00%	6.00%	4/21/2027		—		1		—		(11)(15)(19)
Fairbridge Strategic Capital Funding LLC	Real Estate Operating Companies	First Lien Term Loan			9.00%		12/24/2028		52,658		52,658		52,658		(15)(19)
Fairbridge Strategic Capital Funding LLC	Real Estate Operating Companies	Warrants						2,500			—		3		(11)(15)
FINThrive Software Intermediate Holdings, Inc.	Health Care Technology	Second Lien Term Loan	L+	6.75%	11.94%		12/17/2029		31,074		29,063		18,664		(6)
Fortress Biotech, Inc.	Biotechnology	First Lien Term Loan			11.00%		8/27/2025		11,918		11,572		11,173		(11)(15)
Fortress Biotech, Inc.	Biotechnology	Warrants						417,011			427		113		(11)(15)
Frontier Communications Holdings, LLC	Integrated Telecommunication Services	Fixed Rate Bond			6.00%		1/15/2030		4,881		4,456		3,595		(11)
Galileo Parent, Inc.	Aerospace & Defense	First Lien Term Loan	SOFR+	7.25%	12.34%		5/3/2029		23,774		23,080		23,094		(6)(15)
Galileo Parent, Inc.	Aerospace & Defense	First Lien Revolver	SOFR+	7.25%	12.34%		5/3/2029		1,638		1,530		1,532		(6)(15)(19)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.25%		8/11/2028		2,463		2,039		1,995		(6)(15)

9

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
GoldenTree Loan Management EUR CLO 2 DAC	Multi-Sector Holdings	CLO Notes	E+	2.85%	6.05%		1/20/2032		€	1,000	$	872	$	970	(6)(11)
Grove Hotel Parcel Owner, LLC	Hotels, Resorts & Cruise Lines	First Lien Term Loan	SOFR+	8.00%	13.39%		6/21/2027		$	17,488	17,308		17,314		(6)(15)
Grove Hotel Parcel Owner, LLC	Hotels, Resorts & Cruise Lines	First Lien Term Loan	SOFR+	8.00%			6/21/2027		—		(58)		(35)		(6)(15)(19)
Grove Hotel Parcel Owner, LLC	Hotels, Resorts & Cruise Lines	First Lien Revolver	SOFR+	8.00%			6/21/2027		—		(29)		(18)		(6)(15)(19)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.45%		4/9/2029		14,383		13,885		12,352		(6)
Harrow Health, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	6.50%	11.74%		1/19/2026		7,448		7,279		7,295		(6)(11)(15)
Harrow Health, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	6.50%			1/19/2026		—		(91)		(83)		(6)(11)(15)(19)
Horizon Aircraft Finance I Ltd.	Specialized Finance	CLO Notes			4.46%		12/15/2038		6,932		5,577		6,001		(11)
IAMGOLD Corporation	Gold	Second Lien Term Loan	SOFR+	8.25%	13.30%		5/16/2028		23,975		23,274		23,292		(6)(11)(15)
iCIMs, Inc.	Application Software	First Lien Term Loan	SOFR+	7.25%	8.50%	3.88%	8/18/2028		24,188		23,876		23,235		(6)(15)
iCIMs, Inc.	Application Software	First Lien Term Loan	SOFR+	7.25%	12.38%		8/18/2028		3,636		3,600		3,563		(6)(15)
iCIMs, Inc.	Application Software	First Lien Term Loan	SOFR+	7.25%			8/18/2028		—		—		—		(6)(15)(19)
iCIMs, Inc.	Application Software	First Lien Revolver	SOFR+	6.75%	11.99%		8/18/2028		377		331		288		(6)(15)(19)
Impel Neuropharma, Inc.	Health Care Technology	First Lien Term Loan					2/15/2031		15,302		15,341		14,269		(15)(22)
Impel Neuropharma, Inc.	Health Care Technology	First Lien Term Loan	SOFR+	8.75%	14.14%		3/17/2027		13,109		12,939		12,617		(6)(15)
Innocoll Pharmaceuticals Limited	Health Care Technology	First Lien Term Loan			11.00%		1/26/2027		8,452		8,185		7,730		(11)(15)
Innocoll Pharmaceuticals Limited	Health Care Technology	First Lien Term Loan			11.00%		1/26/2027		—		—		—		(11)(15)(19)
Innocoll Pharmaceuticals Limited	Health Care Technology	First Lien Term Loan			11.00%		1/26/2027		—		—		—		(11)(15)(19)
Innocoll Pharmaceuticals Limited	Health Care Technology	Warrants						112,990			300		172		(11)(15)
Integral Development Corporation	Diversified Financial Services	Warrants						1,078,284			113		—		(15)
Inventus Power, Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	7.50%	12.72%		6/30/2025		33,498		32,494		32,493		(6)(15)
Inventus Power, Inc.	Electrical Components & Equipment	First Lien Revolver	SOFR+	7.50%			6/30/2025		—		(114)		(114)		(6)(15)(19)
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	L+	5.75%	11.29%		3/25/2027		45,169		43,394		35,834		(6)(15)
IPC Corp.	Application Software	First Lien Term Loan	SOFR+	6.50%	11.57%		10/1/2026		40,484		39,779		38,662		(6)(15)
Ivanti Software, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	12.42%		12/1/2028		13,939		12,601		9,252		(6)
Jazz Acquisition, Inc.	Aerospace & Defense	First Lien Term Loan	SOFR+	7.50%	12.70%		1/29/2027		17,069		17,053		16,966		(6)(15)
Jazz Acquisition, Inc.	Aerospace & Defense	First Lien Term Loan	SOFR+	7.50%	12.70%		1/29/2027		27,360		26,872		27,488		(6)(15)
Jazz Acquisition, Inc.	Aerospace & Defense	First Lien Term Loan	SOFR+	5.50%	10.60%		1/29/2027		15,150		14,331		14,924		(6)(15)
Jazz Acquisition, Inc.	Aerospace & Defense	Second Lien Term Loan	SOFR+	8.00%	13.20%		6/18/2027		666		616		652		(6)
Kings Buyer, LLC	Environmental & Facilities Services	First Lien Term Loan	SOFR+	6.50%	11.84%		10/29/2027		16,765		16,636		16,511		(6)(15)
Kings Buyer, LLC	Environmental & Facilities Services	First Lien Revolver	SOFR+	6.50%	11.84%		10/29/2027		545		517		510		(6)(15)(19)
Latam Airlines Group S.A.	Passenger Airlines	First Lien Term Loan	SOFR+	9.50%	14.61%		10/12/2027		26,489		24,888		26,985		(6)(11)
Lift Brands Holdings, Inc.	Leisure Facilities	Common Stock						2,000,000			1,399		—		(15)
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	10.50%		5/9/2026		45,361		44,783		44,227		(6)(15)
Liquid Environmental Solutions Corporation	Environmental & Facilities Services	Second Lien Term Loan	SOFR+	8.50%	13.84%		11/30/2026		5,403		5,344		5,173		(6)(15)
Liquid Environmental Solutions Corporation	Environmental & Facilities Services	Second Lien Term Loan	SOFR+	8.50%	13.84%		11/30/2026		2,939		2,883		2,755		(6)(15)(19)

10

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
Liquid Environmental Solutions Corporation	Environmental & Facilities Services	Common Stock						559			$	563	$	487	(15)
LSL Holdco, LLC	Health Care Distributors	First Lien Term Loan	SOFR+	6.00%	11.20%		1/31/2028		$	2,742	2,594		2,592		(6)(15)
LSL Holdco, LLC	Health Care Distributors	First Lien Term Loan	SOFR+	6.00%	11.20%		1/31/2028		23,554		23,166		22,258		(6)(15)
LSL Holdco, LLC	Health Care Distributors	First Lien Revolver	SOFR+	6.00%			1/31/2028		—		(44)		(146)		(6)(15)(19)
LTI Holdings, Inc.	Electronic Components	Second Lien Term Loan	SOFR+	6.75%	11.97%		9/6/2026		2,140		2,101		1,834		(6)
Marinus Pharmaceuticals, Inc.	Pharmaceuticals	First Lien Term Loan			11.50%		5/11/2026		8,568		8,488		8,225		(11)(15)
Marinus Pharmaceuticals, Inc.	Pharmaceuticals	First Lien Term Loan			11.50%		5/11/2026		4,284		4,244		4,112		(11)(15)
Marinus Pharmaceuticals, Inc.	Pharmaceuticals	First Lien Term Loan			11.50%		5/11/2026		8,568		8,488		8,225		(11)(15)
Marinus Pharmaceuticals, Inc.	Pharmaceuticals	First Lien Term Loan			11.50%		5/11/2026		—		—		—		(11)(15)(19)
Mesoblast, Inc.	Biotechnology	First Lien Term Loan			8.00%	1.75%	11/19/2026		9,066		8,496		8,114		(11)(15)
Mesoblast, Inc.	Biotechnology	First Lien Term Loan			8.00%	1.75%	11/19/2026		—		1		—		(11)(15)(19)
Mesoblast, Inc.	Biotechnology	First Lien Term Loan			8.00%	1.75%	11/19/2026		—		—		—		(11)(15)(19)
Mesoblast, Inc.	Biotechnology	Warrants						259,877			545		437		(11)(15)
Mesoblast, Inc.	Biotechnology	Warrants						66,817			23		153		(11)(15)
MHE Intermediate Holdings, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	6.00%	11.20%		7/21/2027		20,176		19,949		19,648		(6)(15)
MHE Intermediate Holdings, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	6.00%	11.20%		7/21/2027		2,637		2,594		2,568		(6)(15)
MHE Intermediate Holdings, LLC	Diversified Support Services	First Lien Revolver	SOFR+	6.00%	11.25%		7/21/2027		250		220		203		(6)(15)(19)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	12.19%		2/14/2025		7,464		7,416		7,352		(6)(15)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	12.19%		2/14/2025		46,687		46,157		45,987		(6)(15)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	L+	7.00%			2/14/2025		—		(51)		(71)		(6)(15)(19)
MND Holdings III Corp	Other Specialty Retail	First Lien Term Loan	SOFR+	7.50%	12.74%		5/9/2028		40,640		39,937		39,937		(6)(15)
MND Holdings III Corp	Other Specialty Retail	First Lien Revolver	SOFR+	7.50%	12.58%		5/9/2028		2,118		1,853		1,853		(6)(15)(19)
Mosaic Companies, LLC	Home Improvement Retail	First Lien Term Loan	L+	6.75%	11.97%		7/2/2026		55,297		54,939		54,235		(6)(15)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026		12,397		12,357		12,056		(6)(15)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026		21,383		21,055		20,795		(6)(15)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.83%		2/10/2026		570		559		526		(6)(15)(19)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026		—		(29)		(62)		(6)(15)(19)
Navisite, LLC	Data Processing & Outsourced Services	Second Lien Term Loan	L+	8.50%	14.04%		12/30/2026		30,339		30,002		29,125		(6)(15)
NeuAG, LLC	Fertilizers & Agricultural Chemicals	First Lien Term Loan	L+	10.50%	16.04%		9/11/2024		64,606		64,750		63,185		(6)(15)
NFP Corp.	Diversified Financial Services	Fixed Rate Bond			6.88%		8/15/2028		10,191		9,816		8,860
NN, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	6.88%	12.08%	2.00%	9/19/2026		73,178		72,195		69,885		(6)(11)(15)
NN, Inc.	Industrial Machinery & Supplies & Components	Warrants						487,870	—		—		1,161		(11)(15)
NN, Inc.	Industrial Machinery & Supplies & Components	Warrants						487,870	—		—		1,161		(11)(15)
OEConnection LLC	Application Software	Second Lien Term Loan	SOFR+	7.00%	12.34%		9/25/2027		9,323		9,203		9,090		(6)(15)
Oranje Holdco, Inc.	Systems Software	First Lien Term Loan	SOFR+	7.75%	12.79%		2/1/2029		15,231		$	14,876	$	14,882	(6)(15)
Oranje Holdco, Inc.	Systems Software	First Lien Revolver	SOFR+	7.75%			2/1/2029		—		(44)		(44)		(6)(15)(19)
OTG Management, LLC	Airport Services	First Lien Term Loan	L+	10.00%	15.50%		9/2/2025		25,712		25,603		25,712		(6)(15)
OTG Management, LLC	Airport Services	First Lien Term Loan	L+	10.00%			9/2/2025		—		(13)		—		(6)(15)(19)
OTG Management, LLC	Airport Services	First Lien Term Loan	L+	10.00%	15.39%		9/2/2025		1,210		1,192		1,210		(6)(15)(19)
P & L Development, LLC	Pharmaceuticals	Fixed Rate Bond			7.75%		11/15/2025		7,480		7,514		6,090

11

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	10.20%		11/10/2027		$	9,701	$	9,535	$	9,458	(6)
Performance Health Holdings, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	6.00%	10.96%		7/12/2027		22,375		22,177		21,829		(6)(15)
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.59%		12/18/2028		36,499		35,427		32,606		(6)(15)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.04%		4/6/2027		67,244		66,290		64,756		(6)(15)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.04%		4/6/2027		2,395		2,312		2,218		(6)(15)(19)
PPW Aero Buyer, Inc.	Aerospace & Defense	First Lien Term Loan	SOFR+	7.00%	12.10%		2/15/2029		10,923		10,513		10,497		(6)(15)
PPW Aero Buyer, Inc.	Aerospace & Defense	First Lien Revolver	SOFR+	7.00%			2/15/2029		—		(55)		(57)		(6)(15)(19)
PRGX Global, Inc.	Data Processing & Outsourced Services	First Lien Term Loan	L+	6.50%	11.73%		3/3/2026		38,521		38,018		38,205		(6)(15)
PRGX Global, Inc.	Data Processing & Outsourced Services	First Lien Revolver	L+	6.50%			3/3/2026		—		(37)		(26)		(6)(15)(19)
PRGX Global, Inc.	Data Processing & Outsourced Services	Common Stock						100,000			109		221		(15)
Profrac Holdings II, LLC	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	7.25%	12.42%		3/4/2025		24,537		24,245		24,047		(6)(15)
Profrac Holdings II, LLC	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	7.25%	12.42%		3/4/2025		2,823		2,797		2,767		(6)(15)
Project Boost Purchaser, LLC	Application Software	Second Lien Term Loan	SOFR+	8.00%	13.22%		5/31/2027		6,750		6,652		6,235		(6)(15)
Quantum Bidco Limited	Food Distributors	First Lien Term Loan	SONIA+	5.68%	10.88%		1/31/2028		£	4,626	5,900		5,296		(6)(11)(15)
QuorumLabs, Inc.	Application Software	Preferred Equity						64,887,669			375		—		(15)
Relativity ODA LLC	Application Software	First Lien Term Loan	SOFR+	7.50%	11.70%		5/12/2027		$	32,329	32,052		31,715		(6)(15)
Relativity ODA LLC	Application Software	First Lien Revolver	SOFR+	6.50%			5/12/2027		—		(46)		(52)		(6)(15)(19)
Renaissance Holding Corp.	Education Services	Second Lien Term Loan	L+	7.00%	12.19%		5/29/2026		1,789		1,775		1,764		(6)
RumbleOn, Inc.	Automotive Retail	First Lien Term Loan	SOFR+	8.25%	13.75%		8/31/2026		44,602		43,077		41,815		(6)(11)(15)
RumbleOn, Inc.	Automotive Retail	First Lien Term Loan	SOFR+	8.25%	13.75%		8/31/2026		13,495		13,010		12,651		(6)(11)(15)
RumbleOn, Inc.	Automotive Retail	Warrants						204,454			1,202		—		(11)(15)
Salus Workers' Compensation, LLC	Diversified Financial Services	First Lien Term Loan	SOFR+	10.00%	15.24%		10/7/2026		25,558		24,711		24,791		(6)(15)
Salus Workers' Compensation, LLC	Diversified Financial Services	First Lien Revolver	SOFR+	10.00%			10/7/2026		—		(103)		(93)		(6)(15)(19)
Salus Workers' Compensation, LLC	Diversified Financial Services	Warrants						991,019			327		1,883		(15)
Scilex Holding Co	Biotechnology	Common Stock						9,307			78		52		(11)
SCP Eye Care Services, LLC	Health Care Services	Second Lien Term Loan	SOFR+	8.75%	14.00%		10/7/2030		8,010		7,792		7,770		(6)(15)
SCP Eye Care Services, LLC	Health Care Services	Second Lien Term Loan	SOFR+	8.75%			10/7/2030		—		(35)		(71)		(6)(15)(19)
SCP Eye Care Services, LLC	Health Care Services	Common Stock						1,037			1,037		1,024		(15)
scPharmaceuticals Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	8.75%	11.75%		10/13/2027		5,212		4,973		5,034		(6)(15)
scPharmaceuticals Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	8.75%			10/13/2027		—		—		—		(6)(15)(19)
scPharmaceuticals Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	8.75%			10/13/2027		—		—		—		(6)(15)(19)
scPharmaceuticals Inc.	Pharmaceuticals	Warrants						53,700			175		407		(15)
Seres Therapeutics, Inc.	Biotechnology	First Lien Term Loan	SOFR+	7.88%	12.95%		4/27/2029		7,191		6,923		6,931		(6)(11)(15)
Seres Therapeutics, Inc.	Biotechnology	First Lien Term Loan	SOFR+	7.88%	12.88%		4/27/2029		2,697		2,596		2,599		(6)(11)(15)
Seres Therapeutics, Inc.	Biotechnology	First Lien Term Loan	SOFR+	7.88%			4/27/2029		—		—		—		(6)(11)(15)(19)
Seres Therapeutics, Inc.	Biotechnology	First Lien Term Loan	SOFR+	7.88%			4/27/2029		—		—		—		(6)(11)(15)(19)
Seres Therapeutics, Inc.	Biotechnology	Warrants						58,210			182		202		(11)(15)
ShareThis, Inc.	Application Software	Warrants						345,452			367		—		(15)
SiO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan				14.00%	12/21/2026		54,730		41,705		25,997		(15)(20)
SiO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan				14.00%	7/27/2023		14,993		11,582		13,923		(15)(20)
SiO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan			14.00%		7/27/2023		4,813		3,935		4,034		(15)(19)(20)
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	Warrants						491			727		—		(15)

12

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.75%	9.97%		4/17/2028		$	4,463	$	3,780	$	4,139	(6)(15)
SM Wellness Holdings, Inc.	Health Care Services	Second Lien Term Loan	SOFR+	8.00%	13.22%		4/16/2029		12,034		11,220		9,387		(6)(15)
SonicWall US Holdings Inc.	Technology Distributors	Second Lien Term Loan	L+	7.50%	12.69%		5/18/2026		1,095		1,084		1,024		(6)(15)
Sorenson Communications, LLC	Communications Equipment	First Lien Term Loan	L+	5.50%	10.69%		3/17/2026		1,054		1,053		980		(6)
Sorrento Therapeutics, Inc.	Biotechnology	Common Stock						66,000			139		24		(11)
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.50%	10.70%		11/20/2028		4,500		4,431		4,393		(6)(15)
Spanx, LLC	Apparel Retail	First Lien Revolver	L+	5.25%	10.35%		11/18/2027		907		862		837		(6)(15)(19)
SumUp Holdings Luxembourg S.À.R.L.	Diversified Financial Services	First Lien Term Loan	E+	8.50%	11.97%		3/10/2026		€	23,731	26,829		25,632		(6)(11)(15)
Superior Industries International, Inc.	Auto Parts & Equipment	First Lien Term Loan	SOFR+	7.75%	12.85%		12/16/2028		$	49,645	48,611		49,128		(6)(15)
Supreme Fitness Group NY Holdings, LLC	Leisure Facilities	First Lien Term Loan	SOFR+	7.00%	12.18%		12/31/2026		32,185		31,923		30,495		(6)(15)(21)
Supreme Fitness Group NY Holdings, LLC	Leisure Facilities	First Lien Term Loan	SOFR+	7.00%	12.18%		12/31/2026		2,756		2,728		2,593		(6)(15)(19)(21)
Supreme Fitness Group NY Holdings, LLC	Leisure Facilities	First Lien Term Loan	SOFR+	7.00%	12.18%		12/31/2026		1,099		1,059		926		(6)(15)(19)(21)
Supreme Fitness Group NY Holdings, LLC	Leisure Facilities	First Lien Revolver	SOFR+	7.00%	12.18%		12/31/2026		1,552		1,539		1,471		(6)(15)(21)
SVP-Singer Holdings Inc.	Home Furnishings	First Lien Term Loan	L+	6.75%	12.29%		7/28/2028		25,592		23,832		19,514		(6)(15)
Swordfish Merger Sub LLC	Auto Parts & Equipment	Second Lien Term Loan	L+	6.75%	11.94%		2/2/2026		12,500		12,480		11,681		(6)(15)
Tacala, LLC	Restaurants	Second Lien Term Loan	L+	7.50%	12.69%		2/4/2028		12,843		12,589		12,168		(6)
Tahoe Bidco B.V.	Application Software	First Lien Term Loan	L+	6.00%	11.15%		9/29/2028		28,826		28,583		28,537		(6)(11)(15)
Tahoe Bidco B.V.	Application Software	First Lien Revolver	L+	6.00%			10/1/2027		—		(31)		(24)		(6)(11)(15)(19)
Tecta America Corp.	Construction & Engineering	Second Lien Term Loan	SOFR+	8.50%	13.72%		4/9/2029		4,755		4,677		4,529		(6)(15)
Telestream Holdings Corporation	Application Software	First Lien Term Loan	SOFR+	9.75%	14.99%		10/15/2025		23,483		23,239		22,919		(6)(15)
Telestream Holdings Corporation	Application Software	First Lien Revolver	SOFR+	9.75%	14.93%		10/15/2025		1,590		1,572		1,535		(6)(15)(19)
Ten-X LLC	Interactive Media & Services	First Lien Term Loan	SOFR+	6.00%	11.09%		5/26/2028		19,947		18,963		19,000		(6)(15)
TGNR HoldCo LLC	Integrated Oil & Gas	Subordinated Debt			11.50%		5/14/2026		4,984		4,887		4,810		(10)(11)(15)
THL Zinc Ventures Ltd	Diversified Metals & Mining	First Lien Term Loan			13.00%		5/23/2026		50,419		49,787		49,809		(11)(15)
Thrasio, LLC	Broadline Retail	First Lien Term Loan	SOFR+	7.00%	12.50%		12/18/2026		46,832		45,609		41,919		(6)(15)
Thrasio, LLC	Broadline Retail	Preferred Equity						10,616			120		55		(15)
Thrasio, LLC	Broadline Retail	Preferred Equity						358,299			2,912		1,526		(15)
Thrasio, LLC	Broadline Retail	Preferred Equity						60,862			1,207		795		(15)
Thrasio, LLC	Broadline Retail	Preferred Equity						32,447			33,353		36,587		(15)
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.84%		3/30/2029		17,213		15,952		16,141		(6)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.20%		12/29/2028		11,701		11,675		11,408		(6)(15)
Trinitas CLO XV DAC	Multi-Sector Holdings	CLO Notes	L+	7.45%	12.72%		4/22/2034		1,000		814		929		(6)(11)
Uniti Group LP	Other Specialized REITs	Fixed Rate Bond			6.50%		2/15/2029		4,500		4,101		3,189		(11)
Uniti Group LP	Other Specialized REITs	Fixed Rate Bond			4.75%		4/15/2028		300		263		249		(11)
Virgin Pulse, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.47%		4/6/2029		1,540		1,239		1,279		(6)(15)
Win Brands Group LLC	Housewares & Specialties	First Lien Term Loan	L+	15.00%	21.22%		1/23/2026		1,565		1,551		1,475		(6)(15)
WIN Brands Group LLC	Housewares & Specialties	First Lien Term Loan	L+	15.00%	21.22%		1/23/2026		1,323		1,311		1,247		(6)(15)
Win Brands Group LLC	Housewares & Specialties	Warrants						4,871			46		136		(15)
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.45%		9/21/2027		24,419		23,589		22,862		(6)
Windstream Services II, LLC	Integrated Telecommunication Services	Common Stock						127,452			2,057		1,565		(15)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	9.03%		4/30/2025		11,822		11,228		10,743		(6)
WPEngine, Inc.	Application Software	First Lien Term Loan	L+	6.50%	11.38%		3/27/2026		35,853		35,764		35,495		(6)(15)

13

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
WPEngine, Inc.	Application Software	First Lien Term Loan	L+	6.50%	12.00%		3/27/2026		$	19,306	$	19,258	$	19,113	(6)(15)
WWEX Uni Topco Holdings, LLC	Air Freight & Logistics	Second Lien Term Loan	SOFR+	7.00%	12.50%		7/26/2029		5,000		4,925		4,025		(6)(15)
Zep Inc.	Specialty Chemicals	Second Lien Term Loan	L+	8.25%	13.79%		8/11/2025		19,578		19,551		13,693		(6)(15)
Zephyr Bidco Limited	Specialized Finance	Second Lien Term Loan	SONIA+	7.50%	12.46%		7/23/2026		£	20,000	25,857		23,270		(6)(11)(15)
Total Non-Control/Non-Affiliate Investments (190.4% of net assets)											$	2,985,679	$	2,873,512
Total Portfolio Investments (207.7% of net assets)											$	3,296,285	$	3,135,619
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares											$	5,193	$	5,193
Other cash accounts											67,467		67,467
Total Cash and Cash Equivalents and Restricted Cash (4.8% of net assets)											$	72,660	$	72,660
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (212.5% of net assets)											$	3,368,945	$	3,208,279

14

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

Derivative Instrument	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Counterparty	Cumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract	$	78,866	€	71,658	8/10/2023	JPMorgan Chase Bank, N.A.	$	531
Foreign currency forward contract	$	71,438	£	56,556	8/10/2023	JPMorgan Chase Bank, N.A.	(482)
							$	49

Derivative Instrument	Company Receives	Company Pays	Counterparty	Maturity Date	Notional Amount	Fair Value
Interest rate swap	Fixed 2.7%	Floating 3-month LIBOR +1.658%	Royal Bank of Canada	1/15/2027	$350,000	$(39,567)

15

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

June 30, 2023

(dollar amounts in thousands)

(unaudited)

(1)All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.

(2)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.

(3)Equity ownership may be held in shares or units of companies related to the portfolio companies.

(4)Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.

(5)Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

(6)The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the London Interbank Offered Rate ("LIBOR" or "L"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of June 30, 2023, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 180-day LIBOR at 5.73%, the PRIME at 8.25%, the 30-day SOFR at 5.10%, the 90-day SOFR at 5.24%, the 180-day SOFR at 5.34%, the SONIA at 3.47%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.49% and the 180-day EURIBOR at 2.82%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(7)Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

(8)Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

(9)As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

(10)This investment represents a participation interest in the underlying securities shown.

(11)Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of June 30, 2023, qualifying assets represented 73.7% of the Company's total assets and non-qualifying assets represented 26.3% of the Company's total assets.

(12)Income producing through payment of dividends or distributions.

(13)This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.

(14)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

(15)As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

(16)This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.

(17)Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

(18)Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

(19)Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

(20)This investment was on non-accrual status as of June 30, 2023.

(21)This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

(22)This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

See notes to Consolidated Financial Statements.

16

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares		Principal (7)		Cost		Fair Value		Notes
		Control Investments														(8)(9)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						829				$	—	$	—	(15)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						34,984,460				34,984		27,638		(15)
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	L+	5.00%	8.68%		2/28/2024			$	14,333	14,333		14,333		(6)(15)
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	L+	5.00%			2/28/2024			—		—		—		(6)(15)(19)
Dominion Diagnostics, LLC	Health Care Services	Common Stock						30,031				15,222		4,946		(15)
OCSI Glick JV LLC	Multi-Sector Holdings	Subordinated Debt	L+	4.50%	6.30%		10/20/2028			59,662		50,194		50,283		(6)(11)(14)(15)(19)
OCSI Glick JV LLC	Multi-Sector Holdings	Membership Interest						87.5	%			—		—		(11)(14)(16)(19)
Senior Loan Fund JV I, LLC	Multi-Sector Holdings	Subordinated Debt	L+	7.00%	8.80%		12/29/2028			96,250		96,250		96,250		(6)(11)(14)(15)(19)
Senior Loan Fund JV I, LLC	Multi-Sector Holdings	Membership Interest						87.5	%			49,322		20,715		(11)(12)(14)(16)(19)
Total Control Investments (17.2% of net assets)												$	260,305	$	214,165
Affiliate Investments																(17)
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver	L+	6.75%	10.42%		10/17/2023			$	24,490	$	24,490	$	24,225	(6)(15)(19)
Assembled Brands Capital LLC	Specialized Finance	Common Stock						1,609,201				764		370		(15)
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity						1,019,169				1,019		1,223		(15)
Assembled Brands Capital LLC	Specialized Finance	Warrants						70,425				—		—		(15)
Caregiver Services, Inc.	Health Care Services	Preferred Equity						1,080,399				1,080		378		(15)
Total Affiliate Investments (2.1% of net assets)												$	27,353	$	26,196
Non-Control/Non-Affiliate Investments																(18)
109 Montgomery Owner LLC	Real Estate Operating Companies	First Lien Term Loan	L+	7.00%	9.80%		2/2/2023			$	389	$	387	$	727	(6)(15)
109 Montgomery Owner LLC	Real Estate Operating Companies	First Lien Term Loan	L+	7.00%			2/2/2023			—		(31)		—		(6)(15)(19)
A.T. Holdings II SÀRL	Biotechnology	First Lien Term Loan				10.50%	12/22/2022			33,997		33,960		34,891		(11)(15)
Access CIG, LLC	Diversified Support Services	Second Lien Term Loan	L+	7.75%	10.82%		2/27/2026			20,000		19,927		19,075		(6)
Accupac, Inc.	Personal Products	First Lien Term Loan	SOFR+	5.50%	9.12%		1/16/2026			15,976		15,686		15,944		(6)(15)
Accupac, Inc.	Personal Products	First Lien Term Loan	SOFR+	5.50%			1/16/2026			—		—		(6)		(6)(15)(19)
Accupac, Inc.	Personal Products	First Lien Revolver	SOFR+	5.50%	9.14%		1/16/2026			500		462		495		(6)(15)(19)
Acquia Inc.	Application Software	First Lien Term Loan	L+	7.00%	9.63%		10/31/2025			27,349		27,038		27,158		(6)(15)
Acquia Inc.	Application Software	First Lien Revolver	L+	7.00%	10.64%		10/31/2025			914		890		898		(6)(15)(19)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.25%	9.80%		12/18/2025			14,685		14,217		14,431		(6)(15)
ADC Therapeutics SA	Biotechnology	First Lien Term Loan	SOFR+	7.50%	11.20%		8/15/2029			6,589		6,256		6,262		(6)(11)(15)
ADC Therapeutics SA	Biotechnology	First Lien Term Loan	SOFR+	7.50%			8/15/2029			—		(38)		(37)		(6)(11)(15)(19)
ADC Therapeutics SA	Biotechnology	Warrants						28,948				174		73		(11)(15)
Aden & Anais Merger Sub, Inc.	Apparel, Accessories & Luxury Goods	Common Stock						51,645				5,165		—		(15)
AI Sirona (Luxembourg) Acquisition S.a.r.l.	Pharmaceuticals	Second Lien Term Loan	E+	7.25%	7.94%		9/28/2026			€	24,838	27,752		22,143		(6)(11)(15)
AIP RD Buyer Corp.	Distributors	Second Lien Term Loan	SOFR+	7.75%	10.88%		12/21/2029			$	14,414	14,154		13,910		(6)(15)
AIP RD Buyer Corp.	Distributors	Common Stock						14,410				1,352		1,291		(15)
AirStrip Technologies, Inc.	Application Software	Warrants						5,715				90		—		(15)
All Web Leads, Inc.	Advertising	First Lien Term Loan	L+	8.50%		11.64%	12/29/2023			23,338		22,057		22,141		(6)(15)

17

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
Altice France S.A.	Integrated Telecommunication Services	Fixed Rate Bond			5.50%		10/15/2029		$	4,050	$	3,518	$	3,057	(11)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	11.20%		6/30/2025		13,134		12,847		13,068		(6)(15)
Alvotech Holdings S.A.	Biotechnology	Fixed Rate Bond			10.00%		6/24/2025		24,043		23,747		23,923		(11)(15)
Alvotech Holdings S.A.	Biotechnology	Fixed Rate Bond			10.00%		6/24/2025		23,522		23,264		23,404		(11)(15)
Alvotech Holdings S.A.	Biotechnology	Common Stock						587,930			5,308		3,974		(11)
Alvotech Holdings S.A.	Biotechnology	Common Stock						124,780			485		212		(11)(13)(15)
American Auto Auction Group, LLC	Consumer Finance	Second Lien Term Loan	SOFR+	8.75%	12.30%		1/2/2029		14,760		14,492		13,284		(6)(15)
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	L+	6.25%	9.03%		10/20/2028		9,895		9,772		9,293		(6)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	L+	4.25%	7.92%		11/26/2026		15,220		13,973		14,687		(6)(11)(15)
Amplify Finco Pty Ltd.	Movies & Entertainment	Second Lien Term Loan	L+	8.00%	11.67%		11/26/2027		12,500		12,188		11,958		(6)(11)(15)
Anastasia Parent, LLC	Personal Products	First Lien Term Loan	L+	3.75%	7.42%		8/11/2025		2,736		2,260		2,189		(6)
Ankura Consulting Group LLC	Research & Consulting Services	Second Lien Term Loan	L+	8.00%	10.78%		3/19/2029		4,346		4,281		3,813		(6)(15)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.46%		1/10/2025		34,458		33,737		33,738		(6)(15)
Apptio, Inc.	Application Software	First Lien Revolver	L+	6.00%	8.46%		1/10/2025		892		863		846		(6)(15)(19)
APX Group Inc.	Electrical Components & Equipment	Fixed Rate Bond			5.75%		7/15/2029		2,075		1,733		1,645		(11)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	E+	7.00%	8.00%		7/14/2026		€	1,964	2,176		1,927		(6)(11)(15)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	SONIA+	7.00%	9.19%		7/14/2026		£	18,636	23,139		20,826		(6)(11)(15)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	L+	5.75%	8.81%		7/14/2026		$	10,519	10,357		10,328		(6)(11)(15)
Ardonagh Midco 3 PLC	Insurance Brokers	First Lien Term Loan	SONIA+	5.75%			7/14/2026		£	—	(44)		—		(6)(11)(15)(19)
ASP Unifrax Holdings, Inc.	Trading Companies & Distributors	Fixed Rate Bond			7.50%		9/30/2029		$	5,500	5,408		3,641
ASP Unifrax Holdings, Inc.	Trading Companies & Distributors	Fixed Rate Bond			5.25%		9/30/2028		2,500		2,220		1,926
Associated Asphalt Partners, LLC	Construction Materials	First Lien Term Loan	L+	5.25%	8.06%		4/5/2024		2,501		2,331		1,934		(6)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	8.37%		10/25/2028		5,640		5,482		4,822		(6)
athenahealth Group Inc.	Health Care Technology	Preferred Equity						18,635			18,264		16,575		(15)
Athenex, Inc.	Pharmaceuticals	First Lien Term Loan			11.00%		6/19/2026		13,346		12,929		12,812		(11)(15)
Athenex, Inc.	Pharmaceuticals	First Lien Term Loan					5/31/2031		8,309		8,264		8,309		(11)(15)(21)
Athenex, Inc.	Pharmaceuticals	Warrants						328,149			973		16		(11)(15)
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	8.78%		12/24/2026		22,425		22,086		21,326		(6)(11)(15)
The Avery	Real Estate Operating Companies	First Lien Term Loan	L+	7.30%	10.44%		2/17/2023		15,674		15,605		15,682		(6)(15)
The Avery	Real Estate Operating Companies	Subordinated Debt Term Loan	L+	12.50%	16.17%		2/17/2023		3,789		3,774		3,800		(6)(15)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027		2,546		2,503		2,395		(6)(15)(19)
BAART Programs, Inc.	Health Care Services	Second Lien Term Loan	L+	8.50%	11.62%		6/11/2028		7,166		7,059		6,915		(6)(15)
BAART Programs, Inc.	Health Care Services	Second Lien Term Loan	L+	8.50%	11.62%		6/11/2028		4,227		4,070		3,839		(6)(15)(19)
Berner Food & Beverage, LLC	Soft Drinks	First Lien Term Loan	L+	5.50%	8.31%		7/30/2027		33,078		32,612		32,053		(6)(15)
Berner Food & Beverage, LLC	Soft Drinks	First Lien Revolver	PRIME+	4.50%	10.75%		7/30/2026		1,702		1,660		1,617		(6)(15)(19)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan			10.25%		4/19/2027		5,322		5,111		5,114		(11)(15)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan			10.25%		4/19/2027		—		—		—		(11)(15)(19)
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan					9/30/2032		2,353		2,353		2,353		(11)(15)(21)

18

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
BioXcel Therapeutics, Inc.	Pharmaceuticals	First Lien Term Loan					9/30/2032		$	—	$	—	$	—	(11)(15)(19)(21)
BioXcel Therapeutics, Inc.	Pharmaceuticals	Warrants						21,177			125		98		(11)(15)
Blackhawk Network Holdings, Inc.	Data Processing & Outsourced Services	Second Lien Term Loan	L+	7.00%	9.50%		6/15/2026		30,625		30,276		29,017		(6)
Blumenthal Temecula, LLC	Automotive Retail	First Lien Term Loan			9.00%		9/24/2023		3,979		3,980		3,960		(15)
Blumenthal Temecula, LLC	Automotive Retail	Preferred Equity						1,293,324			1,293		1,280		(15)
Blumenthal Temecula, LLC	Automotive Retail	Preferred Equity						298,460			298		295		(15)
Blumenthal Temecula, LLC	Automotive Retail	Common Stock						298,460			298		349		(15)
Cadence Aerospace, LLC	Aerospace & Defense	First Lien Term Loan	L+	6.50%	9.31%	2.00%	11/14/2023		14,294		13,471		13,143		(6)(15)
Carvana Co.	Automotive Retail	Fixed Rate Bond			5.63%		10/1/2025		6,700		5,825		4,724		(11)
CCO Holdings LLC	Cable & Satellite	Fixed Rate Bond			4.50%		5/1/2032		2,097		1,746		1,603		(11)
CircusTrix Holdings, LLC	Leisure Facilities	First Lien Term Loan	L+	5.50%	8.62%		7/16/2023		10,692		10,004		10,209		(6)(15)
CITGO Holding, Inc.	Oil & Gas Refining & Marketing	Fixed Rate Bond			9.25%		8/1/2024		7,857		7,857		7,807
CITGO Petroleum Corp.	Oil & Gas Refining & Marketing	First Lien Term Loan	L+	6.25%	9.37%		3/28/2024		795		770		797		(6)
Clear Channel Outdoor Holdings, Inc.	Advertising	Fixed Rate Bond			7.50%		6/1/2029		4,311		4,311		3,132		(11)
Clear Channel Outdoor Holdings, Inc.	Advertising	Fixed Rate Bond			5.13%		8/15/2027		1,374		1,229		1,163		(11)
Clear Channel Outdoor Holdings, Inc.	Advertising	Fixed Rate Bond			7.75%		4/15/2028		676		648		512		(11)
Condor Merger Sub Inc.	Systems Software	Fixed Rate Bond			7.38%		2/15/2030		8,420		8,243		6,900
Continental Intermodal Group LP	Oil & Gas Storage & Transportation	First Lien Term Loan	L+	8.50%	11.62%		1/28/2025		22,537		21,642		20,396		(6)(15)
Continental Intermodal Group LP	Oil & Gas Storage & Transportation	Warrants									648		457		(15)
Convergeone Holdings, Inc.	IT Consulting & Other Services	First Lien Term Loan	L+	5.00%	8.12%		1/4/2026		11,913		11,697		8,596		(6)
Conviva Inc.	Application Software	Preferred Equity						417,851			605		894		(15)
CorEvitas, LLC	Health Care Technology	First Lien Term Loan	SOFR+	5.75%	8.88%		12/13/2025		13,712		13,554		13,583		(6)(15)
CorEvitas, LLC	Health Care Technology	First Lien Revolver	PRIME+	4.75%	11.00%		12/13/2025		916		898		898		(6)(15)(19)
CorEvitas, LLC	Health Care Technology	Common Stock						1,099			690		2,340		(15)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	7.65%		10/13/2029		10,336		9,716		9,681		(6)
Coyote Buyer, LLC	Specialty Chemicals	First Lien Term Loan	L+	6.00%	8.81%		2/6/2026		18,200		17,790		17,843		(6)(15)
Coyote Buyer, LLC	Specialty Chemicals	First Lien Revolver	L+	6.00%			2/6/2025		—		(13)		(26)		(6)(15)(19)
Delivery Hero FinCo LLC	Internet & Direct Marketing Retail	First Lien Term Loan	SOFR+	5.75%	8.49%		8/12/2027		4,988		4,882		4,757		(6)(11)
Delta Leasing SPV II LLC	Specialized Finance	Subordinated Debt Term Loan			10.00%		8/31/2029		4,183		4,183		4,183		(11)(15)(19)
Delta Leasing SPV II LLC	Specialized Finance	Preferred Equity						419			419		419		(11)(15)
Delta Leasing SPV II LLC	Specialized Finance	Common Stock						2			2		2		(11)(15)
Delta Leasing SPV II LLC	Specialized Finance	Warrants						31			—		—		(11)(15)
Delta Topco, Inc.	Systems Software	Second Lien Term Loan	L+	7.25%	9.34%		12/1/2028		6,680		6,647		5,934		(6)
Dialyze Holdings, LLC	Health Care Equipment	First Lien Term Loan	L+	9.00%	12.67%	2.00%	8/4/2026		24,396		23,083		22,993		(6)(15)
Dialyze Holdings, LLC	Health Care Equipment	First Lien Term Loan	L+	9.00%			8/4/2026		—		(135)		(129)		(6)(15)(19)
Dialyze Holdings, LLC	Health Care Equipment	Warrants						5,403,823			1,405		1,297		(15)
Digital.AI Software Holdings, Inc.	Application Software	First Lien Term Loan	L+	7.00%	9.91%		2/10/2027		9,902		9,599		9,793		(6)(15)
Digital.AI Software Holdings, Inc.	Application Software	First Lien Revolver	L+	6.50%	9.41%		2/10/2027		251		228		239		(6)(15)(19)

19

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	L+	5.00%	8.12%		8/2/2027		$	19,242	$	18,970	$	17,973	(6)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	7.33%		4/26/2029		5,000		4,906		4,760		(6)
Eagleview Technology Corporation	Application Software	Second Lien Term Loan	L+	7.50%	11.17%		8/14/2026		8,974		8,884		8,503		(6)(15)
EOS Fitness Opco Holdings, LLC	Leisure Facilities	Preferred Equity						488			488		966		(15)
EOS Fitness Opco Holdings, LLC	Leisure Facilities	Common Stock						12,500			—		—		(15)
Establishment Labs Holdings Inc.	Health Care Technology	First Lien Term Loan			3.00%	6.00%	4/21/2027		10,418		10,275		10,231		(11)(15)
Establishment Labs Holdings Inc.	Health Care Technology	First Lien Term Loan			3.00%		4/21/2027		—		3		—		(11)(15)(19)
Fairbridge Strategic Capital Funding LLC	Real Estate Operating Companies	First Lien Term Loan			9.00%		12/24/2028		27,850		27,850		27,850		(15)(19)(20)
Fairbridge Strategic Capital Funding LLC	Real Estate Operating Companies	Warrants						2,500			—		3		(11)(15)(20)
FINThrive Software Intermediate Holdings, Inc.	Health Care Technology	Second Lien Term Loan	L+	6.75%	9.87%		12/17/2029		25,061		24,685		21,646		(6)
Fortress Biotech, Inc.	Biotechnology	First Lien Term Loan			11.00%		8/27/2025		9,466		9,071		9,008		(11)(15)
Fortress Biotech, Inc.	Biotechnology	Warrants						331,200			405		66		(11)(15)
Frontier Communications Holdings, LLC	Integrated Telecommunication Services	Fixed Rate Bond			6.00%		1/15/2030		4,881		4,420		3,845		(11)
GKD Index Partners, LLC	Specialized Finance	First Lien Term Loan	L+	7.00%	10.67%		6/29/2023		25,128		24,915		24,851		(6)(15)
GKD Index Partners, LLC	Specialized Finance	First Lien Revolver	L+	7.00%	10.60%		6/29/2023		1,280		1,268		1,262		(6)(15)(19)
Global Medical Response, Inc.	Health Care Services	First Lien Term Loan	L+	4.25%	7.37%		3/14/2025		5,572		5,435		4,848		(6)
Grove Hotel Parcel Owner, LLC	Hotels, Resorts & Cruise Lines	First Lien Term Loan	SOFR+	8.00%	11.04%		6/21/2027		14,311		14,041		14,060		(6)(15)
Grove Hotel Parcel Owner, LLC	Hotels, Resorts & Cruise Lines	First Lien Term Loan	SOFR+	8.00%			6/21/2027		—		(54)		(50)		(6)(15)(19)
Grove Hotel Parcel Owner, LLC	Hotels, Resorts & Cruise Lines	First Lien Revolver	SOFR+	8.00%			6/21/2027		—		(27)		(25)		(6)(15)(19)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	8.38%		4/9/2029		9,392		9,080		8,582		(6)
iCIMs, Inc.	Application Software	First Lien Term Loan	SOFR+	6.75%	9.49%		8/18/2028		19,203		18,874		18,867		(6)(15)
iCIMs, Inc.	Application Software	First Lien Term Loan	SOFR+	6.75%			8/18/2028		—		—		—		(6)(15)(19)
iCIMs, Inc.	Application Software	First Lien Revolver	SOFR+	6.75%			8/18/2028		—		(31)		(32)		(6)(15)(19)
Immucor, Inc.	Health Care Supplies	First Lien Term Loan	L+	5.75%	9.42%		7/2/2025		8,569		8,401		8,407		(6)(15)
Immucor, Inc.	Health Care Supplies	Second Lien Term Loan	L+	8.00%	11.67%	3.50%	10/2/2025		22,619		22,162		22,275		(6)(15)
Impel Neuropharma, Inc.	Health Care Technology	First Lien Term Loan					2/15/2031		13,083		13,083		13,083		(15)(21)
Impel Neuropharma, Inc.	Health Care Technology	First Lien Term Loan	SOFR+	8.75%	12.45%		3/17/2027		12,161		11,944		11,942		(6)(15)
Innocoll Pharmaceuticals Limited	Health Care Technology	First Lien Term Loan			11.00%		1/26/2027		6,817		6,553		6,408		(11)(15)
Innocoll Pharmaceuticals Limited	Health Care Technology	First Lien Term Loan			11.00%		1/26/2027		—		—		—		(11)(15)(19)
Innocoll Pharmaceuticals Limited	Health Care Technology	Warrants						56,999			135		609		(11)(15)
Integral Development Corporation	Other Diversified Financial Services	Warrants						1,078,284			113		—		(15)
Inventus Power, Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	5.00%	8.55%		3/29/2024		18,660		18,567		18,134		(6)(15)
Inventus Power, Inc.	Electrical Components & Equipment	Second Lien Term Loan	L+	8.50%	12.17%		9/29/2024		13,674		13,514		13,154		(6)(15)
INW Manufacturing, LLC	Personal Products	First Lien Term Loan	L+	5.75%	9.42%		3/25/2027		35,625		34,806		31,528		(6)(15)
IPC Corp.	Application Software	First Lien Term Loan	L+	6.50%	9.44%		10/1/2026		34,357		33,612		32,639		(6)(15)
Ivanti Software, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	10.33%		12/1/2028		10,247		10,196		7,702		(6)
Jazz Acquisition, Inc.	Aerospace & Defense	First Lien Term Loan	L+	7.50%	10.62%		1/29/2027		36,234		35,170		36,392		(6)(15)
Jazz Acquisition, Inc.	Aerospace & Defense	Second Lien Term Loan	L+	8.00%	11.12%		6/18/2027		528		478		481		(6)

20

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
Kings Buyer, LLC	Environmental & Facilities Services	First Lien Term Loan	L+	6.50%	10.17%		10/29/2027		$	13,623	$	13,487	$	13,351	(6)(15)
Kings Buyer, LLC	Environmental & Facilities Services	First Lien Revolver	L+	6.50%	10.17%		10/29/2027		329		311		292		(6)(15)(19)
LaserShip, Inc.	Air Freight & Logistics	Second Lien Term Loan	L+	7.50%	10.38%		5/7/2029		2,394		2,370		1,867		(6)(15)
Lift Brands Holdings, Inc.	Leisure Facilities	Common Stock						2,000,000			1,399		—		(15)
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	L+	5.00%	8.67%		5/9/2026		41,008		40,243		39,573		(6)(15)
Liquid Environmental Solutions Corporation	Environmental & Facilities Services	Second Lien Term Loan	L+	8.50%	11.38%		11/30/2026		4,357		4,285		4,226		(6)(15)
Liquid Environmental Solutions Corporation	Environmental & Facilities Services	Second Lien Term Loan	L+	8.50%	11.38%		11/30/2026		2,370		2,323		2,265		(6)(15)(19)
Liquid Environmental Solutions Corporation	Environmental & Facilities Services	Common Stock						451			451		451		(15)
LSL Holdco, LLC	Health Care Distributors	First Lien Term Loan	L+	6.00%	9.12%		1/31/2028		19,236		18,894		18,707		(6)(15)
LSL Holdco, LLC	Health Care Distributors	First Lien Revolver	L+	6.00%	9.12%		1/31/2028		1,710		1,672		1,651		(6)(15)(19)
LTI Holdings, Inc.	Electronic Components	Second Lien Term Loan	L+	6.75%	9.87%		9/6/2026		2,140		2,092		1,890		(6)
Marinus Pharmaceuticals, Inc.	Pharmaceuticals	First Lien Term Loan			11.50%		5/11/2026		17,203		16,954		16,644		(11)(15)
Marinus Pharmaceuticals, Inc.	Pharmaceuticals	First Lien Term Loan			11.50%		5/11/2026		—		—		—		(11)(15)(19)
Mesoblast, Inc.	Biotechnology	First Lien Term Loan			8.00%	1.75%	11/19/2026		7,215		6,650		6,440		(11)(15)
Mesoblast, Inc.	Biotechnology	First Lien Term Loan			8.00%	1.75%	11/19/2026		—		1		—		(11)(15)(19)
Mesoblast, Inc.	Biotechnology	Warrants						209,588			480		170		(11)(15)
MHE Intermediate Holdings, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	6.00%	9.50%		7/21/2027		18,390		18,088		17,691		(6)(15)
MHE Intermediate Holdings, LLC	Diversified Support Services	First Lien Revolver	SOFR+	6.00%			7/21/2027		—		(23)		(54)		(6)(15)(19)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	10.64%	1.50%	2/14/2025		45,665		44,689		44,523		(6)(15)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	L+	8.00%			2/14/2025		—		(54)		(100)		(6)(15)(19)
Mosaic Companies, LLC	Home Improvement Retail	First Lien Term Loan	L+	6.75%	9.89%		7/2/2026		46,499		45,802		45,421		(6)(15)
MRI Software LLC	Application Software	First Lien Term Loan	L+	5.50%	9.17%		2/10/2026		29,565		29,128		28,734		(6)(15)
MRI Software LLC	Application Software	First Lien Term Loan	L+	5.50%			2/10/2026		—		(12)		(96)		(6)(15)(19)
MRI Software LLC	Application Software	First Lien Revolver	L+	5.50%			2/10/2026		—		(13)		(51)		(6)(15)(19)
Navisite, LLC	Data Processing & Outsourced Services	Second Lien Term Loan	L+	8.50%	12.17%		12/30/2026		22,560		22,241		21,524		(6)(15)
NeuAG, LLC	Fertilizers & Agricultural Chemicals	First Lien Term Loan	L+	10.50%	14.17%		9/11/2024		50,459		49,301		51,972		(6)(15)
NFP Corp.	Other Diversified Financial Services	Fixed Rate Bond			6.88%		8/15/2028		10,191		9,773		7,966
NN, Inc.	Industrial Machinery	First Lien Term Loan	L+	6.88%	9.99%		9/19/2026		58,713		57,655		56,805		(6)(11)(15)
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	7.12%		9/25/2026		3,323		3,162		3,207		(6)
OEConnection LLC	Application Software	Second Lien Term Loan	L+	7.00%	10.05%		9/25/2027		7,519		7,389		7,237		(6)(15)
OTG Management, LLC	Airport Services	First Lien Term Loan	L+	2.00%	5.08%	8.00%	9/2/2025		21,557		21,267		21,557		(6)(15)
OTG Management, LLC	Airport Services	First Lien Term Loan	L+	2.00%			9/2/2025		—		(31)		—		(6)(15)(19)
P & L Development, LLC	Pharmaceuticals	Fixed Rate Bond			7.75%		11/15/2025		7,776		7,820		5,846
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	8.13%		11/10/2027		9,850		9,460		9,374		(6)
Performance Health Holdings, Inc.	Health Care Distributors	First Lien Term Loan	L+	6.00%	8.88%		7/12/2027		17,976		17,690		17,537		(6)(15)
PFNY Holdings, LLC	Leisure Facilities	First Lien Term Loan	L+	7.00%	9.28%		12/31/2026		26,154		25,712		25,893		(6)(15)

21

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
PFNY Holdings, LLC	Leisure Facilities	First Lien Term Loan	L+	7.00%	9.25%		12/31/2026		$	2,228	$	2,186	$	2,203	(6)(15)(19)
PFNY Holdings, LLC	Leisure Facilities	First Lien Revolver	L+	7.00%			12/31/2026		—		(21)		(13)		(6)(15)(19)
Planview Parent, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	10.92%		12/18/2028		28,627		28,198		27,482		(6)(15)
Pluralsight, LLC	Application Software	First Lien Term Loan	L+	8.00%	10.68%		4/6/2027		48,689		47,951		47,155		(6)(15)
Pluralsight, LLC	Application Software	First Lien Revolver	L+	8.00%			4/6/2027		—		(53)		(111)		(6)(15)(19)
PRGX Global, Inc.	Data Processing & Outsourced Services	First Lien Term Loan	L+	6.75%	10.42%		3/3/2026		33,775		32,931		33,116		(6)(15)
PRGX Global, Inc.	Data Processing & Outsourced Services	First Lien Revolver	L+	6.75%			3/3/2026		—		(34)		(49)		(6)(15)(19)
PRGX Global, Inc.	Data Processing & Outsourced Services	Common Stock						80,515			79		89		(15)
Profrac Holdings II, LLC	Industrial Machinery	First Lien Term Loan	SOFR+	8.50%	10.01%		3/4/2025		23,275		22,722		22,810		(6)(15)
Project Boost Purchaser, LLC	Application Software	Second Lien Term Loan	L+	8.00%	11.12%		5/31/2027		5,250		5,168		5,047		(6)(15)
Quantum Bidco Limited	Food Distributors	First Lien Term Loan	SONIA+	6.00%	8.39%		1/31/2028		£	3,501	4,646		3,367		(6)(11)(15)
QuorumLabs, Inc.	Application Software	Preferred Equity						64,887,669			375		—		(15)
Radiology Partners, Inc.	Health Care Distributors	First Lien Term Loan	L+	4.25%	7.33%		7/9/2025		$	3,400	3,202		2,880		(6)
Radiology Partners, Inc.	Health Care Distributors	Fixed Rate Bond			9.25%		2/1/2028		4,755		4,720		3,109
Relativity ODA LLC	Application Software	First Lien Term Loan	L+	7.50%		10.59%	5/12/2027		24,692		24,265		24,101		(6)(15)
Relativity ODA LLC	Application Software	First Lien Revolver	L+	6.50%			5/12/2027		—		(43)		(64)		(6)(15)(19)
Renaissance Holding Corp.	Diversified Banks	Second Lien Term Loan	L+	7.00%	10.12%		5/29/2026		3,542		3,515		3,402		(6)
RP Escrow Issuer LLC	Health Care Distributors	Fixed Rate Bond			5.25%		12/15/2025		1,325		1,218		1,097
RumbleOn, Inc.	Automotive Retail	First Lien Term Loan	L+	8.25%	11.92%		8/31/2026		37,656		35,775		36,187		(6)(11)(15)
RumbleOn, Inc.	Automotive Retail	First Lien Term Loan	L+	8.25%	11.92%		8/31/2026		11,393		10,583		10,760		(6)(11)(15)(19)
RumbleOn, Inc.	Automotive Retail	Warrants						164,660			1,202		74		(11)(15)
Sabert Corporation	Metal & Glass Containers	First Lien Term Loan	L+	4.50%	7.63%		12/10/2026		1,691		1,610		1,623		(6)
ShareThis, Inc.	Application Software	Warrants						345,452			367		—		(15)
SiO2 Medical Products, Inc.	Metal & Glass Containers	First Lien Term Loan			5.50%	8.50%	12/21/2026		46,121		45,413		45,295		(15)
SIO2 Medical Products, Inc.	Metal & Glass Containers	Warrants						415			681		681		(15)
SM Wellness Holdings, Inc.	Health Care Services	Second Lien Term Loan	L+	8.00%	10.74%		4/16/2029		9,109		8,972		8,289		(6)(15)
SonicWall US Holdings Inc.	Technology Distributors	Second Lien Term Loan	L+	7.50%	10.48%		5/18/2026		3,195		3,163		2,997		(6)(15)
Sorrento Therapeutics, Inc.	Biotechnology	Common Stock						50,000			197		79		(11)
Spanx, LLC	Apparel Retail	First Lien Term Loan	L+	5.25%	8.30%		11/20/2028		4,534		4,455		4,427		(6)(15)
Spanx, LLC	Apparel Retail	First Lien Revolver	L+	5.25%	8.03%		11/18/2027		866		813		796		(6)(15)(19)
SPX Flow, Inc.	Industrial Machinery	First Lien Term Loan	SOFR+	4.50%	7.63%		4/5/2029		1,500		1,410		1,393		(6)
SumUp Holdings Luxembourg S.À.R.L.	Other Diversified Financial Services	First Lien Term Loan	E+	8.50%	10.00%		3/10/2026		£	16,911	19,414		16,360		(6)(11)(15)
Sunland Asphalt & Construction, LLC	Construction & Engineering	First Lien Term Loan	L+	6.00%	8.88%		1/13/2026		$	42,618	41,654		41,723		(6)(15)
Supermoose Borrower, LLC	Application Software	First Lien Term Loan	L+	3.75%	7.42%		8/29/2025		3,466		3,141		3,056		(6)
SVP-Singer Holdings Inc.	Home Furnishings	First Lien Term Loan	L+	6.75%	10.42%		7/28/2028		20,766		19,550		18,188		(6)(15)
Swordfish Merger Sub LLC	Auto Parts & Equipment	Second Lien Term Loan	L+	6.75%	9.81%		2/2/2026		12,500		12,474		11,469		(6)(15)
Tacala, LLC	Restaurants	Second Lien Term Loan	L+	7.50%	10.62%		2/4/2028		9,448		9,338		8,692		(6)
Tahoe Bidco B.V.	Application Software	First Lien Term Loan	L+	6.00%	8.68%		9/29/2028		23,215		22,815		22,843		(6)(11)(15)
Tahoe Bidco B.V.	Application Software	First Lien Revolver	L+	6.00%			10/1/2027		—		(29)		(28)		(6)(11)(15)(19)
Tecta America Corp.	Construction & Engineering	Second Lien Term Loan	L+	8.50%	11.62%		4/9/2029		5,203		5,125		5,034		(6)(15)

22

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

Portfolio Company	Industry	Type of Investment (1)(2)(3)(4)	Index	Spread	Cash Interest Rate (5)(6)	PIK	Maturity Date	Shares	Principal (7)		Cost		Fair Value		Notes
Telestream Holdings Corporation	Application Software	First Lien Term Loan	SOFR+	9.25%	12.11%		10/15/2025		$	18,323	$	17,956	$	17,865	(6)(15)
Telestream Holdings Corporation	Application Software	First Lien Revolver	SOFR+	9.25%	12.20%		10/15/2025		1,231		1,210		1,187		(6)(15)(19)
TerSera Therapeutics LLC	Pharmaceuticals	Second Lien Term Loan	L+	9.50%	13.17%		3/30/2026		29,663		29,352		29,031		(6)(15)
TerSera Therapeutics LLC	Pharmaceuticals	Common Stock						668,879			2,028		4,077		(15)
TGNR HoldCo LLC	Integrated Oil & Gas	Subordinated Debt			11.50%		5/14/2026		4,984		4,866		4,872		(10)(11)(15)
Thrasio, LLC	Internet & Direct Marketing Retail	First Lien Term Loan	L+	7.00%	11.17%		12/18/2026		37,494		36,569		35,807		(6)(15)
Thrasio, LLC	Internet & Direct Marketing Retail	Preferred Equity						8,434			101		69		(15)
Thrasio, LLC	Internet & Direct Marketing Retail	Preferred Equity						284,650			2,409		2,320		(15)
Thrasio, LLC	Internet & Direct Marketing Retail	Preferred Equity						48,352			979		979		(15)
Thrasio, LLC	Internet & Direct Marketing Retail	Preferred Equity						23,201			22,986		26,487		(15)(19)
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	8.15%		3/30/2029		12,032		10,949		10,827		(6)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	L+	6.00%	9.12%		12/29/2028		6,016		5,908		5,895		(6)(15)
Uniti Group LP	Specialized REITs	Fixed Rate Bond			6.50%		2/15/2029		4,500		4,060		3,026		(11)
Uniti Group LP	Specialized REITs	Fixed Rate Bond			4.75%		4/15/2028		300		258		238		(11)
Win Brands Group LLC	Housewares & Specialties	First Lien Term Loan	L+	15.00%	19.64%		1/23/2026		2,316		2,293		2,264		(6)(15)
Win Brands Group LLC	Housewares & Specialties	Warrants						3,621			—		192		(15)
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	L+	6.25%	9.37%		9/21/2027		25,499		24,632		23,204		(6)
Windstream Services II, LLC	Integrated Telecommunication Services	Common Stock						18,032			216		296		(15)
Windstream Services II, LLC	Integrated Telecommunication Services	Warrants						109,420			1,842		1,799		(15)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	6.56%		4/30/2025		7,564		6,989		6,795		(6)
WP CPP Holdings, LLC	Aerospace & Defense	Second Lien Term Loan	L+	7.75%	10.56%		4/30/2026		6,000		5,855		5,070		(6)(15)
WPEngine, Inc.	Application Software	First Lien Term Loan	L+	6.00%	10.19%		3/27/2026		40,536		39,947		40,131		(6)(15)
WWEX Uni Topco Holdings, LLC	Air Freight & Logistics	Second Lien Term Loan	L+	7.00%	10.67%		7/26/2029		5,000		4,925		4,538		(6)(15)
Zayo Group Holdings, Inc.	Alternative Carriers	Fixed Rate Bond			4.00%		3/1/2027		250		212		201
Zep Inc.	Specialty Chemicals	Second Lien Term Loan	L+	8.25%	11.92%		8/11/2025		19,578		19,542		16,152		(6)(15)
Zephyr Bidco Limited	Specialized Finance	Second Lien Term Loan	SONIA+	7.50%	9.72%		7/23/2026		£	18,000	23,804		16,552		(6)(11)(15)
Total Non-Control/Non-Affiliate Investments (180.9% of net assets)											$	2,330,096	$	2,253,750
Total Portfolio Investments (200.2% of net assets)											$	2,617,754	$	2,494,111
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares											$	5,261	$	5,261
Other cash accounts											21,103		21,103
Total Cash and Cash Equivalents and Restricted Cash (2.1% of net assets)											$	26,364	$	26,364
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (202.4% of net assets)											$	2,644,118	$	2,520,475

23

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

Derivative Instrument	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Counterparty	Cumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract	$	43,179	€	41,444	11/10/2022	JPMorgan Chase Bank, N.A.	$	2,466
Foreign currency forward contract	$	45,692	£	37,033	11/10/2022	JPMorgan Chase Bank, N.A.	4,323
							$	6,789

Derivative Instrument	Company Receives	Company Pays	Counterparty	Maturity Date	Notional Amount	Fair Value
Interest rate swap	Fixed 2.7%	Floating 3-month LIBOR +1.658%	Royal Bank of Canada	1/15/2027	$350,000	$(41,969)

24

Oaktree Specialty Lending Corporation

Consolidated Schedule of Investments

September 30, 2022

(dollar amounts in thousands)

(1)All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.

(2)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.

(3)Equity ownership may be held in shares or units of companies related to the portfolio companies.

(4)Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.

(5)Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

(6)The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR, SOFR, SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 180-day LIBOR at 4.17%, the 360-day LIBOR at 4.78%, the PRIME at 6.25%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55%, the SONIA at 1.69%, the 30-day EURIBOR at 0.69%, the 90-day EURIBOR at 0.99% and the 180-day EURIBOR at 0.38%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(7)Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

(8)Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

(9)As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

(10)This investment represents a participation interest in the underlying securities shown.

(11)Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2022, qualifying assets represented 75.7% of the Company's total assets and non-qualifying assets represented 24.3% of the Company's total assets.

(12)Income producing through payment of dividends or distributions.

(13)This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.

(14)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

(15)As of September 30, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.

(16)This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.

(17)Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

(18)Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

(19)Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

(20)This investment was renamed during the three months ended March 31, 2022. For periods prior to March 31, 2022, this investment was referenced as Realfi Strategic Capital Funding LLC.

(21)This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

See notes to Consolidated Financial Statements.

25

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Note 1. Organization

Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes.

The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions.

The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in Oaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with their own product offerings and investment, marketing and support teams.

On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into the Company in a two-step transaction, with the Company as the surviving company (the "OCSI Merger”).

On January 23, 2023, the Company acquired Oaktree Strategic Income II, Inc. (“OSI2”) pursuant to that certain Agreement and Plan of Merger (the “OSI2 Merger Agreement”), dated as of September 14, 2022, by and among OSI2, the Company, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into the Company in a two-step transaction with the Company as the surviving company (the “OSI2 Merger”). For further information, see Note 14 "Merger with OSI2."

Note 2. Significant Accounting Policies

Basis of Presentation:

The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946").

Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for periods prior to March 31, 2023 reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Use of Estimates:

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.

26

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Consolidation:

The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries.

As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value.

Fair Value Measurements:

The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity.

Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:

•Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

•Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.

•Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.

Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.

Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources.

If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of

27

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.

In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.

Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.

Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022.

Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments:

•The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team;

•Preliminary valuations are then reviewed and discussed with management of Oaktree;

•Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree;

•Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee;

•The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and

•Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio.

The fair value of the Company's investments as of June 30, 2023 and September 30, 2022 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

28

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax asset, net," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable" and "payables from unsettled transactions" approximate fair value due to their short maturities.

Foreign Currency Translation:

The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.

Derivative Instruments:

Foreign Currency Forward Contracts

The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations.

Interest Rate Swaps

The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.

Investment Income:

Interest Income

Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of June 30, 2023,

29

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

there were five investments on non-accrual status that in aggregate represented 3.6% and 3.1% of total debt investments at cost and fair value, respectively. As of September 30, 2022, there were no investments on non-accrual status.

In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.

PIK Interest Income

The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so.

Fee Income

Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered.

Dividend Income

The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.

Cash and Cash Equivalents and Restricted Cash:

Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.

30

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

As of September 30, 2022, included in restricted cash was $2.8 million that was held at Wells Fargo Bank, N.A. in connection with the Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the Citibank Facility, the Company was restricted in terms of access to $2.8 million as of September 30, 2022, until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the Citibank Facility. As of June 30, 2023, included in restricted cash was $13.0 million that was held at Deutsche Bank Trust Company Americas in connection with the Company’s OSI2 Citibank Facility (defined in Note 6. Borrowings). Pursuant to the terms of the OSI2 Citibank Facility, the Company was restricted in terms of access to the $13.0 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the OSI2 Citibank Facility.

Due from Portfolio Companies:

Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date).

Receivables/Payables from Unsettled Transactions:

Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.

Deferred Financing Costs:

Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.

Deferred Offering Costs:

Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.

Income Taxes:

The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar year 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2023.

31

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.

FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

32

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Note 3. Portfolio Investments

As of June 30, 2023, 207.7% of net assets at fair value, or $3.1 billion, was invested in 156 portfolio companies, including (i) $140.6 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $49.6 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of June 30, 2023, 4.8% of net assets at fair value, or $72.7 million, was invested in cash and cash equivalents (including $13.0 million of restricted cash). In comparison, as of September 30, 2022, 200.2% of net assets at fair value, or $2.5 billion, was invested in 149 portfolio investments, including (i) $117.0 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $50.3 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2022, 2.1% of net assets at fair value, or $26.4 million, was invested in cash and cash equivalents (including $2.8 million of restricted cash). As of June 30, 2023, 88.5% of the Company's portfolio at fair value consisted of senior secured debt investments and 6.8% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2022, 86.9% of the Company's portfolio at fair value consisted of senior secured debt investments and 8.1% consisted of subordinated debt investments, including the debt investments in the JVs.

The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants, limited partnership interests or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain.

During the three and nine months ended June 30, 2023, the Company recorded net realized losses of $10.6 million and $19.9 million, respectively. During the three and nine months ended June 30, 2022, the Company recorded net realized gains of $9.2 million and $19.9 million, respectively. During the three and nine months ended June 30, 2023, the Company recorded net unrealized depreciation of $1.0 million and $42.3 million, respectively. During the three and nine months ended June 30, 2022, the Company recorded net unrealized depreciation of $86.8 million and $118.4 million, respectively.

The composition of the Company's investments as of June 30, 2023 and September 30, 2022 at cost and fair value was as follows:

	June 30, 2023				September 30, 2022
	Cost		Fair Value		Cost		Fair Value
Investments in debt securities	$	2,942,222	$	2,826,369	$	2,294,392	$	2,223,329
Investments in equity securities	136,619		118,989		127,596		103,534
Debt investments in the JVs	162,653		162,288		146,444		146,533
Equity investments in the JVs	54,791		27,973		49,322		20,715
Total	$	3,296,285	$	3,135,619	$	2,617,754	$	2,494,111

33

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following table presents the composition of the Company's debt investments as of June 30, 2023 and September 30, 2022 at fixed rates and floating rates:

	June 30, 2023				September 30, 2022
	Fair Value		% of Debt Portfolio		Fair Value		% of Debt Portfolio
Floating rate debt securities, including the debt investments in the JVs	$	2,571,458	86.04	%	$	2,049,644	86.49	%
Fixed rate debt securities	417,199		13.96		320,218		13.51
Total	$	2,988,657	100.00	%	$	2,369,862	100.00	%

The following table presents the financial instruments carried at fair value as of June 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:

	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	245,925	$	2,528,448	$	—	$	2,774,373
Investments in debt securities (subordinated, including the debt investments in the JVs)	—		29,368		184,916		—		214,284
Investments in equity securities (preferred)	—		—		92,186		—		92,186
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	6,455		—		20,348		27,973		54,776
Total investments at fair value	6,455		275,293		2,825,898		27,973		3,135,619
Cash equivalents	5,193		—		—		—		5,193
Derivative asset	—		49		—		—		49
Total assets at fair value	$	11,648	$	275,342	$	2,825,898	$	27,973	$	3,140,861
Derivative liability	$	—	$	39,567	$	—	$	—	$	39,567
Total liabilities at fair value	$	—	$	39,567	$	—	$	—	$	39,567

__________ 

(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

34

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:

	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	255,803	$	1,910,606	$	—	$	2,166,409
Investments in debt securities (subordinated, including the debt investments in the JVs)	—		44,065		159,388		—		203,453
Investments in equity securities (preferred)	—		—		79,523		—		79,523
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	4,053		—		19,958		20,715		44,726
Total investments at fair value	4,053		299,868		2,169,475		20,715		2,494,111
Cash equivalents	5,261		—		—		—		5,261
Derivative assets	—		6,789		—		—		6,789
Total assets at fair value	$	9,314	$	306,657	$	2,169,475	$	20,715	$	2,506,161
Derivative liability	$	—	$	41,969	$	—	$	—	$	41,969
Total liabilities at fair value	$	—	$	41,969	$	—	$	—	$	41,969

__________ 

(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period.

The following table provides a roll-forward in the changes in fair value from March 31, 2023 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of March 31, 2023	$	2,493,622	$	183,756	$	91,447	$	25,509	$	2,794,334
Purchases	228,375		4,183		—		182		232,740
Sales and repayments	(191,409)		(350)		—		(7,320)		(199,079)
Transfers out (a)	—		(2,708)		—		—		(2,708)
Capitalized PIK interest income	3,610		358		—		—		3,968
Accretion of OID	4,086		381		—		—		4,467
Net unrealized appreciation (depreciation)	(8,027)		(704)		739		1,893		(6,099)
Net realized gains (losses)	(1,809)		—		—		84		(1,725)
Fair value as of June 30, 2023	$	2,528,448	$	184,916	$	92,186	$	20,348	$	2,825,898
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023	$	(10,360)	$	(704)	$	739	$	1,095	$	(9,230)

__________

(a) There were transfers out of Level 3 to Level 2 for certain investments during the three months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

35

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following table provides a roll-forward in the changes in fair value from March 31, 2022 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of March 31, 2022	$	1,955,858	$	160,727	$	84,372	$	33,588	$	2,234,545
Purchases	60,692		29		—		125		60,846
Sales and repayments	(91,730)		(733)		—		(3,890)		(96,353)
Transfers in (a)	28,475		—		—		—		28,475
Transfers out (b)	—		—		—		(5,838)		(5,838)
Capitalized PIK interest income	5,537		—		—		—		5,537
Accretion of OID	5,100		430		—		—		5,530
Net unrealized appreciation (depreciation)	(33,208)		(4,873)		(2,756)		(873)		(41,710)
Net realized gains (losses)	(10)		—		—		393		383
Fair value as of June 30, 2022	$	1,930,714	$	155,580	$	81,616	$	23,505	$	2,191,415
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2022	$	(33,199)	$	(4,873)	$	(2,756)	$	(917)	$	(41,745)

__________

(a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity

The following table provides a roll-forward in the changes in fair value from September 30, 2022 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2022	$	1,910,606	$	159,388	$	79,523	$	19,958	$	2,169,475
Purchases (a)	980,595		26,508		14,296		5,610		1,027,009
Sales and repayments	(357,903)		(1,396)		—		(8,295)		(367,594)
Transfers in (b)	19,075		—		—		—		19,075
Capitalized PIK interest income	12,549		376		—		—		12,925
Accretion of OID	11,684		1,109		—		—		12,793
Net unrealized appreciation (depreciation)	(45,019)		(1,069)		(1,633)		2,804		(44,917)
Net realized gains (losses)	(3,139)		—		—		271		(2,868)
Fair value as of June 30, 2023	$	2,528,448	$	184,916	$	92,186	$	20,348	$	2,825,898
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2023	$	(46,680)	$	(1,069)	$	(1,633)	$	(355)	$	(49,737)

__________

(a) Includes Level 3 investments acquired in connection with the OSI2 Merger during the nine months ended June 30, 2023.

(b) There was a transfer into Level 3 from Level 2 for an investment during the nine months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

36

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following table provides a roll-forward in the changes in fair value from September 30, 2021 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2021	$	1,878,536	$	176,317	$	63,565	$	43,163	$	2,161,581
Purchases	437,922		3,777		19,243		2,180		463,122
Sales and repayments	(391,959)		(21,868)		(163)		(12,836)		(426,826)
Transfers in (a)	37,042		—		—		—		37,042
Transfers out (a)(b)	(17,070)		—		—		(5,838)		(22,908)
Capitalized PIK interest income	16,653		313		—		—		16,966
Accretion of OID	19,048		1,628		—		—		20,676
Net unrealized appreciation (depreciation)	(57,909)		(4,587)		(517)		(2,520)		(65,533)
Net realized gains (losses)	8,451		—		(512)		(644)		7,295
Fair value as of June 30, 2022	$	1,930,714	$	155,580	$	81,616	$	23,505	$	2,191,415
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2022	$	(45,187)	$	(4,734)	$	(752)	$	(7,629)	$	(58,302)

__________

(a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the nine months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity.

Significant Unobservable Inputs for Level 3 Investments

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of June 30, 2023:

Asset	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average (a)
Senior Secured Debt	$	2,058,831	Market Yield	Market Yield	(b)	9.0%	-	38.0%	14.1%
	43,954		Enterprise Value	Revenue Multiple	(c)	5.0x	-	7.0x	6.0x
	34,466		Enterprise Value	EBITDA Multiple	(c)	3.4x	-	5.4x	5.2x
	32,379		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
	358,818		Broker quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Subordinated Debt	18,464		Market Yield	Market Yield	(b)	10.0%	-	22.0%	11.4%
	4,164		Broker Quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Debt Investments in the JVs	162,288		Enterprise Value	N/A	(f)	N/A	-	N/A	N/A
Preferred & Common Equity	70,852		Enterprise Value	Revenue Multiple	(c)	0.4x	-	6.0x	1.4x
	37,322		Enterprise Value	EBITDA Multiple	(c)	1.7x	-	17.5x	11.1x
	1,415		Enterprise Value	Asset Multiple	(c)	1.0x	-	1.4x	1.4x
	2,945		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
Total	$	2,825,898

__________ 

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

(e)Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

(f)Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.

37

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2022:

Asset	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average (a)
Senior Secured Debt	$	1,599,148	Market Yield	Market Yield	(b)	9.0%	-	30.0%	13.7%
	14,333		Enterprise Value	EBITDA Multiple	(c)	5.0x	-	7.0x	6.0x
	297,125		Broker Quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Subordinated Debt	12,855		Market Yield	Market Yield	(b)	10.0%	-	19.0%	13.8%
Debt Investments in the JVs	146,533		Enterprise Value	N/A	(f)	N/A	-	N/A	N/A
Preferred & Common Equity	61,693		Enterprise Value	Revenue Multiple	(c)	0.4x	-	10.1x	4.3x
	36,913		Enterprise Value	EBITDA Multiple	(c)	3.0x	-	20.0x	11.4x
	3		Enterprise Value	Asset Multiple	(c)	0.9x	-	1.1x	1.0x
	872		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
Total	$	2,169,475

__________ 

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

(e)Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

(f)Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.

Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.

Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively.

Financial Instruments Disclosed, But Not Carried, At Fair Value

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of June 30, 2023 and the level of each financial liability within the fair value hierarchy:

	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	800,000	$	800,000	$	—	$	—	$	800,000
OSI2 Citibank Facility payable	335,000		335,000		—		—		335,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	297,928		285,717		—		285,717		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	307,138		302,260		—		302,260		—
Total	$	1,740,066	$	1,722,977	$	—	$	587,977	$	1,135,000

38

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2022 and the level of each financial liability within the fair value hierarchy:

	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	540,000	$	540,000	$	—	$	—	$	540,000
Citibank Facility payable	160,000		160,000		—		—		160,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	296,991		283,077		—		283,077		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	304,052		294,028		—		294,028		—
Total	$	1,301,043	$	1,277,105	$	—	$	577,105	$	700,000

The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. Oaktree used market quotes as of the valuation date to estimate the fair value of the Company's 3.500% notes due 2025 (the "2025 Notes") and 2.700% notes due 2027 (the "2027 Notes"), which are included in Level 2 of the hierarchy.

Portfolio Composition

Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,886,772	87.59	%	$	2,227,245	85.08	%
Debt investments in the JVs	162,653		4.93	%	146,444		5.59	%
Preferred equity	99,597		3.02	%	85,300		3.26	%
Subordinated debt	55,450		1.68	%	67,147		2.57	%
LLC equity interests of the JVs	54,791		1.66	%	49,322		1.88	%
Common equity and warrants	37,022		1.12	%	42,296		1.62	%
Total	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,774,373	88.48	%	183.80	%	$	2,166,409	86.86	%	173.93	%
Debt investments in the JVs	162,288		5.18	%	10.75	%	146,533		5.88	%	11.77	%
Preferred equity	92,186		2.94	%	6.11	%	79,523		3.19	%	6.38	%
Subordinated debt	51,996		1.66	%	3.44	%	56,920		2.28	%	4.57	%
LLC equity interests of the JVs	27,973		0.89	%	1.85	%	20,715		0.83	%	1.66	%
Common equity and warrants	26,803		0.85	%	1.78	%	24,011		0.96	%	1.93	%
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

39

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Northeast	$	994,695	30.17	%	$	747,420	28.55	%
Midwest	448,981		13.62	%	373,236		14.26	%
Southeast	446,546		13.55	%	356,041		13.60	%
West	440,634		13.37	%	358,306		13.69	%
International	434,844		13.19	%	301,242		11.51	%
South	197,754		6.00	%	168,819		6.45	%
Northwest	168,992		5.13	%	91,382		3.49	%
Southwest	163,839		4.97	%	221,308		8.45	%
Total	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	936,888	29.87	%	62.07	%	$	696,368	27.93	%	55.90	%
International	432,986		13.81	%	28.69	%	279,646		11.21	%	22.45	%
Midwest	429,317		13.69	%	28.44	%	356,934		14.31	%	28.66	%
West	428,232		13.66	%	28.37	%	345,251		13.84	%	27.72	%
Southeast	406,523		12.96	%	26.93	%	344,567		13.82	%	27.66	%
South	186,792		5.96	%	12.37	%	166,230		6.66	%	13.35	%
Northwest	166,089		5.30	%	11.00	%	90,131		3.61	%	7.24	%
Southwest	148,792		4.75	%	9.86	%	214,984		8.62	%	17.26	%
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

40

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of June 30, 2023 and September 30, 2022:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Application Software	$	560,503	16.98	%	$	391,938	14.98	%
Multi-Sector Holdings (1)	219,130		6.65		195,766		7.48
Data Processing & Outsourced Services	133,422		4.05		120,477		4.60
Health Care Technology	129,178		3.92		100,084		3.82
Biotechnology	127,394		3.86		109,960		4.20
Pharmaceuticals	121,497		3.69		126,508		4.83
Aerospace & Defense	110,680		3.36		61,963		2.37
Industrial Machinery & Supplies & Components	99,237		3.01		—		—
Broadline Retail	83,201		2.52		—		—
Health Care Services	77,364		2.35		58,674		2.24
Real Estate Operating Companies	76,462		2.32		47,585		1.82
Specialized Finance	69,188		2.10		80,864		3.09
Personal Care Products	68,671		2.08		—		—
Automotive Retail	64,825		1.97		59,254		2.26
Fertilizers & Agricultural Chemicals	64,750		1.96		49,301		1.88
Internet Services & Infrastructure	63,057		1.91		54,095		2.07
Health Care Distributors	62,079		1.88		57,112		2.18
Diversified Financial Services	61,693		1.87		—		—
Auto Parts & Equipment	61,091		1.85		12,474		0.48
Metal, Glass & Plastic Containers	57,949		1.76		—		—
Airport Services	55,919		1.70		43,322		1.65
Home Improvement Retail	54,939		1.67		45,802		1.75
Insurance Brokers	52,960		1.61		35,628		1.36
Diversified Metals & Mining	49,787		1.51		—		—
Leisure Facilities	49,501		1.50		39,768		1.52
Real Estate Services	44,783		1.36		40,243		1.54
Soft Drinks & Non-alcoholic Beverages	43,021		1.31		—		—
Diversified Support Services	42,706		1.30		37,992		1.45
Other Specialty Retail	41,790		1.27		—		—
Specialty Chemicals	38,248		1.16		37,319		1.43
Distributors	37,668		1.14		25,278		0.97
Integrated Telecommunication Services	33,663		1.02		34,628		1.32
Electrical Components & Equipment	32,380		0.98		33,814		1.29
Construction & Engineering	27,231		0.83		60,996		2.33
Environmental & Facilities Services	25,943		0.79		20,857		0.80
Advertising	25,597		0.78		28,245		1.08
Passenger Airlines	24,888		0.76		—		—
Oil & Gas Storage & Transportation	24,231		0.74		22,290		0.85
Home Furnishings	23,832		0.72		19,550		0.75
Gold	23,274		0.71		—		—
Systems Software	23,089		0.70		14,890		0.57
Health Care Equipment	22,374		0.68		24,353		0.93
Real Estate Development	19,567		0.59		—		—
Interactive Media & Services	18,963		0.58		—		—
Hotels, Resorts & Cruise Lines	17,221		0.52		13,960		0.53
Consumer Finance	16,411		0.50		14,492		0.55
Education Services	15,660		0.48		9,080		0.35
IT Consulting & Other Services	15,434		0.47		11,697		0.45
Restaurants	12,589		0.38		9,338		0.36
Movies & Entertainment	12,188		0.37		26,161		1.00
Health Care Supplies	11,675		0.35		36,471		1.39
Food Distributors	5,900		0.18		4,646		0.18
Apparel Retail	5,293		0.16		5,268		0.20
Air Freight & Logistics	4,925		0.15		7,295		0.28
Integrated Oil & Gas	4,887		0.15		4,866		0.19
Research & Consulting Services	4,879		0.15		9,187		0.35
Cable & Satellite	4,687		0.14		20,716		0.79
Other Specialized REITs	4,364		0.13		—		—
Paper & Plastic Packaging Products & Materials	3,262		0.10		—		—
Housewares & Specialties	2,908		0.09		2,293		0.09
Electronic Components	2,101		0.06		2,092		0.08
Leisure Products	2,039		0.06		—		—
Technology Distributors	1,084		0.03		3,163		0.12
Communications Equipment	1,053		0.03		—		—
Industrial Machinery	—		—		81,787		3.12
Internet & Direct Marketing Retail	—		—		67,926		2.59
Personal Products	—		—		53,214		2.03
Metal & Glass Containers	—		—		47,704		1.82
Soft Drinks	—		—		34,272		1.31
Other Diversified Financial Services	—		—		29,300		1.12
Oil & Gas Refining & Marketing	—		—		8,627		0.33
Trading Companies & Distributors	—		—		7,628		0.29
Apparel, Accessories & Luxury Goods	—		—		5,165		0.20
Specialized REITs	—		—		4,318		0.16
Diversified Banks	—		—		3,515		0.13
Construction Materials	—		—		2,331		0.09
Alternative Carriers	—		—		212		0.01
	$	3,296,285	100.00	%	$	2,617,754	100.00	%

41

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Application Software	$	544,685	17.38	%	36.03	%	$	384,589	15.43	%	30.87	%
Multi-Sector Holdings (1)	192,160		6.13		12.73		167,248		6.71		13.43
Biotechnology	128,343		4.09		8.50		108,465		4.35		8.71
Data Processing & Outsourced Services	124,548		3.97		8.25		111,335		4.46		8.94
Pharmaceuticals	116,199		3.71		7.70		119,511		4.79		9.59
Health Care Technology	115,659		3.69		7.66		97,315		3.90		7.81
Aerospace & Defense	111,464		3.55		7.38		61,881		2.48		4.97
Industrial Machinery & Supplies & Components	99,021		3.16		6.56		—		—		—
Broadline Retail	80,882		2.58		5.36		—		—		—
Real Estate Operating Companies	75,111		2.40		4.98		48,062		1.93		3.86
Specialized Finance	66,333		2.12		4.39		73,087		2.93		5.87
Fertilizers & Agricultural Chemicals	63,185		2.02		4.19		51,972		2.08		4.17
Internet Services & Infrastructure	62,726		2.00		4.16		53,797		2.16		4.32
Automotive Retail	62,356		1.99		4.13		57,629		2.31		4.63
Health Care Services	62,190		1.98		4.12		45,943		1.84		3.69
Diversified Financial Services	61,073		1.95		4.05		—		—		—
Personal Care Products	60,962		1.94		4.04		—		—		—
Auto Parts & Equipment	60,809		1.94		4.03		11,469		0.46		0.92
Health Care Distributors	60,340		1.92		4.00		54,662		2.19		4.39
Airport Services	55,221		1.76		3.66		42,883		1.72		3.44
Insurance Brokers	54,680		1.74		3.62		33,081		1.33		2.66
Home Improvement Retail	54,235		1.73		3.59		45,421		1.82		3.65
Diversified Metals & Mining	49,809		1.59		3.30		—		—		—
Leisure Facilities	46,990		1.50		3.11		39,258		1.57		3.15
Real Estate Services	44,227		1.41		2.93		39,573		1.59		3.18
Metal, Glass & Plastic Containers	43,954		1.40		2.91		—		—		—
Soft Drinks & Non-alcoholic Beverages	42,798		1.36		2.84		—		—		—
Other Specialty Retail	41,790		1.33		2.77		—		—		—
Diversified Support Services	41,302		1.32		2.74		36,712		1.47		2.95
Distributors	36,829		1.17		2.44		24,494		0.98		1.97
Electrical Components & Equipment	32,379		1.03		2.15		32,933		1.32		2.64
Specialty Chemicals	32,231		1.03		2.14		33,969		1.36		2.73
Integrated Telecommunication Services	30,922		0.99		2.05		32,201		1.29		2.59
Passenger Airlines	26,985		0.86		1.79		—		—		—
Construction & Engineering	26,901		0.86		1.78		61,188		2.45		4.91
Environmental & Facilities Services	25,436		0.81		1.69		20,585		0.83		1.65
Gold	23,292		0.74		1.54		—		—		—
Health Care Equipment	22,531		0.72		1.49		24,161		0.97		1.94
Systems Software	22,168		0.71		1.47		12,834		0.51		1.03
Oil & Gas Storage & Transportation	21,660		0.69		1.43		20,853		0.84		1.67
Home Furnishings	19,514		0.62		1.29		18,188		0.73		1.46
Real Estate Development	19,246		0.61		1.28		—		—		—
Interactive Media & Services	19,000		0.61		1.26		—		—		—
Advertising	18,969		0.60		1.26		26,948		1.08		2.16
Hotels, Resorts & Cruise Lines	17,261		0.55		1.14		13,985		0.56		1.12
Education Services	14,116		0.45		0.94		8,582		0.34		0.69
Consumer Finance	12,616		0.40		0.84		13,284		0.53		1.07
Restaurants	12,168		0.39		0.81		8,692		0.35		0.70
Movies & Entertainment	11,865		0.38		0.79		26,645		1.07		2.14
Health Care Supplies	11,408		0.36		0.76		36,577		1.47		2.94
IT Consulting & Other Services	11,176		0.36		0.74		8,596		0.34		0.69
Food Distributors	5,296		0.17		0.35		3,367		0.13		0.27
Apparel Retail	5,230		0.17		0.35		5,223		0.21		0.42
Integrated Oil & Gas	4,810		0.15		0.32		4,872		0.20		0.39
Cable & Satellite	4,672		0.15		0.31		19,576		0.78		1.57
Research & Consulting Services	4,632		0.15		0.31		8,573		0.34		0.69
Air Freight & Logistics	4,025		0.13		0.27		6,405		0.26		0.51
Other Specialized REITs	3,438		0.11		0.23		—		—		—
Paper & Plastic Packaging Products & Materials	3,100		0.10		0.21		—		—		—
Housewares & Specialties	2,858		0.09		0.19		2,456		0.10		0.20
Leisure Products	1,995		0.06		0.13		—		—		—
Electronic Components	1,834		0.06		0.12		1,890		0.08		0.15
Technology Distributors	1,024		0.03		0.07		2,997		0.12		0.24
Communications Equipment	980		0.03		0.06		—		—		—
Industrial Machinery	—		—		—		81,008		3.25		6.50
Internet & Direct Marketing Retail	—		—		—		70,419		2.82		5.65
Personal Products	—		—		—		50,150		2.01		4.03
Metal & Glass Containers	—		—		—		47,599		1.91		3.82
Soft Drinks	—		—		—		33,670		1.35		2.70
Other Diversified Financial Services	—		—		—		24,326		0.98		1.95

42

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Oil & Gas Refining & Marketing	$	—	—		—		$	8,604	0.34		0.69
Trading Companies & Distributors	—		—		—		5,567		0.22		0.45
Diversified Banks	—		—		—		3,402		0.14		0.27
Specialized REITs	—		—		—		3,264		0.13		0.26
Construction Materials	—		—		—		1,934		0.08		0.16
Alternative Carriers	—		—		—		201		0.01		0.02
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

___________________

(1)This industry includes the Company's investments in the JVs.

As of June 30, 2023 and September 30, 2022, the Company had no single investment that represented greater than 10% of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments.

Senior Loan Fund JV I, LLC

In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I.

SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to the Company and Kemper by SLF JV I. The subordinated notes issued by SLF JV I (the "SLF JV I Notes") are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt. As of June 30, 2023 and September 30, 2022, the Company and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.

SLF JV I has a senior revolving credit facility with Deutsche Bank AG, New York Branch (as amended, the "SLF JV I Deutsche Bank Facility"), which permitted up to $260.0 million of borrowings (subject to borrowing base and other limitations) as of each of June 30, 2023 and September 30, 2022. Borrowings under the SLF JV I Deutsche Bank Facility are secured by all of the assets of SLF JV I Funding LLC, a special purpose financing subsidiary of SLF JV I. As of June 30, 2023, the reinvestment period of the SLF JV I Deutsche Bank Facility was scheduled to expire May 3, 2024 and the maturity date was May 3, 2028. As of June 30, 2023, borrowings under the SLF JV I Deutsche Bank Facility accrued interest at a rate equal to 3-month SOFR plus 2.50% until November 3, 2023, 3-month SOFR plus 2.75% per annum during the remainder of the reinvestment period, 3-month SOFR plus 3.25% per annum for the first year after the reinvestment period, 3-month SOFR plus 3.35% for the following year and 3-month SOFR plus 3.60% thereafter, in each case with a 0.125% SOFR floor. $200.0 million and $230.0 million of borrowings were outstanding under the SLF JV I Deutsche Bank Facility as of June 30, 2023 and September 30, 2022, respectively.

As of June 30, 2023 and September 30, 2022, SLF JV I had total assets of $370.2 million and $385.2 million, respectively. SLF JV I's portfolio primarily consisted of senior secured loans to 52 and 60 portfolio companies as of June 30, 2023 and September 30, 2022, respectively. The portfolio companies in SLF JV I are in industries similar to those in which the Company may invest directly. As of June 30, 2023, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $140.6 million in aggregate, at fair value. As of September 30, 2022, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $117.0 million in aggregate, at fair value.

As of June 30, 2023, the Company and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from the Company. As of September 30, 2022, the Company and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from the Company. As of June 30, 2023, the Company had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the nine months ended June 30, 2023, the Company contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2022, the Company had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.

43

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of June 30, 2023 and September 30, 2022:

	June 30, 2023	September 30, 2022
Senior secured loans (1)	$350,214	$383,194
Weighted average interest rate on senior secured loans (2)	10.40%	8.33%
Number of borrowers in SLF JV I	52	60
Largest exposure to a single borrower (1)	$11,304	$10,093
Total of five largest loan exposures to borrowers (1)	$54,003	$48,139

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

44

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

SLF JV I Portfolio as of June 30, 2023

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	L+	3.75%	8.94%		2/27/2025		$	5,596	$	5,559	$	5,545
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025		6,911		6,832		6,784		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025		1,173		1,158		1,152		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	9.32%		8/14/2026		2,977		2,850		2,808
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.89%		6/30/2025		8,916		8,845		8,514		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.22%		6/9/2028		4,970		4,734		4,692
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.49%		10/20/2028		4,836		4,775		4,219		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.00%	9.39%		11/26/2026		7,740		7,663		7,721
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.25%		8/11/2025		1,527		1,194		1,179		(4)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	5.00%	10.20%		1/10/2025		4,615		4,592		4,615		(4)
Apptio, Inc.	Application Software	First Lien Revolver	L+	5.00%	10.20%		1/10/2025		115		113		115		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.31%		12/29/2027		4,145		4,083		3,938		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027		—		(7)		(25)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	10.44%		10/25/2028		5,052		4,880		3,560		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.20%		8/19/2028		4,963		4,749		4,710
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.47%		8/19/2028		1,995		1,883		1,902
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.47%		1/20/2029		4,346		4,022		3,657
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%	8.59%		2/15/2029		4,331		4,079		4,179
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%			2/15/2029		—		(32)		(19)		(5)
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	11.27%		12/24/2026		6,289		6,211		6,031		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027		6,322		6,263		6,158		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027		1,759		1,748		1,713		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		1,965		1,938		1,930
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		2,366		2,332		2,324
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		1,988		1,957		1,952
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.38%		8/10/2027		200		192		189		(5)
Convergeone Holdings, Inc.	IT Consulting & Other Services	First Lien Term Loan	L+	5.00%	10.37%		1/4/2026		7,315		7,188		4,670		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.24%		10/13/2029		6,359		5,983		5,937		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	9.54%		7/9/2026		7,760		7,689		7,730
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.25%	9.79%		12/2/2027		992		974		987
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.22%		8/2/2027		5,958		5,869		5,838		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.80%		4/26/2029		7,940		7,807		7,411		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.25%		8/11/2028		7,388		7,314		5,984		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.45%		4/9/2029		7,940		7,742		6,818		(4)

45

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.75%		6/30/2026		$	7,350	$	7,260	$	7,359
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	L+	5.75%	11.29%		3/25/2027		9,125		8,950		7,239		(4)
Iris Holding, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.75%	9.90%		6/28/2028		4,963		4,638		4,226
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	10.20%		10/29/2028		3,972		3,817		3,940
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.08%		10/14/2027		7,388		7,281		7,267
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	10.50%		5/9/2026		11,279		11,121		10,997		(4)
LogMeIn, Inc.	Application Software	First Lien Term Loan	L+	4.75%	9.94%		8/31/2027		7,800		7,705		4,918
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	3.50%	8.72%		9/6/2025		7,308		7,246		7,037
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.01%		3/1/2029		5,955		5,655		5,713
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	12.19%		2/14/2025		4,669		4,644		4,599		(4)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	L+	8.00%			2/14/2025		—		(3)		(7)		(4)(5)
Mitchell International Inc	Application Software	First Lien Term Loan	L+	3.75%	8.94%		10/15/2028		2,991		2,845		2,931
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026		8,340		8,172		8,111		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026		—		(3)		(9)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026		2,217		2,216		2,156		(4)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.50%	10.00%		3/31/2025		6,633		6,624		6,583
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	9.25%		9/25/2026		11,015		10,845		10,852
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	10.20%		11/10/2027		9,849		9,495		9,603		(4)
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.50%		12/17/2027		2,422		2,297		2,305
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.59%		12/18/2028		4,503		4,435		4,023		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.04%		4/6/2027		8,116		7,831		7,815		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.04%		4/6/2027		254		236		235		(4)(5)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.75%	9.99%		4/5/2030		5,000		4,855		4,948
RevSpring, Inc.	Commercial Printing	First Lien Term Loan	L+	4.00%	9.50%		10/11/2025		9,550		9,536		9,208
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	10.52%		4/27/2024		8,135		8,132		5,749
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	10.50%		4/27/2024		138		138		100
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.75%	9.97%		4/17/2028		2,985		2,564		2,768		(4)
Sorenson Communications, LLC	Communications Equipment	First Lien Term Loan	L+	5.50%	10.69%		3/17/2026		2,328		2,305		2,166		(4)
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.50%	10.70%		11/20/2028		8,865		8,729		8,655		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.70%		4/5/2029		8,801		8,426		8,710
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.84%		3/30/2029		8,235		7,548		7,722		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.20%		12/29/2028		7,230		7,116		7,050		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	L+	5.00%	10.22%		9/1/2025		6,322		6,266		5,185
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.45%		9/21/2027		7,757		7,570		7,263		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	9.03%		4/30/2025		1,970		1,917		1,791		(4)
Total Portfolio Investments									$	350,214	$	348,782	$	329,809

_________

(1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each

46

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54 %, the 180-day LIBOR at 5.73%, the 30-day SOFR at 5.10%, and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of June 30, 2023.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

47

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

SLF JV I Portfolio as of September 30, 2022

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	L+	3.75%	6.82%		2/27/2025		$	10,093	$	10,028	$	9,692
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.25%	9.80%		12/18/2025		8,518		8,389		8,371		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	6.91%		8/14/2026		3,000		2,841		2,730
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	11.20%		6/30/2025		9,267		9,166		9,221		(4)
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	L+	6.25%	9.03%		10/20/2028		4,873		4,812		4,576		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	L+	4.25%	7.92%		11/26/2026		7,800		7,722		7,527		(4)
Anastasia Parent, LLC	Personal Products	First Lien Term Loan	L+	3.75%	7.42%		8/11/2025		1,539		1,203		1,232		(4)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.46%		1/10/2025		4,615		4,580		4,519		(4)
Apptio, Inc.	Application Software	First Lien Revolver	L+	6.00%	8.46%		1/10/2025		154		151		146		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Term Loan	L+	6.00%	9.67%		12/29/2027		4,176		4,103		4,080
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Revolver	L+	6.00%			12/29/2027				(9)		(11)		(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	8.37%		10/25/2028		5,052		4,858		4,319		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	7.70%		8/19/2028		5,000		4,753		4,276
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	L+	5.25%	8.37%		1/20/2029		4,346		3,981		3,347
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	8.78%		12/24/2026		6,338		6,242		6,027		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027		6,371		6,311		6,148
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027		1,771		1,751		1,664		(4)(5)
Blackhawk Network Holdings, Inc.	Data Processing & Outsourced Services	First Lien Term Loan	L+	3.00%	6.03%		6/15/2025		9,575		9,566		8,977
BYJU's Alpha, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.98%		11/24/2026		7,444		7,347		5,455
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	5.50%	9.12%		8/10/2027		4,358		4,286		4,280
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	5.50%	9.12%		8/10/2027		449		432		413
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	5.50%			8/10/2027		—		(10)		(11)		(5)
CITGO Petroleum Corp.	Oil & Gas Refining & Marketing	First Lien Term Loan	L+	6.25%	9.37%		3/28/2024		7,038		6,967		7,057		(4)
City Football Group Limited	Movies & Entertainment	First Lien Term Loan	L+	3.50%	6.48%		7/21/2028		6,451		6,419		6,166
Convergeone Holdings, Inc.	IT Consulting & Other Services	First Lien Term Loan	L+	5.00%	8.12%		1/4/2026		7,373		7,206		5,320		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	7.65%		9/20/2029		5,375		5,053		5,035		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	7.67%		7/9/2026		5,820		5,776		5,587
Dealer Tire, LLC	Distributors	First Lien Term Loan	L+	4.25%	7.37%		12/12/2025		2,992		2,935		2,924
Delivery Hero FinCo LLC	Internet & Direct Marketing Retail	First Lien Term Loan	SOFR+	5.75%	8.49%		8/12/2027		6,035		5,876		5,756		(4)
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	L+	5.00%	8.12%		8/2/2027		6,436		6,332		6,012		(4)
Domtar Corporation	Paper Products	First Lien Term Loan	L+	5.50%	8.26%		11/30/2028		4,100		4,065		3,921
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	7.33%		4/26/2029		8,000		7,849		7,616		(4)
Eagle Parent Corp.	Industrial Machinery	First Lien Term Loan	SOFR+	4.25%	7.80%		4/2/2029		4,478		4,373		4,367
eResearch Technology, Inc.	Application Software	First Lien Term Loan	L+	4.50%	7.62%		2/4/2027		7,331		7,258		6,859

48

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	L+	5.00%	7.94%		8/11/2028		$	7,444	$	7,369	$	6,029
Global Medical Response, Inc.	Health Care Services	First Lien Term Loan	L+	4.25%	7.37%		3/14/2025		1,979		1,979		1,722		(4)
Global Medical Response, Inc.	Health Care Services	First Lien Term Loan	L+	4.25%	6.81%		10/2/2025		2,192		2,165		1,912
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	8.38%		4/9/2029		8,000		7,774		7,310		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	L+	5.25%	8.80%		6/30/2026		7,406		7,293		7,286
INW Manufacturing, LLC	Personal Products	First Lien Term Loan	L+	5.75%	9.42%		3/25/2027		9,500		9,282		8,408		(4)
Iris Holding, Inc.	Metal & Glass Containers	First Lien Term Loan	SOFR+	4.75%	7.89%		6/28/2028		5,000		4,624		4,610
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	L+	5.75%	8.23%		10/14/2027		7,444		7,318		7,323
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	L+	5.00%	8.67%		5/9/2026		7,367		7,315		7,109		(4)
LogMeIn, Inc.	Application Software	First Lien Term Loan	L+	4.75%	7.80%		8/31/2027		7,860		7,751		5,494
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	L+	3.25%	6.37%		9/6/2025		7,366		7,282		6,835
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	10.64%		2/14/2025		4,687		4,651		4,570		(4)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	L+	8.00%			2/14/2025		—		(4)		(12)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	L+	5.50%	9.17%		2/10/2026		6,139		6,104		5,966		(4)
MRI Software LLC	Application Software	First Lien Revolver	L+	5.50%			2/10/2026				(3)		(10)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	L+	4.75%	7.87%		3/31/2025		6,685		6,673		6,484
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	7.12%		9/25/2026		7,777		7,741		7,505		(4)
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	8.13%		11/10/2027		4,925		4,781		4,687		(4)
Peloton Interactive, Inc.	Leisure Products	First Lien Term Loan	SOFR+	6.50%	8.35%		5/25/2027		5,486		5,251		5,371
Planview Parent, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	10.92%		12/18/2028		4,503		4,435		4,323		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	L+	8.00%	10.68%		4/6/2027		6,796		6,694		6,582		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	L+	8.00%			4/6/2027		—		(6)		(13)		(4)(5)
RevSpring, Inc.	Commercial Printing	First Lien Term Loan	L+	4.00%	7.67%		10/11/2025		9,625		9,607		9,304
Sabert Corporation	Metal & Glass Containers	First Lien Term Loan	L+	4.50%	7.63%		12/10/2026		2,536		2,511		2,435		(4)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	8.06%		4/27/2024		8,201		8,194		7,176
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	8.04%		4/27/2024		138		138		121
Sorenson Communications, LLC	Communications Equipment	First Lien Term Loan	L+	5.50%	9.17%		3/17/2026		2,553		2,528		2,454
Spanx, LLC	Apparel Retail	First Lien Term Loan	L+	5.25%	8.30%		11/20/2028		8,933		8,776		8,721		(4)
SPX Flow, Inc.	Industrial Machinery	First Lien Term Loan	SOFR+	4.50%	7.63%		4/5/2029		7,500		7,184		6,966		(4)
Supermoose Borrower, LLC	Application Software	First Lien Term Loan	L+	3.75%	7.42%		8/29/2025		7,743		7,479		6,827		(4)
Surgery Center Holdings, Inc.	Health Care Facilities	First Lien Term Loan	L+	3.75%	6.51%		8/31/2026		3,377		3,365		3,213
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	8.15%		3/30/2029		6,256		5,693		5,629		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	L+	6.00%	9.12%		12/29/2028		7,285		7,155		7,140		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	L+	5.00%	8.67%		9/1/2025		6,365		6,290		5,087
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	L+	6.25%	9.37%		9/21/2027		7,818		7,596		7,115		(4)
WP CPP Holdings, LLC	Aerospace & Defense	Second Lien Term Loan	L+	7.75%	10.56%		4/30/2026		6,000		5,972		5,070		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	6.56%		4/30/2025		1,985		1,910		1,783		(4)
Zayo Group Holdings, Inc.	Alternative Carriers	First Lien Term Loan	L+	3.00%	6.12%		3/9/2027		2,155		2,000		1,812
Total Portfolio Investments									$	383,194	$	382,673	$	359,625

49

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

_________

(1) Represents the interest rate as of September 30, 2022. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of September 30, 2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55% and the 180-day SOFR at 3.98%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of September 30, 2022.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

50

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Both the cost and fair value of the Company's SLF JV I Notes were $112.7 million as of June 30, 2023. Both the cost and fair value of the Company's SLF JV I Notes were $96.3 million as of September 30, 2022. The Company earned interest income of $3.4 million and $9.2 million on the SLF JV I Notes for the three and nine months ended June 30, 2023, respectively. The Company earned interest income of $1.9 million and $5.8 million on the SLF JV I Notes for the three and nine months ended June 30, 2022, respectively. As of June 30, 2023, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.

The cost and fair value of the LLC equity interests in SLF JV I held by the Company were $54.8 million and $28.0 million, respectively, as of June 30, 2023, and $49.3 million and $20.7 million, respectively, as of September 30, 2022. The Company earned $1.1 million and $3.2 million in dividend income for the three and nine months ended June 30, 2023, respectively, with respect to its investment in the LLC equity interests of SLF JV I. The Company earned $0.9 million and $2.0 million in dividend income for the three and nine months ended June 30, 2022, respectively, with respect to its investment in the LLC equity interests of SLF JV I. The LLC equity interests of SLF JV I are generally dividend producing to the extent SLF JV I has residual cash to be distributed on a quarterly basis.

Below is certain summarized financial information for SLF JV I as of June 30, 2023 and September 30, 2022 and for the three and nine months ended June 30, 2023 and 2022:

	June 30, 2023		September 30, 2022
Selected Balance Sheet Information:
Investments at fair value (cost June 30, 2023:$348,782; cost September 30, 2022: $382,673)	$	329,809	$	359,625
Cash and cash equivalents	21,906		14,274
Restricted cash	8,715		5,642
Other assets	9,798		5,686
Total assets	$	370,228	$	385,227
Senior credit facility payable	$	200,000	$	230,000
SLF JV I Notes payable at fair value (proceeds June 30, 2023: $128,750; proceeds September 30, 2022: $110,000)	128,750		110,000
Other liabilities	9,509		21,539
Total liabilities	$	338,259	$	361,539
Members' equity	31,969		23,688
Total liabilities and members' equity	$	370,228	$	385,227

	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Selected Statements of Operations Information:
Interest income	$	10,312	$	5,796	$	29,106	$	16,664
Other income	—		32		62		105
Total investment income	10,312		5,828		29,168		16,769
Senior credit facility interest expense	4,190		1,929		12,004		4,995
SLF JV I Notes interest expense	3,859		2,224		10,511		6,673
Other expenses	73		77		249		198
Total expenses (1)	8,122		4,230		22,764		11,866
Net investment income	2,190		1,598		6,404		4,903
Net unrealized appreciation (depreciation)	2,652		(16,411)		4,075		(19,856)
Net realized gains (losses)	(2,137)		165		(4,850)		568
Net income (loss)	$	2,705	$	(14,648)	$	5,629	$	(14,385)

 __________

(1) There are no management fees or incentive fees charged at SLF JV I.

SLF JV I has elected to fair value the SLF JV I Notes issued to the Company and Kemper under FASB ASC Topic 825, Financial Instruments - Fair Value Option ("ASC 825"). The SLF JV I Notes are valued based on the total assets less the total liabilities senior to the SLF JV I Notes in an amount not exceeding par under the EV technique.

During the nine months ended June 30, 2023, the Company sold $18.8 million of senior secured debt investments to SLF JV I for $18.0 million cash consideration, which represented the fair value at the time of sale. A loss of $0.2 million was recognized by the Company on these transactions. During the nine months ended June 30, 2022, the Company sold $9.7 million of senior secured debt investments to SLF JV I for $9.7 million cash consideration, which represented the fair value at the time of sale. A gain of $0.5 million was recognized by the Company on these transactions.

51

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

OCSI Glick JV LLC

On March 19, 2021, the Company became party to the LLC agreement of Glick JV. The Company co-invests primarily in senior secured loans of middle-market companies with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by GF Equity Funding. The Glick JV is capitalized as transactions are completed, and portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, which consists of one representative selected by the Company and one representative selected by GF Equity Funding (with approval from a representative of each required). Since the Company does not have a controlling financial interest in the Glick JV, the Company does not consolidate the Glick JV.

The members provide capital to the Glick JV in exchange for LLC equity interests, and the Company and GF Debt Funding 2014 LLC ("GF Debt Funding"), an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV (the "Glick JV Notes"). As of June 30, 2023 and September 30, 2022, the Company and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and the Company and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.

The Glick JV has a senior revolving credit facility with Deutsche Bank AG, New York Branch (the "Glick JV Deutsche Bank Facility"), which, as of June 30, 2023, had a reinvestment period end date and maturity date of May 3, 2024 and May 3, 2028, respectively, and permitted borrowings of up to $90.0 million (subject to borrowing base and other limitations). Borrowings under the Glick JV Deutsche Bank Facility are secured by all of the assets of the Glick JV and all of the equity interests in the Glick JV and, as of June 30, 2023, bore interest at a rate equal to 3-month SOFR plus 2.50% per annum until November 3, 2023, 3-month SOFR plus 2.75% during the remainder of the reinvestment period, 3-month SOFR plus 3.25% for the first year after the end of the reinvestment period, 3-month SOFR plus 3.35% for the following year and 3-month SOFR plus 3.60% thereafter, in each case with a 0.125% SOFR floor. $66.1 million and $82.1 million of borrowings were outstanding under the Glick JV Deutsche Bank Facility as of June 30, 2023 and September 30, 2022, respectively.

As of June 30, 2023 and September 30, 2022, the Glick JV had total assets of $126.8 million and $146.8 million, respectively. The Glick JV's portfolio consisted of middle-market and other corporate debt securities of 37 and 43 portfolio companies as of June 30, 2023 and September 30, 2022, respectively. The portfolio companies in the Glick JV are in industries similar to those in which the Company may invest directly. The Company's investment in the Glick JV consisted of LLC equity interests and Glick JV Notes of $49.6 million and $50.3 million in the aggregate at fair value as of June 30, 2023 and September 30, 2022, respectively. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by the Company to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.

As of each of June 30, 2023 and September 30, 2022, the Glick JV had total capital commitments of $100.0 million, $87.5 million of which was from the Company and the remaining $12.5 million of which was from GF Equity Funding and GF Debt Funding. Approximately $84.0 million in aggregate commitments were funded as of each of June 30, 2023 and September 30, 2022, of which $73.5 million was from the Company. As of each of June 30, 2023 and September 30, 2022, the Company had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million were unfunded. As of each of June 30, 2023 and September 30, 2022, the Company had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million were unfunded.

52

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of June 30, 2023 and September 30, 2022:

	June 30, 2023	September 30, 2022
Senior secured loans (1)	$123,126	$143,225
Weighted average current interest rate on senior secured loans (2)	10.66%	8.52%
Number of borrowers in the Glick JV	37	43
Largest loan exposure to a single borrower (1)	$6,313	$6,562
Total of five largest loan exposures to borrowers (1)	$28,457	$28,973

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Glick JV Portfolio as of June 30, 2023

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025	$	587	$	579	$	576	(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025	3,824		3,782		3,753		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.89%		6/30/2025	6,313		6,261		6,029		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.22%		6/9/2028	2,485		2,367		2,346
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.49%		10/20/2028	2,868		2,832		2,502		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.00%	9.39%		11/26/2026	2,903		2,873		2,895
Amynta Agency Borrower Inc.	Property & Casualty Insurance	First Lien Term Loan	SOFR+	5.00%	10.20%		2/28/2028	3,000		2,915		2,925
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.25%		8/11/2025	910		707		702		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.31%		12/29/2027	1,721		1,695		1,635		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027	—		(3)		(10)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	10.44%		10/25/2028	2,078		2,037		1,464		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.20%		8/19/2028	1,985		1,900		1,884
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.47%		8/19/2028	998		941		951
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.47%		1/20/2029	2,423		2,236		2,039
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%	8.59%		2/15/2029	1,777		1,674		1,715
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%			2/15/2029	—		(13)		(8)		(5)
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	11.27%		12/24/2026	3,628		3,583		3,479		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027	3,372		3,340		3,284		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027	802		798		782		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.24%		10/13/2029	2,773		2,607		2,589		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	9.54%		7/9/2026	2,848		2,827		2,838
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.22%		8/2/2027	2,528		2,502		2,477		(4)

53

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.80%		4/26/2029	$	2,978	$	2,928	$	2,779	(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.25%		8/11/2028	3,940		3,901		3,191		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.45%		4/9/2029	3,970		3,871		3,409		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.75%		6/30/2026	3,920		3,872		3,925
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	L+	5.75%	11.29%		3/25/2027	2,281		2,238		1,810		(4)
Iris Holding, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.75%	9.90%		6/28/2028	1,985		1,852		1,690
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.08%		10/14/2027	3,940		3,883		3,876
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	3.50%	8.72%		9/6/2025	1,347		1,224		1,297
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026	1,634		1,621		1,589		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026	—		(1)		(4)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.50%	10.00%		3/31/2025	5,211		5,205		5,172
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	9.25%		9/25/2026	3,858		3,841		3,802
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.50%		12/17/2027	685		649		652
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.59%		12/18/2028	2,842		2,799		2,539		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.04%		4/6/2027	5,182		5,018		4,990		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.04%		4/6/2027	180		169		167		(4)(5)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	10.52%		4/27/2024	6,045		6,039		4,272
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	10.50%		4/27/2024	102		102		74
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.50%	10.70%		11/20/2028	4,925		4,849		4,808		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.70%		4/5/2029	5,227		5,023		5,174
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.84%		3/30/2029	2,647		2,435		2,483		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.20%		12/29/2028	3,001		2,954		2,926		(4)
Tribe Buyer LLC	Human Resource & Employment Services	First Lien Term Loan	L+	4.50%	9.69%		2/16/2024	1,570		1,570		931
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.45%		9/21/2027	4,848		4,731		4,539		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	9.03%		4/30/2025	985		959		895		(4)
Total Portfolio Investments								$	123,126	$	120,172	$	113,833

__________

(1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 30-day SOFR at 5.10% and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and the Glick JV as of June 30, 2023.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

54

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Glick JV Portfolio as of September 30, 2022

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	L+	6.25%	9.80%		12/18/2025	$	4,647	$	4,579	$	4,567	(4)
Alvogen Pharma Inc	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	11.20%		6/30/2025	6,562		6,489		6,529		(4)
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	L+	6.25%	9.03%		10/20/2028	2,889		2,853		2,714		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	L+	4.25%	7.92%		11/26/2026	2,925		2,896		2,823		(4)
Anastasia Parent, LLC	Personal Products	First Lien Term Loan	L+	3.75%	7.42%		8/11/2025	917		712		734		(4)
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Term Loan	L+	6.00%	9.67%		12/29/2027	1,734		1,704		1,694
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Revolver	L+	6.00%			12/29/2027	—		(4)		(5)		(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	8.37%		10/25/2028	2,078		2,033		1,777		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	7.70%		8/19/2028	2,000		1,901		1,711
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	L+	5.25%	8.37%		1/20/2029	2,423		2,212		1,866
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	8.78%		12/24/2026	3,656		3,601		3,476		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027	3,398		3,366		3,279
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027	808		800		760		(4)(5)
BYJU's Alpha, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.98%		11/24/2026	3,970		3,919		2,909
CITGO Petroleum Corp.	Oil & Gas Refining & Marketing	First Lien Term Loan	L+	6.25%	9.37%		3/28/2024	3,519		3,484		3,529		(4)
City Football Group Limited	Movies & Entertainment	First Lien Term Loan	L+	3.50%	6.48%		7/21/2028	2,481		2,469		2,372
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	7.65%		9/20/2029	2,280		2,143		2,136		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	7.67%		7/9/2026	2,870		2,849		2,756
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	L+	5.00%	8.12%		8/2/2027	2,730		2,703		2,549		(4)
Domtar Corporation	Paper Products	First Lien Term Loan	L+	5.50%	8.26%		11/30/2028	2,503		2,478		2,394
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	7.33%		4/26/2029	3,000		2,943		2,856		(4)
Eagle Parent Corp.	Industrial Machinery	First Lien Term Loan	SOFR+	4.25%	7.80%		4/2/2029	2,488		2,429		2,426
eResearch Technology, Inc.	Application Software	First Lien Term Loan	L+	4.50%	7.62%		2/4/2027	2,444		2,419		2,286
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	L+	5.00%	7.94%		8/11/2028	3,970		3,930		3,216
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	8.38%		4/9/2029	4,000		3,887		3,655		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	L+	5.25%	8.80%		6/30/2026	3,950		3,890		3,886
INW Manufacturing, LLC	Personal Products	First Lien Term Loan	L+	5.75%	9.42%		3/25/2027	2,375		2,320		2,102		(4)
Iris Holding, Inc.	Metal & Glass Containers	First Lien Term Loan	SOFR+	4.75%	7.89%		6/28/2028	2,000		1,846		1,844
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	L+	5.75%	8.23%		10/14/2027	3,970		3,903		3,905
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	L+	3.25%	6.37%		9/6/2025	1,358		1,192		1,260

55

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
MRI Software LLC	Application Software	First Lien Term Loan	L+	5.50%	9.17%		2/10/2026	$	1,647	$	1,632	$	1,600	(4)
MRI Software LLC	Application Software	First Lien Revolver	L+	5.50%			2/10/2026	—		(1)		(4)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	L+	4.75%	7.87%		3/31/2025	5,252		5,243		5,095
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	7.12%		9/25/2026	3,888		3,871		3,752		(4)
Planview Parent, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	10.92%		12/18/2028	2,842		2,799		2,728		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	L+	8.00%	10.68%		4/6/2027	4,465		4,398		4,325		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	L+	8.00%			4/6/2027	—		(5)		(10)		(4)(5)
Sabert Corporation	Metal & Glass Containers	First Lien Term Loan	L+	4.50%	7.63%		12/10/2026	1,691		1,674		1,623		(4)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	8.06%		4/27/2024	6,094		6,082		5,332
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	8.04%		4/27/2024	102		102		90
Spanx, LLC	Apparel Retail	First Lien Term Loan	L+	5.25%	8.30%		11/20/2028	4,962		4,876		4,845		(4)
SPX Flow, Inc.	Industrial Machinery	First Lien Term Loan	SOFR+	4.50%	7.63%		4/5/2029	6,000		5,734		5,572		(4)
Supermoose Borrower, LLC	Application Software	First Lien Term Loan	L+	3.75%	7.42%		8/29/2025	2,820		2,712		2,487		(4)
Surgery Center Holdings, Inc.	Health Care Facilities	First Lien Term Loan	L+	3.75%	6.51%		8/31/2026	3,377		3,365		3,213
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	8.15%		3/30/2029	2,654		2,415		2,388		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	L+	6.00%	9.12%		12/29/2028	3,024		2,970		2,963		(4)
Tribe Buyer LLC	Human Resource & Employment Services	First Lien Term Loan	L+	4.50%	7.62%		2/16/2024	1,583		1,582		1,266
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	L+	6.25%	9.37%		9/21/2027	4,886		4,747		4,447		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	6.56%		4/30/2025	993		955		892		(4)
WP CPP Holdings, LLC	Aerospace & Defense	Second Lien Term Loan	L+	7.75%	10.56%		4/30/2026	3,000		2,986		2,534		(4)
Total Portfolio Investments								$	143,225	$	140,083	$	133,144

__________

(1) Represents the interest rate as of September 30, 2022. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of September 30, 2022, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 30-day SOFR at 3.03% and the 90-day SOFR at 3.55%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and the Glick JV as of September 30, 2022.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

The cost and fair value of the Company's aggregate investment in the Glick JV was $50.0 million and $49.6 million, respectively, as of June 30, 2023. The cost and fair value of the Company's aggregate investment in the Glick JV was $50.2 million and $50.3 million, respectively, as of September 30, 2022. For the three and nine months ended June 30, 2023, the Company's investment in the Glick JV Notes earned interest income of $1.8 million and $5.0 million, respectively. For the three and nine months ended June 30, 2022, the Company's investment in the Glick JV Notes earned interest income of $1.2 million and $3.3 million, respectively. The Company did not earn dividend income for the three and nine months ended June 30, 2023 and June 30, 2022 with respect to its investment in the LLC equity interest of the Glick JV. As of June 30, 2023, the Glick JV Notes bore interest at a rate of one-month LIBOR plus 4.50% per annum and will mature on October 20, 2028.

56

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Below is certain summarized financial information for the Glick JV as of June 30, 2023 and September 30, 2022 and for the three and nine months ended June 30, 2023 and June 30, 2022:

	June 30, 2023		September 30, 2022
Selected Balance Sheet Information:
Investments at fair value (cost June 30, 2023: $120,172; September 30, 2022: $140,083)	$	113,833	$	133,144
Cash and cash equivalents	8,895		7,021
Restricted cash	1,812		1,788
Other assets	2,284		4,855
Total assets	$	126,824	$	146,808
Senior credit facility payable	$	66,082	$	82,082
Glick JV Notes payable at fair value (proceeds June 30, 2023: $66,684; September 30, 2022: $68,185)	56,723		57,463
Other liabilities	4,019		7,263
Total liabilities	$	126,824	$	146,808
Members' equity	—		—
Total liabilities and members' equity	$	126,824	$	146,808

	For the three months ended June 30, 2023		For the three months ended June 30, 2022		For the nine months ended June 30, 2023		For the nine months ended June 30, 2022
Selected Statements of Operations Information:
Interest income	$	3,576	$	2,416	$	10,488	$	6,796
Fee income	—		47		35		82
Total investment income	3,576		2,463		10,523		6,878
Senior credit facility interest expense	1,400		694		4,002		1,742
Glick JV Notes interest expense	1,577		860		4,394		2,479
Other expenses	70		59		148		127
Total expenses (1)	3,047		1,613		8,544		4,348
Net investment income	529		850		1,979		2,530
Net unrealized appreciation (depreciation)	431		(753)		(159)		(2,549)
Realized gain (loss)	(960)		(97)		(1,820)		19
Net income (loss)	$	—	$	—	$	—	$	—

__________

(1) There are no management fees or incentive fees charged at the Glick JV.

The Glick JV has elected to fair value the Glick JV Notes issued to the Company and GF Debt Funding under ASC 825. The Glick JV Notes are valued based on the total assets less the liabilities senior to the Glick JV Notes in an amount not exceeding par under the EV technique.

During the three and nine months ended June 30, 2023 and 2022, the Company did not sell any debt investments to the Glick JV.

57

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Note 4. Fee Income

For the three and nine months ended June 30, 2023, the Company recorded total fee income of $1.6 million and $6.0 million, respectively, of which $0.2 million and $0.8 million, respectively, was recurring in nature. For the three and nine months ended June 30, 2022, the Company recorded total fee income of $2.3 million and $5.1 million, respectively, of which $0.2 million and $0.7 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees and certain exit fees.

Note 5. Share Data and Net Assets

The share and per share information for periods prior to March 31, 2023 disclosed in Note 5 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the three and nine months ended June 30, 2023 and 2022:

(Share amounts in thousands)	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations	$	36,685	$	(37,834)	$	71,379	$	16,015
Weighted average common shares outstanding — basic and diluted	77,080		61,123		70,431		60,593
Earnings (loss) per common share — basic and diluted	$	0.48	$	(0.62)	$	1.01	$	0.26

58

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Changes in Net Assets

The following table presents the changes in net assets for the three and nine months ended June 30, 2023:

	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2022	61,125	$	611	$	1,827,721	$	(582,769)	$	1,245,563
Net investment income	—	—		—		38,808		38,808
Net unrealized appreciation (depreciation)	—	—		—		(22,982)		(22,982)
Net realized gains (losses)	—	—		—		(3,203)		(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		549		549
Distributions to stockholders	—	—		—		(58,679)		(58,679)
Issuance of common stock under dividend reinvestment plan	95	1		1,932		—		1,933
Balance as of December 31, 2022	61,220	$	612	$	1,829,653	$	(628,276)	$	1,201,989
Net investment income	—	—		—		45,978		45,978
Net unrealized appreciation (depreciation)	—	—		—		(18,279)		(18,279)
Net realized gains (losses)	—	—		—		(6,111)		(6,111)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(66)		(66)
Distributions to stockholders	—	—		—		(42,395)		(42,395)
Issuance of common stock in connection with the OSI2 Merger	15,860	159		333,875		—		334,034
Issuance of common stock under dividend reinvestment plan	68	1		1,294		—		1,295
Repurchase of common stock under dividend reinvestment plan	(68)	(1)		(1,294)		—		(1,295)
Balance as of March 31, 2023	77,080	$	771	$	2,163,528	$	(649,149)	$	1,515,150
Net investment income	—	—		—		48,413		48,413
Net unrealized appreciation (depreciation)	—	—		—		(1,039)		(1,039)
Net realized gains (losses)	—	—		—		(10,603)		(10,603)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(86)		(86)
Distributions to stockholders	—	—		—		(42,394)		(42,394)
Issuance of common stock under dividend reinvestment plan	57	1		1,122		—		1,123
Repurchase of common stock under dividend reinvestment plan	(57)	(1)		(1,122)		—		(1,123)
Balance as of June 30, 2023	77,080	$	771	$	2,163,528	$	(654,858)	$	1,509,441

59

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following table presents the changes in net assets for the three and nine months ended June 30, 2022:

	Common Stock
	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2021	60,120	$	601	$	1,805,557	$	(493,335)	$	1,312,823
Net investment income	—	—		—		32,295		32,295
Net unrealized appreciation (depreciation)	—	—		—		(4,586)		(4,586)
Net realized gains (losses)	—	—		—		9,321		9,321
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		2,378		2,378
Distributions to stockholders	—	—		—		(27,956)		(27,956)
Issuance of common stock under dividend reinvestment plan	36	1		785		—		786
Balance as of December 31, 2021	60,156	$	602	$	1,806,342	$	(481,883)	$	1,325,061
Net investment income	—	—		—		40,098		40,098
Net unrealized appreciation (depreciation)	—	—		—		(27,038)		(27,038)
Net realized gains (losses)	—	—		—		1,402		1,402
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(21)		(21)
Distributions to stockholders	—	—		—		(29,271)		(29,271)
Issuance of common stock in connection with the "at the market" offering	877	9		19,370		—		19,379
Issuance of common stock under dividend reinvestment plan	35	—		766		—		766
Balance as of March 31, 2022	61,068	$	611	$	1,826,478	$	(496,713)	$	1,330,376
Net investment income	—	—		—		40,370		40,370
Net unrealized appreciation (depreciation)	—	—		—		(86,755)		(86,755)
Net realized gains (losses)	—	—		—		9,212		9,212
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(661)		(661)
Distributions to stockholders	—	—		—		(30,256)		(30,256)
Issuance of common stock in connection with the "at the market" offering	57	—		1,243		—		1,243
Issuance of common stock under dividend reinvestment plan	44	1		873		—		874
Repurchases of common stock under dividend reinvestment plan	(44)	(1)		(873)		—		(874)
Balance as of June 30, 2022	61,125	$	611	$	1,827,721	$	(564,803)	$	1,263,529

Distributions

Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment.

The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP.

For income tax purposes, the Company has reported its distributions for the 2022 calendar year as ordinary income. The character of such distributions was appropriately reported to the Internal Revenue Service and stockholders for the 2022 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders.

60

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the nine months ended June 30, 2023 and 2022:

Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution (3)			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	November 10, 2022	December 15, 2022	December 30, 2022	$	0.54	$	32.0	million	53,369	(1)	$	1.1	million
Special	November 10, 2022	December 15, 2022	December 30, 2022	0.42		24.8		million	41,510	(1)	0.8		million
Quarterly	January 27, 2023	March 15, 2023	March 31, 2023	0.55		41.1		million	68,412	(2)	1.3		million
Quarterly	April 28, 2023	June 15, 2023	June 30, 2023	0.55		41.3		million	57,279	(2)	1.1		million
Total for the nine months ended June 30, 2023				$	2.06	$	139.1	million	220,570		$	4.4	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	October 13, 2021	December 15, 2021	December 31, 2021	$	0.465	$	27.2	million	35,990	(1)	$	0.8	million
Quarterly	January 28, 2022	March 15, 2022	March 31, 2022	0.48		28.5 million			34,804	(1)	0.8 million
Quarterly	April 29, 2022	June 15, 2022	June 30, 2022	0.495		29.4 million			43,676	(2)	0.9 million
Total for the nine months ended June 30, 2022				$	1.44	$	85.1	million	114,470		$	2.4	million

 __________

(1) New shares were issued and distributed.

(2) Shares were purchased on the open market and distributed.

(3) Totals may not sum due to rounding.

Common Stock Issuances

On January 23, 2023, in connection with the OSI2 Merger, the Company issued an aggregate of 15,860,200 shares of common stock to former OSI2 stockholders. During the three and nine months ended June 30, 2023, the Company issued zero and 94,879 shares of common stock, respectively, as part of the DRIP. During the three and nine months ended June 30, 2022, the Company issued an aggregate of zero and 70,794 shares of common stock, respectively, as part of the DRIP.

On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of the Company’s common stock having an aggregate offering price of up to $125 million under the Company’s current registration statement. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.

In connection with the "at the market" offering, the Company did not issue or sell any shares of common stock during the nine months ended June 30, 2023. In connection with the "at the market" offering, the Company issued and sold 2,801,206 shares of common stock during the nine months ended June 30, 2022 for net proceeds of $20.6 million (net of offering costs).

Note 6. Borrowings

Syndicated Facility

On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans,

61

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.

As of June 30, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.

As of June 30, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.

The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of June 30, 2023, except for assets that were held by OSI 2 Senior Lending SPV, LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility.

The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of June 30, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.

As of June 30, 2023 and September 30, 2022, the Company had $800.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $800.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 6.584% and 2.406% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $14.3 million and $37.4 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $4.8 million and $12.6 million, respectively, related to the Syndicated Facility.

Citibank Facility

On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. In connection with the termination of the Citibank Facility, the Company accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023.

As of September 30, 2022, the Company had $160.0 million outstanding under the Citibank Facility, which had a fair value of $160.0 million. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.762% and 2.563% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $2.4 million and $8.0 million, respectively, related

62

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

to the Citibank Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $1.6 million and $3.5 million, respectively, related to the Citibank Facility.

OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

As of June 30, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

As of June 30, 2023, the Company had $335.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $335.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.275% for the period from January 23, 2023 to June 30, 2023. For the three months ended June 30, 2023 and the period from January 23, 2023 to June 30, 2023, the Company recorded interest expense (inclusive of fees) of $4.9 million and $8.0 million, respectively, related to the OSI2 Citibank Facility.

2025 Notes

On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.

The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2025 Notes in the open market.

63

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.

2027 Notes

On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.

The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2027 Notes in the open market.

The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.

In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.

64

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of June 30, 2023 and September 30, 2022:

	As of June 30, 2023				As of September 30, 2022
($ in millions)	2025 Notes		2027 Notes		2025 Notes		2027 Notes
Principal	$	300.0	$	350.0	$	300.0	$	350.0
Unamortized financing costs	(1.2)		(2.7)		(1.8)		(3.2)
Unaccreted discount	(0.8)		(0.6)		(1.2)		(0.7)
Interest rate swap fair value adjustment	—		(39.6)		—		(42.0)
Net carrying value	$	298.0	$	307.1	$	297.0	$	304.1
Fair Value	$	285.7	$	302.3	$	283.1	$	294.0

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2023:

($ in millions)	2025 Notes						2027 Notes
	Three months ended June 30, 2023			Nine months ended June 30, 2023			Three months ended June 30, 2023			Nine months ended June 30, 2023
Coupon interest	$	2.6		$	7.9		$	2.4		$	7.1
Amortization of financing costs and discount	0.3			0.9			0.2			0.7
Effect of interest rate swap	—			—			3.7			9.4
Total interest expense	$	2.9		$	8.8		$	6.3		$	17.2
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	3.500		%	3.500		%	6.912		%	6.274		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2022:

($ in millions)	2025 Notes						2027 Notes
	Three months ended June 30, 2022			Nine months ended June 30, 2022			Three months ended June 30, 2022			Nine months ended June 30, 2022
Coupon interest	$	2.6		$	7.9		$	2.4		$	7.1
Amortization of financing costs and discount	0.3			0.9			0.2			0.7
Effect of interest rate swap	—			—			(0.1)			(1.6)
Total interest expense	$	2.9		$	8.8		$	2.5		$	6.2
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	3.500		%	3.500		%	2.572		%	2.069		%

 Note 7. Taxable/Distributable Income and Dividend Distributions

Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans.

As of September 30, 2022, the Company had net capital loss carryforwards of $523.7 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $64.5 million are available to offset future short-term capital gains and $459.2 million are available to offset future long-term capital gains. A portion of such net capital loss carryfowards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations.

65

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three and nine months ended June 30, 2023 and 2022.

	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Net increase (decrease) in net assets resulting from operations	$	36,685	$	(37,834)	$	71,379	$	16,015
Net unrealized (appreciation) depreciation	1,039		86,755		42,300		118,379
Book/tax difference due to organizational costs	—		(21)		—		(65)
Book/tax difference due to capital losses utilized	12,118		(3,736)		20,380		(19,183)
Other book/tax differences	(3,825)		(8,819)		(14,912)		(18,597)
Taxable/Distributable Income (1)	$	46,017	$	36,345	$	119,147	$	96,549

 __________

(1) The Company's taxable income for the three and nine months ended June 30, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2023. Therefore, the final taxable income may be different than the estimate.

The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.

When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of June 30, 2023, $6.1 million of the $8.8 million deferred tax assets would not more likely than not be realized in future periods. As of June 30, 2023, the Company recorded a net deferred tax asset of $2.7 million on the Consolidated Statements of Assets and Liabilities.

For the three months ended June 30, 2023, the Company recognized a total expense for income tax related to realized and unrealized gains (losses) of $0.1 million, which was composed of (i) a current income tax expense of approximately $1.0 million and (ii) a deferred income tax benefit of approximately $0.9 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries.

For the nine months ended June 30, 2023, the Company recognized a total benefit for income tax related to realized and unrealized gains (losses) of $0.4 million, which was composed of (i) a current income tax expense of approximately $0.6 million and (ii) a deferred income tax benefit of approximately $1.0 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries.

As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:

Undistributed ordinary income, net	$	(43,624)
Net realized capital losses	473,274
Unrealized losses, net	153,119
Accumulated overdistributed earnings	$	582,769

The aggregate cost of investments for U.S. federal income tax purposes was $2,654.3 million as of September 30, 2022. As of September 30, 2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $466.9 million. As of September 30, 2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was

66

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

$620.0 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $153.1 million.

Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation

Realized Gains or Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.

During the three months ended June 30, 2023, the Company recorded an aggregate net realized loss of $10.6 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	(6.3)
Aden & Anais Merger Sub Inc.	(5.2)
Radiology Partners Inc.	(3.8)
WP CPP Holdings LLC	(1.3)
Tersera Therapeutics LLC	5.2
Other, net	0.8
Total, net	$	(10.6)

During the three months ended June 30, 2022, the Company recorded an aggregate net realized gain of $9.2 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	8.8
Other, net	0.4
Total, net	$	9.2

During the nine months ended June 30, 2023, the Company recorded an aggregate net realized loss of $19.9 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	(5.5)
Aden & Anais Merger Sub Inc.	(5.2)
Radiology Partners Inc.	(4.2)
Carvana Co.	(2.8)
ASP Unifrax Holdings Inc.	(2.1)
WP CPP Holdings LLC	(1.3)
Global Medical Response Inc.	(1.0)
Tersera Therapeutics LLC	5.2
Other, net	(3.0)
Total, net	$	(19.9)

67

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

During the nine months ended June 30, 2022, the Company recorded an aggregate net realized gain of $19.9 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	12.2
OmniSYS Acquisition Corporation	2.2
First Star Speir Aviation Limited	1.9
TigerConnect Inc.	1.8
Other, net	1.8
Total, net	$	19.9

Net Unrealized Appreciation or Depreciation

Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation.

During the three months ended June 30, 2023 and 2022, the Company recorded net unrealized depreciation of $1.0 million and $86.8 million, respectively. For the three months ended June 30, 2023, this consisted of $9.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation on equity investments, partially offset by $5.0 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $4.6 million of net unrealized appreciation of foreign currency forward contracts. For the three months ended June 30, 2022, this consisted of $66.8 million of net unrealized depreciation on debt investments, $17.9 million of net unrealized depreciation on equity investments, $1.6 million of net unrealized depreciation of foreign currency forward contracts and $0.4 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains).

During the nine months ended June 30, 2023 and 2022, the Company recorded net unrealized depreciation of $42.3 million and $118.4 million, respectively. For the nine months ended June 30, 2023, this consisted of $54.3 million of net unrealized depreciation on debt investments and $4.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $11.8 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $5.1 million of net unrealized appreciation on equity investments. For the nine months ended June 30, 2022, this consisted of $84.6 million of net unrealized depreciation on debt investments, $23.8 million of net unrealized depreciation on equity investments, $9.2 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains) and $0.8 million of net unrealized depreciation of foreign currency forward contracts.

During the nine months ended June 30, 2023, unrealized depreciation included a one-time unrealized loss of $20.7 million that resulted solely from accounting adjustments related to the OSI2 Merger.

Note 9. Concentration of Credit Risks

The Company deposits its cash with financial institutions and at times such balances are in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

Note 10. Related Party Transactions

As of June 30, 2023 and September 30, 2022, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $20.1 million and $15.9 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree.

Investment Advisory Agreement

The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a

68

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company.

From October 17, 2017 through May 3, 2020, the Company was externally managed by OCM pursuant to an investment advisory agreement. On May 4, 2020, OCM effected the novation of such investment advisory agreement to Oaktree. Immediately following such novation, the Company and Oaktree entered into a new investment advisory agreement with the same terms, including fee structure, as the investment advisory agreement with OCM. The investment advisory agreement with Oaktree was subsequently amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the closing of OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree and, prior to its novation, with OCM.

Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company.

Base Management Fee

Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger.

For the three and nine months ended June 30, 2023, the base management fee incurred under the Investment Advisory Agreement was $10.5 million (net of waiver) and $29.4 million (net of waiver), respectively. For the three and nine months ended June 30, 2022, the base management fee incurred under the Investment Advisory Agreement was $9.1 million (net of waiver) and $27.6 million (net of waiver), respectively.

Incentive Fee

The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature.

For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from

69

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income.

Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows:

•No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets;

•100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and

•For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved.

There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle.

For the three and nine months ended June 30, 2023, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $9.6 million and $26.3 million, respectively. For the three and nine months ended June 30, 2022, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $6.5 million and $19.7 million, respectively.

Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of June 30, 2023, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of June 30, 2023 under the Investment Advisory Agreement, no Part II incentive fees would be payable.

GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital

70

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three and nine months ended June 30, 2023, there were no accrued capital gains incentive fees. For the three and nine months ended June 30, 2022, $6.8 million and $8.8 million of accrued capital gains incentive fees were reversed, respectively. As of June 30, 2023, the total accrued capital gains incentive fee liability was zero.

Indemnification

The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser.

Administrative Services

The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation.

Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies.

For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities.

For the three months ended June 30, 2023 and 2022, the Company accrued administrative expenses of $0.4 million and $0.3 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively. For the nine months ended June 30, 2023 and 2022, the Company accrued administrative expenses of $1.2 million and $1.2 million, respectively, including $0.2 million and $0.2 million of general and administrative expenses, respectively.

71

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

As of June 30, 2023 and September 30, 2022, $7.7 million and $3.2 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.

72

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Note 11. Financial Highlights

(Share amounts in thousands)	Three months ended June 30, 2023	Three months ended June 30, 2022 (7)	Nine months ended June 30, 2023	Nine months ended June 30, 2022 (7)
Net asset value per share at beginning of period	$19.66	$21.79	$20.38	$21.84
Net investment income (1)	0.63	0.66	1.89	1.86
Net unrealized appreciation (depreciation) (1)(8)	(0.02)	(1.42)	(0.36)	(1.95)
Net realized gains (losses) (1)	(0.14)	0.15	(0.28)	0.33
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	(0.01)	0.01	0.03
Distributions of net investment income to stockholders	(0.55)	(0.50)	(2.06)	(1.44)
Net asset value per share at end of period	$19.58	$20.67	$19.58	$20.67
Per share market value at beginning of period	$18.77	$22.11	$18.00	$21.18
Per share market value at end of period	$19.43	$19.65	$19.43	19.65
Total return (2)	6.42%	(8.93)%	19.58%	(0.79)%
Common shares outstanding at beginning of period	77,080	61,068	61,125	60,120
Common shares outstanding at end of period	77,080	61,125	77,080	61,125
Net assets at beginning of period	$1,515,150	$1,330,376	$1,245,563	$1,312,823
Net assets at end of period	$1,509,441	$1,263,529	$1,509,441	$1,263,529
Average net assets (3)	$1,526,644	$1,306,727	$1,407,814	$1,323,232
Ratio of net investment income to average net assets (4)	12.72%	12.39%	12.65%	11.39%
Ratio of total expenses to average net assets (4)	14.45%	7.22%	14.07%	7.94%
Ratio of net expenses to average net assets (4)	14.05%	6.99%	13.69%	7.71%
Ratio of portfolio turnover to average investments at fair value	7.48%	4.73%	18.43%	21.44%
Weighted average outstanding debt (5)	$1,756,758	$1,369,615	$1,640,062	$1,358,150
Average debt per share (1)	$22.79	$22.41	$23.29	$22.41
Asset coverage ratio at end of period (6)	182.05%	187.82%	182.05%	187.82%

 __________

(1)	Calculated based upon weighted average shares outstanding for the period.
(2)	Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)	Calculated based upon the weighted average net assets for the period.
(4)	Interim periods are annualized.
(5)	Calculated based upon the weighted average of principal debt outstanding for the period.
(6)	Based on outstanding senior securities of $1,785.0 million and $1,395.0 million as of June 30, 2023 and 2022, respectively.
(7)	The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(8)	For the nine months ended June 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger.

73

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Note 12. Derivative Instruments

The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of June 30, 2023, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.

In connection with the issuance of the 2027 Notes, the Company entered into an interest rate swap agreement with the Royal Bank of Canada pursuant to an ISDA Master Agreement. As of June 30, 2023, the Company paid $40.0 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreement, which is included in due from broker on the Consolidated Statement of Assets and Liabilities.

Certain information related to the Company’s foreign currency forward contracts is presented below as of June 30, 2023.

Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	78,866	€	71,658	8/10/2023	$	531	$	—	Derivative asset
Foreign currency forward contract	$	71,438	£	56,556	8/10/2023	$	—	$	482	Derivative asset
						$	531	$	482

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022.

Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	43,179	€	41,444	11/10/2022	$	2,466	$	—	Derivative asset
Foreign currency forward contract	$	45,692	£	37,033	11/10/2022	$	4,323	$	—	Derivative asset
						$	6,789	$	—

Certain information related to the Company’s interest rate swap is presented below as of June 30, 2023.

Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	39,567	Derivative liability
				$	—	$	39,567

Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022.

Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	41,969	Derivative liability
				$	—	$	41,969

Note 13. Commitments and Contingencies

Off-Balance Sheet Arrangements

The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of June 30, 2023, the Company's only off-balance sheet arrangements consisted of $274.4 million of unfunded commitments, which was comprised of $247.3 million to provide debt and equity

74

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, the Company's only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.

A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of June 30, 2023 and September 30, 2022 is shown in the table below:

75

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

	June 30, 2023		September 30, 2022
107-109 Beech OAK22 LLC	$	30,922	$	—
Fairbridge Strategic Capital Funding LLC	20,382		22,150
Delta Leasing SPV II LLC	18,822		27,187
BioXcel Therapeutics, Inc.	14,543		11,785
OCSI Glick JV LLC	13,998		13,998
Senior Loan Fund JV I, LLC	13,125		35,000
SiO2 Medical Products, Inc.	10,765		—
MND Holdings III Corp	8,470		—
Seres Therapeutics, Inc.	8,090		—
iCIMs, Inc.	7,704		6,930
Dominion Diagnostics, LLC	7,664		11,148
Marinus Pharmaceuticals, Inc.	7,139		5,734
Assembled Brands Capital LLC	7,062		2,008
Grove Hotel Parcel Owner, LLC	5,286		4,293
scPharmaceuticals Inc.	5,212		—
Innocoll Pharmaceuticals Limited	5,200		4,195
Avalara, Inc.	5,047		—
Mindbody, Inc.	4,762		4,000
Accupac, Inc.	4,500		4,605
Mesoblast, Inc.	4,405		3,553
107 Fair Street LLC	4,322		—
Harrow Health, Inc.	4,011		—
Inventus Power, Inc.	3,792		—
Establishment Labs Holdings Inc.	3,384		5,075
MRI Software LLC	3,302		5,196
OTG Management, LLC	3,190		3,789
PRGX Global, Inc.	3,127		2,518
Salus Workers' Compensation, LLC	3,102		—
ADC Therapeutics SA	3,020		3,020
Relativity ODA LLC	2,762		2,218
112-126 Van Houten Real22 LLC	2,703		—
LSL Holdco, LLC	2,650		427
Supreme Fitness Group NY Holdings, LLC	2,540		1,527
Pluralsight, LLC	2,395		3,532
SCP Eye Care Services, LLC	2,356		—
Spanx, LLC	2,185		2,226
Tahoe Bidco B.V.	2,162		1,741
Coupa Holdings, LLC	2,075		—
Galileo Parent, Inc.	2,061		—
Oranje Holdco, Inc.	1,904		—
Apptio, Inc.	1,885		1,338
Kings Buyer, LLC	1,771		1,537
MHE Intermediate Holdings, LLC	1,536		1,429
PPW Aero Buyer, Inc.	1,466		—
Liquid Environmental Solutions Corporation	1,383		1,115
Berner Food & Beverage, LLC	1,314		1,392
CorEvitas, LLC	1,251		915
Digital.AI Software Holdings, Inc.	1,156		826
Coyote Buyer, LLC	800		1,333
Telestream Holdings Corporation	678		528
Acquia Inc.	596		1,326
ASP-R-PAC Acquisition Co LLC	396		—
BAART Programs, Inc.	—		8,645
RumbleOn, Inc.	—		4,822
Ardonagh Midco 3 PLC	—		4,372
Dialyze Holdings, LLC	—		3,431
Thrasio, LLC	—		2,578
109 Montgomery Owner LLC	—		477
GKD Index Partners, LLC	—		320
Total	$	274,373	$	224,239

76

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Note 14. Merger with OSI2

On January 23, 2023, the Company completed its previously announced acquisition of OSI2. The Company was the accounting survivor of the OSI2 Merger. In accordance with the terms of the OSI2 Merger Agreement, at the effective time of the OSI2 Merger, each outstanding share of OSI2 common stock was converted into the right to receive 0.9115 shares of the Company’s common stock (with OSI2’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Merger, the Company issued an aggregate of 15,860,200 shares of its common stock to former OSI2 stockholders.

The OSI2 Merger was accounted for as an asset acquisition in accordance with the asset acquisition method of accounting as detailed in ASC 805-50, Business Combinations—Related Issues (“ASC 805”). The Company determined the fair value of the shares of the Company’s common stock that were issued to former OSI2 stockholders pursuant to the OSI2 Merger Agreement plus transaction costs to be the consideration paid in connection with the OSI2 Merger under ASC 805. The consideration paid to OSI2 stockholders, as determined in accordance with ASC 805, was more than the aggregate fair values of the assets acquired and liabilities assumed, which resulted in a purchase premium (the “purchase premium”). The consideration paid was allocated to the individual assets acquired and liabilities assumed based on the relative fair values of net identifiable assets acquired other than “non-qualifying” assets (for example, cash). As a result, the purchase premium was allocated to the cost basis of the OSI2 investments acquired by the Company on a pro-rata basis based on their relative fair values as of the effective time of the OSI2 Merger. Immediately following the OSI2 Merger, the investments were marked to their respective fair values in accordance with ASC 820 which resulted in $20.7 million of unrealized depreciation in the Consolidated Statement of Operations as a result of the OSI2 Merger. The purchase premium allocated to the debt investments acquired will amortize over the life of each respective debt investment through interest income, with a corresponding adjustment recorded to unrealized depreciation on such investment acquired through its ultimate disposition. The purchase premium allocated to equity investments acquired will not amortize over the life of such investments through interest income and, assuming no subsequent change to the fair value of the equity investments acquired and disposition of such equity investments at fair value, the Company will recognize a realized loss with a corresponding reversal of the unrealized depreciation on disposition of such equity investments acquired. The OSI2 Merger was considered a tax-free reorganization, and the Company has elected to carry forward the historical cost basis of the acquired OSI2 investments for tax purposes.

The following table summarizes the allocation of the consideration paid to the assets acquired and liabilities assumed as a result of the OSI2 Merger:

Common stock issued by the Company (1)	$	334,034
Transaction costs	1,932
Consideration paid	$	335,966
Investments	$	592,809
Cash and cash equivalents	22,317
Other assets	6,679
Total assets acquired	621,805
Debt	225,000
Other liabilities	60,839
Total liabilities acquired	285,839
Total net assets acquired	$	335,966

__________

(1) Common stock issued by the Company includes $19 of cash paid in lieu of issuing fractional shares.

77

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Note 15. Subsequent Events

The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the three months ended June 30, 2023, except as discussed below.

Distribution Declaration

On July 28, 2023, the Company’s Board of Directors declared a quarterly distribution of $0.55 per share, payable in cash on September 29, 2023 to stockholders of record on September 15, 2023.

78

Schedule 12-14

Oaktree Specialty Lending Corporation

Schedule of Investments in and Advances to Affiliates

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Nine months ended June 30, 2023

(unaudited)

Portfolio Company	Industry	Investment Type	Index	Spread		Cash		PIK Rate	Maturity Date	Shares		Principal		Net Realized Gain (Loss)		Amount of Interest, Fees or Dividends Credited in Income (2)		Fair Value at October 1, 2022		Gross Additions (3)		Gross Reductions (4)		Fair Value at June 30, 2023		% of Total Net Assets
Control Investments
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock								829		$	—	$	—	$	—	$	—	$	—	$	—	$	—	—	%
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity								34,984,460		—		—		—		27,638		—		—		27,638		1.8	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%	10.39	%		8/28/2025			14,102		—		1,070		14,333		—		(231)		14,102		0.9	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%				8/28/2025			—		—		—		—		—		—		—		—	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	SOFR+	5.00	%	10.24	%		8/28/2025			3,484		—		136		—		3,484		—		3,484		0.2	%
Dominion Diagnostics, LLC	Health Care Services	Common Stock								30,031		—		—		—		4,946		—		(2,235)		2,711		0.2	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Subordinated Debt	L+	4.50	%	9.36	%		10/20/2028			58,349		—		4,961		50,283		1,116		(1,767)		49,632		3.3	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		—		—		—		—		—		—	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Subordinated Debt	L+	7.00	%	11.86	%		12/29/2028			112,656		—		9,197		96,250		16,406		—		112,656		7.5	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		3,150		20,715		7,258		—		27,973		1.9	%
Total Control Investments												$	188,591	$	—	$	18,514	$	214,165	$	28,264	$	(4,233)	$	238,196	15.8	%
Affiliate Investments
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver	L+	6.75	%	12.29	%		10/17/2023			22,304		—		1,985		24,225		2,378		(4,417)		22,186		1.5	%
Assembled Brands Capital LLC	Specialized Finance	Common Stock								1,783,332		—		—		—		370		40		(410)		—		—	%
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity								1,129,453		—		—		—		1,223		189		—		1,412		0.1	%
Assembled Brands Capital LLC	Specialized Finance	Warrants								78,045		—		—		—		—		—		—		—		—	%
Caregiver Services, Inc.	Health Care Services	Preferred Equity								1,080,399		—		—		—		378		—		(65)		313		—	%
Total Affiliate Investments												$	22,304	$	—	$	1,985	$	26,196	$	2,607	$	(4,892)	$	23,911	1.6	%
Total Control & Affiliate Investments												$	210,895	$	—	$	20,499	$	240,361	$	30,871	$	(9,125)	$	262,107	17.4	%

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.

______________________

(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments.

(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.

(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.

(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.

(5)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).

(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).

79

Schedule 12-14

Oaktree Specialty Lending Corporation

Schedule of Investments in and Advances to Affiliates

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Nine months ended June 30, 2022

(unaudited)

Portfolio Company	Industry	Investment Type	Index	Spread		Cash		PIK Rate	Maturity Date	Shares		Principal		Net Realized Gain (Loss)		Amount of Interest, Fees or Dividends Credited in Income (2)		Fair Value at October 1, 2021		Gross Additions (3)		Gross Reductions (4)		Fair Value at June 30, 2022		% of Total Net Assets
Control Investments
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock								829		$	—	$	—	$	—	$	—	$	—	$	—	$	—	—	%
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity								34,984,460		—		—		—		27,638		—		—		27,638		2.2	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	L+	5.00	%	7.26	%		2/28/2024			16,074		—		1,078		27,381		—		(11,307)		16,074		1.3	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	L+	5.00	%				2/28/2024			—		—		42		—		—		—		—		—	%
Dominion Diagnostics, LLC	Health Care Services	Common Stock								30,031		—		—		3,308		18,065		—		(8,798)		9,267		0.7	%
First Star Speir Aviation Limited (5)	Airlines	First Lien Term Loan				9.00	%		12/15/2025			—		7,500		—		7,500		—		(7,500)		—		—	%
First Star Speir Aviation Limited (5)	Airlines	Membership Interest								100.00	%	—		(5,632)		158		698		—		(698)		—		—	%
OCSI Glick JV LLC (6)	Multi-Sector Holdings	Subordinated Debt	L+	4.50	%	4.94	%		10/20/2028			60,274		—		3,292		55,582		1,123		(6,099)		50,606		4.0	%
OCSI Glick JV LLC (6)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		—		—		—		—		—		—	%
Senior Loan Fund JV I, LLC (7)	Multi-Sector Holdings	Subordinated Debt	L+	7.00	%	8.00	%		12/29/2028			96,250		—		5,839		96,250		—		—		96,250		7.6	%
Senior Loan Fund JV I, LLC (7)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		2,026		37,651		—		(14,628)		23,023		1.8	%
Total Control Investments												$	172,598	$	1,868	$	15,743	$	270,765	$	1,123	$	(49,030)	$	222,858	17.6	%
Affiliate Investments
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver	L+	6.75	%	9.00	%		10/17/2023			21,754		—		1,185		15,712		11,585		(6,037)		21,260		1.7	%
Assembled Brands Capital LLC	Specialized Finance	Common Stock								1,609,201		—		—		—		587		—		(24)		563		—	%
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity								1,019,169		—		—		—		1,152		51		—		1,203		0.1	%
Assembled Brands Capital LLC	Specialized Finance	Warrants								70,425		—		—		—		—		—		—		—		—	%
Caregiver Services, Inc.	Health Care Services	Preferred Equity								1,080,399		—		—		—		838		—		(437)		401		—	%
Total Affiliate Investments												$	21,754	$	—	$	1,185	$	18,289	$	11,636	$	(6,498)	$	23,427	1.9	%
Total Control & Affiliate Investments												$	194,352	$	1,868	$	16,928	$	289,054	$	12,759	$	(55,528)	$	246,285	19.5	%

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.

______________________

(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2022.

(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.

(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.

(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.

(5)First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the

80

wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.

(6)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).

(7)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).

81

Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in connection with our Consolidated Financial Statements and the notes thereto included elsewhere in this quarterly report on Form 10-Q.

Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q may include statements as to:

•our future operating results and distribution projections;

•the ability of Oaktree Fund Advisors, LLC, or Oaktree, to reposition our portfolio and to implement Oaktree's future plans with respect to our business;

•the ability of Oaktree and its affiliates to attract and retain highly talented professionals;

•our business prospects and the prospects of our portfolio companies;

•the impact of the investments that we expect to make;

•the ability of our portfolio companies to achieve their objectives;

•our expected financings and investments and additional leverage we may seek to incur in the future;

•the adequacy of our cash resources and working capital;

•the timing of cash flows, if any, from the operations of our portfolio companies; and

•the cost or potential outcome of any litigation to which we may be a party.

In addition, words such as “anticipate,” “believe,” “expect,” “seek,” “plan,” “should,” “estimate,” “project” and “intend” indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended September 30, 2022 and elsewhere in this quarterly report on Form 10-Q.

Other factors that could cause actual results to differ materially include:

•changes or potential disruptions in our operations, the economy, financial markets or political environment, including the impacts of inflation and rising interest rates;

•risks associated with possible disruption in our operations or the economy generally due to terrorism, war or other geopolitical conflict (including the current conflict between Russia and Ukraine), natural disasters or pandemics;

•future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to Business Development Companies or, regulated investment companies, or RICs;

•the ability to realize the benefits of the OSI2 Merger (as defined below); and

•other considerations that may be disclosed from time to time in our publicly disseminated documents and filings.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the Securities and Exchange Commission, or the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

All dollar amounts in tables are in thousands, except share and per share amounts and as otherwise indicated.

Business Overview

We are a specialty finance company dedicated to providing customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. We are a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act of 1940, as amended, or the Investment Company Act. In addition, we have qualified and elected to be treated as a RIC under the Internal Revenue Code of 1986, as amended, or the Code, for U.S. federal income tax purposes.

We are externally managed by Oaktree pursuant to an investment advisory agreement, as amended from time to time, or the Investment Advisory Agreement. Oaktree Fund Administration, LLC, or Oaktree Administrator, an affiliate of Oaktree,

82

provides certain administrative and other services necessary for us to operate pursuant to an administration agreement, as amended from time to time, or the Administration Agreement.

Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.

In the current market environment, Oaktree intends to focus on the following area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, and (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital.

Oaktree intends to continue to rotate our portfolio into investments that are better aligned with Oaktree's overall approach to credit investing and that it believes have the potential to generate attractive returns across market cycles (which we call "core investments"). Oaktree has performed a comprehensive review of our portfolio and categorized our portfolio into core investments, non-core performing investments and underperforming investments. Certain additional information on such categorization and our portfolio composition is included in investor presentations that we file with the SEC. Since an Oaktree affiliate became our investment adviser in October 2017, Oaktree and its affiliates have reduced the investments identified as non-core by approximately $800 million at fair value. Over time, Oaktree intends to rotate us out of the remaining non-core investments, which were approximately $67 million at fair value as of June 30, 2023. Oaktree periodically reviews designations of investments as core and non-core and may change such designations over time.

On March 19, 2021, we acquired Oaktree Strategic Income Corporation, or OCSI, pursuant to an agreement and plan or merger, or the OCSI Merger Agreement, dated as of October 28, 2020, by and among OCSI, us, Lion Merger Sub, Inc., our wholly-owned subsidiary, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into us in a two-step transaction with us as the surviving company, or the OCSI Merger.

On January 23, 2023, we acquired Oaktree Strategic Income II, Inc., or OSI2, pursuant to that certain Agreement and Plan of Merger, or the OSI2 Merger Agreement, dated as of September 14, 2022, by and among OSI2, us, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of us, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into us in a two-step transaction with us as the surviving company, or the OSI2 Merger.

83

Business Environment and Developments

Global financial markets have experienced an increase in volatility as concerns about the impact of higher inflation, rising interest rates, a potential recession and the current conflict in Ukraine have weighed on market participants. These factors have created disruptions in supply chains and economic activity and have had a particularly adverse impact on certain companies in the energy, raw materials and transportation sectors, among others. These uncertainties can ultimately impact the overall supply and demand of the market through changing spreads, deal terms and structures and equity purchase price multiples.

We are unable to predict the full effects of these macroeconomic events or how long any further market disruptions or volatility might last. We continue to closely monitor the impact these events have on our business, industry and portfolio companies and will provide constructive solutions where necessary.

Against this uncertain macroeconomic backdrop, we believe attractive risk-adjusted returns can be achieved by making loans to middle market companies that typically possess resilient business models with strong underlying fundamentals. Given the breadth of the investment platform and decades of credit investing experience of Oaktree and its affiliates, we believe that we have the resources and experience to source, diligence and structure investments in these companies and are well placed to generate attractive returns for investors.

As of June 30, 2023, 86.0% of our debt investment portfolio (at fair value) and 85.8% of our debt investment portfolio (at cost) bore interest at floating rates. Most of our floating rate loans are indexed to the Secured Overnight Financing Rate, or SOFR, or the London Interbank Offered Rate, or LIBOR, which typically resets semi-annually, quarterly or monthly at the borrower’s option. Certain loans are also indexed to an alternate base rate (e.g., prime rate) or the Sterling Overnight Index Average, or SONIA. Most U.S. dollar LIBOR rates are no longer published after June 30, 2023 although certain synthetic rates will be published through September 30, 2024. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, supports replacing U.S.-dollar LIBOR with SOFR. In connection with the cessation of LIBOR, we may need to renegotiate any credit agreements extending beyond the applicable phase out date with our prospective portfolio companies that utilize LIBOR as a factor in determining the interest rate. Certain of the loan agreements with our portfolio companies have included fallback language to address when LIBOR becomes unavailable. This language generally provides that the administrative agent may identify a replacement reference rate, typically with the consent of (or prior consultation with) the borrower. In certain cases, the administrative agent will be required to obtain the consent of either a majority of the lenders under the facility, or the consent of each lender, prior to identifying a replacement reference rate. 

Critical Accounting Estimates

Investment Valuation

We value our investments in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 820, Fair Value Measurements and Disclosures, or ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability’s fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments’ complexity.

Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:

•Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

•Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.

•Level 3 — Unobservable inputs that reflect Oaktree’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

84

This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.

Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of our investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.

Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within our set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources.

If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value, or EV, of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that we are deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company’s assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. Under the EV technique, the significant unobservable input used in the fair value measurement of our investments in debt or equity securities is the EBITDA, revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and we consider the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by us are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry-specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. Under the market yield technique, the significant unobservable input used in the fair value measurement of our investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.

In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.

Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk-free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.

The fair value of our investments as of June 30, 2023 and September 30, 2022 was determined by Oaktree, as our valuation designee. We have and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of our portfolio securities for which market quotations are not readily available or

85

are readily available but deemed not reflective of the fair value of the investment each quarter. As of June 30, 2023, 90.3% of our portfolio at fair value was valued either based on market quotations, the transactions precedent approach or corroborated by independent valuation firms.

Certain factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s earnings and its ability to make payments on its indebtedness, the markets in which the portfolio company does business, comparison to comparable publicly-traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Due to these uncertainties, Oaktree's fair value determinations may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize upon the sale of one or more of our investments.

As of June 30, 2023, we held $3,135.6 million of investments at fair value, up from $2,494.1 million held at September 30, 2022, primarily driven by the growth in assets that resulted from the completion of the OSI2 Merger during the quarter ended March 31, 2023. As of June 30, 2023 and September 30, 2022, approximately 94.0% and 94.2%, respectively, of our total assets represented investments at fair value.

Revenue Recognition

Interest Income

Interest income, adjusted for accretion of original issue discount, or OID, is recorded on an accrual basis to the extent that such amounts are expected to be collected. We stop accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of June 30, 2023, there were five investments on non-accrual status that in the aggregate represented 3.6% and 3.1% of total debt investments at cost and fair value, respectively. As of September 30, 2022, there were no investments on non-accrual status.

In connection with our investment in a portfolio company, we sometimes receive nominal cost equity that is valued as part of the negotiation process with the portfolio company. When we receive nominal cost equity, we allocate our cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.

PIK Interest Income

Our investments in debt securities may contain payment-in-kind, or PIK, interest provisions. PIK interest, which typically represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We generally cease accruing PIK interest if there is insufficient value to support the accrual or if we do not expect the portfolio company to be able to pay all principal and interest due. Our decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; our assessment of the portfolio company's business development success; information obtained by us in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. Our determination to cease accruing PIK interest is generally made well before our full write-down of a loan or debt security. In addition, if it is subsequently determined that we will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on our debt investments increases the recorded cost bases of these investments in our Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by us to Oaktree. To maintain our status as a RIC, certain income from PIK interest may be required to be distributed to our stockholders, even though we have not yet collected the cash and may never do so.

86

Portfolio Composition

Our investments principally consist of loans, common and preferred equity and warrants in privately-held companies, Senior Loan Fund JV I, LLC, or SLF JV I, a joint venture through which we and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation, or Kemper, co-invest in senior secured loans of middle-market companies and other corporate debt securities, and OCSI Glick JV LLC, or the Glick JV, a joint venture through which we and GF Equity Funding 2014 LLC, or GF Equity Funding, co-invest primarily in senior secured loans of middle-market companies. We refer to SLF JV I and the Glick JV collectively as the JVs. Our loans are typically secured by a first, second or subordinated lien on the assets of the portfolio company and generally have terms of up to ten years (but an expected average life of between three and four years).

Excluding the investments acquired in connection with the OSI2 Merger, during the nine months ended June 30, 2023, we originated $625.1 million of investment commitments in 30 new and 14 existing portfolio companies and funded $621.3 million of investments.

During the nine months ended June 30, 2023, we received $527.5 million of proceeds from prepayments, exits, other paydowns and sales and exited 32 portfolio companies.

A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments is shown in the following tables: 

	June 30, 2023		September 30, 2022
Cost:
Senior secured debt	87.59	%	85.08	%
Debt investments in the JVs	4.93		5.59
Preferred equity	3.02		3.26
Subordinated debt	1.68		2.57
LLC equity interests of the JVs	1.66		1.88
Common equity and warrants	1.12		1.62
Total	100.00	%	100.00	%

	June 30, 2023		September 30, 2022
Fair value:
Senior secured debt	88.48	%	86.86	%
Debt investments in the JVs	5.18		5.88
Preferred equity	2.94		3.19
Subordinated debt	1.66		2.28
LLC equity interests of the JVs	0.89		0.83
Common equity and warrants	0.85		0.96
Total	100.00	%	100.00	%

87

The industry composition of our portfolio at cost and fair value as a percentage of total investments was as follows:

	June 30, 2023		September 30, 2022
Cost:
Application Software	16.98	%	14.98	%
Multi-Sector Holdings (1)	6.65		7.48
Data Processing & Outsourced Services	4.05		4.60
Health Care Technology	3.92		3.82
Biotechnology	3.86		4.20
Pharmaceuticals	3.69		4.83
Aerospace & Defense	3.36		2.37
Industrial Machinery & Supplies & Components	3.01		—
Broadline Retail	2.52		—
Health Care Services	2.35		2.24
Real Estate Operating Companies	2.32		1.82
Specialized Finance	2.10		3.09
Personal Care Products	2.08		—
Automotive Retail	1.97		2.26
Fertilizers & Agricultural Chemicals	1.96		1.88
Internet Services & Infrastructure	1.91		2.07
Health Care Distributors	1.88		2.18
Diversified Financial Services	1.87		—
Auto Parts & Equipment	1.85		0.48
Metal, Glass & Plastic Containers	1.76		—
Airport Services	1.70		1.65
Home Improvement Retail	1.67		1.75
Insurance Brokers	1.61		1.36
Diversified Metals & Mining	1.51		—
Leisure Facilities	1.50		1.52
Real Estate Services	1.36		1.54
Soft Drinks & Non-alcoholic Beverages	1.31		—
Diversified Support Services	1.30		1.45
Other Specialty Retail	1.27		—
Specialty Chemicals	1.16		1.43
Distributors	1.14		0.97
Integrated Telecommunication Services	1.02		1.32
Electrical Components & Equipment	0.98		1.29
Construction & Engineering	0.83		2.33
Environmental & Facilities Services	0.79		0.80
Advertising	0.78		1.08
Passenger Airlines	0.76		—
Oil & Gas Storage & Transportation	0.74		0.85
Home Furnishings	0.72		0.75
Gold	0.71		—
Systems Software	0.70		0.57
Health Care Equipment	0.68		0.93
Real Estate Development	0.59		—
Interactive Media & Services	0.58		—
Hotels, Resorts & Cruise Lines	0.52		0.53
Consumer Finance	0.50		0.55
Education Services	0.48		0.35
IT Consulting & Other Services	0.47		0.45
Restaurants	0.38		0.36
Movies & Entertainment	0.37		1.00
Health Care Supplies	0.35		1.39
Food Distributors	0.18		0.18
Apparel Retail	0.16		0.20
Air Freight & Logistics	0.15		0.28
Integrated Oil & Gas	0.15		0.19
Research & Consulting Services	0.15		0.35
Cable & Satellite	0.14		0.79
Other Specialized REITs	0.13		—
Paper & Plastic Packaging Products & Materials	0.10		—
Housewares & Specialties	0.09		0.09
Electronic Components	0.06		0.08
Leisure Products	0.06		—
Technology Distributors	0.03		0.12
Communications Equipment	0.03		—
Industrial Machinery	—		3.12
Internet & Direct Marketing Retail	—		2.59
Personal Products	—		2.03
Metal & Glass Containers	—		1.82
Soft Drinks	—		1.31
Other Diversified Financial Services	—		1.12
Oil & Gas Refining & Marketing	—		0.33
Trading Companies & Distributors	—		0.29
Apparel, Accessories & Luxury Goods	—		0.20
Specialized REITs	—		0.16
Diversified Banks	—		0.13
Construction Materials	—		0.09
Alternative Carriers	—		0.01
Total	100.00	%	100.00	%

88

	June 30, 2023		September 30, 2022
Fair value:
Application Software	17.38	%	15.43	%
Multi-Sector Holdings (1)	6.13		6.71
Biotechnology	4.09		4.35
Data Processing & Outsourced Services	3.97		4.46
Pharmaceuticals	3.71		4.79
Health Care Technology	3.69		3.90
Aerospace & Defense	3.55		2.48
Industrial Machinery & Supplies & Components	3.16		—
Broadline Retail	2.58		—
Real Estate Operating Companies	2.40		1.93
Specialized Finance	2.12		2.93
Fertilizers & Agricultural Chemicals	2.02		2.08
Internet Services & Infrastructure	2.00		2.16
Automotive Retail	1.99		2.31
Health Care Services	1.98		1.84
Diversified Financial Services	1.95		—
Personal Care Products	1.94		—
Auto Parts & Equipment	1.94		0.46
Health Care Distributors	1.92		2.19
Airport Services	1.76		1.72
Insurance Brokers	1.74		1.33
Home Improvement Retail	1.73		1.82
Diversified Metals & Mining	1.59		—
Leisure Facilities	1.50		1.57
Real Estate Services	1.41		1.59
Metal, Glass & Plastic Containers	1.40		—
Soft Drinks & Non-alcoholic Beverages	1.36		—
Other Specialty Retail	1.33		—
Diversified Support Services	1.32		1.47
Distributors	1.17		0.98
Electrical Components & Equipment	1.03		1.32
Specialty Chemicals	1.03		1.36
Integrated Telecommunication Services	0.99		1.29
Passenger Airlines	0.86		—
Construction & Engineering	0.86		2.45
Environmental & Facilities Services	0.81		0.83
Gold	0.74		—
Health Care Equipment	0.72		0.97
Systems Software	0.71		0.51
Oil & Gas Storage & Transportation	0.69		0.84
Home Furnishings	0.62		0.73
Real Estate Development	0.61		—
Interactive Media & Services	0.61		—
Advertising	0.60		1.08
Hotels, Resorts & Cruise Lines	0.55		0.56
Education Services	0.45		0.34
Consumer Finance	0.40		0.53
Restaurants	0.39		0.35
Movies & Entertainment	0.38		1.07
Health Care Supplies	0.36		1.47
IT Consulting & Other Services	0.36		0.34
Food Distributors	0.17		0.13
Apparel Retail	0.17		0.21
Integrated Oil & Gas	0.15		0.20
Cable & Satellite	0.15		0.78
Research & Consulting Services	0.15		0.34
Air Freight & Logistics	0.13		0.26
Other Specialized REITs	0.11		—
Paper & Plastic Packaging Products & Materials	0.10		—
Housewares & Specialties	0.09		0.10
Leisure Products	0.06		—
Electronic Components	0.06		0.08
Technology Distributors	0.03		0.12
Communications Equipment	0.03		—
Industrial Machinery	—		3.25
Internet & Direct Marketing Retail	—		2.82
Personal Products	—		2.01
Metal & Glass Containers	—		1.91
Soft Drinks	—		1.35
Other Diversified Financial Services	—		0.98
Oil & Gas Refining & Marketing	—		0.34
Trading Companies & Distributors	—		0.22
Diversified Banks	—		0.14
Specialized REITs	—		0.13
Construction Materials	—		0.08
Alternative Carriers	—		0.01
Total	100.00	%	100.00	%

___________________

(1)This industry includes our investments in the JVs.

89

The Joint Ventures

Senior Loan Fund JV I, LLC

In May 2014, we entered into a limited liability company, or LLC, agreement with Kemper to form SLF JV I. We co-invest in senior secured loans of middle-market companies and other corporate debt securities with Kemper through our investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by us and one representative selected by Kemper (with approval from a representative of each required). Since we do not have a controlling financial interest in SLF JV I, we do not consolidate SLF JV I. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to us and Kemper by SLF JV I. The subordinated notes issued by SLF JV I are referred to as the SLF JV I Notes. The SLF JV I Notes are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt.

As of June 30, 2023 and September 30, 2022, we and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. As of June 30, 2023, we and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from us. As of September 30, 2022, we and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from us. As of June 30, 2023, we had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the nine months ended June 30, 2023, we contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2022, we had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.

Both the cost and fair value of our SLF JV I Notes were $112.7 million as of June 30, 2023. Both the cost and fair value of our SLF JV I Notes were $96.3 million as of September 30, 2022. We earned interest income of $3.4 million and $9.2 million on the SLF JV I Notes for the three and nine months ended June 30, 2023, respectively. We earned interest income of $1.9 million and $5.8 million on the SLF JV I Notes for the three and nine months ended June 30, 2022, respectively. As of June 30, 2023, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.

The cost and fair value of the LLC equity interests in SLF JV I held by us was $54.8 million and $28.0 million, respectively, as of June 30, 2023, and $49.3 million and $20.7 million, respectively, as of September 30, 2022. We earned $1.1 million and $3.2 million in dividend income for the three and nine months ended June 30, 2023, respectively, with respect to our investment in the LLC equity interests of SLF JV I. We earned $0.9 million and $2.0 million in dividend income for the three and nine months ended June 30, 2022, respectively, with respect to our investment in the LLC equity interests of SLF JV I.

Below is a summary of SLF JV I's portfolio as of June 30, 2023 and September 30, 2022:

	June 30, 2023	September 30, 2022
Senior secured loans (1)	$350	$383,194
Weighted average interest rate on senior secured loans (2)	10.40%	8.33%
Number of borrowers in SLF JV I	52	60
Largest exposure to a single borrower (1)	$11,304	$10,093
Total of five largest loan exposures to borrowers (1)	$54,003	$48,139

__________________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on SLF JV I and its portfolio.

90

OCSI Glick JV LLC

On March 19, 2021, we became party to the LLC agreement of the Glick JV. The Glick JV invests primarily in senior secured loans of middle-market companies. We co-invest in these securities with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by GF Equity Funding. All portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, consisting of one representative selected by us and one representative selected by GF Equity Funding (with approval from a representative of each required). Since we do not have a controlling financial interest in the Glick JV, we do not consolidate the Glick JV. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. The Glick JV is capitalized as transactions are completed. The members provide capital to the Glick JV in exchange for LLC equity interests, and we and GF Debt Funding, an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV, or the Glick JV Notes. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by us to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.

As of June 30, 2023 and September 30, 2022, we and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and we and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. Approximately $84.0 million in aggregate commitments was funded as of each of June 30, 2023 and September 30, 2022, of which $73.5 million was from us. As of June 30, 2023 and September 30, 2022, we had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million was unfunded. As of each of June 30, 2023 and September 30, 2022, we had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million was unfunded.

The cost and fair value of our aggregate investment in the Glick JV was $50.0 million and $49.6 million, respectively, as of June 30, 2023. The cost and fair value of our aggregate investment in the Glick JV was $50.2 million and $50.3 million, respectively, as of September 30, 2022. For the three and nine months ended June 30, 2023, our investment in the Glick JV Notes earned interest income of $1.8 million and $5.0 million, respectively. For the three and nine months ended June 30, 2022, our investment in the Glick JV Notes earned interest income of $1.2 million and $3.3 million, respectively. We did not earn any dividend income for the three and nine months ended June 30, 2023 and June 30, 2022 with respect to our investment in the LLC equity interests of the Glick JV.

Below is a summary of the Glick JV's portfolio as of June 30, 2023 and September 30, 2022:

	June 30, 2023	September 30, 2022
Senior secured loans (1)	$123,126	$143,225
Weighted average current interest rate on senior secured loans (2)	10.66%	8.52%
Number of borrowers in the Glick JV	37	43
Largest loan exposure to a single borrower (1)	$6,313	$6,562
Total of five largest loan exposures to borrowers (1)	$28,457	$28,973

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on the Glick JV and its portfolio.

91

Discussion and Analysis of Results and Operations

Results of Operations

Net increase (decrease) in net assets resulting from operations includes net investment income, net realized gains (losses) and net unrealized appreciation (depreciation). Net investment income is the difference between our income from interest, dividends and fees and net expenses. Net realized gains (losses) is the difference between the proceeds received from dispositions of investment related assets and liabilities and their stated costs. Net unrealized appreciation (depreciation) is the net change in the fair value of our investment related assets and liabilities carried at fair value during the reporting period, including the reversal of previously recorded unrealized appreciation (depreciation) when gains or losses are realized.

Comparison of three and nine months ended June 30, 2023 and June 30, 2022

Total Investment Income

Total investment income includes interest on our investments, fee income and dividend income.

Total investment income for the three months ended June 30, 2023 and 2022 was $101.9 million and $63.1 million, respectively. For the three months ended June 30, 2023, this amount consisted of $99.3 million of interest income from portfolio investments (which included $4.0 million of PIK interest), $1.6 million of fee income and $1.1 million of dividend income. For the three months ended June 30, 2022, this amount consisted of $59.9 million of interest income from portfolio investments (which included $5.2 million of PIK interest), $2.3 million of fee income and $1.0 million of dividend income. The increase of $38.8 million, or 61.4%, in our total investment income for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022, was due primarily to a $39.4 million increase in interest income, which was primarily driven by the growth in assets that resulted from the completion of the OSI2 Merger during the prior quarter, new originations and the impact of higher reference rates on our floating rate investments. That was partially offset by a $0.7 million decrease in fee income primarily due to lower prepayment fees.

Total investment income for the nine months ended June 30, 2023 and 2022 was $277.4 million and $192.4 million, respectively. For the nine months ended June 30, 2023, this amount consisted of $268.3 million of interest income from portfolio investments (which included $14.2 million of PIK interest), $6.0 million of fee income and $3.2 million of dividend income. For the nine months ended June 30, 2022, this amount consisted of $181.7 million of interest income from portfolio investments (which included $14.5 million of PIK interest), $5.1 million of fee income and $5.6 million of dividend income. The increase of $85.0 million, or 44.2%, in our total investment income for the nine months ended June 30, 2023, as compared to the nine months ended June 30, 2022, was due primarily to (1) a $86.5 million increase in interest income, which was primarily driven by the growth in assets that resulted from the completion of the OSI2 Merger during the quarter ended March 31, 2023, new originations and the impact of higher reference rates on our floating rate investments and (2) a $0.9 million increase in fee income primarily due to higher commitment fees and amendment fees. This was partially offset by a $2.4 million decrease in dividend income.

Expenses

Net expenses (expenses net of fee waivers) for the three months ended June 30, 2023 and 2022 were $53.5 million and $22.8 million, respectively. Net expenses increased for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022, by $30.7 million, or 134.9%, primarily due to (1) a $18.9 million increase in interest expense due to higher borrowings outstanding and the impact of rising reference rates, (2) a $6.8 million of reversal of accrued Part II incentive fees in the prior period, (3) a $3.1 million increase in Part I incentive fees mainly due to higher total investment income, (4) a $1.4 million increase in base management fees as a result of a larger investment portfolio and (5) a $0.5 million increase in professional fees.

Net expenses (expenses net of fee waivers) for the nine months ended June 30, 2023 and 2022 were $144.1 million and $76.3 million, respectively. Net expenses increased for the nine months ended June 30, 2023, as compared to the nine months ended June 30, 2022, by $67.8 million, or 88.9%, primarily due to (1) a $48.1 million increase in interest expense due to higher borrowings outstanding and the impact of rising reference rates, (2) a $6.6 million increase in Part I incentive fees mainly due to higher total investment income, (3) a $8.8 million of reversal of accrued Part II incentive fees in the prior period, (4) a $1.9 million increase in professional fees and (5) a $1.8 million increase in base management fees as a result of a larger investment portfolio.

92

Net Investment Income

Primarily as a result of the $38.8 million increase in total investment income and the $30.7 million increase in net expenses, net investment income for the three months ended June 30, 2023 increased by $8.0 million compared to the three months ended June 30, 2022.

Primarily as a result of the $85.0 million increase in total investment income, the $67.8 million increase in net expenses and a $3.3 million decrease in the provision for taxes on net investment income, net investment income for the nine months ended June 30, 2023 increased by $20.4 million compared to the nine months ended June 30, 2022.

Realized Gain (Loss)

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of investments and foreign currency and the cost basis without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with our determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.

During the three months ended June 30, 2023 and 2022, we recorded aggregate net realized gains (losses) of $(10.6) million and $9.2 million, respectively, in connection with the exits of various investments and foreign currency forward contracts. During the nine months ended June 30, 2023 and 2022, we recorded aggregate net realized gains (losses) of $(19.9) million and $19.9 million, respectively, in connection with the exits of various investments and foreign currency forward contracts. See “Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation” in the notes to the accompanying Consolidated Financial Statements for more details regarding investment realization events for the three and nine months ended June 30, 2023 and 2022.

Net Unrealized Appreciation (Depreciation)

Net unrealized appreciation or depreciation is the net change in the fair value of our investments and foreign currency during the reporting period, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.

During the three months ended June 30, 2023 and 2022, we recorded net unrealized depreciation of $1.0 million and $86.8 million, respectively. For the three months ended June 30, 2023, this consisted of $9.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation on equity investments, partially offset by $5.0 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $4.6 million of net unrealized appreciation of foreign currency forward contracts. For the three months ended June 30, 2022, this consisted of $66.8 million of net unrealized depreciation on debt investments, $17.9 million of net unrealized depreciation on equity investments, $1.6 million of net unrealized depreciation of foreign currency forward contracts and $0.4 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains).

During the nine months ended June 30, 2023 and 2022, we recorded net unrealized depreciation of $42.3 million and $118.4 million, respectively. For the nine months ended June 30, 2023, this consisted of $54.3 million of net unrealized depreciation on debt investments and $4.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $11.8 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $5.1 million of net unrealized appreciation on equity investments. For the nine months ended June 30, 2022, this consisted of $84.6 million of net unrealized depreciation on debt investments, $23.8 million of net unrealized depreciation on equity investments, $9.2 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains) and $0.8 million of net unrealized depreciation of foreign currency forward contracts.

During the nine months ended June 30, 2023, unrealized depreciation included a one-time unrealized loss of $20.7 million that resulted solely from accounting adjustments related to the OSI2 Merger.

Financial Condition, Liquidity and Capital Resources

We have a number of alternatives available to fund our investment portfolio and our operations, including raising equity, increasing or refinancing debt and funding from operational cash flow. We generally expect to fund the growth of our investment portfolio through additional debt and equity capital, which may include securitizing a portion of our investments. We cannot assure you, however, that our efforts to grow our portfolio will be successful. For example, our common stock has generally traded at prices below net asset value for the past several years, and we may not be able to raise additional equity at prices below the then-current net asset value per share. We intend to continue to generate cash primarily from cash flows from operations, including interest earned, and future borrowings or equity offerings. We intend to fund our future distribution

93

obligations through operating cash flow or with funds obtained through future equity and debt offerings or credit facilities, as we deem appropriate.

Our primary uses of funds are investments in our targeted asset classes and cash distributions to holders of our common stock. We may also from time to time repurchase or redeem some or all of our outstanding notes. At a special meeting of our stockholders held on June 28, 2019, our stockholders approved the application of the reduced asset coverage requirements in Section 61(a)(2) of the Investment Company Act to us effective as of June 29, 2019. As a result of the reduced asset coverage requirement, we can incur $2 of debt for each $1 of equity as compared to $1 of debt for each $1 of equity. As of June 30, 2023, we had $1,785.0 million in senior securities and our asset coverage ratio was 182.0%. During the year ended September 30, 2022, we increased our target debt to equity ratio from 0.85x to 1.0x to 0.90x to 1.25x (i.e., one dollar of equity for each $0.90 to $1.25 of debt outstanding) to provide us with increased capacity to opportunistically deploy capital into the markets. As of June 30, 2023, our net debt to equity ratio was 1.14x.

For the nine months ended June 30, 2023, we experienced a net increase in cash and cash equivalents (including restricted cash) of $46.3 million. During that period, net cash used in operating activities was $15.0 million, primarily from funding $597.7 million of investments and $58.8 million of net increase in net receivables from unsettled transactions, partially offset by $521.2 million of principal payments and sale proceeds received, the cash activities related to $133.2 million of net investment income, $22.3 million of cash received in connection with the OSI2 merger and a $20.5 million decrease in due from portfolio companies. During the same period, net cash provided by financing activities was $61.0 million, primarily consisting of $210.0 million of net borrowings under the credit facilities, partially offset by $139.1 million of cash distributions paid to our stockholders.

For the nine months ended June 30, 2022, we experienced a net increase in cash and cash equivalents (including restricted cash) of $4.7 million. During that period, we used $43.8 million of net cash from operating activities, primarily from funding $620.8 million of investments and $34.7 million of increase in due from broker (cash held at a broker to cover collateral obligations under the interest swap agreement), partially offset by $554.9 million of principal payments and sale proceeds received, $5.3 million of net decrease in receivables from unsettled transactions and the cash activities related to $112.8 million of net investment income. During the same period, net cash provided by financing activities was $49.4 million, primarily consisting of $115.0 million of net borrowings under the credit facilities and $20.6 million of proceeds (net of offering costs) from shares issued under the "at the market" offering, partially offset by $85.1 million of cash distributions paid to our stockholders, $0.9 million of repurchases of common stock under our dividend reinvestment plan, DRIP, and $0.3 million of deferred financing costs paid.

As of June 30, 2023, we had $72.7 million in cash and cash equivalents (including $13.0 million of restricted cash), portfolio investments (at fair value) of $3.1 billion, $29.5 million of interest, dividends and fees receivable, $2.1 million of due from portfolio companies, $482.5 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $36.5 million of net receivables from unsettled transactions, $1,135.0 million of borrowings outstanding under our credit facilities and $605.1 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).

As of September 30, 2022, we had $26.4 million in cash and cash equivalents (including $2.8 million of restricted cash), portfolio investments (at fair value) of $2.5 billion, $35.6 million of interest, dividends and fees receivable, $22.5 million of due from portfolio companies, $500.0 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $22.3 million of net payables from unsettled transactions, $700.0 million of borrowings outstanding under our credit facilities and $601.0 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).

We may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of our portfolio companies. As of June 30, 2023, our only off-balance sheet arrangements consisted of $274.4 million of unfunded commitments, which was comprised of $247.3 million to provide debt and equity financing to certain of our portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, our only off-balance

94

sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of our portfolio companies and $49.0 million to provide financing to the JVs.

As of June 30, 2023, we have analyzed cash and cash equivalents, availability under our credit facilities, the ability to rotate out of certain assets and amounts of unfunded commitments that could be drawn and believe our liquidity and capital resources are sufficient to take advantage of market opportunities in the current economic climate.

Contractual Obligations

The following table reflects information pertaining to our principal debt outstanding under the Syndicated Facility (as defined below), Citibank Facility (as defined below), OSI2 Citibank Facility (as defined below), our 3.500% notes due 2025, or the 2025 Notes, and our 2.700% notes due 2027, or the 2027 Notes:

	Debt Outstanding as of September 30, 2022		Debt Outstanding as of June 30, 2023		Weighted average debt outstanding for the nine months ended June 30, 2023		Maximum debt outstanding for the nine months ended June 30, 2023
Syndicated Facility	$	540,000	$	800,000	$	710,018	$	840,000
Citibank Facility	160,000		—		138,689		175,000
OSI2 Citibank Facility	—		335,000		141,355		355,000
2025 Notes	300,000		300,000		300,000		300,000
2027 Notes	350,000		350,000		350,000		350,000
Total debt	$	1,350,000	$	1,785,000	$	1,640,062

The following table reflects our contractual obligations arising from the Syndicated Facility, OSI2 Citibank Facility, 2025 Notes and 2027 Notes:

	Payments due by period as of June 30, 2023
Contractual Obligations	Total		Less than 1 year		1-3 years		3-5 years
Syndicated Facility	$	800,000	$	—	$	—	$	800,000
Interest due on Syndicated Facility	287,144		57,587		115,174		114,383
OSI2 Citibank Facility	335,000		—		—		335,000
Interest due on OSI2 Citibank Facility	88,801		24,818		49,636		14,347
2025 Notes	300,000		—		300,000		—
Interest due on 2025 Notes	17,433		10,500		6,933		—
2027 Notes	350,000		—		—		350,000
Interest due on 2027 Notes (a)	85,910		24,214		48,428		13,268
Total	$	2,264,288	$	117,119	$	520,171	$	1,626,998

__________ 

(a) The interest due on the 2027 Notes was calculated net of the interest rate swap.

Equity Issuances

On January 23, 2023, in connection with the OSI2 Merger, we issued an aggregate of 15,860,200 shares of common stock to former OSI2 stockholders.

During the three and nine months ended June 30, 2023, we issued an aggregate of zero and 94,879 shares of common stock, respectively, as part of the DRIP.

On February 7, 2022, we entered into an equity distribution agreement by and among us, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by us of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of our common stock having an aggregate offering price of up to $125 million under our current registration statement. Sales of the common stock, if any, may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.

95

In connection with the "at the market" offering, we did not issue or sell any shares of common stock during the three and nine months ended June 30, 2023.

Distributions

The following table reflects the distributions per share that we have paid, including shares issued under our DRIP, on our common stock since October 1, 2020. The distributions per share and shares issued under our DRIP information disclosed in this table for dates prior to January 23, 2023 have been retrospectively adjusted to reflect our 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution	DRIP Shares Issued (1)	DRIP Shares Value
Quarterly	November 13, 2020	December 15, 2020	December 31, 2020	$	0.33	$ 15.0 million	31,321	$ 0.5 million
Quarterly	January 29, 2021	March 15, 2021	March 31, 2021	0.36		16.4 million	27,234	0.5 million
Quarterly	April 30, 2021	June 15, 2021	June 30, 2021	0.39		22.9 million	25,660	0.5 million
Quarterly	July 30, 2021	September 15, 2021	September 30, 2021	0.435		25.5 million	28,358	0.6 million
Quarterly	October 13, 2021	December 15, 2021	December 31, 2021	0.465		27.2 million	35,990	0.8 million
Quarterly	January 28, 2022	March 15, 2022	March 31, 2022	0.48		28.5 million	34,804	0.8 million
Quarterly	April 29, 2022	June 15, 2022	June 30, 2022	0.495		29.4 million	43,676	0.9 million
Quarterly	July 29, 2022	September 15, 2022	September 30, 2022	0.51		30.2 million	51,181	1.0 million
Quarterly	November 10, 2022	December 15, 2022	December 30, 2022	0.54		32.0 million	53,369	1.1 million
Special	November 10, 2022	December 15, 2022	December 30, 2022	0.42		24.8 million	41,510	0.8 million
Quarterly	January 27, 2023	March 15, 2023	March 31, 2023	0.55		41.1 million	68,412	1.3 million
Quarterly	April 28, 2023	June 15, 2023	June 30, 2023	0.55		41.3 million	57,279	1.1 million

 ______________

(1)Shares were purchased on the open market and distributed other than with respect to the distributions paid on December 31, 2021, March 31, 2022 and December 30, 2022. New shares were issued with respect to distributions paid on December 31, 2021, March 31, 2022 and December 30, 2022.

Indebtedness

See “Note 6. Borrowings” in the Consolidated Financial Statements for more details regarding our indebtedness.

Syndicated Facility

As of June 30, 2023, (i) the size of our senior secured revolving credit facility, or, as amended and/or restated from time to time, the Syndicated Facility, pursuant to a senior secured revolving credit agreement, with the lenders, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A. as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents, was $1.218 billion (with an “accordion” feature that permits us, under certain circumstances, to increase the size of the facility to up to the greater of $1.25 billion and our net worth (as defined in the Syndicated Facility) on the date of such increase), (ii) the period during which we may make drawings on $1.035 billion of commitments will expire on June 23, 2027 and the maturity date was June 23, 2028, (iii) the period during which we may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iv) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at our option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.

Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. Borrowings under the Syndicated Facility are subject to the facility’s various covenants and the leverage restrictions contained in the Investment Company Act. We cannot assure you that we will be able to borrow funds under the Syndicated Facility at any particular time or at all.

96

The following table describes significant financial covenants, as of June 30, 2023, with which we must comply under the Syndicated Facility on a quarterly basis:

Financial Covenant	Description	Target Value	March 31, 2023 Reported Value (1)
Minimum shareholders' equity	Net assets shall not be less than the sum of (x) $600 million, plus (y) 50% of the aggregate net proceeds of all sales of equity interests after May 6, 2020	$768 million	$1,515 million
Asset coverage ratio	Asset coverage ratio shall not be less than the greater of 1.50:1 and the statutory test applicable to us	1.50:1	1.83:1
Interest coverage ratio	Interest coverage ratio shall not be less than 2.25:1	2.25:1	2.95:1
Minimum net worth	Net worth shall not be less than $550 million	$550 million	$1,130 million

 ___________ 

(1) As contractually required, we report financial covenants based on the last filed quarterly or annual report, in this case our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023. We were in compliance with all financial covenants under the Syndicated Facility based on the financial information contained in this Quarterly Report on Form 10-Q.

As of June 30, 2023 and September 30, 2022, we had $800.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $800.0 million and $540.0 million, respectively. Our borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 6.584% and 2.406% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, we recorded interest expense (inclusive of fees) of $14.3 million and $37.4 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2022, we recorded interest expense (inclusive of fees) of $4.8 million and $12.6 million, respectively, related to the Syndicated Facility.

Citibank Facility

On March 19, 2021, we became party to a revolving credit facility, or, as amended and/or restated from time to time, the Citibank Facility, with OCSL Senior Funding II LLC, our wholly-owned, special purpose financing subsidiary, as the borrower, us, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. In connection with the termination of the Citibank Facility, we accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023.

As of September 30, 2022, we had $160.0 million outstanding under the Citibank Facility, which had a fair value of $160.0 million. Our borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.762% and 2.563% for the nine months ended June 30, 2023 and June 30, 2022, respectively. For the three and nine months ended June 30, 2023, we recorded interest expense (inclusive of fees) of $2.4 million and $8.0 million, respectively, related to the Citibank Facility. For the three and nine months ended June 30, 2022, we recorded interest expense (inclusive of fees) of $1.6 million and $3.5 million related to the Citibank Facility.

OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, we became party to a revolving credit facility, or, as amended and/or restated from time to time, the OSI2 Citibank Facility, with OSI 2 Senior Lending SPV, LLC, or OSI 2 SPV, our wholly-owned and consolidated subsidiary, as the borrower, us, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

As of June 30, 2023, we were able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans and (b) for all other lenders under the OSI2 Citibank Facility, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, subject in all cases to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment

97

ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

As of June 30, 2023, we had $335.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $335.0 million. Our borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.275% for the period from January 23, 2023 to June 30, 2023. For three months ended June 30, 2023 and the period from January 23, 2023 to June 30, 2023, we recorded interest expense (inclusive of fees) of $4.9 million and $8.0 million, respectively, related to the OSI2 Citibank Facility.

2025 Notes

On February 25, 2020, we issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the notes.

2027 Notes

On May 18, 2021, we issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the notes.

In connection with the 2027 Notes, we entered into an interest rate swap to more closely align the interest rates of our liabilities with our investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, we receive a fixed interest rate of 2.700% and pay a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. We designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship.

The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of June 30, 2023 and September 30, 2022:

	As of June 30, 2023				As of September 30, 2022
($ in millions)	2025 Notes		2027 Notes		2025 Notes		2027 Notes
Principal	$	300.0	$	350.0	$	300.0	$	350.0
Unamortized financing costs	(1.2)		(2.7)		(1.8)		(3.2)
Unaccreted discount	(0.8)		(0.6)		(1.2)		(0.7)
Interest rate swap fair value adjustment	—		(39.6)		—		(42.0)
Net carrying value	$	298.0	$	307.1	$	297.0	$	304.1
Fair Value	$	285.7	$	302.3	$	283.1	$	294.0

98

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2023:

($ in millions)	2025 Notes						2027 Notes
	Three months ended June 30, 2023			Nine months ended June 30, 2023			Three months ended June 30, 2023			Nine months ended June 30, 2023
Coupon interest	$	2.6		$	7.9		$	2.4		$	7.1
Amortization of financing costs and discount	0.3			0.9			0.2			0.7
Effect of interest rate swap	—			—			3.7			9.4
Total interest expense	$	2.9		$	8.8		$	6.3		$	17.2
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	3.500		%	3.500		%	6.912		%	6.274		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2022:

($ in millions)	2025 Notes						2027 Notes
	Three months ended June 30, 2022			Nine months ended June 30, 2022			Three months ended June 30, 2022			Nine months ended June 30, 2022
Coupon interest	$	2.6		$	7.9		$	2.4		$	7.1
Amortization of financing costs and discount	0.3			0.9			0.2			0.7
Effect of interest rate swap	—			—			(0.1)			(1.6)
Total interest expense	$	2.9		$	8.8		$	2.5		$	6.2
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	3.500		%	3.500		%	2.572		%	2.069		%

Regulated Investment Company Status and Distributions

We have qualified and elected to be treated as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As long as we continue to qualify as a RIC, we will not be subject to tax on our investment company taxable income (determined without regard to any deduction for dividends paid) or realized net capital gains, to the extent that such taxable income or gains is distributed, or deemed to be distributed as dividends, to stockholders on a timely basis.

Taxable income generally differs from net income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses, and generally excludes net unrealized appreciation or depreciation. Distributions declared and paid by us in a taxable year may differ from taxable income for that taxable year as such distributions may include the distribution of taxable income derived from the current taxable year or the distribution of taxable income derived from the prior taxable year carried forward into and distributed in the current taxable year. Distributions also may include returns of capital.

To maintain RIC tax treatment, we must, among other things, distribute dividends, with respect to each taxable year, of an amount at least equal to 90% of our investment company taxable income (i.e., our net ordinary income and our realized net short-term capital gains in excess of realized net long-term capital losses, if any), determined without regard to any deduction for dividends paid. As a RIC, we are also subject to a federal excise tax, based on distribution requirements of our taxable income on a calendar year basis. We anticipate timely distribution of our taxable income in accordance with tax rules. We did not incur a U.S. federal excise tax for calendar year 2021. For the calendar year 2022, we incurred $0.1 million of excise tax. We do not expect to incur a U.S. federal excise tax for calendar year 2023.

We intend to distribute at least 90% of our annual taxable income (which includes our taxable interest and fee income) to our stockholders. The covenants contained in our credit facilities may prohibit us from making distributions to our stockholders, and, as a result, could hinder our ability to satisfy the distribution requirement associated with our ability to be subject to tax as a RIC. In addition, we may retain for investment some or all of our net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) and treat such amounts as deemed distributions to our stockholders. If we do this, our stockholders will be treated as if they received actual distributions of the capital gains we retained and then reinvested the net after-tax proceeds in our common stock. Our stockholders also may be eligible to claim tax credits (or, in certain circumstances, tax refunds) equal to their allocable share of the tax we paid on the capital gains deemed distributed to them. To the extent our taxable earnings for a fiscal and taxable year fall below the total amount of our dividend distributions for that fiscal and taxable year, a portion of those distributions may be deemed a return of capital to our stockholders.

99

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, we may be limited in our ability to make distributions due to the asset coverage test for borrowings applicable to us as a Business Development Company under the Investment Company Act and due to provisions in our credit facilities and debt instruments. If we do not distribute a certain percentage of our taxable income annually, we will suffer adverse tax consequences, including possible loss of our ability to be subject to tax as a RIC. We cannot assure stockholders that they will receive any distributions or distributions at a particular level.

A RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder elects to receive his or her entire distribution in either cash or stock of the RIC, subject to certain limitations regarding the aggregate amount of cash to be distributed to all stockholders. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

We may generate qualified net interest income or qualified net short-term capital gains that may be exempt from U.S. withholding tax when distributed to foreign stockholders. A RIC is permitted to designate distributions of qualified net interest income and qualified short-term capital gains as exempt from U.S. withholding tax when paid to non-U.S. shareholders with proper documentation. The following table, which may be subject to change as we finalize our annual tax filings, lists the percentage of qualified net interest income and qualified short-term capital gains for the year ended September 30, 2022.

Year Ended	Qualified Net Interest Income		Qualified Short-Term Capital Gains
September 30, 2022	80.8	%	—

We have adopted a DRIP that provides for the reinvestment of any distributions that we declare in cash on behalf of our stockholders, unless a stockholder elects to receive cash. As a result, if our Board of Directors declares a cash distribution, then our stockholders who have not “opted out” of the DRIP will have their cash distributions automatically reinvested in additional shares of our common stock, rather than receiving a cash distribution. If our shares are trading at a premium to net asset value, we typically issue new shares to implement the DRIP, with such shares issued at the greater of the most recently computed net asset value per share of our common stock or 95% of the current market value per share of our common stock on the payment date for such distribution. If our shares are trading at a discount to net asset value, we typically purchase shares in the open market in connection with our obligations under the DRIP.

Related Party Transactions

We have entered into the Investment Advisory Agreement with Oaktree and the Administration Agreement with Oaktree Administrator, an affiliate of Oaktree. Mr. John B. Frank, an interested member of our Board of Directors, has an indirect pecuniary interest in Oaktree. Oaktree is a registered investment adviser under the Investment Advisers Act of 1940, as amended, that is partially and indirectly owned by Oaktree Capital Group, LLC. See “Note 10. Related Party Transactions – Investment Advisory Agreement” and “– Administrative Services” in the notes to the accompanying Consolidated Financial Statements.

Recent Developments

Distribution Declaration

On July 28, 2023, our Board of Directors declared a quarterly distribution of $0.55 per share, payable in cash on September 29, 2023 to stockholders of record on September 15, 2023.

100

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are subject to financial market risks, including changes in the valuations of our investment portfolio and interest rates.

Valuation Risk

Our investments may not have a readily available market price, and we value these investments at fair value as determined by Oaktree, as our valuation designee. There is no single standard for determining fair value in good faith and valuation methodologies involve a significant degree of management judgment. In addition, our valuation methodology utilizes discount rates in part in valuing our investments, and changes in those discount rates may have an impact on the valuation of our investments. Accordingly, valuations by Oaktree do not necessarily represent the amounts which may eventually be realized from sales or other dispositions of investments. Estimated fair values may differ from the values that would have been used had a ready market for the investment existed, and the differences could be material to the financial statements.

Interest Rate Risk

We are subject to financial market risks, including changes in interest rates. Changes in interest rates may affect both our cost of funding and our interest income from portfolio investments, cash and cash equivalents and idle fund investments. Our risk management procedures are designed to identify and analyze our risk, to set appropriate policies and to continually monitor these risks. Our investment income will be affected by changes in various interest rates, including SOFR, LIBOR, SONIA and prime rates, to the extent our debt investments include floating interest rates.

As of June 30, 2023, 86.0% of our debt investment portfolio (at fair value) and 85.8% of our debt investment portfolio (at cost) bore interest at floating rates. As of September 30, 2022, 86.5% of our debt investment portfolio (at fair value) and 86.3% of our debt investment portfolio (at cost) bore interest at floating rates. The composition of our floating rate debt investments by interest rate floor as of June 30, 2023 and September 30, 2022, was as follows: 

	June 30, 2023				September 30, 2022
($ in thousands)	Fair Value		% of Floating Rate Portfolio		Fair Value		% of Floating Rate Portfolio
0%	$	230,265	9.0	%	$	228,186	11.1	%
>0% and <1%	341,280		13.3	%	388,458		19.0	%
1%	1,525,626		59.3	%	1,364,668		66.6	%
>1%	474,287		18.4	%	68,332		3.3	%
Total Floating Rate Investments	$	2,571,458	100.0	%	$	2,049,644	100.0	%

Based on our Consolidated Statement of Assets and Liabilities as of June 30, 2023, the following table shows the approximate annualized net increase (decrease) in net assets resulting from operations (excluding the impact of any potential incentive fees) of hypothetical base rate changes in interest rates, assuming no changes in our investment and capital structure. However, there can be no assurances our portfolio companies will be able to meet their contractual obligations at any or all levels on increases in interest rates.

($ in thousands) Basis point increase	Increase in Interest Income		(Increase) in Interest Expense		Net increase in net assets resulting from operations
250	$	66,346	$	(37,125)	$	29,221
200	53,072		(29,700)		23,372
150	39,798		(22,275)		17,523
100	26,523		(14,850)		11,673
50	13,262		(7,425)		5,837

101

($ in thousands) Basis point decrease	(Decrease) in Interest Income		Decrease in Interest Expense		Net (decrease) in net assets resulting from operations
50	$	(13,262)	$	7,425	$	(5,837)
100	(26,523)		14,850		(11,673)
150	(39,785)		22,275		(17,510)
200	(53,033)		29,700		(23,333)
250	(66,142)		37,125		(29,017)

We regularly measure exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate sensitive assets to our interest rate sensitive liabilities. Based on this review, we determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates. The following table shows a comparison of the interest rate base for our interest-bearing cash and outstanding investments, at principal, and our outstanding borrowings as of June 30, 2023 and September 30, 2022: 

	June 30, 2023				September 30, 2022
($ in thousands)	Interest Bearing Cash and Investments		Borrowings		Interest Bearing Cash and Investments		Borrowings
Money market rate	$	5,193	$	—	$	5,262	$	—
Prime rate	3,778		—		2,618		—
LIBOR
30 day	431,019		—		669,273		540,000
90 day (a)	535,860		350,000		928,978		510,000
180 day	18,060		—		199,301		—
EURIBOR
30 day	€	29,985	—		€	24,838	—
90 day	25,731		—		16,911		—
180 day	6,666		—		1,964		—
SOFR
30 day	$	479,666	800,000		$	50,099	—
90 day	1,108,422		335,000		190,799		—
180 day	10,519		—		18,390		—
SONIA	£	53,250	—		£	40,137	—
Fixed rate	$	466,429	300,000		$	341,749	300,000

__________ 

(a)Borrowings include the 2027 Notes, which pay interest at a floating rate under the terms of the interest rate swap.

102

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

Management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2023. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives. Based on the evaluation of our disclosure controls and procedures as of June 30, 2023, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, in timely identifying, recording, processing, summarizing and reporting any material information relating to us that is required to be disclosed in the reports we file or submit under the Exchange Act.

There were no changes in our internal control over financial reporting that occurred during the three months ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II

Item 1.     Legal Proceedings

We are currently not a party to any pending material legal proceedings.

Item 1A. Risk Factors

There have been no material changes during the three months ended June 30, 2023 to the risk factors discussed in Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended September 30, 2022.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4.     Mine Safety Disclosures

Not applicable.

Item 5. Other Information

During the three months ended June 30, 2023, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement”.

103

Item 6. Exhibits

10.1	Sixth Amendment to Loan and Security Agreement, dated as of May 25, 2023, by and among the Registrant, OSI 2 Senior Lending SPV, LLC, and Citibank, N.A. (incorporated by reference to Exhibit 1.1 filed with the Registrant’s Form 8-K (File No. 814-00755) filed on May 30, 2023).
10.2	Amendment No. 6 to Amended and Restated Senior Secured Revolving Credit Agreement, dated as of June 23, 2023, by and among the Registrant, as borrower, the lenders party thereto and ING Capital LLC, as administrative agent (incorporated by reference to Exhibit 10.1 filed with the Registrant’s Form 8-K (File No. 814-00755) filed on June 26, 2023).
31.1*	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
31.2*	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
32.1*	Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
32.2*	Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
101.INS*	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*	Inline XBRL Taxonomy Extension Schema Document.
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Filed herewith.

104

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

OAKTREE SPECIALTY LENDING CORPORATION
By:	/s/   Armen Panossian
	Armen Panossian
	Chief Executive Officer
By:	/s/   Christopher McKown
	Christopher McKown
	Chief Financial Officer and Treasurer

Date: August 2, 2023

105

EX-31.1

Exhibit 31.1

I, Armen Panossian, Chief Executive Officer of Oaktree Specialty Lending Corporation, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended June 30, 2023 of Oaktree Specialty Lending Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 2nd day of August, 2023.

By:	/s/    Armen Panossian
	Armen Panossian Chief Executive Officer

EX-31.2

Exhibit 31.2

I, Christopher McKown, Chief Financial Officer of Oaktree Specialty Lending Corporation, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended June 30, 2023 of Oaktree Specialty Lending Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 2nd day of August, 2023.

By:	/s/    Christopher McKown
	Christopher McKown Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

In connection with the quarterly report on Form 10-Q for the quarter ended June 30, 2023 (the “Report”) of Oaktree Specialty Lending Corporation (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Armen Panossian, the Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/    Armen Panossian

Name:    Armen Panossian

Date: August 2, 2023

EX-32.2

Exhibit 32.2

Certification of Chief Financial Officer

Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

In connection with the quarterly report on Form 10-Q for the quarter ended June 30, 2023 (the “Report”) of Oaktree Specialty Lending Corporation (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Christopher McKown, the Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/    Christopher McKown

Name:    Christopher McKown

Date: August 2, 2023

XML

Cover - shares	9 Months Ended
	Jun. 30, 2023	Aug. 01, 2023
Cover [Abstract]
Document Type	10-Q
Document Annual Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Securities Act File Number	1-33901
Entity Registrant Name	Oaktree Specialty Lending Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1219283
Entity Address, Address Line One	333 South Grand Avenue
Entity Address, Address Line Two	28th Floor
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90071
City Area Code	213
Local Phone Number	830-6300
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	OCSL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		77,079,811
Entity Central Index Key	0001414932
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Current Fiscal Year End Date	--09-30

XML

Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands		Jun. 30, 2023		Sep. 30, 2022
Assets [Abstract]
Investments at fair value		$ 3,135,619		$ 2,494,111
Cash and cash equivalents		59,704		23,528
Restricted cash		12,956		2,836
Interest, dividends and fees receivable		29,457		35,598
Due from portfolio companies		2,080		22,495
Receivables from unsettled transactions		39,261		4,692
Due from broker		39,990		45,530
Deferred financing costs		13,284		7,350
Deferred offering costs		186		32
Deferred tax asset, net		2,695		1,687
Derivative assets at fair value		49		6,789
Other assets		693		1,665
Total assets		3,335,974		2,646,313
Liabilities [Abstract]
Accounts payable, accrued expenses and other liabilities		3,412		3,701
Base management fee and incentive fee payable		20,072		15,940
Due to affiliate		7,724		3,180
Interest payable		12,907		7,936
Payables from unsettled transactions		2,785		26,981
Derivative liability at fair value		39,567		41,969
Credit facilities payable		1,135,000		700,000
Unsecured notes payable (net of $3,909 and $5,020 of unamortized financing costs as of June 30, 2023 and September 30, 2022, respectively)		605,066		601,043
Total liabilities		1,826,533		1,400,750
Commitments and contingencies (Note 13)
Net Assets [Abstract]
Common stock, $0.01 par value per share, 250,000 shares authorized; 77,080 and 61,125 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively (1)	[1]	771		611
Additional paid-in-capital		2,163,528		1,827,721
Accumulated overdistributed earnings		(654,858)		(582,769)
Total net assets (equivalent to $19.58 and $20.38 per common share as of June 30, 2023 and September 30, 2022, respectively) (Note 11) (1)	[1]	1,509,441		1,245,563
Total liabilities and net assets		3,335,974		2,646,313
Control Investments
Assets [Abstract]
Investments at fair value		238,196	[2],[3]	214,165	[4],[5]
Control & Affiliate Investments
Assets [Abstract]
Investments at fair value		23,911		26,196
Non-control/Non-affiliate
Assets [Abstract]
Investments at fair value		$ 2,873,512	[6]	$ 2,253,750	[7]

[1] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.

[2] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[3] Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[4] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[5] Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[6] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[7] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

XML

Consolidated Statements of Assets and Liabilities (Parenthetical) $ in Thousands	Jun. 30, 2023 USD ($) $ / shares shares		Sep. 30, 2022 USD ($) $ / shares shares
Investment, cost	$ 3,296,285		$ 2,617,754
Unamortized financing costs	$ 3,909		$ 5,020
Common stock, par value, (in dollars per share) | $ / shares	$ 0.01		$ 0.01
Common stock, shares authorized (in shares) | shares	250,000,000		250,000,000
Common stock, shares issued (in shares) | shares	77,080,000		61,125,000
Common stock, shares outstanding (in shares) | shares	77,080,000	[1]	61,125,000
Net asset value per common share (dollars per share) | $ / shares	$ 19.58	[1]	$ 20.38
Control Investments
Investment, cost	$ 285,236	[2],[3]	$ 260,305	[4],[5]
Affiliate Investments
Investment, cost	25,370	[6]	27,353	[7]
Non-control/Non-affiliate
Investment, cost	$ 2,985,679	[8]	$ 2,330,096	[9]

[1] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

[2] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[3] Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[4] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[5] Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[6] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[7] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[8] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[9] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

XML

Consolidated Statements of Operations $ in Thousands		3 Months Ended		9 Months Ended
		Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares
Revenues [Abstract]
Interest on cash and cash equivalents		$ 992	$ 151	$ 2,221	$ 157
Total interest income		95,310	54,728	254,033	167,197
Interest income, PIK		3,967	5,178	14,220	14,515
Fee income		1,573	2,275	5,974	5,092
Dividend income		1,050	956	3,154	5,572
Total investment income		101,900	63,137	277,381	192,376
Operating Expenses [Abstract]
Base management fee		11,983	9,819	33,383	29,853
Part I incentive fee		9,590	6,497	26,300	19,658
Part II incentive fee		0	(6,796)	0	(8,791)
Professional fees		1,387	885	4,962	3,029
Directors fees		160	160	480	443
Interest expense		30,793	11,870	79,316	31,178
Administrator expense		322	271	935	968
General and administrative expenses		752	811	2,753	2,217
Total expenses		54,987	23,517	148,129	78,555
Fees waived		(1,500)	(750)	(4,025)	(2,250)
Net expenses		53,487	22,767	144,104	76,305
Net investment income before taxes		48,413	40,370	133,277	116,071
(Provision) benefit for taxes on net investment income		0	0	0	(3,308)
Excise tax		0	0	(78)	0
Net investment income		48,413	40,370	133,199	112,763
Unrealized appreciation (depreciation):
Foreign currency forward contracts		4,575	(1,630)	(4,802)	(778)
Net unrealized appreciation (depreciation)		(1,039)	(86,755)	(42,300)	(118,379)
Realized gains (losses):
Foreign currency forward contracts		(6,309)	8,796	(5,513)	12,179
Net realized gains (losses)		(10,603)	9,212	(19,917)	19,935
(Provision) benefit for taxes on realized and unrealized gains (losses)		(86)	(661)	397	1,696
Net realized and unrealized gains (losses), net of taxes		(11,728)	(78,204)	(61,820)	(96,748)
Net increase (decrease) in net assets resulting from operations		$ 36,685	$ (37,834)	$ 71,379	$ 16,015
Net investment income per common share - basic and diluted (dollars per share) | $ / shares	[1]	$ 0.63	$ 0.66	$ 1.89	$ 1.86
Earnings (loss) per common share - basic (dollars per share) | $ / shares	[1]	0.48	(0.62)	1.01	0.26
Earnings (loss) per common share - diluted (dollars per share) | $ / shares	[1]	$ 0.48	$ (0.62)	$ 1.01	$ 0.26
Weighted average common shares outstanding - basic (shares) | shares	[1]	77,080,000	61,123,000	70,431,000	60,593,000
Weighted average common shares outstanding - diluted (shares) | shares	[1]	77,080,000	61,123,000	70,431,000	60,593,000
Control Investments
Revenues [Abstract]
Interest income		$ 5,568	$ 3,400	$ 15,326	$ 10,214
Fee income		13	12	38	38
Dividend income		1,050	875	3,150	5,491
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		734	(16,991)	(900)	(26,552)
Realized gains (losses):
Realized gain (loss)		0	0	0	1,868
Control & Affiliate Investments
Revenues [Abstract]
Interest income		681	470	1,970	1,170
Fee income		5	5	15	15
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		149	(328)	(302)	(716)
Non-control/Non-affiliate
Revenues [Abstract]
Interest income		88,069	50,707	234,516	155,656
Interest income, PIK		3,967	5,178	14,220	14,515
Fee income		1,555	2,258	5,921	5,039
Dividend income		0	81	4	81
Unrealized appreciation (depreciation):
Net unrealized appreciation (depreciation)		(6,497)	(67,806)	(36,296)	(90,333)
Realized gains (losses):
Realized gain (loss)		$ (4,294)	$ 416	$ (14,404)	$ 5,888

[1] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

XML

Consolidated Statements of Changes in Net Assets $ in Thousands						3 Months Ended								9 Months Ended
	Jan. 20, 2023	Jun. 30, 2022 USD ($) $ / shares shares		Mar. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($)	Jun. 30, 2023 USD ($) $ / shares shares		Mar. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($) $ / shares shares		Mar. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($)	Jun. 30, 2023 USD ($) $ / shares shares		Jun. 30, 2022 USD ($) $ / shares shares		Sep. 30, 2022 USD ($) $ / shares shares		Sep. 30, 2021 USD ($) $ / shares shares
Net increase (decrease) in net assets resulting from operations
Net investment income						$ 48,413		$ 45,978	$ 38,808	$ 40,370		$ 40,098	$ 32,295	$ 133,199		$ 112,763
Net unrealized appreciation (depreciation)						(1,039)				(86,755)				(42,300)		(118,379)
Net realized gains (losses)						(10,603)				9,212				(19,917)		19,935
(Provision) benefit for taxes on realized and unrealized gains (losses)						(86)		(66)	549	(661)		(21)	2,378	397		1,696
Net increase (decrease) in net assets resulting from operations						36,685				(37,834)				71,379		16,015
Stockholder transactions:
Net increase (decrease) in net assets from stockholder transactions						(42,394)		(42,395)	(58,679)	(30,256)		(29,271)	(27,956)	(143,468)		(87,483)
Capital share transactions:
Issuance of common stock in connection with the OSI2 Merger						0		334,034		0				334,034		0
Issuance of common stock under dividend reinvestment plan		$ 900		$ 800	$ 800	1,123		1,295	1,933	874		766	786	4,351		2,426
Repurchase of common stock under dividend reinvestment plan						(1,123)		(1,295)		(874)				(2,418)		(874)
Issuance of common stock in connection with the "at the market" offering						0				1,243		19,379		0		20,622
Net increase (decrease) in net assets from capital share transactions						0				1,243				335,967		22,174
Total increase (decrease) in net assets						(5,709)				(66,847)				263,878		(49,294)
Net assets		$ 1,263,529		$ 1,330,376	$ 1,325,061	$ 1,509,441	[1]	$ 1,515,150	$ 1,201,989	$ 1,263,529		$ 1,330,376	$ 1,325,061	$ 1,509,441	[1]	$ 1,263,529		$ 1,245,563	[1]	$ 1,312,823
Net asset value per common share (dollars per share) | $ / shares		$ 20.67	[2]	$ 21.79		$ 19.58	[2]	$ 19.66		$ 20.67	[2]	$ 21.79		$ 19.58	[2]	$ 20.67	[2]	$ 20.38		$ 21.84
Common shares outstanding at end of period (shares) | shares		61,125,000	[2]	61,068,000		77,080,000	[2]	77,080,000		61,125,000	[2]	61,068,000		77,080,000	[2]	61,125,000	[2]	61,125,000		60,120,000
Stock split, conversion ratio	0.0033

[1] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.

[2] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

XML

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022
Operating activities:
Net increase (decrease) in net assets resulting from operations	$ 36,685	$ 71,379	$ 16,015
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation	1,039	42,300	118,379
Net realized (gains) losses	10,603	19,917	(19,935)
PIK interest income	(3,967)	(14,220)	(14,515)
Accretion of original issue discount on investments		(15,554)	(22,707)
Accretion of original issue discount on unsecured notes payable		509	509
Amortization of deferred financing costs		3,407	2,801
Deferred taxes	(900)	(1,030)	(984)
Purchases of investments		(597,662)	(620,843)
Proceeds from the sales and repayments of investments		521,163	554,933
Cash received in the OSI2 Merger		22,317	0
Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable		12,866	(9,456)
(Increase) decrease in due from portfolio companies		20,520	(4,891)
(Increase) decrease in receivables from unsettled transactions		(34,562)	4,876
(Increase) decrease in due from broker		5,540	(34,700)
(Increase) decrease in other assets		(548)	1,017
Increase (decrease) in accounts payable, accrued expenses and other liabilities		(52,290)	(700)
Increase (decrease) in base management fee and incentive fee payable		37	(17,086)
Increase (decrease) in due to affiliate		3,823	(817)
Increase (decrease) in interest payable		1,278	3,759
Increase (decrease) in payables from unsettled transactions		(24,196)	470
Increase (decrease) in director fees payable		(9)	38
Net cash provided by (used in) operating activities		(15,015)	(43,837)
Financing activities:
Distributions paid in cash		(139,117)	(85,057)
Borrowings under credit facilities		572,000	290,000
Repayments of borrowings under credit facilities		(362,000)	(175,000)
Shares issued under the "at the market" offering		0	20,839
Repurchase of common stock under dividend reinvestment plan		(2,418)	(874)
Deferred financing costs paid		(7,314)	(334)
Offering costs paid		(186)	(215)
Net cash provided by (used in) financing activities		60,965	49,359
Effect of exchange rate changes on foreign currency		346	(842)
Net increase (decrease) in cash and cash equivalents and restricted cash		46,296	4,680
Cash and cash equivalents and restricted cash, beginning of period		26,364	31,635
Cash and cash equivalents and restricted cash, end of period	72,660	72,660	36,315
Supplemental information:
Cash paid for interest		70,429	24,109
Non-cash financing activities:
Issuance of common stock under dividend reinvestment plan		1,933	2,426
Deferred Financing costs		125	0
Issuance of common stock in connection with the OSI2 Merger		334,034	$ 0
Reconciliation to the Consolidated Statements of Assets and Liabilities [Abstract]
Cash and cash equivalents	59,704	59,704
Restricted cash	12,956	12,956
Total cash and cash equivalents and restricted cash	$ 72,660	$ 72,660

XML

Consolidated Schedule of Investments € in Thousands, £ in Thousands, $ in Thousands		Jun. 30, 2023 USD ($) shares		Jun. 30, 2023 EUR (€) shares		Jun. 30, 2023 GBP (£) shares		Sep. 30, 2022 USD ($) shares		Sep. 30, 2022 EUR (€) shares		Sep. 30, 2022 GBP (£) shares		Jun. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($)
Investment, cost		$ 3,296,285						$ 2,617,754
Investments at fair value		$ 3,135,619						$ 2,494,111
Investment owned, percent of net assets		207.73%		207.73%		207.73%		200.24%		200.24%		200.24%
Money market funds, at carrying value		$ 72,660						$ 26,364
Money market funds, percent of net assets		4.80%		4.80%		4.80%		2.10%		2.10%		2.10%
Investment owned and money market funds, percent of net assets		212.50%		212.50%		212.50%		202.40%		202.40%		202.40%
Total investment owned, at cost and money market funds, at carrying value		$ 3,368,945						$ 2,644,118
Total investment owned, at fair value and money market funds, at carrying value		3,208,279						2,520,475
Control Investments
Investment, principal		188,591												$ 172,598
Investment, cost		285,236	[1],[2]					260,305	[3],[4]
Investments at fair value		$ 238,196	[1],[2]					$ 214,165	[3],[4]					$ 222,858	$ 270,765
Investment owned, ownership percentage	[3],[4]							17.20%		17.20%		17.20%
Investment owned, percent of net assets		15.80%	[1],[2]	15.80%	[1],[2]	15.80%	[1],[2]							17.60%
Affiliate Investments
Investment, interest rate	[5]							2.10%		2.10%		2.10%
Investment, principal		$ 22,304												$ 21,754
Investment, cost		25,370	[6]					$ 27,353	[5]
Investments at fair value		$ 23,911	[6]					26,196	[5]					$ 23,427	18,289
Investment owned, percent of net assets		1.60%	[6]	1.60%	[6]	1.60%	[6]							1.90%
Non-control/Non-affiliate
Investment, cost		$ 2,985,679	[7]					2,330,096	[8]
Investments at fair value		$ 2,873,512	[7]					$ 2,253,750	[8]
Investment owned, percent of net assets		190.40%	[7]	190.40%	[7]	190.40%	[7]	180.90%	[8]	180.90%	[8]	180.90%	[8]
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan
Investment, interest rate	[7],[9],[10],[11],[12],[13]	12.50%		12.50%		12.50%
Investment, principal	[7],[9],[11],[13],[14]	$ 1,174
Investment, cost	[7],[9],[11],[13]	1,133
Investments at fair value	[7],[9],[11],[13]	$ 1,112
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver
Investment, interest rate	[7],[9],[10],[11],[12]	11.00%		11.00%		11.00%
Investment, principal	[7],[9],[11],[14]	$ 14,916
Investment, cost	[7],[9],[11]	14,770
Investments at fair value	[7],[9],[11]	$ 14,489
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 1
Investment, basis spread, variable rate	[8],[15],[16]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[15],[16],[17]							9.80%		9.80%		9.80%
Investment, principal	[8],[15],[16],[18]							$ 389
Investment, cost	[8],[15],[16]							387
Investments at fair value	[8],[15],[16]							$ 727
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 2
Investment, basis spread, variable rate	[8],[15],[16],[19]							7.00%		7.00%		7.00%
Investment, principal	[8],[15],[16],[18],[19]							$ 0
Investment, cost	[8],[15],[16],[19]							(31)
Investments at fair value	[8],[15],[16],[19]							$ 0
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan
Investment, interest rate	[7],[9],[10],[11],[12],[13]	12.00%		12.00%		12.00%
Investment, principal	[7],[9],[11],[13],[14]	$ 3,710
Investment, cost	[7],[9],[11],[13]	3,664
Investments at fair value	[7],[9],[11],[13]	$ 3,645
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan
Investment, interest rate	[7],[9],[10],[12],[20],[21]	14.25%		14.25%		14.25%
Investment, principal	[7],[9],[14],[20],[21]	$ 21,434
Investment, cost	[7],[9],[20],[21]	21,620
Investments at fair value	[7],[9],[20],[21]	$ 21,434
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan
Investment, interest rate, paid in kind		20.00%	[7],[9],[20]	20.00%	[7],[9],[20]	20.00%	[7],[9],[20]	10.50%	[8],[15],[22]	10.50%	[8],[15],[22]	10.50%	[8],[15],[22]
Investment, principal		$ 5,576	[7],[9],[14],[20]					$ 33,997	[8],[15],[18],[22]
Investment, cost		5,561	[7],[9],[20]					33,960	[8],[15],[22]
Investments at fair value		$ 5,464	[7],[9],[20]					$ 34,891	[8],[15],[22]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							6.25%		6.25%		6.25%
Investment, interest rate	[8],[15],[16],[17]							9.80%		9.80%		9.80%
Investment, principal	[8],[15],[16],[18]							$ 14,685
Investment, cost	[8],[15],[16]							14,217
Investments at fair value	[8],[15],[16]							$ 14,431
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	12.00%		12.00%		12.00%
Investment, principal	[7],[9],[12],[14]	$ 3,520
Investment, cost	[7],[9],[12]	3,480
Investments at fair value	[7],[9],[12]	$ 3,455
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	12.00%		12.00%		12.00%
Investment, principal	[7],[9],[12],[14]	$ 18,271
Investment, cost	[7],[9],[12]	18,091
Investments at fair value	[7],[9],[12]	$ 17,935
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	11.66%		11.66%		11.66%
Investment, principal	[7],[9],[12],[14]	$ 1,000
Investment, cost	[7],[9],[12]	983
Investments at fair value	[7],[9],[12]	$ 982
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1
Investment, basis spread, variable rate		7.50%	[7],[9],[20]	7.50%	[7],[9],[20]	7.50%	[7],[9],[20]	7.50%	[8],[15],[16],[22]	7.50%	[8],[15],[16],[22]	7.50%	[8],[15],[16],[22]
Investment, interest rate		12.89%	[7],[9],[10],[12],[20]	12.89%	[7],[9],[10],[12],[20]	12.89%	[7],[9],[10],[12],[20]	11.20%	[8],[15],[16],[17],[22]	11.20%	[8],[15],[16],[17],[22]	11.20%	[8],[15],[16],[17],[22]
Investment, principal		$ 6,589	[7],[9],[12],[14],[20]					$ 6,589	[8],[15],[16],[18],[22]
Investment, cost		6,292	[7],[9],[12],[20]					6,256	[8],[15],[16],[22]
Investments at fair value		$ 6,267	[7],[9],[12],[20]					$ 6,262	[8],[15],[16],[22]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2
Investment, basis spread, variable rate		7.50%	[7],[9],[11],[20]	7.50%	[7],[9],[11],[20]	7.50%	[7],[9],[11],[20]	7.50%	[8],[15],[16],[19],[22]	7.50%	[8],[15],[16],[19],[22]	7.50%	[8],[15],[16],[19],[22]
Investment, principal		$ 0	[7],[9],[11],[12],[14],[20]					$ 0	[8],[15],[16],[18],[19],[22]
Investment, cost		(38)	[7],[9],[11],[12],[20]					(38)	[8],[15],[16],[19],[22]
Investments at fair value		$ (38)	[7],[9],[11],[12],[20]					$ (37)	[8],[15],[16],[19],[22]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants
Investment owned, balance (in shares) | shares		28,948	[7],[9],[20]	28,948	[7],[9],[20]	28,948	[7],[9],[20]	28,948	[8],[15],[22]	28,948	[8],[15],[22]	28,948	[8],[15],[22]
Investment, cost		$ 174	[7],[9],[20]					$ 174	[8],[15],[22]
Investments at fair value		$ 18	[7],[9],[20]					$ 73	[8],[15],[22]
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, Second Lien Term Loan
Investment, basis spread, variable rate		7.25%	[7],[9],[12],[20]	7.25%	[7],[9],[12],[20]	7.25%	[7],[9],[12],[20]	7.25%	[8],[15],[16],[22]	7.25%	[8],[15],[16],[22]	7.25%	[8],[15],[16],[22]
Investment, interest rate		10.67%	[7],[9],[10],[12],[20]	10.67%	[7],[9],[10],[12],[20]	10.67%	[7],[9],[10],[12],[20]	7.94%	[8],[15],[16],[17],[22]	7.94%	[8],[15],[16],[17],[22]	7.94%	[8],[15],[16],[17],[22]
Investment, principal | €				€ 29,985	[7],[9],[12],[14],[20]					€ 24,838	[8],[15],[16],[18],[22]
Investment, cost		$ 33,119	[7],[9],[12],[20]					$ 27,752	[8],[15],[16],[22]
Investments at fair value		$ 32,128	[7],[9],[12],[20]					$ 22,143	[8],[15],[16],[22]
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock
Investment owned, balance (in shares) | shares		17,870	[7],[9]	17,870	[7],[9]	17,870	[7],[9]	14,410	[8],[15]	14,410	[8],[15]	14,410	[8],[15]
Investment, cost		$ 1,733	[7],[9]					$ 1,352	[8],[15]
Investments at fair value		$ 2,578	[7],[9]					$ 1,291	[8],[15]
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan
Investment, basis spread, variable rate		7.75%	[7],[9],[12]	7.75%	[7],[9],[12]	7.75%	[7],[9],[12]	7.75%	[8],[15],[16]	7.75%	[8],[15],[16]	7.75%	[8],[15],[16]
Investment, interest rate		12.95%	[7],[9],[10],[12]	12.95%	[7],[9],[10],[12]	12.95%	[7],[9],[10],[12]	10.88%	[8],[15],[16],[17]	10.88%	[8],[15],[16],[17]	10.88%	[8],[15],[16],[17]
Investment, principal		$ 17,873	[7],[9],[12],[14]					$ 14,414	[8],[15],[16],[18]
Investment, cost		17,646	[7],[9],[12]					14,154	[8],[15],[16]
Investments at fair value		$ 17,533	[7],[9],[12]					$ 13,910	[8],[15],[16]
Investment, Identifier [Axis]: APX Group Inc., Electrical Components & Equipment, Fixed Rate Bond
Investment, interest rate	[8],[16],[17],[22]							5.75%		5.75%		5.75%
Investment, principal	[8],[18],[22]							$ 2,075
Investment, cost	[8],[22]							1,733
Investments at fair value	[8],[22]							$ 1,645
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 1
Investment, interest rate	[8],[16],[17]							7.50%		7.50%		7.50%
Investment, principal	[8],[18]							$ 5,500
Investment, cost	[8]							5,408
Investments at fair value	[8]							$ 3,641
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 2
Investment, interest rate	[8],[16],[17]							5.25%		5.25%		5.25%
Investment, principal	[8],[18]							$ 2,500
Investment, cost	[8]							2,220
Investments at fair value	[8]							$ 1,926
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12],[20]	6.00%		6.00%		6.00%
Investment, principal	[7],[9],[11],[12],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[12],[20]	(14)
Investments at fair value	[7],[9],[11],[12],[20]	$ (20)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12],[20]	6.00%		6.00%		6.00%
Investment, interest rate	[7],[9],[10],[12],[20]	11.31%		11.31%		11.31%
Investment, principal	[7],[9],[12],[14],[20]	$ 3,284
Investment, cost	[7],[9],[12],[20]	3,276
Investments at fair value	[7],[9],[12],[20]	3,120
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan
Investment, principal	[7],[9],[14],[20],[21]	11,683
Investment, cost	[7],[9],[20],[21]	11,723
Investments at fair value	[7],[9],[20],[21]	$ 11,274
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, Second Lien Term Loan
Investment, basis spread, variable rate		7.75%	[7],[9]	7.75%	[7],[9]	7.75%	[7],[9]	7.75%	[8],[16]	7.75%	[8],[16]	7.75%	[8],[16]
Investment, interest rate		12.94%	[7],[9],[10],[12]	12.94%	[7],[9],[10],[12]	12.94%	[7],[9],[10],[12]	10.82%	[8],[16],[17]	10.82%	[8],[16],[17]	10.82%	[8],[16],[17]
Investment, principal		$ 20,000	[7],[9],[12],[14]					$ 20,000	[8],[16],[18]
Investment, cost		19,943	[7],[9],[12]					19,927	[8],[16]
Investments at fair value		$ 18,883	[7],[9],[12]					$ 19,075	[8],[16]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[11],[12]	10.86%		10.86%		10.86%
Investment, principal	[7],[9],[11],[12],[14]	$ 2,033
Investment, cost	[7],[9],[11],[12]	2,011
Investments at fair value	[7],[9],[11],[12]	$ 2,027
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[12]	10.86%		10.86%		10.86%
Investment, principal	[7],[9],[12],[14]	$ 20,286
Investment, cost	[7],[9],[12]	20,193
Investments at fair value	[7],[9],[12]	$ 20,246
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[11]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[11],[12]
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(2)
Investments at fair value	[7],[9],[11],[12]	$ (8)
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Revolver
Investment, basis spread, variable rate	[8],[15],[16],[19]							5.50%		5.50%		5.50%
Investment, interest rate	[8],[15],[16],[17],[19]							9.14%		9.14%		9.14%
Investment, principal	[8],[15],[16],[18],[19]							$ 500
Investment, cost	[8],[15],[16],[19]							462
Investments at fair value	[8],[15],[16],[19]							$ 495
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 1
Investment, basis spread, variable rate	[8],[15],[16]							5.50%		5.50%		5.50%
Investment, interest rate	[8],[15],[16],[17]							9.12%		9.12%		9.12%
Investment, principal	[8],[15],[16],[18]							$ 15,976
Investment, cost	[8],[15],[16]							15,686
Investments at fair value	[8],[15],[16]							$ 15,944
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 2
Investment, basis spread, variable rate	[8],[15],[16],[19]							5.50%		5.50%		5.50%
Investment, principal	[8],[15],[16],[18],[19]							$ 0
Investment, cost	[8],[15],[16],[19]							0
Investments at fair value	[8],[15],[16],[19]							$ (6)
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		7.00%	[7],[9],[11]	7.00%	[7],[9],[11]	7.00%	[7],[9],[11]	7.00%	[8],[15],[16],[19]	7.00%	[8],[15],[16],[19]	7.00%	[8],[15],[16],[19]
Investment, interest rate		12.05%	[7],[9],[10],[11],[12]	12.05%	[7],[9],[10],[11],[12]	12.05%	[7],[9],[10],[11],[12]	10.64%	[8],[15],[16],[17],[19]	10.64%	[8],[15],[16],[17],[19]	10.64%	[8],[15],[16],[17],[19]
Investment, principal		$ 2,113	[7],[9],[11],[12],[14]					$ 914	[8],[15],[16],[18],[19]
Investment, cost		2,101	[7],[9],[11],[12]					890	[8],[15],[16],[19]
Investments at fair value		$ 2,102	[7],[9],[11],[12]					$ 898	[8],[15],[16],[19]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[15],[16],[17]							9.63%		9.63%		9.63%
Investment, principal	[8],[15],[16],[18]							$ 27,349
Investment, cost	[8],[15],[16]							27,038
Investments at fair value	[8],[15],[16]							$ 27,158
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[12]	12.34%		12.34%		12.34%
Investment, principal	[7],[9],[12],[14]	$ 6,400
Investment, cost	[7],[9],[12]	6,327
Investments at fair value	[7],[9],[12]	$ 6,374
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[12]	12.34%		12.34%		12.34%
Investment, principal	[7],[9],[12],[14]	$ 25,332
Investment, cost	[7],[9],[12]	25,283
Investments at fair value	[7],[9],[12]	$ 25,230
Investment, Identifier [Axis]: Aden & Anais Merger Sub, Inc., Apparel, Accessories & Luxury Goods, Common Stock
Investment owned, balance (in shares) | shares	[8],[15]							51,645		51,645		51,645
Investment, cost	[8],[15]							$ 5,165
Investments at fair value	[8],[15]							$ 0
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants
Investment owned, balance (in shares) | shares		5,715	[7],[9]	5,715	[7],[9]	5,715	[7],[9]	5,715	[8],[15]	5,715	[8],[15]	5,715	[8],[15]
Investment, cost		$ 90	[7],[9]					$ 90	[8],[15]
Investments at fair value		$ 0	[7],[9]					$ 0	[8],[15]
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							8.50%		8.50%		8.50%
Investment, interest rate, paid in kind	[8],[15],[16]							11.64%		11.64%		11.64%
Investment, principal	[8],[15],[16],[18]							$ 23,338
Investment, cost	[8],[15],[16]							22,057
Investments at fair value	[8],[15],[16]							$ 22,141
Investment, Identifier [Axis]: All Web Leads, Inc., First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12],[23]	8.50%		8.50%		8.50%
Investment, principal	[7],[9],[12],[14],[23]	$ 23,562
Investment, cost	[7],[9],[12],[23]	22,795
Investments at fair value	[7],[9],[12],[23]	$ 16,880
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond
Investment, interest rate		5.50%	[7],[10],[12],[20]	5.50%	[7],[10],[12],[20]	5.50%	[7],[10],[12],[20]	5.50%	[8],[16],[17],[22]	5.50%	[8],[16],[17],[22]	5.50%	[8],[16],[17],[22]
Investment, principal		$ 4,050	[7],[14],[20]					$ 4,050	[8],[18],[22]
Investment, cost		3,561	[7],[20]					3,518	[8],[22]
Investments at fair value		$ 2,900	[7],[20]					$ 3,057	[8],[22]
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	8.00%		8.00%		8.00%
Investment, interest rate	[7],[9],[10],[12]	13.34%		13.34%		13.34%
Investment, interest rate, paid in kind	[7],[9],[12]	3.50%		3.50%		3.50%
Investment, principal	[7],[9],[12],[14]	$ 8,794
Investment, cost	[7],[9],[12]	8,132
Investments at fair value	[7],[9],[12]	$ 8,011
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants
Investment owned, balance (in shares) | shares	[7],[9]	166,414		166,414		166,414
Investment, cost	[7],[9]	$ 642
Investments at fair value	[7],[9]	$ 518
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Investment, basis spread, variable rate		7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[8],[15],[16]	7.50%	[8],[15],[16]	7.50%	[8],[15],[16]
Investment, interest rate		12.89%	[7],[9],[10],[12]	12.89%	[7],[9],[10],[12]	12.89%	[7],[9],[10],[12]	11.20%	[8],[15],[16],[17]	11.20%	[8],[15],[16],[17]	11.20%	[8],[15],[16],[17]
Investment, principal		$ 17,280	[7],[9],[12],[14]					$ 13,134	[8],[15],[16],[18]
Investment, cost		17,197	[7],[9],[12]					12,847	[8],[15],[16]
Investments at fair value		$ 16,503	[7],[9],[12]					$ 13,068	[8],[15],[16]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1
Investment, interest rate	[8],[15],[16],[17],[22]							10.00%		10.00%		10.00%
Investment, principal	[8],[15],[18],[22]							$ 24,043
Investment, cost	[8],[15],[22]							23,747
Investments at fair value	[8],[15],[22]							$ 23,923
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1
Investment owned, balance (in shares) | shares		824,197	[7],[20]	824,197	[7],[20]	824,197	[7],[20]	587,930	[8],[22]	587,930	[8],[22]	587,930	[8],[22]
Investment, cost		$ 2,426	[7],[20]					$ 5,308	[8],[22]
Investments at fair value		$ 6,379	[7],[20]					$ 3,974	[8],[22]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2
Investment owned, balance (in shares) | shares		141,640	[7],[9],[20],[24]	141,640	[7],[9],[20],[24]	141,640	[7],[9],[20],[24]	124,780	[8],[15],[22],[25]	124,780	[8],[15],[22],[25]	124,780	[8],[15],[22],[25]
Investment, cost		$ 566	[7],[9],[20],[24]					$ 485	[8],[15],[22],[25]
Investments at fair value		$ 339	[7],[9],[20],[24]					$ 212	[8],[15],[22],[25]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 1
Investment, interest rate	[7],[9],[10],[12],[20]	8.50%		8.50%		8.50%
Investment, interest rate, paid in kind	[7],[9],[20]	3.50%		3.50%		3.50%
Investment, principal	[7],[9],[14],[20]	$ 28,464
Investment, cost	[7],[9],[20]	28,363
Investments at fair value	[7],[9],[20]	$ 27,682
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 2
Investment, interest rate	[7],[9],[10],[12],[20]	8.50%		8.50%		8.50%
Investment, interest rate, paid in kind	[7],[9],[20]	3.50%		3.50%		3.50%
Investment, principal	[7],[9],[14],[20]	$ 2,121
Investment, cost	[7],[9],[20]	1,945
Investments at fair value	[7],[9],[20]	$ 2,063
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 3
Investment, interest rate	[7],[9],[10],[12],[20]	8.50%		8.50%		8.50%
Investment, interest rate, paid in kind	[7],[9],[20]	3.50%		3.50%		3.50%
Investment, principal	[7],[9],[14],[20]	$ 27,692
Investment, cost	[7],[9],[20]	27,612
Investments at fair value	[7],[9],[20]	$ 26,930
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 4
Investment, interest rate	[7],[9],[10],[12],[20]	8.50%		8.50%		8.50%
Investment, interest rate, paid in kind	[7],[9],[20]	3.50%		3.50%		3.50%
Investment, principal	[7],[9],[14],[20]	$ 2,064
Investment, cost	[7],[9],[20]	1,891
Investments at fair value	[7],[9],[20]	$ 2,007
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2
Investment, interest rate	[8],[15],[16],[17],[22]							10.00%		10.00%		10.00%
Investment, principal	[8],[15],[18],[22]							$ 23,522
Investment, cost	[8],[15],[22]							23,264
Investments at fair value	[8],[15],[22]							$ 23,404
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan
Investment, basis spread, variable rate		8.75%	[7],[9],[12]	8.75%	[7],[9],[12]	8.75%	[7],[9],[12]	8.75%	[8],[15],[16]	8.75%	[8],[15],[16]	8.75%	[8],[15],[16]
Investment, interest rate		13.99%	[7],[9],[10],[12]	13.99%	[7],[9],[10],[12]	13.99%	[7],[9],[10],[12]	12.30%	[8],[15],[16],[17]	12.30%	[8],[15],[16],[17]	12.30%	[8],[15],[16],[17]
Investment, principal		$ 17,048	[7],[9],[12],[14]					$ 14,760	[8],[15],[16],[18]
Investment, cost		16,411	[7],[9],[12]					14,492	[8],[15],[16]
Investments at fair value		$ 12,616	[7],[9],[12]					$ 13,284	[8],[15],[16]
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Investment, basis spread, variable rate		6.25%	[7],[12]	6.25%	[7],[12]	6.25%	[7],[12]	6.25%	[8],[16]	6.25%	[8],[16]	6.25%	[8],[16]
Investment, interest rate		11.49%	[7],[10],[12]	11.49%	[7],[10],[12]	11.49%	[7],[10],[12]	9.03%	[8],[16],[17]	9.03%	[8],[16],[17]	9.03%	[8],[16],[17]
Investment, principal		$ 19,163	[7],[12],[14]					$ 9,895	[8],[16],[18]
Investment, cost		18,289	[7],[12]					9,772	[8],[16]
Investments at fair value		$ 16,718	[7],[12]					$ 9,293	[8],[16]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16],[22]							4.25%		4.25%		4.25%
Investment, interest rate	[8],[15],[16],[17],[22]							7.92%		7.92%		7.92%
Investment, principal	[8],[15],[16],[18],[22]							$ 15,220
Investment, cost	[8],[15],[16],[22]							13,973
Investments at fair value	[8],[15],[16],[22]							$ 14,687
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan
Investment, basis spread, variable rate		8.00%	[7],[9],[12],[20]	8.00%	[7],[9],[12],[20]	8.00%	[7],[9],[12],[20]	8.00%	[8],[15],[16],[22]	8.00%	[8],[15],[16],[22]	8.00%	[8],[15],[16],[22]
Investment, interest rate		13.39%	[7],[9],[10],[12],[20]	13.39%	[7],[9],[10],[12],[20]	13.39%	[7],[9],[10],[12],[20]	11.67%	[8],[15],[16],[17],[22]	11.67%	[8],[15],[16],[17],[22]	11.67%	[8],[15],[16],[17],[22]
Investment, principal		$ 12,500	[7],[9],[12],[14],[20]					$ 12,500	[8],[15],[16],[18],[22]
Investment, cost		12,188	[7],[9],[12],[20]					12,188	[8],[15],[16],[22]
Investments at fair value		$ 11,865	[7],[9],[12],[20]					$ 11,958	[8],[15],[16],[22]
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Investment, basis spread, variable rate	[7],[12]	3.75%		3.75%		3.75%
Investment, interest rate	[7],[10],[12]	9.25%		9.25%		9.25%
Investment, principal	[7],[12],[14]	$ 3,710
Investment, cost	[7],[12]	3,075
Investments at fair value	[7],[12]	$ 2,863
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Products, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							3.75%		3.75%		3.75%
Investment, interest rate	[8],[16],[17]							7.42%		7.42%		7.42%
Investment, principal	[8],[16],[18]							$ 2,736
Investment, cost	[8],[16]							2,260
Investments at fair value	[8],[16]							$ 2,189
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Research & Consulting Services, Second Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							8.00%		8.00%		8.00%
Investment, interest rate	[8],[15],[16],[17]							10.78%		10.78%		10.78%
Investment, principal	[8],[15],[16],[18]							$ 4,346
Investment, cost	[8],[15],[16]							4,281
Investments at fair value	[8],[15],[16]							$ 3,813
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		5.00%	[7],[9],[11],[12]	5.00%	[7],[9],[11],[12]	5.00%	[7],[9],[11],[12]	6.00%	[8],[15],[16],[19]	6.00%	[8],[15],[16],[19]	6.00%	[8],[15],[16],[19]
Investment, interest rate		10.20%	[7],[9],[10],[11],[12]	10.20%	[7],[9],[10],[11],[12]	10.20%	[7],[9],[10],[11],[12]	8.46%	[8],[15],[16],[17],[19]	8.46%	[8],[15],[16],[17],[19]	8.46%	[8],[15],[16],[17],[19]
Investment, principal		$ 808	[7],[9],[11],[12],[14]					$ 892	[8],[15],[16],[18],[19]
Investment, cost		792	[7],[9],[11],[12]					863	[8],[15],[16],[19]
Investments at fair value		$ 808	[7],[9],[11],[12]					$ 846	[8],[15],[16],[19]
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[15],[16],[17]							8.46%		8.46%		8.46%
Investment, principal	[8],[15],[16],[18]							$ 34,458
Investment, cost	[8],[15],[16]							33,737
Investments at fair value	[8],[15],[16]							$ 33,738
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	5.00%		5.00%		5.00%
Investment, interest rate	[7],[9],[10],[12]	10.20%		10.20%		10.20%
Investment, principal	[7],[9],[12],[14]	$ 9,280
Investment, cost	[7],[9],[12]	9,189
Investments at fair value	[7],[9],[12]	$ 9,280
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	5.00%		5.00%		5.00%
Investment, interest rate	[7],[9],[10],[12]	10.20%		10.20%		10.20%
Investment, principal	[7],[9],[12],[14]	$ 32,308
Investment, cost	[7],[9],[12]	31,999
Investments at fair value	[7],[9],[12]	$ 32,308
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1
Investment, basis spread, variable rate		7.25%	[7],[9],[12],[20]	7.25%	[7],[9],[12],[20]	7.25%	[7],[9],[12],[20]	7.00%	[8],[15],[16],[22]	7.00%	[8],[15],[16],[22]	7.00%	[8],[15],[16],[22]
Investment, interest rate		10.07%	[7],[9],[10],[12],[20]	10.07%	[7],[9],[10],[12],[20]	10.07%	[7],[9],[10],[12],[20]	8.00%	[8],[15],[16],[17],[22]	8.00%	[8],[15],[16],[17],[22]	8.00%	[8],[15],[16],[17],[22]
Investment, principal | €				€ 3,017	[7],[9],[12],[14],[20]					€ 1,964	[8],[15],[16],[18],[22]
Investment, cost		$ 3,341	[7],[9],[12],[20]					$ 2,176	[8],[15],[16],[22]
Investments at fair value		$ 3,321	[7],[9],[12],[20]					$ 1,927	[8],[15],[16],[22]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2
Investment, basis spread, variable rate		6.00%	[7],[9],[12],[20]	6.00%	[7],[9],[12],[20]	6.00%	[7],[9],[12],[20]	7.00%	[8],[15],[16],[22]	7.00%	[8],[15],[16],[22]	7.00%	[8],[15],[16],[22]
Investment, interest rate		11.25%	[7],[9],[10],[12],[20]	11.25%	[7],[9],[10],[12],[20]	11.25%	[7],[9],[10],[12],[20]	9.19%	[8],[15],[16],[17],[22]	9.19%	[8],[15],[16],[17],[22]	9.19%	[8],[15],[16],[17],[22]
Investment, principal		$ 10,519	[7],[9],[12],[14],[20]									£ 18,636	[8],[15],[16],[18],[22]
Investment, cost		10,389	[7],[9],[12],[20]					$ 23,139	[8],[15],[16],[22]
Investments at fair value		$ 10,614	[7],[9],[12],[20]					$ 20,826	[8],[15],[16],[22]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3
Investment, basis spread, variable rate		7.25%	[7],[9],[12],[20]	7.25%	[7],[9],[12],[20]	7.25%	[7],[9],[12],[20]	5.75%	[8],[15],[16],[22]	5.75%	[8],[15],[16],[22]	5.75%	[8],[15],[16],[22]
Investment, interest rate		12.18%	[7],[9],[10],[12],[20]	12.18%	[7],[9],[10],[12],[20]	12.18%	[7],[9],[10],[12],[20]	8.81%	[8],[15],[16],[17],[22]	8.81%	[8],[15],[16],[17],[22]	8.81%	[8],[15],[16],[17],[22]
Investment, principal						£ 4,949	[7],[9],[12],[14],[20]	$ 10,519	[8],[15],[16],[18],[22]
Investment, cost		$ 6,364	[7],[9],[12],[20]					10,357	[8],[15],[16],[22]
Investments at fair value		$ 6,348	[7],[9],[12],[20]					$ 10,328	[8],[15],[16],[22]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4
Investment, basis spread, variable rate		7.25%	[7],[9],[12],[20]	7.25%	[7],[9],[12],[20]	7.25%	[7],[9],[12],[20]	5.75%	[8],[15],[16],[19],[22]	5.75%	[8],[15],[16],[19],[22]	5.75%	[8],[15],[16],[19],[22]
Investment, interest rate	[7],[9],[10],[12],[20]	12.45%		12.45%		12.45%
Investment, principal | £						£ 23,675	[7],[9],[12],[14],[20]					£ 0	[8],[15],[16],[18],[19],[22]
Investment, cost		$ 28,939	[7],[9],[12],[20]					$ (44)	[8],[15],[16],[19],[22]
Investments at fair value		$ 30,370	[7],[9],[12],[20]					0	[8],[15],[16],[19],[22]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5
Investment, basis spread, variable rate	[7],[9],[12],[20]	5.75%		5.75%		5.75%
Investment, interest rate	[7],[9],[10],[12],[20]	8.57%		8.57%		8.57%
Investment, principal | €	[7],[9],[12],[14],[20]			€ 3,649
Investment, cost	[7],[9],[12],[20]	$ 3,927
Investments at fair value	[7],[9],[12],[20]	$ 4,027
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Common Stock
Investment owned, balance (in shares) | shares		1,783,332		1,783,332		1,783,332								1,609,201
Investment, principal		$ 0												$ 0
Investments at fair value		$ 0						370						$ 563	587
Investment owned, percent of net assets		0.00%		0.00%		0.00%								0.00%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver
Investment, basis spread, variable rate		6.75%		6.75%		6.75%								6.75%
Investment, interest rate		12.29%		12.29%		12.29%								9.00%
Investment, principal		$ 22,304												$ 21,754
Investments at fair value		$ 22,186						24,225						$ 21,260	15,712
Investment owned, percent of net assets		1.50%		1.50%		1.50%								1.70%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Equity
Investment owned, balance (in shares) | shares		1,129,453		1,129,453		1,129,453								1,019,169
Investment, principal		$ 0												$ 0
Investments at fair value		$ 1,412						$ 1,223						$ 1,203	1,152
Investment owned, percent of net assets		0.10%		0.10%		0.10%								0.10%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock
Investment owned, balance (in shares) | shares		1,783,332	[6],[9]	1,783,332	[6],[9]	1,783,332	[6],[9]	1,609,201	[5],[15]	1,609,201	[5],[15]	1,609,201	[5],[15]
Investment, cost		$ 804	[6],[9]					$ 764	[5],[15]
Investments at fair value		$ 0	[6],[9]					$ 370	[5],[15]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver
Investment, basis spread, variable rate		6.75%	[6],[9],[11],[12]	6.75%	[6],[9],[11],[12]	6.75%	[6],[9],[11],[12]	6.75%	[5],[15],[16],[19]	6.75%	[5],[15],[16],[19]	6.75%	[5],[15],[16],[19]
Investment, interest rate		12.29%	[6],[9],[10],[11],[12]	12.29%	[6],[9],[10],[11],[12]	12.29%	[6],[9],[10],[11],[12]	10.42%	[5],[15],[16],[17],[19]	10.42%	[5],[15],[16],[17],[19]	10.42%	[5],[15],[16],[17],[19]
Investment, principal		$ 22,304	[6],[9],[11],[12],[14]					$ 24,490	[5],[15],[16],[18],[19]
Investment, cost		22,327	[6],[9],[11],[12]					24,490	[5],[15],[16],[19]
Investments at fair value		$ 22,186	[6],[9],[11],[12]					$ 24,225	[5],[15],[16],[19]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity
Investment owned, balance (in shares) | shares		1,129,453	[6],[9]	1,129,453	[6],[9]	1,129,453	[6],[9]	1,019,169	[5],[15]	1,019,169	[5],[15]	1,019,169	[5],[15]
Investment, cost		$ 1,159	[6],[9]					$ 1,019	[5],[15]
Investments at fair value		$ 1,412	[6],[9]					$ 1,223	[5],[15]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants
Investment owned, balance (in shares) | shares		78,045	[6],[9]	78,045	[6],[9]	78,045	[6],[9]	70,425	[5],[15]	70,425	[5],[15]	70,425	[5],[15]
Investment, cost		$ 0	[6],[9]					$ 0	[5],[15]
Investments at fair value		$ 0	[6],[9]					0	[5],[15]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Warrants
Investment owned, balance (in shares) | shares		78,045		78,045		78,045								70,425
Investment, principal		$ 0												$ 0
Investments at fair value		$ 0						$ 0						$ 0	0
Investment owned, percent of net assets		0.00%		0.00%		0.00%								0.00%
Investment, Identifier [Axis]: Associated Asphalt Partners, LLC, Construction Materials, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							5.25%		5.25%		5.25%
Investment, interest rate	[8],[16],[17]							8.06%		8.06%		8.06%
Investment, principal	[8],[16],[18]							$ 2,501
Investment, cost	[8],[16]							2,331
Investments at fair value	[8],[16]							$ 1,934
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		5.25%	[7],[12]	5.25%	[7],[12]	5.25%	[7],[12]	5.25%	[8],[16]	5.25%	[8],[16]	5.25%	[8],[16]
Investment, interest rate		10.44%	[7],[10],[12]	10.44%	[7],[10],[12]	10.44%	[7],[10],[12]	8.37%	[8],[16],[17]	8.37%	[8],[16],[17]	8.37%	[8],[16],[17]
Investment, principal		$ 8,490	[7],[12],[14]					$ 5,640	[8],[16],[18]
Investment, cost		8,153	[7],[12]					5,482	[8],[16]
Investments at fair value		$ 5,983	[7],[12]					$ 4,822	[8],[16]
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, interest rate		11.00%	[7],[9],[10],[12],[20],[23]	11.00%	[7],[9],[10],[12],[20],[23]	11.00%	[7],[9],[10],[12],[20],[23]	11.00%	[8],[15],[16],[17],[22]	11.00%	[8],[15],[16],[17],[22]	11.00%	[8],[15],[16],[17],[22]
Investment, principal		$ 1,338	[7],[9],[14],[20],[23]					$ 13,346	[8],[15],[18],[22]
Investment, cost		1,257	[7],[9],[20],[23]					12,929	[8],[15],[22]
Investments at fair value		$ 1,257	[7],[9],[20],[23]					12,812	[8],[15],[22]
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, interest rate	[7],[9],[10],[12],[20],[23]	11.00%		11.00%		11.00%
Investment, principal		$ 1,338	[7],[9],[14],[20],[23]					8,309	[8],[15],[18],[22],[26]
Investment, cost		1,241	[7],[9],[20],[23]					8,264	[8],[15],[22],[26]
Investments at fair value		$ 1,257	[7],[9],[20],[23]					$ 8,309	[8],[15],[22],[26]
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment, interest rate	[7],[9],[10],[12],[20],[23]	11.00%		11.00%		11.00%
Investment, principal	[7],[9],[14],[20],[23]	$ 5,350
Investment, cost	[7],[9],[20],[23]	4,951
Investments at fair value	[7],[9],[20],[23]	$ 5,029
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants
Investment owned, balance (in shares) | shares	[8],[15],[22]							328,149		328,149		328,149
Investment, cost	[8],[15],[22]							$ 973
Investments at fair value	[8],[15],[22]							$ 16
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 1
Investment owned, balance (in shares) | shares		10,634		10,634		10,634
Investment, principal	[7],[9],[14],[20]	$ 0
Investment, cost	[7],[9],[20]	488
Investments at fair value	[7],[9],[20]	$ 0
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 2
Investment owned, balance (in shares) | shares	[7],[9],[20]	10,634		10,634		10,634
Investment, cost	[7],[9],[20]	$ 488
Investments at fair value	[7],[9],[20]	$ 0
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Investment, basis spread, variable rate		6.00%	[7],[9],[12],[20]	6.00%	[7],[9],[12],[20]	6.00%	[7],[9],[12],[20]	6.00%	[8],[15],[16],[22]	6.00%	[8],[15],[16],[22]	6.00%	[8],[15],[16],[22]
Investment, interest rate		11.27%	[7],[9],[10],[12],[20]	11.27%	[7],[9],[10],[12],[20]	11.27%	[7],[9],[10],[12],[20]	8.78%	[8],[15],[16],[17],[22]	8.78%	[8],[15],[16],[17],[22]	8.78%	[8],[15],[16],[17],[22]
Investment, principal		$ 29,509	[7],[9],[12],[14],[20]					$ 22,425	[8],[15],[16],[18],[22]
Investment, cost		29,137	[7],[9],[12],[20]					22,086	[8],[15],[16],[22]
Investments at fair value		$ 28,299	[7],[9],[12],[20]					$ 21,326	[8],[15],[16],[22]
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.25%		7.25%		7.25%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(113)
Investments at fair value	[7],[9],[11],[12]	$ (101)
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	7.25%		7.25%		7.25%
Investment, interest rate	[7],[9],[10],[12]	12.49%		12.49%		12.49%
Investment, principal	[7],[9],[12],[14]	$ 50,470
Investment, cost	[7],[9],[12]	49,639
Investments at fair value	[7],[9],[12]	$ 49,461
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16],[19]							5.00%		5.00%		5.00%
Investment, interest rate	[8],[15],[16],[17],[19]							8.12%		8.12%		8.12%
Investment, principal	[8],[15],[16],[18],[19]							$ 2,546
Investment, cost	[8],[15],[16],[19]							2,503
Investments at fair value	[8],[15],[16],[19]							$ 2,395
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	5.00%		5.00%		5.00%
Investment, interest rate	[7],[9],[10],[12]	10.50%		10.50%		10.50%
Investment, principal	[7],[9],[12],[14]	$ 3,258
Investment, cost	[7],[9],[12]	3,227
Investments at fair value	[7],[9],[12]	$ 3,173
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	5.00%		5.00%		5.00%
Investment, interest rate	[7],[9],[10],[12]	10.50%		10.50%		10.50%
Investment, principal	[7],[9],[12],[14]	$ 1,264
Investment, cost	[7],[9],[12]	1,273
Investments at fair value	[7],[9],[12]	$ 1,232
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1
Investment, basis spread, variable rate		8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]
Investment, interest rate		14.00%	[7],[9],[10],[12]	14.00%	[7],[9],[10],[12]	14.00%	[7],[9],[10],[12]	11.62%	[8],[15],[16],[17]	11.62%	[8],[15],[16],[17]	11.62%	[8],[15],[16],[17]
Investment, principal		$ 8,920	[7],[9],[12],[14]					$ 7,166	[8],[15],[16],[18]
Investment, cost		8,819	[7],[9],[12]					7,059	[8],[15],[16]
Investments at fair value		$ 8,661	[7],[9],[12]					$ 6,915	[8],[15],[16]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2
Investment, basis spread, variable rate		8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[8],[15],[16],[19]	8.50%	[8],[15],[16],[19]	8.50%	[8],[15],[16],[19]
Investment, interest rate		14.00%	[7],[9],[10],[12]	14.00%	[7],[9],[10],[12]	14.00%	[7],[9],[10],[12]	11.62%	[8],[15],[16],[17],[19]	11.62%	[8],[15],[16],[17],[19]	11.62%	[8],[15],[16],[17],[19]
Investment, principal		$ 2,091	[7],[9],[12],[14]					$ 4,227	[8],[15],[16],[18],[19]
Investment, cost		2,067	[7],[9],[12]					4,070	[8],[15],[16],[19]
Investments at fair value		$ 2,030	[7],[9],[12]					$ 3,839	[8],[15],[16],[19]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[12]	8.50%		8.50%		8.50%
Investment, interest rate	[7],[9],[10],[12]	14.00%		14.00%		14.00%
Investment, principal	[7],[9],[12],[14]	$ 4,361
Investment, cost	[7],[9],[12]	4,296
Investments at fair value	[7],[9],[12]	$ 4,235
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	4.50%		4.50%		4.50%
Investment, interest rate	[7],[9],[10],[11],[12]	12.50%		12.50%		12.50%
Investment, principal	[7],[9],[11],[12],[14]	$ 2,528
Investment, cost	[7],[9],[11],[12]	2,492
Investments at fair value	[7],[9],[11],[12]	$ 2,482
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[12]	10.70%		10.70%		10.70%
Investment, principal	[7],[9],[12],[14]	$ 40,764
Investment, cost	[7],[9],[12]	40,529
Investments at fair value	[7],[9],[12]	$ 40,316
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Revolver
Investment, basis spread, variable rate	[8],[15],[16],[19]							4.50%		4.50%		4.50%
Investment, interest rate	[8],[15],[16],[17],[19]							10.75%		10.75%		10.75%
Investment, principal	[8],[15],[16],[18],[19]							$ 1,702
Investment, cost	[8],[15],[16],[19]							1,660
Investments at fair value	[8],[15],[16],[19]							$ 1,617
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							5.50%		5.50%		5.50%
Investment, interest rate	[8],[15],[16],[17]							8.31%		8.31%		8.31%
Investment, principal	[8],[15],[16],[18]							$ 33,078
Investment, cost	[8],[15],[16]							32,612
Investments at fair value	[8],[15],[16]							32,053
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan
Investment, principal	[8],[15],[18],[19],[22],[26]							0
Investment, cost	[8],[15],[19],[22],[26]							0
Investments at fair value	[8],[15],[19],[22],[26]							$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, interest rate		8.00%	[7],[9],[10],[12],[20]	8.00%	[7],[9],[10],[12],[20]	8.00%	[7],[9],[10],[12],[20]	10.25%	[8],[15],[16],[17],[22]	10.25%	[8],[15],[16],[17],[22]	10.25%	[8],[15],[16],[17],[22]
Investment, interest rate, paid in kind	[7],[9],[20]	2.25%		2.25%		2.25%
Investment, principal		$ 6,719	[7],[9],[14],[20]					$ 5,322	[8],[15],[18],[22]
Investment, cost		6,508	[7],[9],[20]					5,111	[8],[15],[22]
Investments at fair value		6,282	[7],[9],[20]					$ 5,114	[8],[15],[22]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, interest rate	[8],[15],[16],[17],[19],[22]							10.25%		10.25%		10.25%
Investment, principal		3,210	[7],[9],[14],[20],[21]					$ 0	[8],[15],[18],[19],[22]
Investment, cost		3,230	[7],[9],[20],[21]					0	[8],[15],[19],[22]
Investments at fair value		$ 3,130	[7],[9],[20],[21]					0	[8],[15],[19],[22]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment, interest rate	[7],[9],[10],[12],[20]	8.00%		8.00%		8.00%
Investment, interest rate, paid in kind	[7],[9],[20]	2.25%		2.25%		2.25%
Investment, principal		$ 0	[7],[9],[11],[14],[20]					2,353	[8],[15],[18],[22],[26]
Investment, cost		0	[7],[9],[11],[20]					2,353	[8],[15],[22],[26]
Investments at fair value		$ 0	[7],[9],[11],[20]					$ 2,353	[8],[15],[22],[26]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment, interest rate	[7],[9],[10],[12],[20]	8.00%		8.00%		8.00%
Investment, interest rate, paid in kind	[7],[9],[20]	2.25%		2.25%		2.25%
Investment, principal	[7],[9],[11],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[20]	0
Investments at fair value	[7],[9],[11],[20]	0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5
Investment, principal	[7],[9],[11],[14],[20],[21]	0
Investment, cost	[7],[9],[11],[20],[21]	0
Investments at fair value	[7],[9],[11],[20],[21]	0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6
Investment, principal	[7],[9],[11],[14],[20],[21]	0
Investment, cost	[7],[9],[11],[20],[21]	0
Investments at fair value	[7],[9],[11],[20],[21]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants
Investment owned, balance (in shares) | shares		26,131	[7],[9],[20]	26,131	[7],[9],[20]	26,131	[7],[9],[20]	21,177	[8],[15],[22]	21,177	[8],[15],[22]	21,177	[8],[15],[22]
Investment, cost		$ 225	[7],[9],[20]					$ 125	[8],[15],[22]
Investments at fair value		$ 34	[7],[9],[20]					$ 98	[8],[15],[22]
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan
Investment, basis spread, variable rate		7.00%	[7],[12]	7.00%	[7],[12]	7.00%	[7],[12]	7.00%	[8],[16]	7.00%	[8],[16]	7.00%	[8],[16]
Investment, interest rate		12.25%	[7],[10],[12]	12.25%	[7],[10],[12]	12.25%	[7],[10],[12]	9.50%	[8],[16],[17]	9.50%	[8],[16],[17]	9.50%	[8],[16],[17]
Investment, principal		$ 30,625	[7],[12],[14]					$ 30,625	[8],[16],[18]
Investment, cost		30,346	[7],[12]					30,276	[8],[16]
Investments at fair value		$ 29,385	[7],[12]					$ 29,017	[8],[16]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock
Investment owned, balance (in shares) | shares		394,297	[7],[9]	394,297	[7],[9]	394,297	[7],[9]	298,460	[8],[15]	298,460	[8],[15]	298,460	[8],[15]
Investment, cost		$ 424	[7],[9]					$ 298	[8],[15]
Investments at fair value		$ 355	[7],[9]					$ 349	[8],[15]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan
Investment, interest rate		9.00%	[7],[9],[10],[12]	9.00%	[7],[9],[10],[12]	9.00%	[7],[9],[10],[12]	9.00%	[8],[15],[16],[17]	9.00%	[8],[15],[16],[17]	9.00%	[8],[15],[16],[17]
Investment, principal		$ 4,994	[7],[9],[14]					$ 3,979	[8],[15],[18]
Investment, cost		5,006	[7],[9]					3,980	[8],[15]
Investments at fair value		$ 4,969	[7],[9]					$ 3,960	[8],[15]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1
Investment owned, balance (in shares) | shares		1,708,618	[7],[9]	1,708,618	[7],[9]	1,708,618	[7],[9]	1,293,324	[8],[15]	1,293,324	[8],[15]	1,293,324	[8],[15]
Investment, cost		$ 1,711	[7],[9]					$ 1,293	[8],[15]
Investments at fair value		$ 2,085	[7],[9]					$ 1,280	[8],[15]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2
Investment owned, balance (in shares) | shares		394,297	[7],[9]	394,297	[7],[9]	394,297	[7],[9]	298,460	[8],[15]	298,460	[8],[15]	298,460	[8],[15]
Investment, cost		$ 395	[7],[9]					$ 298	[8],[15]
Investments at fair value		$ 481	[7],[9]					$ 295	[8],[15]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock
Investment owned, balance (in shares) | shares														829
Investment, principal														$ 0
Investments at fair value														$ 0	0
Investment owned, percent of net assets														0.00%
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock
Investment owned, balance (in shares) | shares		829	[1],[2],[9]	829	[1],[2],[9]	829	[1],[2],[9]	829	[3],[4],[15]	829	[3],[4],[15]	829	[3],[4],[15]
Investment, principal		$ 0
Investment, cost		0	[1],[2],[9]					$ 0	[3],[4],[15]
Investments at fair value		$ 0	[1],[2],[9]					$ 0	[3],[4],[15]
Investment owned, percent of net assets		0.00%		0.00%		0.00%
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity
Investment owned, balance (in shares) | shares		34,984,460	[1],[2],[9]	34,984,460	[1],[2],[9]	34,984,460	[1],[2],[9]	34,984,460	[3],[4],[15]	34,984,460	[3],[4],[15]	34,984,460	[3],[4],[15]
Investment, principal		$ 0
Investment, cost		34,984	[1],[2],[9]					$ 34,984	[3],[4],[15]
Investments at fair value		$ 27,638	[1],[2],[9]					$ 27,638	[3],[4],[15]
Investment owned, percent of net assets		1.80%		1.80%		1.80%
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity
Investment owned, balance (in shares) | shares														34,984,460
Investment, principal														$ 0
Investments at fair value														$ 27,638	27,638
Investment owned, percent of net assets														2.20%
Investment, Identifier [Axis]: CCO Holdings LLC, Cable & Satellite, Fixed Rate Bond
Investment, interest rate	[8],[16],[17],[22]							4.50%		4.50%		4.50%
Investment, principal	[8],[18],[22]							$ 2,097
Investment, cost	[8],[22]							1,746
Investments at fair value	[8],[22]							$ 1,603
Investment, Identifier [Axis]: CITGO Holding, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond
Investment, interest rate	[8],[16],[17]							9.25%		9.25%		9.25%
Investment, principal	[8],[18]							$ 7,857
Investment, cost	[8]							7,857
Investments at fair value	[8]							$ 7,807
Investment, Identifier [Axis]: CITGO Petroleum Corp., Oil & Gas Refining & Marketing, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							6.25%		6.25%		6.25%
Investment, interest rate	[8],[16],[17]							9.37%		9.37%		9.37%
Investment, principal	[8],[16],[18]							$ 795
Investment, cost	[8],[16]							770
Investments at fair value	[8],[16]							$ 797
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12],[23]	7.75%		7.75%		7.75%
Investment, principal	[7],[9],[12],[14],[23]	$ 727
Investment, cost	[7],[9],[12],[23]	462
Investments at fair value	[7],[9],[12],[23]	$ 325
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							6.50%		6.50%		6.50%
Investment, interest rate	[8],[15],[16],[17]							9.31%		9.31%		9.31%
Investment, interest rate, paid in kind	[8],[15],[16]							2.00%		2.00%		2.00%
Investment, principal	[8],[15],[16],[18]							$ 14,294
Investment, cost	[8],[15],[16]							13,471
Investments at fair value	[8],[15],[16]							$ 13,143
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	11.91%		11.91%		11.91%
Investment, interest rate, paid in kind	[7],[9],[12]	2.00%		2.00%		2.00%
Investment, principal	[7],[9],[12],[14]	$ 13
Investment, cost	[7],[9],[12]	13
Investments at fair value	[7],[9],[12]	$ 13
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	11.91%		11.91%		11.91%
Investment, interest rate, paid in kind	[7],[9],[12]	2.00%		2.00%		2.00%
Investment, principal	[7],[9],[12],[14]	$ 3,031
Investment, cost	[7],[9],[12]	2,971
Investments at fair value	[7],[9],[12]	$ 3,031
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[12]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	11.91%		11.91%		11.91%
Investment, interest rate, paid in kind	[7],[9],[12]	2.00%		2.00%		2.00%
Investment, principal	[7],[9],[12],[14]	$ 1,557
Investment, cost	[7],[9],[12]	1,526
Investments at fair value	[7],[9],[12]	$ 1,557
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4
Investment, basis spread, variable rate	[7],[9],[12]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	11.91%		11.91%		11.91%
Investment, interest rate, paid in kind	[7],[9],[12]	2.00%		2.00%		2.00%
Investment, principal	[7],[9],[12],[14]	$ 1,024
Investment, cost	[7],[9],[12]	1,002
Investments at fair value	[7],[9],[12]	$ 1,024
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity
Investment owned, balance (in shares) | shares		1,080,399	[6],[9]	1,080,399	[6],[9]	1,080,399	[6],[9]	1,080,399	[5],[15]	1,080,399	[5],[15]	1,080,399	[5],[15]
Investment, cost		$ 1,080	[6],[9]					$ 1,080	[5],[15]
Investments at fair value		$ 313	[6],[9]					378	[5],[15]
Investment, Identifier [Axis]: Caregiver Services, Inc., Preferred Equity
Investment owned, balance (in shares) | shares		1,080,399		1,080,399		1,080,399								1,080,399
Investment, principal		$ 0												$ 0
Investments at fair value		$ 313						$ 378						$ 401	838
Investment owned, percent of net assets		0.00%		0.00%		0.00%								0.00%
Investment, Identifier [Axis]: Carvana Co., Automotive Retail, Fixed Rate Bond
Investment, interest rate	[8],[16],[17],[22]							5.63%		5.63%		5.63%
Investment, principal	[8],[18],[22]							$ 6,700
Investment, cost	[8],[22]							5,825
Investments at fair value	[8],[22]							$ 4,724
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							5.50%		5.50%		5.50%
Investment, interest rate	[8],[15],[16],[17]							8.62%		8.62%		8.62%
Investment, principal	[8],[15],[16],[18]							$ 10,692
Investment, cost	[8],[15],[16]							10,004
Investments at fair value	[8],[15],[16]							$ 10,209
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[12]	10.70%		10.70%		10.70%
Investment, principal	[7],[9],[12],[14]	$ 130
Investment, cost	[7],[9],[12]	130
Investments at fair value	[7],[9],[12]	$ 130
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[12]	10.70%		10.70%		10.70%
Investment, principal	[7],[9],[12],[14]	$ 129
Investment, cost	[7],[9],[12]	129
Investments at fair value	[7],[9],[12]	$ 129
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[12]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[12]	10.70%		10.70%		10.70%
Investment, principal	[7],[9],[12],[14]	$ 1,084
Investment, cost	[7],[9],[12]	1,103
Investments at fair value	[7],[9],[12]	$ 1,084
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 4
Investment, basis spread, variable rate	[7],[9],[12]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[12]	10.70%		10.70%		10.70%
Investment, principal	[7],[9],[12],[14]	$ 9,002
Investment, cost	[7],[9],[12]	9,003
Investments at fair value	[7],[9],[12]	$ 9,002
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1
Investment, interest rate		7.50%	[7],[10],[12],[20]	7.50%	[7],[10],[12],[20]	7.50%	[7],[10],[12],[20]	7.50%	[8],[16],[17],[22]	7.50%	[8],[16],[17],[22]	7.50%	[8],[16],[17],[22]
Investment, principal		$ 2,632	[7],[14],[20]					$ 4,311	[8],[18],[22]
Investment, cost		2,632	[7],[20]					4,311	[8],[22]
Investments at fair value		$ 1,951	[7],[20]					$ 3,132	[8],[22]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2
Investment, interest rate		7.75%	[7],[10],[12],[20]	7.75%	[7],[10],[12],[20]	7.75%	[7],[10],[12],[20]	5.13%	[8],[16],[17],[22]	5.13%	[8],[16],[17],[22]	5.13%	[8],[16],[17],[22]
Investment, principal		$ 176	[7],[14],[20]					$ 1,374	[8],[18],[22]
Investment, cost		170	[7],[20]					1,229	[8],[22]
Investments at fair value		$ 138	[7],[20]					$ 1,163	[8],[22]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 3
Investment, interest rate	[8],[16],[17],[22]							7.75%		7.75%		7.75%
Investment, principal	[8],[18],[22]							$ 676
Investment, cost	[8],[22]							648
Investments at fair value	[8],[22]							$ 512
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond
Investment, interest rate		7.38%	[7],[10],[12]	7.38%	[7],[10],[12]	7.38%	[7],[10],[12]	7.38%	[8],[16],[17]	7.38%	[8],[16],[17]	7.38%	[8],[16],[17]
Investment, principal		$ 8,420	[7],[14]					$ 8,420	[8],[18]
Investment, cost		8,257	[7]					8,243	[8]
Investments at fair value		$ 7,330	[7]					$ 6,900	[8]
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan
Investment, basis spread, variable rate		8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]
Investment, interest rate		13.69%	[7],[9],[10],[12]	13.69%	[7],[9],[10],[12]	13.69%	[7],[9],[10],[12]	11.62%	[8],[15],[16],[17]	11.62%	[8],[15],[16],[17]	11.62%	[8],[15],[16],[17]
Investment, principal		$ 24,350	[7],[9],[12],[14]					$ 22,537	[8],[15],[16],[18]
Investment, cost		23,525	[7],[9],[12]					21,642	[8],[15],[16]
Investments at fair value		21,506	[7],[9],[12]					20,396	[8],[15],[16]
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants
Investment, cost		706	[7],[9]					648	[8],[15]
Investments at fair value		$ 154	[7],[9]					$ 457	[8],[15]
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan
Investment, basis spread, variable rate		5.00%	[7],[12]	5.00%	[7],[12]	5.00%	[7],[12]	5.00%	[8],[16]	5.00%	[8],[16]	5.00%	[8],[16]
Investment, interest rate		10.37%	[7],[10],[12]	10.37%	[7],[10],[12]	10.37%	[7],[10],[12]	8.12%	[8],[16],[17]	8.12%	[8],[16],[17]	8.12%	[8],[16],[17]
Investment, principal		$ 17,506	[7],[12],[14]					$ 11,913	[8],[16],[18]
Investment, cost		15,434	[7],[12]					11,697	[8],[16]
Investments at fair value		$ 11,176	[7],[12]					$ 8,596	[8],[16]
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity
Investment owned, balance (in shares) | shares		417,851	[7],[9]	417,851	[7],[9]	417,851	[7],[9]	417,851	[8],[15]	417,851	[8],[15]	417,851	[8],[15]
Investment, cost		$ 605	[7],[9]					$ 605	[8],[15]
Investments at fair value		$ 894	[7],[9]					$ 894	[8],[15]
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, Common Stock
Investment owned, balance (in shares) | shares		1,500	[7],[9]	1,500	[7],[9]	1,500	[7],[9]	1,099	[8],[15]	1,099	[8],[15]	1,099	[8],[15]
Investment, cost		$ 1,574	[7],[9]					$ 690	[8],[15]
Investments at fair value		$ 3,299	[7],[9]					$ 2,340	[8],[15]
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Revolver
Investment, basis spread, variable rate		5.75%	[7],[9],[11],[12]	5.75%	[7],[9],[11],[12]	5.75%	[7],[9],[11],[12]	4.75%	[8],[15],[16],[19]	4.75%	[8],[15],[16],[19]	4.75%	[8],[15],[16],[19]
Investment, interest rate		14.00%	[7],[9],[10],[11],[12]	14.00%	[7],[9],[10],[11],[12]	14.00%	[7],[9],[10],[11],[12]	11.00%	[8],[15],[16],[17],[19]	11.00%	[8],[15],[16],[17],[19]	11.00%	[8],[15],[16],[17],[19]
Investment, principal		$ 1,250	[7],[9],[11],[12],[14]					$ 916	[8],[15],[16],[18],[19]
Investment, cost		1,226	[7],[9],[11],[12]					898	[8],[15],[16],[19]
Investments at fair value		$ 1,202	[7],[9],[11],[12]					$ 898	[8],[15],[16],[19]
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							5.75%		5.75%		5.75%
Investment, interest rate	[8],[15],[16],[17]							8.88%		8.88%		8.88%
Investment, principal	[8],[15],[16],[18]							$ 13,712
Investment, cost	[8],[15],[16]							13,554
Investments at fair value	[8],[15],[16]							$ 13,583
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	6.13%		6.13%		6.13%
Investment, interest rate	[7],[9],[10],[12]	11.33%		11.33%		11.33%
Investment, principal	[7],[9],[12],[14]	$ 13,671
Investment, cost	[7],[9],[12]	13,633
Investments at fair value	[7],[9],[12]	$ 13,408
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	6.13%		6.13%		6.13%
Investment, interest rate	[7],[9],[10],[12]	11.33%		11.33%		11.33%
Investment, principal	[7],[9],[12],[14]	$ 4,903
Investment, cost	[7],[9],[12]	4,853
Investments at fair value	[7],[9],[12]	$ 4,809
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.50%		7.50%		7.50%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(21)
Investments at fair value	[7],[9],[11],[12]	$ (21)
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	7.50%		7.50%		7.50%
Investment, interest rate	[7],[9],[10],[12]	12.60%		12.60%		12.60%
Investment, principal	[7],[9],[12],[14]	$ 13,157
Investment, cost	[7],[9],[12]	12,843
Investments at fair value	[7],[9],[12]	$ 12,852
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.50%		7.50%		7.50%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(15)
Investments at fair value	[7],[9],[11],[12]	$ (14)
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Investment, basis spread, variable rate		5.00%	[7],[12]	5.00%	[7],[12]	5.00%	[7],[12]	5.00%	[8],[16]	5.00%	[8],[16]	5.00%	[8],[16]
Investment, interest rate		10.24%	[7],[10],[12]	10.24%	[7],[10],[12]	10.24%	[7],[10],[12]	7.65%	[8],[16],[17]	7.65%	[8],[16],[17]	7.65%	[8],[16],[17]
Investment, principal		$ 14,787	[7],[12],[14]					$ 10,336	[8],[16],[18]
Investment, cost		14,186	[7],[12]					9,716	[8],[16]
Investments at fair value		$ 13,807	[7],[12]					$ 9,681	[8],[16]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver
Investment, basis spread, variable rate		6.00%	[7],[9],[11],[12]	6.00%	[7],[9],[11],[12]	6.00%	[7],[9],[11],[12]	6.00%	[8],[15],[16],[19]	6.00%	[8],[15],[16],[19]	6.00%	[8],[15],[16],[19]
Investment, interest rate	[10],[12]	11.20%		11.20%		11.20%
Investment, principal		$ 533	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		520	[7],[9],[11],[12]					(13)	[8],[15],[16],[19]
Investments at fair value		$ 507	[7],[9],[11],[12]					$ (26)	[8],[15],[16],[19]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan
Investment, basis spread, variable rate		6.00%	[7],[9],[12]	6.00%	[7],[9],[12]	6.00%	[7],[9],[12]	6.00%	[8],[15],[16]	6.00%	[8],[15],[16]	6.00%	[8],[15],[16]
Investment, interest rate		11.10%	[7],[9],[10],[12]	11.10%	[7],[9],[10],[12]	11.10%	[7],[9],[10],[12]	8.81%	[8],[15],[16],[17]	8.81%	[8],[15],[16],[17]	8.81%	[8],[15],[16],[17]
Investment, principal		$ 18,060	[7],[9],[12],[14]					$ 18,200	[8],[15],[16],[18]
Investment, cost		17,715	[7],[9],[12]					17,790	[8],[15],[16]
Investments at fair value		$ 17,706	[7],[9],[12]					$ 17,843	[8],[15],[16]
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Investment, basis spread, variable rate		4.75%	[7],[12]	4.75%	[7],[12]	4.75%	[7],[12]	4.75%	[8],[16]	4.75%	[8],[16]	4.75%	[8],[16]
Investment, interest rate		9.80%	[7],[10],[12]	9.80%	[7],[10],[12]	9.80%	[7],[10],[12]	7.33%	[8],[16],[17]	7.33%	[8],[16],[17]	7.33%	[8],[16],[17]
Investment, principal		$ 4,963	[7],[12],[14]					$ 5,000	[8],[16],[18]
Investment, cost		4,879	[7],[12]					4,906	[8],[16]
Investments at fair value		$ 4,632	[7],[12]					$ 4,760	[8],[16]
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, Internet & Direct Marketing Retail, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16],[22]							5.75%		5.75%		5.75%
Investment, interest rate	[8],[16],[17],[22]							8.49%		8.49%		8.49%
Investment, principal	[8],[16],[18],[22]							$ 4,988
Investment, cost	[8],[16],[22]							4,882
Investments at fair value	[8],[16],[22]							$ 4,757
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock
Investment owned, balance (in shares) | shares		2	[7],[9],[20]	2	[7],[9],[20]	2	[7],[9],[20]	2	[8],[15],[22]	2	[8],[15],[22]	2	[8],[15],[22]
Investment, cost		$ 2	[7],[9],[20]					$ 2	[8],[15],[22]
Investments at fair value		$ 2	[7],[9],[20]					$ 2	[8],[15],[22]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity
Investment owned, balance (in shares) | shares		419	[7],[9],[20]	419	[7],[9],[20]	419	[7],[9],[20]	419	[8],[15],[22]	419	[8],[15],[22]	419	[8],[15],[22]
Investment, cost		$ 419	[7],[9],[20]					$ 419	[8],[15],[22]
Investments at fair value		$ 419	[7],[9],[20]					$ 419	[8],[15],[22]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan
Investment, interest rate		3.00%	[7],[9],[10],[11],[12],[20]	3.00%	[7],[9],[10],[11],[12],[20]	3.00%	[7],[9],[10],[11],[12],[20]	10.00%	[8],[15],[16],[17],[19],[22]	10.00%	[8],[15],[16],[17],[19],[22]	10.00%	[8],[15],[16],[17],[19],[22]
Investment, interest rate, paid in kind	[7],[9],[11],[20]	7.00%		7.00%		7.00%
Investment, principal		$ 13,043	[7],[9],[11],[14],[20]					$ 4,183	[8],[15],[18],[19],[22]
Investment, cost		13,043	[7],[9],[11],[20]					4,183	[8],[15],[19],[22]
Investments at fair value		$ 13,043	[7],[9],[11],[20]					$ 4,183	[8],[15],[19],[22]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants
Investment owned, balance (in shares) | shares		31	[7],[9],[20]	31	[7],[9],[20]	31	[7],[9],[20]	31	[8],[15],[22]	31	[8],[15],[22]	31	[8],[15],[22]
Investment, cost		$ 0	[7],[9],[20]					$ 0	[8],[15],[22]
Investments at fair value		$ 0	[7],[9],[20]					$ 0	[8],[15],[22]
Investment, Identifier [Axis]: Delta Topco, Inc., Systems Software, Second Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							7.25%		7.25%		7.25%
Investment, interest rate	[8],[16],[17]							9.34%		9.34%		9.34%
Investment, principal	[8],[16],[18]							$ 6,680
Investment, cost	[8],[16]							6,647
Investments at fair value	[8],[16]							$ 5,934
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	9.00%		9.00%		9.00%
Investment, interest rate	[7],[9],[10],[12]	14.42%		14.42%		14.42%
Investment, principal	[7],[9],[12],[14]	$ 20,757
Investment, cost	[7],[9],[12]	20,092
Investments at fair value	[7],[9],[12]	$ 20,705
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1
Investment, basis spread, variable rate	[8],[15],[16]							9.00%		9.00%		9.00%
Investment, interest rate	[8],[15],[16],[17]							12.67%		12.67%		12.67%
Investment, interest rate, paid in kind	[8],[15],[16]							2.00%		2.00%		2.00%
Investment, principal	[8],[15],[16],[18]							$ 24,396
Investment, cost	[8],[15],[16]							23,083
Investments at fair value	[8],[15],[16]							$ 22,993
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2
Investment, basis spread, variable rate	[8],[15],[16],[19]							9.00%		9.00%		9.00%
Investment, principal	[8],[15],[16],[18],[19]							$ 0
Investment, cost	[8],[15],[16],[19]							(135)
Investments at fair value	[8],[15],[16],[19]							$ (129)
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan
Investment, interest rate, paid in kind	[7],[9]	8.00%		8.00%		8.00%
Investment, principal	[7],[9],[14]	$ 641
Investment, cost	[7],[9]	640
Investments at fair value	[7],[9]	$ 611
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants
Investment owned, balance (in shares) | shares		6,397,254	[7],[9]	6,397,254	[7],[9]	6,397,254	[7],[9]	5,403,823	[8],[15]	5,403,823	[8],[15]	5,403,823	[8],[15]
Investment, cost		$ 1,642	[7],[9]					$ 1,405	[8],[15]
Investments at fair value		$ 1,215	[7],[9]					$ 1,297	[8],[15]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		6.75%	[7],[9],[11],[12]	6.75%	[7],[9],[11],[12]	6.75%	[7],[9],[11],[12]	6.50%	[8],[15],[16],[19]	6.50%	[8],[15],[16],[19]	6.50%	[8],[15],[16],[19]
Investment, interest rate		12.09%	[7],[9],[10],[11],[12]	12.09%	[7],[9],[10],[11],[12]	12.09%	[7],[9],[10],[11],[12]	9.41%	[8],[15],[16],[17],[19]	9.41%	[8],[15],[16],[17],[19]	9.41%	[8],[15],[16],[17],[19]
Investment, principal		$ 204	[7],[9],[11],[12],[14]					$ 251	[8],[15],[16],[18],[19]
Investment, cost		184	[7],[9],[11],[12]					228	[8],[15],[16],[19]
Investments at fair value		$ 172	[7],[9],[11],[12]					$ 239	[8],[15],[16],[19]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		7.00%	[7],[9],[12]	7.00%	[7],[9],[12]	7.00%	[7],[9],[12]	7.00%	[8],[15],[16]	7.00%	[8],[15],[16]	7.00%	[8],[15],[16]
Investment, interest rate		12.34%	[7],[9],[10],[12]	12.34%	[7],[9],[10],[12]	12.34%	[7],[9],[10],[12]	9.91%	[8],[15],[16],[17]	9.91%	[8],[15],[16],[17]	9.91%	[8],[15],[16],[17]
Investment, principal		$ 12,418	[7],[9],[12],[14]					$ 9,902	[8],[15],[16],[18]
Investment, cost		12,226	[7],[9],[12]					9,599	[8],[15],[16]
Investments at fair value		$ 12,120	[7],[9],[12]					$ 9,793	[8],[15],[16]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Investment, basis spread, variable rate		5.00%	[7],[12]	5.00%	[7],[12]	5.00%	[7],[12]	5.00%	[8],[16]	5.00%	[8],[16]	5.00%	[8],[16]
Investment, interest rate		10.22%	[7],[10],[12]	10.22%	[7],[10],[12]	10.22%	[7],[10],[12]	8.12%	[8],[16],[17]	8.12%	[8],[16],[17]	8.12%	[8],[16],[17]
Investment, principal		$ 4,769	[7],[12],[14]					$ 19,242	[8],[16],[18]
Investment, cost		4,687	[7],[12]					18,970	[8],[16]
Investments at fair value		$ 4,672	[7],[12]					$ 17,973	[8],[16]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Stock
Investment owned, balance (in shares) | shares														30,031
Investment, principal														$ 0
Investments at fair value														$ 9,267	18,065
Investment owned, percent of net assets														0.70%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver
Investment, basis spread, variable rate														5.00%
Investment, principal														$ 0
Investments at fair value														$ 0	0
Investment owned, percent of net assets														0.00%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Term Loan
Investment, basis spread, variable rate														5.00%
Investment, interest rate														7.26%
Investment, principal														$ 16,074
Investments at fair value														$ 16,074	27,381
Investment owned, percent of net assets														1.30%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock
Investment owned, balance (in shares) | shares		30,031	[1],[2],[9]	30,031	[1],[2],[9]	30,031	[1],[2],[9]	30,031	[3],[4],[15]	30,031	[3],[4],[15]	30,031	[3],[4],[15]
Investment, principal		$ 0
Investment, cost		15,222	[1],[2],[9]					$ 15,222	[3],[4],[15]
Investments at fair value		$ 2,711	[1],[2],[9]					$ 4,946	[3],[4],[15]
Investment owned, percent of net assets		0.20%		0.20%		0.20%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver
Investment, basis spread, variable rate		5.00%	[1],[2],[9],[11],[12]	5.00%	[1],[2],[9],[11],[12]	5.00%	[1],[2],[9],[11],[12]	5.00%	[3],[4],[15],[16],[19]	5.00%	[3],[4],[15],[16],[19]	5.00%	[3],[4],[15],[16],[19]
Investment, interest rate	[1],[2],[9],[10],[11],[12]	10.24%		10.24%		10.24%
Investment, principal		$ 3,484	[1],[2],[9],[11],[12],[14]					$ 0	[3],[4],[15],[16],[18],[19]
Investment, cost		3,484	[1],[2],[9],[11],[12]					0	[3],[4],[15],[16],[19]
Investments at fair value		$ 3,484	[1],[2],[9],[11],[12]					$ 0	[3],[4],[15],[16],[19]
Investment owned, percent of net assets		0.20%		0.20%		0.20%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan
Investment, basis spread, variable rate	[3],[4],[15],[16]							5.00%		5.00%		5.00%
Investment, interest rate	[3],[4],[15],[16],[17]							8.68%		8.68%		8.68%
Investment, principal	[3],[4],[15],[16],[18]							$ 14,333
Investment, cost	[3],[4],[15],[16]							14,333
Investments at fair value	[3],[4],[15],[16]							14,333
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1
Investment, basis spread, variable rate	[1],[2],[9],[12]	5.00%		5.00%		5.00%
Investment, interest rate	[1],[2],[9],[10],[12]	10.39%		10.39%		10.39%
Investment, principal	[1],[2],[9],[12],[14]	$ 14,102
Investment, cost	[1],[2],[9],[12]	14,102
Investments at fair value		$ 14,102	[1],[2],[9],[12]					14,333
Investment owned, percent of net assets		0.90%		0.90%		0.90%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2
Investment, basis spread, variable rate	[1],[2],[9],[12]	5.00%		5.00%		5.00%
Investment, principal	[1],[2],[9],[11],[12],[14]	$ 0
Investment, cost	[1],[2],[9],[11],[12]	0
Investments at fair value		$ 0	[1],[2],[9],[11],[12]					$ 0
Investment owned, percent of net assets		0.00%		0.00%		0.00%
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock
Investment owned, balance (in shares) | shares		12,500	[7],[9]	12,500	[7],[9]	12,500	[7],[9]	12,500	[8],[15]	12,500	[8],[15]	12,500	[8],[15]
Investment, cost		$ 0	[7],[9]					$ 0	[8],[15]
Investments at fair value		$ 0	[7],[9]					$ 0	[8],[15]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity
Investment owned, balance (in shares) | shares		488	[7],[9]	488	[7],[9]	488	[7],[9]	488	[8],[15]	488	[8],[15]	488	[8],[15]
Investment, cost		$ 488	[7],[9]					$ 488	[8],[15]
Investments at fair value		$ 1,160	[7],[9]					$ 966	[8],[15]
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[8],[15],[16]	7.50%	[8],[15],[16]	7.50%	[8],[15],[16]
Investment, interest rate		13.04%	[7],[9],[10],[12]	13.04%	[7],[9],[10],[12]	13.04%	[7],[9],[10],[12]	11.17%	[8],[15],[16],[17]	11.17%	[8],[15],[16],[17]	11.17%	[8],[15],[16],[17]
Investment, principal		$ 8,974	[7],[9],[12],[14]					$ 8,974	[8],[15],[16],[18]
Investment, cost		8,884	[7],[9],[12]					8,884	[8],[15],[16]
Investments at fair value		$ 7,359	[7],[9],[12]					$ 8,503	[8],[15],[16]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1
Investment, interest rate		3.00%	[7],[9],[10],[12],[20]	3.00%	[7],[9],[10],[12],[20]	3.00%	[7],[9],[10],[12],[20]	3.00%	[8],[15],[16],[17],[22]	3.00%	[8],[15],[16],[17],[22]	3.00%	[8],[15],[16],[17],[22]
Investment, interest rate, paid in kind		6.00%	[7],[9],[20]	6.00%	[7],[9],[20]	6.00%	[7],[9],[20]	6.00%	[8],[15],[22]	6.00%	[8],[15],[22]	6.00%	[8],[15],[22]
Investment, principal		$ 10,899	[7],[9],[14],[20]					$ 10,418	[8],[15],[18],[22]
Investment, cost		10,779	[7],[9],[20]					10,275	[8],[15],[22]
Investments at fair value		$ 10,463	[7],[9],[20]					$ 10,231	[8],[15],[22]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2
Investment, interest rate		3.00%	[7],[9],[10],[12],[20]	3.00%	[7],[9],[10],[12],[20]	3.00%	[7],[9],[10],[12],[20]	3.00%	[8],[15],[16],[17],[19],[22]	3.00%	[8],[15],[16],[17],[19],[22]	3.00%	[8],[15],[16],[17],[19],[22]
Investment, interest rate, paid in kind	[7],[9],[20]	6.00%		6.00%		6.00%
Investment, principal		$ 1,746	[7],[9],[14],[20]					$ 0	[8],[15],[18],[19],[22]
Investment, cost		1,720	[7],[9],[20]					3	[8],[15],[19],[22]
Investments at fair value		$ 1,676	[7],[9],[20]					$ 0	[8],[15],[19],[22]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3
Investment, interest rate	[7],[9],[10],[11],[12],[20]	3.00%		3.00%		3.00%
Investment, interest rate, paid in kind	[7],[9],[11],[20]	6.00%		6.00%		6.00%
Investment, principal	[7],[9],[11],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[20]	1
Investments at fair value	[7],[9],[11],[20]	$ 0
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4
Investment, interest rate	[7],[9],[10],[11],[12],[20]	3.00%		3.00%		3.00%
Investment, interest rate, paid in kind	[7],[9],[11],[20]	6.00%		6.00%		6.00%
Investment, principal	[7],[9],[11],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[20]	1
Investments at fair value	[7],[9],[11],[20]	$ 0
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan
Investment, basis spread, variable rate		6.75%	[7],[12]	6.75%	[7],[12]	6.75%	[7],[12]	6.75%	[8],[16]	6.75%	[8],[16]	6.75%	[8],[16]
Investment, interest rate		11.94%	[7],[10],[12]	11.94%	[7],[10],[12]	11.94%	[7],[10],[12]	9.87%	[8],[16],[17]	9.87%	[8],[16],[17]	9.87%	[8],[16],[17]
Investment, principal		$ 31,074	[7],[12],[14]					$ 25,061	[8],[16],[18]
Investment, cost		29,063	[7],[12]					24,685	[8],[16]
Investments at fair value		$ 18,664	[7],[12]					$ 21,646	[8],[16]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan
Investment, interest rate		9.00%	[7],[9],[10],[11],[12]	9.00%	[7],[9],[10],[11],[12]	9.00%	[7],[9],[10],[11],[12]	9.00%	[8],[15],[16],[17],[27]	9.00%	[8],[15],[16],[17],[27]	9.00%	[8],[15],[16],[17],[27]
Investment, principal		$ 52,658	[7],[9],[11],[14]					$ 27,850	[8],[15],[18],[27]
Investment, cost		52,658	[7],[9],[11]					27,850	[8],[15],[27]
Investments at fair value		$ 52,658	[7],[9],[11]					$ 27,850	[8],[15],[27]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants
Investment owned, balance (in shares) | shares		2,500	[7],[9],[20]	2,500	[7],[9],[20]	2,500	[7],[9],[20]	2,500	[8],[15],[22],[27]	2,500	[8],[15],[22],[27]	2,500	[8],[15],[22],[27]
Investment, cost		$ 0	[7],[9],[20]					$ 0	[8],[15],[22],[27]
Investments at fair value		$ 3	[7],[9],[20]					$ 3	[8],[15],[22],[27]
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan
Investment, interest rate														9.00%
Investment, principal														$ 0
Investments at fair value														$ 0	7,500
Investment owned, percent of net assets														0.00%
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Membership Interest
Investment, principal														$ 0
Investments at fair value														$ 0	698
Investment owned, ownership percentage														100.00%
Investment owned, percent of net assets														0.00%
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan
Investment, interest rate		11.00%	[7],[9],[10],[12],[20]	11.00%	[7],[9],[10],[12],[20]	11.00%	[7],[9],[10],[12],[20]	11.00%	[8],[15],[16],[17],[22]	11.00%	[8],[15],[16],[17],[22]	11.00%	[8],[15],[16],[17],[22]
Investment, principal		$ 11,918	[7],[9],[14],[20]					$ 9,466	[8],[15],[18],[22]
Investment, cost		11,572	[7],[9],[20]					9,071	[8],[15],[22]
Investments at fair value		$ 11,173	[7],[9],[20]					$ 9,008	[8],[15],[22]
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants
Investment owned, balance (in shares) | shares		417,011	[7],[9],[20]	417,011	[7],[9],[20]	417,011	[7],[9],[20]	331,200	[8],[15],[22]	331,200	[8],[15],[22]	331,200	[8],[15],[22]
Investment, cost		$ 427	[7],[9],[20]					$ 405	[8],[15],[22]
Investments at fair value		$ 113	[7],[9],[20]					$ 66	[8],[15],[22]
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond
Investment, interest rate		6.00%	[7],[10],[12],[20]	6.00%	[7],[10],[12],[20]	6.00%	[7],[10],[12],[20]	6.00%	[8],[16],[17],[22]	6.00%	[8],[16],[17],[22]	6.00%	[8],[16],[17],[22]
Investment, principal		$ 4,881	[7],[14],[20]					$ 4,881	[8],[18],[22]
Investment, cost		4,456	[7],[20]					4,420	[8],[22]
Investments at fair value		$ 3,595	[7],[20]					$ 3,845	[8],[22]
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Revolver
Investment, basis spread, variable rate	[8],[15],[16],[19]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[15],[16],[17],[19]							10.60%		10.60%		10.60%
Investment, principal	[8],[15],[16],[18],[19]							$ 1,280
Investment, cost	[8],[15],[16],[19]							1,268
Investments at fair value	[8],[15],[16],[19]							$ 1,262
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[15],[16],[17]							10.67%		10.67%		10.67%
Investment, principal	[8],[15],[16],[18]							$ 25,128
Investment, cost	[8],[15],[16]							24,915
Investments at fair value	[8],[15],[16]							$ 24,851
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.25%		7.25%		7.25%
Investment, interest rate	[7],[9],[10],[11],[12]	12.34%		12.34%		12.34%
Investment, principal	[7],[9],[11],[12],[14]	$ 1,638
Investment, cost	[7],[9],[11],[12]	1,530
Investments at fair value	[7],[9],[11],[12]	$ 1,532
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	7.25%		7.25%		7.25%
Investment, interest rate	[7],[9],[10],[12]	12.34%		12.34%		12.34%
Investment, principal	[7],[9],[12],[14]	$ 23,774
Investment, cost	[7],[9],[12]	23,080
Investments at fair value	[7],[9],[12]	$ 23,094
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	5.00%		5.00%		5.00%
Investment, interest rate	[7],[9],[10],[12]	10.25%		10.25%		10.25%
Investment, principal	[7],[9],[12],[14]	$ 2,463
Investment, cost	[7],[9],[12]	2,039
Investments at fair value	[7],[9],[12]	$ 1,995
Investment, Identifier [Axis]: Global Medical Response, Inc., Health Care Services, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							4.25%		4.25%		4.25%
Investment, interest rate	[8],[16],[17]							7.37%		7.37%		7.37%
Investment, principal	[8],[16],[18]							$ 5,572
Investment, cost	[8],[16]							5,435
Investments at fair value	[8],[16]							$ 4,848
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes
Investment, basis spread, variable rate	[7],[12],[20]	2.85%		2.85%		2.85%
Investment, interest rate	[7],[10],[12],[20]	6.05%		6.05%		6.05%
Investment, principal | €	[7],[12],[14],[20]			€ 1,000
Investment, cost	[7],[12],[20]	$ 872
Investments at fair value	[7],[12],[20]	$ 970
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver
Investment, basis spread, variable rate		8.00%	[7],[9],[11],[12]	8.00%	[7],[9],[11],[12]	8.00%	[7],[9],[11],[12]	8.00%	[8],[15],[16],[19]	8.00%	[8],[15],[16],[19]	8.00%	[8],[15],[16],[19]
Investment, principal		$ 0	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		(29)	[7],[9],[11],[12]					(27)	[8],[15],[16],[19]
Investments at fair value		$ (18)	[7],[9],[11],[12]					$ (25)	[8],[15],[16],[19]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1
Investment, basis spread, variable rate		8.00%	[7],[9],[12]	8.00%	[7],[9],[12]	8.00%	[7],[9],[12]	8.00%	[8],[15],[16]	8.00%	[8],[15],[16]	8.00%	[8],[15],[16]
Investment, interest rate		13.39%	[7],[9],[10],[12]	13.39%	[7],[9],[10],[12]	13.39%	[7],[9],[10],[12]	11.04%	[8],[15],[16],[17]	11.04%	[8],[15],[16],[17]	11.04%	[8],[15],[16],[17]
Investment, principal		$ 17,488	[7],[9],[12],[14]					$ 14,311	[8],[15],[16],[18]
Investment, cost		17,308	[7],[9],[12]					14,041	[8],[15],[16]
Investments at fair value		$ 17,314	[7],[9],[12]					$ 14,060	[8],[15],[16]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2
Investment, basis spread, variable rate		8.00%	[7],[9],[11],[12]	8.00%	[7],[9],[11],[12]	8.00%	[7],[9],[11],[12]	8.00%	[8],[15],[16],[19]	8.00%	[8],[15],[16],[19]	8.00%	[8],[15],[16],[19]
Investment, principal		$ 0	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		(58)	[7],[9],[11],[12]					(54)	[8],[15],[16],[19]
Investments at fair value		$ (35)	[7],[9],[11],[12]					$ (50)	[8],[15],[16],[19]
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Investment, basis spread, variable rate		5.25%	[7],[12]	5.25%	[7],[12]	5.25%	[7],[12]	5.25%	[8],[16]	5.25%	[8],[16]	5.25%	[8],[16]
Investment, interest rate		10.45%	[7],[10],[12]	10.45%	[7],[10],[12]	10.45%	[7],[10],[12]	8.38%	[8],[16],[17]	8.38%	[8],[16],[17]	8.38%	[8],[16],[17]
Investment, principal		$ 14,383	[7],[12],[14]					$ 9,392	[8],[16],[18]
Investment, cost		13,885	[7],[12]					9,080	[8],[16]
Investments at fair value		$ 12,352	[7],[12]					$ 8,582	[8],[16]
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12],[20]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12],[20]	11.74%		11.74%		11.74%
Investment, principal	[7],[9],[12],[14],[20]	$ 7,448
Investment, cost	[7],[9],[12],[20]	7,279
Investments at fair value	[7],[9],[12],[20]	$ 7,295
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[11],[12],[20]	6.50%		6.50%		6.50%
Investment, principal	[7],[9],[11],[12],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[12],[20]	(91)
Investments at fair value	[7],[9],[11],[12],[20]	$ (83)
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes
Investment, interest rate	[7],[10],[12],[20]	4.46%		4.46%		4.46%
Investment, principal	[7],[14],[20]	$ 6,932
Investment, cost	[7],[20]	5,577
Investments at fair value	[7],[20]	$ 6,001
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12],[20]	8.25%		8.25%		8.25%
Investment, interest rate	[7],[9],[10],[12],[20]	13.30%		13.30%		13.30%
Investment, principal	[7],[9],[12],[14],[20]	$ 23,975
Investment, cost	[7],[9],[12],[20]	23,274
Investments at fair value	[7],[9],[12],[20]	$ 23,292
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	5.75%		5.75%		5.75%
Investment, interest rate	[7],[9],[10],[12]	11.29%		11.29%		11.29%
Investment, principal	[7],[9],[12],[14]	$ 45,169
Investment, cost	[7],[9],[12]	43,394
Investments at fair value	[7],[9],[12]	$ 35,834
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Products, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							5.75%		5.75%		5.75%
Investment, interest rate	[8],[15],[16],[17]							9.42%		9.42%		9.42%
Investment, principal	[8],[15],[16],[18]							$ 35,625
Investment, cost	[8],[15],[16]							34,806
Investments at fair value	[8],[15],[16]							$ 31,528
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		6.50%	[7],[9],[12]	6.50%	[7],[9],[12]	6.50%	[7],[9],[12]	6.50%	[8],[15],[16]	6.50%	[8],[15],[16]	6.50%	[8],[15],[16]
Investment, interest rate		11.57%	[7],[9],[10],[12]	11.57%	[7],[9],[10],[12]	11.57%	[7],[9],[10],[12]	9.44%	[8],[15],[16],[17]	9.44%	[8],[15],[16],[17]	9.44%	[8],[15],[16],[17]
Investment, principal		$ 40,484	[7],[9],[12],[14]					$ 34,357	[8],[15],[16],[18]
Investment, cost		39,779	[7],[9],[12]					33,612	[8],[15],[16]
Investments at fair value		38,662	[7],[9],[12]					$ 32,639	[8],[15],[16]
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							5.75%		5.75%		5.75%
Investment, interest rate	[8],[15],[16],[17]							9.42%		9.42%		9.42%
Investment, principal	[8],[15],[16],[18]							$ 8,569
Investment, cost	[8],[15],[16]							8,401
Investments at fair value	[8],[15],[16]							$ 8,407
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, Second Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							8.00%		8.00%		8.00%
Investment, interest rate	[8],[15],[16],[17]							11.67%		11.67%		11.67%
Investment, interest rate, paid in kind	[8],[15],[16]							3.50%		3.50%		3.50%
Investment, principal	[8],[15],[16],[18]							$ 22,619
Investment, cost	[8],[15],[16]							22,162
Investments at fair value	[8],[15],[16]							22,275
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 1
Investment, principal		15,302	[7],[9],[14],[21]					13,083	[8],[15],[18],[26]
Investment, cost		15,341	[7],[9],[21]					13,083	[8],[15],[26]
Investments at fair value		$ 14,269	[7],[9],[21]					$ 13,083	[8],[15],[26]
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 2
Investment, basis spread, variable rate		8.75%	[7],[9],[12]	8.75%	[7],[9],[12]	8.75%	[7],[9],[12]	8.75%	[8],[15],[16]	8.75%	[8],[15],[16]	8.75%	[8],[15],[16]
Investment, interest rate		14.14%	[7],[9],[10],[12]	14.14%	[7],[9],[10],[12]	14.14%	[7],[9],[10],[12]	12.45%	[8],[15],[16],[17]	12.45%	[8],[15],[16],[17]	12.45%	[8],[15],[16],[17]
Investment, principal		$ 13,109	[7],[9],[12],[14]					$ 12,161	[8],[15],[16],[18]
Investment, cost		12,939	[7],[9],[12]					11,944	[8],[15],[16]
Investments at fair value		$ 12,617	[7],[9],[12]					$ 11,942	[8],[15],[16]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 1
Investment, interest rate		11.00%	[7],[9],[10],[12],[20]	11.00%	[7],[9],[10],[12],[20]	11.00%	[7],[9],[10],[12],[20]	11.00%	[8],[15],[16],[17],[22]	11.00%	[8],[15],[16],[17],[22]	11.00%	[8],[15],[16],[17],[22]
Investment, principal		$ 8,452	[7],[9],[14],[20]					$ 6,817	[8],[15],[18],[22]
Investment, cost		8,185	[7],[9],[20]					6,553	[8],[15],[22]
Investments at fair value		$ 7,730	[7],[9],[20]					$ 6,408	[8],[15],[22]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 2
Investment, interest rate		11.00%	[7],[9],[10],[11],[12],[20]	11.00%	[7],[9],[10],[11],[12],[20]	11.00%	[7],[9],[10],[11],[12],[20]	11.00%	[8],[15],[16],[17],[19],[22]	11.00%	[8],[15],[16],[17],[19],[22]	11.00%	[8],[15],[16],[17],[19],[22]
Investment, principal		$ 0	[7],[9],[11],[14],[20]					$ 0	[8],[15],[18],[19],[22]
Investment, cost		0	[7],[9],[11],[20]					0	[8],[15],[19],[22]
Investments at fair value		$ 0	[7],[9],[11],[20]					$ 0	[8],[15],[19],[22]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 3
Investment, interest rate	[7],[9],[10],[11],[12],[20]	11.00%		11.00%		11.00%
Investment, principal	[7],[9],[11],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[20]	0
Investments at fair value	[7],[9],[11],[20]	$ 0
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants
Investment owned, balance (in shares) | shares		112,990	[7],[9],[20]	112,990	[7],[9],[20]	112,990	[7],[9],[20]	56,999	[8],[15],[22]	56,999	[8],[15],[22]	56,999	[8],[15],[22]
Investment, cost		$ 300	[7],[9],[20]					$ 135	[8],[15],[22]
Investments at fair value		$ 172	[7],[9],[20]					$ 609	[8],[15],[22]
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants
Investment owned, balance (in shares) | shares	[7],[9]	1,078,284		1,078,284		1,078,284
Investment, cost	[7],[9]	$ 113
Investments at fair value	[7],[9]	$ 0
Investment, Identifier [Axis]: Integral Development Corporation, Other Diversified Financial Services, Warrants
Investment owned, balance (in shares) | shares	[8],[15]							1,078,284		1,078,284		1,078,284
Investment, cost	[8],[15]							$ 113
Investments at fair value	[8],[15]							$ 0
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.50%		7.50%		7.50%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(114)
Investments at fair value	[7],[9],[11],[12]	$ (114)
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan
Investment, basis spread, variable rate		7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	5.00%	[8],[15],[16]	5.00%	[8],[15],[16]	5.00%	[8],[15],[16]
Investment, interest rate		12.72%	[7],[9],[10],[12]	12.72%	[7],[9],[10],[12]	12.72%	[7],[9],[10],[12]	8.55%	[8],[15],[16],[17]	8.55%	[8],[15],[16],[17]	8.55%	[8],[15],[16],[17]
Investment, principal		$ 33,498	[7],[9],[12],[14]					$ 18,660	[8],[15],[16],[18]
Investment, cost		32,494	[7],[9],[12]					18,567	[8],[15],[16]
Investments at fair value		$ 32,493	[7],[9],[12]					$ 18,134	[8],[15],[16]
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, Second Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							8.50%		8.50%		8.50%
Investment, interest rate	[8],[15],[16],[17]							12.17%		12.17%		12.17%
Investment, principal	[8],[15],[16],[18]							$ 13,674
Investment, cost	[8],[15],[16]							13,514
Investments at fair value	[8],[15],[16]							$ 13,154
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		7.25%	[7],[12]	7.25%	[7],[12]	7.25%	[7],[12]	7.25%	[8],[16]	7.25%	[8],[16]	7.25%	[8],[16]
Investment, interest rate		12.42%	[7],[10],[12]	12.42%	[7],[10],[12]	12.42%	[7],[10],[12]	10.33%	[8],[16],[17]	10.33%	[8],[16],[17]	10.33%	[8],[16],[17]
Investment, principal		$ 13,939	[7],[12],[14]					$ 10,247	[8],[16],[18]
Investment, cost		12,601	[7],[12]					10,196	[8],[16]
Investments at fair value		9,252	[7],[12]					7,702	[8],[16]
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares
Investment, cost		5,193
Investments at fair value		$ 5,193
Money market funds, at carrying value								$ 5,261
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							7.50%		7.50%		7.50%
Investment, interest rate	[8],[15],[16],[17]							10.62%		10.62%		10.62%
Investment, principal	[8],[15],[16],[18]							$ 36,234
Investment, cost	[8],[15],[16]							35,170
Investments at fair value	[8],[15],[16]							$ 36,392
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	7.50%		7.50%		7.50%
Investment, interest rate	[7],[9],[10],[12]	12.70%		12.70%		12.70%
Investment, principal	[7],[9],[12],[14]	$ 17,069
Investment, cost	[7],[9],[12]	17,053
Investments at fair value	[7],[9],[12]	$ 16,966
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	7.50%		7.50%		7.50%
Investment, interest rate	[7],[9],[10],[12]	12.70%		12.70%		12.70%
Investment, principal	[7],[9],[12],[14]	$ 27,360
Investment, cost	[7],[9],[12]	26,872
Investments at fair value	[7],[9],[12]	$ 27,488
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[12]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[12]	10.60%		10.60%		10.60%
Investment, principal	[7],[9],[12],[14]	$ 15,150
Investment, cost	[7],[9],[12]	14,331
Investments at fair value	[7],[9],[12]	$ 14,924
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, Second Lien Term Loan
Investment, basis spread, variable rate		8.00%	[7],[12]	8.00%	[7],[12]	8.00%	[7],[12]	8.00%	[8],[16]	8.00%	[8],[16]	8.00%	[8],[16]
Investment, interest rate		13.20%	[7],[10],[12]	13.20%	[7],[10],[12]	13.20%	[7],[10],[12]	11.12%	[8],[16],[17]	11.12%	[8],[16],[17]	11.12%	[8],[16],[17]
Investment, principal		$ 666	[7],[12],[14]					$ 528	[8],[16],[18]
Investment, cost		616	[7],[12]					478	[8],[16]
Investments at fair value		$ 652	[7],[12]					$ 481	[8],[16]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver
Investment, basis spread, variable rate		6.50%	[7],[9],[11],[12]	6.50%	[7],[9],[11],[12]	6.50%	[7],[9],[11],[12]	6.50%	[8],[15],[16],[19]	6.50%	[8],[15],[16],[19]	6.50%	[8],[15],[16],[19]
Investment, interest rate		11.84%	[7],[9],[10],[11],[12]	11.84%	[7],[9],[10],[11],[12]	11.84%	[7],[9],[10],[11],[12]	10.17%	[8],[15],[16],[17],[19]	10.17%	[8],[15],[16],[17],[19]	10.17%	[8],[15],[16],[17],[19]
Investment, principal		$ 545	[7],[9],[11],[12],[14]					$ 329	[8],[15],[16],[18],[19]
Investment, cost		517	[7],[9],[11],[12]					311	[8],[15],[16],[19]
Investments at fair value		$ 510	[7],[9],[11],[12]					$ 292	[8],[15],[16],[19]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan
Investment, basis spread, variable rate		6.50%	[7],[9],[12]	6.50%	[7],[9],[12]	6.50%	[7],[9],[12]	6.50%	[8],[15],[16]	6.50%	[8],[15],[16]	6.50%	[8],[15],[16]
Investment, interest rate		11.84%	[7],[9],[10],[12]	11.84%	[7],[9],[10],[12]	11.84%	[7],[9],[10],[12]	10.17%	[8],[15],[16],[17]	10.17%	[8],[15],[16],[17]	10.17%	[8],[15],[16],[17]
Investment, principal		$ 16,765	[7],[9],[12],[14]					$ 13,623	[8],[15],[16],[18]
Investment, cost		16,636	[7],[9],[12]					13,487	[8],[15],[16]
Investments at fair value		$ 16,511	[7],[9],[12]					$ 13,351	[8],[15],[16]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver
Investment, basis spread, variable rate		6.00%	[7],[9],[11],[12]	6.00%	[7],[9],[11],[12]	6.00%	[7],[9],[11],[12]	6.00%	[8],[15],[16],[19]	6.00%	[8],[15],[16],[19]	6.00%	[8],[15],[16],[19]
Investment, interest rate	[8],[15],[16],[17],[19]							9.12%		9.12%		9.12%
Investment, principal		$ 0	[7],[9],[11],[12],[14]					$ 1,710	[8],[15],[16],[18],[19]
Investment, cost		(44)	[7],[9],[11],[12]					1,672	[8],[15],[16],[19]
Investments at fair value		$ (146)	[7],[9],[11],[12]					$ 1,651	[8],[15],[16],[19]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[15],[16],[17]							9.12%		9.12%		9.12%
Investment, principal	[8],[15],[16],[18]							$ 19,236
Investment, cost	[8],[15],[16]							18,894
Investments at fair value	[8],[15],[16]							$ 18,707
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	6.00%		6.00%		6.00%
Investment, interest rate	[7],[9],[10],[12]	11.20%		11.20%		11.20%
Investment, principal	[7],[9],[12],[14]	$ 2,742
Investment, cost	[7],[9],[12]	2,594
Investments at fair value	[7],[9],[12]	$ 2,592
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	6.00%		6.00%		6.00%
Investment, interest rate	[7],[9],[10],[12]	11.20%		11.20%		11.20%
Investment, principal	[7],[9],[12],[14]	$ 23,554
Investment, cost	[7],[9],[12]	23,166
Investments at fair value	[7],[9],[12]	$ 22,258
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, Second Lien Term Loan
Investment, basis spread, variable rate		6.75%	[7],[12]	6.75%	[7],[12]	6.75%	[7],[12]	6.75%	[8],[16]	6.75%	[8],[16]	6.75%	[8],[16]
Investment, interest rate		11.97%	[7],[10],[12]	11.97%	[7],[10],[12]	11.97%	[7],[10],[12]	9.87%	[8],[16],[17]	9.87%	[8],[16],[17]	9.87%	[8],[16],[17]
Investment, principal		$ 2,140	[7],[12],[14]					$ 2,140	[8],[16],[18]
Investment, cost		2,101	[7],[12]					2,092	[8],[16]
Investments at fair value		$ 1,834	[7],[12]					$ 1,890	[8],[16]
Investment, Identifier [Axis]: LaserShip, Inc., Air Freight & Logistics, Second Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							7.50%		7.50%		7.50%
Investment, interest rate	[8],[15],[16],[17]							10.38%		10.38%		10.38%
Investment, principal	[8],[15],[16],[18]							$ 2,394
Investment, cost	[8],[15],[16]							2,370
Investments at fair value	[8],[15],[16]							$ 1,867
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan
Investment, basis spread, variable rate	[7],[12],[20]	9.50%		9.50%		9.50%
Investment, interest rate	[7],[10],[12],[20]	14.61%		14.61%		14.61%
Investment, principal	[7],[12],[14],[20]	$ 26,489
Investment, cost	[7],[12],[20]	24,888
Investments at fair value	[7],[12],[20]	$ 26,985
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock
Investment owned, balance (in shares) | shares		2,000,000	[7],[9]	2,000,000	[7],[9]	2,000,000	[7],[9]	2,000,000	[8],[15]	2,000,000	[8],[15]	2,000,000	[8],[15]
Investment, cost		$ 1,399	[7],[9]					$ 1,399	[8],[15]
Investments at fair value		$ 0	[7],[9]					$ 0	[8],[15]
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Investment, basis spread, variable rate		5.00%	[7],[9],[12]	5.00%	[7],[9],[12]	5.00%	[7],[9],[12]	5.00%	[8],[15],[16]	5.00%	[8],[15],[16]	5.00%	[8],[15],[16]
Investment, interest rate		10.50%	[7],[9],[10],[12]	10.50%	[7],[9],[10],[12]	10.50%	[7],[9],[10],[12]	8.67%	[8],[15],[16],[17]	8.67%	[8],[15],[16],[17]	8.67%	[8],[15],[16],[17]
Investment, principal		$ 45,361	[7],[9],[12],[14]					$ 41,008	[8],[15],[16],[18]
Investment, cost		44,783	[7],[9],[12]					40,243	[8],[15],[16]
Investments at fair value		$ 44,227	[7],[9],[12]					$ 39,573	[8],[15],[16]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock
Investment owned, balance (in shares) | shares		559	[7],[9]	559	[7],[9]	559	[7],[9]	451	[8],[15]	451	[8],[15]	451	[8],[15]
Investment, principal	[7],[9],[14]
Investment, cost		563	[7],[9]					$ 451	[8],[15]
Investments at fair value		$ 487	[7],[9]					$ 451	[8],[15]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1
Investment, basis spread, variable rate		8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]
Investment, interest rate		13.84%	[7],[9],[10],[12]	13.84%	[7],[9],[10],[12]	13.84%	[7],[9],[10],[12]	11.38%	[8],[15],[16],[17]	11.38%	[8],[15],[16],[17]	11.38%	[8],[15],[16],[17]
Investment, principal		$ 5,403	[7],[9],[12],[14]					$ 4,357	[8],[15],[16],[18]
Investment, cost		5,344	[7],[9],[12]					4,285	[8],[15],[16]
Investments at fair value		$ 5,173	[7],[9],[12]					$ 4,226	[8],[15],[16]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2
Investment, basis spread, variable rate		8.50%	[7],[9],[11],[12]	8.50%	[7],[9],[11],[12]	8.50%	[7],[9],[11],[12]	8.50%	[8],[15],[16],[19]	8.50%	[8],[15],[16],[19]	8.50%	[8],[15],[16],[19]
Investment, interest rate		13.84%	[7],[9],[10],[11],[12]	13.84%	[7],[9],[10],[11],[12]	13.84%	[7],[9],[10],[11],[12]	11.38%	[8],[15],[16],[17],[19]	11.38%	[8],[15],[16],[17],[19]	11.38%	[8],[15],[16],[17],[19]
Investment, principal		$ 2,939	[7],[9],[11],[12],[14]					$ 2,370	[8],[15],[16],[18],[19]
Investment, cost		2,883	[7],[9],[11],[12]					2,323	[8],[15],[16],[19]
Investments at fair value		$ 2,755	[7],[9],[11],[12]					$ 2,265	[8],[15],[16],[19]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver
Investment, basis spread, variable rate		6.00%	[7],[9],[11],[12]	6.00%	[7],[9],[11],[12]	6.00%	[7],[9],[11],[12]	6.00%	[8],[15],[16],[19]	6.00%	[8],[15],[16],[19]	6.00%	[8],[15],[16],[19]
Investment, interest rate	[7],[9],[10],[11],[12]	11.25%		11.25%		11.25%
Investment, principal		$ 250	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		220	[7],[9],[11],[12]					(23)	[8],[15],[16],[19]
Investments at fair value		$ 203	[7],[9],[11],[12]					$ (54)	[8],[15],[16],[19]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[15],[16],[17]							9.50%		9.50%		9.50%
Investment, principal	[8],[15],[16],[18]							$ 18,390
Investment, cost	[8],[15],[16]							18,088
Investments at fair value	[8],[15],[16]							$ 17,691
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	6.00%		6.00%		6.00%
Investment, interest rate	[7],[9],[10],[12]	11.20%		11.20%		11.20%
Investment, principal	[7],[9],[12],[14]	$ 20,176
Investment, cost	[7],[9],[12]	19,949
Investments at fair value	[7],[9],[12]	$ 19,648
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	6.00%		6.00%		6.00%
Investment, interest rate	[7],[9],[10],[12]	11.20%		11.20%		11.20%
Investment, principal	[7],[9],[12],[14]	$ 2,637
Investment, cost	[7],[9],[12]	2,594
Investments at fair value	[7],[9],[12]	$ 2,568
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.50%		7.50%		7.50%
Investment, interest rate	[7],[9],[10],[11],[12]	12.58%		12.58%		12.58%
Investment, principal	[7],[9],[11],[12],[14]	$ 2,118
Investment, cost	[7],[9],[11],[12]	1,853
Investments at fair value	[7],[9],[11],[12]	$ 1,853
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	7.50%		7.50%		7.50%
Investment, interest rate	[7],[9],[10],[12]	12.74%		12.74%		12.74%
Investment, principal	[7],[9],[12],[14]	$ 40,640
Investment, cost	[7],[9],[12]	39,937
Investments at fair value	[7],[9],[12]	$ 39,937
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate		5.50%	[7],[9],[11],[12]	5.50%	[7],[9],[11],[12]	5.50%	[7],[9],[11],[12]	5.50%	[8],[15],[16],[19]	5.50%	[8],[15],[16],[19]	5.50%	[8],[15],[16],[19]
Investment, principal		$ 0	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		(29)	[7],[9],[11],[12]					(13)	[8],[15],[16],[19]
Investments at fair value		$ (62)	[7],[9],[11],[12]					$ (51)	[8],[15],[16],[19]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate		5.50%	[7],[9],[12]	5.50%	[7],[9],[12]	5.50%	[7],[9],[12]	5.50%	[8],[15],[16]	5.50%	[8],[15],[16]	5.50%	[8],[15],[16]
Investment, interest rate		10.84%	[7],[9],[10],[12]	10.84%	[7],[9],[10],[12]	10.84%	[7],[9],[10],[12]	9.17%	[8],[15],[16],[17]	9.17%	[8],[15],[16],[17]	9.17%	[8],[15],[16],[17]
Investment, principal		$ 12,397	[7],[9],[12],[14]					$ 29,565	[8],[15],[16],[18]
Investment, cost		12,357	[7],[9],[12]					29,128	[8],[15],[16]
Investments at fair value		$ 12,056	[7],[9],[12]					$ 28,734	[8],[15],[16]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate		5.50%	[7],[9],[12]	5.50%	[7],[9],[12]	5.50%	[7],[9],[12]	5.50%	[8],[15],[16],[19]	5.50%	[8],[15],[16],[19]	5.50%	[8],[15],[16],[19]
Investment, interest rate	[7],[9],[10],[12]	10.84%		10.84%		10.84%
Investment, principal		$ 21,383	[7],[9],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		21,055	[7],[9],[12]					(12)	[8],[15],[16],[19]
Investments at fair value		$ 20,795	[7],[9],[12]					$ (96)	[8],[15],[16],[19]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[11],[12]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[9],[10],[11],[12]	10.83%		10.83%		10.83%
Investment, principal	[7],[9],[11],[12],[14]	$ 570
Investment, cost	[7],[9],[11],[12]	559
Investments at fair value	[7],[9],[11],[12]	$ 526
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, interest rate		11.50%	[7],[9],[10],[12],[20]	11.50%	[7],[9],[10],[12],[20]	11.50%	[7],[9],[10],[12],[20]	11.50%	[8],[15],[16],[17],[22]	11.50%	[8],[15],[16],[17],[22]	11.50%	[8],[15],[16],[17],[22]
Investment, principal		$ 8,568	[7],[9],[14],[20]					$ 17,203	[8],[15],[18],[22]
Investment, cost		8,488	[7],[9],[20]					16,954	[8],[15],[22]
Investments at fair value		$ 8,225	[7],[9],[20]					$ 16,644	[8],[15],[22]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, interest rate		11.50%	[7],[9],[10],[12],[20]	11.50%	[7],[9],[10],[12],[20]	11.50%	[7],[9],[10],[12],[20]	11.50%	[8],[15],[16],[17],[19],[22]	11.50%	[8],[15],[16],[17],[19],[22]	11.50%	[8],[15],[16],[17],[19],[22]
Investment, principal		$ 4,284	[7],[9],[14],[20]					$ 0	[8],[15],[18],[19],[22]
Investment, cost		4,244	[7],[9],[20]					0	[8],[15],[19],[22]
Investments at fair value		$ 4,112	[7],[9],[20]					$ 0	[8],[15],[19],[22]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment, interest rate	[7],[9],[10],[12],[20]	11.50%		11.50%		11.50%
Investment, principal	[7],[9],[14],[20]	$ 8,568
Investment, cost	[7],[9],[20]	8,488
Investments at fair value	[7],[9],[20]	$ 8,225
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment, interest rate	[7],[9],[10],[12],[20]	11.50%		11.50%		11.50%
Investment, principal	[7],[9],[11],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[20]	0
Investments at fair value	[7],[9],[11],[20]	$ 0
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 1
Investment, interest rate		8.00%	[7],[9],[10],[12],[20]	8.00%	[7],[9],[10],[12],[20]	8.00%	[7],[9],[10],[12],[20]	8.00%	[8],[15],[16],[17],[22]	8.00%	[8],[15],[16],[17],[22]	8.00%	[8],[15],[16],[17],[22]
Investment, interest rate, paid in kind		1.75%	[7],[9],[20]	1.75%	[7],[9],[20]	1.75%	[7],[9],[20]	1.75%	[8],[15],[22]	1.75%	[8],[15],[22]	1.75%	[8],[15],[22]
Investment, principal		$ 9,066	[7],[9],[14],[20]					$ 7,215	[8],[15],[18],[22]
Investment, cost		8,496	[7],[9],[20]					6,650	[8],[15],[22]
Investments at fair value		$ 8,114	[7],[9],[20]					$ 6,440	[8],[15],[22]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 2
Investment, interest rate		8.00%	[7],[9],[10],[12],[20]	8.00%	[7],[9],[10],[12],[20]	8.00%	[7],[9],[10],[12],[20]	8.00%	[8],[15],[16],[17],[19],[22]	8.00%	[8],[15],[16],[17],[19],[22]	8.00%	[8],[15],[16],[17],[19],[22]
Investment, interest rate, paid in kind		1.75%	[7],[9],[20]	1.75%	[7],[9],[20]	1.75%	[7],[9],[20]	1.75%	[8],[15],[19],[22]	1.75%	[8],[15],[19],[22]	1.75%	[8],[15],[19],[22]
Investment, principal		$ 0	[7],[9],[11],[14],[20]					$ 0	[8],[15],[18],[19],[22]
Investment, cost		1	[7],[9],[11],[20]					1	[8],[15],[19],[22]
Investments at fair value		$ 0	[7],[9],[11],[20]					$ 0	[8],[15],[19],[22]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 3
Investment, interest rate	[7],[9],[10],[12],[20]	8.00%		8.00%		8.00%
Investment, interest rate, paid in kind	[7],[9],[20]	1.75%		1.75%		1.75%
Investment, principal	[7],[9],[11],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[20]	0
Investments at fair value	[7],[9],[11],[20]	$ 0
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants
Investment owned, balance (in shares) | shares	[8],[15],[22]							209,588		209,588		209,588
Investment, cost	[8],[15],[22]							$ 480
Investments at fair value	[8],[15],[22]							$ 170
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1
Investment owned, balance (in shares) | shares	[7],[9],[20]	259,877		259,877		259,877
Investment, principal	[7],[9],[14],[20]
Investment, cost	[7],[9],[20]	545
Investments at fair value	[7],[9],[20]	$ 437
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2
Investment owned, balance (in shares) | shares	[7],[9],[20]	66,817		66,817		66,817
Investment, principal	[7],[9],[14],[20]
Investment, cost	[7],[9],[20]	23
Investments at fair value	[7],[9],[20]	$ 153
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Investment, basis spread, variable rate		7.00%	[7],[9],[11],[12]	7.00%	[7],[9],[11],[12]	7.00%	[7],[9],[11],[12]	8.00%	[8],[15],[16],[19]	8.00%	[8],[15],[16],[19]	8.00%	[8],[15],[16],[19]
Investment, principal		$ 0	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		(51)	[7],[9],[11],[12]					(54)	[8],[15],[16],[19]
Investments at fair value		$ (71)	[7],[9],[11],[12]					$ (100)	[8],[15],[16],[19]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[15],[16],[17]							10.64%		10.64%		10.64%
Investment, interest rate, paid in kind	[8],[15],[16]							1.50%		1.50%		1.50%
Investment, principal	[8],[15],[16],[18]							$ 45,665
Investment, cost	[8],[15],[16]							44,689
Investments at fair value	[8],[15],[16]							$ 44,523
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[12]	12.19%		12.19%		12.19%
Investment, principal	[7],[9],[12],[14]	$ 7,464
Investment, cost	[7],[9],[12]	7,416
Investments at fair value	[7],[9],[12]	$ 7,352
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[12]	12.19%		12.19%		12.19%
Investment, principal	[7],[9],[12],[14]	$ 46,687
Investment, cost	[7],[9],[12]	46,157
Investments at fair value	[7],[9],[12]	$ 45,987
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan
Investment, basis spread, variable rate		6.75%	[7],[9],[12]	6.75%	[7],[9],[12]	6.75%	[7],[9],[12]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]
Investment, interest rate		11.97%	[7],[9],[10],[12]	11.97%	[7],[9],[10],[12]	11.97%	[7],[9],[10],[12]	9.89%	[8],[15],[16],[17]	9.89%	[8],[15],[16],[17]	9.89%	[8],[15],[16],[17]
Investment, principal		$ 55,297	[7],[9],[12],[14]					$ 46,499	[8],[15],[16],[18]
Investment, cost		54,939	[7],[9],[12]					45,802	[8],[15],[16]
Investments at fair value		$ 54,235	[7],[9],[12]					$ 45,421	[8],[15],[16]
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond
Investment, interest rate	[7],[10],[12]	6.88%		6.88%		6.88%
Investment, principal	[7],[14]	$ 10,191
Investment, cost	[7]	9,816
Investments at fair value	[7]	$ 8,860
Investment, Identifier [Axis]: NFP Corp., Other Diversified Financial Services, Fixed Rate Bond
Investment, interest rate	[8],[16],[17]							6.88%		6.88%		6.88%
Investment, principal	[8],[18]							$ 10,191
Investment, cost	[8]							9,773
Investments at fair value	[8]							$ 7,966
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12],[20]	6.88%		6.88%		6.88%
Investment, interest rate	[7],[9],[10],[12],[20]	12.08%		12.08%		12.08%
Investment, interest rate, paid in kind	[7],[9],[12],[20]	2.00%		2.00%		2.00%
Investment, principal	[7],[9],[12],[14],[20]	$ 73,178
Investment, cost	[7],[9],[12],[20]	72,195
Investments at fair value	[7],[9],[12],[20]	$ 69,885
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1
Investment owned, balance (in shares) | shares		487,870		487,870		487,870
Investment, principal | €	[7],[9],[12],[14],[20]			€ 0
Investment, cost	[7],[9],[12],[20]	$ 0
Investments at fair value	[7],[9],[12],[20]	$ 1,161
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2
Investment owned, balance (in shares) | shares		487,870		487,870		487,870
Investment, principal | €	[7],[12],[14],[20]			€ 0
Investment, cost	[7],[12],[20]	$ 0
Investments at fair value	[7],[12],[20]	$ 1,161
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16],[22]							6.88%		6.88%		6.88%
Investment, interest rate	[8],[15],[16],[17],[22]							9.99%		9.99%		9.99%
Investment, principal	[8],[15],[16],[18],[22]							$ 58,713
Investment, cost	[8],[15],[16],[22]							57,655
Investments at fair value	[8],[15],[16],[22]							$ 56,805
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan
Investment, basis spread, variable rate		8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]
Investment, interest rate		14.04%	[7],[9],[10],[12]	14.04%	[7],[9],[10],[12]	14.04%	[7],[9],[10],[12]	12.17%	[8],[15],[16],[17]	12.17%	[8],[15],[16],[17]	12.17%	[8],[15],[16],[17]
Investment, principal		$ 30,339	[7],[9],[12],[14]					$ 22,560	[8],[15],[16],[18]
Investment, cost		30,002	[7],[9],[12]					22,241	[8],[15],[16]
Investments at fair value		$ 29,125	[7],[9],[12]					$ 21,524	[8],[15],[16]
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan
Investment, basis spread, variable rate		10.50%	[7],[9],[12]	10.50%	[7],[9],[12]	10.50%	[7],[9],[12]	10.50%	[8],[15],[16]	10.50%	[8],[15],[16]	10.50%	[8],[15],[16]
Investment, interest rate		16.04%	[7],[9],[10],[12]	16.04%	[7],[9],[10],[12]	16.04%	[7],[9],[10],[12]	14.17%	[8],[15],[16],[17]	14.17%	[8],[15],[16],[17]	14.17%	[8],[15],[16],[17]
Investment, principal		$ 64,606	[7],[9],[12],[14]					$ 50,459	[8],[15],[16],[18]
Investment, cost		64,750	[7],[9],[12]					49,301	[8],[15],[16]
Investments at fair value		63,185	[7],[9],[12]					$ 51,972	[8],[15],[16]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Membership Interest
Investment, principal														$ 0
Investments at fair value														$ 0	0
Investment owned, ownership percentage														87.50%
Investment owned, percent of net assets														0.00%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest
Investment owned, balance (in shares) | shares	[3],[4],[19],[22],[28],[29]							0.875		0.875		0.875
Investment, principal		0
Investment, cost		0	[1],[2],[11],[20],[30],[31]					$ 0	[3],[4],[19],[22],[28],[29]
Investments at fair value		$ 0	[1],[2],[11],[20],[30],[31]					$ 0	[3],[4],[19],[22],[28],[29]
Investment owned, ownership percentage	[1],[2],[11],[20],[30],[31]	87.50%		87.50%		87.50%
Investment owned, percent of net assets		0.00%		0.00%		0.00%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt
Investment, basis spread, variable rate		4.50%	[1],[2],[9],[11],[12],[20],[30]	4.50%	[1],[2],[9],[11],[12],[20],[30]	4.50%	[1],[2],[9],[11],[12],[20],[30]	4.50%	[3],[4],[15],[16],[19],[22],[28]	4.50%	[3],[4],[15],[16],[19],[22],[28]	4.50%	[3],[4],[15],[16],[19],[22],[28]
Investment, interest rate		9.36%	[1],[2],[9],[10],[11],[12],[20],[30]	9.36%	[1],[2],[9],[10],[11],[12],[20],[30]	9.36%	[1],[2],[9],[10],[11],[12],[20],[30]	6.30%	[3],[4],[15],[16],[17],[19],[22],[28]	6.30%	[3],[4],[15],[16],[17],[19],[22],[28]	6.30%	[3],[4],[15],[16],[17],[19],[22],[28]
Investment, principal		$ 58,349	[1],[2],[9],[11],[12],[14],[20],[30]					$ 59,662	[3],[4],[15],[16],[18],[19],[22],[28]
Investment, cost		49,997	[1],[2],[9],[11],[12],[20],[30]					50,194	[3],[4],[15],[16],[19],[22],[28]
Investments at fair value		$ 49,632	[1],[2],[9],[11],[12],[20],[30]					$ 50,283	[3],[4],[15],[16],[19],[22],[28]
Investment owned, percent of net assets		3.30%		3.30%		3.30%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt
Investment, basis spread, variable rate														4.50%
Investment, interest rate														4.94%
Investment, principal														$ 60,274
Investments at fair value														$ 50,606	55,582
Investment owned, percent of net assets														4.00%
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							4.00%		4.00%		4.00%
Investment, interest rate	[8],[16],[17]							7.12%		7.12%		7.12%
Investment, principal	[8],[16],[18]							$ 3,323
Investment, cost	[8],[16]							3,162
Investments at fair value	[8],[16]							$ 3,207
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		7.00%	[7],[9],[12]	7.00%	[7],[9],[12]	7.00%	[7],[9],[12]	7.00%	[8],[15],[16]	7.00%	[8],[15],[16]	7.00%	[8],[15],[16]
Investment, interest rate		12.34%	[7],[9],[10],[12]	12.34%	[7],[9],[10],[12]	12.34%	[7],[9],[10],[12]	10.05%	[8],[15],[16],[17]	10.05%	[8],[15],[16],[17]	10.05%	[8],[15],[16],[17]
Investment, principal		$ 9,323	[7],[9],[12],[14]					$ 7,519	[8],[15],[16],[18]
Investment, cost		9,203	[7],[9],[12]					7,389	[8],[15],[16]
Investments at fair value		$ 9,090	[7],[9],[12]					$ 7,237	[8],[15],[16]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1
Investment, basis spread, variable rate		10.00%	[7],[9],[12]	10.00%	[7],[9],[12]	10.00%	[7],[9],[12]	2.00%	[8],[15],[16]	2.00%	[8],[15],[16]	2.00%	[8],[15],[16]
Investment, interest rate		15.50%	[7],[9],[10],[12]	15.50%	[7],[9],[10],[12]	15.50%	[7],[9],[10],[12]	5.08%	[8],[15],[16],[17]	5.08%	[8],[15],[16],[17]	5.08%	[8],[15],[16],[17]
Investment, interest rate, paid in kind	[8],[15],[16]							8.00%		8.00%		8.00%
Investment, principal		$ 25,712	[7],[9],[12],[14]					$ 21,557	[8],[15],[16],[18]
Investment, cost		25,603	[7],[9],[12]					21,267	[8],[15],[16]
Investments at fair value		$ 25,712	[7],[9],[12]					$ 21,557	[8],[15],[16]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2
Investment, basis spread, variable rate		10.00%	[7],[9],[11],[12]	10.00%	[7],[9],[11],[12]	10.00%	[7],[9],[11],[12]	2.00%	[8],[15],[16],[19]	2.00%	[8],[15],[16],[19]	2.00%	[8],[15],[16],[19]
Investment, principal		$ 0	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		(13)	[7],[9],[11],[12]					(31)	[8],[15],[16],[19]
Investments at fair value		$ 0	[7],[9],[11],[12]					0	[8],[15],[16],[19]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[11],[12]	10.00%		10.00%		10.00%
Investment, interest rate	[7],[9],[10],[11],[12]	15.39%		15.39%		15.39%
Investment, principal	[7],[9],[11],[12],[14]	$ 1,210
Investment, cost	[7],[9],[11],[12]	1,192
Investments at fair value	[7],[9],[11],[12]	$ 1,210
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.75%		7.75%		7.75%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(44)
Investments at fair value	[7],[9],[11],[12]	$ (44)
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	7.75%		7.75%		7.75%
Investment, interest rate	[7],[9],[10],[12]	12.79%		12.79%		12.79%
Investment, principal	[7],[9],[12],[14]	$ 15,231
Investment, cost	[7],[9],[12]	14,876
Investments at fair value	[7],[9],[12]	14,882
Investment, Identifier [Axis]: Other cash accounts
Investment, cost		67,467
Investments at fair value		$ 67,467
Money market funds, at carrying value								$ 21,103
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond
Investment, interest rate		7.75%	[7],[10],[12]	7.75%	[7],[10],[12]	7.75%	[7],[10],[12]	7.75%	[8],[16],[17]	7.75%	[8],[16],[17]	7.75%	[8],[16],[17]
Investment, principal		$ 7,480	[7],[14]					$ 7,776	[8],[18]
Investment, cost		7,514	[7]					7,820	[8]
Investments at fair value		$ 6,090	[7]					$ 5,846	[8]
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment, basis spread, variable rate	[8],[15],[16],[19]							7.00%		7.00%		7.00%
Investment, principal	[8],[15],[16],[18],[19]							$ 0
Investment, cost	[8],[15],[16],[19]							(21)
Investments at fair value	[8],[15],[16],[19]							$ (13)
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[15],[16],[17]							9.28%		9.28%		9.28%
Investment, principal	[8],[15],[16],[18]							$ 26,154
Investment, cost	[8],[15],[16]							25,712
Investments at fair value	[8],[15],[16]							$ 25,893
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment, basis spread, variable rate	[8],[15],[16],[19]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[15],[16],[17],[19]							9.25%		9.25%		9.25%
Investment, principal	[8],[15],[16],[18],[19]							$ 2,228
Investment, cost	[8],[15],[16],[19]							2,186
Investments at fair value	[8],[15],[16],[19]							$ 2,203
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.00%		7.00%		7.00%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(55)
Investments at fair value	[7],[9],[11],[12]	$ (57)
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[12]	12.10%		12.10%		12.10%
Investment, principal	[7],[9],[12],[14]	$ 10,923
Investment, cost	[7],[9],[12]	10,513
Investments at fair value	[7],[9],[12]	$ 10,497
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock
Investment owned, balance (in shares) | shares		100,000	[7],[9]	100,000	[7],[9]	100,000	[7],[9]	80,515	[8],[15]	80,515	[8],[15]	80,515	[8],[15]
Investment, cost		$ 109	[7],[9]					$ 79	[8],[15]
Investments at fair value		$ 221	[7],[9]					$ 89	[8],[15]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver
Investment, basis spread, variable rate		6.50%	[7],[9],[11],[12]	6.50%	[7],[9],[11],[12]	6.50%	[7],[9],[11],[12]	6.75%	[8],[15],[16],[19]	6.75%	[8],[15],[16],[19]	6.75%	[8],[15],[16],[19]
Investment, principal		$ 0	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		(37)	[7],[9],[11],[12]					(34)	[8],[15],[16],[19]
Investments at fair value		$ (26)	[7],[9],[11],[12]					$ (49)	[8],[15],[16],[19]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan
Investment, basis spread, variable rate		6.50%	[7],[9],[12]	6.50%	[7],[9],[12]	6.50%	[7],[9],[12]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]
Investment, interest rate		11.73%	[7],[9],[10],[12]	11.73%	[7],[9],[10],[12]	11.73%	[7],[9],[10],[12]	10.42%	[8],[15],[16],[17]	10.42%	[8],[15],[16],[17]	10.42%	[8],[15],[16],[17]
Investment, principal		$ 38,521	[7],[9],[12],[14]					$ 33,775	[8],[15],[16],[18]
Investment, cost		38,018	[7],[9],[12]					32,931	[8],[15],[16]
Investments at fair value		$ 38,205	[7],[9],[12]					$ 33,116	[8],[15],[16]
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Investment, basis spread, variable rate		5.00%	[7],[12]	5.00%	[7],[12]	5.00%	[7],[12]	5.00%	[8],[16]	5.00%	[8],[16]	5.00%	[8],[16]
Investment, interest rate		10.20%	[7],[10],[12]	10.20%	[7],[10],[12]	10.20%	[7],[10],[12]	8.13%	[8],[16],[17]	8.13%	[8],[16],[17]	8.13%	[8],[16],[17]
Investment, principal		$ 9,701	[7],[12],[14]					$ 9,850	[8],[16],[18]
Investment, cost		9,535	[7],[12]					9,460	[8],[16]
Investments at fair value		$ 9,458	[7],[12]					$ 9,374	[8],[16]
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan
Investment, basis spread, variable rate		6.00%	[7],[9],[12]	6.00%	[7],[9],[12]	6.00%	[7],[9],[12]	6.00%	[8],[15],[16]	6.00%	[8],[15],[16]	6.00%	[8],[15],[16]
Investment, interest rate		10.96%	[7],[9],[10],[12]	10.96%	[7],[9],[10],[12]	10.96%	[7],[9],[10],[12]	8.88%	[8],[15],[16],[17]	8.88%	[8],[15],[16],[17]	8.88%	[8],[15],[16],[17]
Investment, principal		$ 22,375	[7],[9],[12],[14]					$ 17,976	[8],[15],[16],[18]
Investment, cost		22,177	[7],[9],[12]					17,690	[8],[15],[16]
Investments at fair value		$ 21,829	[7],[9],[12]					$ 17,537	[8],[15],[16]
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		7.25%	[7],[9],[12]	7.25%	[7],[9],[12]	7.25%	[7],[9],[12]	7.25%	[8],[15],[16]	7.25%	[8],[15],[16]	7.25%	[8],[15],[16]
Investment, interest rate		12.59%	[7],[9],[10],[12]	12.59%	[7],[9],[10],[12]	12.59%	[7],[9],[10],[12]	10.92%	[8],[15],[16],[17]	10.92%	[8],[15],[16],[17]	10.92%	[8],[15],[16],[17]
Investment, principal		$ 36,499	[7],[9],[12],[14]					$ 28,627	[8],[15],[16],[18]
Investment, cost		35,427	[7],[9],[12]					28,198	[8],[15],[16]
Investments at fair value		$ 32,606	[7],[9],[12]					$ 27,482	[8],[15],[16]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate		8.00%	[7],[9],[11],[12]	8.00%	[7],[9],[11],[12]	8.00%	[7],[9],[11],[12]	8.00%	[8],[15],[16],[19]	8.00%	[8],[15],[16],[19]	8.00%	[8],[15],[16],[19]
Investment, interest rate	[7],[9],[10],[11],[12]	13.04%		13.04%		13.04%
Investment, principal		$ 2,395	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		2,312	[7],[9],[11],[12]					(53)	[8],[15],[16],[19]
Investments at fair value		$ 2,218	[7],[9],[11],[12]					$ (111)	[8],[15],[16],[19]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Investment, basis spread, variable rate		8.00%	[7],[9],[12]	8.00%	[7],[9],[12]	8.00%	[7],[9],[12]	8.00%	[8],[15],[16]	8.00%	[8],[15],[16]	8.00%	[8],[15],[16]
Investment, interest rate		13.04%	[7],[9],[10],[12]	13.04%	[7],[9],[10],[12]	13.04%	[7],[9],[10],[12]	10.68%	[8],[15],[16],[17]	10.68%	[8],[15],[16],[17]	10.68%	[8],[15],[16],[17]
Investment, principal		$ 67,244	[7],[9],[12],[14]					$ 48,689	[8],[15],[16],[18]
Investment, cost		66,290	[7],[9],[12]					47,951	[8],[15],[16]
Investments at fair value		$ 64,756	[7],[9],[12]					$ 47,155	[8],[15],[16]
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	7.25%		7.25%		7.25%
Investment, interest rate	[7],[9],[10],[12]	12.42%		12.42%		12.42%
Investment, principal	[7],[9],[12],[14]	$ 24,537
Investment, cost	[7],[9],[12]	24,245
Investments at fair value	[7],[9],[12]	$ 24,047
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	7.25%		7.25%		7.25%
Investment, interest rate	[7],[9],[10],[12]	12.42%		12.42%		12.42%
Investment, principal	[7],[9],[12],[14]	$ 2,823
Investment, cost	[7],[9],[12]	2,797
Investments at fair value	[7],[9],[12]	$ 2,767
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							8.50%		8.50%		8.50%
Investment, interest rate	[8],[15],[16],[17]							10.01%		10.01%		10.01%
Investment, principal	[8],[15],[16],[18]							$ 23,275
Investment, cost	[8],[15],[16]							22,722
Investments at fair value	[8],[15],[16]							$ 22,810
Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Application Software, Second Lien Term Loan
Investment, basis spread, variable rate		8.00%	[7],[9],[12]	8.00%	[7],[9],[12]	8.00%	[7],[9],[12]	8.00%	[8],[15],[16]	8.00%	[8],[15],[16]	8.00%	[8],[15],[16]
Investment, interest rate		13.22%	[7],[9],[10],[12]	13.22%	[7],[9],[10],[12]	13.22%	[7],[9],[10],[12]	11.12%	[8],[15],[16],[17]	11.12%	[8],[15],[16],[17]	11.12%	[8],[15],[16],[17]
Investment, principal		$ 6,750	[7],[9],[12],[14]					$ 5,250	[8],[15],[16],[18]
Investment, cost		6,652	[7],[9],[12]					5,168	[8],[15],[16]
Investments at fair value		$ 6,235	[7],[9],[12]					$ 5,047	[8],[15],[16]
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan
Investment, basis spread, variable rate		5.68%	[7],[9],[12],[20]	5.68%	[7],[9],[12],[20]	5.68%	[7],[9],[12],[20]	6.00%	[8],[15],[16],[22]	6.00%	[8],[15],[16],[22]	6.00%	[8],[15],[16],[22]
Investment, interest rate		10.88%	[7],[9],[10],[12],[20]	10.88%	[7],[9],[10],[12],[20]	10.88%	[7],[9],[10],[12],[20]	8.39%	[8],[15],[16],[17],[22]	8.39%	[8],[15],[16],[17],[22]	8.39%	[8],[15],[16],[17],[22]
Investment, principal | £						£ 4,626	[7],[9],[12],[14],[20]					£ 3,501	[8],[15],[16],[18],[22]
Investment, cost		$ 5,900	[7],[9],[12],[20]					$ 4,646	[8],[15],[16],[22]
Investments at fair value		$ 5,296	[7],[9],[12],[20]					$ 3,367	[8],[15],[16],[22]
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Common Stock
Investment owned, balance (in shares) | shares		64,887,669	[7],[9]	64,887,669	[7],[9]	64,887,669	[7],[9]	64,887,669	[8],[15]	64,887,669	[8],[15]	64,887,669	[8],[15]
Investment, cost		$ 375	[7],[9]					$ 375	[8],[15]
Investments at fair value		$ 0	[7],[9]					$ 0	[8],[15]
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Health Care Distributors, Fixed Rate Bond
Investment, interest rate	[8],[16],[17]							5.25%		5.25%		5.25%
Investment, principal	[8],[18]							$ 1,325
Investment, cost	[8]							1,218
Investments at fair value	[8]							$ 1,097
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							4.25%		4.25%		4.25%
Investment, interest rate	[8],[16],[17]							7.33%		7.33%		7.33%
Investment, principal	[8],[16],[18]							$ 3,400
Investment, cost	[8],[16]							3,202
Investments at fair value	[8],[16]							$ 2,880
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, Fixed Rate Bond
Investment, interest rate	[8],[16],[17]							9.25%		9.25%		9.25%
Investment, principal	[8],[18]							$ 4,755
Investment, cost	[8]							4,720
Investments at fair value	[8]							$ 3,109
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver
Investment, basis spread, variable rate		6.50%	[7],[9],[11],[12]	6.50%	[7],[9],[11],[12]	6.50%	[7],[9],[11],[12]	6.50%	[8],[15],[16],[19]	6.50%	[8],[15],[16],[19]	6.50%	[8],[15],[16],[19]
Investment, principal		$ 0	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		(46)	[7],[9],[11],[12]					(43)	[8],[15],[16],[19]
Investments at fair value		$ (52)	[7],[9],[11],[12]					$ (64)	[8],[15],[16],[19]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan
Investment, basis spread, variable rate		7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[8],[15],[16]	7.50%	[8],[15],[16]	7.50%	[8],[15],[16]
Investment, interest rate	[7],[9],[10],[12]	11.70%		11.70%		11.70%
Investment, interest rate, paid in kind	[8],[15],[16]							10.59%		10.59%		10.59%
Investment, principal		$ 32,329	[7],[9],[12],[14]					$ 24,692	[8],[15],[16],[18]
Investment, cost		32,052	[7],[9],[12]					24,265	[8],[15],[16]
Investments at fair value		$ 31,715	[7],[9],[12]					$ 24,101	[8],[15],[16]
Investment, Identifier [Axis]: Renaissance Holding Corp., Diversified Banks, Second Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[16],[17]							10.12%		10.12%		10.12%
Investment, principal	[8],[16],[18]							$ 3,542
Investment, cost	[8],[16]							3,515
Investments at fair value	[8],[16]							$ 3,402
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, Second Lien Term Loan
Investment, basis spread, variable rate	[7],[12]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[10],[12]	12.19%		12.19%		12.19%
Investment, principal	[7],[12],[14]	$ 1,789
Investment, cost	[7],[12]	1,775
Investments at fair value	[7],[12]	$ 1,764
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1
Investment, basis spread, variable rate		8.25%	[7],[9],[12],[20]	8.25%	[7],[9],[12],[20]	8.25%	[7],[9],[12],[20]	8.25%	[8],[15],[16],[22]	8.25%	[8],[15],[16],[22]	8.25%	[8],[15],[16],[22]
Investment, interest rate		13.75%	[7],[9],[10],[12],[20]	13.75%	[7],[9],[10],[12],[20]	13.75%	[7],[9],[10],[12],[20]	11.92%	[8],[15],[16],[17],[22]	11.92%	[8],[15],[16],[17],[22]	11.92%	[8],[15],[16],[17],[22]
Investment, principal		$ 44,602	[7],[9],[12],[14],[20]					$ 37,656	[8],[15],[16],[18],[22]
Investment, cost		43,077	[7],[9],[12],[20]					35,775	[8],[15],[16],[22]
Investments at fair value		$ 41,815	[7],[9],[12],[20]					$ 36,187	[8],[15],[16],[22]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2
Investment, basis spread, variable rate		8.25%	[7],[9],[12],[20]	8.25%	[7],[9],[12],[20]	8.25%	[7],[9],[12],[20]	8.25%	[8],[15],[16],[19],[22]	8.25%	[8],[15],[16],[19],[22]	8.25%	[8],[15],[16],[19],[22]
Investment, interest rate		13.75%	[7],[9],[10],[12],[20]	13.75%	[7],[9],[10],[12],[20]	13.75%	[7],[9],[10],[12],[20]	11.92%	[8],[15],[16],[17],[19],[22]	11.92%	[8],[15],[16],[17],[19],[22]	11.92%	[8],[15],[16],[17],[19],[22]
Investment, principal		$ 13,495	[7],[9],[12],[14],[20]					$ 11,393	[8],[15],[16],[18],[19],[22]
Investment, cost		13,010	[7],[9],[12],[20]					10,583	[8],[15],[16],[19],[22]
Investments at fair value		$ 12,651	[7],[9],[12],[20]					$ 10,760	[8],[15],[16],[19],[22]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants
Investment owned, balance (in shares) | shares		204,454	[7],[9],[20]	204,454	[7],[9],[20]	204,454	[7],[9],[20]	164,660	[8],[15],[22]	164,660	[8],[15],[22]	164,660	[8],[15],[22]
Investment, cost		$ 1,202	[7],[9],[20]					$ 1,202	[8],[15],[22]
Investments at fair value		$ 0	[7],[9],[20]					$ 74	[8],[15],[22]
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock
Investment owned, balance (in shares) | shares	[7],[9]	1,037		1,037		1,037
Investment, cost	[7],[9]	$ 1,037
Investments at fair value	[7],[9]	$ 1,024
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	8.75%		8.75%		8.75%
Investment, interest rate	[7],[9],[10],[12]	14.00%		14.00%		14.00%
Investment, principal	[7],[9],[12],[14]	$ 8,010
Investment, cost	[7],[9],[12]	7,792
Investments at fair value	[7],[9],[12]	$ 7,770
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[11],[12]	8.75%		8.75%		8.75%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(35)
Investments at fair value	[7],[9],[11],[12]	$ (71)
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal & Glass Containers, Warrants
Investment owned, balance (in shares) | shares	[8],[15]							415		415		415
Investment, cost	[8],[15]							$ 681
Investments at fair value	[8],[15]							$ 681
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants
Investment owned, balance (in shares) | shares	[7],[9]	491		491		491
Investment, cost	[7],[9]	$ 727
Investments at fair value	[7],[9]	$ 0
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	4.75%		4.75%		4.75%
Investment, interest rate	[7],[9],[10],[12]	9.97%		9.97%		9.97%
Investment, principal	[7],[9],[12],[14]	$ 4,463
Investment, cost	[7],[9],[12]	3,780
Investments at fair value	[7],[9],[12]	$ 4,139
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan
Investment, basis spread, variable rate		8.00%	[7],[9],[12]	8.00%	[7],[9],[12]	8.00%	[7],[9],[12]	8.00%	[8],[15],[16]	8.00%	[8],[15],[16]	8.00%	[8],[15],[16]
Investment, interest rate		13.22%	[7],[9],[10],[12]	13.22%	[7],[9],[10],[12]	13.22%	[7],[9],[10],[12]	10.74%	[8],[15],[16],[17]	10.74%	[8],[15],[16],[17]	10.74%	[8],[15],[16],[17]
Investment, principal		$ 12,034	[7],[9],[12],[14]					$ 9,109	[8],[15],[16],[18]
Investment, cost		11,220	[7],[9],[12]					8,972	[8],[15],[16]
Investments at fair value		$ 9,387	[7],[9],[12]					$ 8,289	[8],[15],[16]
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							4.50%		4.50%		4.50%
Investment, interest rate	[8],[16],[17]							7.63%		7.63%		7.63%
Investment, principal	[8],[16],[18]							$ 1,500
Investment, cost	[8],[16]							1,410
Investments at fair value	[8],[16]							$ 1,393
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan
Investment, basis spread, variable rate		6.75%	[7],[9],[12]	6.75%	[7],[9],[12]	6.75%	[7],[9],[12]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]
Investment, interest rate		12.29%	[7],[9],[10],[12]	12.29%	[7],[9],[10],[12]	12.29%	[7],[9],[10],[12]	10.42%	[8],[15],[16],[17]	10.42%	[8],[15],[16],[17]	10.42%	[8],[15],[16],[17]
Investment, principal		$ 25,592	[7],[9],[12],[14]					$ 20,766	[8],[15],[16],[18]
Investment, cost		23,832	[7],[9],[12]					19,550	[8],[15],[16]
Investments at fair value		$ 19,514	[7],[9],[12]					$ 18,188	[8],[15],[16]
Investment, Identifier [Axis]: Sabert Corporation, Metal & Glass Containers, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							4.50%		4.50%		4.50%
Investment, interest rate	[8],[16],[17]							7.63%		7.63%		7.63%
Investment, principal	[8],[16],[18]							$ 1,691
Investment, cost	[8],[16]							1,610
Investments at fair value	[8],[16]							$ 1,623
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[11],[12]	10.00%		10.00%		10.00%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	(103)
Investments at fair value	[7],[9],[11],[12]	$ (93)
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	10.00%		10.00%		10.00%
Investment, interest rate	[7],[9],[10],[12]	15.24%		15.24%		15.24%
Investment, principal	[7],[9],[12],[14]	$ 25,558
Investment, cost	[7],[9],[12]	24,711
Investments at fair value	[7],[9],[12]	$ 24,791
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants
Investment owned, balance (in shares) | shares	[7],[9]	991,019		991,019		991,019
Investment, cost	[7],[9]	$ 327
Investments at fair value	[7],[9]	$ 1,883
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock
Investment owned, balance (in shares) | shares	[7],[20]	9,307		9,307		9,307
Investment, cost	[7],[20]	$ 78
Investments at fair value	[7],[20]	52
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Membership Interest
Investment, principal														$ 0
Investments at fair value														$ 23,023	37,651
Investment owned, ownership percentage														87.50%
Investment owned, percent of net assets														1.80%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest
Investment owned, balance (in shares) | shares	[3],[4],[19],[22],[28],[29],[32]							0.875		0.875		0.875
Investment, principal		0
Investment, cost		54,791	[1],[2],[11],[20],[30],[31],[33]					$ 49,322	[3],[4],[19],[22],[28],[29],[32]
Investments at fair value		$ 27,973	[1],[2],[11],[20],[30],[31],[33]					$ 20,715	[3],[4],[19],[22],[28],[29],[32]
Investment owned, ownership percentage	[1],[2],[11],[20],[30],[31],[33]	87.50%		87.50%		87.50%
Investment owned, percent of net assets		1.90%		1.90%		1.90%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt
Investment, basis spread, variable rate		7.00%	[1],[2],[9],[11],[12],[20],[30]	7.00%	[1],[2],[9],[11],[12],[20],[30]	7.00%	[1],[2],[9],[11],[12],[20],[30]	7.00%	[3],[4],[15],[16],[19],[22],[28]	7.00%	[3],[4],[15],[16],[19],[22],[28]	7.00%	[3],[4],[15],[16],[19],[22],[28]
Investment, interest rate		11.86%	[1],[2],[9],[10],[11],[12],[20],[30]	11.86%	[1],[2],[9],[10],[11],[12],[20],[30]	11.86%	[1],[2],[9],[10],[11],[12],[20],[30]	8.80%	[3],[4],[15],[16],[17],[19],[22],[28]	8.80%	[3],[4],[15],[16],[17],[19],[22],[28]	8.80%	[3],[4],[15],[16],[17],[19],[22],[28]
Investment, principal		$ 112,656	[1],[2],[9],[11],[12],[14],[20],[30]					$ 96,250	[3],[4],[15],[16],[18],[19],[22],[28]
Investment, cost		112,656	[1],[2],[9],[11],[12],[20],[30]					96,250	[3],[4],[15],[16],[19],[22],[28]
Investments at fair value		$ 112,656	[1],[2],[9],[11],[12],[20],[30]					$ 96,250	[3],[4],[15],[16],[19],[22],[28]
Investment owned, percent of net assets		7.50%		7.50%		7.50%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt
Investment, basis spread, variable rate														7.00%
Investment, interest rate														8.00%
Investment, principal														$ 96,250
Investments at fair value														$ 96,250	$ 96,250
Investment owned, percent of net assets														7.60%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12],[20]	7.88%		7.88%		7.88%
Investment, interest rate	[7],[9],[12],[20]	12.95%		12.95%		12.95%
Investment, principal	[7],[9],[12],[14],[20]	$ 7,191
Investment, cost	[7],[9],[12],[20]	6,923
Investments at fair value	[7],[9],[12],[20]	$ 6,931
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12],[20]	7.88%		7.88%		7.88%
Investment, interest rate	[7],[9],[12],[20]	12.88%		12.88%		12.88%
Investment, principal	[7],[9],[12],[14],[20]	$ 2,697
Investment, cost	[7],[9],[12],[20]	2,596
Investments at fair value	[7],[9],[12],[20]	$ 2,599
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[11],[12],[20]	7.88%		7.88%		7.88%
Investment, principal	[7],[9],[11],[12],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[12],[20]	0
Investments at fair value	[7],[9],[11],[12],[20]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4
Investment, basis spread, variable rate	[7],[9],[11],[12],[20]	7.88%		7.88%		7.88%
Investment, principal	[7],[9],[11],[12],[14],[20]	$ 0
Investment, cost	[7],[9],[11],[12],[20]	0
Investments at fair value	[7],[9],[11],[12],[20]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants
Investment owned, balance (in shares) | shares	[7],[9],[20]	58,210		58,210		58,210
Investment, cost	[7],[9],[20]	$ 182
Investments at fair value	[7],[9],[20]	$ 202
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants
Investment owned, balance (in shares) | shares		345,452	[7],[9]	345,452	[7],[9]	345,452	[7],[9]	345,452	[8],[15]	345,452	[8],[15]	345,452	[8],[15]
Investment, cost		$ 367	[7],[9]					$ 367	[8],[15]
Investments at fair value		$ 0	[7],[9]					$ 0	[8],[15]
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal & Glass Containers, First Lien Term Loan
Investment, interest rate	[8],[15],[16],[17]							5.50%		5.50%		5.50%
Investment, interest rate, paid in kind	[8],[15]							8.50%		8.50%		8.50%
Investment, principal	[8],[15],[18]							$ 46,121
Investment, cost	[8],[15]							45,413
Investments at fair value	[8],[15]							$ 45,295
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1
Investment, interest rate	[7],[9],[23]	14.00%		14.00%		14.00%
Investment, principal	[7],[9],[14],[23]	$ 54,730
Investment, cost	[7],[9],[23]	41,705
Investments at fair value	[7],[9],[23]	$ 25,997
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2
Investment, interest rate	[7],[9],[23]	14.00%		14.00%		14.00%
Investment, principal	[7],[9],[14],[23]	$ 14,993
Investment, cost	[7],[9],[23]	11,582
Investments at fair value	[7],[9],[23]	$ 13,923
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3
Investment, interest rate	[7],[9],[10],[11],[12],[23]	14.00%		14.00%		14.00%
Investment, principal	[7],[9],[11],[14],[23]	$ 4,813
Investment, cost	[7],[9],[11],[23]	3,935
Investments at fair value	[7],[9],[11],[23]	$ 4,034
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan
Investment, basis spread, variable rate		7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[7],[9],[12]	7.50%	[8],[15],[16]	7.50%	[8],[15],[16]	7.50%	[8],[15],[16]
Investment, interest rate		12.69%	[7],[9],[10],[12]	12.69%	[7],[9],[10],[12]	12.69%	[7],[9],[10],[12]	10.48%	[8],[15],[16],[17]	10.48%	[8],[15],[16],[17]	10.48%	[8],[15],[16],[17]
Investment, principal		$ 1,095	[7],[9],[12],[14]					$ 3,195	[8],[15],[16],[18]
Investment, cost		1,084	[7],[9],[12]					3,163	[8],[15],[16]
Investments at fair value		$ 1,024	[7],[9],[12]					$ 2,997	[8],[15],[16]
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan
Investment, basis spread, variable rate	[7],[12]	5.50%		5.50%		5.50%
Investment, interest rate	[7],[10],[12]	10.69%		10.69%		10.69%
Investment, principal	[7],[12],[14]	$ 1,054
Investment, cost	[7],[12]	1,053
Investments at fair value	[7],[12]	$ 980
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock
Investment owned, balance (in shares) | shares		66,000	[7],[20]	66,000	[7],[20]	66,000	[7],[20]	50,000	[8],[22]	50,000	[8],[22]	50,000	[8],[22]
Investment, cost		$ 139	[7],[20]					$ 197	[8],[22]
Investments at fair value		$ 24	[7],[20]					$ 79	[8],[22]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver
Investment, basis spread, variable rate		5.25%	[7],[9],[11],[12]	5.25%	[7],[9],[11],[12]	5.25%	[7],[9],[11],[12]	5.25%	[8],[15],[16],[19]	5.25%	[8],[15],[16],[19]	5.25%	[8],[15],[16],[19]
Investment, interest rate		10.35%	[7],[9],[10],[11],[12]	10.35%	[7],[9],[10],[11],[12]	10.35%	[7],[9],[10],[11],[12]	8.03%	[8],[15],[16],[17],[19]	8.03%	[8],[15],[16],[17],[19]	8.03%	[8],[15],[16],[17],[19]
Investment, principal		$ 907	[7],[9],[11],[12],[14]					$ 866	[8],[15],[16],[18],[19]
Investment, cost		862	[7],[9],[11],[12]					813	[8],[15],[16],[19]
Investments at fair value		$ 837	[7],[9],[11],[12]					$ 796	[8],[15],[16],[19]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Investment, basis spread, variable rate		5.50%	[7],[9],[12]	5.50%	[7],[9],[12]	5.50%	[7],[9],[12]	5.25%	[8],[15],[16]	5.25%	[8],[15],[16]	5.25%	[8],[15],[16]
Investment, interest rate		10.70%	[7],[9],[10],[12]	10.70%	[7],[9],[10],[12]	10.70%	[7],[9],[10],[12]	8.30%	[8],[15],[16],[17]	8.30%	[8],[15],[16],[17]	8.30%	[8],[15],[16],[17]
Investment, principal		$ 4,500	[7],[9],[12],[14]					$ 4,534	[8],[15],[16],[18]
Investment, cost		4,431	[7],[9],[12]					4,455	[8],[15],[16]
Investments at fair value		$ 4,393	[7],[9],[12]					$ 4,427	[8],[15],[16]
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12],[20]	8.50%		8.50%		8.50%
Investment, interest rate	[7],[9],[10],[12],[20]	11.97%		11.97%		11.97%
Investment, principal | €	[7],[9],[12],[14],[20]			€ 23,731
Investment, cost	[7],[9],[12],[20]	$ 26,829
Investments at fair value	[7],[9],[12],[20]	$ 25,632
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Other Diversified Financial Services, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16],[22]							8.50%		8.50%		8.50%
Investment, interest rate	[8],[15],[16],[17],[22]							10.00%		10.00%		10.00%
Investment, principal | £	[8],[15],[16],[18],[22]											£ 16,911
Investment, cost	[8],[15],[16],[22]							$ 19,414
Investments at fair value	[8],[15],[16],[22]							$ 16,360
Investment, Identifier [Axis]: Sunland Asphalt & Construction, LLC, Construction & Engineering, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[15],[16],[17]							8.88%		8.88%		8.88%
Investment, principal	[8],[15],[16],[18]							$ 42,618
Investment, cost	[8],[15],[16]							41,654
Investments at fair value	[8],[15],[16]							$ 41,723
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	7.75%		7.75%		7.75%
Investment, interest rate	[7],[9],[10],[12]	12.85%		12.85%		12.85%
Investment, principal	[7],[9],[12],[14]	$ 49,645
Investment, cost	[7],[9],[12]	48,611
Investments at fair value	[7],[9],[12]	$ 49,128
Investment, Identifier [Axis]: Supermoose Borrower, LLC, Application Software, First Lien Term Loan
Investment, basis spread, variable rate	[8],[16]							3.75%		3.75%		3.75%
Investment, interest rate	[8],[16],[17]							7.42%		7.42%		7.42%
Investment, principal	[8],[16],[18]							$ 3,466
Investment, cost	[8],[16]							3,141
Investments at fair value	[8],[16]							$ 3,056
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment, basis spread, variable rate	[7],[9],[12],[34]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[12],[34]	12.18%		12.18%		12.18%
Investment, principal	[7],[9],[12],[14],[34]	$ 1,552
Investment, cost	[7],[9],[12],[34]	1,539
Investments at fair value	[7],[9],[12],[34]	$ 1,471
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12],[34]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[12],[34]	12.18%		12.18%		12.18%
Investment, principal	[7],[9],[12],[14],[34]	$ 32,185
Investment, cost	[7],[9],[12],[34]	31,923
Investments at fair value	[7],[9],[12],[34]	$ 30,495
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[11],[12],[34]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[11],[12],[34]	12.18%		12.18%		12.18%
Investment, principal	[7],[9],[11],[12],[14],[34]	$ 2,756
Investment, cost	[7],[9],[11],[12],[34]	2,728
Investments at fair value	[7],[9],[11],[12],[34]	$ 2,593
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[11],[12],[34]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[11],[12],[34]	12.18%		12.18%		12.18%
Investment, principal	[7],[9],[11],[12],[14],[34]	$ 1,099
Investment, cost	[7],[9],[11],[12],[34]	1,059
Investments at fair value	[7],[9],[11],[12],[34]	$ 926
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Auto Parts & Equipment, Second Lien Term Loan
Investment, basis spread, variable rate		6.75%	[7],[9],[12]	6.75%	[7],[9],[12]	6.75%	[7],[9],[12]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]
Investment, interest rate		11.94%	[7],[9],[10],[12]	11.94%	[7],[9],[10],[12]	11.94%	[7],[9],[10],[12]	9.81%	[8],[15],[16],[17]	9.81%	[8],[15],[16],[17]	9.81%	[8],[15],[16],[17]
Investment, principal		$ 12,500	[7],[9],[12],[14]					$ 12,500	[8],[15],[16],[18]
Investment, cost		12,480	[7],[9],[12]					12,474	[8],[15],[16]
Investments at fair value		$ 11,681	[7],[9],[12]					$ 11,469	[8],[15],[16]
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt
Investment, interest rate		11.50%	[7],[10],[12],[13],[20]	11.50%	[7],[10],[12],[13],[20]	11.50%	[7],[10],[12],[13],[20]	11.50%	[8],[15],[16],[17],[22]	11.50%	[8],[15],[16],[17],[22]	11.50%	[8],[15],[16],[17],[22]
Investment, principal		$ 4,984	[7],[13],[14],[20]					$ 4,984	[8],[15],[18],[22]
Investment, cost		4,887	[7],[13],[20]					4,866	[8],[15],[22]
Investments at fair value		$ 4,810	[7],[13],[20]					$ 4,872	[8],[15],[22]
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan
Investment, interest rate	[7],[9],[10],[12],[20]	13.00%		13.00%		13.00%
Investment, principal	[7],[9],[14],[20]	$ 50,419
Investment, cost	[7],[9],[20]	49,787
Investments at fair value	[7],[9],[20]	$ 49,809
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		4.50%	[7],[12]	4.50%	[7],[12]	4.50%	[7],[12]	4.50%	[8],[16]	4.50%	[8],[16]	4.50%	[8],[16]
Investment, interest rate		9.84%	[7],[10],[12]	9.84%	[7],[10],[12]	9.84%	[7],[10],[12]	8.15%	[8],[16],[17]	8.15%	[8],[16],[17]	8.15%	[8],[16],[17]
Investment, principal		$ 17,213	[7],[12],[14]					$ 12,032	[8],[16],[18]
Investment, cost		15,952	[7],[12]					10,949	[8],[16]
Investments at fair value		$ 16,141	[7],[12]					$ 10,827	[8],[16]
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan
Investment, basis spread, variable rate		7.50%	[7],[12]	7.50%	[7],[12]	7.50%	[7],[12]	7.50%	[8],[16]	7.50%	[8],[16]	7.50%	[8],[16]
Investment, interest rate		12.69%	[7],[10],[12]	12.69%	[7],[10],[12]	12.69%	[7],[10],[12]	10.62%	[8],[16],[17]	10.62%	[8],[16],[17]	10.62%	[8],[16],[17]
Investment, principal		$ 12,843	[7],[12],[14]					$ 9,448	[8],[16],[18]
Investment, cost		12,589	[7],[12]					9,338	[8],[16]
Investments at fair value		$ 12,168	[7],[12]					$ 8,692	[8],[16]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver
Investment, basis spread, variable rate		6.00%	[7],[9],[11],[12],[20]	6.00%	[7],[9],[11],[12],[20]	6.00%	[7],[9],[11],[12],[20]	6.00%	[8],[15],[16],[19],[22]	6.00%	[8],[15],[16],[19],[22]	6.00%	[8],[15],[16],[19],[22]
Investment, principal		$ 0	[7],[9],[11],[12],[14],[20]					$ 0	[8],[15],[16],[18],[19],[22]
Investment, cost		(31)	[7],[9],[11],[12],[20]					(29)	[8],[15],[16],[19],[22]
Investments at fair value		$ (24)	[7],[9],[11],[12],[20]					$ (28)	[8],[15],[16],[19],[22]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan
Investment, basis spread, variable rate		6.00%	[7],[9],[12],[20]	6.00%	[7],[9],[12],[20]	6.00%	[7],[9],[12],[20]	6.00%	[8],[15],[16],[22]	6.00%	[8],[15],[16],[22]	6.00%	[8],[15],[16],[22]
Investment, interest rate		11.15%	[7],[9],[10],[12],[20]	11.15%	[7],[9],[10],[12],[20]	11.15%	[7],[9],[10],[12],[20]	8.68%	[8],[15],[16],[17],[22]	8.68%	[8],[15],[16],[17],[22]	8.68%	[8],[15],[16],[17],[22]
Investment, principal		$ 28,826	[7],[9],[12],[14],[20]					$ 23,215	[8],[15],[16],[18],[22]
Investment, cost		28,583	[7],[9],[12],[20]					22,815	[8],[15],[16],[22]
Investments at fair value		$ 28,537	[7],[9],[12],[20]					$ 22,843	[8],[15],[16],[22]
Investment, Identifier [Axis]: Tecta America Corp., Construction & Engineering, Second Lien Term Loan
Investment, basis spread, variable rate		8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[7],[9],[12]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]	8.50%	[8],[15],[16]
Investment, interest rate		13.72%	[7],[9],[10],[12]	13.72%	[7],[9],[10],[12]	13.72%	[7],[9],[10],[12]	11.62%	[8],[15],[16],[17]	11.62%	[8],[15],[16],[17]	11.62%	[8],[15],[16],[17]
Investment, principal		$ 4,755	[7],[9],[12],[14]					$ 5,203	[8],[15],[16],[18]
Investment, cost		4,677	[7],[9],[12]					5,125	[8],[15],[16]
Investments at fair value		$ 4,529	[7],[9],[12]					$ 5,034	[8],[15],[16]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver
Investment, basis spread, variable rate		9.75%	[7],[9],[11],[12]	9.75%	[7],[9],[11],[12]	9.75%	[7],[9],[11],[12]	9.25%	[8],[15],[16],[19]	9.25%	[8],[15],[16],[19]	9.25%	[8],[15],[16],[19]
Investment, interest rate		14.93%	[7],[9],[10],[11],[12]	14.93%	[7],[9],[10],[11],[12]	14.93%	[7],[9],[10],[11],[12]	12.20%	[8],[15],[16],[17],[19]	12.20%	[8],[15],[16],[17],[19]	12.20%	[8],[15],[16],[17],[19]
Investment, principal		$ 1,590	[7],[9],[11],[12],[14]					$ 1,231	[8],[15],[16],[18],[19]
Investment, cost		1,572	[7],[9],[11],[12]					1,210	[8],[15],[16],[19]
Investments at fair value		$ 1,535	[7],[9],[11],[12]					$ 1,187	[8],[15],[16],[19]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan
Investment, basis spread, variable rate		9.75%	[7],[9],[12]	9.75%	[7],[9],[12]	9.75%	[7],[9],[12]	9.25%	[8],[15],[16]	9.25%	[8],[15],[16]	9.25%	[8],[15],[16]
Investment, interest rate		14.99%	[7],[9],[10],[12]	14.99%	[7],[9],[10],[12]	14.99%	[7],[9],[10],[12]	12.11%	[8],[15],[16],[17]	12.11%	[8],[15],[16],[17]	12.11%	[8],[15],[16],[17]
Investment, principal		$ 23,483	[7],[9],[12],[14]					$ 18,323	[8],[15],[16],[18]
Investment, cost		23,239	[7],[9],[12]					17,956	[8],[15],[16]
Investments at fair value		$ 22,919	[7],[9],[12]					$ 17,865	[8],[15],[16]
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	6.00%		6.00%		6.00%
Investment, interest rate	[7],[9],[10],[12]	11.09%		11.09%		11.09%
Investment, principal	[7],[9],[12],[14]	$ 19,947
Investment, cost	[7],[9],[12]	18,963
Investments at fair value	[7],[9],[12]	$ 19,000
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Common Stock
Investment owned, balance (in shares) | shares	[8],[15]							668,879		668,879		668,879
Investment, principal	[8],[15],[18]
Investment, cost	[8],[15]							2,028
Investments at fair value	[8],[15]							$ 4,077
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Second Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							9.50%		9.50%		9.50%
Investment, interest rate	[8],[15],[16],[17]							13.17%		13.17%		13.17%
Investment, principal	[8],[15],[16],[18]							$ 29,663
Investment, cost	[8],[15],[16]							29,352
Investments at fair value	[8],[15],[16]							$ 29,031
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan
Investment, basis spread, variable rate		7.30%	[7],[9],[12],[23]	7.30%	[7],[9],[12],[23]	7.30%	[7],[9],[12],[23]	7.30%	[8],[15],[16]	7.30%	[8],[15],[16]	7.30%	[8],[15],[16]
Investment, interest rate	[8],[15],[16],[17]							10.44%		10.44%		10.44%
Investment, principal		$ 19,163	[7],[9],[12],[14],[23]					$ 15,674	[8],[15],[16],[18]
Investment, cost		19,163	[7],[9],[12],[23]					15,605	[8],[15],[16]
Investments at fair value		$ 18,286	[7],[9],[12],[23]					$ 15,682	[8],[15],[16]
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan
Investment, basis spread, variable rate		12.50%	[7],[9],[12],[23]	12.50%	[7],[9],[12],[23]	12.50%	[7],[9],[12],[23]	12.50%	[8],[15],[16]	12.50%	[8],[15],[16]	12.50%	[8],[15],[16]
Investment, interest rate	[8],[15],[16],[17]							16.17%		16.17%		16.17%
Investment, principal		$ 4,641	[7],[9],[12],[14],[23]					$ 3,789	[8],[15],[16],[18]
Investment, cost		4,641	[7],[9],[12],[23]					3,774	[8],[15],[16]
Investments at fair value		$ 4,164	[7],[9],[12],[23]					$ 3,800	[8],[15],[16]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	7.00%		7.00%		7.00%
Investment, interest rate	[7],[9],[10],[12]	12.50%		12.50%		12.50%
Investment, principal	[7],[9],[12],[14]	$ 46,832
Investment, cost	[7],[9],[12]	45,609
Investments at fair value	[7],[9],[12]	$ 41,919
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1
Investment owned, balance (in shares) | shares	[7],[9]	10,616		10,616		10,616
Investment, cost	[7],[9]	$ 120
Investments at fair value	[7],[9]	$ 55
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2
Investment owned, balance (in shares) | shares	[7],[9]	358,299		358,299		358,299
Investment, cost	[7],[9]	$ 2,912
Investments at fair value	[7],[9]	$ 1,526
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3
Investment owned, balance (in shares) | shares	[7],[9]	60,862		60,862		60,862
Investment, cost	[7],[9]	$ 1,207
Investments at fair value	[7],[9]	$ 795
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4
Investment owned, balance (in shares) | shares	[7],[9]	32,447		32,447		32,447
Investment, cost	[7],[9]	$ 33,353
Investments at fair value	[7],[9]	$ 36,587
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[15],[16],[17]							11.17%		11.17%		11.17%
Investment, principal	[8],[15],[16],[18]							$ 37,494
Investment, cost	[8],[15],[16]							36,569
Investments at fair value	[8],[15],[16]							$ 35,807
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 1
Investment owned, balance (in shares) | shares	[8],[15]							8,434		8,434		8,434
Investment, cost	[8],[15]							$ 101
Investments at fair value	[8],[15]							$ 69
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 2
Investment owned, balance (in shares) | shares	[8],[15]							284,650		284,650		284,650
Investment, cost	[8],[15]							$ 2,409
Investments at fair value	[8],[15]							$ 2,320
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 3
Investment owned, balance (in shares) | shares	[8],[15]							48,352		48,352		48,352
Investment, cost	[8],[15]							$ 979
Investments at fair value	[8],[15]							$ 979
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 4
Investment owned, balance (in shares) | shares	[8],[15],[19]							23,201		23,201		23,201
Investment, cost	[8],[15],[19]							$ 22,986
Investments at fair value	[8],[15],[19]							$ 26,487
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Investment, basis spread, variable rate		6.00%	[7],[9],[12]	6.00%	[7],[9],[12]	6.00%	[7],[9],[12]	6.00%	[8],[15],[16]	6.00%	[8],[15],[16]	6.00%	[8],[15],[16]
Investment, interest rate		11.20%	[7],[9],[10],[12]	11.20%	[7],[9],[10],[12]	11.20%	[7],[9],[10],[12]	9.12%	[8],[15],[16],[17]	9.12%	[8],[15],[16],[17]	9.12%	[8],[15],[16],[17]
Investment, principal		$ 11,701	[7],[9],[12],[14]					$ 6,016	[8],[15],[16],[18]
Investment, cost		11,675	[7],[9],[12]					5,908	[8],[15],[16]
Investments at fair value		$ 11,408	[7],[9],[12]					$ 5,895	[8],[15],[16]
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes
Investment, basis spread, variable rate	[7],[12],[20]	7.45%		7.45%		7.45%
Investment, interest rate	[7],[10],[12],[20]	12.72%		12.72%		12.72%
Investment, principal	[7],[12],[14],[20]	$ 1,000
Investment, cost	[7],[12],[20]	814
Investments at fair value	[7],[12],[20]	$ 929
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1
Investment, interest rate	[7],[10],[12],[20]	6.50%		6.50%		6.50%
Investment, principal	[7],[14],[20]	$ 4,500
Investment, cost	[7],[20]	4,101
Investments at fair value	[7],[20]	$ 3,189
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2
Investment, interest rate	[7],[10],[12],[20]	4.75%		4.75%		4.75%
Investment, principal	[7],[14],[20]	$ 300
Investment, cost	[7],[20]	263
Investments at fair value	[7],[20]	$ 249
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 1
Investment, interest rate	[8],[16],[17],[22]							6.50%		6.50%		6.50%
Investment, principal	[8],[18],[22]							$ 4,500
Investment, cost	[8],[22]							4,060
Investments at fair value	[8],[22]							$ 3,026
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 2
Investment, interest rate	[8],[16],[17],[22]							4.75%		4.75%		4.75%
Investment, principal	[8],[18],[22]							$ 300
Investment, cost	[8],[22]							258
Investments at fair value	[8],[22]							$ 238
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	7.25%		7.25%		7.25%
Investment, interest rate	[7],[9],[10],[12]	12.47%		12.47%		12.47%
Investment, principal	[7],[9],[12],[14]	$ 1,540
Investment, cost	[7],[9],[12]	1,239
Investments at fair value	[7],[9],[12]	$ 1,279
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment, basis spread, variable rate	[7],[9],[12]	15.00%		15.00%		15.00%
Investment, interest rate	[7],[9],[10],[12]	21.22%		21.22%		21.22%
Investment, principal	[7],[9],[12]	$ 1,323
Investment, cost	[7],[9],[12]	1,311
Investments at fair value	[7],[9],[12]	$ 1,247
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Investment, basis spread, variable rate		3.75%	[7],[12]	3.75%	[7],[12]	3.75%	[7],[12]	3.75%	[8],[16]	3.75%	[8],[16]	3.75%	[8],[16]
Investment, interest rate		9.03%	[7],[10],[12]	9.03%	[7],[10],[12]	9.03%	[7],[10],[12]	6.56%	[8],[16],[17]	6.56%	[8],[16],[17]	6.56%	[8],[16],[17]
Investment, principal		$ 11,822	[7],[12]					$ 7,564	[8],[16],[18]
Investment, cost		11,228	[7],[12]					6,989	[8],[16]
Investments at fair value		$ 10,743	[7],[12]					$ 6,795	[8],[16]
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, Second Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							7.75%		7.75%		7.75%
Investment, interest rate	[8],[15],[16],[17]							10.56%		10.56%		10.56%
Investment, principal	[8],[15],[16],[18]							$ 6,000
Investment, cost	[8],[15],[16]							5,855
Investments at fair value	[8],[15],[16]							$ 5,070
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan
Investment, basis spread, variable rate	[8],[15],[16]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[15],[16],[17]							10.19%		10.19%		10.19%
Investment, principal	[8],[15],[16],[18]							$ 40,536
Investment, cost	[8],[15],[16]							39,947
Investments at fair value	[8],[15],[16]							$ 40,131
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	11.38%		11.38%		11.38%
Investment, principal	[7],[9],[12]	$ 35,853
Investment, cost	[7],[9],[12]	35,764
Investments at fair value	[7],[9],[12]	$ 35,495
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[12]	6.50%		6.50%		6.50%
Investment, interest rate	[7],[9],[10],[12]	12.00%		12.00%		12.00%
Investment, principal	[7],[9],[12]	$ 19,306
Investment, cost	[7],[9],[12]	19,258
Investments at fair value	[7],[9],[12]	$ 19,113
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan
Investment, basis spread, variable rate		7.00%	[7],[9],[12]	7.00%	[7],[9],[12]	7.00%	[7],[9],[12]	7.00%	[8],[15],[16]	7.00%	[8],[15],[16]	7.00%	[8],[15],[16]
Investment, interest rate		12.50%	[7],[9],[10],[12]	12.50%	[7],[9],[10],[12]	12.50%	[7],[9],[10],[12]	10.67%	[8],[15],[16],[17]	10.67%	[8],[15],[16],[17]	10.67%	[8],[15],[16],[17]
Investment, principal		$ 5,000	[7],[9],[12]					$ 5,000	[8],[15],[16],[18]
Investment, cost		4,925	[7],[9],[12]					4,925	[8],[15],[16]
Investments at fair value		$ 4,025	[7],[9],[12]					$ 4,538	[8],[15],[16]
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment, basis spread, variable rate		15.00%	[7],[9],[12]	15.00%	[7],[9],[12]	15.00%	[7],[9],[12]	15.00%	[8],[15],[16]	15.00%	[8],[15],[16]	15.00%	[8],[15],[16]
Investment, interest rate		21.22%	[7],[9],[10],[12]	21.22%	[7],[9],[10],[12]	21.22%	[7],[9],[10],[12]	19.64%	[8],[15],[16],[17]	19.64%	[8],[15],[16],[17]	19.64%	[8],[15],[16],[17]
Investment, principal		$ 1,565	[7],[9],[12]					$ 2,316	[8],[15],[16],[18]
Investment, cost		1,551	[7],[9],[12]					2,293	[8],[15],[16]
Investments at fair value		$ 1,475	[7],[9],[12]					$ 2,264	[8],[15],[16]
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants
Investment owned, balance (in shares) | shares		4,871	[7],[9]	4,871	[7],[9]	4,871	[7],[9]	3,621	[8],[15]	3,621	[8],[15]	3,621	[8],[15]
Investment, cost		$ 46	[7],[9]					$ 0	[8],[15]
Investments at fair value		$ 136	[7],[9]					$ 192	[8],[15]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock
Investment owned, balance (in shares) | shares		127,452	[7],[9]	127,452	[7],[9]	127,452	[7],[9]	18,032	[8],[15]	18,032	[8],[15]	18,032	[8],[15]
Investment, cost		$ 2,057	[7],[9]					$ 216	[8],[15]
Investments at fair value		$ 1,565	[7],[9]					$ 296	[8],[15]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Investment, basis spread, variable rate		6.25%	[7],[12]	6.25%	[7],[12]	6.25%	[7],[12]	6.25%	[8],[16]	6.25%	[8],[16]	6.25%	[8],[16]
Investment, interest rate		11.45%	[7],[10],[12]	11.45%	[7],[10],[12]	11.45%	[7],[10],[12]	9.37%	[8],[16],[17]	9.37%	[8],[16],[17]	9.37%	[8],[16],[17]
Investment, principal		$ 24,419	[7],[12]					$ 25,499	[8],[16],[18]
Investment, cost		23,589	[7],[12]					24,632	[8],[16]
Investments at fair value		$ 22,862	[7],[12]					$ 23,204	[8],[16]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Warrants
Investment owned, balance (in shares) | shares	[8],[15]							109,420		109,420		109,420
Investment, cost	[8],[15]							$ 1,842
Investments at fair value	[8],[15]							$ 1,799
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Alternative Carriers, Fixed Rate Bond
Investment, interest rate	[8],[16],[17]							4.00%		4.00%		4.00%
Investment, principal	[8],[18]							$ 250
Investment, cost	[8]							212
Investments at fair value	[8]							$ 201
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, Second Lien Term Loan
Investment, basis spread, variable rate		8.25%	[7],[9],[12]	8.25%	[7],[9],[12]	8.25%	[7],[9],[12]	8.25%	[8],[15],[16]	8.25%	[8],[15],[16]	8.25%	[8],[15],[16]
Investment, interest rate		13.79%	[7],[9],[10],[12]	13.79%	[7],[9],[10],[12]	13.79%	[7],[9],[10],[12]	11.92%	[8],[15],[16],[17]	11.92%	[8],[15],[16],[17]	11.92%	[8],[15],[16],[17]
Investment, principal		$ 19,578	[7],[9],[12]					$ 19,578	[8],[15],[16],[18]
Investment, cost		19,551	[7],[9],[12]					19,542	[8],[15],[16]
Investments at fair value		$ 13,693	[7],[9],[12]					$ 16,152	[8],[15],[16]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan
Investment, basis spread, variable rate		7.50%	[7],[9],[12],[20]	7.50%	[7],[9],[12],[20]	7.50%	[7],[9],[12],[20]	7.50%	[8],[15],[16],[22]	7.50%	[8],[15],[16],[22]	7.50%	[8],[15],[16],[22]
Investment, interest rate		12.46%	[7],[9],[10],[12],[20]	12.46%	[7],[9],[10],[12],[20]	12.46%	[7],[9],[10],[12],[20]	9.72%	[8],[15],[16],[17],[22]	9.72%	[8],[15],[16],[17],[22]	9.72%	[8],[15],[16],[17],[22]
Investment, principal | £						£ 20,000	[7],[9],[12],[20]					£ 18,000	[8],[15],[16],[18],[22]
Investment, cost		$ 25,857	[7],[9],[12],[20]					$ 23,804	[8],[15],[16],[22]
Investments at fair value		$ 23,270	[7],[9],[12],[20]					$ 16,552	[8],[15],[16],[22]
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity
Investment owned, balance (in shares) | shares		21,523	[7],[9]	21,523	[7],[9]	21,523	[7],[9]	18,635	[8],[15]	18,635	[8],[15]	18,635	[8],[15]
Investment, cost		$ 20,789	[7],[9]					$ 18,264	[8],[15]
Investments at fair value		$ 18,821	[7],[9]					$ 16,575	[8],[15]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver
Investment, basis spread, variable rate		6.75%	[7],[9],[11],[12]	6.75%	[7],[9],[11],[12]	6.75%	[7],[9],[11],[12]	6.75%	[8],[15],[16],[19]	6.75%	[8],[15],[16],[19]	6.75%	[8],[15],[16],[19]
Investment, interest rate	[7],[9],[10],[11],[12]	11.99%		11.99%		11.99%
Investment, principal		$ 377	[7],[9],[11],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		331	[7],[9],[11],[12]					(31)	[8],[15],[16],[19]
Investments at fair value		$ 288	[7],[9],[11],[12]					$ (32)	[8],[15],[16],[19]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1
Investment, basis spread, variable rate		7.25%	[7],[9],[12]	7.25%	[7],[9],[12]	7.25%	[7],[9],[12]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]	6.75%	[8],[15],[16]
Investment, interest rate		8.50%	[7],[9],[10],[12]	8.50%	[7],[9],[10],[12]	8.50%	[7],[9],[10],[12]	9.49%	[8],[15],[16],[17]	9.49%	[8],[15],[16],[17]	9.49%	[8],[15],[16],[17]
Investment, interest rate, paid in kind	[7],[9]	3.88%		3.88%		3.88%
Investment, principal		$ 24,188	[7],[9],[12],[14]					$ 19,203	[8],[15],[16],[18]
Investment, cost		23,876	[7],[9],[12]					18,874	[8],[15],[16]
Investments at fair value		$ 23,235	[7],[9],[12]					$ 18,867	[8],[15],[16]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2
Investment, basis spread, variable rate		7.25%	[7],[9],[12]	7.25%	[7],[9],[12]	7.25%	[7],[9],[12]	6.75%	[8],[15],[16],[19]	6.75%	[8],[15],[16],[19]	6.75%	[8],[15],[16],[19]
Investment, interest rate	[7],[9],[10],[12]	12.38%		12.38%		12.38%
Investment, principal		$ 3,636	[7],[9],[12],[14]					$ 0	[8],[15],[16],[18],[19]
Investment, cost		3,600	[7],[9],[12]					0	[8],[15],[16],[19]
Investments at fair value		$ 3,563	[7],[9],[12]					$ 0	[8],[15],[16],[19]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[11],[12]	7.25%		7.25%		7.25%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	0
Investments at fair value	[7],[9],[11],[12]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1
Investment, basis spread, variable rate	[7],[9],[12]	8.75%		8.75%		8.75%
Investment, interest rate	[7],[9],[10],[12]	11.75%		11.75%		11.75%
Investment, principal	[7],[9],[12],[14]	$ 5,212
Investment, cost	[7],[9],[12]	4,973
Investments at fair value	[7],[9],[12]	$ 5,034
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2
Investment, basis spread, variable rate	[7],[9],[11],[12]	8.75%		8.75%		8.75%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	0
Investments at fair value	[7],[9],[11],[12]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3
Investment, basis spread, variable rate	[7],[9],[11],[12]	8.75%		8.75%		8.75%
Investment, principal	[7],[9],[11],[12],[14]	$ 0
Investment, cost	[7],[9],[11],[12]	0
Investments at fair value	[7],[9],[11],[12]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants
Investment owned, balance (in shares) | shares	[7],[9]	53,700		53,700		53,700
Investment, cost	[7],[9]	$ 175
Investments at fair value	[7],[9]	$ 407

[1] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[2] Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[3] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[4] Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[5] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[6] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[7] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[8] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[9] As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

[10] Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

[11] Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

[12] The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the London Interbank Offered Rate ("LIBOR" or "L"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of June 30, 2023, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 180-day LIBOR at 5.73%, the PRIME at 8.25%, the 30-day SOFR at 5.10%, the 90-day SOFR at 5.24%, the 180-day SOFR at 5.34%, the SONIA at 3.47%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.49% and the 180-day EURIBOR at 2.82%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

[13] This investment represents a participation interest in the underlying securities shown.

[14] Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

[15] As of September 30, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.

[16] The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR, SOFR, SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 180-day LIBOR at 4.17%, the 360-day LIBOR at 4.78%, the PRIME at 6.25%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55%, the SONIA at 1.69%, the 30-day EURIBOR at 0.69%, the 90-day EURIBOR at 0.99% and the 180-day EURIBOR at 0.38%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

[17] Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

[18] Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

[19] Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

[20] Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of June 30, 2023, qualifying assets represented 73.7% of the Company's total assets and non-qualifying assets represented 26.3% of the Company's total assets.

[21] This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

[22] Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2022, qualifying assets represented 75.7% of the Company's total assets and non-qualifying assets represented 24.3% of the Company's total assets.

[23] This investment was on non-accrual status as of June 30, 2023.

[24] One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.

[25] One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.

[26] This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

[27] This investment was renamed during the three months ended March 31, 2022. For periods prior to March 31, 2022, this investment was referenced as Realfi Strategic Capital Funding LLC.

[28] See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

[29] This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.

[30] See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

[31] This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.

[32] Income producing through payment of dividends or distributions.

[33] Income producing through payment of dividends or distributions.

[34] This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

XML

Consolidated Schedule of Investments - Derivatives € in Thousands, £ in Thousands, $ in Thousands	Jun. 30, 2023 USD ($)	Jun. 30, 2023 EUR (€)	Jun. 30, 2023 GBP (£)	Sep. 30, 2022 USD ($)	Sep. 30, 2022 EUR (€)	Sep. 30, 2022 GBP (£)
Schedule of Investments [Line Items]
Derivative liability at fair value	$ (39,567)			$ (41,969)
Derivative asset at fair value	49			6,789
Interest rate swap
Schedule of Investments [Line Items]
Derivative liability at fair value	$ (39,567)			$ (41,969)
Interest rate	2.70%	2.70%	2.70%	2.70%	2.70%	2.70%
Floating interest rate	1.658%	1.658%	1.658%	1.658%	1.658%	1.658%
Notional amount	$ 350,000			$ 350,000
Foreign currency forward contract
Schedule of Investments [Line Items]
Derivative asset at fair value	49			6,789
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022, 1
Schedule of Investments [Line Items]
Notional Amount to be Purchased				43,179
Notional Amount to be Sold | €					€ 41,444
Derivative asset at fair value				2,466
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing August 10, 2023
Schedule of Investments [Line Items]
Derivative liability at fair value	(482)
Derivative asset at fair value	531
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing May 11, 2023
Schedule of Investments [Line Items]
Notional Amount to be Purchased	78,866
Notional Amount to be Sold | €		€ 71,658
Derivative asset at fair value	531
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022
Schedule of Investments [Line Items]
Notional Amount to be Purchased				43,179
Notional Amount to be Sold | €					€ 41,444
Derivative asset at fair value				2,466
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing May 11, 2023
Schedule of Investments [Line Items]
Notional Amount to be Purchased	71,438
Notional Amount to be Sold | £			£ 56,556
Derivative liability at fair value	$ (482)
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 10, 2022
Schedule of Investments [Line Items]
Notional Amount to be Purchased				45,692
Notional Amount to be Sold | £						£ 37,033
Derivative asset at fair value				4,323
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 19, 2022, 2
Schedule of Investments [Line Items]
Notional Amount to be Purchased				45,692
Notional Amount to be Sold | £						£ 37,033
Derivative asset at fair value				$ 4,323

XML

Consolidated Schedule of Investments (Parenthetical) - $ / shares	6 Months Ended	9 Months Ended
	Mar. 31, 2023	Jun. 30, 2023	Sep. 30, 2022
Schedule of Investments [Line Items]
Percentage of total assets representing qualifying assets		73.70%	75.70%
Percentage of total assets representing non-qualifying assets		26.30%	24.30%
Share-Based Payment Arrangement, Tranche One
Schedule of Investments [Line Items]
Investment owned, balance, shares, VWAP threshold (in dollars per share)		$ 15.00	$ 15.00
Investment owned, balance, shares, VWAP number of trading days	10 days	10 days
Investment owned, balance, shares, VWAP, number of consecutive trading days	20 days	20 days
Share-Based Payment Arrangement, Tranche Two
Schedule of Investments [Line Items]
Investment owned, balance, shares, VWAP threshold (in dollars per share)		$ 20.00	$ 20.00
Investment owned, balance, shares, VWAP number of trading days	10 days	10 days
Investment owned, balance, shares, VWAP, number of consecutive trading days	20 days	20 days

XML

Organization

9 Months Ended

Jun. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

Organization

Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes.

The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions.

The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in Oaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with their own product offerings and investment, marketing and support teams.

On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into the Company in a two-step transaction, with the Company as the surviving company (the "OCSI Merger”).

On January 23, 2023, the Company acquired Oaktree Strategic Income II, Inc. (“OSI2”) pursuant to that certain Agreement and Plan of Merger (the “OSI2 Merger Agreement”), dated as of September 14, 2022, by and among OSI2, the Company, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into the Company in a two-step transaction with the Company as the surviving company (the “OSI2 Merger”). For further information, see Note 14 "Merger with OSI2."

XML

Significant Accounting Policies

9 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Significant Accounting Policies

Significant Accounting Policies

Basis of Presentation:

The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946").

Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for periods prior to March 31, 2023 reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Use of Estimates:

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.

Consolidation:

The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries.

As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value.

Fair Value Measurements:

The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity.

Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:

•Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

•Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.

•Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.

Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.

Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources.

If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of

equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.

In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.

Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.

Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022.

Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments:

•The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team;

•Preliminary valuations are then reviewed and discussed with management of Oaktree;

•Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree;

•Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee;

•The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and

•Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio.

The fair value of the Company's investments as of June 30, 2023 and September 30, 2022 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax asset, net," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable" and "payables from unsettled transactions" approximate fair value due to their short maturities.

Foreign Currency Translation:

The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.

Derivative Instruments:

Foreign Currency Forward Contracts

The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations.

Interest Rate Swaps

The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.

Investment Income:

Interest Income

Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of June 30, 2023,

there were five investments on non-accrual status that in aggregate represented 3.6% and 3.1% of total debt investments at cost and fair value, respectively. As of September 30, 2022, there were no investments on non-accrual status.

In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.

PIK Interest Income

The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so.

Fee Income

Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered.

Dividend Income

The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.

Cash and Cash Equivalents and Restricted Cash:

Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.

As of September 30, 2022, included in restricted cash was $2.8 million that was held at Wells Fargo Bank, N.A. in connection with the Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the Citibank Facility, the Company was restricted in terms of access to $2.8 million as of September 30, 2022, until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the Citibank Facility. As of June 30, 2023, included in restricted cash was $13.0 million that was held at Deutsche Bank Trust Company Americas in connection with the Company’s OSI2 Citibank Facility (defined in Note 6. Borrowings). Pursuant to the terms of the OSI2 Citibank Facility, the Company was restricted in terms of access to the $13.0 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the OSI2 Citibank Facility.

Due from Portfolio Companies:

Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date).

Receivables/Payables from Unsettled Transactions:

Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.

Deferred Financing Costs:

Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.

Deferred Offering Costs:

Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.

Income Taxes:

The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar year 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2023.

The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.

FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

XML

Portfolio Investments

9 Months Ended

Jun. 30, 2023

Schedule of Investments [Abstract]

Portfolio Investments

Portfolio Investments

As of June 30, 2023, 207.7% of net assets at fair value, or $3.1 billion, was invested in 156 portfolio companies, including (i) $140.6 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $49.6 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of June 30, 2023, 4.8% of net assets at fair value, or $72.7 million, was invested in cash and cash equivalents (including $13.0 million of restricted cash). In comparison, as of September 30, 2022, 200.2% of net assets at fair value, or $2.5 billion, was invested in 149 portfolio investments, including (i) $117.0 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $50.3 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2022, 2.1% of net assets at fair value, or $26.4 million, was invested in cash and cash equivalents (including $2.8 million of restricted cash). As of June 30, 2023, 88.5% of the Company's portfolio at fair value consisted of senior secured debt investments and 6.8% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2022, 86.9% of the Company's portfolio at fair value consisted of senior secured debt investments and 8.1% consisted of subordinated debt investments, including the debt investments in the JVs.

The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants, limited partnership interests or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain.

During the three and nine months ended June 30, 2023, the Company recorded net realized losses of $10.6 million and $19.9 million, respectively. During the three and nine months ended June 30, 2022, the Company recorded net realized gains of $9.2 million and $19.9 million, respectively. During the three and nine months ended June 30, 2023, the Company recorded net unrealized depreciation of $1.0 million and $42.3 million, respectively. During the three and nine months ended June 30, 2022, the Company recorded net unrealized depreciation of $86.8 million and $118.4 million, respectively.

The composition of the Company's investments as of June 30, 2023 and September 30, 2022 at cost and fair value was as follows:

	June 30, 2023				September 30, 2022
	Cost		Fair Value		Cost		Fair Value
Investments in debt securities	$	2,942,222	$	2,826,369	$	2,294,392	$	2,223,329
Investments in equity securities	136,619		118,989		127,596		103,534
Debt investments in the JVs	162,653		162,288		146,444		146,533
Equity investments in the JVs	54,791		27,973		49,322		20,715
Total	$	3,296,285	$	3,135,619	$	2,617,754	$	2,494,111

The following table presents the composition of the Company's debt investments as of June 30, 2023 and September 30, 2022 at fixed rates and floating rates:

	June 30, 2023				September 30, 2022
	Fair Value		% of Debt Portfolio		Fair Value		% of Debt Portfolio
Floating rate debt securities, including the debt investments in the JVs	$	2,571,458	86.04	%	$	2,049,644	86.49	%
Fixed rate debt securities	417,199		13.96		320,218		13.51
Total	$	2,988,657	100.00	%	$	2,369,862	100.00	%

The following table presents the financial instruments carried at fair value as of June 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:

	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	245,925	$	2,528,448	$	—	$	2,774,373
Investments in debt securities (subordinated, including the debt investments in the JVs)	—		29,368		184,916		—		214,284
Investments in equity securities (preferred)	—		—		92,186		—		92,186
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	6,455		—		20,348		27,973		54,776
Total investments at fair value	6,455		275,293		2,825,898		27,973		3,135,619
Cash equivalents	5,193		—		—		—		5,193
Derivative asset	—		49		—		—		49
Total assets at fair value	$	11,648	$	275,342	$	2,825,898	$	27,973	$	3,140,861
Derivative liability	$	—	$	39,567	$	—	$	—	$	39,567
Total liabilities at fair value	$	—	$	39,567	$	—	$	—	$	39,567

__________ 

(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:

	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	255,803	$	1,910,606	$	—	$	2,166,409
Investments in debt securities (subordinated, including the debt investments in the JVs)	—		44,065		159,388		—		203,453
Investments in equity securities (preferred)	—		—		79,523		—		79,523
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	4,053		—		19,958		20,715		44,726
Total investments at fair value	4,053		299,868		2,169,475		20,715		2,494,111
Cash equivalents	5,261		—		—		—		5,261
Derivative assets	—		6,789		—		—		6,789
Total assets at fair value	$	9,314	$	306,657	$	2,169,475	$	20,715	$	2,506,161
Derivative liability	$	—	$	41,969	$	—	$	—	$	41,969
Total liabilities at fair value	$	—	$	41,969	$	—	$	—	$	41,969

__________ 

(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period.

The following table provides a roll-forward in the changes in fair value from March 31, 2023 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of March 31, 2023	$	2,493,622	$	183,756	$	91,447	$	25,509	$	2,794,334
Purchases	228,375		4,183		—		182		232,740
Sales and repayments	(191,409)		(350)		—		(7,320)		(199,079)
Transfers out (a)	—		(2,708)		—		—		(2,708)
Capitalized PIK interest income	3,610		358		—		—		3,968
Accretion of OID	4,086		381		—		—		4,467
Net unrealized appreciation (depreciation)	(8,027)		(704)		739		1,893		(6,099)
Net realized gains (losses)	(1,809)		—		—		84		(1,725)
Fair value as of June 30, 2023	$	2,528,448	$	184,916	$	92,186	$	20,348	$	2,825,898
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023	$	(10,360)	$	(704)	$	739	$	1,095	$	(9,230)

__________

(a) There were transfers out of Level 3 to Level 2 for certain investments during the three months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

The following table provides a roll-forward in the changes in fair value from March 31, 2022 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of March 31, 2022	$	1,955,858	$	160,727	$	84,372	$	33,588	$	2,234,545
Purchases	60,692		29		—		125		60,846
Sales and repayments	(91,730)		(733)		—		(3,890)		(96,353)
Transfers in (a)	28,475		—		—		—		28,475
Transfers out (b)	—		—		—		(5,838)		(5,838)
Capitalized PIK interest income	5,537		—		—		—		5,537
Accretion of OID	5,100		430		—		—		5,530
Net unrealized appreciation (depreciation)	(33,208)		(4,873)		(2,756)		(873)		(41,710)
Net realized gains (losses)	(10)		—		—		393		383
Fair value as of June 30, 2022	$	1,930,714	$	155,580	$	81,616	$	23,505	$	2,191,415
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2022	$	(33,199)	$	(4,873)	$	(2,756)	$	(917)	$	(41,745)

__________

(a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity

The following table provides a roll-forward in the changes in fair value from September 30, 2022 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2022	$	1,910,606	$	159,388	$	79,523	$	19,958	$	2,169,475
Purchases (a)	980,595		26,508		14,296		5,610		1,027,009
Sales and repayments	(357,903)		(1,396)		—		(8,295)		(367,594)
Transfers in (b)	19,075		—		—		—		19,075
Capitalized PIK interest income	12,549		376		—		—		12,925
Accretion of OID	11,684		1,109		—		—		12,793
Net unrealized appreciation (depreciation)	(45,019)		(1,069)		(1,633)		2,804		(44,917)
Net realized gains (losses)	(3,139)		—		—		271		(2,868)
Fair value as of June 30, 2023	$	2,528,448	$	184,916	$	92,186	$	20,348	$	2,825,898
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2023	$	(46,680)	$	(1,069)	$	(1,633)	$	(355)	$	(49,737)

__________

(a) Includes Level 3 investments acquired in connection with the OSI2 Merger during the nine months ended June 30, 2023.

(b) There was a transfer into Level 3 from Level 2 for an investment during the nine months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

The following table provides a roll-forward in the changes in fair value from September 30, 2021 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2021	$	1,878,536	$	176,317	$	63,565	$	43,163	$	2,161,581
Purchases	437,922		3,777		19,243		2,180		463,122
Sales and repayments	(391,959)		(21,868)		(163)		(12,836)		(426,826)
Transfers in (a)	37,042		—		—		—		37,042
Transfers out (a)(b)	(17,070)		—		—		(5,838)		(22,908)
Capitalized PIK interest income	16,653		313		—		—		16,966
Accretion of OID	19,048		1,628		—		—		20,676
Net unrealized appreciation (depreciation)	(57,909)		(4,587)		(517)		(2,520)		(65,533)
Net realized gains (losses)	8,451		—		(512)		(644)		7,295
Fair value as of June 30, 2022	$	1,930,714	$	155,580	$	81,616	$	23,505	$	2,191,415
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2022	$	(45,187)	$	(4,734)	$	(752)	$	(7,629)	$	(58,302)

__________

(a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the nine months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity.

Significant Unobservable Inputs for Level 3 Investments

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of June 30, 2023:

Asset	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average (a)
Senior Secured Debt	$	2,058,831	Market Yield	Market Yield	(b)	9.0%	-	38.0%	14.1%
	43,954		Enterprise Value	Revenue Multiple	(c)	5.0x	-	7.0x	6.0x
	34,466		Enterprise Value	EBITDA Multiple	(c)	3.4x	-	5.4x	5.2x
	32,379		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
	358,818		Broker quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Subordinated Debt	18,464		Market Yield	Market Yield	(b)	10.0%	-	22.0%	11.4%
	4,164		Broker Quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Debt Investments in the JVs	162,288		Enterprise Value	N/A	(f)	N/A	-	N/A	N/A
Preferred & Common Equity	70,852		Enterprise Value	Revenue Multiple	(c)	0.4x	-	6.0x	1.4x
	37,322		Enterprise Value	EBITDA Multiple	(c)	1.7x	-	17.5x	11.1x
	1,415		Enterprise Value	Asset Multiple	(c)	1.0x	-	1.4x	1.4x
	2,945		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
Total	$	2,825,898

__________ 

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

(e)Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

(f)Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2022:

Asset	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average (a)
Senior Secured Debt	$	1,599,148	Market Yield	Market Yield	(b)	9.0%	-	30.0%	13.7%
	14,333		Enterprise Value	EBITDA Multiple	(c)	5.0x	-	7.0x	6.0x
	297,125		Broker Quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Subordinated Debt	12,855		Market Yield	Market Yield	(b)	10.0%	-	19.0%	13.8%
Debt Investments in the JVs	146,533		Enterprise Value	N/A	(f)	N/A	-	N/A	N/A
Preferred & Common Equity	61,693		Enterprise Value	Revenue Multiple	(c)	0.4x	-	10.1x	4.3x
	36,913		Enterprise Value	EBITDA Multiple	(c)	3.0x	-	20.0x	11.4x
	3		Enterprise Value	Asset Multiple	(c)	0.9x	-	1.1x	1.0x
	872		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
Total	$	2,169,475

__________ 

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

(e)Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

(f)Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.

Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.

Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively.

Financial Instruments Disclosed, But Not Carried, At Fair Value

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of June 30, 2023 and the level of each financial liability within the fair value hierarchy:

	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	800,000	$	800,000	$	—	$	—	$	800,000
OSI2 Citibank Facility payable	335,000		335,000		—		—		335,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	297,928		285,717		—		285,717		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	307,138		302,260		—		302,260		—
Total	$	1,740,066	$	1,722,977	$	—	$	587,977	$	1,135,000

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2022 and the level of each financial liability within the fair value hierarchy:

	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	540,000	$	540,000	$	—	$	—	$	540,000
Citibank Facility payable	160,000		160,000		—		—		160,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	296,991		283,077		—		283,077		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	304,052		294,028		—		294,028		—
Total	$	1,301,043	$	1,277,105	$	—	$	577,105	$	700,000

The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. Oaktree used market quotes as of the valuation date to estimate the fair value of the Company's 3.500% notes due 2025 (the "2025 Notes") and 2.700% notes due 2027 (the "2027 Notes"), which are included in Level 2 of the hierarchy.

Portfolio Composition

Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,886,772	87.59	%	$	2,227,245	85.08	%
Debt investments in the JVs	162,653		4.93	%	146,444		5.59	%
Preferred equity	99,597		3.02	%	85,300		3.26	%
Subordinated debt	55,450		1.68	%	67,147		2.57	%
LLC equity interests of the JVs	54,791		1.66	%	49,322		1.88	%
Common equity and warrants	37,022		1.12	%	42,296		1.62	%
Total	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,774,373	88.48	%	183.80	%	$	2,166,409	86.86	%	173.93	%
Debt investments in the JVs	162,288		5.18	%	10.75	%	146,533		5.88	%	11.77	%
Preferred equity	92,186		2.94	%	6.11	%	79,523		3.19	%	6.38	%
Subordinated debt	51,996		1.66	%	3.44	%	56,920		2.28	%	4.57	%
LLC equity interests of the JVs	27,973		0.89	%	1.85	%	20,715		0.83	%	1.66	%
Common equity and warrants	26,803		0.85	%	1.78	%	24,011		0.96	%	1.93	%
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Northeast	$	994,695	30.17	%	$	747,420	28.55	%
Midwest	448,981		13.62	%	373,236		14.26	%
Southeast	446,546		13.55	%	356,041		13.60	%
West	440,634		13.37	%	358,306		13.69	%
International	434,844		13.19	%	301,242		11.51	%
South	197,754		6.00	%	168,819		6.45	%
Northwest	168,992		5.13	%	91,382		3.49	%
Southwest	163,839		4.97	%	221,308		8.45	%
Total	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	936,888	29.87	%	62.07	%	$	696,368	27.93	%	55.90	%
International	432,986		13.81	%	28.69	%	279,646		11.21	%	22.45	%
Midwest	429,317		13.69	%	28.44	%	356,934		14.31	%	28.66	%
West	428,232		13.66	%	28.37	%	345,251		13.84	%	27.72	%
Southeast	406,523		12.96	%	26.93	%	344,567		13.82	%	27.66	%
South	186,792		5.96	%	12.37	%	166,230		6.66	%	13.35	%
Northwest	166,089		5.30	%	11.00	%	90,131		3.61	%	7.24	%
Southwest	148,792		4.75	%	9.86	%	214,984		8.62	%	17.26	%
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of June 30, 2023 and September 30, 2022:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Application Software	$	560,503	16.98	%	$	391,938	14.98	%
Multi-Sector Holdings (1)	219,130		6.65		195,766		7.48
Data Processing & Outsourced Services	133,422		4.05		120,477		4.60
Health Care Technology	129,178		3.92		100,084		3.82
Biotechnology	127,394		3.86		109,960		4.20
Pharmaceuticals	121,497		3.69		126,508		4.83
Aerospace & Defense	110,680		3.36		61,963		2.37
Industrial Machinery & Supplies & Components	99,237		3.01		—		—
Broadline Retail	83,201		2.52		—		—
Health Care Services	77,364		2.35		58,674		2.24
Real Estate Operating Companies	76,462		2.32		47,585		1.82
Specialized Finance	69,188		2.10		80,864		3.09
Personal Care Products	68,671		2.08		—		—
Automotive Retail	64,825		1.97		59,254		2.26
Fertilizers & Agricultural Chemicals	64,750		1.96		49,301		1.88
Internet Services & Infrastructure	63,057		1.91		54,095		2.07
Health Care Distributors	62,079		1.88		57,112		2.18
Diversified Financial Services	61,693		1.87		—		—
Auto Parts & Equipment	61,091		1.85		12,474		0.48
Metal, Glass & Plastic Containers	57,949		1.76		—		—
Airport Services	55,919		1.70		43,322		1.65
Home Improvement Retail	54,939		1.67		45,802		1.75
Insurance Brokers	52,960		1.61		35,628		1.36
Diversified Metals & Mining	49,787		1.51		—		—
Leisure Facilities	49,501		1.50		39,768		1.52
Real Estate Services	44,783		1.36		40,243		1.54
Soft Drinks & Non-alcoholic Beverages	43,021		1.31		—		—
Diversified Support Services	42,706		1.30		37,992		1.45
Other Specialty Retail	41,790		1.27		—		—
Specialty Chemicals	38,248		1.16		37,319		1.43
Distributors	37,668		1.14		25,278		0.97
Integrated Telecommunication Services	33,663		1.02		34,628		1.32
Electrical Components & Equipment	32,380		0.98		33,814		1.29
Construction & Engineering	27,231		0.83		60,996		2.33
Environmental & Facilities Services	25,943		0.79		20,857		0.80
Advertising	25,597		0.78		28,245		1.08
Passenger Airlines	24,888		0.76		—		—
Oil & Gas Storage & Transportation	24,231		0.74		22,290		0.85
Home Furnishings	23,832		0.72		19,550		0.75
Gold	23,274		0.71		—		—
Systems Software	23,089		0.70		14,890		0.57
Health Care Equipment	22,374		0.68		24,353		0.93
Real Estate Development	19,567		0.59		—		—
Interactive Media & Services	18,963		0.58		—		—
Hotels, Resorts & Cruise Lines	17,221		0.52		13,960		0.53
Consumer Finance	16,411		0.50		14,492		0.55
Education Services	15,660		0.48		9,080		0.35
IT Consulting & Other Services	15,434		0.47		11,697		0.45
Restaurants	12,589		0.38		9,338		0.36
Movies & Entertainment	12,188		0.37		26,161		1.00
Health Care Supplies	11,675		0.35		36,471		1.39
Food Distributors	5,900		0.18		4,646		0.18
Apparel Retail	5,293		0.16		5,268		0.20
Air Freight & Logistics	4,925		0.15		7,295		0.28
Integrated Oil & Gas	4,887		0.15		4,866		0.19
Research & Consulting Services	4,879		0.15		9,187		0.35
Cable & Satellite	4,687		0.14		20,716		0.79
Other Specialized REITs	4,364		0.13		—		—
Paper & Plastic Packaging Products & Materials	3,262		0.10		—		—
Housewares & Specialties	2,908		0.09		2,293		0.09
Electronic Components	2,101		0.06		2,092		0.08
Leisure Products	2,039		0.06		—		—
Technology Distributors	1,084		0.03		3,163		0.12
Communications Equipment	1,053		0.03		—		—
Industrial Machinery	—		—		81,787		3.12
Internet & Direct Marketing Retail	—		—		67,926		2.59
Personal Products	—		—		53,214		2.03
Metal & Glass Containers	—		—		47,704		1.82
Soft Drinks	—		—		34,272		1.31
Other Diversified Financial Services	—		—		29,300		1.12
Oil & Gas Refining & Marketing	—		—		8,627		0.33
Trading Companies & Distributors	—		—		7,628		0.29
Apparel, Accessories & Luxury Goods	—		—		5,165		0.20
Specialized REITs	—		—		4,318		0.16
Diversified Banks	—		—		3,515		0.13
Construction Materials	—		—		2,331		0.09
Alternative Carriers	—		—		212		0.01
	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Application Software	$	544,685	17.38	%	36.03	%	$	384,589	15.43	%	30.87	%
Multi-Sector Holdings (1)	192,160		6.13		12.73		167,248		6.71		13.43
Biotechnology	128,343		4.09		8.50		108,465		4.35		8.71
Data Processing & Outsourced Services	124,548		3.97		8.25		111,335		4.46		8.94
Pharmaceuticals	116,199		3.71		7.70		119,511		4.79		9.59
Health Care Technology	115,659		3.69		7.66		97,315		3.90		7.81
Aerospace & Defense	111,464		3.55		7.38		61,881		2.48		4.97
Industrial Machinery & Supplies & Components	99,021		3.16		6.56		—		—		—
Broadline Retail	80,882		2.58		5.36		—		—		—
Real Estate Operating Companies	75,111		2.40		4.98		48,062		1.93		3.86
Specialized Finance	66,333		2.12		4.39		73,087		2.93		5.87
Fertilizers & Agricultural Chemicals	63,185		2.02		4.19		51,972		2.08		4.17
Internet Services & Infrastructure	62,726		2.00		4.16		53,797		2.16		4.32
Automotive Retail	62,356		1.99		4.13		57,629		2.31		4.63
Health Care Services	62,190		1.98		4.12		45,943		1.84		3.69
Diversified Financial Services	61,073		1.95		4.05		—		—		—
Personal Care Products	60,962		1.94		4.04		—		—		—
Auto Parts & Equipment	60,809		1.94		4.03		11,469		0.46		0.92
Health Care Distributors	60,340		1.92		4.00		54,662		2.19		4.39
Airport Services	55,221		1.76		3.66		42,883		1.72		3.44
Insurance Brokers	54,680		1.74		3.62		33,081		1.33		2.66
Home Improvement Retail	54,235		1.73		3.59		45,421		1.82		3.65
Diversified Metals & Mining	49,809		1.59		3.30		—		—		—
Leisure Facilities	46,990		1.50		3.11		39,258		1.57		3.15
Real Estate Services	44,227		1.41		2.93		39,573		1.59		3.18
Metal, Glass & Plastic Containers	43,954		1.40		2.91		—		—		—
Soft Drinks & Non-alcoholic Beverages	42,798		1.36		2.84		—		—		—
Other Specialty Retail	41,790		1.33		2.77		—		—		—
Diversified Support Services	41,302		1.32		2.74		36,712		1.47		2.95
Distributors	36,829		1.17		2.44		24,494		0.98		1.97
Electrical Components & Equipment	32,379		1.03		2.15		32,933		1.32		2.64
Specialty Chemicals	32,231		1.03		2.14		33,969		1.36		2.73
Integrated Telecommunication Services	30,922		0.99		2.05		32,201		1.29		2.59
Passenger Airlines	26,985		0.86		1.79		—		—		—
Construction & Engineering	26,901		0.86		1.78		61,188		2.45		4.91
Environmental & Facilities Services	25,436		0.81		1.69		20,585		0.83		1.65
Gold	23,292		0.74		1.54		—		—		—
Health Care Equipment	22,531		0.72		1.49		24,161		0.97		1.94
Systems Software	22,168		0.71		1.47		12,834		0.51		1.03
Oil & Gas Storage & Transportation	21,660		0.69		1.43		20,853		0.84		1.67
Home Furnishings	19,514		0.62		1.29		18,188		0.73		1.46
Real Estate Development	19,246		0.61		1.28		—		—		—
Interactive Media & Services	19,000		0.61		1.26		—		—		—
Advertising	18,969		0.60		1.26		26,948		1.08		2.16
Hotels, Resorts & Cruise Lines	17,261		0.55		1.14		13,985		0.56		1.12
Education Services	14,116		0.45		0.94		8,582		0.34		0.69
Consumer Finance	12,616		0.40		0.84		13,284		0.53		1.07
Restaurants	12,168		0.39		0.81		8,692		0.35		0.70
Movies & Entertainment	11,865		0.38		0.79		26,645		1.07		2.14
Health Care Supplies	11,408		0.36		0.76		36,577		1.47		2.94
IT Consulting & Other Services	11,176		0.36		0.74		8,596		0.34		0.69
Food Distributors	5,296		0.17		0.35		3,367		0.13		0.27
Apparel Retail	5,230		0.17		0.35		5,223		0.21		0.42
Integrated Oil & Gas	4,810		0.15		0.32		4,872		0.20		0.39
Cable & Satellite	4,672		0.15		0.31		19,576		0.78		1.57
Research & Consulting Services	4,632		0.15		0.31		8,573		0.34		0.69
Air Freight & Logistics	4,025		0.13		0.27		6,405		0.26		0.51
Other Specialized REITs	3,438		0.11		0.23		—		—		—
Paper & Plastic Packaging Products & Materials	3,100		0.10		0.21		—		—		—
Housewares & Specialties	2,858		0.09		0.19		2,456		0.10		0.20
Leisure Products	1,995		0.06		0.13		—		—		—
Electronic Components	1,834		0.06		0.12		1,890		0.08		0.15
Technology Distributors	1,024		0.03		0.07		2,997		0.12		0.24
Communications Equipment	980		0.03		0.06		—		—		—
Industrial Machinery	—		—		—		81,008		3.25		6.50
Internet & Direct Marketing Retail	—		—		—		70,419		2.82		5.65
Personal Products	—		—		—		50,150		2.01		4.03
Metal & Glass Containers	—		—		—		47,599		1.91		3.82
Soft Drinks	—		—		—		33,670		1.35		2.70
Other Diversified Financial Services	—		—		—		24,326		0.98		1.95

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Oil & Gas Refining & Marketing	$	—	—		—		$	8,604	0.34		0.69
Trading Companies & Distributors	—		—		—		5,567		0.22		0.45
Diversified Banks	—		—		—		3,402		0.14		0.27
Specialized REITs	—		—		—		3,264		0.13		0.26
Construction Materials	—		—		—		1,934		0.08		0.16
Alternative Carriers	—		—		—		201		0.01		0.02
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

___________________

(1)This industry includes the Company's investments in the JVs.

As of June 30, 2023 and September 30, 2022, the Company had no single investment that represented greater than 10% of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments.

Senior Loan Fund JV I, LLC

In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I.

SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to the Company and Kemper by SLF JV I. The subordinated notes issued by SLF JV I (the "SLF JV I Notes") are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt. As of June 30, 2023 and September 30, 2022, the Company and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.

SLF JV I has a senior revolving credit facility with Deutsche Bank AG, New York Branch (as amended, the "SLF JV I Deutsche Bank Facility"), which permitted up to $260.0 million of borrowings (subject to borrowing base and other limitations) as of each of June 30, 2023 and September 30, 2022. Borrowings under the SLF JV I Deutsche Bank Facility are secured by all of the assets of SLF JV I Funding LLC, a special purpose financing subsidiary of SLF JV I. As of June 30, 2023, the reinvestment period of the SLF JV I Deutsche Bank Facility was scheduled to expire May 3, 2024 and the maturity date was May 3, 2028. As of June 30, 2023, borrowings under the SLF JV I Deutsche Bank Facility accrued interest at a rate equal to 3-month SOFR plus 2.50% until November 3, 2023, 3-month SOFR plus 2.75% per annum during the remainder of the reinvestment period, 3-month SOFR plus 3.25% per annum for the first year after the reinvestment period, 3-month SOFR plus 3.35% for the following year and 3-month SOFR plus 3.60% thereafter, in each case with a 0.125% SOFR floor. $200.0 million and $230.0 million of borrowings were outstanding under the SLF JV I Deutsche Bank Facility as of June 30, 2023 and September 30, 2022, respectively.

As of June 30, 2023 and September 30, 2022, SLF JV I had total assets of $370.2 million and $385.2 million, respectively. SLF JV I's portfolio primarily consisted of senior secured loans to 52 and 60 portfolio companies as of June 30, 2023 and September 30, 2022, respectively. The portfolio companies in SLF JV I are in industries similar to those in which the Company may invest directly. As of June 30, 2023, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $140.6 million in aggregate, at fair value. As of September 30, 2022, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $117.0 million in aggregate, at fair value.

As of June 30, 2023, the Company and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from the Company. As of September 30, 2022, the Company and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from the Company. As of June 30, 2023, the Company had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the nine months ended June 30, 2023, the Company contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2022, the Company had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.

Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of June 30, 2023 and September 30, 2022:

	June 30, 2023	September 30, 2022
Senior secured loans (1)	$350,214	$383,194
Weighted average interest rate on senior secured loans (2)	10.40%	8.33%
Number of borrowers in SLF JV I	52	60
Largest exposure to a single borrower (1)	$11,304	$10,093
Total of five largest loan exposures to borrowers (1)	$54,003	$48,139

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

SLF JV I Portfolio as of June 30, 2023

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	L+	3.75%	8.94%		2/27/2025		$	5,596	$	5,559	$	5,545
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025		6,911		6,832		6,784		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025		1,173		1,158		1,152		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	9.32%		8/14/2026		2,977		2,850		2,808
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.89%		6/30/2025		8,916		8,845		8,514		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.22%		6/9/2028		4,970		4,734		4,692
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.49%		10/20/2028		4,836		4,775		4,219		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.00%	9.39%		11/26/2026		7,740		7,663		7,721
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.25%		8/11/2025		1,527		1,194		1,179		(4)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	5.00%	10.20%		1/10/2025		4,615		4,592		4,615		(4)
Apptio, Inc.	Application Software	First Lien Revolver	L+	5.00%	10.20%		1/10/2025		115		113		115		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.31%		12/29/2027		4,145		4,083		3,938		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027		—		(7)		(25)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	10.44%		10/25/2028		5,052		4,880		3,560		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.20%		8/19/2028		4,963		4,749		4,710
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.47%		8/19/2028		1,995		1,883		1,902
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.47%		1/20/2029		4,346		4,022		3,657
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%	8.59%		2/15/2029		4,331		4,079		4,179
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%			2/15/2029		—		(32)		(19)		(5)
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	11.27%		12/24/2026		6,289		6,211		6,031		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027		6,322		6,263		6,158		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027		1,759		1,748		1,713		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		1,965		1,938		1,930
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		2,366		2,332		2,324
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		1,988		1,957		1,952
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.38%		8/10/2027		200		192		189		(5)
Convergeone Holdings, Inc.	IT Consulting & Other Services	First Lien Term Loan	L+	5.00%	10.37%		1/4/2026		7,315		7,188		4,670		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.24%		10/13/2029		6,359		5,983		5,937		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	9.54%		7/9/2026		7,760		7,689		7,730
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.25%	9.79%		12/2/2027		992		974		987
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.22%		8/2/2027		5,958		5,869		5,838		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.80%		4/26/2029		7,940		7,807		7,411		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.25%		8/11/2028		7,388		7,314		5,984		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.45%		4/9/2029		7,940		7,742		6,818		(4)

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.75%		6/30/2026		$	7,350	$	7,260	$	7,359
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	L+	5.75%	11.29%		3/25/2027		9,125		8,950		7,239		(4)
Iris Holding, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.75%	9.90%		6/28/2028		4,963		4,638		4,226
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	10.20%		10/29/2028		3,972		3,817		3,940
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.08%		10/14/2027		7,388		7,281		7,267
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	10.50%		5/9/2026		11,279		11,121		10,997		(4)
LogMeIn, Inc.	Application Software	First Lien Term Loan	L+	4.75%	9.94%		8/31/2027		7,800		7,705		4,918
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	3.50%	8.72%		9/6/2025		7,308		7,246		7,037
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.01%		3/1/2029		5,955		5,655		5,713
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	12.19%		2/14/2025		4,669		4,644		4,599		(4)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	L+	8.00%			2/14/2025		—		(3)		(7)		(4)(5)
Mitchell International Inc	Application Software	First Lien Term Loan	L+	3.75%	8.94%		10/15/2028		2,991		2,845		2,931
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026		8,340		8,172		8,111		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026		—		(3)		(9)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026		2,217		2,216		2,156		(4)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.50%	10.00%		3/31/2025		6,633		6,624		6,583
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	9.25%		9/25/2026		11,015		10,845		10,852
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	10.20%		11/10/2027		9,849		9,495		9,603		(4)
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.50%		12/17/2027		2,422		2,297		2,305
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.59%		12/18/2028		4,503		4,435		4,023		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.04%		4/6/2027		8,116		7,831		7,815		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.04%		4/6/2027		254		236		235		(4)(5)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.75%	9.99%		4/5/2030		5,000		4,855		4,948
RevSpring, Inc.	Commercial Printing	First Lien Term Loan	L+	4.00%	9.50%		10/11/2025		9,550		9,536		9,208
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	10.52%		4/27/2024		8,135		8,132		5,749
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	10.50%		4/27/2024		138		138		100
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.75%	9.97%		4/17/2028		2,985		2,564		2,768		(4)
Sorenson Communications, LLC	Communications Equipment	First Lien Term Loan	L+	5.50%	10.69%		3/17/2026		2,328		2,305		2,166		(4)
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.50%	10.70%		11/20/2028		8,865		8,729		8,655		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.70%		4/5/2029		8,801		8,426		8,710
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.84%		3/30/2029		8,235		7,548		7,722		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.20%		12/29/2028		7,230		7,116		7,050		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	L+	5.00%	10.22%		9/1/2025		6,322		6,266		5,185
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.45%		9/21/2027		7,757		7,570		7,263		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	9.03%		4/30/2025		1,970		1,917		1,791		(4)
Total Portfolio Investments									$	350,214	$	348,782	$	329,809

_________

(1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each

respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54 %, the 180-day LIBOR at 5.73%, the 30-day SOFR at 5.10%, and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of June 30, 2023.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

SLF JV I Portfolio as of September 30, 2022

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	L+	3.75%	6.82%		2/27/2025		$	10,093	$	10,028	$	9,692
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.25%	9.80%		12/18/2025		8,518		8,389		8,371		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	6.91%		8/14/2026		3,000		2,841		2,730
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	11.20%		6/30/2025		9,267		9,166		9,221		(4)
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	L+	6.25%	9.03%		10/20/2028		4,873		4,812		4,576		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	L+	4.25%	7.92%		11/26/2026		7,800		7,722		7,527		(4)
Anastasia Parent, LLC	Personal Products	First Lien Term Loan	L+	3.75%	7.42%		8/11/2025		1,539		1,203		1,232		(4)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.46%		1/10/2025		4,615		4,580		4,519		(4)
Apptio, Inc.	Application Software	First Lien Revolver	L+	6.00%	8.46%		1/10/2025		154		151		146		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Term Loan	L+	6.00%	9.67%		12/29/2027		4,176		4,103		4,080
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Revolver	L+	6.00%			12/29/2027				(9)		(11)		(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	8.37%		10/25/2028		5,052		4,858		4,319		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	7.70%		8/19/2028		5,000		4,753		4,276
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	L+	5.25%	8.37%		1/20/2029		4,346		3,981		3,347
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	8.78%		12/24/2026		6,338		6,242		6,027		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027		6,371		6,311		6,148
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027		1,771		1,751		1,664		(4)(5)
Blackhawk Network Holdings, Inc.	Data Processing & Outsourced Services	First Lien Term Loan	L+	3.00%	6.03%		6/15/2025		9,575		9,566		8,977
BYJU's Alpha, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.98%		11/24/2026		7,444		7,347		5,455
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	5.50%	9.12%		8/10/2027		4,358		4,286		4,280
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	5.50%	9.12%		8/10/2027		449		432		413
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	5.50%			8/10/2027		—		(10)		(11)		(5)
CITGO Petroleum Corp.	Oil & Gas Refining & Marketing	First Lien Term Loan	L+	6.25%	9.37%		3/28/2024		7,038		6,967		7,057		(4)
City Football Group Limited	Movies & Entertainment	First Lien Term Loan	L+	3.50%	6.48%		7/21/2028		6,451		6,419		6,166
Convergeone Holdings, Inc.	IT Consulting & Other Services	First Lien Term Loan	L+	5.00%	8.12%		1/4/2026		7,373		7,206		5,320		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	7.65%		9/20/2029		5,375		5,053		5,035		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	7.67%		7/9/2026		5,820		5,776		5,587
Dealer Tire, LLC	Distributors	First Lien Term Loan	L+	4.25%	7.37%		12/12/2025		2,992		2,935		2,924
Delivery Hero FinCo LLC	Internet & Direct Marketing Retail	First Lien Term Loan	SOFR+	5.75%	8.49%		8/12/2027		6,035		5,876		5,756		(4)
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	L+	5.00%	8.12%		8/2/2027		6,436		6,332		6,012		(4)
Domtar Corporation	Paper Products	First Lien Term Loan	L+	5.50%	8.26%		11/30/2028		4,100		4,065		3,921
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	7.33%		4/26/2029		8,000		7,849		7,616		(4)
Eagle Parent Corp.	Industrial Machinery	First Lien Term Loan	SOFR+	4.25%	7.80%		4/2/2029		4,478		4,373		4,367
eResearch Technology, Inc.	Application Software	First Lien Term Loan	L+	4.50%	7.62%		2/4/2027		7,331		7,258		6,859

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	L+	5.00%	7.94%		8/11/2028		$	7,444	$	7,369	$	6,029
Global Medical Response, Inc.	Health Care Services	First Lien Term Loan	L+	4.25%	7.37%		3/14/2025		1,979		1,979		1,722		(4)
Global Medical Response, Inc.	Health Care Services	First Lien Term Loan	L+	4.25%	6.81%		10/2/2025		2,192		2,165		1,912
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	8.38%		4/9/2029		8,000		7,774		7,310		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	L+	5.25%	8.80%		6/30/2026		7,406		7,293		7,286
INW Manufacturing, LLC	Personal Products	First Lien Term Loan	L+	5.75%	9.42%		3/25/2027		9,500		9,282		8,408		(4)
Iris Holding, Inc.	Metal & Glass Containers	First Lien Term Loan	SOFR+	4.75%	7.89%		6/28/2028		5,000		4,624		4,610
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	L+	5.75%	8.23%		10/14/2027		7,444		7,318		7,323
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	L+	5.00%	8.67%		5/9/2026		7,367		7,315		7,109		(4)
LogMeIn, Inc.	Application Software	First Lien Term Loan	L+	4.75%	7.80%		8/31/2027		7,860		7,751		5,494
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	L+	3.25%	6.37%		9/6/2025		7,366		7,282		6,835
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	10.64%		2/14/2025		4,687		4,651		4,570		(4)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	L+	8.00%			2/14/2025		—		(4)		(12)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	L+	5.50%	9.17%		2/10/2026		6,139		6,104		5,966		(4)
MRI Software LLC	Application Software	First Lien Revolver	L+	5.50%			2/10/2026				(3)		(10)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	L+	4.75%	7.87%		3/31/2025		6,685		6,673		6,484
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	7.12%		9/25/2026		7,777		7,741		7,505		(4)
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	8.13%		11/10/2027		4,925		4,781		4,687		(4)
Peloton Interactive, Inc.	Leisure Products	First Lien Term Loan	SOFR+	6.50%	8.35%		5/25/2027		5,486		5,251		5,371
Planview Parent, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	10.92%		12/18/2028		4,503		4,435		4,323		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	L+	8.00%	10.68%		4/6/2027		6,796		6,694		6,582		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	L+	8.00%			4/6/2027		—		(6)		(13)		(4)(5)
RevSpring, Inc.	Commercial Printing	First Lien Term Loan	L+	4.00%	7.67%		10/11/2025		9,625		9,607		9,304
Sabert Corporation	Metal & Glass Containers	First Lien Term Loan	L+	4.50%	7.63%		12/10/2026		2,536		2,511		2,435		(4)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	8.06%		4/27/2024		8,201		8,194		7,176
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	8.04%		4/27/2024		138		138		121
Sorenson Communications, LLC	Communications Equipment	First Lien Term Loan	L+	5.50%	9.17%		3/17/2026		2,553		2,528		2,454
Spanx, LLC	Apparel Retail	First Lien Term Loan	L+	5.25%	8.30%		11/20/2028		8,933		8,776		8,721		(4)
SPX Flow, Inc.	Industrial Machinery	First Lien Term Loan	SOFR+	4.50%	7.63%		4/5/2029		7,500		7,184		6,966		(4)
Supermoose Borrower, LLC	Application Software	First Lien Term Loan	L+	3.75%	7.42%		8/29/2025		7,743		7,479		6,827		(4)
Surgery Center Holdings, Inc.	Health Care Facilities	First Lien Term Loan	L+	3.75%	6.51%		8/31/2026		3,377		3,365		3,213
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	8.15%		3/30/2029		6,256		5,693		5,629		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	L+	6.00%	9.12%		12/29/2028		7,285		7,155		7,140		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	L+	5.00%	8.67%		9/1/2025		6,365		6,290		5,087
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	L+	6.25%	9.37%		9/21/2027		7,818		7,596		7,115		(4)
WP CPP Holdings, LLC	Aerospace & Defense	Second Lien Term Loan	L+	7.75%	10.56%		4/30/2026		6,000		5,972		5,070		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	6.56%		4/30/2025		1,985		1,910		1,783		(4)
Zayo Group Holdings, Inc.	Alternative Carriers	First Lien Term Loan	L+	3.00%	6.12%		3/9/2027		2,155		2,000		1,812
Total Portfolio Investments									$	383,194	$	382,673	$	359,625

_________

(1) Represents the interest rate as of September 30, 2022. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of September 30, 2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55% and the 180-day SOFR at 3.98%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of September 30, 2022.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

Both the cost and fair value of the Company's SLF JV I Notes were $112.7 million as of June 30, 2023. Both the cost and fair value of the Company's SLF JV I Notes were $96.3 million as of September 30, 2022. The Company earned interest income of $3.4 million and $9.2 million on the SLF JV I Notes for the three and nine months ended June 30, 2023, respectively. The Company earned interest income of $1.9 million and $5.8 million on the SLF JV I Notes for the three and nine months ended June 30, 2022, respectively. As of June 30, 2023, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.

The cost and fair value of the LLC equity interests in SLF JV I held by the Company were $54.8 million and $28.0 million, respectively, as of June 30, 2023, and $49.3 million and $20.7 million, respectively, as of September 30, 2022. The Company earned $1.1 million and $3.2 million in dividend income for the three and nine months ended June 30, 2023, respectively, with respect to its investment in the LLC equity interests of SLF JV I. The Company earned $0.9 million and $2.0 million in dividend income for the three and nine months ended June 30, 2022, respectively, with respect to its investment in the LLC equity interests of SLF JV I. The LLC equity interests of SLF JV I are generally dividend producing to the extent SLF JV I has residual cash to be distributed on a quarterly basis.

Below is certain summarized financial information for SLF JV I as of June 30, 2023 and September 30, 2022 and for the three and nine months ended June 30, 2023 and 2022:

	June 30, 2023		September 30, 2022
Selected Balance Sheet Information:
Investments at fair value (cost June 30, 2023:$348,782; cost September 30, 2022: $382,673)	$	329,809	$	359,625
Cash and cash equivalents	21,906		14,274
Restricted cash	8,715		5,642
Other assets	9,798		5,686
Total assets	$	370,228	$	385,227
Senior credit facility payable	$	200,000	$	230,000
SLF JV I Notes payable at fair value (proceeds June 30, 2023: $128,750; proceeds September 30, 2022: $110,000)	128,750		110,000
Other liabilities	9,509		21,539
Total liabilities	$	338,259	$	361,539
Members' equity	31,969		23,688
Total liabilities and members' equity	$	370,228	$	385,227

	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Selected Statements of Operations Information:
Interest income	$	10,312	$	5,796	$	29,106	$	16,664
Other income	—		32		62		105
Total investment income	10,312		5,828		29,168		16,769
Senior credit facility interest expense	4,190		1,929		12,004		4,995
SLF JV I Notes interest expense	3,859		2,224		10,511		6,673
Other expenses	73		77		249		198
Total expenses (1)	8,122		4,230		22,764		11,866
Net investment income	2,190		1,598		6,404		4,903
Net unrealized appreciation (depreciation)	2,652		(16,411)		4,075		(19,856)
Net realized gains (losses)	(2,137)		165		(4,850)		568
Net income (loss)	$	2,705	$	(14,648)	$	5,629	$	(14,385)

 __________

(1) There are no management fees or incentive fees charged at SLF JV I.

SLF JV I has elected to fair value the SLF JV I Notes issued to the Company and Kemper under FASB ASC Topic 825, Financial Instruments - Fair Value Option ("ASC 825"). The SLF JV I Notes are valued based on the total assets less the total liabilities senior to the SLF JV I Notes in an amount not exceeding par under the EV technique.

During the nine months ended June 30, 2023, the Company sold $18.8 million of senior secured debt investments to SLF JV I for $18.0 million cash consideration, which represented the fair value at the time of sale. A loss of $0.2 million was recognized by the Company on these transactions. During the nine months ended June 30, 2022, the Company sold $9.7 million of senior secured debt investments to SLF JV I for $9.7 million cash consideration, which represented the fair value at the time of sale. A gain of $0.5 million was recognized by the Company on these transactions.

OCSI Glick JV LLC

On March 19, 2021, the Company became party to the LLC agreement of Glick JV. The Company co-invests primarily in senior secured loans of middle-market companies with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by GF Equity Funding. The Glick JV is capitalized as transactions are completed, and portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, which consists of one representative selected by the Company and one representative selected by GF Equity Funding (with approval from a representative of each required). Since the Company does not have a controlling financial interest in the Glick JV, the Company does not consolidate the Glick JV.

The members provide capital to the Glick JV in exchange for LLC equity interests, and the Company and GF Debt Funding 2014 LLC ("GF Debt Funding"), an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV (the "Glick JV Notes"). As of June 30, 2023 and September 30, 2022, the Company and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and the Company and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.

The Glick JV has a senior revolving credit facility with Deutsche Bank AG, New York Branch (the "Glick JV Deutsche Bank Facility"), which, as of June 30, 2023, had a reinvestment period end date and maturity date of May 3, 2024 and May 3, 2028, respectively, and permitted borrowings of up to $90.0 million (subject to borrowing base and other limitations). Borrowings under the Glick JV Deutsche Bank Facility are secured by all of the assets of the Glick JV and all of the equity interests in the Glick JV and, as of June 30, 2023, bore interest at a rate equal to 3-month SOFR plus 2.50% per annum until November 3, 2023, 3-month SOFR plus 2.75% during the remainder of the reinvestment period, 3-month SOFR plus 3.25% for the first year after the end of the reinvestment period, 3-month SOFR plus 3.35% for the following year and 3-month SOFR plus 3.60% thereafter, in each case with a 0.125% SOFR floor. $66.1 million and $82.1 million of borrowings were outstanding under the Glick JV Deutsche Bank Facility as of June 30, 2023 and September 30, 2022, respectively.

As of June 30, 2023 and September 30, 2022, the Glick JV had total assets of $126.8 million and $146.8 million, respectively. The Glick JV's portfolio consisted of middle-market and other corporate debt securities of 37 and 43 portfolio companies as of June 30, 2023 and September 30, 2022, respectively. The portfolio companies in the Glick JV are in industries similar to those in which the Company may invest directly. The Company's investment in the Glick JV consisted of LLC equity interests and Glick JV Notes of $49.6 million and $50.3 million in the aggregate at fair value as of June 30, 2023 and September 30, 2022, respectively. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by the Company to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.

As of each of June 30, 2023 and September 30, 2022, the Glick JV had total capital commitments of $100.0 million, $87.5 million of which was from the Company and the remaining $12.5 million of which was from GF Equity Funding and GF Debt Funding. Approximately $84.0 million in aggregate commitments were funded as of each of June 30, 2023 and September 30, 2022, of which $73.5 million was from the Company. As of each of June 30, 2023 and September 30, 2022, the Company had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million were unfunded. As of each of June 30, 2023 and September 30, 2022, the Company had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million were unfunded.

Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of June 30, 2023 and September 30, 2022:

	June 30, 2023	September 30, 2022
Senior secured loans (1)	$123,126	$143,225
Weighted average current interest rate on senior secured loans (2)	10.66%	8.52%
Number of borrowers in the Glick JV	37	43
Largest loan exposure to a single borrower (1)	$6,313	$6,562
Total of five largest loan exposures to borrowers (1)	$28,457	$28,973

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Glick JV Portfolio as of June 30, 2023

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025	$	587	$	579	$	576	(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025	3,824		3,782		3,753		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.89%		6/30/2025	6,313		6,261		6,029		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.22%		6/9/2028	2,485		2,367		2,346
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.49%		10/20/2028	2,868		2,832		2,502		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.00%	9.39%		11/26/2026	2,903		2,873		2,895
Amynta Agency Borrower Inc.	Property & Casualty Insurance	First Lien Term Loan	SOFR+	5.00%	10.20%		2/28/2028	3,000		2,915		2,925
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.25%		8/11/2025	910		707		702		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.31%		12/29/2027	1,721		1,695		1,635		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027	—		(3)		(10)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	10.44%		10/25/2028	2,078		2,037		1,464		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.20%		8/19/2028	1,985		1,900		1,884
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.47%		8/19/2028	998		941		951
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.47%		1/20/2029	2,423		2,236		2,039
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%	8.59%		2/15/2029	1,777		1,674		1,715
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%			2/15/2029	—		(13)		(8)		(5)
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	11.27%		12/24/2026	3,628		3,583		3,479		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027	3,372		3,340		3,284		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027	802		798		782		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.24%		10/13/2029	2,773		2,607		2,589		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	9.54%		7/9/2026	2,848		2,827		2,838
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.22%		8/2/2027	2,528		2,502		2,477		(4)

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.80%		4/26/2029	$	2,978	$	2,928	$	2,779	(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.25%		8/11/2028	3,940		3,901		3,191		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.45%		4/9/2029	3,970		3,871		3,409		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.75%		6/30/2026	3,920		3,872		3,925
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	L+	5.75%	11.29%		3/25/2027	2,281		2,238		1,810		(4)
Iris Holding, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.75%	9.90%		6/28/2028	1,985		1,852		1,690
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.08%		10/14/2027	3,940		3,883		3,876
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	3.50%	8.72%		9/6/2025	1,347		1,224		1,297
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026	1,634		1,621		1,589		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026	—		(1)		(4)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.50%	10.00%		3/31/2025	5,211		5,205		5,172
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	9.25%		9/25/2026	3,858		3,841		3,802
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.50%		12/17/2027	685		649		652
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.59%		12/18/2028	2,842		2,799		2,539		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.04%		4/6/2027	5,182		5,018		4,990		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.04%		4/6/2027	180		169		167		(4)(5)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	10.52%		4/27/2024	6,045		6,039		4,272
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	10.50%		4/27/2024	102		102		74
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.50%	10.70%		11/20/2028	4,925		4,849		4,808		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.70%		4/5/2029	5,227		5,023		5,174
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.84%		3/30/2029	2,647		2,435		2,483		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.20%		12/29/2028	3,001		2,954		2,926		(4)
Tribe Buyer LLC	Human Resource & Employment Services	First Lien Term Loan	L+	4.50%	9.69%		2/16/2024	1,570		1,570		931
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.45%		9/21/2027	4,848		4,731		4,539		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	9.03%		4/30/2025	985		959		895		(4)
Total Portfolio Investments								$	123,126	$	120,172	$	113,833

__________

(1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 30-day SOFR at 5.10% and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and the Glick JV as of June 30, 2023.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

Glick JV Portfolio as of September 30, 2022

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	L+	6.25%	9.80%		12/18/2025	$	4,647	$	4,579	$	4,567	(4)
Alvogen Pharma Inc	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	11.20%		6/30/2025	6,562		6,489		6,529		(4)
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	L+	6.25%	9.03%		10/20/2028	2,889		2,853		2,714		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	L+	4.25%	7.92%		11/26/2026	2,925		2,896		2,823		(4)
Anastasia Parent, LLC	Personal Products	First Lien Term Loan	L+	3.75%	7.42%		8/11/2025	917		712		734		(4)
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Term Loan	L+	6.00%	9.67%		12/29/2027	1,734		1,704		1,694
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Revolver	L+	6.00%			12/29/2027	—		(4)		(5)		(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	8.37%		10/25/2028	2,078		2,033		1,777		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	7.70%		8/19/2028	2,000		1,901		1,711
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	L+	5.25%	8.37%		1/20/2029	2,423		2,212		1,866
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	8.78%		12/24/2026	3,656		3,601		3,476		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027	3,398		3,366		3,279
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027	808		800		760		(4)(5)
BYJU's Alpha, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.98%		11/24/2026	3,970		3,919		2,909
CITGO Petroleum Corp.	Oil & Gas Refining & Marketing	First Lien Term Loan	L+	6.25%	9.37%		3/28/2024	3,519		3,484		3,529		(4)
City Football Group Limited	Movies & Entertainment	First Lien Term Loan	L+	3.50%	6.48%		7/21/2028	2,481		2,469		2,372
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	7.65%		9/20/2029	2,280		2,143		2,136		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	7.67%		7/9/2026	2,870		2,849		2,756
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	L+	5.00%	8.12%		8/2/2027	2,730		2,703		2,549		(4)
Domtar Corporation	Paper Products	First Lien Term Loan	L+	5.50%	8.26%		11/30/2028	2,503		2,478		2,394
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	7.33%		4/26/2029	3,000		2,943		2,856		(4)
Eagle Parent Corp.	Industrial Machinery	First Lien Term Loan	SOFR+	4.25%	7.80%		4/2/2029	2,488		2,429		2,426
eResearch Technology, Inc.	Application Software	First Lien Term Loan	L+	4.50%	7.62%		2/4/2027	2,444		2,419		2,286
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	L+	5.00%	7.94%		8/11/2028	3,970		3,930		3,216
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	8.38%		4/9/2029	4,000		3,887		3,655		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	L+	5.25%	8.80%		6/30/2026	3,950		3,890		3,886
INW Manufacturing, LLC	Personal Products	First Lien Term Loan	L+	5.75%	9.42%		3/25/2027	2,375		2,320		2,102		(4)
Iris Holding, Inc.	Metal & Glass Containers	First Lien Term Loan	SOFR+	4.75%	7.89%		6/28/2028	2,000		1,846		1,844
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	L+	5.75%	8.23%		10/14/2027	3,970		3,903		3,905
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	L+	3.25%	6.37%		9/6/2025	1,358		1,192		1,260

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
MRI Software LLC	Application Software	First Lien Term Loan	L+	5.50%	9.17%		2/10/2026	$	1,647	$	1,632	$	1,600	(4)
MRI Software LLC	Application Software	First Lien Revolver	L+	5.50%			2/10/2026	—		(1)		(4)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	L+	4.75%	7.87%		3/31/2025	5,252		5,243		5,095
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	7.12%		9/25/2026	3,888		3,871		3,752		(4)
Planview Parent, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	10.92%		12/18/2028	2,842		2,799		2,728		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	L+	8.00%	10.68%		4/6/2027	4,465		4,398		4,325		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	L+	8.00%			4/6/2027	—		(5)		(10)		(4)(5)
Sabert Corporation	Metal & Glass Containers	First Lien Term Loan	L+	4.50%	7.63%		12/10/2026	1,691		1,674		1,623		(4)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	8.06%		4/27/2024	6,094		6,082		5,332
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	8.04%		4/27/2024	102		102		90
Spanx, LLC	Apparel Retail	First Lien Term Loan	L+	5.25%	8.30%		11/20/2028	4,962		4,876		4,845		(4)
SPX Flow, Inc.	Industrial Machinery	First Lien Term Loan	SOFR+	4.50%	7.63%		4/5/2029	6,000		5,734		5,572		(4)
Supermoose Borrower, LLC	Application Software	First Lien Term Loan	L+	3.75%	7.42%		8/29/2025	2,820		2,712		2,487		(4)
Surgery Center Holdings, Inc.	Health Care Facilities	First Lien Term Loan	L+	3.75%	6.51%		8/31/2026	3,377		3,365		3,213
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	8.15%		3/30/2029	2,654		2,415		2,388		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	L+	6.00%	9.12%		12/29/2028	3,024		2,970		2,963		(4)
Tribe Buyer LLC	Human Resource & Employment Services	First Lien Term Loan	L+	4.50%	7.62%		2/16/2024	1,583		1,582		1,266
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	L+	6.25%	9.37%		9/21/2027	4,886		4,747		4,447		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	6.56%		4/30/2025	993		955		892		(4)
WP CPP Holdings, LLC	Aerospace & Defense	Second Lien Term Loan	L+	7.75%	10.56%		4/30/2026	3,000		2,986		2,534		(4)
Total Portfolio Investments								$	143,225	$	140,083	$	133,144

__________

(1) Represents the interest rate as of September 30, 2022. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of September 30, 2022, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 30-day SOFR at 3.03% and the 90-day SOFR at 3.55%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and the Glick JV as of September 30, 2022.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

The cost and fair value of the Company's aggregate investment in the Glick JV was $50.0 million and $49.6 million, respectively, as of June 30, 2023. The cost and fair value of the Company's aggregate investment in the Glick JV was $50.2 million and $50.3 million, respectively, as of September 30, 2022. For the three and nine months ended June 30, 2023, the Company's investment in the Glick JV Notes earned interest income of $1.8 million and $5.0 million, respectively. For the three and nine months ended June 30, 2022, the Company's investment in the Glick JV Notes earned interest income of $1.2 million and $3.3 million, respectively. The Company did not earn dividend income for the three and nine months ended June 30, 2023 and June 30, 2022 with respect to its investment in the LLC equity interest of the Glick JV. As of June 30, 2023, the Glick JV Notes bore interest at a rate of one-month LIBOR plus 4.50% per annum and will mature on October 20, 2028.

Below is certain summarized financial information for the Glick JV as of June 30, 2023 and September 30, 2022 and for the three and nine months ended June 30, 2023 and June 30, 2022:

	June 30, 2023		September 30, 2022
Selected Balance Sheet Information:
Investments at fair value (cost June 30, 2023: $120,172; September 30, 2022: $140,083)	$	113,833	$	133,144
Cash and cash equivalents	8,895		7,021
Restricted cash	1,812		1,788
Other assets	2,284		4,855
Total assets	$	126,824	$	146,808
Senior credit facility payable	$	66,082	$	82,082
Glick JV Notes payable at fair value (proceeds June 30, 2023: $66,684; September 30, 2022: $68,185)	56,723		57,463
Other liabilities	4,019		7,263
Total liabilities	$	126,824	$	146,808
Members' equity	—		—
Total liabilities and members' equity	$	126,824	$	146,808

	For the three months ended June 30, 2023		For the three months ended June 30, 2022		For the nine months ended June 30, 2023		For the nine months ended June 30, 2022
Selected Statements of Operations Information:
Interest income	$	3,576	$	2,416	$	10,488	$	6,796
Fee income	—		47		35		82
Total investment income	3,576		2,463		10,523		6,878
Senior credit facility interest expense	1,400		694		4,002		1,742
Glick JV Notes interest expense	1,577		860		4,394		2,479
Other expenses	70		59		148		127
Total expenses (1)	3,047		1,613		8,544		4,348
Net investment income	529		850		1,979		2,530
Net unrealized appreciation (depreciation)	431		(753)		(159)		(2,549)
Realized gain (loss)	(960)		(97)		(1,820)		19
Net income (loss)	$	—	$	—	$	—	$	—

__________

(1) There are no management fees or incentive fees charged at the Glick JV.

The Glick JV has elected to fair value the Glick JV Notes issued to the Company and GF Debt Funding under ASC 825. The Glick JV Notes are valued based on the total assets less the liabilities senior to the Glick JV Notes in an amount not exceeding par under the EV technique.

During the three and nine months ended June 30, 2023 and 2022, the Company did not sell any debt investments to the Glick JV.

XML

Fee Income	9 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Fee Income	Fee IncomeFor the three and nine months ended June 30, 2023, the Company recorded total fee income of $1.6 million and $6.0 million, respectively, of which $0.2 million and $0.8 million, respectively, was recurring in nature. For the three and nine months ended June 30, 2022, the Company recorded total fee income of $2.3 million and $5.1 million, respectively, of which $0.2 million and $0.7 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees and certain exit fees.

XML

Share Data and Net Assets

9 Months Ended

Jun. 30, 2023

Stockholders' Equity Note [Abstract]

Share Data and Net Assets

Share Data and Net Assets

The share and per share information for periods prior to March 31, 2023 disclosed in Note 5 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the three and nine months ended June 30, 2023 and 2022:

(Share amounts in thousands)	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations	$	36,685	$	(37,834)	$	71,379	$	16,015
Weighted average common shares outstanding — basic and diluted	77,080		61,123		70,431		60,593
Earnings (loss) per common share — basic and diluted	$	0.48	$	(0.62)	$	1.01	$	0.26

Changes in Net Assets

The following table presents the changes in net assets for the three and nine months ended June 30, 2023:

	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2022	61,125	$	611	$	1,827,721	$	(582,769)	$	1,245,563
Net investment income	—	—		—		38,808		38,808
Net unrealized appreciation (depreciation)	—	—		—		(22,982)		(22,982)
Net realized gains (losses)	—	—		—		(3,203)		(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		549		549
Distributions to stockholders	—	—		—		(58,679)		(58,679)
Issuance of common stock under dividend reinvestment plan	95	1		1,932		—		1,933
Balance as of December 31, 2022	61,220	$	612	$	1,829,653	$	(628,276)	$	1,201,989
Net investment income	—	—		—		45,978		45,978
Net unrealized appreciation (depreciation)	—	—		—		(18,279)		(18,279)
Net realized gains (losses)	—	—		—		(6,111)		(6,111)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(66)		(66)
Distributions to stockholders	—	—		—		(42,395)		(42,395)
Issuance of common stock in connection with the OSI2 Merger	15,860	159		333,875		—		334,034
Issuance of common stock under dividend reinvestment plan	68	1		1,294		—		1,295
Repurchase of common stock under dividend reinvestment plan	(68)	(1)		(1,294)		—		(1,295)
Balance as of March 31, 2023	77,080	$	771	$	2,163,528	$	(649,149)	$	1,515,150
Net investment income	—	—		—		48,413		48,413
Net unrealized appreciation (depreciation)	—	—		—		(1,039)		(1,039)
Net realized gains (losses)	—	—		—		(10,603)		(10,603)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(86)		(86)
Distributions to stockholders	—	—		—		(42,394)		(42,394)
Issuance of common stock under dividend reinvestment plan	57	1		1,122		—		1,123
Repurchase of common stock under dividend reinvestment plan	(57)	(1)		(1,122)		—		(1,123)
Balance as of June 30, 2023	77,080	$	771	$	2,163,528	$	(654,858)	$	1,509,441

The following table presents the changes in net assets for the three and nine months ended June 30, 2022:

	Common Stock
	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2021	60,120	$	601	$	1,805,557	$	(493,335)	$	1,312,823
Net investment income	—	—		—		32,295		32,295
Net unrealized appreciation (depreciation)	—	—		—		(4,586)		(4,586)
Net realized gains (losses)	—	—		—		9,321		9,321
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		2,378		2,378
Distributions to stockholders	—	—		—		(27,956)		(27,956)
Issuance of common stock under dividend reinvestment plan	36	1		785		—		786
Balance as of December 31, 2021	60,156	$	602	$	1,806,342	$	(481,883)	$	1,325,061
Net investment income	—	—		—		40,098		40,098
Net unrealized appreciation (depreciation)	—	—		—		(27,038)		(27,038)
Net realized gains (losses)	—	—		—		1,402		1,402
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(21)		(21)
Distributions to stockholders	—	—		—		(29,271)		(29,271)
Issuance of common stock in connection with the "at the market" offering	877	9		19,370		—		19,379
Issuance of common stock under dividend reinvestment plan	35	—		766		—		766
Balance as of March 31, 2022	61,068	$	611	$	1,826,478	$	(496,713)	$	1,330,376
Net investment income	—	—		—		40,370		40,370
Net unrealized appreciation (depreciation)	—	—		—		(86,755)		(86,755)
Net realized gains (losses)	—	—		—		9,212		9,212
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(661)		(661)
Distributions to stockholders	—	—		—		(30,256)		(30,256)
Issuance of common stock in connection with the "at the market" offering	57	—		1,243		—		1,243
Issuance of common stock under dividend reinvestment plan	44	1		873		—		874
Repurchases of common stock under dividend reinvestment plan	(44)	(1)		(873)		—		(874)
Balance as of June 30, 2022	61,125	$	611	$	1,827,721	$	(564,803)	$	1,263,529

Distributions

Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment.

The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP.

For income tax purposes, the Company has reported its distributions for the 2022 calendar year as ordinary income. The character of such distributions was appropriately reported to the Internal Revenue Service and stockholders for the 2022 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders.

The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the nine months ended June 30, 2023 and 2022:

Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution (3)			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	November 10, 2022	December 15, 2022	December 30, 2022	$	0.54	$	32.0	million	53,369	(1)	$	1.1	million
Special	November 10, 2022	December 15, 2022	December 30, 2022	0.42		24.8		million	41,510	(1)	0.8		million
Quarterly	January 27, 2023	March 15, 2023	March 31, 2023	0.55		41.1		million	68,412	(2)	1.3		million
Quarterly	April 28, 2023	June 15, 2023	June 30, 2023	0.55		41.3		million	57,279	(2)	1.1		million
Total for the nine months ended June 30, 2023				$	2.06	$	139.1	million	220,570		$	4.4	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	October 13, 2021	December 15, 2021	December 31, 2021	$	0.465	$	27.2	million	35,990	(1)	$	0.8	million
Quarterly	January 28, 2022	March 15, 2022	March 31, 2022	0.48		28.5 million			34,804	(1)	0.8 million
Quarterly	April 29, 2022	June 15, 2022	June 30, 2022	0.495		29.4 million			43,676	(2)	0.9 million
Total for the nine months ended June 30, 2022				$	1.44	$	85.1	million	114,470		$	2.4	million

 __________

(1) New shares were issued and distributed.

(2) Shares were purchased on the open market and distributed.

(3) Totals may not sum due to rounding.

Common Stock Issuances

On January 23, 2023, in connection with the OSI2 Merger, the Company issued an aggregate of 15,860,200 shares of common stock to former OSI2 stockholders. During the three and nine months ended June 30, 2023, the Company issued zero and 94,879 shares of common stock, respectively, as part of the DRIP. During the three and nine months ended June 30, 2022, the Company issued an aggregate of zero and 70,794 shares of common stock, respectively, as part of the DRIP.

On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of the Company’s common stock having an aggregate offering price of up to $125 million under the Company’s current registration statement. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.

In connection with the "at the market" offering, the Company did not issue or sell any shares of common stock during the nine months ended June 30, 2023. In connection with the "at the market" offering, the Company issued and sold 2,801,206 shares of common stock during the nine months ended June 30, 2022 for net proceeds of $20.6 million (net of offering costs).

XML

Borrowings

9 Months Ended

Jun. 30, 2023

Debt Disclosure [Abstract]

Borrowings

Borrowings

Syndicated Facility

On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans,

mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.

As of June 30, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.

As of June 30, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.

The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of June 30, 2023, except for assets that were held by OSI 2 Senior Lending SPV, LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility.

The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of June 30, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.

As of June 30, 2023 and September 30, 2022, the Company had $800.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $800.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 6.584% and 2.406% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $14.3 million and $37.4 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $4.8 million and $12.6 million, respectively, related to the Syndicated Facility.

Citibank Facility

On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. In connection with the termination of the Citibank Facility, the Company accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023.

As of September 30, 2022, the Company had $160.0 million outstanding under the Citibank Facility, which had a fair value of $160.0 million. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.762% and 2.563% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $2.4 million and $8.0 million, respectively, related

to the Citibank Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $1.6 million and $3.5 million, respectively, related to the Citibank Facility.

OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

As of June 30, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

As of June 30, 2023, the Company had $335.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $335.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.275% for the period from January 23, 2023 to June 30, 2023. For the three months ended June 30, 2023 and the period from January 23, 2023 to June 30, 2023, the Company recorded interest expense (inclusive of fees) of $4.9 million and $8.0 million, respectively, related to the OSI2 Citibank Facility.

2025 Notes

On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.

The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2025 Notes in the open market.

The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.

2027 Notes

On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.

The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2027 Notes in the open market.

The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.

In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.

The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of June 30, 2023 and September 30, 2022:

	As of June 30, 2023				As of September 30, 2022
($ in millions)	2025 Notes		2027 Notes		2025 Notes		2027 Notes
Principal	$	300.0	$	350.0	$	300.0	$	350.0
Unamortized financing costs	(1.2)		(2.7)		(1.8)		(3.2)
Unaccreted discount	(0.8)		(0.6)		(1.2)		(0.7)
Interest rate swap fair value adjustment	—		(39.6)		—		(42.0)
Net carrying value	$	298.0	$	307.1	$	297.0	$	304.1
Fair Value	$	285.7	$	302.3	$	283.1	$	294.0

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2023:

($ in millions)	2025 Notes						2027 Notes
	Three months ended June 30, 2023			Nine months ended June 30, 2023			Three months ended June 30, 2023			Nine months ended June 30, 2023
Coupon interest	$	2.6		$	7.9		$	2.4		$	7.1
Amortization of financing costs and discount	0.3			0.9			0.2			0.7
Effect of interest rate swap	—			—			3.7			9.4
Total interest expense	$	2.9		$	8.8		$	6.3		$	17.2
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	3.500		%	3.500		%	6.912		%	6.274		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2022:

($ in millions)	2025 Notes						2027 Notes
	Three months ended June 30, 2022			Nine months ended June 30, 2022			Three months ended June 30, 2022			Nine months ended June 30, 2022
Coupon interest	$	2.6		$	7.9		$	2.4		$	7.1
Amortization of financing costs and discount	0.3			0.9			0.2			0.7
Effect of interest rate swap	—			—			(0.1)			(1.6)
Total interest expense	$	2.9		$	8.8		$	2.5		$	6.2
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	3.500		%	3.500		%	2.572		%	2.069		%

XML

Taxable/Distributable Income and Dividend Distributions

9 Months Ended

Jun. 30, 2023

Income Tax Disclosure [Abstract]

Taxable/Distributable Income and Dividend Distributions

Taxable/Distributable Income and Dividend Distributions

Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans.

As of September 30, 2022, the Company had net capital loss carryforwards of $523.7 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $64.5 million are available to offset future short-term capital gains and $459.2 million are available to offset future long-term capital gains. A portion of such net capital loss carryfowards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations.

Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three and nine months ended June 30, 2023 and 2022.

	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Net increase (decrease) in net assets resulting from operations	$	36,685	$	(37,834)	$	71,379	$	16,015
Net unrealized (appreciation) depreciation	1,039		86,755		42,300		118,379
Book/tax difference due to organizational costs	—		(21)		—		(65)
Book/tax difference due to capital losses utilized	12,118		(3,736)		20,380		(19,183)
Other book/tax differences	(3,825)		(8,819)		(14,912)		(18,597)
Taxable/Distributable Income (1)	$	46,017	$	36,345	$	119,147	$	96,549

 __________

(1) The Company's taxable income for the three and nine months ended June 30, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2023. Therefore, the final taxable income may be different than the estimate.

The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.

When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of June 30, 2023, $6.1 million of the $8.8 million deferred tax assets would not more likely than not be realized in future periods. As of June 30, 2023, the Company recorded a net deferred tax asset of $2.7 million on the Consolidated Statements of Assets and Liabilities.

For the three months ended June 30, 2023, the Company recognized a total expense for income tax related to realized and unrealized gains (losses) of $0.1 million, which was composed of (i) a current income tax expense of approximately $1.0 million and (ii) a deferred income tax benefit of approximately $0.9 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries.

For the nine months ended June 30, 2023, the Company recognized a total benefit for income tax related to realized and unrealized gains (losses) of $0.4 million, which was composed of (i) a current income tax expense of approximately $0.6 million and (ii) a deferred income tax benefit of approximately $1.0 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries.

As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:

Undistributed ordinary income, net	$	(43,624)
Net realized capital losses	473,274
Unrealized losses, net	153,119
Accumulated overdistributed earnings	$	582,769

The aggregate cost of investments for U.S. federal income tax purposes was $2,654.3 million as of September 30, 2022. As of September 30, 2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $466.9 million. As of September 30, 2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was

$620.0 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $153.1 million.

XML

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation

9 Months Ended

Jun. 30, 2023

Investment Company [Abstract]

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation

Realized Gains or Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.

During the three months ended June 30, 2023, the Company recorded an aggregate net realized loss of $10.6 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	(6.3)
Aden & Anais Merger Sub Inc.	(5.2)
Radiology Partners Inc.	(3.8)
WP CPP Holdings LLC	(1.3)
Tersera Therapeutics LLC	5.2
Other, net	0.8
Total, net	$	(10.6)

During the three months ended June 30, 2022, the Company recorded an aggregate net realized gain of $9.2 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	8.8
Other, net	0.4
Total, net	$	9.2

During the nine months ended June 30, 2023, the Company recorded an aggregate net realized loss of $19.9 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	(5.5)
Aden & Anais Merger Sub Inc.	(5.2)
Radiology Partners Inc.	(4.2)
Carvana Co.	(2.8)
ASP Unifrax Holdings Inc.	(2.1)
WP CPP Holdings LLC	(1.3)
Global Medical Response Inc.	(1.0)
Tersera Therapeutics LLC	5.2
Other, net	(3.0)
Total, net	$	(19.9)

During the nine months ended June 30, 2022, the Company recorded an aggregate net realized gain of $19.9 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	12.2
OmniSYS Acquisition Corporation	2.2
First Star Speir Aviation Limited	1.9
TigerConnect Inc.	1.8
Other, net	1.8
Total, net	$	19.9

Net Unrealized Appreciation or Depreciation

Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation.

During the three months ended June 30, 2023 and 2022, the Company recorded net unrealized depreciation of $1.0 million and $86.8 million, respectively. For the three months ended June 30, 2023, this consisted of $9.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation on equity investments, partially offset by $5.0 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $4.6 million of net unrealized appreciation of foreign currency forward contracts. For the three months ended June 30, 2022, this consisted of $66.8 million of net unrealized depreciation on debt investments, $17.9 million of net unrealized depreciation on equity investments, $1.6 million of net unrealized depreciation of foreign currency forward contracts and $0.4 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains).

During the nine months ended June 30, 2023 and 2022, the Company recorded net unrealized depreciation of $42.3 million and $118.4 million, respectively. For the nine months ended June 30, 2023, this consisted of $54.3 million of net unrealized depreciation on debt investments and $4.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $11.8 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $5.1 million of net unrealized appreciation on equity investments. For the nine months ended June 30, 2022, this consisted of $84.6 million of net unrealized depreciation on debt investments, $23.8 million of net unrealized depreciation on equity investments, $9.2 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains) and $0.8 million of net unrealized depreciation of foreign currency forward contracts.

During the nine months ended June 30, 2023, unrealized depreciation included a one-time unrealized loss of $20.7 million that resulted solely from accounting adjustments related to the OSI2 Merger.

XML

Concentration of Credit Risk	9 Months Ended
	Jun. 30, 2023
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	Concentration of Credit Risks The Company deposits its cash with financial institutions and at times such balances are in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

XML

Related Party Transactions

9 Months Ended

Jun. 30, 2023

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

As of June 30, 2023 and September 30, 2022, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $20.1 million and $15.9 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree.

Investment Advisory Agreement

The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a

base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company.

From October 17, 2017 through May 3, 2020, the Company was externally managed by OCM pursuant to an investment advisory agreement. On May 4, 2020, OCM effected the novation of such investment advisory agreement to Oaktree. Immediately following such novation, the Company and Oaktree entered into a new investment advisory agreement with the same terms, including fee structure, as the investment advisory agreement with OCM. The investment advisory agreement with Oaktree was subsequently amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the closing of OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree and, prior to its novation, with OCM.

Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company.

Base Management Fee

Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger.

For the three and nine months ended June 30, 2023, the base management fee incurred under the Investment Advisory Agreement was $10.5 million (net of waiver) and $29.4 million (net of waiver), respectively. For the three and nine months ended June 30, 2022, the base management fee incurred under the Investment Advisory Agreement was $9.1 million (net of waiver) and $27.6 million (net of waiver), respectively.

Incentive Fee

The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature.

For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from

merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income.

Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows:

•No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets;

•100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and

•For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved.

There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle.

For the three and nine months ended June 30, 2023, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $9.6 million and $26.3 million, respectively. For the three and nine months ended June 30, 2022, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $6.5 million and $19.7 million, respectively.

Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of June 30, 2023, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of June 30, 2023 under the Investment Advisory Agreement, no Part II incentive fees would be payable.

GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital

gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three and nine months ended June 30, 2023, there were no accrued capital gains incentive fees. For the three and nine months ended June 30, 2022, $6.8 million and $8.8 million of accrued capital gains incentive fees were reversed, respectively. As of June 30, 2023, the total accrued capital gains incentive fee liability was zero.

Indemnification

The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser.

Administrative Services

The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation.

Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies.

For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities.

For the three months ended June 30, 2023 and 2022, the Company accrued administrative expenses of $0.4 million and $0.3 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively. For the nine months ended June 30, 2023 and 2022, the Company accrued administrative expenses of $1.2 million and $1.2 million, respectively, including $0.2 million and $0.2 million of general and administrative expenses, respectively.

As of June 30, 2023 and September 30, 2022, $7.7 million and $3.2 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.

XML

Financial Highlights

9 Months Ended

Jun. 30, 2023

Investment Company [Abstract]

Financial Highlights

Financial Highlights

(Share amounts in thousands)	Three months ended June 30, 2023	Three months ended June 30, 2022 (7)	Nine months ended June 30, 2023	Nine months ended June 30, 2022 (7)
Net asset value per share at beginning of period	$19.66	$21.79	$20.38	$21.84
Net investment income (1)	0.63	0.66	1.89	1.86
Net unrealized appreciation (depreciation) (1)(8)	(0.02)	(1.42)	(0.36)	(1.95)
Net realized gains (losses) (1)	(0.14)	0.15	(0.28)	0.33
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	(0.01)	0.01	0.03
Distributions of net investment income to stockholders	(0.55)	(0.50)	(2.06)	(1.44)
Net asset value per share at end of period	$19.58	$20.67	$19.58	$20.67
Per share market value at beginning of period	$18.77	$22.11	$18.00	$21.18
Per share market value at end of period	$19.43	$19.65	$19.43	19.65
Total return (2)	6.42%	(8.93)%	19.58%	(0.79)%
Common shares outstanding at beginning of period	77,080	61,068	61,125	60,120
Common shares outstanding at end of period	77,080	61,125	77,080	61,125
Net assets at beginning of period	$1,515,150	$1,330,376	$1,245,563	$1,312,823
Net assets at end of period	$1,509,441	$1,263,529	$1,509,441	$1,263,529
Average net assets (3)	$1,526,644	$1,306,727	$1,407,814	$1,323,232
Ratio of net investment income to average net assets (4)	12.72%	12.39%	12.65%	11.39%
Ratio of total expenses to average net assets (4)	14.45%	7.22%	14.07%	7.94%
Ratio of net expenses to average net assets (4)	14.05%	6.99%	13.69%	7.71%
Ratio of portfolio turnover to average investments at fair value	7.48%	4.73%	18.43%	21.44%
Weighted average outstanding debt (5)	$1,756,758	$1,369,615	$1,640,062	$1,358,150
Average debt per share (1)	$22.79	$22.41	$23.29	$22.41
Asset coverage ratio at end of period (6)	182.05%	187.82%	182.05%	187.82%

 __________

(1)	Calculated based upon weighted average shares outstanding for the period.
(2)	Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)	Calculated based upon the weighted average net assets for the period.
(4)	Interim periods are annualized.
(5)	Calculated based upon the weighted average of principal debt outstanding for the period.
(6)	Based on outstanding senior securities of $1,785.0 million and $1,395.0 million as of June 30, 2023 and 2022, respectively.
(7)	The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(8)	For the nine months ended June 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger.

XML

Derivative Instruments

9 Months Ended

Jun. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Derivative Instruments

The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of June 30, 2023, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.

In connection with the issuance of the 2027 Notes, the Company entered into an interest rate swap agreement with the Royal Bank of Canada pursuant to an ISDA Master Agreement. As of June 30, 2023, the Company paid $40.0 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreement, which is included in due from broker on the Consolidated Statement of Assets and Liabilities.

Certain information related to the Company’s foreign currency forward contracts is presented below as of June 30, 2023.

Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	78,866	€	71,658	8/10/2023	$	531	$	—	Derivative asset
Foreign currency forward contract	$	71,438	£	56,556	8/10/2023	$	—	$	482	Derivative asset
						$	531	$	482

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022.

Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	43,179	€	41,444	11/10/2022	$	2,466	$	—	Derivative asset
Foreign currency forward contract	$	45,692	£	37,033	11/10/2022	$	4,323	$	—	Derivative asset
						$	6,789	$	—

Certain information related to the Company’s interest rate swap is presented below as of June 30, 2023.

Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	39,567	Derivative liability
				$	—	$	39,567

Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022.

Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	41,969	Derivative liability
				$	—	$	41,969

XML

Commitments and Contingencies

9 Months Ended

Jun. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Off-Balance Sheet Arrangements

The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of June 30, 2023, the Company's only off-balance sheet arrangements consisted of $274.4 million of unfunded commitments, which was comprised of $247.3 million to provide debt and equity

financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, the Company's only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.

A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of June 30, 2023 and September 30, 2022 is shown in the table below:

	June 30, 2023		September 30, 2022
107-109 Beech OAK22 LLC	$	30,922	$	—
Fairbridge Strategic Capital Funding LLC	20,382		22,150
Delta Leasing SPV II LLC	18,822		27,187
BioXcel Therapeutics, Inc.	14,543		11,785
OCSI Glick JV LLC	13,998		13,998
Senior Loan Fund JV I, LLC	13,125		35,000
SiO2 Medical Products, Inc.	10,765		—
MND Holdings III Corp	8,470		—
Seres Therapeutics, Inc.	8,090		—
iCIMs, Inc.	7,704		6,930
Dominion Diagnostics, LLC	7,664		11,148
Marinus Pharmaceuticals, Inc.	7,139		5,734
Assembled Brands Capital LLC	7,062		2,008
Grove Hotel Parcel Owner, LLC	5,286		4,293
scPharmaceuticals Inc.	5,212		—
Innocoll Pharmaceuticals Limited	5,200		4,195
Avalara, Inc.	5,047		—
Mindbody, Inc.	4,762		4,000
Accupac, Inc.	4,500		4,605
Mesoblast, Inc.	4,405		3,553
107 Fair Street LLC	4,322		—
Harrow Health, Inc.	4,011		—
Inventus Power, Inc.	3,792		—
Establishment Labs Holdings Inc.	3,384		5,075
MRI Software LLC	3,302		5,196
OTG Management, LLC	3,190		3,789
PRGX Global, Inc.	3,127		2,518
Salus Workers' Compensation, LLC	3,102		—
ADC Therapeutics SA	3,020		3,020
Relativity ODA LLC	2,762		2,218
112-126 Van Houten Real22 LLC	2,703		—
LSL Holdco, LLC	2,650		427
Supreme Fitness Group NY Holdings, LLC	2,540		1,527
Pluralsight, LLC	2,395		3,532
SCP Eye Care Services, LLC	2,356		—
Spanx, LLC	2,185		2,226
Tahoe Bidco B.V.	2,162		1,741
Coupa Holdings, LLC	2,075		—
Galileo Parent, Inc.	2,061		—
Oranje Holdco, Inc.	1,904		—
Apptio, Inc.	1,885		1,338
Kings Buyer, LLC	1,771		1,537
MHE Intermediate Holdings, LLC	1,536		1,429
PPW Aero Buyer, Inc.	1,466		—
Liquid Environmental Solutions Corporation	1,383		1,115
Berner Food & Beverage, LLC	1,314		1,392
CorEvitas, LLC	1,251		915
Digital.AI Software Holdings, Inc.	1,156		826
Coyote Buyer, LLC	800		1,333
Telestream Holdings Corporation	678		528
Acquia Inc.	596		1,326
ASP-R-PAC Acquisition Co LLC	396		—
BAART Programs, Inc.	—		8,645
RumbleOn, Inc.	—		4,822
Ardonagh Midco 3 PLC	—		4,372
Dialyze Holdings, LLC	—		3,431
Thrasio, LLC	—		2,578
109 Montgomery Owner LLC	—		477
GKD Index Partners, LLC	—		320
Total	$	274,373	$	224,239

XML

Merger with OSI2

9 Months Ended

Jun. 30, 2023

Business Combination and Asset Acquisition [Abstract]

Merger with OSI2

Merger with OSI2

On January 23, 2023, the Company completed its previously announced acquisition of OSI2. The Company was the accounting survivor of the OSI2 Merger. In accordance with the terms of the OSI2 Merger Agreement, at the effective time of the OSI2 Merger, each outstanding share of OSI2 common stock was converted into the right to receive 0.9115 shares of the Company’s common stock (with OSI2’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Merger, the Company issued an aggregate of 15,860,200 shares of its common stock to former OSI2 stockholders.

The OSI2 Merger was accounted for as an asset acquisition in accordance with the asset acquisition method of accounting as detailed in ASC 805-50, Business Combinations—Related Issues (“ASC 805”). The Company determined the fair value of the shares of the Company’s common stock that were issued to former OSI2 stockholders pursuant to the OSI2 Merger Agreement plus transaction costs to be the consideration paid in connection with the OSI2 Merger under ASC 805. The consideration paid to OSI2 stockholders, as determined in accordance with ASC 805, was more than the aggregate fair values of the assets acquired and liabilities assumed, which resulted in a purchase premium (the “purchase premium”). The consideration paid was allocated to the individual assets acquired and liabilities assumed based on the relative fair values of net identifiable assets acquired other than “non-qualifying” assets (for example, cash). As a result, the purchase premium was allocated to the cost basis of the OSI2 investments acquired by the Company on a pro-rata basis based on their relative fair values as of the effective time of the OSI2 Merger. Immediately following the OSI2 Merger, the investments were marked to their respective fair values in accordance with ASC 820 which resulted in $20.7 million of unrealized depreciation in the Consolidated Statement of Operations as a result of the OSI2 Merger. The purchase premium allocated to the debt investments acquired will amortize over the life of each respective debt investment through interest income, with a corresponding adjustment recorded to unrealized depreciation on such investment acquired through its ultimate disposition. The purchase premium allocated to equity investments acquired will not amortize over the life of such investments through interest income and, assuming no subsequent change to the fair value of the equity investments acquired and disposition of such equity investments at fair value, the Company will recognize a realized loss with a corresponding reversal of the unrealized depreciation on disposition of such equity investments acquired. The OSI2 Merger was considered a tax-free reorganization, and the Company has elected to carry forward the historical cost basis of the acquired OSI2 investments for tax purposes.

The following table summarizes the allocation of the consideration paid to the assets acquired and liabilities assumed as a result of the OSI2 Merger:

Common stock issued by the Company (1)	$	334,034
Transaction costs	1,932
Consideration paid	$	335,966
Investments	$	592,809
Cash and cash equivalents	22,317
Other assets	6,679
Total assets acquired	621,805
Debt	225,000
Other liabilities	60,839
Total liabilities acquired	285,839
Total net assets acquired	$	335,966

__________

(1) Common stock issued by the Company includes $19 of cash paid in lieu of issuing fractional shares.

XML

Schedule 12-14

9 Months Ended

Jun. 30, 2023

Investments in and Advances to Affiliates [Abstract]

Schedule 12-14

Schedule 12-14

Oaktree Specialty Lending Corporation

Schedule of Investments in and Advances to Affiliates

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Nine months ended June 30, 2023

(unaudited)

Portfolio Company	Industry	Investment Type	Index	Spread		Cash		PIK Rate	Maturity Date	Shares		Principal		Net Realized Gain (Loss)		Amount of Interest, Fees or Dividends Credited in Income (2)		Fair Value at October 1, 2022		Gross Additions (3)		Gross Reductions (4)		Fair Value at June 30, 2023		% of Total Net Assets
Control Investments
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock								829		$	—	$	—	$	—	$	—	$	—	$	—	$	—	—	%
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity								34,984,460		—		—		—		27,638		—		—		27,638		1.8	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%	10.39	%		8/28/2025			14,102		—		1,070		14,333		—		(231)		14,102		0.9	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%				8/28/2025			—		—		—		—		—		—		—		—	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	SOFR+	5.00	%	10.24	%		8/28/2025			3,484		—		136		—		3,484		—		3,484		0.2	%
Dominion Diagnostics, LLC	Health Care Services	Common Stock								30,031		—		—		—		4,946		—		(2,235)		2,711		0.2	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Subordinated Debt	L+	4.50	%	9.36	%		10/20/2028			58,349		—		4,961		50,283		1,116		(1,767)		49,632		3.3	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		—		—		—		—		—		—	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Subordinated Debt	L+	7.00	%	11.86	%		12/29/2028			112,656		—		9,197		96,250		16,406		—		112,656		7.5	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		3,150		20,715		7,258		—		27,973		1.9	%
Total Control Investments												$	188,591	$	—	$	18,514	$	214,165	$	28,264	$	(4,233)	$	238,196	15.8	%
Affiliate Investments
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver	L+	6.75	%	12.29	%		10/17/2023			22,304		—		1,985		24,225		2,378		(4,417)		22,186		1.5	%
Assembled Brands Capital LLC	Specialized Finance	Common Stock								1,783,332		—		—		—		370		40		(410)		—		—	%
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity								1,129,453		—		—		—		1,223		189		—		1,412		0.1	%
Assembled Brands Capital LLC	Specialized Finance	Warrants								78,045		—		—		—		—		—		—		—		—	%
Caregiver Services, Inc.	Health Care Services	Preferred Equity								1,080,399		—		—		—		378		—		(65)		313		—	%
Total Affiliate Investments												$	22,304	$	—	$	1,985	$	26,196	$	2,607	$	(4,892)	$	23,911	1.6	%
Total Control & Affiliate Investments												$	210,895	$	—	$	20,499	$	240,361	$	30,871	$	(9,125)	$	262,107	17.4	%

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.

______________________

(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments.

(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.

(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.

(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.

(5)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).

(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).

Schedule 12-14

Oaktree Specialty Lending Corporation

Schedule of Investments in and Advances to Affiliates

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Nine months ended June 30, 2022

(unaudited)

Portfolio Company	Industry	Investment Type	Index	Spread		Cash		PIK Rate	Maturity Date	Shares		Principal		Net Realized Gain (Loss)		Amount of Interest, Fees or Dividends Credited in Income (2)		Fair Value at October 1, 2021		Gross Additions (3)		Gross Reductions (4)		Fair Value at June 30, 2022		% of Total Net Assets
Control Investments
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock								829		$	—	$	—	$	—	$	—	$	—	$	—	$	—	—	%
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity								34,984,460		—		—		—		27,638		—		—		27,638		2.2	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	L+	5.00	%	7.26	%		2/28/2024			16,074		—		1,078		27,381		—		(11,307)		16,074		1.3	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	L+	5.00	%				2/28/2024			—		—		42		—		—		—		—		—	%
Dominion Diagnostics, LLC	Health Care Services	Common Stock								30,031		—		—		3,308		18,065		—		(8,798)		9,267		0.7	%
First Star Speir Aviation Limited (5)	Airlines	First Lien Term Loan				9.00	%		12/15/2025			—		7,500		—		7,500		—		(7,500)		—		—	%
First Star Speir Aviation Limited (5)	Airlines	Membership Interest								100.00	%	—		(5,632)		158		698		—		(698)		—		—	%
OCSI Glick JV LLC (6)	Multi-Sector Holdings	Subordinated Debt	L+	4.50	%	4.94	%		10/20/2028			60,274		—		3,292		55,582		1,123		(6,099)		50,606		4.0	%
OCSI Glick JV LLC (6)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		—		—		—		—		—		—	%
Senior Loan Fund JV I, LLC (7)	Multi-Sector Holdings	Subordinated Debt	L+	7.00	%	8.00	%		12/29/2028			96,250		—		5,839		96,250		—		—		96,250		7.6	%
Senior Loan Fund JV I, LLC (7)	Multi-Sector Holdings	Membership Interest								87.50	%	—		—		2,026		37,651		—		(14,628)		23,023		1.8	%
Total Control Investments												$	172,598	$	1,868	$	15,743	$	270,765	$	1,123	$	(49,030)	$	222,858	17.6	%
Affiliate Investments
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver	L+	6.75	%	9.00	%		10/17/2023			21,754		—		1,185		15,712		11,585		(6,037)		21,260		1.7	%
Assembled Brands Capital LLC	Specialized Finance	Common Stock								1,609,201		—		—		—		587		—		(24)		563		—	%
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity								1,019,169		—		—		—		1,152		51		—		1,203		0.1	%
Assembled Brands Capital LLC	Specialized Finance	Warrants								70,425		—		—		—		—		—		—		—		—	%
Caregiver Services, Inc.	Health Care Services	Preferred Equity								1,080,399		—		—		—		838		—		(437)		401		—	%
Total Affiliate Investments												$	21,754	$	—	$	1,185	$	18,289	$	11,636	$	(6,498)	$	23,427	1.9	%
Total Control & Affiliate Investments												$	194,352	$	1,868	$	16,928	$	289,054	$	12,759	$	(55,528)	$	246,285	19.5	%

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.

______________________

(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2022.

(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.

(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.

(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.

(5)First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the

wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.

(6)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).

(7)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net increase (decrease) in net assets resulting from operations	$ 36,685	$ (37,834)	$ 71,379	$ 16,015

XML

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

N-2 - USD ($)
$ / shares in Units, $ in Millions

9 Months Ended

Jun. 30, 2023

Mar. 31, 2023

Sep. 30, 2022

Jun. 30, 2022

Mar. 31, 2022

Sep. 30, 2021

Cover [Abstract]

Entity Central Index Key

0001414932

Amendment Flag

false

Securities Act File Number

1-33901

Document Type

10-Q

Entity Registrant Name

Oaktree Specialty Lending Corporation

Entity Address, Address Line One

333 South Grand Avenue

Entity Address, Address Line Two

28th Floor

Entity Address, City or Town

Los Angeles

Entity Address, State or Province

CA

Entity Address, Postal Zip Code

90071

City Area Code

213

Local Phone Number

830-6300

Entity Emerging Growth Company

false

Financial Highlights [Abstract]

Senior Securities Amount

$ 1,785.0

$ 1,395.0

General Description of Registrant [Abstract]

Investment Objectives and Practices [Text Block]

Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.

In the current market environment, Oaktree intends to focus on the following area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, and (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital.

Oaktree intends to continue to rotate our portfolio into investments that are better aligned with Oaktree's overall approach to credit investing and that it believes have the potential to generate attractive returns across market cycles (which we call "core investments"). Oaktree has performed a comprehensive review of our portfolio and categorized our portfolio into core investments, non-core performing investments and underperforming investments. Certain additional information on such categorization and our portfolio composition is included in investor presentations that we file with the SEC. Since an Oaktree affiliate became our investment adviser in October 2017, Oaktree and its affiliates have reduced the investments identified as non-core by approximately $800 million at fair value. Over time, Oaktree intends to rotate us out of the remaining non-core investments, which were approximately $67 million at fair value as of June 30, 2023. Oaktree periodically reviews designations of investments as core and non-core and may change such designations over time.

NAV Per Share

$ 19.58

^[1]

$ 19.66

$ 20.38

$ 20.67

^[1]

$ 21.79

$ 21.84

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt [Table Text Block]

Syndicated Facility

On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans,

mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.

As of June 30, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.

As of June 30, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.

The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of June 30, 2023, except for assets that were held by OSI 2 Senior Lending SPV, LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility.

The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of June 30, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.

As of June 30, 2023 and September 30, 2022, the Company had $800.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $800.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 6.584% and 2.406% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $14.3 million and $37.4 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $4.8 million and $12.6 million, respectively, related to the Syndicated Facility.

Citibank Facility

On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. In connection with the termination of the Citibank Facility, the Company accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023.

As of September 30, 2022, the Company had $160.0 million outstanding under the Citibank Facility, which had a fair value of $160.0 million. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.762% and 2.563% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $2.4 million and $8.0 million, respectively, related

to the Citibank Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $1.6 million and $3.5 million, respectively, related to the Citibank Facility.

OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

As of June 30, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

As of June 30, 2023, the Company had $335.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $335.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.275% for the period from January 23, 2023 to June 30, 2023. For the three months ended June 30, 2023 and the period from January 23, 2023 to June 30, 2023, the Company recorded interest expense (inclusive of fees) of $4.9 million and $8.0 million, respectively, related to the OSI2 Citibank Facility.

2025 Notes

On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.

The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2025 Notes in the open market.

The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.

2027 Notes

On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.

The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2027 Notes in the open market.

The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.

In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.

2025 Notes [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt, Title [Text Block]

2025 Notes

Long Term Debt, Structuring [Text Block]

On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.

The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2025 Notes in the open market.

Long Term Debt, Dividends and Covenants [Text Block]

The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.

2027 Notes [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt, Title [Text Block]

2027 Notes

Long Term Debt, Structuring [Text Block]

On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.

The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2027 Notes in the open market.

Long Term Debt, Dividends and Covenants [Text Block]

The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.

Syndicated Facility [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt, Title [Text Block]

Syndicated Facility

Long Term Debt, Structuring [Text Block]

On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans,

mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.

As of June 30, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.

As of June 30, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.

The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of June 30, 2023, except for assets that were held by OSI 2 Senior Lending SPV, LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility.

Long Term Debt, Dividends and Covenants [Text Block]

The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of June 30, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.

Citibank Facility [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt, Title [Text Block]

Citibank Facility

Long Term Debt, Structuring [Text Block]

On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. In connection with the termination of the Citibank Facility, the Company accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023.

OSI2 Citibank Facility [Member]

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt, Title [Text Block]

OSI2 Citibank Facility

Long Term Debt, Structuring [Text Block]

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.As of June 30, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations).

Long Term Debt, Dividends and Covenants [Text Block]

As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

[1] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

XML

Significant Accounting Policies (Policies)

9 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation:

The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946").

Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for periods prior to March 31, 2023 reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Use of Estimates

Use of Estimates:

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.

Consolidation

Consolidation:

The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries.

As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value.

Fair Value Measurements

Fair Value Measurements:

The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity.

Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:

•Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

•Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.

•Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.

Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.

Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources.

If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of

equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.

In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.

Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.

Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022.

Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments:

•The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team;

•Preliminary valuations are then reviewed and discussed with management of Oaktree;

•Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree;

•Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee;

•The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and

•Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio.

The fair value of the Company's investments as of June 30, 2023 and September 30, 2022 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax asset, net," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable" and "payables from unsettled transactions" approximate fair value due to their short maturities.

Foreign Currency Translation

Foreign Currency Translation:

The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.

Derivative Instruments

Derivative Instruments:

Foreign Currency Forward Contracts

The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations.

Interest Rate Swaps

The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.

Investment Income

Investment Income:

Interest Income

Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of June 30, 2023,

there were five investments on non-accrual status that in aggregate represented 3.6% and 3.1% of total debt investments at cost and fair value, respectively. As of September 30, 2022, there were no investments on non-accrual status.

In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.

PIK Interest Income

The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so.

Fee Income

Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered.

Dividend Income

The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.

Cash and Cash Equivalents and Restricted Cash

Cash and Cash Equivalents and Restricted Cash:

Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.

Due From Portfolio Companies

Due from Portfolio Companies:

Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date).

Receivables/Payables from Unsettled Transactions

Receivables/Payables from Unsettled Transactions:

Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.

Deferred Financing Costs

Deferred Financing Costs:

Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.

Deferred Offering Costs

Deferred Offering Costs:

Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.

Income Taxes

Income Taxes:

The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar year 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2023.

The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.

FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

XML

Portfolio Investments (Tables)

9 Months Ended

Jun. 30, 2023

Schedule of Investments [Abstract]

Composition of Investments

Below is certain summarized financial information for SLF JV I as of June 30, 2023 and September 30, 2022 and for the three and nine months ended June 30, 2023 and 2022:

	June 30, 2023		September 30, 2022
Selected Balance Sheet Information:
Investments at fair value (cost June 30, 2023:$348,782; cost September 30, 2022: $382,673)	$	329,809	$	359,625
Cash and cash equivalents	21,906		14,274
Restricted cash	8,715		5,642
Other assets	9,798		5,686
Total assets	$	370,228	$	385,227
Senior credit facility payable	$	200,000	$	230,000
SLF JV I Notes payable at fair value (proceeds June 30, 2023: $128,750; proceeds September 30, 2022: $110,000)	128,750		110,000
Other liabilities	9,509		21,539
Total liabilities	$	338,259	$	361,539
Members' equity	31,969		23,688
Total liabilities and members' equity	$	370,228	$	385,227

	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Selected Statements of Operations Information:
Interest income	$	10,312	$	5,796	$	29,106	$	16,664
Other income	—		32		62		105
Total investment income	10,312		5,828		29,168		16,769
Senior credit facility interest expense	4,190		1,929		12,004		4,995
SLF JV I Notes interest expense	3,859		2,224		10,511		6,673
Other expenses	73		77		249		198
Total expenses (1)	8,122		4,230		22,764		11,866
Net investment income	2,190		1,598		6,404		4,903
Net unrealized appreciation (depreciation)	2,652		(16,411)		4,075		(19,856)
Net realized gains (losses)	(2,137)		165		(4,850)		568
Net income (loss)	$	2,705	$	(14,648)	$	5,629	$	(14,385)

 __________

(1) There are no management fees or incentive fees charged at SLF JV I.

Below is certain summarized financial information for the Glick JV as of June 30, 2023 and September 30, 2022 and for the three and nine months ended June 30, 2023 and June 30, 2022:

	June 30, 2023		September 30, 2022
Selected Balance Sheet Information:
Investments at fair value (cost June 30, 2023: $120,172; September 30, 2022: $140,083)	$	113,833	$	133,144
Cash and cash equivalents	8,895		7,021
Restricted cash	1,812		1,788
Other assets	2,284		4,855
Total assets	$	126,824	$	146,808
Senior credit facility payable	$	66,082	$	82,082
Glick JV Notes payable at fair value (proceeds June 30, 2023: $66,684; September 30, 2022: $68,185)	56,723		57,463
Other liabilities	4,019		7,263
Total liabilities	$	126,824	$	146,808
Members' equity	—		—
Total liabilities and members' equity	$	126,824	$	146,808

	For the three months ended June 30, 2023		For the three months ended June 30, 2022		For the nine months ended June 30, 2023		For the nine months ended June 30, 2022
Selected Statements of Operations Information:
Interest income	$	3,576	$	2,416	$	10,488	$	6,796
Fee income	—		47		35		82
Total investment income	3,576		2,463		10,523		6,878
Senior credit facility interest expense	1,400		694		4,002		1,742
Glick JV Notes interest expense	1,577		860		4,394		2,479
Other expenses	70		59		148		127
Total expenses (1)	3,047		1,613		8,544		4,348
Net investment income	529		850		1,979		2,530
Net unrealized appreciation (depreciation)	431		(753)		(159)		(2,549)
Realized gain (loss)	(960)		(97)		(1,820)		19
Net income (loss)	$	—	$	—	$	—	$	—

__________

(1) There are no management fees or incentive fees charged at the Glick JV.

The Glick JV has elected to fair value the Glick JV Notes issued to the Company and GF Debt Funding under ASC 825. The Glick JV Notes are valued based on the total assets less the liabilities senior to the Glick JV Notes in an amount not exceeding par under the EV technique.

During the three and nine months ended June 30, 2023 and 2022, the Company did not sell any debt investments to the Glick JV.

Investment Holdings, Schedule of Investments

The composition of the Company's investments as of June 30, 2023 and September 30, 2022 at cost and fair value was as follows:

	June 30, 2023				September 30, 2022
	Cost		Fair Value		Cost		Fair Value
Investments in debt securities	$	2,942,222	$	2,826,369	$	2,294,392	$	2,223,329
Investments in equity securities	136,619		118,989		127,596		103,534
Debt investments in the JVs	162,653		162,288		146,444		146,533
Equity investments in the JVs	54,791		27,973		49,322		20,715
Total	$	3,296,285	$	3,135,619	$	2,617,754	$	2,494,111

The following table presents the composition of the Company's debt investments as of June 30, 2023 and September 30, 2022 at fixed rates and floating rates:

	June 30, 2023				September 30, 2022
	Fair Value		% of Debt Portfolio		Fair Value		% of Debt Portfolio
Floating rate debt securities, including the debt investments in the JVs	$	2,571,458	86.04	%	$	2,049,644	86.49	%
Fixed rate debt securities	417,199		13.96		320,218		13.51
Total	$	2,988,657	100.00	%	$	2,369,862	100.00	%

The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of June 30, 2023 and September 30, 2022:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Application Software	$	560,503	16.98	%	$	391,938	14.98	%
Multi-Sector Holdings (1)	219,130		6.65		195,766		7.48
Data Processing & Outsourced Services	133,422		4.05		120,477		4.60
Health Care Technology	129,178		3.92		100,084		3.82
Biotechnology	127,394		3.86		109,960		4.20
Pharmaceuticals	121,497		3.69		126,508		4.83
Aerospace & Defense	110,680		3.36		61,963		2.37
Industrial Machinery & Supplies & Components	99,237		3.01		—		—
Broadline Retail	83,201		2.52		—		—
Health Care Services	77,364		2.35		58,674		2.24
Real Estate Operating Companies	76,462		2.32		47,585		1.82
Specialized Finance	69,188		2.10		80,864		3.09
Personal Care Products	68,671		2.08		—		—
Automotive Retail	64,825		1.97		59,254		2.26
Fertilizers & Agricultural Chemicals	64,750		1.96		49,301		1.88
Internet Services & Infrastructure	63,057		1.91		54,095		2.07
Health Care Distributors	62,079		1.88		57,112		2.18
Diversified Financial Services	61,693		1.87		—		—
Auto Parts & Equipment	61,091		1.85		12,474		0.48
Metal, Glass & Plastic Containers	57,949		1.76		—		—
Airport Services	55,919		1.70		43,322		1.65
Home Improvement Retail	54,939		1.67		45,802		1.75
Insurance Brokers	52,960		1.61		35,628		1.36
Diversified Metals & Mining	49,787		1.51		—		—
Leisure Facilities	49,501		1.50		39,768		1.52
Real Estate Services	44,783		1.36		40,243		1.54
Soft Drinks & Non-alcoholic Beverages	43,021		1.31		—		—
Diversified Support Services	42,706		1.30		37,992		1.45
Other Specialty Retail	41,790		1.27		—		—
Specialty Chemicals	38,248		1.16		37,319		1.43
Distributors	37,668		1.14		25,278		0.97
Integrated Telecommunication Services	33,663		1.02		34,628		1.32
Electrical Components & Equipment	32,380		0.98		33,814		1.29
Construction & Engineering	27,231		0.83		60,996		2.33
Environmental & Facilities Services	25,943		0.79		20,857		0.80
Advertising	25,597		0.78		28,245		1.08
Passenger Airlines	24,888		0.76		—		—
Oil & Gas Storage & Transportation	24,231		0.74		22,290		0.85
Home Furnishings	23,832		0.72		19,550		0.75
Gold	23,274		0.71		—		—
Systems Software	23,089		0.70		14,890		0.57
Health Care Equipment	22,374		0.68		24,353		0.93
Real Estate Development	19,567		0.59		—		—
Interactive Media & Services	18,963		0.58		—		—
Hotels, Resorts & Cruise Lines	17,221		0.52		13,960		0.53
Consumer Finance	16,411		0.50		14,492		0.55
Education Services	15,660		0.48		9,080		0.35
IT Consulting & Other Services	15,434		0.47		11,697		0.45
Restaurants	12,589		0.38		9,338		0.36
Movies & Entertainment	12,188		0.37		26,161		1.00
Health Care Supplies	11,675		0.35		36,471		1.39
Food Distributors	5,900		0.18		4,646		0.18
Apparel Retail	5,293		0.16		5,268		0.20
Air Freight & Logistics	4,925		0.15		7,295		0.28
Integrated Oil & Gas	4,887		0.15		4,866		0.19
Research & Consulting Services	4,879		0.15		9,187		0.35
Cable & Satellite	4,687		0.14		20,716		0.79
Other Specialized REITs	4,364		0.13		—		—
Paper & Plastic Packaging Products & Materials	3,262		0.10		—		—
Housewares & Specialties	2,908		0.09		2,293		0.09
Electronic Components	2,101		0.06		2,092		0.08
Leisure Products	2,039		0.06		—		—
Technology Distributors	1,084		0.03		3,163		0.12
Communications Equipment	1,053		0.03		—		—
Industrial Machinery	—		—		81,787		3.12
Internet & Direct Marketing Retail	—		—		67,926		2.59
Personal Products	—		—		53,214		2.03
Metal & Glass Containers	—		—		47,704		1.82
Soft Drinks	—		—		34,272		1.31
Other Diversified Financial Services	—		—		29,300		1.12
Oil & Gas Refining & Marketing	—		—		8,627		0.33
Trading Companies & Distributors	—		—		7,628		0.29
Apparel, Accessories & Luxury Goods	—		—		5,165		0.20
Specialized REITs	—		—		4,318		0.16
Diversified Banks	—		—		3,515		0.13
Construction Materials	—		—		2,331		0.09
Alternative Carriers	—		—		212		0.01
	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Application Software	$	544,685	17.38	%	36.03	%	$	384,589	15.43	%	30.87	%
Multi-Sector Holdings (1)	192,160		6.13		12.73		167,248		6.71		13.43
Biotechnology	128,343		4.09		8.50		108,465		4.35		8.71
Data Processing & Outsourced Services	124,548		3.97		8.25		111,335		4.46		8.94
Pharmaceuticals	116,199		3.71		7.70		119,511		4.79		9.59
Health Care Technology	115,659		3.69		7.66		97,315		3.90		7.81
Aerospace & Defense	111,464		3.55		7.38		61,881		2.48		4.97
Industrial Machinery & Supplies & Components	99,021		3.16		6.56		—		—		—
Broadline Retail	80,882		2.58		5.36		—		—		—
Real Estate Operating Companies	75,111		2.40		4.98		48,062		1.93		3.86
Specialized Finance	66,333		2.12		4.39		73,087		2.93		5.87
Fertilizers & Agricultural Chemicals	63,185		2.02		4.19		51,972		2.08		4.17
Internet Services & Infrastructure	62,726		2.00		4.16		53,797		2.16		4.32
Automotive Retail	62,356		1.99		4.13		57,629		2.31		4.63
Health Care Services	62,190		1.98		4.12		45,943		1.84		3.69
Diversified Financial Services	61,073		1.95		4.05		—		—		—
Personal Care Products	60,962		1.94		4.04		—		—		—
Auto Parts & Equipment	60,809		1.94		4.03		11,469		0.46		0.92
Health Care Distributors	60,340		1.92		4.00		54,662		2.19		4.39
Airport Services	55,221		1.76		3.66		42,883		1.72		3.44
Insurance Brokers	54,680		1.74		3.62		33,081		1.33		2.66
Home Improvement Retail	54,235		1.73		3.59		45,421		1.82		3.65
Diversified Metals & Mining	49,809		1.59		3.30		—		—		—
Leisure Facilities	46,990		1.50		3.11		39,258		1.57		3.15
Real Estate Services	44,227		1.41		2.93		39,573		1.59		3.18
Metal, Glass & Plastic Containers	43,954		1.40		2.91		—		—		—
Soft Drinks & Non-alcoholic Beverages	42,798		1.36		2.84		—		—		—
Other Specialty Retail	41,790		1.33		2.77		—		—		—
Diversified Support Services	41,302		1.32		2.74		36,712		1.47		2.95
Distributors	36,829		1.17		2.44		24,494		0.98		1.97
Electrical Components & Equipment	32,379		1.03		2.15		32,933		1.32		2.64
Specialty Chemicals	32,231		1.03		2.14		33,969		1.36		2.73
Integrated Telecommunication Services	30,922		0.99		2.05		32,201		1.29		2.59
Passenger Airlines	26,985		0.86		1.79		—		—		—
Construction & Engineering	26,901		0.86		1.78		61,188		2.45		4.91
Environmental & Facilities Services	25,436		0.81		1.69		20,585		0.83		1.65
Gold	23,292		0.74		1.54		—		—		—
Health Care Equipment	22,531		0.72		1.49		24,161		0.97		1.94
Systems Software	22,168		0.71		1.47		12,834		0.51		1.03
Oil & Gas Storage & Transportation	21,660		0.69		1.43		20,853		0.84		1.67
Home Furnishings	19,514		0.62		1.29		18,188		0.73		1.46
Real Estate Development	19,246		0.61		1.28		—		—		—
Interactive Media & Services	19,000		0.61		1.26		—		—		—
Advertising	18,969		0.60		1.26		26,948		1.08		2.16
Hotels, Resorts & Cruise Lines	17,261		0.55		1.14		13,985		0.56		1.12
Education Services	14,116		0.45		0.94		8,582		0.34		0.69
Consumer Finance	12,616		0.40		0.84		13,284		0.53		1.07
Restaurants	12,168		0.39		0.81		8,692		0.35		0.70
Movies & Entertainment	11,865		0.38		0.79		26,645		1.07		2.14
Health Care Supplies	11,408		0.36		0.76		36,577		1.47		2.94
IT Consulting & Other Services	11,176		0.36		0.74		8,596		0.34		0.69
Food Distributors	5,296		0.17		0.35		3,367		0.13		0.27
Apparel Retail	5,230		0.17		0.35		5,223		0.21		0.42
Integrated Oil & Gas	4,810		0.15		0.32		4,872		0.20		0.39
Cable & Satellite	4,672		0.15		0.31		19,576		0.78		1.57
Research & Consulting Services	4,632		0.15		0.31		8,573		0.34		0.69
Air Freight & Logistics	4,025		0.13		0.27		6,405		0.26		0.51
Other Specialized REITs	3,438		0.11		0.23		—		—		—
Paper & Plastic Packaging Products & Materials	3,100		0.10		0.21		—		—		—
Housewares & Specialties	2,858		0.09		0.19		2,456		0.10		0.20
Leisure Products	1,995		0.06		0.13		—		—		—
Electronic Components	1,834		0.06		0.12		1,890		0.08		0.15
Technology Distributors	1,024		0.03		0.07		2,997		0.12		0.24
Communications Equipment	980		0.03		0.06		—		—		—
Industrial Machinery	—		—		—		81,008		3.25		6.50
Internet & Direct Marketing Retail	—		—		—		70,419		2.82		5.65
Personal Products	—		—		—		50,150		2.01		4.03
Metal & Glass Containers	—		—		—		47,599		1.91		3.82
Soft Drinks	—		—		—		33,670		1.35		2.70
Other Diversified Financial Services	—		—		—		24,326		0.98		1.95

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Oil & Gas Refining & Marketing	$	—	—		—		$	8,604	0.34		0.69
Trading Companies & Distributors	—		—		—		5,567		0.22		0.45
Diversified Banks	—		—		—		3,402		0.14		0.27
Specialized REITs	—		—		—		3,264		0.13		0.26
Construction Materials	—		—		—		1,934		0.08		0.16
Alternative Carriers	—		—		—		201		0.01		0.02
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

SLF JV I Portfolio as of June 30, 2023

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	L+	3.75%	8.94%		2/27/2025		$	5,596	$	5,559	$	5,545
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025		6,911		6,832		6,784		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025		1,173		1,158		1,152		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	9.32%		8/14/2026		2,977		2,850		2,808
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.89%		6/30/2025		8,916		8,845		8,514		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.22%		6/9/2028		4,970		4,734		4,692
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.49%		10/20/2028		4,836		4,775		4,219		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.00%	9.39%		11/26/2026		7,740		7,663		7,721
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.25%		8/11/2025		1,527		1,194		1,179		(4)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	5.00%	10.20%		1/10/2025		4,615		4,592		4,615		(4)
Apptio, Inc.	Application Software	First Lien Revolver	L+	5.00%	10.20%		1/10/2025		115		113		115		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.31%		12/29/2027		4,145		4,083		3,938		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027		—		(7)		(25)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	10.44%		10/25/2028		5,052		4,880		3,560		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.20%		8/19/2028		4,963		4,749		4,710
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.47%		8/19/2028		1,995		1,883		1,902
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.47%		1/20/2029		4,346		4,022		3,657
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%	8.59%		2/15/2029		4,331		4,079		4,179
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%			2/15/2029		—		(32)		(19)		(5)
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	11.27%		12/24/2026		6,289		6,211		6,031		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027		6,322		6,263		6,158		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027		1,759		1,748		1,713		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		1,965		1,938		1,930
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		2,366		2,332		2,324
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.44%		8/10/2027		1,988		1,957		1,952
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.38%		8/10/2027		200		192		189		(5)
Convergeone Holdings, Inc.	IT Consulting & Other Services	First Lien Term Loan	L+	5.00%	10.37%		1/4/2026		7,315		7,188		4,670		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.24%		10/13/2029		6,359		5,983		5,937		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	9.54%		7/9/2026		7,760		7,689		7,730
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.25%	9.79%		12/2/2027		992		974		987
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.22%		8/2/2027		5,958		5,869		5,838		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.80%		4/26/2029		7,940		7,807		7,411		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.25%		8/11/2028		7,388		7,314		5,984		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.45%		4/9/2029		7,940		7,742		6,818		(4)

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.75%		6/30/2026		$	7,350	$	7,260	$	7,359
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	L+	5.75%	11.29%		3/25/2027		9,125		8,950		7,239		(4)
Iris Holding, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.75%	9.90%		6/28/2028		4,963		4,638		4,226
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	10.20%		10/29/2028		3,972		3,817		3,940
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.08%		10/14/2027		7,388		7,281		7,267
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	10.50%		5/9/2026		11,279		11,121		10,997		(4)
LogMeIn, Inc.	Application Software	First Lien Term Loan	L+	4.75%	9.94%		8/31/2027		7,800		7,705		4,918
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	3.50%	8.72%		9/6/2025		7,308		7,246		7,037
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.01%		3/1/2029		5,955		5,655		5,713
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	12.19%		2/14/2025		4,669		4,644		4,599		(4)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	L+	8.00%			2/14/2025		—		(3)		(7)		(4)(5)
Mitchell International Inc	Application Software	First Lien Term Loan	L+	3.75%	8.94%		10/15/2028		2,991		2,845		2,931
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026		8,340		8,172		8,111		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026		—		(3)		(9)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026		2,217		2,216		2,156		(4)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.50%	10.00%		3/31/2025		6,633		6,624		6,583
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	9.25%		9/25/2026		11,015		10,845		10,852
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	10.20%		11/10/2027		9,849		9,495		9,603		(4)
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.50%		12/17/2027		2,422		2,297		2,305
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.59%		12/18/2028		4,503		4,435		4,023		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.04%		4/6/2027		8,116		7,831		7,815		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.04%		4/6/2027		254		236		235		(4)(5)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.75%	9.99%		4/5/2030		5,000		4,855		4,948
RevSpring, Inc.	Commercial Printing	First Lien Term Loan	L+	4.00%	9.50%		10/11/2025		9,550		9,536		9,208
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	10.52%		4/27/2024		8,135		8,132		5,749
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	10.50%		4/27/2024		138		138		100
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.75%	9.97%		4/17/2028		2,985		2,564		2,768		(4)
Sorenson Communications, LLC	Communications Equipment	First Lien Term Loan	L+	5.50%	10.69%		3/17/2026		2,328		2,305		2,166		(4)
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.50%	10.70%		11/20/2028		8,865		8,729		8,655		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.70%		4/5/2029		8,801		8,426		8,710
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.84%		3/30/2029		8,235		7,548		7,722		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.20%		12/29/2028		7,230		7,116		7,050		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	L+	5.00%	10.22%		9/1/2025		6,322		6,266		5,185
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.45%		9/21/2027		7,757		7,570		7,263		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	9.03%		4/30/2025		1,970		1,917		1,791		(4)
Total Portfolio Investments									$	350,214	$	348,782	$	329,809

_________

(1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each

respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54 %, the 180-day LIBOR at 5.73%, the 30-day SOFR at 5.10%, and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of June 30, 2023.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

SLF JV I Portfolio as of September 30, 2022

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	L+	3.75%	6.82%		2/27/2025		$	10,093	$	10,028	$	9,692
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.25%	9.80%		12/18/2025		8,518		8,389		8,371		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	6.91%		8/14/2026		3,000		2,841		2,730
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	11.20%		6/30/2025		9,267		9,166		9,221		(4)
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	L+	6.25%	9.03%		10/20/2028		4,873		4,812		4,576		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	L+	4.25%	7.92%		11/26/2026		7,800		7,722		7,527		(4)
Anastasia Parent, LLC	Personal Products	First Lien Term Loan	L+	3.75%	7.42%		8/11/2025		1,539		1,203		1,232		(4)
Apptio, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.46%		1/10/2025		4,615		4,580		4,519		(4)
Apptio, Inc.	Application Software	First Lien Revolver	L+	6.00%	8.46%		1/10/2025		154		151		146		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Term Loan	L+	6.00%	9.67%		12/29/2027		4,176		4,103		4,080
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Revolver	L+	6.00%			12/29/2027				(9)		(11)		(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	8.37%		10/25/2028		5,052		4,858		4,319		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	7.70%		8/19/2028		5,000		4,753		4,276
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	L+	5.25%	8.37%		1/20/2029		4,346		3,981		3,347
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	8.78%		12/24/2026		6,338		6,242		6,027		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027		6,371		6,311		6,148
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027		1,771		1,751		1,664		(4)(5)
Blackhawk Network Holdings, Inc.	Data Processing & Outsourced Services	First Lien Term Loan	L+	3.00%	6.03%		6/15/2025		9,575		9,566		8,977
BYJU's Alpha, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.98%		11/24/2026		7,444		7,347		5,455
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	5.50%	9.12%		8/10/2027		4,358		4,286		4,280
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	5.50%	9.12%		8/10/2027		449		432		413
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	5.50%			8/10/2027		—		(10)		(11)		(5)
CITGO Petroleum Corp.	Oil & Gas Refining & Marketing	First Lien Term Loan	L+	6.25%	9.37%		3/28/2024		7,038		6,967		7,057		(4)
City Football Group Limited	Movies & Entertainment	First Lien Term Loan	L+	3.50%	6.48%		7/21/2028		6,451		6,419		6,166
Convergeone Holdings, Inc.	IT Consulting & Other Services	First Lien Term Loan	L+	5.00%	8.12%		1/4/2026		7,373		7,206		5,320		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	7.65%		9/20/2029		5,375		5,053		5,035		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	7.67%		7/9/2026		5,820		5,776		5,587
Dealer Tire, LLC	Distributors	First Lien Term Loan	L+	4.25%	7.37%		12/12/2025		2,992		2,935		2,924
Delivery Hero FinCo LLC	Internet & Direct Marketing Retail	First Lien Term Loan	SOFR+	5.75%	8.49%		8/12/2027		6,035		5,876		5,756		(4)
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	L+	5.00%	8.12%		8/2/2027		6,436		6,332		6,012		(4)
Domtar Corporation	Paper Products	First Lien Term Loan	L+	5.50%	8.26%		11/30/2028		4,100		4,065		3,921
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	7.33%		4/26/2029		8,000		7,849		7,616		(4)
Eagle Parent Corp.	Industrial Machinery	First Lien Term Loan	SOFR+	4.25%	7.80%		4/2/2029		4,478		4,373		4,367
eResearch Technology, Inc.	Application Software	First Lien Term Loan	L+	4.50%	7.62%		2/4/2027		7,331		7,258		6,859

Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	L+	5.00%	7.94%		8/11/2028		$	7,444	$	7,369	$	6,029
Global Medical Response, Inc.	Health Care Services	First Lien Term Loan	L+	4.25%	7.37%		3/14/2025		1,979		1,979		1,722		(4)
Global Medical Response, Inc.	Health Care Services	First Lien Term Loan	L+	4.25%	6.81%		10/2/2025		2,192		2,165		1,912
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	8.38%		4/9/2029		8,000		7,774		7,310		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	L+	5.25%	8.80%		6/30/2026		7,406		7,293		7,286
INW Manufacturing, LLC	Personal Products	First Lien Term Loan	L+	5.75%	9.42%		3/25/2027		9,500		9,282		8,408		(4)
Iris Holding, Inc.	Metal & Glass Containers	First Lien Term Loan	SOFR+	4.75%	7.89%		6/28/2028		5,000		4,624		4,610
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	L+	5.75%	8.23%		10/14/2027		7,444		7,318		7,323
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	L+	5.00%	8.67%		5/9/2026		7,367		7,315		7,109		(4)
LogMeIn, Inc.	Application Software	First Lien Term Loan	L+	4.75%	7.80%		8/31/2027		7,860		7,751		5,494
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	L+	3.25%	6.37%		9/6/2025		7,366		7,282		6,835
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	L+	7.00%	10.64%		2/14/2025		4,687		4,651		4,570		(4)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	L+	8.00%			2/14/2025		—		(4)		(12)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	L+	5.50%	9.17%		2/10/2026		6,139		6,104		5,966		(4)
MRI Software LLC	Application Software	First Lien Revolver	L+	5.50%			2/10/2026				(3)		(10)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	L+	4.75%	7.87%		3/31/2025		6,685		6,673		6,484
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	7.12%		9/25/2026		7,777		7,741		7,505		(4)
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	8.13%		11/10/2027		4,925		4,781		4,687		(4)
Peloton Interactive, Inc.	Leisure Products	First Lien Term Loan	SOFR+	6.50%	8.35%		5/25/2027		5,486		5,251		5,371
Planview Parent, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	10.92%		12/18/2028		4,503		4,435		4,323		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	L+	8.00%	10.68%		4/6/2027		6,796		6,694		6,582		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	L+	8.00%			4/6/2027		—		(6)		(13)		(4)(5)
RevSpring, Inc.	Commercial Printing	First Lien Term Loan	L+	4.00%	7.67%		10/11/2025		9,625		9,607		9,304
Sabert Corporation	Metal & Glass Containers	First Lien Term Loan	L+	4.50%	7.63%		12/10/2026		2,536		2,511		2,435		(4)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	8.06%		4/27/2024		8,201		8,194		7,176
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	8.04%		4/27/2024		138		138		121
Sorenson Communications, LLC	Communications Equipment	First Lien Term Loan	L+	5.50%	9.17%		3/17/2026		2,553		2,528		2,454
Spanx, LLC	Apparel Retail	First Lien Term Loan	L+	5.25%	8.30%		11/20/2028		8,933		8,776		8,721		(4)
SPX Flow, Inc.	Industrial Machinery	First Lien Term Loan	SOFR+	4.50%	7.63%		4/5/2029		7,500		7,184		6,966		(4)
Supermoose Borrower, LLC	Application Software	First Lien Term Loan	L+	3.75%	7.42%		8/29/2025		7,743		7,479		6,827		(4)
Surgery Center Holdings, Inc.	Health Care Facilities	First Lien Term Loan	L+	3.75%	6.51%		8/31/2026		3,377		3,365		3,213
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	8.15%		3/30/2029		6,256		5,693		5,629		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	L+	6.00%	9.12%		12/29/2028		7,285		7,155		7,140		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	L+	5.00%	8.67%		9/1/2025		6,365		6,290		5,087
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	L+	6.25%	9.37%		9/21/2027		7,818		7,596		7,115		(4)
WP CPP Holdings, LLC	Aerospace & Defense	Second Lien Term Loan	L+	7.75%	10.56%		4/30/2026		6,000		5,972		5,070		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	6.56%		4/30/2025		1,985		1,910		1,783		(4)
Zayo Group Holdings, Inc.	Alternative Carriers	First Lien Term Loan	L+	3.00%	6.12%		3/9/2027		2,155		2,000		1,812
Total Portfolio Investments									$	383,194	$	382,673	$	359,625

_________

(1) Represents the interest rate as of September 30, 2022. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of September 30, 2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55% and the 180-day SOFR at 3.98%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of September 30, 2022.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

Glick JV Portfolio as of June 30, 2023

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025	$	587	$	579	$	576	(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.00%		12/18/2025	3,824		3,782		3,753		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.89%		6/30/2025	6,313		6,261		6,029		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.22%		6/9/2028	2,485		2,367		2,346
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.49%		10/20/2028	2,868		2,832		2,502		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.00%	9.39%		11/26/2026	2,903		2,873		2,895
Amynta Agency Borrower Inc.	Property & Casualty Insurance	First Lien Term Loan	SOFR+	5.00%	10.20%		2/28/2028	3,000		2,915		2,925
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.25%		8/11/2025	910		707		702		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.31%		12/29/2027	1,721		1,695		1,635		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027	—		(3)		(10)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	10.44%		10/25/2028	2,078		2,037		1,464		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.20%		8/19/2028	1,985		1,900		1,884
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.47%		8/19/2028	998		941		951
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.47%		1/20/2029	2,423		2,236		2,039
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%	8.59%		2/15/2029	1,777		1,674		1,715
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.50%			2/15/2029	—		(13)		(8)		(5)
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	11.27%		12/24/2026	3,628		3,583		3,479		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027	3,372		3,340		3,284		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.50%		6/11/2027	802		798		782		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.24%		10/13/2029	2,773		2,607		2,589		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	9.54%		7/9/2026	2,848		2,827		2,838
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.22%		8/2/2027	2,528		2,502		2,477		(4)

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.80%		4/26/2029	$	2,978	$	2,928	$	2,779	(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.25%		8/11/2028	3,940		3,901		3,191		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.45%		4/9/2029	3,970		3,871		3,409		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.75%		6/30/2026	3,920		3,872		3,925
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	L+	5.75%	11.29%		3/25/2027	2,281		2,238		1,810		(4)
Iris Holding, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.75%	9.90%		6/28/2028	1,985		1,852		1,690
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.08%		10/14/2027	3,940		3,883		3,876
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	3.50%	8.72%		9/6/2025	1,347		1,224		1,297
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.84%		2/10/2026	1,634		1,621		1,589		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026	—		(1)		(4)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.50%	10.00%		3/31/2025	5,211		5,205		5,172
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	9.25%		9/25/2026	3,858		3,841		3,802
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.50%		12/17/2027	685		649		652
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.59%		12/18/2028	2,842		2,799		2,539		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.04%		4/6/2027	5,182		5,018		4,990		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.04%		4/6/2027	180		169		167		(4)(5)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	10.52%		4/27/2024	6,045		6,039		4,272
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	10.50%		4/27/2024	102		102		74
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.50%	10.70%		11/20/2028	4,925		4,849		4,808		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.70%		4/5/2029	5,227		5,023		5,174
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.84%		3/30/2029	2,647		2,435		2,483		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.20%		12/29/2028	3,001		2,954		2,926		(4)
Tribe Buyer LLC	Human Resource & Employment Services	First Lien Term Loan	L+	4.50%	9.69%		2/16/2024	1,570		1,570		931
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.45%		9/21/2027	4,848		4,731		4,539		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	9.03%		4/30/2025	985		959		895		(4)
Total Portfolio Investments								$	123,126	$	120,172	$	113,833

__________

(1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 30-day SOFR at 5.10% and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and the Glick JV as of June 30, 2023.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

Glick JV Portfolio as of September 30, 2022

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	L+	6.25%	9.80%		12/18/2025	$	4,647	$	4,579	$	4,567	(4)
Alvogen Pharma Inc	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	11.20%		6/30/2025	6,562		6,489		6,529		(4)
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	L+	6.25%	9.03%		10/20/2028	2,889		2,853		2,714		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	L+	4.25%	7.92%		11/26/2026	2,925		2,896		2,823		(4)
Anastasia Parent, LLC	Personal Products	First Lien Term Loan	L+	3.75%	7.42%		8/11/2025	917		712		734		(4)
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Term Loan	L+	6.00%	9.67%		12/29/2027	1,734		1,704		1,694
ASP-R-PAC Acquisition Co LLC	Paper Packaging	First Lien Revolver	L+	6.00%			12/29/2027	—		(4)		(5)		(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	L+	5.25%	8.37%		10/25/2028	2,078		2,033		1,777		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	7.70%		8/19/2028	2,000		1,901		1,711
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	L+	5.25%	8.37%		1/20/2029	2,423		2,212		1,866
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	L+	6.00%	8.78%		12/24/2026	3,656		3,601		3,476		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027	3,398		3,366		3,279
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	L+	5.00%	8.12%		6/11/2027	808		800		760		(4)(5)
BYJU's Alpha, Inc.	Application Software	First Lien Term Loan	L+	6.00%	8.98%		11/24/2026	3,970		3,919		2,909
CITGO Petroleum Corp.	Oil & Gas Refining & Marketing	First Lien Term Loan	L+	6.25%	9.37%		3/28/2024	3,519		3,484		3,529		(4)
City Football Group Limited	Movies & Entertainment	First Lien Term Loan	L+	3.50%	6.48%		7/21/2028	2,481		2,469		2,372
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	7.65%		9/20/2029	2,280		2,143		2,136		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	L+	4.00%	7.67%		7/9/2026	2,870		2,849		2,756
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	L+	5.00%	8.12%		8/2/2027	2,730		2,703		2,549		(4)
Domtar Corporation	Paper Products	First Lien Term Loan	L+	5.50%	8.26%		11/30/2028	2,503		2,478		2,394
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	7.33%		4/26/2029	3,000		2,943		2,856		(4)
Eagle Parent Corp.	Industrial Machinery	First Lien Term Loan	SOFR+	4.25%	7.80%		4/2/2029	2,488		2,429		2,426
eResearch Technology, Inc.	Application Software	First Lien Term Loan	L+	4.50%	7.62%		2/4/2027	2,444		2,419		2,286
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	L+	5.00%	7.94%		8/11/2028	3,970		3,930		3,216
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	8.38%		4/9/2029	4,000		3,887		3,655		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	L+	5.25%	8.80%		6/30/2026	3,950		3,890		3,886
INW Manufacturing, LLC	Personal Products	First Lien Term Loan	L+	5.75%	9.42%		3/25/2027	2,375		2,320		2,102		(4)
Iris Holding, Inc.	Metal & Glass Containers	First Lien Term Loan	SOFR+	4.75%	7.89%		6/28/2028	2,000		1,846		1,844
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	L+	5.75%	8.23%		10/14/2027	3,970		3,903		3,905
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	L+	3.25%	6.37%		9/6/2025	1,358		1,192		1,260

Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
MRI Software LLC	Application Software	First Lien Term Loan	L+	5.50%	9.17%		2/10/2026	$	1,647	$	1,632	$	1,600	(4)
MRI Software LLC	Application Software	First Lien Revolver	L+	5.50%			2/10/2026	—		(1)		(4)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	L+	4.75%	7.87%		3/31/2025	5,252		5,243		5,095
OEConnection LLC	Application Software	First Lien Term Loan	L+	4.00%	7.12%		9/25/2026	3,888		3,871		3,752		(4)
Planview Parent, Inc.	Application Software	Second Lien Term Loan	L+	7.25%	10.92%		12/18/2028	2,842		2,799		2,728		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	L+	8.00%	10.68%		4/6/2027	4,465		4,398		4,325		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	L+	8.00%			4/6/2027	—		(5)		(10)		(4)(5)
Sabert Corporation	Metal & Glass Containers	First Lien Term Loan	L+	4.50%	7.63%		12/10/2026	1,691		1,674		1,623		(4)
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.25%	8.06%		4/27/2024	6,094		6,082		5,332
SHO Holding I Corporation	Footwear	First Lien Term Loan	L+	5.23%	8.04%		4/27/2024	102		102		90
Spanx, LLC	Apparel Retail	First Lien Term Loan	L+	5.25%	8.30%		11/20/2028	4,962		4,876		4,845		(4)
SPX Flow, Inc.	Industrial Machinery	First Lien Term Loan	SOFR+	4.50%	7.63%		4/5/2029	6,000		5,734		5,572		(4)
Supermoose Borrower, LLC	Application Software	First Lien Term Loan	L+	3.75%	7.42%		8/29/2025	2,820		2,712		2,487		(4)
Surgery Center Holdings, Inc.	Health Care Facilities	First Lien Term Loan	L+	3.75%	6.51%		8/31/2026	3,377		3,365		3,213
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	8.15%		3/30/2029	2,654		2,415		2,388		(4)
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	L+	6.00%	9.12%		12/29/2028	3,024		2,970		2,963		(4)
Tribe Buyer LLC	Human Resource & Employment Services	First Lien Term Loan	L+	4.50%	7.62%		2/16/2024	1,583		1,582		1,266
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	L+	6.25%	9.37%		9/21/2027	4,886		4,747		4,447		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	L+	3.75%	6.56%		4/30/2025	993		955		892		(4)
WP CPP Holdings, LLC	Aerospace & Defense	Second Lien Term Loan	L+	7.75%	10.56%		4/30/2026	3,000		2,986		2,534		(4)
Total Portfolio Investments								$	143,225	$	140,083	$	133,144

__________

(1) Represents the interest rate as of September 30, 2022. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of September 30, 2022, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 30-day SOFR at 3.03% and the 90-day SOFR at 3.55%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and the Glick JV as of September 30, 2022.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

Schedule of Financial Instruments Carried at Fair Value

The following table presents the financial instruments carried at fair value as of June 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:

	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	245,925	$	2,528,448	$	—	$	2,774,373
Investments in debt securities (subordinated, including the debt investments in the JVs)	—		29,368		184,916		—		214,284
Investments in equity securities (preferred)	—		—		92,186		—		92,186
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	6,455		—		20,348		27,973		54,776
Total investments at fair value	6,455		275,293		2,825,898		27,973		3,135,619
Cash equivalents	5,193		—		—		—		5,193
Derivative asset	—		49		—		—		49
Total assets at fair value	$	11,648	$	275,342	$	2,825,898	$	27,973	$	3,140,861
Derivative liability	$	—	$	39,567	$	—	$	—	$	39,567
Total liabilities at fair value	$	—	$	39,567	$	—	$	—	$	39,567

__________ 

(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:

	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	255,803	$	1,910,606	$	—	$	2,166,409
Investments in debt securities (subordinated, including the debt investments in the JVs)	—		44,065		159,388		—		203,453
Investments in equity securities (preferred)	—		—		79,523		—		79,523
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	4,053		—		19,958		20,715		44,726
Total investments at fair value	4,053		299,868		2,169,475		20,715		2,494,111
Cash equivalents	5,261		—		—		—		5,261
Derivative assets	—		6,789		—		—		6,789
Total assets at fair value	$	9,314	$	306,657	$	2,169,475	$	20,715	$	2,506,161
Derivative liability	$	—	$	41,969	$	—	$	—	$	41,969
Total liabilities at fair value	$	—	$	41,969	$	—	$	—	$	41,969

__________ 

(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

Roll-Forward in the Changes in Fair Value

The following table provides a roll-forward in the changes in fair value from March 31, 2023 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of March 31, 2023	$	2,493,622	$	183,756	$	91,447	$	25,509	$	2,794,334
Purchases	228,375		4,183		—		182		232,740
Sales and repayments	(191,409)		(350)		—		(7,320)		(199,079)
Transfers out (a)	—		(2,708)		—		—		(2,708)
Capitalized PIK interest income	3,610		358		—		—		3,968
Accretion of OID	4,086		381		—		—		4,467
Net unrealized appreciation (depreciation)	(8,027)		(704)		739		1,893		(6,099)
Net realized gains (losses)	(1,809)		—		—		84		(1,725)
Fair value as of June 30, 2023	$	2,528,448	$	184,916	$	92,186	$	20,348	$	2,825,898
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023	$	(10,360)	$	(704)	$	739	$	1,095	$	(9,230)

__________

(a) There were transfers out of Level 3 to Level 2 for certain investments during the three months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

The following table provides a roll-forward in the changes in fair value from March 31, 2022 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of March 31, 2022	$	1,955,858	$	160,727	$	84,372	$	33,588	$	2,234,545
Purchases	60,692		29		—		125		60,846
Sales and repayments	(91,730)		(733)		—		(3,890)		(96,353)
Transfers in (a)	28,475		—		—		—		28,475
Transfers out (b)	—		—		—		(5,838)		(5,838)
Capitalized PIK interest income	5,537		—		—		—		5,537
Accretion of OID	5,100		430		—		—		5,530
Net unrealized appreciation (depreciation)	(33,208)		(4,873)		(2,756)		(873)		(41,710)
Net realized gains (losses)	(10)		—		—		393		383
Fair value as of June 30, 2022	$	1,930,714	$	155,580	$	81,616	$	23,505	$	2,191,415
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2022	$	(33,199)	$	(4,873)	$	(2,756)	$	(917)	$	(41,745)

__________

(a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity

The following table provides a roll-forward in the changes in fair value from September 30, 2022 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2022	$	1,910,606	$	159,388	$	79,523	$	19,958	$	2,169,475
Purchases (a)	980,595		26,508		14,296		5,610		1,027,009
Sales and repayments	(357,903)		(1,396)		—		(8,295)		(367,594)
Transfers in (b)	19,075		—		—		—		19,075
Capitalized PIK interest income	12,549		376		—		—		12,925
Accretion of OID	11,684		1,109		—		—		12,793
Net unrealized appreciation (depreciation)	(45,019)		(1,069)		(1,633)		2,804		(44,917)
Net realized gains (losses)	(3,139)		—		—		271		(2,868)
Fair value as of June 30, 2023	$	2,528,448	$	184,916	$	92,186	$	20,348	$	2,825,898
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2023	$	(46,680)	$	(1,069)	$	(1,633)	$	(355)	$	(49,737)

__________

(a) Includes Level 3 investments acquired in connection with the OSI2 Merger during the nine months ended June 30, 2023.

(b) There was a transfer into Level 3 from Level 2 for an investment during the nine months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

The following table provides a roll-forward in the changes in fair value from September 30, 2021 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2021	$	1,878,536	$	176,317	$	63,565	$	43,163	$	2,161,581
Purchases	437,922		3,777		19,243		2,180		463,122
Sales and repayments	(391,959)		(21,868)		(163)		(12,836)		(426,826)
Transfers in (a)	37,042		—		—		—		37,042
Transfers out (a)(b)	(17,070)		—		—		(5,838)		(22,908)
Capitalized PIK interest income	16,653		313		—		—		16,966
Accretion of OID	19,048		1,628		—		—		20,676
Net unrealized appreciation (depreciation)	(57,909)		(4,587)		(517)		(2,520)		(65,533)
Net realized gains (losses)	8,451		—		(512)		(644)		7,295
Fair value as of June 30, 2022	$	1,930,714	$	155,580	$	81,616	$	23,505	$	2,191,415
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2022	$	(45,187)	$	(4,734)	$	(752)	$	(7,629)	$	(58,302)

__________

(a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the nine months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity.

Schedule of Significant Unobservable Inputs for Level 3 Investments

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of June 30, 2023:

Asset	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average (a)
Senior Secured Debt	$	2,058,831	Market Yield	Market Yield	(b)	9.0%	-	38.0%	14.1%
	43,954		Enterprise Value	Revenue Multiple	(c)	5.0x	-	7.0x	6.0x
	34,466		Enterprise Value	EBITDA Multiple	(c)	3.4x	-	5.4x	5.2x
	32,379		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
	358,818		Broker quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Subordinated Debt	18,464		Market Yield	Market Yield	(b)	10.0%	-	22.0%	11.4%
	4,164		Broker Quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Debt Investments in the JVs	162,288		Enterprise Value	N/A	(f)	N/A	-	N/A	N/A
Preferred & Common Equity	70,852		Enterprise Value	Revenue Multiple	(c)	0.4x	-	6.0x	1.4x
	37,322		Enterprise Value	EBITDA Multiple	(c)	1.7x	-	17.5x	11.1x
	1,415		Enterprise Value	Asset Multiple	(c)	1.0x	-	1.4x	1.4x
	2,945		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
Total	$	2,825,898

__________ 

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

(e)Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

(f)Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2022:

Asset	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average (a)
Senior Secured Debt	$	1,599,148	Market Yield	Market Yield	(b)	9.0%	-	30.0%	13.7%
	14,333		Enterprise Value	EBITDA Multiple	(c)	5.0x	-	7.0x	6.0x
	297,125		Broker Quotations	Broker Quoted Price	(e)	N/A	-	N/A	N/A
Subordinated Debt	12,855		Market Yield	Market Yield	(b)	10.0%	-	19.0%	13.8%
Debt Investments in the JVs	146,533		Enterprise Value	N/A	(f)	N/A	-	N/A	N/A
Preferred & Common Equity	61,693		Enterprise Value	Revenue Multiple	(c)	0.4x	-	10.1x	4.3x
	36,913		Enterprise Value	EBITDA Multiple	(c)	3.0x	-	20.0x	11.4x
	3		Enterprise Value	Asset Multiple	(c)	0.9x	-	1.1x	1.0x
	872		Transaction Precedent	Transaction Price	(d)	N/A	-	N/A	N/A
Total	$	2,169,475

__________ 

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

(e)Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

(f)Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.

Fair Value Disclosure of Asset and Liability Not Measured at Fair Value

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of June 30, 2023 and the level of each financial liability within the fair value hierarchy:

	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	800,000	$	800,000	$	—	$	—	$	800,000
OSI2 Citibank Facility payable	335,000		335,000		—		—		335,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	297,928		285,717		—		285,717		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	307,138		302,260		—		302,260		—
Total	$	1,740,066	$	1,722,977	$	—	$	587,977	$	1,135,000

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2022 and the level of each financial liability within the fair value hierarchy:

	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	540,000	$	540,000	$	—	$	—	$	540,000
Citibank Facility payable	160,000		160,000		—		—		160,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	296,991		283,077		—		283,077		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	304,052		294,028		—		294,028		—
Total	$	1,301,043	$	1,277,105	$	—	$	577,105	$	700,000

Portfolio Composition

Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,886,772	87.59	%	$	2,227,245	85.08	%
Debt investments in the JVs	162,653		4.93	%	146,444		5.59	%
Preferred equity	99,597		3.02	%	85,300		3.26	%
Subordinated debt	55,450		1.68	%	67,147		2.57	%
LLC equity interests of the JVs	54,791		1.66	%	49,322		1.88	%
Common equity and warrants	37,022		1.12	%	42,296		1.62	%
Total	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,774,373	88.48	%	183.80	%	$	2,166,409	86.86	%	173.93	%
Debt investments in the JVs	162,288		5.18	%	10.75	%	146,533		5.88	%	11.77	%
Preferred equity	92,186		2.94	%	6.11	%	79,523		3.19	%	6.38	%
Subordinated debt	51,996		1.66	%	3.44	%	56,920		2.28	%	4.57	%
LLC equity interests of the JVs	27,973		0.89	%	1.85	%	20,715		0.83	%	1.66	%
Common equity and warrants	26,803		0.85	%	1.78	%	24,011		0.96	%	1.93	%
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Northeast	$	994,695	30.17	%	$	747,420	28.55	%
Midwest	448,981		13.62	%	373,236		14.26	%
Southeast	446,546		13.55	%	356,041		13.60	%
West	440,634		13.37	%	358,306		13.69	%
International	434,844		13.19	%	301,242		11.51	%
South	197,754		6.00	%	168,819		6.45	%
Northwest	168,992		5.13	%	91,382		3.49	%
Southwest	163,839		4.97	%	221,308		8.45	%
Total	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	936,888	29.87	%	62.07	%	$	696,368	27.93	%	55.90	%
International	432,986		13.81	%	28.69	%	279,646		11.21	%	22.45	%
Midwest	429,317		13.69	%	28.44	%	356,934		14.31	%	28.66	%
West	428,232		13.66	%	28.37	%	345,251		13.84	%	27.72	%
Southeast	406,523		12.96	%	26.93	%	344,567		13.82	%	27.66	%
South	186,792		5.96	%	12.37	%	166,230		6.66	%	13.35	%
Northwest	166,089		5.30	%	11.00	%	90,131		3.61	%	7.24	%
Southwest	148,792		4.75	%	9.86	%	214,984		8.62	%	17.26	%
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

(Share amounts in thousands)	Three months ended June 30, 2023	Three months ended June 30, 2022 (7)	Nine months ended June 30, 2023	Nine months ended June 30, 2022 (7)
Net asset value per share at beginning of period	$19.66	$21.79	$20.38	$21.84
Net investment income (1)	0.63	0.66	1.89	1.86
Net unrealized appreciation (depreciation) (1)(8)	(0.02)	(1.42)	(0.36)	(1.95)
Net realized gains (losses) (1)	(0.14)	0.15	(0.28)	0.33
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	(0.01)	0.01	0.03
Distributions of net investment income to stockholders	(0.55)	(0.50)	(2.06)	(1.44)
Net asset value per share at end of period	$19.58	$20.67	$19.58	$20.67
Per share market value at beginning of period	$18.77	$22.11	$18.00	$21.18
Per share market value at end of period	$19.43	$19.65	$19.43	19.65
Total return (2)	6.42%	(8.93)%	19.58%	(0.79)%
Common shares outstanding at beginning of period	77,080	61,068	61,125	60,120
Common shares outstanding at end of period	77,080	61,125	77,080	61,125
Net assets at beginning of period	$1,515,150	$1,330,376	$1,245,563	$1,312,823
Net assets at end of period	$1,509,441	$1,263,529	$1,509,441	$1,263,529
Average net assets (3)	$1,526,644	$1,306,727	$1,407,814	$1,323,232
Ratio of net investment income to average net assets (4)	12.72%	12.39%	12.65%	11.39%
Ratio of total expenses to average net assets (4)	14.45%	7.22%	14.07%	7.94%
Ratio of net expenses to average net assets (4)	14.05%	6.99%	13.69%	7.71%
Ratio of portfolio turnover to average investments at fair value	7.48%	4.73%	18.43%	21.44%
Weighted average outstanding debt (5)	$1,756,758	$1,369,615	$1,640,062	$1,358,150
Average debt per share (1)	$22.79	$22.41	$23.29	$22.41
Asset coverage ratio at end of period (6)	182.05%	187.82%	182.05%	187.82%

 __________

(1)	Calculated based upon weighted average shares outstanding for the period.
(2)	Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)	Calculated based upon the weighted average net assets for the period.
(4)	Interim periods are annualized.
(5)	Calculated based upon the weighted average of principal debt outstanding for the period.
(6)	Based on outstanding senior securities of $1,785.0 million and $1,395.0 million as of June 30, 2023 and 2022, respectively.
(7)	The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(8)	For the nine months ended June 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger.

XML

Share Data and Net Assets (Tables)

9 Months Ended

Jun. 30, 2023

Stockholders' Equity Note [Abstract]

Schedule of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the three and nine months ended June 30, 2023 and 2022:

(Share amounts in thousands)	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations	$	36,685	$	(37,834)	$	71,379	$	16,015
Weighted average common shares outstanding — basic and diluted	77,080		61,123		70,431		60,593
Earnings (loss) per common share — basic and diluted	$	0.48	$	(0.62)	$	1.01	$	0.26

Schedule of Changes in Net Assets

The following table presents the changes in net assets for the three and nine months ended June 30, 2023:

	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2022	61,125	$	611	$	1,827,721	$	(582,769)	$	1,245,563
Net investment income	—	—		—		38,808		38,808
Net unrealized appreciation (depreciation)	—	—		—		(22,982)		(22,982)
Net realized gains (losses)	—	—		—		(3,203)		(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		549		549
Distributions to stockholders	—	—		—		(58,679)		(58,679)
Issuance of common stock under dividend reinvestment plan	95	1		1,932		—		1,933
Balance as of December 31, 2022	61,220	$	612	$	1,829,653	$	(628,276)	$	1,201,989
Net investment income	—	—		—		45,978		45,978
Net unrealized appreciation (depreciation)	—	—		—		(18,279)		(18,279)
Net realized gains (losses)	—	—		—		(6,111)		(6,111)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(66)		(66)
Distributions to stockholders	—	—		—		(42,395)		(42,395)
Issuance of common stock in connection with the OSI2 Merger	15,860	159		333,875		—		334,034
Issuance of common stock under dividend reinvestment plan	68	1		1,294		—		1,295
Repurchase of common stock under dividend reinvestment plan	(68)	(1)		(1,294)		—		(1,295)
Balance as of March 31, 2023	77,080	$	771	$	2,163,528	$	(649,149)	$	1,515,150
Net investment income	—	—		—		48,413		48,413
Net unrealized appreciation (depreciation)	—	—		—		(1,039)		(1,039)
Net realized gains (losses)	—	—		—		(10,603)		(10,603)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(86)		(86)
Distributions to stockholders	—	—		—		(42,394)		(42,394)
Issuance of common stock under dividend reinvestment plan	57	1		1,122		—		1,123
Repurchase of common stock under dividend reinvestment plan	(57)	(1)		(1,122)		—		(1,123)
Balance as of June 30, 2023	77,080	$	771	$	2,163,528	$	(654,858)	$	1,509,441

The following table presents the changes in net assets for the three and nine months ended June 30, 2022:

	Common Stock
	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2021	60,120	$	601	$	1,805,557	$	(493,335)	$	1,312,823
Net investment income	—	—		—		32,295		32,295
Net unrealized appreciation (depreciation)	—	—		—		(4,586)		(4,586)
Net realized gains (losses)	—	—		—		9,321		9,321
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		2,378		2,378
Distributions to stockholders	—	—		—		(27,956)		(27,956)
Issuance of common stock under dividend reinvestment plan	36	1		785		—		786
Balance as of December 31, 2021	60,156	$	602	$	1,806,342	$	(481,883)	$	1,325,061
Net investment income	—	—		—		40,098		40,098
Net unrealized appreciation (depreciation)	—	—		—		(27,038)		(27,038)
Net realized gains (losses)	—	—		—		1,402		1,402
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(21)		(21)
Distributions to stockholders	—	—		—		(29,271)		(29,271)
Issuance of common stock in connection with the "at the market" offering	877	9		19,370		—		19,379
Issuance of common stock under dividend reinvestment plan	35	—		766		—		766
Balance as of March 31, 2022	61,068	$	611	$	1,826,478	$	(496,713)	$	1,330,376
Net investment income	—	—		—		40,370		40,370
Net unrealized appreciation (depreciation)	—	—		—		(86,755)		(86,755)
Net realized gains (losses)	—	—		—		9,212		9,212
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(661)		(661)
Distributions to stockholders	—	—		—		(30,256)		(30,256)
Issuance of common stock in connection with the "at the market" offering	57	—		1,243		—		1,243
Issuance of common stock under dividend reinvestment plan	44	1		873		—		874
Repurchases of common stock under dividend reinvestment plan	(44)	(1)		(873)		—		(874)
Balance as of June 30, 2022	61,125	$	611	$	1,827,721	$	(564,803)	$	1,263,529

Schedule of Distributions

The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the nine months ended June 30, 2023 and 2022:

Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution (3)			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	November 10, 2022	December 15, 2022	December 30, 2022	$	0.54	$	32.0	million	53,369	(1)	$	1.1	million
Special	November 10, 2022	December 15, 2022	December 30, 2022	0.42		24.8		million	41,510	(1)	0.8		million
Quarterly	January 27, 2023	March 15, 2023	March 31, 2023	0.55		41.1		million	68,412	(2)	1.3		million
Quarterly	April 28, 2023	June 15, 2023	June 30, 2023	0.55		41.3		million	57,279	(2)	1.1		million
Total for the nine months ended June 30, 2023				$	2.06	$	139.1	million	220,570		$	4.4	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	October 13, 2021	December 15, 2021	December 31, 2021	$	0.465	$	27.2	million	35,990	(1)	$	0.8	million
Quarterly	January 28, 2022	March 15, 2022	March 31, 2022	0.48		28.5 million			34,804	(1)	0.8 million
Quarterly	April 29, 2022	June 15, 2022	June 30, 2022	0.495		29.4 million			43,676	(2)	0.9 million
Total for the nine months ended June 30, 2022				$	1.44	$	85.1	million	114,470		$	2.4	million

 __________

(1) New shares were issued and distributed.

(2) Shares were purchased on the open market and distributed.

(3) Totals may not sum due to rounding.

XML

Borrowings (Tables)

9 Months Ended

Jun. 30, 2023

Debt Disclosure [Abstract]

Components of Debt

The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of June 30, 2023 and September 30, 2022:

	As of June 30, 2023				As of September 30, 2022
($ in millions)	2025 Notes		2027 Notes		2025 Notes		2027 Notes
Principal	$	300.0	$	350.0	$	300.0	$	350.0
Unamortized financing costs	(1.2)		(2.7)		(1.8)		(3.2)
Unaccreted discount	(0.8)		(0.6)		(1.2)		(0.7)
Interest rate swap fair value adjustment	—		(39.6)		—		(42.0)
Net carrying value	$	298.0	$	307.1	$	297.0	$	304.1
Fair Value	$	285.7	$	302.3	$	283.1	$	294.0

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2023:

($ in millions)	2025 Notes						2027 Notes
	Three months ended June 30, 2023			Nine months ended June 30, 2023			Three months ended June 30, 2023			Nine months ended June 30, 2023
Coupon interest	$	2.6		$	7.9		$	2.4		$	7.1
Amortization of financing costs and discount	0.3			0.9			0.2			0.7
Effect of interest rate swap	—			—			3.7			9.4
Total interest expense	$	2.9		$	8.8		$	6.3		$	17.2
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	3.500		%	3.500		%	6.912		%	6.274		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2022:

($ in millions)	2025 Notes						2027 Notes
	Three months ended June 30, 2022			Nine months ended June 30, 2022			Three months ended June 30, 2022			Nine months ended June 30, 2022
Coupon interest	$	2.6		$	7.9		$	2.4		$	7.1
Amortization of financing costs and discount	0.3			0.9			0.2			0.7
Effect of interest rate swap	—			—			(0.1)			(1.6)
Total interest expense	$	2.9		$	8.8		$	2.5		$	6.2
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)	3.500		%	3.500		%	2.572		%	2.069		%

XML

Taxable/Distributable Income and Dividend Distributions (Tables)

9 Months Ended

Jun. 30, 2023

Income Tax Disclosure [Abstract]

Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations

Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three and nine months ended June 30, 2023 and 2022.

	Three months ended June 30, 2023		Three months ended June 30, 2022		Nine months ended June 30, 2023		Nine months ended June 30, 2022
Net increase (decrease) in net assets resulting from operations	$	36,685	$	(37,834)	$	71,379	$	16,015
Net unrealized (appreciation) depreciation	1,039		86,755		42,300		118,379
Book/tax difference due to organizational costs	—		(21)		—		(65)
Book/tax difference due to capital losses utilized	12,118		(3,736)		20,380		(19,183)
Other book/tax differences	(3,825)		(8,819)		(14,912)		(18,597)
Taxable/Distributable Income (1)	$	46,017	$	36,345	$	119,147	$	96,549

Components of Accumulated Overdistributed Earnings

As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:

Undistributed ordinary income, net	$	(43,624)
Net realized capital losses	473,274
Unrealized losses, net	153,119
Accumulated overdistributed earnings	$	582,769

XML

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation (Tables)

9 Months Ended

Jun. 30, 2023

Investment Company [Abstract]

Schedule of Aggregate Net Realized Gains

During the three months ended June 30, 2023, the Company recorded an aggregate net realized loss of $10.6 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	(6.3)
Aden & Anais Merger Sub Inc.	(5.2)
Radiology Partners Inc.	(3.8)
WP CPP Holdings LLC	(1.3)
Tersera Therapeutics LLC	5.2
Other, net	0.8
Total, net	$	(10.6)

During the three months ended June 30, 2022, the Company recorded an aggregate net realized gain of $9.2 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	8.8
Other, net	0.4
Total, net	$	9.2

During the nine months ended June 30, 2023, the Company recorded an aggregate net realized loss of $19.9 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	(5.5)
Aden & Anais Merger Sub Inc.	(5.2)
Radiology Partners Inc.	(4.2)
Carvana Co.	(2.8)
ASP Unifrax Holdings Inc.	(2.1)
WP CPP Holdings LLC	(1.3)
Global Medical Response Inc.	(1.0)
Tersera Therapeutics LLC	5.2
Other, net	(3.0)
Total, net	$	(19.9)

During the nine months ended June 30, 2022, the Company recorded an aggregate net realized gain of $19.9 million, which consisted of the following:

($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	12.2
OmniSYS Acquisition Corporation	2.2
First Star Speir Aviation Limited	1.9
TigerConnect Inc.	1.8
Other, net	1.8
Total, net	$	19.9

XML

Financial Highlights (Tables)

9 Months Ended

Jun. 30, 2023

Investment Company [Abstract]

Portfolio Composition

Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,886,772	87.59	%	$	2,227,245	85.08	%
Debt investments in the JVs	162,653		4.93	%	146,444		5.59	%
Preferred equity	99,597		3.02	%	85,300		3.26	%
Subordinated debt	55,450		1.68	%	67,147		2.57	%
LLC equity interests of the JVs	54,791		1.66	%	49,322		1.88	%
Common equity and warrants	37,022		1.12	%	42,296		1.62	%
Total	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,774,373	88.48	%	183.80	%	$	2,166,409	86.86	%	173.93	%
Debt investments in the JVs	162,288		5.18	%	10.75	%	146,533		5.88	%	11.77	%
Preferred equity	92,186		2.94	%	6.11	%	79,523		3.19	%	6.38	%
Subordinated debt	51,996		1.66	%	3.44	%	56,920		2.28	%	4.57	%
LLC equity interests of the JVs	27,973		0.89	%	1.85	%	20,715		0.83	%	1.66	%
Common equity and warrants	26,803		0.85	%	1.78	%	24,011		0.96	%	1.93	%
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:

	June 30, 2023				September 30, 2022
Cost:			% of Total Investments				% of Total Investments
Northeast	$	994,695	30.17	%	$	747,420	28.55	%
Midwest	448,981		13.62	%	373,236		14.26	%
Southeast	446,546		13.55	%	356,041		13.60	%
West	440,634		13.37	%	358,306		13.69	%
International	434,844		13.19	%	301,242		11.51	%
South	197,754		6.00	%	168,819		6.45	%
Northwest	168,992		5.13	%	91,382		3.49	%
Southwest	163,839		4.97	%	221,308		8.45	%
Total	$	3,296,285	100.00	%	$	2,617,754	100.00	%

	June 30, 2023						September 30, 2022
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	936,888	29.87	%	62.07	%	$	696,368	27.93	%	55.90	%
International	432,986		13.81	%	28.69	%	279,646		11.21	%	22.45	%
Midwest	429,317		13.69	%	28.44	%	356,934		14.31	%	28.66	%
West	428,232		13.66	%	28.37	%	345,251		13.84	%	27.72	%
Southeast	406,523		12.96	%	26.93	%	344,567		13.82	%	27.66	%
South	186,792		5.96	%	12.37	%	166,230		6.66	%	13.35	%
Northwest	166,089		5.30	%	11.00	%	90,131		3.61	%	7.24	%
Southwest	148,792		4.75	%	9.86	%	214,984		8.62	%	17.26	%
Total	$	3,135,619	100.00	%	207.73	%	$	2,494,111	100.00	%	200.24	%

(Share amounts in thousands)	Three months ended June 30, 2023	Three months ended June 30, 2022 (7)	Nine months ended June 30, 2023	Nine months ended June 30, 2022 (7)
Net asset value per share at beginning of period	$19.66	$21.79	$20.38	$21.84
Net investment income (1)	0.63	0.66	1.89	1.86
Net unrealized appreciation (depreciation) (1)(8)	(0.02)	(1.42)	(0.36)	(1.95)
Net realized gains (losses) (1)	(0.14)	0.15	(0.28)	0.33
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	(0.01)	0.01	0.03
Distributions of net investment income to stockholders	(0.55)	(0.50)	(2.06)	(1.44)
Net asset value per share at end of period	$19.58	$20.67	$19.58	$20.67
Per share market value at beginning of period	$18.77	$22.11	$18.00	$21.18
Per share market value at end of period	$19.43	$19.65	$19.43	19.65
Total return (2)	6.42%	(8.93)%	19.58%	(0.79)%
Common shares outstanding at beginning of period	77,080	61,068	61,125	60,120
Common shares outstanding at end of period	77,080	61,125	77,080	61,125
Net assets at beginning of period	$1,515,150	$1,330,376	$1,245,563	$1,312,823
Net assets at end of period	$1,509,441	$1,263,529	$1,509,441	$1,263,529
Average net assets (3)	$1,526,644	$1,306,727	$1,407,814	$1,323,232
Ratio of net investment income to average net assets (4)	12.72%	12.39%	12.65%	11.39%
Ratio of total expenses to average net assets (4)	14.45%	7.22%	14.07%	7.94%
Ratio of net expenses to average net assets (4)	14.05%	6.99%	13.69%	7.71%
Ratio of portfolio turnover to average investments at fair value	7.48%	4.73%	18.43%	21.44%
Weighted average outstanding debt (5)	$1,756,758	$1,369,615	$1,640,062	$1,358,150
Average debt per share (1)	$22.79	$22.41	$23.29	$22.41
Asset coverage ratio at end of period (6)	182.05%	187.82%	182.05%	187.82%

 __________

(1)	Calculated based upon weighted average shares outstanding for the period.
(2)	Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)	Calculated based upon the weighted average net assets for the period.
(4)	Interim periods are annualized.
(5)	Calculated based upon the weighted average of principal debt outstanding for the period.
(6)	Based on outstanding senior securities of $1,785.0 million and $1,395.0 million as of June 30, 2023 and 2022, respectively.
(7)	The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(8)	For the nine months ended June 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger.

XML

Derivative Instruments (Tables)

9 Months Ended

Jun. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Foreign Currency Forward Contracts and Interest Rate Swap

Certain information related to the Company’s foreign currency forward contracts is presented below as of June 30, 2023.

Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	78,866	€	71,658	8/10/2023	$	531	$	—	Derivative asset
Foreign currency forward contract	$	71,438	£	56,556	8/10/2023	$	—	$	482	Derivative asset
						$	531	$	482

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022.

Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	43,179	€	41,444	11/10/2022	$	2,466	$	—	Derivative asset
Foreign currency forward contract	$	45,692	£	37,033	11/10/2022	$	4,323	$	—	Derivative asset
						$	6,789	$	—

Certain information related to the Company’s interest rate swap is presented below as of June 30, 2023.

Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	39,567	Derivative liability
				$	—	$	39,567

Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022.

Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	41,969	Derivative liability
				$	—	$	41,969

XML

Commitments and Contingencies (Tables)

9 Months Ended

Jun. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Unfunded Commitments

A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of June 30, 2023 and September 30, 2022 is shown in the table below:

	June 30, 2023		September 30, 2022
107-109 Beech OAK22 LLC	$	30,922	$	—
Fairbridge Strategic Capital Funding LLC	20,382		22,150
Delta Leasing SPV II LLC	18,822		27,187
BioXcel Therapeutics, Inc.	14,543		11,785
OCSI Glick JV LLC	13,998		13,998
Senior Loan Fund JV I, LLC	13,125		35,000
SiO2 Medical Products, Inc.	10,765		—
MND Holdings III Corp	8,470		—
Seres Therapeutics, Inc.	8,090		—
iCIMs, Inc.	7,704		6,930
Dominion Diagnostics, LLC	7,664		11,148
Marinus Pharmaceuticals, Inc.	7,139		5,734
Assembled Brands Capital LLC	7,062		2,008
Grove Hotel Parcel Owner, LLC	5,286		4,293
scPharmaceuticals Inc.	5,212		—
Innocoll Pharmaceuticals Limited	5,200		4,195
Avalara, Inc.	5,047		—
Mindbody, Inc.	4,762		4,000
Accupac, Inc.	4,500		4,605
Mesoblast, Inc.	4,405		3,553
107 Fair Street LLC	4,322		—
Harrow Health, Inc.	4,011		—
Inventus Power, Inc.	3,792		—
Establishment Labs Holdings Inc.	3,384		5,075
MRI Software LLC	3,302		5,196
OTG Management, LLC	3,190		3,789
PRGX Global, Inc.	3,127		2,518
Salus Workers' Compensation, LLC	3,102		—
ADC Therapeutics SA	3,020		3,020
Relativity ODA LLC	2,762		2,218
112-126 Van Houten Real22 LLC	2,703		—
LSL Holdco, LLC	2,650		427
Supreme Fitness Group NY Holdings, LLC	2,540		1,527
Pluralsight, LLC	2,395		3,532
SCP Eye Care Services, LLC	2,356		—
Spanx, LLC	2,185		2,226
Tahoe Bidco B.V.	2,162		1,741
Coupa Holdings, LLC	2,075		—
Galileo Parent, Inc.	2,061		—
Oranje Holdco, Inc.	1,904		—
Apptio, Inc.	1,885		1,338
Kings Buyer, LLC	1,771		1,537
MHE Intermediate Holdings, LLC	1,536		1,429
PPW Aero Buyer, Inc.	1,466		—
Liquid Environmental Solutions Corporation	1,383		1,115
Berner Food & Beverage, LLC	1,314		1,392
CorEvitas, LLC	1,251		915
Digital.AI Software Holdings, Inc.	1,156		826
Coyote Buyer, LLC	800		1,333
Telestream Holdings Corporation	678		528
Acquia Inc.	596		1,326
ASP-R-PAC Acquisition Co LLC	396		—
BAART Programs, Inc.	—		8,645
RumbleOn, Inc.	—		4,822
Ardonagh Midco 3 PLC	—		4,372
Dialyze Holdings, LLC	—		3,431
Thrasio, LLC	—		2,578
109 Montgomery Owner LLC	—		477
GKD Index Partners, LLC	—		320
Total	$	274,373	$	224,239

XML

Merger with OSI2 (Tables)

9 Months Ended

Jun. 30, 2023

Business Combination and Asset Acquisition [Abstract]

Allocation of Consideration Paid to the Assets Acquired and Liabilities Assumed

The following table summarizes the allocation of the consideration paid to the assets acquired and liabilities assumed as a result of the OSI2 Merger:

Common stock issued by the Company (1)	$	334,034
Transaction costs	1,932
Consideration paid	$	335,966
Investments	$	592,809
Cash and cash equivalents	22,317
Other assets	6,679
Total assets acquired	621,805
Debt	225,000
Other liabilities	60,839
Total liabilities acquired	285,839
Total net assets acquired	$	335,966

__________

(1) Common stock issued by the Company includes $19 of cash paid in lieu of issuing fractional shares.

XML

Significant Accounting Policies (Details) $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 20, 2023	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)
Restricted Cash and Cash Equivalents Items [Line Items]
Stock split, conversion ratio	0.0033
Restricted cash		$ 12,956		$ 12,956		$ 2,836
Excise tax		0	$ 0	$ 78	$ 0	$ 100
Investment Owned, Cost | Non-Accrual Status, Debt Securities | Investment Type Concentration Risk
Restricted Cash and Cash Equivalents Items [Line Items]
Stock split, conversion ratio				0.036
Concentration risk						0.00%
Investment Owned, Fair Value | Non-Accrual Status, Debt Securities | Investment Type Concentration Risk
Restricted Cash and Cash Equivalents Items [Line Items]
Stock split, conversion ratio				0.031
Concentration risk						0.00%
Wells Fargo Bank, N.A.
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash						$ 2,800
Deutsche Bank Trust Company Americas
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash		$ 13,000		$ 13,000

XML

Portfolio Investments - Narrative (Details)	3 Months Ended						9 Months Ended		12 Months Ended
	Jun. 30, 2023 USD ($) borrower member	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2023 USD ($) borrower member	Jun. 30, 2022 USD ($)	Sep. 30, 2022 USD ($) borrower	Sep. 30, 2021 USD ($)	May 18, 2021	Feb. 25, 2020
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets	207.73%						207.73%		200.24%
Investments at fair value	$ 3,135,619,000						$ 3,135,619,000		$ 2,494,111,000
Number of borrowers | borrower	156						156		149
Money market funds, percent of net assets	4.80%						4.80%		2.10%
Cash, cash equivalents and restricted cash	$ 72,660,000			$ 36,315,000			$ 72,660,000	$ 36,315,000	$ 26,364,000	$ 31,635,000
Restricted cash	12,956,000						12,956,000		2,836,000
Net realized gains (losses)	(10,603,000)	$ (6,111,000)	$ (3,203,000)	9,212,000	$ 1,402,000	$ 9,321,000	(19,900,000)	19,900,000
Net unrealized appreciation (depreciation)	(1,039,000)	$ (18,279,000)	$ (22,982,000)	(86,755,000)	$ (27,038,000)	$ (4,586,000)	(42,300,000)	(118,400,000)
Credit facilities payable	1,135,000,000						1,135,000,000		700,000,000
Assets	3,335,974,000						3,335,974,000		2,646,313,000
Unfunded commitments	274,373,000						274,373,000		224,239,000
Investment owned, at cost	3,296,285,000						3,296,285,000		2,617,754,000
Senior Loan Fund JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	140,600,000						140,600,000		117,000,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 49,600,000						$ 49,600,000		$ 50,300,000
Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk							100.00%		100.00%
Debt Securities, Senior Secured
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets	183.80%						183.80%		173.93%
Investments at fair value	$ 2,774,373,000						$ 2,774,373,000		$ 2,166,409,000
Investment owned, at cost	2,886,772,000						$ 2,886,772,000		$ 2,227,245,000
Debt Securities, Senior Secured | Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk							88.48%		86.86%
Debt Securities, Subordinated, Including JV Debt Instruments
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	214,284,000						$ 214,284,000		$ 203,453,000
Debt Securities, Subordinated, Including JV Debt Instruments | Investment Owned, At Fair Value | Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk							6.80%		8.10%
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	140,600,000						$ 140,600,000		$ 117,000,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	49,600,000						49,600,000		50,300,000
Investment owned, at cost	$ 50,000,000						$ 50,000,000		50,200,000
2025 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	3.50%						3.50%					3.50%
2027 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest rate, percentage	2.70%						2.70%				2.70%
The JVs
Investment Company, Nonconsolidated Subsidiary [Line Items]
Money market funds, percent of net assets	4.80%						4.80%
Cash, cash equivalents and restricted cash	$ 72,700,000						$ 72,700,000
Restricted cash	13,000,000						13,000,000
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 329,809,000						$ 329,809,000		$ 359,625,000
Number of borrowers | borrower	52,000						52,000		60
Restricted cash	$ 8,715,000						$ 8,715,000		$ 5,642,000
Number of board of directors | member	4						4
Number of board of directors selected by company | member	2						2
Number of board of directors selected by counterparty | member	2						2
Number of investment committee members selected by company | member	1						1
Number of investment committee members selected by counterparty | member	1						1
Investment owned, ownership percentage	87.50%						87.50%		87.50%
Credit facilities payable	$ 200,000,000						$ 200,000,000		$ 230,000,000
Assets	370,228,000						370,228,000		385,227,000
Financial support funded by company and counterparty	190,500,000						190,500,000		165,500,000
Financial support funded by company for investee	166,700,000						166,700,000		144,800,000
Unfunded commitments	13,100,000						13,100,000		35,000,000
Investment owned, at cost	348,782,000						348,782,000		382,673,000
Interest income	10,312,000			5,796,000			29,106,000	16,664,000
Investments sold							18,800,000	9,700,000
Proceeds from sale of investments							18,000,000	9,700,000
Gain (loss) on sale of investments							(200,000)	500,000
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	260,000,000						260,000,000		260,000,000
Credit facilities payable	$ 200,000,000						$ 200,000,000		$ 230,000,000
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Secured Overnight Financing Rate, Floor
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							0.125%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Until November 3, 2023 | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							2.50%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Remainder of Reinvestment Period | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							2.75%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | First Year After Reinvestment Period | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							3.25%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Second Year After Reinvestment Period | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							3.35%
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Third Year After Reinvestment Period, And There After | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							3.60%
SLF JV I | Kemper
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, ownership percentage	12.50%						12.50%		12.50%
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 113,833,000						$ 113,833,000		$ 133,144,000
Number of borrowers | borrower	37						37		43
Restricted cash	$ 1,812,000						$ 1,812,000		$ 1,788,000
Number of board of directors | member	4						4
Number of board of directors selected by company | member	2						2
Number of board of directors selected by counterparty | member	2						2
Number of investment committee members selected by company | member	1						1
Number of investment committee members selected by counterparty | member	1						1
Credit facilities payable	$ 66,082,000						$ 66,082,000		82,082,000
Assets	126,824,000						126,824,000		146,808,000
Financial support funded by company and counterparty	84,000,000						84,000,000		84,000,000
Financial support funded by company for investee	73,500,000						73,500,000		73,500,000
Investment owned, at cost	120,172,000						120,172,000		140,083,000
Interest income	3,576,000			$ 2,416,000			10,488,000	$ 6,796,000
Financial commitment to investee by company and counterparty, aggregate amount	100,000,000						100,000,000		100,000,000
Financial commitment to investee, aggregate amount	87,500,000						87,500,000		87,500,000
Financial commitment to investee by counterparty, aggregate amount	12,500,000						12,500,000		12,500,000
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	90,000,000						90,000,000
Credit facilities payable	$ 66,100,000						$ 66,100,000		$ 82,100,000
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Secured Overnight Financing Rate, Floor
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							0.125%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Until November 3, 2023 | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							2.50%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Remainder of Reinvestment Period | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							2.75%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | First Year After Reinvestment Period | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							3.25%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Second Year After Reinvestment Period | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							3.35%
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Third Year After Reinvestment Period, And There After | Secured Overnight Financing Rate
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate							3.60%

XML

Portfolio Investments - Composition of Investments (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,296,285	$ 2,617,754
Investments at fair value	3,135,619	2,494,111
Debt investments, fair value	$ 2,988,657	$ 2,369,862
% of Debt Portfolio	100.00%	100.00%
Investments in debt securities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,942,222	$ 2,294,392
Investments at fair value	2,826,369	2,223,329
Investments in equity securities
Schedule of Investments [Line Items]
Investment owned, at cost	136,619	127,596
Investments at fair value	118,989	103,534
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	162,653	146,444
Investments at fair value	162,288	146,533
Equity investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	54,791	49,322
Investments at fair value	27,973	20,715
Floating rate debt securities, including the debt investments in the JVs
Schedule of Investments [Line Items]
Debt investments, fair value	$ 2,571,458	$ 2,049,644
% of Debt Portfolio	86.04%	86.49%
Fixed rate debt securities
Schedule of Investments [Line Items]
Debt investments, fair value	$ 417,199	$ 320,218
% of Debt Portfolio	13.96%	13.51%

XML

Portfolio Investments - Schedule of Financial Instruments Carried at Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Schedule of Investments [Line Items]
Investments at fair value	$ 3,135,619	$ 2,494,111
Cash equivalents	5,193	5,261
Derivative assets at fair value	49	6,789
Total assets at fair value	3,140,861	2,506,161
Derivative liability at fair value	39,567	41,969
Total liabilities at fair value	39,567	41,969
Carrying Value	1,740,066	1,301,043
Fair Value	1,722,977	1,277,105
Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	2,774,373	2,166,409
Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	214,284	203,453
Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	92,186	79,523
Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	54,776	44,726
Syndicated Facility
Schedule of Investments [Line Items]
Carrying Value	800,000	540,000
Fair Value	800,000	540,000
Citibank Facility
Schedule of Investments [Line Items]
Carrying Value		160,000
Fair Value		160,000
2027 Notes
Schedule of Investments [Line Items]
Carrying Value	307,138	304,052
Fair Value	302,260	294,028
Level 1
Schedule of Investments [Line Items]
Investments at fair value	6,455	4,053
Cash equivalents	5,193	5,261
Derivative assets at fair value	0	0
Total assets at fair value	11,648	9,314
Derivative liability at fair value	0	0
Total liabilities at fair value	0	0
Fair Value	0	0
Level 1 | Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	6,455	4,053
Level 1 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value		0
Level 1 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2
Schedule of Investments [Line Items]
Investments at fair value	275,293	299,868
Cash equivalents	0	0
Derivative assets at fair value	49	6,789
Total assets at fair value	275,342	306,657
Derivative liability at fair value	39,567	41,969
Total liabilities at fair value	39,567	41,969
Fair Value	587,977	577,105
Level 2 | Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	245,925	255,803
Level 2 | Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	29,368	44,065
Level 2 | Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 2 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 2 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value		0
Level 2 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	302,260	294,028
Level 3
Schedule of Investments [Line Items]
Investments at fair value	2,825,898	2,169,475
Cash equivalents	0	0
Derivative assets at fair value	0	0
Total assets at fair value	2,825,898	2,169,475
Derivative liability at fair value	0	0
Total liabilities at fair value	0	0
Fair Value	1,135,000	700,000
Level 3 | Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	2,528,448	1,910,606
Level 3 | Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	184,916	159,388
Level 3 | Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	92,186	79,523
Level 3 | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	20,348	19,958
Level 3 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	800,000	540,000
Level 3 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value		160,000
Level 3 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Fair Value Measured at Net Asset Value Per Share
Schedule of Investments [Line Items]
Investments at fair value	27,973	20,715
Cash equivalents	0	0
Derivative assets at fair value	0	0
Total assets at fair value	27,973	20,715
Derivative liability at fair value	0	0
Total liabilities at fair value	0
Fair Value Measured at Net Asset Value Per Share | Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investments at fair value	0	0
Total liabilities at fair value		0
Fair Value Measured at Net Asset Value Per Share | Debt Securities, Subordinated, Including JV Debt Instruments
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share | Equity Securities, Preferred
Schedule of Investments [Line Items]
Investments at fair value	0	0
Fair Value Measured at Net Asset Value Per Share | Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	$ 27,973	$ 20,715

XML

Portfolio Investments - Roll-Forward in the Changes in Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	$ 2,794,334	$ 2,234,545	$ 2,169,475	$ 2,161,581
Purchases	232,740	60,846	1,027,009	463,122
Sales and repayments	(199,079)	(96,353)	(367,594)	(426,826)
Transfers in		28,475	19,075	37,042
Transfers out	(2,708)	(5,838)		(22,908)
Capitalized PIK interest income	3,968	5,537	12,925	16,966
Accretion of OID	4,467	5,530	12,793	20,676
Fair value, ending balance	2,825,898	2,191,415	2,825,898	2,191,415
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023	(9,230)	(41,745)	(49,737)	(58,302)
Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(6,099)	(41,710)	(44,917)	(65,533)
Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,725)	383	(2,868)	7,295
Debt Securities, Senior Secured
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	2,493,622	1,955,858	1,910,606	1,878,536
Purchases	228,375	60,692	980,595	437,922
Sales and repayments	(191,409)	(91,730)	(357,903)	(391,959)
Transfers in		28,475	19,075	37,042
Transfers out	0	0		(17,070)
Capitalized PIK interest income	3,610	5,537	12,549	16,653
Accretion of OID	4,086	5,100	11,684	19,048
Fair value, ending balance	2,528,448	1,930,714	2,528,448	1,930,714
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023	(10,360)	(33,199)	(46,680)	(45,187)
Debt Securities, Senior Secured | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(8,027)	(33,208)	(45,019)	(57,909)
Debt Securities, Senior Secured | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,809)	(10)	(3,139)	8,451
Debt Securities, Subordinated
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	183,756	160,727	159,388	176,317
Purchases	4,183	29	26,508	3,777
Sales and repayments	(350)	(733)	(1,396)	(21,868)
Transfers in		0	0	0
Transfers out	(2,708)	0		0
Capitalized PIK interest income	358	0	376	313
Accretion of OID	381	430	1,109	1,628
Fair value, ending balance	184,916	155,580	184,916	155,580
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023	(704)	(4,873)	(1,069)	(4,734)
Debt Securities, Subordinated | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(704)	(4,873)	(1,069)	(4,587)
Debt Securities, Subordinated | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0	0	0
Equity Securities, Preferred
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	91,447	84,372	79,523	63,565
Purchases	0	0	14,296	19,243
Sales and repayments	0	0	0	(163)
Transfers in		0	0	0
Transfers out	0	0		0
Capitalized PIK interest income	0	0	0	0
Accretion of OID	0	0	0	0
Fair value, ending balance	92,186	81,616	92,186	81,616
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023	739	(2,756)	(1,633)	(752)
Equity Securities, Preferred | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	739	(2,756)	(1,633)	(517)
Equity Securities, Preferred | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0	0	(512)
Equity Securities, Common And Warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	25,509	33,588	19,958	43,163
Purchases	182	125	5,610	2,180
Sales and repayments	(7,320)	(3,890)	(8,295)	(12,836)
Transfers in		0	0	0
Transfers out	0	(5,838)		(5,838)
Capitalized PIK interest income	0	0	0	0
Accretion of OID	0	0	0	0
Fair value, ending balance	20,348	23,505	20,348	23,505
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023	1,095	(917)	(355)	(7,629)
Equity Securities, Common And Warrants | Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	1,893	(873)	2,804	(2,520)
Equity Securities, Common And Warrants | Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	$ 84	$ 393	$ 271	$ (644)

XML

Portfolio Investments - Significant Unobservable Inputs for Level 3 Investments (Details) $ in Thousands	Jun. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 3,135,619	$ 2,494,111
Debt Securities, Senior Secured
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,774,373	2,166,409
Debt investments in the JVs
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	162,288	146,533
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,825,898	2,169,475
Level 3 | Debt Securities, Senior Secured
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,528,448	1,910,606
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 2,058,831	$ 1,599,148
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.090	0.090
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.380	0.300
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.141	0.137
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 34,466	$ 14,333
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3.4	5.0
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	5.4	7.0
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	5.2	6.0
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 43,954
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	5.0
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	7.0
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	6.0
Level 3 | Debt Securities, Senior Secured | Valuation, Transaction Precedent | Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 32,379
Level 3 | Debt Securities, Senior Secured | Valuation, Broker Quotations | Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value		$ 297,125
Level 3 | Debt Securities, Senior Secured | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	358,818
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 18,464	$ 12,855
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.100	0.100
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.220	0.190
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.114	0.138
Level 3 | Subordinated Debt | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 4,164
Level 3 | Debt investments in the JVs | Valuation, Enterprise Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	162,288	$ 146,533
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 37,322	$ 36,913
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.7	3.0
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	17.5	20.0
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	11.1	11.4
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 70,852	$ 61,693
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.4	0.4
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	6.0	10.1
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.4	4.3
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,415	$ 3
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.0	0.9
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.4	1.1
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	1.4	1.0
Level 3 | Equity Securities, Preferred & Common | Valuation, Transaction Precedent | Measurement Input, Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 2,945	$ 872

XML

Portfolio Investments - Schedule of Financial Instruments Disclosed, but Carried at Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Schedule of Investments [Line Items]
Carrying Value	$ 1,740,066	$ 1,301,043
Fair Value	1,722,977	1,277,105
Syndicated Facility
Schedule of Investments [Line Items]
Carrying Value	800,000	540,000
Fair Value	800,000	540,000
Citibank Facility
Schedule of Investments [Line Items]
Carrying Value		160,000
Fair Value		160,000
OSI2 Citibank Facility
Schedule of Investments [Line Items]
Carrying Value	335,000
Fair Value	335,000
2025 Notes
Schedule of Investments [Line Items]
Carrying Value	297,928	296,991
Fair Value	285,717	283,077
2027 Notes
Schedule of Investments [Line Items]
Carrying Value	307,138	304,052
Fair Value	302,260	294,028
Level 1
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value		0
Level 1 | OSI2 Citibank Facility
Schedule of Investments [Line Items]
Fair Value	0
Level 1 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2
Schedule of Investments [Line Items]
Fair Value	587,977	577,105
Level 2 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value		0
Level 2 | OSI2 Citibank Facility
Schedule of Investments [Line Items]
Fair Value	0
Level 2 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	285,717	283,077
Level 2 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	302,260	294,028
Level 3
Schedule of Investments [Line Items]
Fair Value	1,135,000	700,000
Level 3 | Syndicated Facility
Schedule of Investments [Line Items]
Fair Value	800,000	540,000
Level 3 | Citibank Facility
Schedule of Investments [Line Items]
Fair Value		160,000
Level 3 | OSI2 Citibank Facility
Schedule of Investments [Line Items]
Fair Value	335,000
Level 3 | 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 3 | 2027 Notes
Schedule of Investments [Line Items]
Fair Value	$ 0	$ 0

XML

Portfolio Investments - Portfolio Composition (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,296,285	$ 2,617,754
Investments at fair value	$ 3,135,619	$ 2,494,111
Investment owned, percent of net assets	207.73%	200.24%
Northeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 994,695	$ 747,420
Investments at fair value	$ 936,888	$ 696,368
Investment owned, percent of net assets	62.07%	55.90%
Midwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 448,981	$ 373,236
Investments at fair value	$ 429,317	$ 356,934
Investment owned, percent of net assets	28.44%	28.66%
Southeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 446,546	$ 356,041
Investments at fair value	$ 406,523	$ 344,567
Investment owned, percent of net assets	26.93%	27.66%
West
Schedule of Investments [Line Items]
Investment owned, at cost	$ 440,634	$ 358,306
Investments at fair value	$ 428,232	$ 345,251
Investment owned, percent of net assets	28.37%	27.72%
International
Schedule of Investments [Line Items]
Investment owned, at cost	$ 434,844	$ 301,242
Investments at fair value	$ 432,986	$ 279,646
Investment owned, percent of net assets	28.69%	22.45%
South
Schedule of Investments [Line Items]
Investment owned, at cost	$ 197,754	$ 168,819
Investments at fair value	$ 186,792	$ 166,230
Investment owned, percent of net assets	12.37%	13.35%
Northwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 168,992	$ 91,382
Investments at fair value	$ 166,089	$ 90,131
Investment owned, percent of net assets	11.00%	7.24%
Southwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 163,839	$ 221,308
Investments at fair value	$ 148,792	$ 214,984
Investment owned, percent of net assets	9.86%	17.26%
Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Cost | Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Cost | Geographic Concentration Risk | Northeast
Schedule of Investments [Line Items]
Concentration risk	30.17%	28.55%
Investment Owned, At Cost | Geographic Concentration Risk | Midwest
Schedule of Investments [Line Items]
Concentration risk	13.62%	14.26%
Investment Owned, At Cost | Geographic Concentration Risk | Southeast
Schedule of Investments [Line Items]
Concentration risk	13.55%	13.60%
Investment Owned, At Cost | Geographic Concentration Risk | West
Schedule of Investments [Line Items]
Concentration risk	13.37%	13.69%
Investment Owned, At Cost | Geographic Concentration Risk | International
Schedule of Investments [Line Items]
Concentration risk	13.19%	11.51%
Investment Owned, At Cost | Geographic Concentration Risk | South
Schedule of Investments [Line Items]
Concentration risk	6.00%	6.45%
Investment Owned, At Cost | Geographic Concentration Risk | Northwest
Schedule of Investments [Line Items]
Concentration risk	5.13%	3.49%
Investment Owned, At Cost | Geographic Concentration Risk | Southwest
Schedule of Investments [Line Items]
Concentration risk	4.97%	8.45%
Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Fair Value | Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Fair Value | Geographic Concentration Risk | Northeast
Schedule of Investments [Line Items]
Concentration risk	29.87%	27.93%
Investment Owned, At Fair Value | Geographic Concentration Risk | Midwest
Schedule of Investments [Line Items]
Concentration risk	13.69%	14.31%
Investment Owned, At Fair Value | Geographic Concentration Risk | Southeast
Schedule of Investments [Line Items]
Concentration risk	12.96%	13.82%
Investment Owned, At Fair Value | Geographic Concentration Risk | West
Schedule of Investments [Line Items]
Concentration risk	13.66%	13.84%
Investment Owned, At Fair Value | Geographic Concentration Risk | International
Schedule of Investments [Line Items]
Concentration risk	13.81%	11.21%
Investment Owned, At Fair Value | Geographic Concentration Risk | South
Schedule of Investments [Line Items]
Concentration risk	5.96%	6.66%
Investment Owned, At Fair Value | Geographic Concentration Risk | Northwest
Schedule of Investments [Line Items]
Concentration risk	5.30%	3.61%
Investment Owned, At Fair Value | Geographic Concentration Risk | Southwest
Schedule of Investments [Line Items]
Concentration risk	4.75%	8.62%
Debt Securities, Senior Secured
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,886,772	$ 2,227,245
Investments at fair value	$ 2,774,373	$ 2,166,409
Investment owned, percent of net assets	183.80%	173.93%
Debt Securities, Senior Secured | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	87.59%	85.08%
Debt Securities, Senior Secured | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	88.48%	86.86%
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 162,653	$ 146,444
Investments at fair value	$ 162,288	$ 146,533
Investment owned, percent of net assets	10.75%	11.77%
Debt investments in the JVs | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.93%	5.59%
Debt investments in the JVs | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	5.18%	5.88%
Equity Securities, Preferred
Schedule of Investments [Line Items]
Investment owned, at cost	$ 99,597	$ 85,300
Investments at fair value	$ 92,186	$ 79,523
Investment owned, percent of net assets	6.11%	6.38%
Equity Securities, Preferred | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.02%	3.26%
Equity Securities, Preferred | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.94%	3.19%
Debt Securities, Subordinated
Schedule of Investments [Line Items]
Investment owned, at cost	$ 55,450	$ 67,147
Investments at fair value	$ 51,996	$ 56,920
Investment owned, percent of net assets	3.44%	4.57%
Debt Securities, Subordinated | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.68%	2.57%
Debt Securities, Subordinated | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.66%	2.28%
Equity Securities, JV LLC
Schedule of Investments [Line Items]
Investment owned, at cost	$ 54,791	$ 49,322
Investments at fair value	$ 27,973	$ 20,715
Investment owned, percent of net assets	1.85%	1.66%
Equity Securities, JV LLC | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.66%	1.88%
Equity Securities, JV LLC | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.89%	0.83%
Equity Securities, Common And Warrants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 37,022	$ 42,296
Investments at fair value	$ 26,803	$ 24,011
Investment owned, percent of net assets	1.78%	1.93%
Equity Securities, Common And Warrants | Investment Owned, At Cost | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.12%	1.62%
Equity Securities, Common And Warrants | Investment Owned, At Fair Value | Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.85%	0.96%

XML

Portfolio Investments - Portfolio of Investments by Industry (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,296,285	$ 2,617,754
Investments at fair value	$ 3,135,619	$ 2,494,111
Investment owned, percent of net assets	207.73%	200.24%
Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	100.00%	100.00%
Application Software
Schedule of Investments [Line Items]
Investment owned, at cost	$ 560,503	$ 391,938
Application Software | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 544,685	$ 384,589
Investment owned, percent of net assets	36.03%	30.87%
Application Software | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	17.38%	15.43%
Application Software | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	16.98%	14.98%
Multi-Sector Holdings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 219,130	$ 195,766
Multi-Sector Holdings | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 192,160	$ 167,248
Investment owned, percent of net assets	12.73%	13.43%
Multi-Sector Holdings | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	6.13%	6.71%
Multi-Sector Holdings | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	6.65%	7.48%
Data Processing & Outsourced Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 133,422	$ 120,477
Data Processing & Outsourced Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 124,548	$ 111,335
Investment owned, percent of net assets	8.25%	8.94%
Data Processing & Outsourced Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.97%	4.46%
Data Processing & Outsourced Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.05%	4.60%
Health Care Technology
Schedule of Investments [Line Items]
Investment owned, at cost	$ 129,178	$ 100,084
Health Care Technology | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 115,659	$ 97,315
Investment owned, percent of net assets	7.66%	7.81%
Health Care Technology | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.69%	3.90%
Health Care Technology | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.92%	3.82%
Biotechnology
Schedule of Investments [Line Items]
Investment owned, at cost	$ 127,394	$ 109,960
Biotechnology | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 128,343	$ 108,465
Investment owned, percent of net assets	8.50%	8.71%
Biotechnology | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	4.09%	4.35%
Biotechnology | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.86%	4.20%
Pharmaceuticals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 121,497	$ 126,508
Pharmaceuticals | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 116,199	$ 119,511
Investment owned, percent of net assets	7.70%	9.59%
Pharmaceuticals | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.71%	4.79%
Pharmaceuticals | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.69%	4.83%
Aerospace & Defense
Schedule of Investments [Line Items]
Investment owned, at cost	$ 110,680	$ 61,963
Aerospace & Defense | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 111,464	$ 61,881
Investment owned, percent of net assets	7.38%	4.97%
Aerospace & Defense | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.55%	2.48%
Aerospace & Defense | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.36%	2.37%
Industrial Machinery & Supplies & Components
Schedule of Investments [Line Items]
Investment owned, at cost	$ 99,237	$ 0
Industrial Machinery & Supplies & Components | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 99,021	$ 0
Investment owned, percent of net assets	6.56%	0.00%
Industrial Machinery & Supplies & Components | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.16%	0.00%
Industrial Machinery & Supplies & Components | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	3.01%	0.00%
Broadline Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 83,201	$ 0
Broadline Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 80,882	$ 0
Investment owned, percent of net assets	5.36%	0.00%
Broadline Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.58%	0.00%
Broadline Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.52%	0.00%
Health Care Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 77,364	$ 58,674
Health Care Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,190	$ 45,943
Investment owned, percent of net assets	4.12%	3.69%
Health Care Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.98%	1.84%
Health Care Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.35%	2.24%
Real Estate Operating Companies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 76,462	$ 47,585
Real Estate Operating Companies | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 75,111	$ 48,062
Investment owned, percent of net assets	4.98%	3.86%
Real Estate Operating Companies | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.40%	1.93%
Real Estate Operating Companies | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.32%	1.82%
Specialized Finance
Schedule of Investments [Line Items]
Investment owned, at cost	$ 69,188	$ 80,864
Specialized Finance | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 66,333	$ 73,087
Investment owned, percent of net assets	4.39%	5.87%
Specialized Finance | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.12%	2.93%
Specialized Finance | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.10%	3.09%
Personal Care Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 68,671	$ 0
Personal Care Products | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 60,962	$ 0
Investment owned, percent of net assets	4.04%	0.00%
Personal Care Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.94%	0.00%
Personal Care Products | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.08%	0.00%
Automotive Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 64,825	$ 59,254
Automotive Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,356	$ 57,629
Investment owned, percent of net assets	4.13%	4.63%
Automotive Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.99%	2.31%
Automotive Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.97%	2.26%
Fertilizers & Agricultural Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 64,750	$ 49,301
Fertilizers & Agricultural Chemicals | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 63,185	$ 51,972
Investment owned, percent of net assets	4.19%	4.17%
Fertilizers & Agricultural Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.02%	2.08%
Fertilizers & Agricultural Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.96%	1.88%
Internet Services & Infrastructure
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,057	$ 54,095
Internet Services & Infrastructure | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 62,726	$ 53,797
Investment owned, percent of net assets	4.16%	4.32%
Internet Services & Infrastructure | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	2.00%	2.16%
Internet Services & Infrastructure | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.91%	2.07%
Health Care Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 62,079	$ 57,112
Health Care Distributors | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 60,340	$ 54,662
Investment owned, percent of net assets	4.00%	4.39%
Health Care Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.92%	2.19%
Health Care Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.88%	2.18%
Diversified Financial Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 61,693	$ 0
Diversified Financial Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 61,073	$ 0
Investment owned, percent of net assets	4.05%	0.00%
Diversified Financial Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.95%	0.00%
Diversified Financial Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.87%	0.00%
Auto Parts & Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 61,091	$ 12,474
Auto Parts & Equipment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 60,809	$ 11,469
Investment owned, percent of net assets	4.03%	0.92%
Auto Parts & Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.94%	0.46%
Auto Parts & Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.85%	0.48%
Metal, Glass & Plastic Containers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 57,949	$ 0
Metal, Glass & Plastic Containers | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 43,954	$ 0
Investment owned, percent of net assets	2.91%	0.00%
Metal, Glass & Plastic Containers | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.40%	0.00%
Metal, Glass & Plastic Containers | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.76%	0.00%
Airport Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 55,919	$ 43,322
Airport Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 55,221	$ 42,883
Investment owned, percent of net assets	3.66%	3.44%
Airport Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.76%	1.72%
Airport Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.70%	1.65%
Home Improvement Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 54,939	$ 45,802
Home Improvement Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 54,235	$ 45,421
Investment owned, percent of net assets	3.59%	3.65%
Home Improvement Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.73%	1.82%
Home Improvement Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.67%	1.75%
Insurance Brokers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 52,960	$ 35,628
Insurance Brokers | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 54,680	$ 33,081
Investment owned, percent of net assets	3.62%	2.66%
Insurance Brokers | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.74%	1.33%
Insurance Brokers | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.61%	1.36%
Diversified Metals & Mining
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,787	$ 0
Diversified Metals & Mining | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 49,809	$ 0
Investment owned, percent of net assets	3.30%	0.00%
Diversified Metals & Mining | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.59%	0.00%
Diversified Metals & Mining | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.51%	0.00%
Leisure Facilities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,501	$ 39,768
Leisure Facilities | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 46,990	$ 39,258
Investment owned, percent of net assets	3.11%	3.15%
Leisure Facilities | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.50%	1.57%
Leisure Facilities | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.50%	1.52%
Real Estate Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 44,783	$ 40,243
Real Estate Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 44,227	$ 39,573
Investment owned, percent of net assets	2.93%	3.18%
Real Estate Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.41%	1.59%
Real Estate Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.36%	1.54%
Soft Drinks & Non-alcoholic Beverages
Schedule of Investments [Line Items]
Investment owned, at cost	$ 43,021	$ 0
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 42,798	$ 0
Investment owned, percent of net assets	2.84%	0.00%
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.36%	0.00%
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.31%	0.00%
Diversified Support Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 42,706	$ 37,992
Diversified Support Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 41,302	$ 36,712
Investment owned, percent of net assets	2.74%	2.95%
Diversified Support Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.32%	1.47%
Diversified Support Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.30%	1.45%
Other Specialty Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 41,790	$ 0
Other Specialty Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 41,790	$ 0
Investment owned, percent of net assets	2.77%	0.00%
Other Specialty Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.33%	0.00%
Other Specialty Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.27%	0.00%
Specialty Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 38,248	$ 37,319
Specialty Chemicals | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 32,231	$ 33,969
Investment owned, percent of net assets	2.14%	2.73%
Specialty Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.03%	1.36%
Specialty Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.16%	1.43%
Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 37,668	$ 25,278
Distributors | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 36,829	$ 24,494
Investment owned, percent of net assets	2.44%	1.97%
Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.17%	0.98%
Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.14%	0.97%
Integrated Telecommunication Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 33,663	$ 34,628
Integrated Telecommunication Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 30,922	$ 32,201
Investment owned, percent of net assets	2.05%	2.59%
Integrated Telecommunication Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.99%	1.29%
Integrated Telecommunication Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.02%	1.32%
Electrical Components & Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 32,380	$ 33,814
Electrical Components & Equipment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 32,379	$ 32,933
Investment owned, percent of net assets	2.15%	2.64%
Electrical Components & Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	1.03%	1.32%
Electrical Components & Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.98%	1.29%
Construction & Engineering
Schedule of Investments [Line Items]
Investment owned, at cost	$ 27,231	$ 60,996
Construction & Engineering | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 26,901	$ 61,188
Investment owned, percent of net assets	1.78%	4.91%
Construction & Engineering | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.86%	2.45%
Construction & Engineering | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.83%	2.33%
Environmental & Facilities Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 25,943	$ 20,857
Environmental & Facilities Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 25,436	$ 20,585
Investment owned, percent of net assets	1.69%	1.65%
Environmental & Facilities Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.81%	0.83%
Environmental & Facilities Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.79%	0.80%
Advertising
Schedule of Investments [Line Items]
Investment owned, at cost	$ 25,597	$ 28,245
Advertising | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 18,969	$ 26,948
Investment owned, percent of net assets	1.26%	2.16%
Advertising | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.60%	1.08%
Advertising | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.78%	1.08%
Passenger Airlines
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,888	$ 0
Passenger Airlines | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 26,985	$ 0
Investment owned, percent of net assets	1.79%	0.00%
Passenger Airlines | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.86%	0.00%
Passenger Airlines | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.76%	0.00%
Oil & Gas Storage & Transportation
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,231	$ 22,290
Oil & Gas Storage & Transportation | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 21,660	$ 20,853
Investment owned, percent of net assets	1.43%	1.67%
Oil & Gas Storage & Transportation | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.69%	0.84%
Oil & Gas Storage & Transportation | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.74%	0.85%
Home Furnishings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 23,832	$ 19,550
Home Furnishings | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 19,514	$ 18,188
Investment owned, percent of net assets	1.29%	1.46%
Home Furnishings | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.62%	0.73%
Home Furnishings | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.72%	0.75%
Gold
Schedule of Investments [Line Items]
Investment owned, at cost	$ 23,274	$ 0
Gold | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 23,292	$ 0
Investment owned, percent of net assets	1.54%	0.00%
Gold | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.74%	0.00%
Gold | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.71%	0.00%
Systems Software
Schedule of Investments [Line Items]
Investment owned, at cost	$ 23,089	$ 14,890
Systems Software | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 22,168	$ 12,834
Investment owned, percent of net assets	1.47%	1.03%
Systems Software | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.71%	0.51%
Systems Software | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.70%	0.57%
Health Care Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 22,374	$ 24,353
Health Care Equipment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 22,531	$ 24,161
Investment owned, percent of net assets	1.49%	1.94%
Health Care Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.72%	0.97%
Health Care Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.68%	0.93%
Real Estate Development
Schedule of Investments [Line Items]
Investment owned, at cost	$ 19,567	$ 0
Real Estate Development | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 19,246	$ 0
Investment owned, percent of net assets	1.28%	0.00%
Real Estate Development | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.61%	0.00%
Real Estate Development | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.59%	0.00%
Interactive Media & Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 18,963	$ 0
Interactive Media & Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 19,000	$ 0
Investment owned, percent of net assets	1.26%	0.00%
Interactive Media & Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.61%	0.00%
Interactive Media & Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.58%	0.00%
Hotels, Resorts & Cruise Lines
Schedule of Investments [Line Items]
Investment owned, at cost	$ 17,221	$ 13,960
Hotels, Resorts & Cruise Lines | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 17,261	$ 13,985
Investment owned, percent of net assets	1.14%	1.12%
Hotels, Resorts & Cruise Lines | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.55%	0.56%
Hotels, Resorts & Cruise Lines | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.52%	0.53%
Consumer Finance
Schedule of Investments [Line Items]
Investment owned, at cost	$ 16,411	$ 14,492
Consumer Finance | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 12,616	$ 13,284
Investment owned, percent of net assets	0.84%	1.07%
Consumer Finance | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.40%	0.53%
Consumer Finance | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.50%	0.55%
Education Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 15,660	$ 9,080
Education Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 14,116	$ 8,582
Investment owned, percent of net assets	0.94%	0.69%
Education Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.45%	0.34%
Education Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.48%	0.35%
IT Consulting & Other Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 15,434	$ 11,697
IT Consulting & Other Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 11,176	$ 8,596
Investment owned, percent of net assets	0.74%	0.69%
IT Consulting & Other Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.36%	0.34%
IT Consulting & Other Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.47%	0.45%
Restaurants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 12,589	$ 9,338
Restaurants | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 12,168	$ 8,692
Investment owned, percent of net assets	0.81%	0.70%
Restaurants | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.39%	0.35%
Restaurants | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.38%	0.36%
Movies & Entertainment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 12,188	$ 26,161
Movies & Entertainment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 11,865	$ 26,645
Investment owned, percent of net assets	0.79%	2.14%
Movies & Entertainment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.38%	1.07%
Movies & Entertainment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.37%	1.00%
Health Care Supplies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 11,675	$ 36,471
Health Care Supplies | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 11,408	$ 36,577
Investment owned, percent of net assets	0.76%	2.94%
Health Care Supplies | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.36%	1.47%
Health Care Supplies | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.35%	1.39%
Food Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 5,900	$ 4,646
Food Distributors | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 5,296	$ 3,367
Investment owned, percent of net assets	0.35%	0.27%
Food Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.17%	0.13%
Food Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.18%	0.18%
Apparel Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 5,293	$ 5,268
Apparel Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 5,230	$ 5,223
Investment owned, percent of net assets	0.35%	0.42%
Apparel Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.17%	0.21%
Apparel Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.16%	0.20%
Air Freight & Logistics
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,925	$ 7,295
Air Freight & Logistics | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,025	$ 6,405
Investment owned, percent of net assets	0.27%	0.51%
Air Freight & Logistics | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.13%	0.26%
Air Freight & Logistics | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.28%
Integrated Oil & Gas
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,887	$ 4,866
Integrated Oil & Gas | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,810	$ 4,872
Investment owned, percent of net assets	0.32%	0.39%
Integrated Oil & Gas | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.20%
Integrated Oil & Gas | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.19%
Research & Consulting Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,879	$ 9,187
Research & Consulting Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,632	$ 8,573
Investment owned, percent of net assets	0.31%	0.69%
Research & Consulting Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.34%
Research & Consulting Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.35%
Cable & Satellite
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,687	$ 20,716
Cable & Satellite | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 4,672	$ 19,576
Investment owned, percent of net assets	0.31%	1.57%
Cable & Satellite | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.15%	0.78%
Cable & Satellite | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.14%	0.79%
Other Specialized REITs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 4,364	$ 0
Other Specialized REITs | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,438	$ 0
Investment owned, percent of net assets	0.23%	0.00%
Other Specialized REITs | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.11%	0.00%
Other Specialized REITs | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.13%	0.00%
Paper & Plastic Packaging Products & Materials
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,262	$ 0
Paper & Plastic Packaging Products & Materials | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,100	$ 0
Investment owned, percent of net assets	0.21%	0.00%
Paper & Plastic Packaging Products & Materials | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.10%	0.00%
Paper & Plastic Packaging Products & Materials | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.10%	0.00%
Housewares & Specialties
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,908	$ 2,293
Housewares & Specialties | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 2,858	$ 2,456
Investment owned, percent of net assets	0.19%	0.20%
Housewares & Specialties | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.09%	0.10%
Housewares & Specialties | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.09%	0.09%
Electronic Components
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,101	$ 2,092
Electronic Components | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 1,834	$ 1,890
Investment owned, percent of net assets	0.12%	0.15%
Electronic Components | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%	0.08%
Electronic Components | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%	0.08%
Leisure Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,039	$ 0
Leisure Products | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 1,995	$ 0
Investment owned, percent of net assets	0.13%	0.00%
Leisure Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%	0.00%
Leisure Products | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.06%	0.00%
Technology Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,084	$ 3,163
Technology Distributors | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 1,024	$ 2,997
Investment owned, percent of net assets	0.07%	0.24%
Technology Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.03%	0.12%
Technology Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.03%	0.12%
Communications Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,053	$ 0
Communications Equipment | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 980	$ 0
Investment owned, percent of net assets	0.06%	0.00%
Communications Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.03%	0.00%
Communications Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.03%	0.00%
Industrial Machinery
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 81,787
Industrial Machinery | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 81,008
Investment owned, percent of net assets	0.00%	6.50%
Industrial Machinery | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	3.25%
Industrial Machinery | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	3.12%
Internet & Direct Marketing Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 67,926
Internet & Direct Marketing Retail | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 70,419
Investment owned, percent of net assets	0.00%	5.65%
Internet & Direct Marketing Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	2.82%
Internet & Direct Marketing Retail | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	2.59%
Personal Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 53,214
Personal Products | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 50,150
Investment owned, percent of net assets	0.00%	4.03%
Personal Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	2.01%
Personal Products | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	2.03%
Metal & Glass Containers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 47,704
Metal & Glass Containers | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 47,599
Investment owned, percent of net assets	0.00%	3.82%
Metal & Glass Containers | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	1.91%
Metal & Glass Containers | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	1.82%
Soft Drinks
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 34,272
Soft Drinks | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 33,670
Investment owned, percent of net assets	0.00%	2.70%
Soft Drinks | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	1.35%
Soft Drinks | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	1.31%
Other Diversified Financial Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 29,300
Other Diversified Financial Services | Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 24,326
Investment owned, percent of net assets	0.00%	1.95%
Other Diversified Financial Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.98%
Other Diversified Financial Services | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	1.12%
Oil & Gas Refining & Marketing
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 8,627
Investments at fair value	$ 0	$ 8,604
Investment owned, percent of net assets	0.00%	0.69%
Oil & Gas Refining & Marketing | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.34%
Oil & Gas Refining & Marketing | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.33%
Trading Companies & Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 7,628
Investments at fair value	$ 0	$ 5,567
Investment owned, percent of net assets	0.00%	0.45%
Trading Companies & Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.22%
Trading Companies & Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.29%
Apparel, Accessories & Luxury Goods
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 5,165
Apparel, Accessories & Luxury Goods | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.20%
Specialized REITs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,318
Investments at fair value	$ 0	$ 3,264
Investment owned, percent of net assets	0.00%	0.26%
Specialized REITs | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.13%
Specialized REITs | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.16%
Diversified Banks
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 3,515
Investments at fair value	$ 0	$ 3,402
Investment owned, percent of net assets	0.00%	0.27%
Diversified Banks | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.14%
Diversified Banks | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.13%
Construction Materials
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 2,331
Investments at fair value	$ 0	$ 1,934
Investment owned, percent of net assets	0.00%	0.16%
Construction Materials | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.08%
Construction Materials | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.09%
Alternative Carriers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 212
Investments at fair value	$ 0	$ 201
Investment owned, percent of net assets	0.00%	0.02%
Alternative Carriers | Investment Owned, At Fair Value | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.01%
Alternative Carriers | Investment Owned, At Cost | Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk	0.00%	0.01%

XML

Portfolio Investments - Summary of Portfolio (Details) € in Thousands, £ in Thousands, $ in Thousands		Jun. 30, 2023 USD ($) borrower		Jun. 30, 2023 EUR (€) borrower		Jun. 30, 2023 GBP (£) borrower		Sep. 30, 2022 USD ($) borrower		Sep. 30, 2022 EUR (€) borrower		Sep. 30, 2022 GBP (£) borrower		Jun. 30, 2022 USD ($)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Number of borrowers in the Glick JV | borrower		156		156		156		149		149		149
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[5]	$ 1,174
Investment, interest rate	[1],[2],[3],[5],[6],[7]	12.50%		12.50%		12.50%
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4]	$ 14,916
Investment, interest rate	[1],[2],[3],[6],[7]	11.00%		11.00%		11.00%
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 389
Investment, interest rate	[8],[9],[11],[12]							9.80%		9.80%		9.80%
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 0
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[5]	$ 3,710
Investment, interest rate	[1],[2],[3],[5],[6],[7]	12.00%		12.00%		12.00%
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14],[15]	$ 21,434
Investment, interest rate	[1],[3],[6],[7],[14],[15]	14.25%		14.25%		14.25%
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,576	[1],[3],[4],[14]					33,997	[8],[9],[10],[16]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 14,685
Investment, interest rate	[8],[9],[11],[12]							9.80%		9.80%		9.80%
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 3,520
Investment, interest rate	[1],[3],[6],[7]	12.00%		12.00%		12.00%
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 18,271
Investment, interest rate	[1],[3],[6],[7]	12.00%		12.00%		12.00%
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 1,000
Investment, interest rate	[1],[3],[6],[7]	11.66%		11.66%		11.66%
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,589	[1],[3],[4],[7],[14]					$ 6,589	[8],[9],[10],[11],[16]
Investment, interest rate		12.89%	[1],[3],[6],[7],[14]	12.89%	[1],[3],[6],[7],[14]	12.89%	[1],[3],[6],[7],[14]	11.20%	[8],[9],[11],[12],[16]	11.20%	[8],[9],[11],[12],[16]	11.20%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7],[14]					$ 0	[8],[9],[10],[11],[13],[16]
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €				€ 29,985	[1],[3],[4],[7],[14]					€ 24,838	[8],[9],[10],[11],[16]
Investment, interest rate		10.67%	[1],[3],[6],[7],[14]	10.67%	[1],[3],[6],[7],[14]	10.67%	[1],[3],[6],[7],[14]	7.94%	[8],[9],[11],[12],[16]	7.94%	[8],[9],[11],[12],[16]	7.94%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,873	[1],[3],[4],[7]					$ 14,414	[8],[9],[10],[11]
Investment, interest rate		12.95%	[1],[3],[6],[7]	12.95%	[1],[3],[6],[7]	12.95%	[1],[3],[6],[7]	10.88%	[8],[9],[11],[12]	10.88%	[8],[9],[11],[12]	10.88%	[8],[9],[11],[12]
Investment, Identifier [Axis]: APX Group Inc., Electrical Components & Equipment, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[16]							$ 2,075
Investment, interest rate	[9],[11],[12],[16]							5.75%		5.75%		5.75%
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10]							$ 5,500
Investment, interest rate	[9],[11],[12]							7.50%		7.50%		7.50%
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10]							$ 2,500
Investment, interest rate	[9],[11],[12]							5.25%		5.25%		5.25%
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7],[14]	$ 0
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[14]	$ 3,284
Investment, interest rate	[1],[3],[6],[7],[14]	11.31%		11.31%		11.31%
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14],[15]	$ 11,683
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 20,000	[1],[3],[4],[7]					$ 20,000	[9],[10],[11]
Investment, interest rate		12.94%	[1],[3],[6],[7]	12.94%	[1],[3],[6],[7]	12.94%	[1],[3],[6],[7]	10.82%	[9],[11],[12]	10.82%	[9],[11],[12]	10.82%	[9],[11],[12]
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 2,033
Investment, interest rate	[1],[2],[3],[6],[7]	10.86%		10.86%		10.86%
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 20,286
Investment, interest rate	[1],[3],[6],[7]	10.86%		10.86%		10.86%
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, interest rate	[1],[2],[3],[6],[7]
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 500
Investment, interest rate	[8],[9],[11],[12],[13]							9.14%		9.14%		9.14%
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 15,976
Investment, interest rate	[8],[9],[11],[12]							9.12%		9.12%		9.12%
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 0
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,113	[1],[2],[3],[4],[7]					$ 914	[8],[9],[10],[11],[13]
Investment, interest rate		12.05%	[1],[2],[3],[6],[7]	12.05%	[1],[2],[3],[6],[7]	12.05%	[1],[2],[3],[6],[7]	10.64%	[8],[9],[11],[12],[13]	10.64%	[8],[9],[11],[12],[13]	10.64%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 27,349
Investment, interest rate	[8],[9],[11],[12]							9.63%		9.63%		9.63%
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 6,400
Investment, interest rate	[1],[3],[6],[7]	12.34%		12.34%		12.34%
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 25,332
Investment, interest rate	[1],[3],[6],[7]	12.34%		12.34%		12.34%
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 23,338
Investment, Identifier [Axis]: All Web Leads, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[17]	$ 23,562
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,050	[3],[4],[14]					$ 4,050	[9],[10],[16]
Investment, interest rate		5.50%	[3],[6],[7],[14]	5.50%	[3],[6],[7],[14]	5.50%	[3],[6],[7],[14]	5.50%	[9],[11],[12],[16]	5.50%	[9],[11],[12],[16]	5.50%	[9],[11],[12],[16]
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 8,794
Investment, interest rate	[1],[3],[6],[7]	13.34%		13.34%		13.34%
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,280	[1],[3],[4],[7]					$ 13,134	[8],[9],[10],[11]
Investment, interest rate		12.89%	[1],[3],[6],[7]	12.89%	[1],[3],[6],[7]	12.89%	[1],[3],[6],[7]	11.20%	[8],[9],[11],[12]	11.20%	[8],[9],[11],[12]	11.20%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[16]							$ 24,043
Investment, interest rate	[8],[9],[11],[12],[16]							10.00%		10.00%		10.00%
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]	$ 28,464
Investment, interest rate	[1],[3],[6],[7],[14]	8.50%		8.50%		8.50%
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]	$ 2,121
Investment, interest rate	[1],[3],[6],[7],[14]	8.50%		8.50%		8.50%
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]	$ 27,692
Investment, interest rate	[1],[3],[6],[7],[14]	8.50%		8.50%		8.50%
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]	$ 2,064
Investment, interest rate	[1],[3],[6],[7],[14]	8.50%		8.50%		8.50%
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[16]							$ 23,522
Investment, interest rate	[8],[9],[11],[12],[16]							10.00%		10.00%		10.00%
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,048	[1],[3],[4],[7]					$ 14,760	[8],[9],[10],[11]
Investment, interest rate		13.99%	[1],[3],[6],[7]	13.99%	[1],[3],[6],[7]	13.99%	[1],[3],[6],[7]	12.30%	[8],[9],[11],[12]	12.30%	[8],[9],[11],[12]	12.30%	[8],[9],[11],[12]
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 19,163	[3],[4],[7]					$ 9,895	[9],[10],[11]
Investment, interest rate		11.49%	[3],[6],[7]	11.49%	[3],[6],[7]	11.49%	[3],[6],[7]	9.03%	[9],[11],[12]	9.03%	[9],[11],[12]	9.03%	[9],[11],[12]
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[16]							$ 15,220
Investment, interest rate	[8],[9],[11],[12],[16]							7.92%		7.92%		7.92%
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,500	[1],[3],[4],[7],[14]					$ 12,500	[8],[9],[10],[11],[16]
Investment, interest rate		13.39%	[1],[3],[6],[7],[14]	13.39%	[1],[3],[6],[7],[14]	13.39%	[1],[3],[6],[7],[14]	11.67%	[8],[9],[11],[12],[16]	11.67%	[8],[9],[11],[12],[16]	11.67%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4],[7]	$ 3,710
Investment, interest rate	[3],[6],[7]	9.25%		9.25%		9.25%
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 2,736
Investment, interest rate	[9],[11],[12]							7.42%		7.42%		7.42%
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Research & Consulting Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 4,346
Investment, interest rate	[8],[9],[11],[12]							10.78%		10.78%		10.78%
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 808	[1],[2],[3],[4],[7]					$ 892	[8],[9],[10],[11],[13]
Investment, interest rate		10.20%	[1],[2],[3],[6],[7]	10.20%	[1],[2],[3],[6],[7]	10.20%	[1],[2],[3],[6],[7]	8.46%	[8],[9],[11],[12],[13]	8.46%	[8],[9],[11],[12],[13]	8.46%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 34,458
Investment, interest rate	[8],[9],[11],[12]							8.46%		8.46%		8.46%
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 9,280
Investment, interest rate	[1],[3],[6],[7]	10.20%		10.20%		10.20%
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 32,308
Investment, interest rate	[1],[3],[6],[7]	10.20%		10.20%		10.20%
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €				€ 3,017	[1],[3],[4],[7],[14]					€ 1,964	[8],[9],[10],[11],[16]
Investment, interest rate		10.07%	[1],[3],[6],[7],[14]	10.07%	[1],[3],[6],[7],[14]	10.07%	[1],[3],[6],[7],[14]	8.00%	[8],[9],[11],[12],[16]	8.00%	[8],[9],[11],[12],[16]	8.00%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 10,519	[1],[3],[4],[7],[14]									£ 18,636	[8],[9],[10],[11],[16]
Investment, interest rate		11.25%	[1],[3],[6],[7],[14]	11.25%	[1],[3],[6],[7],[14]	11.25%	[1],[3],[6],[7],[14]	9.19%	[8],[9],[11],[12],[16]	9.19%	[8],[9],[11],[12],[16]	9.19%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal						£ 4,949	[1],[3],[4],[7],[14]	$ 10,519	[8],[9],[10],[11],[16]
Investment, interest rate		12.18%	[1],[3],[6],[7],[14]	12.18%	[1],[3],[6],[7],[14]	12.18%	[1],[3],[6],[7],[14]	8.81%	[8],[9],[11],[12],[16]	8.81%	[8],[9],[11],[12],[16]	8.81%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £						£ 23,675	[1],[3],[4],[7],[14]					£ 0	[8],[9],[10],[11],[13],[16]
Investment, interest rate	[1],[3],[6],[7],[14]	12.45%		12.45%		12.45%
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €	[1],[3],[4],[7],[14]			€ 3,649
Investment, interest rate	[1],[3],[6],[7],[14]	8.57%		8.57%		8.57%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0												$ 0
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 22,304												$ 21,754
Investment, interest rate		12.29%		12.29%		12.29%								9.00%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0												$ 0
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 22,304	[1],[2],[4],[7],[18]					$ 24,490	[8],[10],[11],[13],[19]
Investment, interest rate		12.29%	[1],[2],[6],[7],[18]	12.29%	[1],[2],[6],[7],[18]	12.29%	[1],[2],[6],[7],[18]	10.42%	[8],[11],[12],[13],[19]	10.42%	[8],[11],[12],[13],[19]	10.42%	[8],[11],[12],[13],[19]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0												0
Investment, Identifier [Axis]: Associated Asphalt Partners, LLC, Construction Materials, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 2,501
Investment, interest rate	[9],[11],[12]							8.06%		8.06%		8.06%
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,490	[3],[4],[7]					$ 5,640	[9],[10],[11]
Investment, interest rate		10.44%	[3],[6],[7]	10.44%	[3],[6],[7]	10.44%	[3],[6],[7]	8.37%	[9],[11],[12]	8.37%	[9],[11],[12]	8.37%	[9],[11],[12]
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,338	[1],[3],[4],[14],[17]					$ 13,346	[8],[9],[10],[16]
Investment, interest rate		11.00%	[1],[3],[6],[7],[14],[17]	11.00%	[1],[3],[6],[7],[14],[17]	11.00%	[1],[3],[6],[7],[14],[17]	11.00%	[8],[9],[11],[12],[16]	11.00%	[8],[9],[11],[12],[16]	11.00%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,338	[1],[3],[4],[14],[17]					$ 8,309	[8],[9],[10],[16],[20]
Investment, interest rate	[1],[3],[6],[7],[14],[17]	11.00%		11.00%		11.00%
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14],[17]	$ 5,350
Investment, interest rate	[1],[3],[6],[7],[14],[17]	11.00%		11.00%		11.00%
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]	$ 0
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 29,509	[1],[3],[4],[7],[14]					$ 22,425	[8],[9],[10],[11],[16]
Investment, interest rate		11.27%	[1],[3],[6],[7],[14]	11.27%	[1],[3],[6],[7],[14]	11.27%	[1],[3],[6],[7],[14]	8.78%	[8],[9],[11],[12],[16]	8.78%	[8],[9],[11],[12],[16]	8.78%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 50,470
Investment, interest rate	[1],[3],[6],[7]	12.49%		12.49%		12.49%
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 2,546
Investment, interest rate	[8],[9],[11],[12],[13]							8.12%		8.12%		8.12%
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 3,258
Investment, interest rate	[1],[3],[6],[7]	10.50%		10.50%		10.50%
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 1,264
Investment, interest rate	[1],[3],[6],[7]	10.50%		10.50%		10.50%
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,920	[1],[3],[4],[7]					$ 7,166	[8],[9],[10],[11]
Investment, interest rate		14.00%	[1],[3],[6],[7]	14.00%	[1],[3],[6],[7]	14.00%	[1],[3],[6],[7]	11.62%	[8],[9],[11],[12]	11.62%	[8],[9],[11],[12]	11.62%	[8],[9],[11],[12]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,091	[1],[3],[4],[7]					$ 4,227	[8],[9],[10],[11],[13]
Investment, interest rate		14.00%	[1],[3],[6],[7]	14.00%	[1],[3],[6],[7]	14.00%	[1],[3],[6],[7]	11.62%	[8],[9],[11],[12],[13]	11.62%	[8],[9],[11],[12],[13]	11.62%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 4,361
Investment, interest rate	[1],[3],[6],[7]	14.00%		14.00%		14.00%
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 2,528
Investment, interest rate	[1],[2],[3],[6],[7]	12.50%		12.50%		12.50%
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 40,764
Investment, interest rate	[1],[3],[6],[7]	10.70%		10.70%		10.70%
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 1,702
Investment, interest rate	[8],[9],[11],[12],[13]							10.75%		10.75%		10.75%
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 33,078
Investment, interest rate	[8],[9],[11],[12]							8.31%		8.31%		8.31%
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[13],[16],[20]							$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,719	[1],[3],[4],[14]					$ 5,322	[8],[9],[10],[16]
Investment, interest rate		8.00%	[1],[3],[6],[7],[14]	8.00%	[1],[3],[6],[7],[14]	8.00%	[1],[3],[6],[7],[14]	10.25%	[8],[9],[11],[12],[16]	10.25%	[8],[9],[11],[12],[16]	10.25%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,210	[1],[3],[4],[14],[15]					$ 0	[8],[9],[10],[13],[16]
Investment, interest rate	[8],[9],[11],[12],[13],[16]							10.25%		10.25%		10.25%
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[14]					$ 2,353	[8],[9],[10],[16],[20]
Investment, interest rate	[1],[3],[6],[7],[14]	8.00%		8.00%		8.00%
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[14]	$ 0
Investment, interest rate	[1],[3],[6],[7],[14]	8.00%		8.00%		8.00%
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[14],[15]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[14],[15]	0
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 30,625	[3],[4],[7]					$ 30,625	[9],[10],[11]
Investment, interest rate		12.25%	[3],[6],[7]	12.25%	[3],[6],[7]	12.25%	[3],[6],[7]	9.50%	[9],[11],[12]	9.50%	[9],[11],[12]	9.50%	[9],[11],[12]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,994	[1],[3],[4]					$ 3,979	[8],[9],[10]
Investment, interest rate		9.00%	[1],[3],[6],[7]	9.00%	[1],[3],[6],[7]	9.00%	[1],[3],[6],[7]	9.00%	[8],[9],[11],[12]	9.00%	[8],[9],[11],[12]	9.00%	[8],[9],[11],[12]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment, Identifier [Axis]: CCO Holdings LLC, Cable & Satellite, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[16]							$ 2,097
Investment, interest rate	[9],[11],[12],[16]							4.50%		4.50%		4.50%
Investment, Identifier [Axis]: CITGO Holding, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10]							$ 7,857
Investment, interest rate	[9],[11],[12]							9.25%		9.25%		9.25%
Investment, Identifier [Axis]: CITGO Petroleum Corp., Oil & Gas Refining & Marketing, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 795
Investment, interest rate	[9],[11],[12]							9.37%		9.37%		9.37%
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[17]	727
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 14,294
Investment, interest rate	[8],[9],[11],[12]							9.31%		9.31%		9.31%
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 13
Investment, interest rate	[1],[3],[6],[7]	11.91%		11.91%		11.91%
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 3,031
Investment, interest rate	[1],[3],[6],[7]	11.91%		11.91%		11.91%
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 1,557
Investment, interest rate	[1],[3],[6],[7]	11.91%		11.91%		11.91%
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 1,024
Investment, interest rate	[1],[3],[6],[7]	11.91%		11.91%		11.91%
Investment, Identifier [Axis]: Caregiver Services, Inc., Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0												0
Investment, Identifier [Axis]: Carvana Co., Automotive Retail, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[16]							$ 6,700
Investment, interest rate	[9],[11],[12],[16]							5.63%		5.63%		5.63%
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 10,692
Investment, interest rate	[8],[9],[11],[12]							8.62%		8.62%		8.62%
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 130
Investment, interest rate	[1],[3],[6],[7]	10.70%		10.70%		10.70%
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 129
Investment, interest rate	[1],[3],[6],[7]	10.70%		10.70%		10.70%
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 1,084
Investment, interest rate	[1],[3],[6],[7]	10.70%		10.70%		10.70%
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 9,002
Investment, interest rate	[1],[3],[6],[7]	10.70%		10.70%		10.70%
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,632	[3],[4],[14]					$ 4,311	[9],[10],[16]
Investment, interest rate		7.50%	[3],[6],[7],[14]	7.50%	[3],[6],[7],[14]	7.50%	[3],[6],[7],[14]	7.50%	[9],[11],[12],[16]	7.50%	[9],[11],[12],[16]	7.50%	[9],[11],[12],[16]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 176	[3],[4],[14]					$ 1,374	[9],[10],[16]
Investment, interest rate		7.75%	[3],[6],[7],[14]	7.75%	[3],[6],[7],[14]	7.75%	[3],[6],[7],[14]	5.13%	[9],[11],[12],[16]	5.13%	[9],[11],[12],[16]	5.13%	[9],[11],[12],[16]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[16]							$ 676
Investment, interest rate	[9],[11],[12],[16]							7.75%		7.75%		7.75%
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,420	[3],[4]					$ 8,420	[9],[10]
Investment, interest rate		7.38%	[3],[6],[7]	7.38%	[3],[6],[7]	7.38%	[3],[6],[7]	7.38%	[9],[11],[12]	7.38%	[9],[11],[12]	7.38%	[9],[11],[12]
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 24,350	[1],[3],[4],[7]					$ 22,537	[8],[9],[10],[11]
Investment, interest rate		13.69%	[1],[3],[6],[7]	13.69%	[1],[3],[6],[7]	13.69%	[1],[3],[6],[7]	11.62%	[8],[9],[11],[12]	11.62%	[8],[9],[11],[12]	11.62%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,506	[3],[4],[7]					$ 11,913	[9],[10],[11]
Investment, interest rate		10.37%	[3],[6],[7]	10.37%	[3],[6],[7]	10.37%	[3],[6],[7]	8.12%	[9],[11],[12]	8.12%	[9],[11],[12]	8.12%	[9],[11],[12]
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,250	[1],[2],[3],[4],[7]					$ 916	[8],[9],[10],[11],[13]
Investment, interest rate		14.00%	[1],[2],[3],[6],[7]	14.00%	[1],[2],[3],[6],[7]	14.00%	[1],[2],[3],[6],[7]	11.00%	[8],[9],[11],[12],[13]	11.00%	[8],[9],[11],[12],[13]	11.00%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 13,712
Investment, interest rate	[8],[9],[11],[12]							8.88%		8.88%		8.88%
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 13,671
Investment, interest rate	[1],[3],[6],[7]	11.33%		11.33%		11.33%
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 4,903
Investment, interest rate	[1],[3],[6],[7]	11.33%		11.33%		11.33%
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 13,157
Investment, interest rate	[1],[3],[6],[7]	12.60%		12.60%		12.60%
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 14,787	[3],[4],[7]					$ 10,336	[9],[10],[11]
Investment, interest rate		10.24%	[3],[6],[7]	10.24%	[3],[6],[7]	10.24%	[3],[6],[7]	7.65%	[9],[11],[12]	7.65%	[9],[11],[12]	7.65%	[9],[11],[12]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 533	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, interest rate	[6],[7]	11.20%		11.20%		11.20%
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 18,060	[1],[3],[4],[7]					$ 18,200	[8],[9],[10],[11]
Investment, interest rate		11.10%	[1],[3],[6],[7]	11.10%	[1],[3],[6],[7]	11.10%	[1],[3],[6],[7]	8.81%	[8],[9],[11],[12]	8.81%	[8],[9],[11],[12]	8.81%	[8],[9],[11],[12]
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,963	[3],[4],[7]					$ 5,000	[9],[10],[11]
Investment, interest rate		9.80%	[3],[6],[7]	9.80%	[3],[6],[7]	9.80%	[3],[6],[7]	7.33%	[9],[11],[12]	7.33%	[9],[11],[12]	7.33%	[9],[11],[12]
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, Internet & Direct Marketing Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11],[16]							$ 4,988
Investment, interest rate	[9],[11],[12],[16]							8.49%		8.49%		8.49%
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 13,043	[1],[2],[3],[4],[14]					$ 4,183	[8],[9],[10],[13],[16]
Investment, interest rate		3.00%	[1],[2],[3],[6],[7],[14]	3.00%	[1],[2],[3],[6],[7],[14]	3.00%	[1],[2],[3],[6],[7],[14]	10.00%	[8],[9],[11],[12],[13],[16]	10.00%	[8],[9],[11],[12],[13],[16]	10.00%	[8],[9],[11],[12],[13],[16]
Investment, Identifier [Axis]: Delta Topco, Inc., Systems Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 6,680
Investment, interest rate	[9],[11],[12]							9.34%		9.34%		9.34%
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 20,757
Investment, interest rate	[1],[3],[6],[7]	14.42%		14.42%		14.42%
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 24,396
Investment, interest rate	[8],[9],[11],[12]							12.67%		12.67%		12.67%
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 0
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4]	$ 641
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 204	[1],[2],[3],[4],[7]					$ 251	[8],[9],[10],[11],[13]
Investment, interest rate		12.09%	[1],[2],[3],[6],[7]	12.09%	[1],[2],[3],[6],[7]	12.09%	[1],[2],[3],[6],[7]	9.41%	[8],[9],[11],[12],[13]	9.41%	[8],[9],[11],[12],[13]	9.41%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,418	[1],[3],[4],[7]					$ 9,902	[8],[9],[10],[11]
Investment, interest rate		12.34%	[1],[3],[6],[7]	12.34%	[1],[3],[6],[7]	12.34%	[1],[3],[6],[7]	9.91%	[8],[9],[11],[12]	9.91%	[8],[9],[11],[12]	9.91%	[8],[9],[11],[12]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,769	[3],[4],[7]					$ 19,242	[9],[10],[11]
Investment, interest rate		10.22%	[3],[6],[7]	10.22%	[3],[6],[7]	10.22%	[3],[6],[7]	8.12%	[9],[11],[12]	8.12%	[9],[11],[12]	8.12%	[9],[11],[12]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 16,074
Investment, interest rate														7.26%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,484	[1],[2],[4],[7],[21],[22]					$ 0	[8],[10],[11],[13],[23],[24]
Investment, interest rate	[1],[2],[6],[7],[21],[22]	10.24%		10.24%		10.24%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[10],[11],[23],[24]							$ 14,333
Investment, interest rate	[8],[11],[12],[23],[24]							8.68%		8.68%		8.68%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[7],[21],[22]	$ 14,102
Investment, interest rate	[1],[6],[7],[21],[22]	10.39%		10.39%		10.39%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[4],[7],[21],[22]	$ 0
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,974	[1],[3],[4],[7]					$ 8,974	[8],[9],[10],[11]
Investment, interest rate		13.04%	[1],[3],[6],[7]	13.04%	[1],[3],[6],[7]	13.04%	[1],[3],[6],[7]	11.17%	[8],[9],[11],[12]	11.17%	[8],[9],[11],[12]	11.17%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 10,899	[1],[3],[4],[14]					$ 10,418	[8],[9],[10],[16]
Investment, interest rate		3.00%	[1],[3],[6],[7],[14]	3.00%	[1],[3],[6],[7],[14]	3.00%	[1],[3],[6],[7],[14]	3.00%	[8],[9],[11],[12],[16]	3.00%	[8],[9],[11],[12],[16]	3.00%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,746	[1],[3],[4],[14]					$ 0	[8],[9],[10],[13],[16]
Investment, interest rate		3.00%	[1],[3],[6],[7],[14]	3.00%	[1],[3],[6],[7],[14]	3.00%	[1],[3],[6],[7],[14]	3.00%	[8],[9],[11],[12],[13],[16]	3.00%	[8],[9],[11],[12],[13],[16]	3.00%	[8],[9],[11],[12],[13],[16]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[14]	$ 0
Investment, interest rate	[1],[2],[3],[6],[7],[14]	3.00%		3.00%		3.00%
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[14]	$ 0
Investment, interest rate	[1],[2],[3],[6],[7],[14]	3.00%		3.00%		3.00%
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 31,074	[3],[4],[7]					$ 25,061	[9],[10],[11]
Investment, interest rate		11.94%	[3],[6],[7]	11.94%	[3],[6],[7]	11.94%	[3],[6],[7]	9.87%	[9],[11],[12]	9.87%	[9],[11],[12]	9.87%	[9],[11],[12]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 52,658	[1],[2],[3],[4]					$ 27,850	[8],[9],[10],[25]
Investment, interest rate		9.00%	[1],[2],[3],[6],[7]	9.00%	[1],[2],[3],[6],[7]	9.00%	[1],[2],[3],[6],[7]	9.00%	[8],[9],[11],[12],[25]	9.00%	[8],[9],[11],[12],[25]	9.00%	[8],[9],[11],[12],[25]
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 0
Investment, interest rate														9.00%
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 0
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,918	[1],[3],[4],[14]					$ 9,466	[8],[9],[10],[16]
Investment, interest rate		11.00%	[1],[3],[6],[7],[14]	11.00%	[1],[3],[6],[7],[14]	11.00%	[1],[3],[6],[7],[14]	11.00%	[8],[9],[11],[12],[16]	11.00%	[8],[9],[11],[12],[16]	11.00%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,881	[3],[4],[14]					$ 4,881	[9],[10],[16]
Investment, interest rate		6.00%	[3],[6],[7],[14]	6.00%	[3],[6],[7],[14]	6.00%	[3],[6],[7],[14]	6.00%	[9],[11],[12],[16]	6.00%	[9],[11],[12],[16]	6.00%	[9],[11],[12],[16]
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 1,280
Investment, interest rate	[8],[9],[11],[12],[13]							10.60%		10.60%		10.60%
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 25,128
Investment, interest rate	[8],[9],[11],[12]							10.67%		10.67%		10.67%
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 1,638
Investment, interest rate	[1],[2],[3],[6],[7]	12.34%		12.34%		12.34%
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 23,774
Investment, interest rate	[1],[3],[6],[7]	12.34%		12.34%		12.34%
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 2,463
Investment, interest rate	[1],[3],[6],[7]	10.25%		10.25%		10.25%
Investment, Identifier [Axis]: Global Medical Response, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 5,572
Investment, interest rate	[9],[11],[12]							7.37%		7.37%		7.37%
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €	[3],[4],[7],[14]			€ 1,000
Investment, interest rate	[3],[6],[7],[14]	6.05%		6.05%		6.05%
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,488	[1],[3],[4],[7]					$ 14,311	[8],[9],[10],[11]
Investment, interest rate		13.39%	[1],[3],[6],[7]	13.39%	[1],[3],[6],[7]	13.39%	[1],[3],[6],[7]	11.04%	[8],[9],[11],[12]	11.04%	[8],[9],[11],[12]	11.04%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 14,383	[3],[4],[7]					$ 9,392	[9],[10],[11]
Investment, interest rate		10.45%	[3],[6],[7]	10.45%	[3],[6],[7]	10.45%	[3],[6],[7]	8.38%	[9],[11],[12]	8.38%	[9],[11],[12]	8.38%	[9],[11],[12]
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[14]	$ 7,448
Investment, interest rate	[1],[3],[6],[7],[14]	11.74%		11.74%		11.74%
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7],[14]	$ 0
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4],[14]	$ 6,932
Investment, interest rate	[3],[6],[7],[14]	4.46%		4.46%		4.46%
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[14]	$ 23,975
Investment, interest rate	[1],[3],[6],[7],[14]	13.30%		13.30%		13.30%
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 45,169
Investment, interest rate	[1],[3],[6],[7]	11.29%		11.29%		11.29%
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 35,625
Investment, interest rate	[8],[9],[11],[12]							9.42%		9.42%		9.42%
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 40,484	[1],[3],[4],[7]					$ 34,357	[8],[9],[10],[11]
Investment, interest rate		11.57%	[1],[3],[6],[7]	11.57%	[1],[3],[6],[7]	11.57%	[1],[3],[6],[7]	9.44%	[8],[9],[11],[12]	9.44%	[8],[9],[11],[12]	9.44%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 8,569
Investment, interest rate	[8],[9],[11],[12]							9.42%		9.42%		9.42%
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 22,619
Investment, interest rate	[8],[9],[11],[12]							11.67%		11.67%		11.67%
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 15,302	[1],[3],[4],[15]					$ 13,083	[8],[9],[10],[20]
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 13,109	[1],[3],[4],[7]					$ 12,161	[8],[9],[10],[11]
Investment, interest rate		14.14%	[1],[3],[6],[7]	14.14%	[1],[3],[6],[7]	14.14%	[1],[3],[6],[7]	12.45%	[8],[9],[11],[12]	12.45%	[8],[9],[11],[12]	12.45%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,452	[1],[3],[4],[14]					$ 6,817	[8],[9],[10],[16]
Investment, interest rate		11.00%	[1],[3],[6],[7],[14]	11.00%	[1],[3],[6],[7],[14]	11.00%	[1],[3],[6],[7],[14]	11.00%	[8],[9],[11],[12],[16]	11.00%	[8],[9],[11],[12],[16]	11.00%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[14]					$ 0	[8],[9],[10],[13],[16]
Investment, interest rate		11.00%	[1],[2],[3],[6],[7],[14]	11.00%	[1],[2],[3],[6],[7],[14]	11.00%	[1],[2],[3],[6],[7],[14]	11.00%	[8],[9],[11],[12],[13],[16]	11.00%	[8],[9],[11],[12],[13],[16]	11.00%	[8],[9],[11],[12],[13],[16]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[14]	$ 0
Investment, interest rate	[1],[2],[3],[6],[7],[14]	11.00%		11.00%		11.00%
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 33,498	[1],[3],[4],[7]					$ 18,660	[8],[9],[10],[11]
Investment, interest rate		12.72%	[1],[3],[6],[7]	12.72%	[1],[3],[6],[7]	12.72%	[1],[3],[6],[7]	8.55%	[8],[9],[11],[12]	8.55%	[8],[9],[11],[12]	8.55%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 13,674
Investment, interest rate	[8],[9],[11],[12]							12.17%		12.17%		12.17%
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 13,939	[3],[4],[7]					$ 10,247	[9],[10],[11]
Investment, interest rate		12.42%	[3],[6],[7]	12.42%	[3],[6],[7]	12.42%	[3],[6],[7]	10.33%	[9],[11],[12]	10.33%	[9],[11],[12]	10.33%	[9],[11],[12]
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 36,234
Investment, interest rate	[8],[9],[11],[12]							10.62%		10.62%		10.62%
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 17,069
Investment, interest rate	[1],[3],[6],[7]	12.70%		12.70%		12.70%
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 27,360
Investment, interest rate	[1],[3],[6],[7]	12.70%		12.70%		12.70%
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 15,150
Investment, interest rate	[1],[3],[6],[7]	10.60%		10.60%		10.60%
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 666	[3],[4],[7]					$ 528	[9],[10],[11]
Investment, interest rate		13.20%	[3],[6],[7]	13.20%	[3],[6],[7]	13.20%	[3],[6],[7]	11.12%	[9],[11],[12]	11.12%	[9],[11],[12]	11.12%	[9],[11],[12]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 545	[1],[2],[3],[4],[7]					$ 329	[8],[9],[10],[11],[13]
Investment, interest rate		11.84%	[1],[2],[3],[6],[7]	11.84%	[1],[2],[3],[6],[7]	11.84%	[1],[2],[3],[6],[7]	10.17%	[8],[9],[11],[12],[13]	10.17%	[8],[9],[11],[12],[13]	10.17%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 16,765	[1],[3],[4],[7]					$ 13,623	[8],[9],[10],[11]
Investment, interest rate		11.84%	[1],[3],[6],[7]	11.84%	[1],[3],[6],[7]	11.84%	[1],[3],[6],[7]	10.17%	[8],[9],[11],[12]	10.17%	[8],[9],[11],[12]	10.17%	[8],[9],[11],[12]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7]					$ 1,710	[8],[9],[10],[11],[13]
Investment, interest rate	[8],[9],[11],[12],[13]							9.12%		9.12%		9.12%
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 19,236
Investment, interest rate	[8],[9],[11],[12]							9.12%		9.12%		9.12%
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 2,742
Investment, interest rate	[1],[3],[6],[7]	11.20%		11.20%		11.20%
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 23,554
Investment, interest rate	[1],[3],[6],[7]	11.20%		11.20%		11.20%
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,140	[3],[4],[7]					$ 2,140	[9],[10],[11]
Investment, interest rate		11.97%	[3],[6],[7]	11.97%	[3],[6],[7]	11.97%	[3],[6],[7]	9.87%	[9],[11],[12]	9.87%	[9],[11],[12]	9.87%	[9],[11],[12]
Investment, Identifier [Axis]: LaserShip, Inc., Air Freight & Logistics, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 2,394
Investment, interest rate	[8],[9],[11],[12]							10.38%		10.38%		10.38%
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4],[7],[14]	$ 26,489
Investment, interest rate	[3],[6],[7],[14]	14.61%		14.61%		14.61%
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 45,361	[1],[3],[4],[7]					$ 41,008	[8],[9],[10],[11]
Investment, interest rate		10.50%	[1],[3],[6],[7]	10.50%	[1],[3],[6],[7]	10.50%	[1],[3],[6],[7]	8.67%	[8],[9],[11],[12]	8.67%	[8],[9],[11],[12]	8.67%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,403	[1],[3],[4],[7]					$ 4,357	[8],[9],[10],[11]
Investment, interest rate		13.84%	[1],[3],[6],[7]	13.84%	[1],[3],[6],[7]	13.84%	[1],[3],[6],[7]	11.38%	[8],[9],[11],[12]	11.38%	[8],[9],[11],[12]	11.38%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,939	[1],[2],[3],[4],[7]					$ 2,370	[8],[9],[10],[11],[13]
Investment, interest rate		13.84%	[1],[2],[3],[6],[7]	13.84%	[1],[2],[3],[6],[7]	13.84%	[1],[2],[3],[6],[7]	11.38%	[8],[9],[11],[12],[13]	11.38%	[8],[9],[11],[12],[13]	11.38%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 250	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, interest rate	[1],[2],[3],[6],[7]	11.25%		11.25%		11.25%
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 18,390
Investment, interest rate	[8],[9],[11],[12]							9.50%		9.50%		9.50%
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 20,176
Investment, interest rate	[1],[3],[6],[7]	11.20%		11.20%		11.20%
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 2,637
Investment, interest rate	[1],[3],[6],[7]	11.20%		11.20%		11.20%
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 2,118
Investment, interest rate	[1],[2],[3],[6],[7]	12.58%		12.58%		12.58%
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 40,640
Investment, interest rate	[1],[3],[6],[7]	12.74%		12.74%		12.74%
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,397	[1],[3],[4],[7]					$ 29,565	[8],[9],[10],[11]
Investment, interest rate		10.84%	[1],[3],[6],[7]	10.84%	[1],[3],[6],[7]	10.84%	[1],[3],[6],[7]	9.17%	[8],[9],[11],[12]	9.17%	[8],[9],[11],[12]	9.17%	[8],[9],[11],[12]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 21,383	[1],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, interest rate	[1],[3],[6],[7]	10.84%		10.84%		10.84%
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 570
Investment, interest rate	[1],[2],[3],[6],[7]	10.83%		10.83%		10.83%
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,568	[1],[3],[4],[14]					$ 17,203	[8],[9],[10],[16]
Investment, interest rate		11.50%	[1],[3],[6],[7],[14]	11.50%	[1],[3],[6],[7],[14]	11.50%	[1],[3],[6],[7],[14]	11.50%	[8],[9],[11],[12],[16]	11.50%	[8],[9],[11],[12],[16]	11.50%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,284	[1],[3],[4],[14]					$ 0	[8],[9],[10],[13],[16]
Investment, interest rate		11.50%	[1],[3],[6],[7],[14]	11.50%	[1],[3],[6],[7],[14]	11.50%	[1],[3],[6],[7],[14]	11.50%	[8],[9],[11],[12],[13],[16]	11.50%	[8],[9],[11],[12],[13],[16]	11.50%	[8],[9],[11],[12],[13],[16]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]	$ 8,568
Investment, interest rate	[1],[3],[6],[7],[14]	11.50%		11.50%		11.50%
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[14]	$ 0
Investment, interest rate	[1],[3],[6],[7],[14]	11.50%		11.50%		11.50%
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,066	[1],[3],[4],[14]					$ 7,215	[8],[9],[10],[16]
Investment, interest rate		8.00%	[1],[3],[6],[7],[14]	8.00%	[1],[3],[6],[7],[14]	8.00%	[1],[3],[6],[7],[14]	8.00%	[8],[9],[11],[12],[16]	8.00%	[8],[9],[11],[12],[16]	8.00%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[14]					$ 0	[8],[9],[10],[13],[16]
Investment, interest rate		8.00%	[1],[3],[6],[7],[14]	8.00%	[1],[3],[6],[7],[14]	8.00%	[1],[3],[6],[7],[14]	8.00%	[8],[9],[11],[12],[13],[16]	8.00%	[8],[9],[11],[12],[13],[16]	8.00%	[8],[9],[11],[12],[13],[16]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[14]	$ 0
Investment, interest rate	[1],[3],[6],[7],[14]	8.00%		8.00%		8.00%
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		0	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 45,665
Investment, interest rate	[8],[9],[11],[12]							10.64%		10.64%		10.64%
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 7,464
Investment, interest rate	[1],[3],[6],[7]	12.19%		12.19%		12.19%
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 46,687
Investment, interest rate	[1],[3],[6],[7]	12.19%		12.19%		12.19%
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 55,297	[1],[3],[4],[7]					$ 46,499	[8],[9],[10],[11]
Investment, interest rate		11.97%	[1],[3],[6],[7]	11.97%	[1],[3],[6],[7]	11.97%	[1],[3],[6],[7]	9.89%	[8],[9],[11],[12]	9.89%	[8],[9],[11],[12]	9.89%	[8],[9],[11],[12]
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4]	$ 10,191
Investment, interest rate	[3],[6],[7]	6.88%		6.88%		6.88%
Investment, Identifier [Axis]: NFP Corp., Other Diversified Financial Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10]							$ 10,191
Investment, interest rate	[9],[11],[12]							6.88%		6.88%		6.88%
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[14]	$ 73,178
Investment, interest rate	[1],[3],[6],[7],[14]	12.08%		12.08%		12.08%
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €	[1],[3],[4],[7],[14]			€ 0
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €	[3],[4],[7],[14]			€ 0
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[16]							$ 58,713
Investment, interest rate	[8],[9],[11],[12],[16]							9.99%		9.99%		9.99%
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 30,339	[1],[3],[4],[7]					$ 22,560	[8],[9],[10],[11]
Investment, interest rate		14.04%	[1],[3],[6],[7]	14.04%	[1],[3],[6],[7]	14.04%	[1],[3],[6],[7]	12.17%	[8],[9],[11],[12]	12.17%	[8],[9],[11],[12]	12.17%	[8],[9],[11],[12]
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 64,606	[1],[3],[4],[7]					$ 50,459	[8],[9],[10],[11]
Investment, interest rate		16.04%	[1],[3],[6],[7]	16.04%	[1],[3],[6],[7]	16.04%	[1],[3],[6],[7]	14.17%	[8],[9],[11],[12]	14.17%	[8],[9],[11],[12]	14.17%	[8],[9],[11],[12]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 58,349	[1],[2],[4],[7],[14],[21],[22],[26]					$ 59,662	[8],[10],[11],[13],[16],[23],[24],[27]
Investment, interest rate		9.36%	[1],[2],[6],[7],[14],[21],[22],[26]	9.36%	[1],[2],[6],[7],[14],[21],[22],[26]	9.36%	[1],[2],[6],[7],[14],[21],[22],[26]	6.30%	[8],[11],[12],[13],[16],[23],[24],[27]	6.30%	[8],[11],[12],[13],[16],[23],[24],[27]	6.30%	[8],[11],[12],[13],[16],[23],[24],[27]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 60,274
Investment, interest rate														4.94%
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 3,323
Investment, interest rate	[9],[11],[12]							7.12%		7.12%		7.12%
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,323	[1],[3],[4],[7]					$ 7,519	[8],[9],[10],[11]
Investment, interest rate		12.34%	[1],[3],[6],[7]	12.34%	[1],[3],[6],[7]	12.34%	[1],[3],[6],[7]	10.05%	[8],[9],[11],[12]	10.05%	[8],[9],[11],[12]	10.05%	[8],[9],[11],[12]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 25,712	[1],[3],[4],[7]					$ 21,557	[8],[9],[10],[11]
Investment, interest rate		15.50%	[1],[3],[6],[7]	15.50%	[1],[3],[6],[7]	15.50%	[1],[3],[6],[7]	5.08%	[8],[9],[11],[12]	5.08%	[8],[9],[11],[12]	5.08%	[8],[9],[11],[12]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 1,210
Investment, interest rate	[1],[2],[3],[6],[7]	15.39%		15.39%		15.39%
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 15,231
Investment, interest rate	[1],[3],[6],[7]	12.79%		12.79%		12.79%
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,480	[3],[4]					$ 7,776	[9],[10]
Investment, interest rate		7.75%	[3],[6],[7]	7.75%	[3],[6],[7]	7.75%	[3],[6],[7]	7.75%	[9],[11],[12]	7.75%	[9],[11],[12]	7.75%	[9],[11],[12]
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 0
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 26,154
Investment, interest rate	[8],[9],[11],[12]							9.28%		9.28%		9.28%
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11],[13]							$ 2,228
Investment, interest rate	[8],[9],[11],[12],[13]							9.25%		9.25%		9.25%
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 10,923
Investment, interest rate	[1],[3],[6],[7]	12.10%		12.10%		12.10%
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 38,521	[1],[3],[4],[7]					$ 33,775	[8],[9],[10],[11]
Investment, interest rate		11.73%	[1],[3],[6],[7]	11.73%	[1],[3],[6],[7]	11.73%	[1],[3],[6],[7]	10.42%	[8],[9],[11],[12]	10.42%	[8],[9],[11],[12]	10.42%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,701	[3],[4],[7]					$ 9,850	[9],[10],[11]
Investment, interest rate		10.20%	[3],[6],[7]	10.20%	[3],[6],[7]	10.20%	[3],[6],[7]	8.13%	[9],[11],[12]	8.13%	[9],[11],[12]	8.13%	[9],[11],[12]
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 22,375	[1],[3],[4],[7]					$ 17,976	[8],[9],[10],[11]
Investment, interest rate		10.96%	[1],[3],[6],[7]	10.96%	[1],[3],[6],[7]	10.96%	[1],[3],[6],[7]	8.88%	[8],[9],[11],[12]	8.88%	[8],[9],[11],[12]	8.88%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 36,499	[1],[3],[4],[7]					$ 28,627	[8],[9],[10],[11]
Investment, interest rate		12.59%	[1],[3],[6],[7]	12.59%	[1],[3],[6],[7]	12.59%	[1],[3],[6],[7]	10.92%	[8],[9],[11],[12]	10.92%	[8],[9],[11],[12]	10.92%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,395	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, interest rate	[1],[2],[3],[6],[7]	13.04%		13.04%		13.04%
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 67,244	[1],[3],[4],[7]					$ 48,689	[8],[9],[10],[11]
Investment, interest rate		13.04%	[1],[3],[6],[7]	13.04%	[1],[3],[6],[7]	13.04%	[1],[3],[6],[7]	10.68%	[8],[9],[11],[12]	10.68%	[8],[9],[11],[12]	10.68%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 24,537
Investment, interest rate	[1],[3],[6],[7]	12.42%		12.42%		12.42%
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 2,823
Investment, interest rate	[1],[3],[6],[7]	12.42%		12.42%		12.42%
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 23,275
Investment, interest rate	[8],[9],[11],[12]							10.01%		10.01%		10.01%
Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,750	[1],[3],[4],[7]					$ 5,250	[8],[9],[10],[11]
Investment, interest rate		13.22%	[1],[3],[6],[7]	13.22%	[1],[3],[6],[7]	13.22%	[1],[3],[6],[7]	11.12%	[8],[9],[11],[12]	11.12%	[8],[9],[11],[12]	11.12%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £						£ 4,626	[1],[3],[4],[7],[14]					£ 3,501	[8],[9],[10],[11],[16]
Investment, interest rate		10.88%	[1],[3],[6],[7],[14]	10.88%	[1],[3],[6],[7],[14]	10.88%	[1],[3],[6],[7],[14]	8.39%	[8],[9],[11],[12],[16]	8.39%	[8],[9],[11],[12],[16]	8.39%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Health Care Distributors, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10]							$ 1,325
Investment, interest rate	[9],[11],[12]							5.25%		5.25%		5.25%
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 3,400
Investment, interest rate	[9],[11],[12]							7.33%		7.33%		7.33%
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10]							$ 4,755
Investment, interest rate	[9],[11],[12]							9.25%		9.25%		9.25%
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 32,329	[1],[3],[4],[7]					24,692	[8],[9],[10],[11]
Investment, interest rate	[1],[3],[6],[7]	11.70%		11.70%		11.70%
Investment, Identifier [Axis]: Renaissance Holding Corp., Diversified Banks, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 3,542
Investment, interest rate	[9],[11],[12]							10.12%		10.12%		10.12%
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4],[7]	$ 1,789
Investment, interest rate	[3],[6],[7]	12.19%		12.19%		12.19%
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 44,602	[1],[3],[4],[7],[14]					$ 37,656	[8],[9],[10],[11],[16]
Investment, interest rate		13.75%	[1],[3],[6],[7],[14]	13.75%	[1],[3],[6],[7],[14]	13.75%	[1],[3],[6],[7],[14]	11.92%	[8],[9],[11],[12],[16]	11.92%	[8],[9],[11],[12],[16]	11.92%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 13,495	[1],[3],[4],[7],[14]					$ 11,393	[8],[9],[10],[11],[13],[16]
Investment, interest rate		13.75%	[1],[3],[6],[7],[14]	13.75%	[1],[3],[6],[7],[14]	13.75%	[1],[3],[6],[7],[14]	11.92%	[8],[9],[11],[12],[13],[16]	11.92%	[8],[9],[11],[12],[13],[16]	11.92%	[8],[9],[11],[12],[13],[16]
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 8,010
Investment, interest rate	[1],[3],[6],[7]	14.00%		14.00%		14.00%
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 4,463
Investment, interest rate	[1],[3],[6],[7]	9.97%		9.97%		9.97%
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,034	[1],[3],[4],[7]					$ 9,109	[8],[9],[10],[11]
Investment, interest rate		13.22%	[1],[3],[6],[7]	13.22%	[1],[3],[6],[7]	13.22%	[1],[3],[6],[7]	10.74%	[8],[9],[11],[12]	10.74%	[8],[9],[11],[12]	10.74%	[8],[9],[11],[12]
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 1,500
Investment, interest rate	[9],[11],[12]							7.63%		7.63%		7.63%
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 25,592	[1],[3],[4],[7]					$ 20,766	[8],[9],[10],[11]
Investment, interest rate		12.29%	[1],[3],[6],[7]	12.29%	[1],[3],[6],[7]	12.29%	[1],[3],[6],[7]	10.42%	[8],[9],[11],[12]	10.42%	[8],[9],[11],[12]	10.42%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Sabert Corporation, Metal & Glass Containers, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 1,691
Investment, interest rate	[9],[11],[12]							7.63%		7.63%		7.63%
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 25,558
Investment, interest rate	[1],[3],[6],[7]	15.24%		15.24%		15.24%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 0
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 112,656	[1],[2],[4],[7],[14],[21],[22],[26]					$ 96,250	[8],[10],[11],[13],[16],[23],[24],[27]
Investment, interest rate		11.86%	[1],[2],[6],[7],[14],[21],[22],[26]	11.86%	[1],[2],[6],[7],[14],[21],[22],[26]	11.86%	[1],[2],[6],[7],[14],[21],[22],[26]	8.80%	[8],[11],[12],[13],[16],[23],[24],[27]	8.80%	[8],[11],[12],[13],[16],[23],[24],[27]	8.80%	[8],[11],[12],[13],[16],[23],[24],[27]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														$ 96,250
Investment, interest rate														8.00%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[14]	$ 7,191
Investment, interest rate	[1],[3],[7],[14]	12.95%		12.95%		12.95%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[14]	$ 2,697
Investment, interest rate	[1],[3],[7],[14]	12.88%		12.88%		12.88%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7],[14]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7],[14]	0
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal & Glass Containers, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10]							$ 46,121
Investment, interest rate	[8],[9],[11],[12]							5.50%		5.50%		5.50%
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[17]	$ 54,730
Investment, interest rate	[1],[3],[17]	14.00%		14.00%		14.00%
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[17]	$ 14,993
Investment, interest rate	[1],[3],[17]	14.00%		14.00%		14.00%
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[17]	$ 4,813
Investment, interest rate	[1],[2],[3],[6],[7],[17]	14.00%		14.00%		14.00%
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,095	[1],[3],[4],[7]					$ 3,195	[8],[9],[10],[11]
Investment, interest rate		12.69%	[1],[3],[6],[7]	12.69%	[1],[3],[6],[7]	12.69%	[1],[3],[6],[7]	10.48%	[8],[9],[11],[12]	10.48%	[8],[9],[11],[12]	10.48%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4],[7]	$ 1,054
Investment, interest rate	[3],[6],[7]	10.69%		10.69%		10.69%
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 907	[1],[2],[3],[4],[7]					$ 866	[8],[9],[10],[11],[13]
Investment, interest rate		10.35%	[1],[2],[3],[6],[7]	10.35%	[1],[2],[3],[6],[7]	10.35%	[1],[2],[3],[6],[7]	8.03%	[8],[9],[11],[12],[13]	8.03%	[8],[9],[11],[12],[13]	8.03%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,500	[1],[3],[4],[7]					$ 4,534	[8],[9],[10],[11]
Investment, interest rate		10.70%	[1],[3],[6],[7]	10.70%	[1],[3],[6],[7]	10.70%	[1],[3],[6],[7]	8.30%	[8],[9],[11],[12]	8.30%	[8],[9],[11],[12]	8.30%	[8],[9],[11],[12]
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | €	[1],[3],[4],[7],[14]			€ 23,731
Investment, interest rate	[1],[3],[6],[7],[14]	11.97%		11.97%		11.97%
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Other Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £	[8],[9],[10],[11],[16]											£ 16,911
Investment, interest rate	[8],[9],[11],[12],[16]							10.00%		10.00%		10.00%
Investment, Identifier [Axis]: Sunland Asphalt & Construction, LLC, Construction & Engineering, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 42,618
Investment, interest rate	[8],[9],[11],[12]							8.88%		8.88%		8.88%
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 49,645
Investment, interest rate	[1],[3],[6],[7]	12.85%		12.85%		12.85%
Investment, Identifier [Axis]: Supermoose Borrower, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[11]							$ 3,466
Investment, interest rate	[9],[11],[12]							7.42%		7.42%		7.42%
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[28]	$ 1,552
Investment, interest rate	[1],[3],[6],[7],[28]	12.18%		12.18%		12.18%
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[28]	$ 32,185
Investment, interest rate	[1],[3],[6],[7],[28]	12.18%		12.18%		12.18%
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7],[28]	$ 2,756
Investment, interest rate	[1],[2],[3],[6],[7],[28]	12.18%		12.18%		12.18%
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7],[28]	$ 1,099
Investment, interest rate	[1],[2],[3],[6],[7],[28]	12.18%		12.18%		12.18%
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Auto Parts & Equipment, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,500	[1],[3],[4],[7]					$ 12,500	[8],[9],[10],[11]
Investment, interest rate		11.94%	[1],[3],[6],[7]	11.94%	[1],[3],[6],[7]	11.94%	[1],[3],[6],[7]	9.81%	[8],[9],[11],[12]	9.81%	[8],[9],[11],[12]	9.81%	[8],[9],[11],[12]
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,984	[3],[4],[5],[14]					$ 4,984	[8],[9],[10],[16]
Investment, interest rate		11.50%	[3],[5],[6],[7],[14]	11.50%	[3],[5],[6],[7],[14]	11.50%	[3],[5],[6],[7],[14]	11.50%	[8],[9],[11],[12],[16]	11.50%	[8],[9],[11],[12],[16]	11.50%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[14]	$ 50,419
Investment, interest rate	[1],[3],[6],[7],[14]	13.00%		13.00%		13.00%
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 17,213	[3],[4],[7]					$ 12,032	[9],[10],[11]
Investment, interest rate		9.84%	[3],[6],[7]	9.84%	[3],[6],[7]	9.84%	[3],[6],[7]	8.15%	[9],[11],[12]	8.15%	[9],[11],[12]	8.15%	[9],[11],[12]
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 12,843	[3],[4],[7]					$ 9,448	[9],[10],[11]
Investment, interest rate		12.69%	[3],[6],[7]	12.69%	[3],[6],[7]	12.69%	[3],[6],[7]	10.62%	[9],[11],[12]	10.62%	[9],[11],[12]	10.62%	[9],[11],[12]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0	[1],[2],[3],[4],[7],[14]					$ 0	[8],[9],[10],[11],[13],[16]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 28,826	[1],[3],[4],[7],[14]					$ 23,215	[8],[9],[10],[11],[16]
Investment, interest rate		11.15%	[1],[3],[6],[7],[14]	11.15%	[1],[3],[6],[7],[14]	11.15%	[1],[3],[6],[7],[14]	8.68%	[8],[9],[11],[12],[16]	8.68%	[8],[9],[11],[12],[16]	8.68%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: Tecta America Corp., Construction & Engineering, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,755	[1],[3],[4],[7]					$ 5,203	[8],[9],[10],[11]
Investment, interest rate		13.72%	[1],[3],[6],[7]	13.72%	[1],[3],[6],[7]	13.72%	[1],[3],[6],[7]	11.62%	[8],[9],[11],[12]	11.62%	[8],[9],[11],[12]	11.62%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,590	[1],[2],[3],[4],[7]					$ 1,231	[8],[9],[10],[11],[13]
Investment, interest rate		14.93%	[1],[2],[3],[6],[7]	14.93%	[1],[2],[3],[6],[7]	14.93%	[1],[2],[3],[6],[7]	12.20%	[8],[9],[11],[12],[13]	12.20%	[8],[9],[11],[12],[13]	12.20%	[8],[9],[11],[12],[13]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 23,483	[1],[3],[4],[7]					$ 18,323	[8],[9],[10],[11]
Investment, interest rate		14.99%	[1],[3],[6],[7]	14.99%	[1],[3],[6],[7]	14.99%	[1],[3],[6],[7]	12.11%	[8],[9],[11],[12]	12.11%	[8],[9],[11],[12]	12.11%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 19,947
Investment, interest rate	[1],[3],[6],[7]	11.09%		11.09%		11.09%
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10]
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 29,663
Investment, interest rate	[8],[9],[11],[12]							13.17%		13.17%		13.17%
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 19,163	[1],[3],[4],[7],[17]					$ 15,674	[8],[9],[10],[11]
Investment, interest rate	[8],[9],[11],[12]							10.44%		10.44%		10.44%
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		4,641	[1],[3],[4],[7],[17]					$ 3,789	[8],[9],[10],[11]
Investment, interest rate	[8],[9],[11],[12]							16.17%		16.17%		16.17%
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 46,832
Investment, interest rate	[1],[3],[6],[7]	12.50%		12.50%		12.50%
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 37,494
Investment, interest rate	[8],[9],[11],[12]							11.17%		11.17%		11.17%
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,701	[1],[3],[4],[7]					$ 6,016	[8],[9],[10],[11]
Investment, interest rate		11.20%	[1],[3],[6],[7]	11.20%	[1],[3],[6],[7]	11.20%	[1],[3],[6],[7]	9.12%	[8],[9],[11],[12]	9.12%	[8],[9],[11],[12]	9.12%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4],[7],[14]	$ 1,000
Investment, interest rate	[3],[6],[7],[14]	12.72%		12.72%		12.72%
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4],[14]	$ 4,500
Investment, interest rate	[3],[6],[7],[14]	6.50%		6.50%		6.50%
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[3],[4],[14]	$ 300
Investment, interest rate	[3],[6],[7],[14]	4.75%		4.75%		4.75%
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[16]							$ 4,500
Investment, interest rate	[9],[11],[12],[16]							6.50%		6.50%		6.50%
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10],[16]							$ 300
Investment, interest rate	[9],[11],[12],[16]							4.75%		4.75%		4.75%
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 1,540
Investment, interest rate	[1],[3],[6],[7]	12.47%		12.47%		12.47%
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[7]	$ 1,323
Investment, interest rate	[1],[3],[6],[7]	21.22%		21.22%		21.22%
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,822	[3],[7]					$ 7,564	[9],[10],[11]
Investment, interest rate		9.03%	[3],[6],[7]	9.03%	[3],[6],[7]	9.03%	[3],[6],[7]	6.56%	[9],[11],[12]	6.56%	[9],[11],[12]	6.56%	[9],[11],[12]
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 6,000
Investment, interest rate	[8],[9],[11],[12]							10.56%		10.56%		10.56%
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[10],[11]							$ 40,536
Investment, interest rate	[8],[9],[11],[12]							10.19%		10.19%		10.19%
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[7]	$ 35,853
Investment, interest rate	[1],[3],[6],[7]	11.38%		11.38%		11.38%
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[7]	$ 19,306
Investment, interest rate	[1],[3],[6],[7]	12.00%		12.00%		12.00%
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,000	[1],[3],[7]					$ 5,000	[8],[9],[10],[11]
Investment, interest rate		12.50%	[1],[3],[6],[7]	12.50%	[1],[3],[6],[7]	12.50%	[1],[3],[6],[7]	10.67%	[8],[9],[11],[12]	10.67%	[8],[9],[11],[12]	10.67%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,565	[1],[3],[7]					$ 2,316	[8],[9],[10],[11]
Investment, interest rate		21.22%	[1],[3],[6],[7]	21.22%	[1],[3],[6],[7]	21.22%	[1],[3],[6],[7]	19.64%	[8],[9],[11],[12]	19.64%	[8],[9],[11],[12]	19.64%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 24,419	[3],[7]					$ 25,499	[9],[10],[11]
Investment, interest rate		11.45%	[3],[6],[7]	11.45%	[3],[6],[7]	11.45%	[3],[6],[7]	9.37%	[9],[11],[12]	9.37%	[9],[11],[12]	9.37%	[9],[11],[12]
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Alternative Carriers, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[9],[10]							$ 250
Investment, interest rate	[9],[11],[12]							4.00%		4.00%		4.00%
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 19,578	[1],[3],[7]					$ 19,578	[8],[9],[10],[11]
Investment, interest rate		13.79%	[1],[3],[6],[7]	13.79%	[1],[3],[6],[7]	13.79%	[1],[3],[6],[7]	11.92%	[8],[9],[11],[12]	11.92%	[8],[9],[11],[12]	11.92%	[8],[9],[11],[12]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal | £						£ 20,000	[1],[3],[7],[14]					£ 18,000	[8],[9],[10],[11],[16]
Investment, interest rate		12.46%	[1],[3],[6],[7],[14]	12.46%	[1],[3],[6],[7],[14]	12.46%	[1],[3],[6],[7],[14]	9.72%	[8],[9],[11],[12],[16]	9.72%	[8],[9],[11],[12],[16]	9.72%	[8],[9],[11],[12],[16]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 377	[1],[2],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, interest rate	[1],[2],[3],[6],[7]	11.99%		11.99%		11.99%
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 24,188	[1],[3],[4],[7]					$ 19,203	[8],[9],[10],[11]
Investment, interest rate		8.50%	[1],[3],[6],[7]	8.50%	[1],[3],[6],[7]	8.50%	[1],[3],[6],[7]	9.49%	[8],[9],[11],[12]	9.49%	[8],[9],[11],[12]	9.49%	[8],[9],[11],[12]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,636	[1],[3],[4],[7]					$ 0	[8],[9],[10],[11],[13]
Investment, interest rate	[1],[3],[6],[7]	12.38%		12.38%		12.38%
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7]	$ 5,212
Investment, interest rate	[1],[3],[6],[7]	11.75%		11.75%		11.75%
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[2],[3],[4],[7]	0
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 350,214						$ 383,194
Number of borrowers in the Glick JV | borrower		52,000		52,000		52,000		60		60		60
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,911
Investment, interest rate		12.00%		12.00%		12.00%
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,173
Investment, interest rate		12.00%		12.00%		12.00%
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 8,518
Investment, interest rate								9.80%		9.80%		9.80%
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,176
Investment, interest rate								9.67%		9.67%		9.67%
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,145
Investment, interest rate		11.31%		11.31%		11.31%
SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,596
Investment, interest rate		8.94%		8.94%		8.94%
SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 10,093
Investment, interest rate								6.82%		6.82%		6.82%
SLF JV I | Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,000
Investment, interest rate								6.91%		6.91%		6.91%
SLF JV I | Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,977
Investment, interest rate		9.32%		9.32%		9.32%
SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 9,267
Investment, interest rate								11.20%		11.20%		11.20%
SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,916
Investment, interest rate		12.89%		12.89%		12.89%
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, Diversified Metals & Mining, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,970
Investment, interest rate		9.22%		9.22%		9.22%
SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,836
Investment, interest rate		11.49%		11.49%		11.49%
SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,873
Investment, interest rate								9.03%		9.03%		9.03%
SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,800
Investment, interest rate								7.92%		7.92%		7.92%
SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,740
Investment, interest rate		9.39%		9.39%		9.39%
SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 1,539
Investment, interest rate								7.42%		7.42%		7.42%
SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,527
Investment, interest rate		9.25%		9.25%		9.25%
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 115
Investment, interest rate		10.20%		10.20%		10.20%
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,615
Investment, interest rate		10.20%		10.20%		10.20%
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 154
Investment, interest rate								8.46%		8.46%		8.46%
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,615
Investment, interest rate								8.46%		8.46%		8.46%
SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,052
Investment, interest rate		10.44%		10.44%		10.44%
SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 5,052
Investment, interest rate								8.37%		8.37%		8.37%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 5,000
Investment, interest rate								7.70%		7.70%		7.70%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,963
Investment, interest rate		9.20%		9.20%		9.20%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,995
Investment, interest rate		9.47%		9.47%		9.47%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,346
Investment, interest rate		10.47%		10.47%		10.47%
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,346
Investment, interest rate								8.37%		8.37%		8.37%
SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,289
Investment, interest rate		11.27%		11.27%		11.27%
SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,338
Investment, interest rate								8.78%		8.78%		8.78%
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,371
Investment, interest rate								8.12%		8.12%		8.12%
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 1,771
Investment, interest rate								8.12%		8.12%		8.12%
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,322
Investment, interest rate		10.50%		10.50%		10.50%
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,759
Investment, interest rate		10.50%		10.50%		10.50%
SLF JV I | Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,444
Investment, interest rate								8.98%		8.98%		8.98%
SLF JV I | Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 9,575
Investment, interest rate								6.03%		6.03%		6.03%
SLF JV I | Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,038
Investment, interest rate								9.37%		9.37%		9.37%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 0
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,358
Investment, interest rate								9.12%		9.12%		9.12%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 449
Investment, interest rate								9.12%		9.12%		9.12%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 200
Investment, interest rate		11.38%		11.38%		11.38%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,965
Investment, interest rate		11.44%		11.44%		11.44%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,366
Investment, interest rate		11.44%		11.44%		11.44%
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,988
Investment, interest rate		11.44%		11.44%		11.44%
SLF JV I | Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,451
Investment, interest rate								6.48%		6.48%		6.48%
SLF JV I | Investment, Identifier [Axis]: Convergeone Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,373
Investment, interest rate								8.12%		8.12%		8.12%
SLF JV I | Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,315
Investment, interest rate		10.37%		10.37%		10.37%
SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 5,375
Investment, interest rate								7.65%		7.65%		7.65%
SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,359
Investment, interest rate		10.24%		10.24%		10.24%
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,760
Investment, interest rate		9.54%		9.54%		9.54%
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 992
Investment, interest rate		9.79%		9.79%		9.79%
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 5,820
Investment, interest rate								7.67%		7.67%		7.67%
SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 8,000
Investment, interest rate								7.33%		7.33%		7.33%
SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,940
Investment, interest rate		9.80%		9.80%		9.80%
SLF JV I | Investment, Identifier [Axis]: Dealer Tire, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,992
Investment, interest rate								7.37%		7.37%		7.37%
SLF JV I | Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,035
Investment, interest rate								8.49%		8.49%		8.49%
SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,958
Investment, interest rate		10.22%		10.22%		10.22%
SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,436
Investment, interest rate								8.12%		8.12%		8.12%
SLF JV I | Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,100
Investment, interest rate								8.26%		8.26%		8.26%
SLF JV I | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,478
Investment, interest rate								7.80%		7.80%		7.80%
SLF JV I | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 54,003,000						$ 48,139
SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,444
Investment, interest rate								7.94%		7.94%		7.94%
SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,388
Investment, interest rate		10.25%		10.25%		10.25%
SLF JV I | Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 1,979
Investment, interest rate								7.37%		7.37%		7.37%
SLF JV I | Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,192
Investment, interest rate								6.81%		6.81%		6.81%
SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,940
Investment, interest rate		10.45%		10.45%		10.45%
SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 8,000
Investment, interest rate								8.38%		8.38%		8.38%
SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 9,500
Investment, interest rate								9.42%		9.42%		9.42%
SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,125
Investment, interest rate		11.29%		11.29%		11.29%
SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,406
Investment, interest rate								8.80%		8.80%		8.80%
SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,350
Investment, interest rate		10.75%		10.75%		10.75%
SLF JV I | Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 5,000
Investment, interest rate								7.89%		7.89%		7.89%
SLF JV I | Investment, Identifier [Axis]: Iris Holding, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,963
Investment, interest rate		9.90%		9.90%		9.90%
SLF JV I | Investment, Identifier [Axis]: LABL, Inc., Office Services & Supplies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,972
Investment, interest rate		10.20%		10.20%		10.20%
SLF JV I | Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,308
Investment, interest rate		8.72%		8.72%		8.72%
SLF JV I | Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,366
Investment, interest rate								6.37%		6.37%		6.37%
SLF JV I | Investment, Identifier [Axis]: Largest Exposure To A Single Borrower
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,304,000						$ 10,093
SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,444
Investment, interest rate								8.23%		8.23%		8.23%
SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,388
Investment, interest rate		11.08%		11.08%		11.08%
SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,367
Investment, interest rate								8.67%		8.67%		8.67%
SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,279
Investment, interest rate		10.50%		10.50%		10.50%
SLF JV I | Investment, Identifier [Axis]: LogMeIn, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,800
Investment, interest rate		9.94%		9.94%		9.94%
SLF JV I | Investment, Identifier [Axis]: LogMeIn, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,860
Investment, interest rate								7.80%		7.80%		7.80%
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,340
Investment, interest rate		10.84%		10.84%		10.84%
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,217
Investment, interest rate		10.84%		10.84%		10.84%
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,139
Investment, interest rate								9.17%		9.17%		9.17%
SLF JV I | Investment, Identifier [Axis]: McAfee Corp., Systems Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,955
Investment, interest rate		9.01%		9.01%		9.01%
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 0
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,687
Investment, interest rate								10.64%		10.64%		10.64%
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,669
Investment, interest rate		12.19%		12.19%		12.19%
SLF JV I | Investment, Identifier [Axis]: Mitchell International Inc, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,991
Investment, interest rate		8.94%		8.94%		8.94%
SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., Electrical Components & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,633
Investment, interest rate		10.00%		10.00%		10.00%
SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,685
Investment, interest rate								7.87%		7.87%		7.87%
SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 11,015
Investment, interest rate		9.25%		9.25%		9.25%
SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,777
Investment, interest rate								7.12%		7.12%		7.12%
SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,925
Investment, interest rate								8.13%		8.13%		8.13%
SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,849
Investment, interest rate		10.20%		10.20%		10.20%
SLF JV I | Investment, Identifier [Axis]: Peloton Interactive, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 5,486
Investment, interest rate								8.35%		8.35%		8.35%
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,422
Investment, interest rate		9.50%		9.50%		9.50%
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,503
Investment, interest rate		12.59%		12.59%		12.59%
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,503
Investment, interest rate								10.92%		10.92%		10.92%
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 254
Investment, interest rate		13.04%		13.04%		13.04%
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,116
Investment, interest rate		13.04%		13.04%		13.04%
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 0
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,796
Investment, interest rate								10.68%		10.68%		10.68%
SLF JV I | Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,000
Investment, interest rate		9.99%		9.99%		9.99%
SLF JV I | Investment, Identifier [Axis]: RevSpring, Inc., Commercial Printing, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 9,550
Investment, interest rate		9.50%		9.50%		9.50%
SLF JV I | Investment, Identifier [Axis]: RevSpring, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 9,625
Investment, interest rate								7.67%		7.67%		7.67%
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 8,201
Investment, interest rate								8.06%		8.06%		8.06%
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 138
Investment, interest rate								8.04%		8.04%		8.04%
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, Footwear, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,135
Investment, interest rate		10.52%		10.52%		10.52%
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, Footwear, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 138
Investment, interest rate		10.50%		10.50%		10.50%
SLF JV I | Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,985
Investment, interest rate		9.97%		9.97%		9.97%
SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,500
Investment, interest rate								7.63%		7.63%		7.63%
SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,801
Investment, interest rate		9.70%		9.70%		9.70%
SLF JV I | Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,536
Investment, interest rate								7.63%		7.63%		7.63%
SLF JV I | Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,328
Investment, interest rate		10.69%		10.69%		10.69%
SLF JV I | Investment, Identifier [Axis]: Sorenson Communications, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,553
Investment, interest rate								9.17%		9.17%		9.17%
SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,865
Investment, interest rate		10.70%		10.70%		10.70%
SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 8,933
Investment, interest rate								8.30%		8.30%		8.30%
SLF JV I | Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,743
Investment, interest rate								7.42%		7.42%		7.42%
SLF JV I | Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,377
Investment, interest rate								6.51%		6.51%		6.51%
SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 8,235
Investment, interest rate		9.84%		9.84%		9.84%
SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,256
Investment, interest rate								8.15%		8.15%		8.15%
SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,285
Investment, interest rate								9.12%		9.12%		9.12%
SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,230
Investment, interest rate		11.20%		11.20%		11.20%
SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,322
Investment, interest rate		10.22%		10.22%		10.22%
SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,365
Investment, interest rate								8.67%		8.67%		8.67%
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,970
Investment, interest rate		9.03%		9.03%		9.03%
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 1,985
Investment, interest rate								6.56%		6.56%		6.56%
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 6,000
Investment, interest rate								10.56%		10.56%		10.56%
SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,818
Investment, interest rate								9.37%		9.37%		9.37%
SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 7,757
Investment, interest rate		11.45%		11.45%		11.45%
SLF JV I | Investment, Identifier [Axis]: Zayo Group Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,155
Investment, interest rate								6.12%		6.12%		6.12%
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,331
Investment, interest rate		8.59%		8.59%		8.59%
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
SLF JV I | Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 7,331
Investment, interest rate								7.62%		7.62%		7.62%
SLF JV I | Senior secured loans
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 350,214						$ 383,194
SLF JV I | Weighted Average
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		10.40%		10.40%		10.40%		8.33%		8.33%		8.33%
Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 123,126						$ 143,225
Number of borrowers in the Glick JV | borrower		37		37		37		43		43		43
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 4,647
Investment, interest rate								9.80%		9.80%		9.80%
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 587
Investment, interest rate		12.00%		12.00%		12.00%
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,824
Investment, interest rate		12.00%		12.00%		12.00%
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0						$ 0
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,721						$ 1,734
Investment, interest rate		11.31%		11.31%		11.31%		9.67%		9.67%		9.67%
Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,313						$ 6,562
Investment, interest rate		12.89%		12.89%		12.89%		11.20%		11.20%		11.20%
Glick JV LLC | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,485
Investment, interest rate		9.22%		9.22%		9.22%
Glick JV LLC | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,868						$ 2,889
Investment, interest rate		11.49%		11.49%		11.49%		9.03%		9.03%		9.03%
Glick JV LLC | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,903						$ 2,925
Investment, interest rate		9.39%		9.39%		9.39%		7.92%		7.92%		7.92%
Glick JV LLC | Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,000
Investment, interest rate		10.20%		10.20%		10.20%
Glick JV LLC | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 910						$ 917
Investment, interest rate		9.25%		9.25%		9.25%		7.42%		7.42%		7.42%
Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,078						$ 2,078
Investment, interest rate		10.44%		10.44%		10.44%		8.37%		8.37%		8.37%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,000
Investment, interest rate								7.70%		7.70%		7.70%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,985
Investment, interest rate		9.20%		9.20%		9.20%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 998
Investment, interest rate		9.47%		9.47%		9.47%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,423
Investment, interest rate		10.47%		10.47%		10.47%
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,423
Investment, interest rate								8.37%		8.37%		8.37%
Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,628
Investment, interest rate		11.27%		11.27%		11.27%
Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,656
Investment, interest rate								8.78%		8.78%		8.78%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 808
Investment, interest rate								8.12%		8.12%		8.12%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,398
Investment, interest rate								8.12%		8.12%		8.12%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,372
Investment, interest rate		10.50%		10.50%		10.50%
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 802
Investment, interest rate		10.50%		10.50%		10.50%
Glick JV LLC | Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,970
Investment, interest rate								8.98%		8.98%		8.98%
Glick JV LLC | Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,519
Investment, interest rate								9.37%		9.37%		9.37%
Glick JV LLC | Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,481
Investment, interest rate								6.48%		6.48%		6.48%
Glick JV LLC | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,773						$ 2,280
Investment, interest rate		10.24%		10.24%		10.24%		7.65%		7.65%		7.65%
Glick JV LLC | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,848						$ 2,870
Investment, interest rate		9.54%		9.54%		9.54%		7.67%		7.67%		7.67%
Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,978
Investment, interest rate		9.80%		9.80%		9.80%
Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,000
Investment, interest rate								7.33%		7.33%		7.33%
Glick JV LLC | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,528						$ 2,730
Investment, interest rate		10.22%		10.22%		10.22%		8.12%		8.12%		8.12%
Glick JV LLC | Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,503
Investment, interest rate								8.26%		8.26%		8.26%
Glick JV LLC | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,488
Investment, interest rate								7.80%		7.80%		7.80%
Glick JV LLC | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 28,457						$ 28,973
Glick JV LLC | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,940						$ 3,970
Investment, interest rate		10.25%		10.25%		10.25%		7.94%		7.94%		7.94%
Glick JV LLC | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,970						$ 4,000
Investment, interest rate		10.45%		10.45%		10.45%		8.38%		8.38%		8.38%
Glick JV LLC | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,281						$ 2,375
Investment, interest rate		11.29%		11.29%		11.29%		9.42%		9.42%		9.42%
Glick JV LLC | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,920						$ 3,950
Investment, interest rate		10.75%		10.75%		10.75%		8.80%		8.80%		8.80%
Glick JV LLC | Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,985						$ 2,000
Investment, interest rate		9.90%		9.90%		9.90%		7.89%		7.89%		7.89%
Glick JV LLC | Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,347						$ 1,358
Investment, interest rate		8.72%		8.72%		8.72%		6.37%		6.37%		6.37%
Glick JV LLC | Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,313						$ 6,562
Glick JV LLC | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,940						$ 3,970
Investment, interest rate		11.08%		11.08%		11.08%		8.23%		8.23%		8.23%
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0						$ 0
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,634						$ 1,647
Investment, interest rate		10.84%		10.84%		10.84%		9.17%		9.17%		9.17%
Glick JV LLC | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,211						$ 5,252
Investment, interest rate		10.00%		10.00%		10.00%		7.87%		7.87%		7.87%
Glick JV LLC | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,858						$ 3,888
Investment, interest rate		9.25%		9.25%		9.25%		7.12%		7.12%		7.12%
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 685
Investment, interest rate		9.50%		9.50%		9.50%
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,842						$ 2,842
Investment, interest rate		12.59%		12.59%		12.59%		10.92%		10.92%		10.92%
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 180						$ 0
Investment, interest rate		13.04%		13.04%		13.04%
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,182						$ 4,465
Investment, interest rate		13.04%		13.04%		13.04%		10.68%		10.68%		10.68%
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,045						$ 6,094
Investment, interest rate		10.52%		10.52%		10.52%		8.06%		8.06%		8.06%
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 102						$ 102
Investment, interest rate		10.50%		10.50%		10.50%		8.04%		8.04%		8.04%
Glick JV LLC | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 5,227						$ 6,000
Investment, interest rate		9.70%		9.70%		9.70%		7.63%		7.63%		7.63%
Glick JV LLC | Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 1,691
Investment, interest rate								7.63%		7.63%		7.63%
Glick JV LLC | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,925						$ 4,962
Investment, interest rate		10.70%		10.70%		10.70%		8.30%		8.30%		8.30%
Glick JV LLC | Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,820
Investment, interest rate								7.42%		7.42%		7.42%
Glick JV LLC | Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,377
Investment, interest rate								6.51%		6.51%		6.51%
Glick JV LLC | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 2,647						$ 2,654
Investment, interest rate		9.84%		9.84%		9.84%		8.15%		8.15%		8.15%
Glick JV LLC | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 3,001						$ 3,024
Investment, interest rate		11.20%		11.20%		11.20%		9.12%		9.12%		9.12%
Glick JV LLC | Investment, Identifier [Axis]: Tribe Buyer LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,570						$ 1,583
Investment, interest rate		9.69%		9.69%		9.69%		7.62%		7.62%		7.62%
Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 985						$ 993
Investment, interest rate		9.03%		9.03%		9.03%		6.56%		6.56%		6.56%
Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 3,000
Investment, interest rate								10.56%		10.56%		10.56%
Glick JV LLC | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 4,848						$ 4,886
Investment, interest rate		11.45%		11.45%		11.45%		9.37%		9.37%		9.37%
Glick JV LLC | Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Delayed Draw Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 0
Glick JV LLC | Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 1,777
Investment, interest rate		8.59%		8.59%		8.59%
Glick JV LLC | Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal								$ 2,444
Investment, interest rate								7.62%		7.62%		7.62%
Glick JV LLC | Senior secured loans
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 123,126						$ 143,225
Glick JV LLC | Weighted Average
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		10.66%		10.66%		10.66%		8.52%		8.52%		8.52%

[1] As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

[2] Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

[3] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[4] Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

[5] This investment represents a participation interest in the underlying securities shown.

[6] Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

[7] The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the London Interbank Offered Rate ("LIBOR" or "L"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of June 30, 2023, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 180-day LIBOR at 5.73%, the PRIME at 8.25%, the 30-day SOFR at 5.10%, the 90-day SOFR at 5.24%, the 180-day SOFR at 5.34%, the SONIA at 3.47%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.49% and the 180-day EURIBOR at 2.82%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

[8] As of September 30, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.

[9] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[10] Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

[11] The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR, SOFR, SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 180-day LIBOR at 4.17%, the 360-day LIBOR at 4.78%, the PRIME at 6.25%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55%, the SONIA at 1.69%, the 30-day EURIBOR at 0.69%, the 90-day EURIBOR at 0.99% and the 180-day EURIBOR at 0.38%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

[12] Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

[13] Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

[14] Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of June 30, 2023, qualifying assets represented 73.7% of the Company's total assets and non-qualifying assets represented 26.3% of the Company's total assets.

[15] This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

[16] Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2022, qualifying assets represented 75.7% of the Company's total assets and non-qualifying assets represented 24.3% of the Company's total assets.

[17] This investment was on non-accrual status as of June 30, 2023.

[18] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[19] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[20] This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

[21] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[22] Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[23] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[24] Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[25] This investment was renamed during the three months ended March 31, 2022. For periods prior to March 31, 2022, this investment was referenced as Realfi Strategic Capital Funding LLC.

[26] See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

[27] See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

[28] This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

XML

Portfolio Investments - Portfolio Listing (Details) € in Thousands, £ in Thousands, $ in Thousands		Jun. 30, 2023 USD ($) shares		Jun. 30, 2023 EUR (€) shares		Jun. 30, 2023 GBP (£) shares		Sep. 30, 2022 USD ($) shares		Sep. 30, 2022 EUR (€) shares		Sep. 30, 2022 GBP (£) shares		Jun. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, at cost		$ 3,296,285						$ 2,617,754
Investments at fair value		3,135,619						2,494,111
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		350,214						383,194
Investment owned, at cost		348,782						382,673
Investments at fair value		329,809						359,625
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		123,126						143,225
Investment owned, at cost		120,172						140,083
Investments at fair value		$ 113,833						$ 133,144
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[3],[4],[5],[6]	12.50%		12.50%		12.50%
Investment, principal	[1],[3],[4],[6],[7]	$ 1,174
Investment owned, at cost	[1],[3],[4],[6]	1,133
Investments at fair value	[1],[3],[4],[6]	$ 1,112
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[3],[4],[5]	11.00%		11.00%		11.00%
Investment, principal	[1],[3],[4],[7]	$ 14,916
Investment owned, at cost	[1],[3],[4]	14,770
Investments at fair value	[1],[3],[4]	$ 14,489
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[9],[10],[11]							9.80%		9.80%		9.80%
Investment, principal	[8],[9],[10],[12]							$ 389
Investment owned, at cost	[8],[9],[10]							387
Investments at fair value	[8],[9],[10]							$ 727
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							7.00%		7.00%		7.00%
Investment, principal	[8],[9],[10],[12],[13]							$ 0
Investment owned, at cost	[8],[9],[10],[13]							(31)
Investments at fair value	[8],[9],[10],[13]							0
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[3],[4],[5],[6]	12.00%		12.00%		12.00%
Investment, principal	[1],[3],[4],[6],[7]	$ 3,710
Investment owned, at cost	[1],[3],[4],[6]	3,664
Investments at fair value	[1],[3],[4],[6]	$ 3,645
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14],[15]	14.25%		14.25%		14.25%
Investment, principal	[1],[4],[7],[14],[15]	$ 21,434
Investment owned, at cost	[1],[4],[14],[15]	21,620
Investments at fair value	[1],[4],[14],[15]	21,434
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		5,576	[1],[4],[7],[14]					33,997	[8],[9],[12],[16]
Investment owned, at cost		5,561	[1],[4],[14]					33,960	[8],[9],[16]
Investments at fair value		$ 5,464	[1],[4],[14]					$ 34,891	[8],[9],[16]
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							6.25%		6.25%		6.25%
Investment, interest rate	[8],[9],[10],[11]							9.80%		9.80%		9.80%
Investment, principal	[8],[9],[10],[12]							$ 14,685
Investment owned, at cost	[8],[9],[10]							14,217
Investments at fair value	[8],[9],[10]							$ 14,431
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	12.00%		12.00%		12.00%
Investment, principal	[1],[4],[5],[7]	$ 3,520
Investment owned, at cost	[1],[4],[5]	3,480
Investments at fair value	[1],[4],[5]	$ 3,455
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%		6.50%		6.50%
Investment, interest rate		12.00%		12.00%		12.00%
Investment, principal		$ 6,911
Investment owned, at cost		6,832
Investments at fair value		$ 6,784
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	12.00%		12.00%		12.00%
Investment, principal	[1],[4],[5],[7]	$ 18,271
Investment owned, at cost	[1],[4],[5]	18,091
Investments at fair value	[1],[4],[5]	$ 17,935
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%		6.50%		6.50%
Investment, interest rate		12.00%		12.00%		12.00%
Investment, principal		$ 1,173
Investment owned, at cost		1,158
Investments at fair value		$ 1,152
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	11.66%		11.66%		11.66%
Investment, principal	[1],[4],[5],[7]	$ 1,000
Investment owned, at cost	[1],[4],[5]	983
Investments at fair value	[1],[4],[5]	$ 982
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.25%		6.25%		6.25%
Investment, interest rate								9.80%		9.80%		9.80%
Investment, principal								$ 8,518
Investment owned, at cost								8,389
Investments at fair value								$ 8,371
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.25%		6.25%		6.25%
Investment, interest rate								9.80%		9.80%		9.80%
Investment, principal								$ 4,647
Investment owned, at cost								4,579
Investments at fair value								$ 4,567
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%		6.50%		6.50%
Investment, interest rate		12.00%		12.00%		12.00%
Investment, principal		$ 587
Investment owned, at cost		579
Investments at fair value		$ 576
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%		6.50%		6.50%
Investment, interest rate		12.00%		12.00%		12.00%
Investment, principal		$ 3,824
Investment owned, at cost		3,782
Investments at fair value		$ 3,753
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[4],[14]	7.50%	[1],[4],[14]	7.50%	[1],[4],[14]	7.50%	[8],[9],[10],[16]	7.50%	[8],[9],[10],[16]	7.50%	[8],[9],[10],[16]
Investment, interest rate		12.89%	[1],[2],[4],[5],[14]	12.89%	[1],[2],[4],[5],[14]	12.89%	[1],[2],[4],[5],[14]	11.20%	[8],[9],[10],[11],[16]	11.20%	[8],[9],[10],[11],[16]	11.20%	[8],[9],[10],[11],[16]
Investment, principal		$ 6,589	[1],[4],[5],[7],[14]					$ 6,589	[8],[9],[10],[12],[16]
Investment owned, at cost		6,292	[1],[4],[5],[14]					6,256	[8],[9],[10],[16]
Investments at fair value		$ 6,267	[1],[4],[5],[14]					$ 6,262	[8],[9],[10],[16]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[3],[4],[14]	7.50%	[1],[3],[4],[14]	7.50%	[1],[3],[4],[14]	7.50%	[8],[9],[10],[13],[16]	7.50%	[8],[9],[10],[13],[16]	7.50%	[8],[9],[10],[13],[16]
Investment, principal		$ 0	[1],[3],[4],[5],[7],[14]					$ 0	[8],[9],[10],[12],[13],[16]
Investment owned, at cost		(38)	[1],[3],[4],[5],[14]					(38)	[8],[9],[10],[13],[16]
Investments at fair value		$ (38)	[1],[3],[4],[5],[14]					$ (37)	[8],[9],[10],[13],[16]
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		28,948	[1],[4],[14]	28,948	[1],[4],[14]	28,948	[1],[4],[14]	28,948	[8],[9],[16]	28,948	[8],[9],[16]	28,948	[8],[9],[16]
Investment owned, at cost		$ 174	[1],[4],[14]					$ 174	[8],[9],[16]
Investments at fair value		$ 18	[1],[4],[14]					$ 73	[8],[9],[16]
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[4],[5],[14]	7.25%	[1],[4],[5],[14]	7.25%	[1],[4],[5],[14]	7.25%	[8],[9],[10],[16]	7.25%	[8],[9],[10],[16]	7.25%	[8],[9],[10],[16]
Investment, interest rate		10.67%	[1],[2],[4],[5],[14]	10.67%	[1],[2],[4],[5],[14]	10.67%	[1],[2],[4],[5],[14]	7.94%	[8],[9],[10],[11],[16]	7.94%	[8],[9],[10],[11],[16]	7.94%	[8],[9],[10],[11],[16]
Investment, principal | €				€ 29,985	[1],[4],[5],[7],[14]					€ 24,838	[8],[9],[10],[12],[16]
Investment owned, at cost		$ 33,119	[1],[4],[5],[14]					$ 27,752	[8],[9],[10],[16]
Investments at fair value		$ 32,128	[1],[4],[5],[14]					$ 22,143	[8],[9],[10],[16]
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		17,870	[1],[4]	17,870	[1],[4]	17,870	[1],[4]	14,410	[8],[9]	14,410	[8],[9]	14,410	[8],[9]
Investment owned, at cost		$ 1,733	[1],[4]					$ 1,352	[8],[9]
Investments at fair value		$ 2,578	[1],[4]					$ 1,291	[8],[9]
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.75%	[1],[4],[5]	7.75%	[1],[4],[5]	7.75%	[1],[4],[5]	7.75%	[8],[9],[10]	7.75%	[8],[9],[10]	7.75%	[8],[9],[10]
Investment, interest rate		12.95%	[1],[2],[4],[5]	12.95%	[1],[2],[4],[5]	12.95%	[1],[2],[4],[5]	10.88%	[8],[9],[10],[11]	10.88%	[8],[9],[10],[11]	10.88%	[8],[9],[10],[11]
Investment, principal		$ 17,873	[1],[4],[5],[7]					$ 14,414	[8],[9],[10],[12]
Investment owned, at cost		17,646	[1],[4],[5]					14,154	[8],[9],[10]
Investments at fair value		$ 17,533	[1],[4],[5]					$ 13,910	[8],[9],[10]
Investment, Identifier [Axis]: APX Group Inc., Electrical Components & Equipment, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11],[16]							5.75%		5.75%		5.75%
Investment, principal	[9],[12],[16]							$ 2,075
Investment owned, at cost	[9],[16]							1,733
Investments at fair value	[9],[16]							$ 1,645
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11]							7.50%		7.50%		7.50%
Investment, principal	[9],[12]							$ 5,500
Investment owned, at cost	[9]							5,408
Investments at fair value	[9]							$ 3,641
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11]							5.25%		5.25%		5.25%
Investment, principal	[9],[12]							$ 2,500
Investment owned, at cost	[9]							2,220
Investments at fair value	[9]							$ 1,926
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment owned, at cost								$ (9)
Investments at fair value								$ (11)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%		6.00%		6.00%		6.00%
Investment, principal		$ 0						$ 0
Investment owned, at cost		(3)						(4)
Investments at fair value		$ (10)						$ (5)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment, interest rate								9.67%		9.67%		9.67%
Investment, principal								$ 4,176
Investment owned, at cost								4,103
Investments at fair value								$ 4,080
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%		6.00%		6.00%		6.00%
Investment, interest rate		11.31%		11.31%		11.31%		9.67%		9.67%		9.67%
Investment, principal		$ 1,721						$ 1,734
Investment owned, at cost		1,695						1,704
Investments at fair value		$ 1,635						$ 1,694
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5],[14]	6.00%		6.00%		6.00%
Investment, principal	[1],[3],[4],[5],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[5],[14]	(14)
Investments at fair value	[1],[3],[4],[5],[14]	$ (20)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, principal		$ 0
Investment owned, at cost		(7)
Investments at fair value		$ (25)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[14]	6.00%		6.00%		6.00%
Investment, interest rate	[1],[2],[4],[5],[14]	11.31%		11.31%		11.31%
Investment, principal	[1],[4],[5],[7],[14]	$ 3,284
Investment owned, at cost	[1],[4],[5],[14]	3,276
Investments at fair value	[1],[4],[5],[14]	$ 3,120
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, interest rate		11.31%		11.31%		11.31%
Investment, principal		$ 4,145
Investment owned, at cost		4,083
Investments at fair value		3,938
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[7],[14],[15]	11,683
Investment owned, at cost	[1],[4],[14],[15]	11,723
Investments at fair value	[1],[4],[14],[15]	$ 11,274
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		8.94%		8.94%		8.94%
Investment, principal		$ 5,596
Investment owned, at cost		5,559
Investments at fair value		$ 5,545
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.75%	[1],[4]	7.75%	[1],[4]	7.75%	[1],[4]	7.75%	[9],[10]	7.75%	[9],[10]	7.75%	[9],[10]
Investment, interest rate		12.94%	[1],[2],[4],[5]	12.94%	[1],[2],[4],[5]	12.94%	[1],[2],[4],[5]	10.82%	[9],[10],[11]	10.82%	[9],[10],[11]	10.82%	[9],[10],[11]
Investment, principal		$ 20,000	[1],[4],[5],[7]					$ 20,000	[9],[10],[12]
Investment owned, at cost		19,943	[1],[4],[5]					19,927	[9],[10]
Investments at fair value		$ 18,883	[1],[4],[5]					$ 19,075	[9],[10]
Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								6.82%		6.82%		6.82%
Investment, principal								$ 10,093
Investment owned, at cost								10,028
Investments at fair value								$ 9,692
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[3],[4],[5]	10.86%		10.86%		10.86%
Investment, principal	[1],[3],[4],[5],[7]	$ 2,033
Investment owned, at cost	[1],[3],[4],[5]	2,011
Investments at fair value	[1],[3],[4],[5]	$ 2,027
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[4],[5]	10.86%		10.86%		10.86%
Investment, principal	[1],[4],[5],[7]	$ 20,286
Investment owned, at cost	[1],[4],[5]	20,193
Investments at fair value	[1],[4],[5]	$ 20,246
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[3],[4],[5]
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(2)
Investments at fair value	[1],[3],[4],[5]	$ (8)
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							5.50%		5.50%		5.50%
Investment, interest rate	[8],[9],[10],[11],[13]							9.14%		9.14%		9.14%
Investment, principal	[8],[9],[10],[12],[13]							$ 500
Investment owned, at cost	[8],[9],[10],[13]							462
Investments at fair value	[8],[9],[10],[13]							$ 495
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							5.50%		5.50%		5.50%
Investment, interest rate	[8],[9],[10],[11]							9.12%		9.12%		9.12%
Investment, principal	[8],[9],[10],[12]							$ 15,976
Investment owned, at cost	[8],[9],[10]							15,686
Investments at fair value	[8],[9],[10]							$ 15,944
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							5.50%		5.50%		5.50%
Investment, principal	[8],[9],[10],[12],[13]							$ 0
Investment owned, at cost	[8],[9],[10],[13]							0
Investments at fair value	[8],[9],[10],[13]							$ (6)
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.00%	[1],[3],[4]	7.00%	[1],[3],[4]	7.00%	[1],[3],[4]	7.00%	[8],[9],[10],[13]	7.00%	[8],[9],[10],[13]	7.00%	[8],[9],[10],[13]
Investment, interest rate		12.05%	[1],[2],[3],[4],[5]	12.05%	[1],[2],[3],[4],[5]	12.05%	[1],[2],[3],[4],[5]	10.64%	[8],[9],[10],[11],[13]	10.64%	[8],[9],[10],[11],[13]	10.64%	[8],[9],[10],[11],[13]
Investment, principal		$ 2,113	[1],[3],[4],[5],[7]					$ 914	[8],[9],[10],[12],[13]
Investment owned, at cost		2,101	[1],[3],[4],[5]					890	[8],[9],[10],[13]
Investments at fair value		$ 2,102	[1],[3],[4],[5]					$ 898	[8],[9],[10],[13]
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[9],[10],[11]							9.63%		9.63%		9.63%
Investment, principal	[8],[9],[10],[12]							$ 27,349
Investment owned, at cost	[8],[9],[10]							27,038
Investments at fair value	[8],[9],[10]							$ 27,158
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[4],[5]	12.34%		12.34%		12.34%
Investment, principal	[1],[4],[5],[7]	$ 6,400
Investment owned, at cost	[1],[4],[5]	6,327
Investments at fair value	[1],[4],[5]	$ 6,374
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[4],[5]	12.34%		12.34%		12.34%
Investment, principal	[1],[4],[5],[7]	$ 25,332
Investment owned, at cost	[1],[4],[5]	25,283
Investments at fair value	[1],[4],[5]	$ 25,230
Investment, Identifier [Axis]: Aden & Anais Merger Sub, Inc., Apparel, Accessories & Luxury Goods, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9]							51,645		51,645		51,645
Investment owned, at cost	[8],[9]							$ 5,165
Investments at fair value	[8],[9]							$ 0
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		5,715	[1],[4]	5,715	[1],[4]	5,715	[1],[4]	5,715	[8],[9]	5,715	[8],[9]	5,715	[8],[9]
Investment owned, at cost		$ 90	[1],[4]					$ 90	[8],[9]
Investments at fair value		$ 0	[1],[4]					$ 0	[8],[9]
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							8.50%		8.50%		8.50%
Investment, principal	[8],[9],[10],[12]							$ 23,338
Investment owned, at cost	[8],[9],[10]							22,057
Investments at fair value	[8],[9],[10]							$ 22,141
Investment, Identifier [Axis]: All Web Leads, Inc., First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[17]	8.50%		8.50%		8.50%
Investment, principal	[1],[4],[5],[7],[17]	$ 23,562
Investment owned, at cost	[1],[4],[5],[17]	22,795
Investments at fair value	[1],[4],[5],[17]	$ 16,880
Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.00%		4.00%		4.00%
Investment, interest rate								6.91%		6.91%		6.91%
Investment, principal								$ 3,000
Investment owned, at cost								2,841
Investments at fair value								$ 2,730
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.32%		9.32%		9.32%
Investment, principal		$ 2,977
Investment owned, at cost		2,850
Investments at fair value		$ 2,808
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		5.50%	[2],[4],[5],[14]	5.50%	[2],[4],[5],[14]	5.50%	[2],[4],[5],[14]	5.50%	[9],[10],[11],[16]	5.50%	[9],[10],[11],[16]	5.50%	[9],[10],[11],[16]
Investment, principal		$ 4,050	[4],[7],[14]					$ 4,050	[9],[12],[16]
Investment owned, at cost		3,561	[4],[14]					3,518	[9],[16]
Investments at fair value		$ 2,900	[4],[14]					$ 3,057	[9],[16]
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	8.00%		8.00%		8.00%
Investment, interest rate	[1],[2],[4],[5]	13.34%		13.34%		13.34%
Investment, principal	[1],[4],[5],[7]	$ 8,794
Investment owned, at cost	[1],[4],[5]	8,132
Investments at fair value	[1],[4],[5]	$ 8,011
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	166,414		166,414		166,414
Investment owned, at cost	[1],[4]	$ 642
Investments at fair value	[1],[4]	$ 518
Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%		7.50%		7.50%		7.50%		7.50%		7.50%
Investment, interest rate		12.89%		12.89%		12.89%		11.20%		11.20%		11.20%
Investment, principal		$ 6,313						$ 6,562
Investment owned, at cost		6,261						6,489
Investments at fair value		$ 6,029						$ 6,529
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								7.50%		7.50%		7.50%
Investment, interest rate								11.20%		11.20%		11.20%
Investment, principal								$ 9,267
Investment owned, at cost								9,166
Investments at fair value								$ 9,221
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[8],[9],[10]	7.50%	[8],[9],[10]	7.50%	[8],[9],[10]
Investment, interest rate		12.89%	[1],[2],[4],[5]	12.89%	[1],[2],[4],[5]	12.89%	[1],[2],[4],[5]	11.20%	[8],[9],[10],[11]	11.20%	[8],[9],[10],[11]	11.20%	[8],[9],[10],[11]
Investment, principal		$ 17,280	[1],[4],[5],[7]					$ 13,134	[8],[9],[10],[12]
Investment owned, at cost		17,197	[1],[4],[5]					12,847	[8],[9],[10]
Investments at fair value		$ 16,503	[1],[4],[5]					$ 13,068	[8],[9],[10]
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%		7.50%		7.50%
Investment, interest rate		12.89%		12.89%		12.89%
Investment, principal		$ 8,916
Investment owned, at cost		8,845
Investments at fair value		$ 8,514
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[8],[9],[10],[11],[16]							10.00%		10.00%		10.00%
Investment, principal	[8],[9],[12],[16]							$ 24,043
Investment owned, at cost	[8],[9],[16]							23,747
Investments at fair value	[8],[9],[16]							$ 23,923
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		824,197	[4],[14]	824,197	[4],[14]	824,197	[4],[14]	587,930	[9],[16]	587,930	[9],[16]	587,930	[9],[16]
Investment owned, at cost		$ 2,426	[4],[14]					$ 5,308	[9],[16]
Investments at fair value		$ 6,379	[4],[14]					$ 3,974	[9],[16]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		141,640	[1],[4],[14],[18]	141,640	[1],[4],[14],[18]	141,640	[1],[4],[14],[18]	124,780	[8],[9],[16],[19]	124,780	[8],[9],[16],[19]	124,780	[8],[9],[16],[19]
Investment owned, at cost		$ 566	[1],[4],[14],[18]					$ 485	[8],[9],[16],[19]
Investments at fair value		$ 339	[1],[4],[14],[18]					$ 212	[8],[9],[16],[19]
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	8.50%		8.50%		8.50%
Investment, principal	[1],[4],[7],[14]	$ 28,464
Investment owned, at cost	[1],[4],[14]	28,363
Investments at fair value	[1],[4],[14]	$ 27,682
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	8.50%		8.50%		8.50%
Investment, principal	[1],[4],[7],[14]	$ 2,121
Investment owned, at cost	[1],[4],[14]	1,945
Investments at fair value	[1],[4],[14]	$ 2,063
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	8.50%		8.50%		8.50%
Investment, principal	[1],[4],[7],[14]	$ 27,692
Investment owned, at cost	[1],[4],[14]	27,612
Investments at fair value	[1],[4],[14]	$ 26,930
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	8.50%		8.50%		8.50%
Investment, principal	[1],[4],[7],[14]	$ 2,064
Investment owned, at cost	[1],[4],[14]	1,891
Investments at fair value	[1],[4],[14]	$ 2,007
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[8],[9],[10],[11],[16]							10.00%		10.00%		10.00%
Investment, principal	[8],[9],[12],[16]							$ 23,522
Investment owned, at cost	[8],[9],[16]							23,264
Investments at fair value	[8],[9],[16]							$ 23,404
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.75%	[1],[4],[5]	8.75%	[1],[4],[5]	8.75%	[1],[4],[5]	8.75%	[8],[9],[10]	8.75%	[8],[9],[10]	8.75%	[8],[9],[10]
Investment, interest rate		13.99%	[1],[2],[4],[5]	13.99%	[1],[2],[4],[5]	13.99%	[1],[2],[4],[5]	12.30%	[8],[9],[10],[11]	12.30%	[8],[9],[10],[11]	12.30%	[8],[9],[10],[11]
Investment, principal		$ 17,048	[1],[4],[5],[7]					$ 14,760	[8],[9],[10],[12]
Investment owned, at cost		16,411	[1],[4],[5]					14,492	[8],[9],[10]
Investments at fair value		$ 12,616	[1],[4],[5]					$ 13,284	[8],[9],[10]
Investment, Identifier [Axis]: American Rock Salt Company LLC, Diversified Metals & Mining, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.22%		9.22%		9.22%
Investment, principal		$ 4,970
Investment owned, at cost		4,734
Investments at fair value		$ 4,692
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.22%		9.22%		9.22%
Investment, principal		$ 2,485
Investment owned, at cost		2,367
Investments at fair value		$ 2,346
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%	[4],[5]	6.25%	[4],[5]	6.25%	[4],[5]	6.25%	[9],[10]	6.25%	[9],[10]	6.25%	[9],[10]
Investment, interest rate		11.49%	[2],[4],[5]	11.49%	[2],[4],[5]	11.49%	[2],[4],[5]	9.03%	[9],[10],[11]	9.03%	[9],[10],[11]	9.03%	[9],[10],[11]
Investment, principal		$ 19,163	[4],[5],[7]					$ 9,895	[9],[10],[12]
Investment owned, at cost		18,289	[4],[5]					9,772	[9],[10]
Investments at fair value		$ 16,718	[4],[5]					$ 9,293	[9],[10]
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%		6.25%		6.25%
Investment, interest rate		11.49%		11.49%		11.49%
Investment, principal		$ 4,836
Investment owned, at cost		4,775
Investments at fair value		$ 4,219
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.25%		6.25%		6.25%
Investment, interest rate								9.03%		9.03%		9.03%
Investment, principal								$ 4,873
Investment owned, at cost								4,812
Investments at fair value								$ 4,576
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%		6.25%		6.25%		6.25%		6.25%		6.25%
Investment, interest rate		11.49%		11.49%		11.49%		9.03%		9.03%		9.03%
Investment, principal		$ 2,868						$ 2,889
Investment owned, at cost		2,832						2,853
Investments at fair value		$ 2,502						$ 2,714
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.25%		4.25%		4.25%
Investment, interest rate								7.92%		7.92%		7.92%
Investment, principal								$ 7,800
Investment owned, at cost								7,722
Investments at fair value								$ 7,527
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%		4.25%		4.25%		4.25%
Investment, interest rate		9.39%		9.39%		9.39%		7.92%		7.92%		7.92%
Investment, principal		$ 2,903						$ 2,925
Investment owned, at cost		2,873						2,896
Investments at fair value		$ 2,895						$ 2,823
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[16]							4.25%		4.25%		4.25%
Investment, interest rate	[8],[9],[10],[11],[16]							7.92%		7.92%		7.92%
Investment, principal	[8],[9],[10],[12],[16]							$ 15,220
Investment owned, at cost	[8],[9],[10],[16]							13,973
Investments at fair value	[8],[9],[10],[16]							$ 14,687
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.39%		9.39%		9.39%
Investment, principal		$ 7,740
Investment owned, at cost		7,663
Investments at fair value		$ 7,721
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[1],[4],[5],[14]	8.00%	[1],[4],[5],[14]	8.00%	[1],[4],[5],[14]	8.00%	[8],[9],[10],[16]	8.00%	[8],[9],[10],[16]	8.00%	[8],[9],[10],[16]
Investment, interest rate		13.39%	[1],[2],[4],[5],[14]	13.39%	[1],[2],[4],[5],[14]	13.39%	[1],[2],[4],[5],[14]	11.67%	[8],[9],[10],[11],[16]	11.67%	[8],[9],[10],[11],[16]	11.67%	[8],[9],[10],[11],[16]
Investment, principal		$ 12,500	[1],[4],[5],[7],[14]					$ 12,500	[8],[9],[10],[12],[16]
Investment owned, at cost		12,188	[1],[4],[5],[14]					12,188	[8],[9],[10],[16]
Investments at fair value		$ 11,865	[1],[4],[5],[14]					$ 11,958	[8],[9],[10],[16]
Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.20%		10.20%		10.20%
Investment, principal		$ 3,000
Investment owned, at cost		2,915
Investments at fair value		$ 2,925
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								7.42%		7.42%		7.42%
Investment, principal								$ 1,539
Investment owned, at cost								1,203
Investments at fair value								$ 1,232
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%		3.75%		3.75%		3.75%
Investment, interest rate		9.25%		9.25%		9.25%		7.42%		7.42%		7.42%
Investment, principal		$ 910						$ 917
Investment owned, at cost		707						712
Investments at fair value		$ 702						$ 734
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[4],[5]	3.75%		3.75%		3.75%
Investment, interest rate	[2],[4],[5]	9.25%		9.25%		9.25%
Investment, principal	[4],[5],[7]	$ 3,710
Investment owned, at cost	[4],[5]	3,075
Investments at fair value	[4],[5]	$ 2,863
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.25%		9.25%		9.25%
Investment, principal		$ 1,527
Investment owned, at cost		1,194
Investments at fair value		$ 1,179
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							3.75%		3.75%		3.75%
Investment, interest rate	[9],[10],[11]							7.42%		7.42%		7.42%
Investment, principal	[9],[10],[12]							$ 2,736
Investment owned, at cost	[9],[10]							2,260
Investments at fair value	[9],[10]							$ 2,189
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Research & Consulting Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							8.00%		8.00%		8.00%
Investment, interest rate	[8],[9],[10],[11]							10.78%		10.78%		10.78%
Investment, principal	[8],[9],[10],[12]							$ 4,346
Investment owned, at cost	[8],[9],[10]							4,281
Investments at fair value	[8],[9],[10]							$ 3,813
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%	[1],[3],[4],[5]	5.00%	[1],[3],[4],[5]	5.00%	[1],[3],[4],[5]	6.00%	[8],[9],[10],[13]	6.00%	[8],[9],[10],[13]	6.00%	[8],[9],[10],[13]
Investment, interest rate		10.20%	[1],[2],[3],[4],[5]	10.20%	[1],[2],[3],[4],[5]	10.20%	[1],[2],[3],[4],[5]	8.46%	[8],[9],[10],[11],[13]	8.46%	[8],[9],[10],[11],[13]	8.46%	[8],[9],[10],[11],[13]
Investment, principal		$ 808	[1],[3],[4],[5],[7]					$ 892	[8],[9],[10],[12],[13]
Investment owned, at cost		792	[1],[3],[4],[5]					863	[8],[9],[10],[13]
Investments at fair value		$ 808	[1],[3],[4],[5]					$ 846	[8],[9],[10],[13]
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.20%		10.20%		10.20%
Investment, principal		$ 115
Investment owned, at cost		113
Investments at fair value		$ 115
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[9],[10],[11]							8.46%		8.46%		8.46%
Investment, principal	[8],[9],[10],[12]							$ 34,458
Investment owned, at cost	[8],[9],[10]							33,737
Investments at fair value	[8],[9],[10]							$ 33,738
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.20%		10.20%		10.20%
Investment, principal		$ 4,615
Investment owned, at cost		4,592
Investments at fair value		$ 4,615
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.00%		5.00%		5.00%
Investment, interest rate	[1],[2],[4],[5]	10.20%		10.20%		10.20%
Investment, principal	[1],[4],[5],[7]	$ 9,280
Investment owned, at cost	[1],[4],[5]	9,189
Investments at fair value	[1],[4],[5]	$ 9,280
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.00%		5.00%		5.00%
Investment, interest rate	[1],[2],[4],[5]	10.20%		10.20%		10.20%
Investment, principal	[1],[4],[5],[7]	$ 32,308
Investment owned, at cost	[1],[4],[5]	31,999
Investments at fair value	[1],[4],[5]	$ 32,308
Investment, Identifier [Axis]: Apptio, Inc., First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment, interest rate								8.46%		8.46%		8.46%
Investment, principal								$ 154
Investment owned, at cost								151
Investments at fair value								$ 146
Investment, Identifier [Axis]: Apptio, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment, interest rate								8.46%		8.46%		8.46%
Investment, principal								$ 4,615
Investment owned, at cost								4,580
Investments at fair value								$ 4,519
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[4],[5],[14]	7.25%	[1],[4],[5],[14]	7.25%	[1],[4],[5],[14]	7.00%	[8],[9],[10],[16]	7.00%	[8],[9],[10],[16]	7.00%	[8],[9],[10],[16]
Investment, interest rate		10.07%	[1],[2],[4],[5],[14]	10.07%	[1],[2],[4],[5],[14]	10.07%	[1],[2],[4],[5],[14]	8.00%	[8],[9],[10],[11],[16]	8.00%	[8],[9],[10],[11],[16]	8.00%	[8],[9],[10],[11],[16]
Investment, principal | €				€ 3,017	[1],[4],[5],[7],[14]					€ 1,964	[8],[9],[10],[12],[16]
Investment owned, at cost		$ 3,341	[1],[4],[5],[14]					$ 2,176	[8],[9],[10],[16]
Investments at fair value		$ 3,321	[1],[4],[5],[14]					$ 1,927	[8],[9],[10],[16]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[4],[5],[14]	6.00%	[1],[4],[5],[14]	6.00%	[1],[4],[5],[14]	7.00%	[8],[9],[10],[16]	7.00%	[8],[9],[10],[16]	7.00%	[8],[9],[10],[16]
Investment, interest rate		11.25%	[1],[2],[4],[5],[14]	11.25%	[1],[2],[4],[5],[14]	11.25%	[1],[2],[4],[5],[14]	9.19%	[8],[9],[10],[11],[16]	9.19%	[8],[9],[10],[11],[16]	9.19%	[8],[9],[10],[11],[16]
Investment, principal		$ 10,519	[1],[4],[5],[7],[14]									£ 18,636	[8],[9],[10],[12],[16]
Investment owned, at cost		10,389	[1],[4],[5],[14]					$ 23,139	[8],[9],[10],[16]
Investments at fair value		$ 10,614	[1],[4],[5],[14]					$ 20,826	[8],[9],[10],[16]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[4],[5],[14]	7.25%	[1],[4],[5],[14]	7.25%	[1],[4],[5],[14]	5.75%	[8],[9],[10],[16]	5.75%	[8],[9],[10],[16]	5.75%	[8],[9],[10],[16]
Investment, interest rate		12.18%	[1],[2],[4],[5],[14]	12.18%	[1],[2],[4],[5],[14]	12.18%	[1],[2],[4],[5],[14]	8.81%	[8],[9],[10],[11],[16]	8.81%	[8],[9],[10],[11],[16]	8.81%	[8],[9],[10],[11],[16]
Investment, principal						£ 4,949	[1],[4],[5],[7],[14]	$ 10,519	[8],[9],[10],[12],[16]
Investment owned, at cost		$ 6,364	[1],[4],[5],[14]					10,357	[8],[9],[10],[16]
Investments at fair value		$ 6,348	[1],[4],[5],[14]					$ 10,328	[8],[9],[10],[16]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[4],[5],[14]	7.25%	[1],[4],[5],[14]	7.25%	[1],[4],[5],[14]	5.75%	[8],[9],[10],[13],[16]	5.75%	[8],[9],[10],[13],[16]	5.75%	[8],[9],[10],[13],[16]
Investment, interest rate	[1],[2],[4],[5],[14]	12.45%		12.45%		12.45%
Investment, principal | £						£ 23,675	[1],[4],[5],[7],[14]					£ 0	[8],[9],[10],[12],[13],[16]
Investment owned, at cost		$ 28,939	[1],[4],[5],[14]					$ (44)	[8],[9],[10],[13],[16]
Investments at fair value		$ 30,370	[1],[4],[5],[14]					0	[8],[9],[10],[13],[16]
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[14]	5.75%		5.75%		5.75%
Investment, interest rate	[1],[2],[4],[5],[14]	8.57%		8.57%		8.57%
Investment, principal | €	[1],[4],[5],[7],[14]			€ 3,649
Investment owned, at cost	[1],[4],[5],[14]	$ 3,927
Investments at fair value	[1],[4],[5],[14]	$ 4,027
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,783,332		1,783,332		1,783,332								1,609,201
Investment, principal		$ 0												$ 0
Investments at fair value		$ 0						370						$ 563	$ 587
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%		6.75%		6.75%								6.75%
Investment, interest rate		12.29%		12.29%		12.29%								9.00%
Investment, principal		$ 22,304												$ 21,754
Investments at fair value		$ 22,186						24,225						$ 21,260	15,712
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,129,453		1,129,453		1,129,453								1,019,169
Investment, principal		$ 0												$ 0
Investments at fair value		$ 1,412						$ 1,223						$ 1,203	1,152
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,783,332	[1],[20]	1,783,332	[1],[20]	1,783,332	[1],[20]	1,609,201	[8],[21]	1,609,201	[8],[21]	1,609,201	[8],[21]
Investment owned, at cost		$ 804	[1],[20]					$ 764	[8],[21]
Investments at fair value		$ 0	[1],[20]					$ 370	[8],[21]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[3],[5],[20]	6.75%	[1],[3],[5],[20]	6.75%	[1],[3],[5],[20]	6.75%	[8],[10],[13],[21]	6.75%	[8],[10],[13],[21]	6.75%	[8],[10],[13],[21]
Investment, interest rate		12.29%	[1],[2],[3],[5],[20]	12.29%	[1],[2],[3],[5],[20]	12.29%	[1],[2],[3],[5],[20]	10.42%	[8],[10],[11],[13],[21]	10.42%	[8],[10],[11],[13],[21]	10.42%	[8],[10],[11],[13],[21]
Investment, principal		$ 22,304	[1],[3],[5],[7],[20]					$ 24,490	[8],[10],[12],[13],[21]
Investment owned, at cost		22,327	[1],[3],[5],[20]					24,490	[8],[10],[13],[21]
Investments at fair value		$ 22,186	[1],[3],[5],[20]					$ 24,225	[8],[10],[13],[21]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,129,453	[1],[20]	1,129,453	[1],[20]	1,129,453	[1],[20]	1,019,169	[8],[21]	1,019,169	[8],[21]	1,019,169	[8],[21]
Investment owned, at cost		$ 1,159	[1],[20]					$ 1,019	[8],[21]
Investments at fair value		$ 1,412	[1],[20]					$ 1,223	[8],[21]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		78,045	[1],[20]	78,045	[1],[20]	78,045	[1],[20]	70,425	[8],[21]	70,425	[8],[21]	70,425	[8],[21]
Investment owned, at cost		$ 0	[1],[20]					$ 0	[8],[21]
Investments at fair value		$ 0	[1],[20]					0	[8],[21]
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		78,045		78,045		78,045								70,425
Investment, principal		$ 0												$ 0
Investments at fair value		$ 0						$ 0						$ 0	0
Investment, Identifier [Axis]: Associated Asphalt Partners, LLC, Construction Materials, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							5.25%		5.25%		5.25%
Investment, interest rate	[9],[10],[11]							8.06%		8.06%		8.06%
Investment, principal	[9],[10],[12]							$ 2,501
Investment owned, at cost	[9],[10]							2,331
Investments at fair value	[9],[10]							$ 1,934
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%	[4],[5]	5.25%	[4],[5]	5.25%	[4],[5]	5.25%	[9],[10]	5.25%	[9],[10]	5.25%	[9],[10]
Investment, interest rate		10.44%	[2],[4],[5]	10.44%	[2],[4],[5]	10.44%	[2],[4],[5]	8.37%	[9],[10],[11]	8.37%	[9],[10],[11]	8.37%	[9],[10],[11]
Investment, principal		$ 8,490	[4],[5],[7]					$ 5,640	[9],[10],[12]
Investment owned, at cost		8,153	[4],[5]					5,482	[9],[10]
Investments at fair value		$ 5,983	[4],[5]					$ 4,822	[9],[10]
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%
Investment, interest rate		10.44%		10.44%		10.44%
Investment, principal		$ 5,052
Investment owned, at cost		4,880
Investments at fair value		$ 3,560
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								8.37%		8.37%		8.37%
Investment, principal								$ 5,052
Investment owned, at cost								4,858
Investments at fair value								$ 4,319
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.44%		10.44%		10.44%		8.37%		8.37%		8.37%
Investment, principal		$ 2,078						$ 2,078
Investment owned, at cost		2,037						2,033
Investments at fair value		$ 1,464						$ 1,777
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.00%		4.00%		4.00%
Investment, interest rate								7.70%		7.70%		7.70%
Investment, principal								$ 5,000
Investment owned, at cost								4,753
Investments at fair value								$ 4,276
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.00%		4.00%		4.00%
Investment, interest rate								7.70%		7.70%		7.70%
Investment, principal								$ 2,000
Investment owned, at cost								1,901
Investments at fair value								$ 1,711
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.20%		9.20%		9.20%
Investment, principal		$ 4,963
Investment owned, at cost		4,749
Investments at fair value		$ 4,710
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.20%		9.20%		9.20%
Investment, principal		$ 1,985
Investment owned, at cost		1,900
Investments at fair value		$ 1,884
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.25%		4.25%		4.25%
Investment, interest rate		9.47%		9.47%		9.47%
Investment, principal		$ 1,995
Investment owned, at cost		1,883
Investments at fair value		$ 1,902
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.25%		4.25%		4.25%
Investment, interest rate		9.47%		9.47%		9.47%
Investment, principal		$ 998
Investment owned, at cost		941
Investments at fair value		$ 951
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%
Investment, interest rate		10.47%		10.47%		10.47%
Investment, principal		$ 4,346
Investment owned, at cost		4,022
Investments at fair value		$ 3,657
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%
Investment, interest rate		10.47%		10.47%		10.47%
Investment, principal		$ 2,423
Investment owned, at cost		2,236
Investments at fair value		$ 2,039
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								8.37%		8.37%		8.37%
Investment, principal								$ 4,346
Investment owned, at cost								3,981
Investments at fair value								$ 3,347
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								8.37%		8.37%		8.37%
Investment, principal								$ 2,423
Investment owned, at cost								2,212
Investments at fair value								$ 1,866
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.00%	[1],[2],[4],[5],[14],[17]	11.00%	[1],[2],[4],[5],[14],[17]	11.00%	[1],[2],[4],[5],[14],[17]	11.00%	[8],[9],[10],[11],[16]	11.00%	[8],[9],[10],[11],[16]	11.00%	[8],[9],[10],[11],[16]
Investment, principal		$ 1,338	[1],[4],[7],[14],[17]					$ 13,346	[8],[9],[12],[16]
Investment owned, at cost		1,257	[1],[4],[14],[17]					12,929	[8],[9],[16]
Investments at fair value		$ 1,257	[1],[4],[14],[17]					12,812	[8],[9],[16]
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14],[17]	11.00%		11.00%		11.00%
Investment, principal		$ 1,338	[1],[4],[7],[14],[17]					8,309	[8],[9],[12],[16],[22]
Investment owned, at cost		1,241	[1],[4],[14],[17]					8,264	[8],[9],[16],[22]
Investments at fair value		$ 1,257	[1],[4],[14],[17]					$ 8,309	[8],[9],[16],[22]
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14],[17]	11.00%		11.00%		11.00%
Investment, principal	[1],[4],[7],[14],[17]	$ 5,350
Investment owned, at cost	[1],[4],[14],[17]	4,951
Investments at fair value	[1],[4],[14],[17]	$ 5,029
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9],[16]							328,149		328,149		328,149
Investment owned, at cost	[8],[9],[16]							$ 973
Investments at fair value	[8],[9],[16]							$ 16
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		10,634		10,634		10,634
Investment, principal	[1],[4],[7],[14]	$ 0
Investment owned, at cost	[1],[4],[14]	488
Investments at fair value	[1],[4],[14]	$ 0
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4],[14]	10,634		10,634		10,634
Investment owned, at cost	[1],[4],[14]	$ 488
Investments at fair value	[1],[4],[14]	$ 0
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[4],[5],[14]	6.00%	[1],[4],[5],[14]	6.00%	[1],[4],[5],[14]	6.00%	[8],[9],[10],[16]	6.00%	[8],[9],[10],[16]	6.00%	[8],[9],[10],[16]
Investment, interest rate		11.27%	[1],[2],[4],[5],[14]	11.27%	[1],[2],[4],[5],[14]	11.27%	[1],[2],[4],[5],[14]	8.78%	[8],[9],[10],[11],[16]	8.78%	[8],[9],[10],[11],[16]	8.78%	[8],[9],[10],[11],[16]
Investment, principal		$ 29,509	[1],[4],[5],[7],[14]					$ 22,425	[8],[9],[10],[12],[16]
Investment owned, at cost		29,137	[1],[4],[5],[14]					22,086	[8],[9],[10],[16]
Investments at fair value		$ 28,299	[1],[4],[5],[14]					$ 21,326	[8],[9],[10],[16]
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, interest rate		11.27%		11.27%		11.27%
Investment, principal		$ 6,289
Investment owned, at cost		6,211
Investments at fair value		$ 6,031
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, interest rate		11.27%		11.27%		11.27%
Investment, principal		$ 3,628
Investment owned, at cost		3,583
Investments at fair value		$ 3,479
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment, interest rate								8.78%		8.78%		8.78%
Investment, principal								$ 6,338
Investment owned, at cost								6,242
Investments at fair value								$ 6,027
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment, interest rate								8.78%		8.78%		8.78%
Investment, principal								$ 3,656
Investment owned, at cost								3,601
Investments at fair value								$ 3,476
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.25%		7.25%		7.25%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(113)
Investments at fair value	[1],[3],[4],[5]	$ (101)
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.25%		7.25%		7.25%
Investment, interest rate	[1],[2],[4],[5]	12.49%		12.49%		12.49%
Investment, principal	[1],[4],[5],[7]	$ 50,470
Investment owned, at cost	[1],[4],[5]	49,639
Investments at fair value	[1],[4],[5]	$ 49,461
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Delayed Draw Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.12%		8.12%		8.12%
Investment, principal								$ 808
Investment owned, at cost								800
Investments at fair value								$ 760
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.12%		8.12%		8.12%
Investment, principal								$ 3,398
Investment owned, at cost								3,366
Investments at fair value								$ 3,279
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.12%		8.12%		8.12%
Investment, principal								$ 6,371
Investment owned, at cost								6,311
Investments at fair value								$ 6,148
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.50%		10.50%		10.50%
Investment, principal		$ 3,372
Investment owned, at cost		3,340
Investments at fair value		$ 3,284
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.12%		8.12%		8.12%
Investment, principal								$ 1,771
Investment owned, at cost								1,751
Investments at fair value								$ 1,664
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.50%		10.50%		10.50%
Investment, principal		$ 802
Investment owned, at cost		798
Investments at fair value		$ 782
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							5.00%		5.00%		5.00%
Investment, interest rate	[8],[9],[10],[11],[13]							8.12%		8.12%		8.12%
Investment, principal	[8],[9],[10],[12],[13]							$ 2,546
Investment owned, at cost	[8],[9],[10],[13]							2,503
Investments at fair value	[8],[9],[10],[13]							$ 2,395
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.00%		5.00%		5.00%
Investment, interest rate	[1],[2],[4],[5]	10.50%		10.50%		10.50%
Investment, principal	[1],[4],[5],[7]	$ 3,258
Investment owned, at cost	[1],[4],[5]	3,227
Investments at fair value	[1],[4],[5]	$ 3,173
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.50%		10.50%		10.50%
Investment, principal		$ 6,322
Investment owned, at cost		6,263
Investments at fair value		$ 6,158
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.00%		5.00%		5.00%
Investment, interest rate	[1],[2],[4],[5]	10.50%		10.50%		10.50%
Investment, principal	[1],[4],[5],[7]	$ 1,264
Investment owned, at cost	[1],[4],[5]	1,273
Investments at fair value	[1],[4],[5]	$ 1,232
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.50%		10.50%		10.50%
Investment, principal		$ 1,759
Investment owned, at cost		1,748
Investments at fair value		$ 1,713
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]
Investment, interest rate		14.00%	[1],[2],[4],[5]	14.00%	[1],[2],[4],[5]	14.00%	[1],[2],[4],[5]	11.62%	[8],[9],[10],[11]	11.62%	[8],[9],[10],[11]	11.62%	[8],[9],[10],[11]
Investment, principal		$ 8,920	[1],[4],[5],[7]					$ 7,166	[8],[9],[10],[12]
Investment owned, at cost		8,819	[1],[4],[5]					7,059	[8],[9],[10]
Investments at fair value		$ 8,661	[1],[4],[5]					$ 6,915	[8],[9],[10]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[8],[9],[10],[13]	8.50%	[8],[9],[10],[13]	8.50%	[8],[9],[10],[13]
Investment, interest rate		14.00%	[1],[2],[4],[5]	14.00%	[1],[2],[4],[5]	14.00%	[1],[2],[4],[5]	11.62%	[8],[9],[10],[11],[13]	11.62%	[8],[9],[10],[11],[13]	11.62%	[8],[9],[10],[11],[13]
Investment, principal		$ 2,091	[1],[4],[5],[7]					$ 4,227	[8],[9],[10],[12],[13]
Investment owned, at cost		2,067	[1],[4],[5]					4,070	[8],[9],[10],[13]
Investments at fair value		$ 2,030	[1],[4],[5]					$ 3,839	[8],[9],[10],[13]
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	8.50%		8.50%		8.50%
Investment, interest rate	[1],[2],[4],[5]	14.00%		14.00%		14.00%
Investment, principal	[1],[4],[5],[7]	$ 4,361
Investment owned, at cost	[1],[4],[5]	4,296
Investments at fair value	[1],[4],[5]	$ 4,235
Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment, interest rate								8.98%		8.98%		8.98%
Investment, principal								$ 7,444
Investment owned, at cost								7,347
Investments at fair value								$ 5,455
Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment, interest rate								8.98%		8.98%		8.98%
Investment, principal								$ 3,970
Investment owned, at cost								3,919
Investments at fair value								$ 2,909
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	4.50%		4.50%		4.50%
Investment, interest rate	[1],[2],[3],[4],[5]	12.50%		12.50%		12.50%
Investment, principal	[1],[3],[4],[5],[7]	$ 2,528
Investment owned, at cost	[1],[3],[4],[5]	2,492
Investments at fair value	[1],[3],[4],[5]	$ 2,482
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[4],[5]	10.70%		10.70%		10.70%
Investment, principal	[1],[4],[5],[7]	$ 40,764
Investment owned, at cost	[1],[4],[5]	40,529
Investments at fair value	[1],[4],[5]	$ 40,316
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							4.50%		4.50%		4.50%
Investment, interest rate	[8],[9],[10],[11],[13]							10.75%		10.75%		10.75%
Investment, principal	[8],[9],[10],[12],[13]							$ 1,702
Investment owned, at cost	[8],[9],[10],[13]							1,660
Investments at fair value	[8],[9],[10],[13]							$ 1,617
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							5.50%		5.50%		5.50%
Investment, interest rate	[8],[9],[10],[11]							8.31%		8.31%		8.31%
Investment, principal	[8],[9],[10],[12]							$ 33,078
Investment owned, at cost	[8],[9],[10]							32,612
Investments at fair value	[8],[9],[10]							32,053
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[8],[9],[12],[13],[16],[22]							0
Investment owned, at cost	[8],[9],[13],[16],[22]							0
Investments at fair value	[8],[9],[13],[16],[22]							$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8.00%	[1],[2],[4],[5],[14]	8.00%	[1],[2],[4],[5],[14]	8.00%	[1],[2],[4],[5],[14]	10.25%	[8],[9],[10],[11],[16]	10.25%	[8],[9],[10],[11],[16]	10.25%	[8],[9],[10],[11],[16]
Investment, principal		$ 6,719	[1],[4],[7],[14]					$ 5,322	[8],[9],[12],[16]
Investment owned, at cost		6,508	[1],[4],[14]					5,111	[8],[9],[16]
Investments at fair value		6,282	[1],[4],[14]					$ 5,114	[8],[9],[16]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[8],[9],[10],[11],[13],[16]							10.25%		10.25%		10.25%
Investment, principal		3,210	[1],[4],[7],[14],[15]					$ 0	[8],[9],[12],[13],[16]
Investment owned, at cost		3,230	[1],[4],[14],[15]					0	[8],[9],[13],[16]
Investments at fair value		$ 3,130	[1],[4],[14],[15]					0	[8],[9],[13],[16]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	8.00%		8.00%		8.00%
Investment, principal		$ 0	[1],[3],[4],[7],[14]					2,353	[8],[9],[12],[16],[22]
Investment owned, at cost		0	[1],[3],[4],[14]					2,353	[8],[9],[16],[22]
Investments at fair value		$ 0	[1],[3],[4],[14]					$ 2,353	[8],[9],[16],[22]
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	8.00%		8.00%		8.00%
Investment, principal	[1],[3],[4],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[14]	0
Investments at fair value	[1],[3],[4],[14]	0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[14],[15]	0
Investment owned, at cost	[1],[3],[4],[14],[15]	0
Investments at fair value	[1],[3],[4],[14],[15]	0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[3],[4],[7],[14],[15]	0
Investment owned, at cost	[1],[3],[4],[14],[15]	0
Investments at fair value	[1],[3],[4],[14],[15]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		26,131	[1],[4],[14]	26,131	[1],[4],[14]	26,131	[1],[4],[14]	21,177	[8],[9],[16]	21,177	[8],[9],[16]	21,177	[8],[9],[16]
Investment owned, at cost		$ 225	[1],[4],[14]					$ 125	[8],[9],[16]
Investments at fair value		$ 34	[1],[4],[14]					$ 98	[8],[9],[16]
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.00%	[4],[5]	7.00%	[4],[5]	7.00%	[4],[5]	7.00%	[9],[10]	7.00%	[9],[10]	7.00%	[9],[10]
Investment, interest rate		12.25%	[2],[4],[5]	12.25%	[2],[4],[5]	12.25%	[2],[4],[5]	9.50%	[9],[10],[11]	9.50%	[9],[10],[11]	9.50%	[9],[10],[11]
Investment, principal		$ 30,625	[4],[5],[7]					$ 30,625	[9],[10],[12]
Investment owned, at cost		30,346	[4],[5]					30,276	[9],[10]
Investments at fair value		$ 29,385	[4],[5]					$ 29,017	[9],[10]
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.00%		3.00%		3.00%
Investment, interest rate								6.03%		6.03%		6.03%
Investment, principal								$ 9,575
Investment owned, at cost								9,566
Investments at fair value								$ 8,977
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		394,297	[1],[4]	394,297	[1],[4]	394,297	[1],[4]	298,460	[8],[9]	298,460	[8],[9]	298,460	[8],[9]
Investment owned, at cost		$ 424	[1],[4]					$ 298	[8],[9]
Investments at fair value		$ 355	[1],[4]					$ 349	[8],[9]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		9.00%	[1],[2],[4],[5]	9.00%	[1],[2],[4],[5]	9.00%	[1],[2],[4],[5]	9.00%	[8],[9],[10],[11]	9.00%	[8],[9],[10],[11]	9.00%	[8],[9],[10],[11]
Investment, principal		$ 4,994	[1],[4],[7]					$ 3,979	[8],[9],[12]
Investment owned, at cost		5,006	[1],[4]					3,980	[8],[9]
Investments at fair value		$ 4,969	[1],[4]					$ 3,960	[8],[9]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,708,618	[1],[4]	1,708,618	[1],[4]	1,708,618	[1],[4]	1,293,324	[8],[9]	1,293,324	[8],[9]	1,293,324	[8],[9]
Investment owned, at cost		$ 1,711	[1],[4]					$ 1,293	[8],[9]
Investments at fair value		$ 2,085	[1],[4]					$ 1,280	[8],[9]
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		394,297	[1],[4]	394,297	[1],[4]	394,297	[1],[4]	298,460	[8],[9]	298,460	[8],[9]	298,460	[8],[9]
Investment owned, at cost		$ 395	[1],[4]					$ 298	[8],[9]
Investments at fair value		$ 481	[1],[4]					$ 295	[8],[9]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares														829
Investment, principal														$ 0
Investments at fair value														$ 0	0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares								171,000		171,000		171,000
Investment owned, at cost								$ 0
Investments at fair value								$ 0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		829	[1],[23],[24]	829	[1],[23],[24]	829	[1],[23],[24]	829	[8],[25],[26]	829	[8],[25],[26]	829	[8],[25],[26]
Investment, principal		$ 0
Investment owned, at cost		0	[1],[23],[24]					$ 0	[8],[25],[26]
Investments at fair value		$ 0	[1],[23],[24]					$ 0	[8],[25],[26]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		171,000		171,000		171,000
Investment owned, at cost		$ 0
Investments at fair value		$ 0
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		34,984,460	[1],[23],[24]	34,984,460	[1],[23],[24]	34,984,460	[1],[23],[24]	34,984,460	[8],[25],[26]	34,984,460	[8],[25],[26]	34,984,460	[8],[25],[26]
Investment, principal		$ 0
Investment owned, at cost		34,984	[1],[23],[24]					$ 34,984	[8],[25],[26]
Investments at fair value		$ 27,638	[1],[23],[24]					$ 27,638	[8],[25],[26]
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		7,193,540,000		7,193,540,000		7,193,540,000
Investment owned, at cost		$ 7,194
Investments at fair value		$ 5,683
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares														34,984,460
Investment, principal														$ 0
Investments at fair value														$ 27,638	27,638
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares								7,193,540		7,193,540		7,193,540
Investment owned, at cost								$ 7,194
Investments at fair value								$ 5,683
Investment, Identifier [Axis]: CCO Holdings LLC, Cable & Satellite, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11],[16]							4.50%		4.50%		4.50%
Investment, principal	[9],[12],[16]							$ 2,097
Investment owned, at cost	[9],[16]							1,746
Investments at fair value	[9],[16]							$ 1,603
Investment, Identifier [Axis]: CITGO Holding, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11]							9.25%		9.25%		9.25%
Investment, principal	[9],[12]							$ 7,857
Investment owned, at cost	[9]							7,857
Investments at fair value	[9]							$ 7,807
Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.25%		6.25%		6.25%
Investment, interest rate								9.37%		9.37%		9.37%
Investment, principal								$ 7,038
Investment owned, at cost								6,967
Investments at fair value								$ 7,057
Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.25%		6.25%		6.25%
Investment, interest rate								9.37%		9.37%		9.37%
Investment, principal								$ 3,519
Investment owned, at cost								3,484
Investments at fair value								$ 3,529
Investment, Identifier [Axis]: CITGO Petroleum Corp., Oil & Gas Refining & Marketing, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							6.25%		6.25%		6.25%
Investment, interest rate	[9],[10],[11]							9.37%		9.37%		9.37%
Investment, principal	[9],[10],[12]							$ 795
Investment owned, at cost	[9],[10]							770
Investments at fair value	[9],[10]							$ 797
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[17]	7.75%		7.75%		7.75%
Investment, principal	[1],[4],[5],[7],[17]	$ 727
Investment owned, at cost	[1],[4],[5],[17]	462
Investments at fair value	[1],[4],[5],[17]	$ 325
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							6.50%		6.50%		6.50%
Investment, interest rate	[8],[9],[10],[11]							9.31%		9.31%		9.31%
Investment, principal	[8],[9],[10],[12]							$ 14,294
Investment owned, at cost	[8],[9],[10]							13,471
Investments at fair value	[8],[9],[10]							$ 13,143
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	11.91%		11.91%		11.91%
Investment, principal	[1],[4],[5],[7]	$ 13
Investment owned, at cost	[1],[4],[5]	13
Investments at fair value	[1],[4],[5]	$ 13
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	11.91%		11.91%		11.91%
Investment, principal	[1],[4],[5],[7]	$ 3,031
Investment owned, at cost	[1],[4],[5]	2,971
Investments at fair value	[1],[4],[5]	$ 3,031
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	11.91%		11.91%		11.91%
Investment, principal	[1],[4],[5],[7]	$ 1,557
Investment owned, at cost	[1],[4],[5]	1,526
Investments at fair value	[1],[4],[5]	$ 1,557
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	11.91%		11.91%		11.91%
Investment, principal	[1],[4],[5],[7]	$ 1,024
Investment owned, at cost	[1],[4],[5]	1,002
Investments at fair value	[1],[4],[5]	$ 1,024
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,080,399	[1],[20]	1,080,399	[1],[20]	1,080,399	[1],[20]	1,080,399	[8],[21]	1,080,399	[8],[21]	1,080,399	[8],[21]
Investment owned, at cost		$ 1,080	[1],[20]					$ 1,080	[8],[21]
Investments at fair value		$ 313	[1],[20]					378	[8],[21]
Investment, Identifier [Axis]: Caregiver Services, Inc., Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,080,399		1,080,399		1,080,399								1,080,399
Investment, principal		$ 0												$ 0
Investments at fair value		$ 313						$ 378						$ 401	838
Investment, Identifier [Axis]: Carvana Co., Automotive Retail, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11],[16]							5.63%		5.63%		5.63%
Investment, principal	[9],[12],[16]							$ 6,700
Investment owned, at cost	[9],[16]							5,825
Investments at fair value	[9],[16]							$ 4,724
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.50%		5.50%		5.50%
Investment, principal								$ 0
Investment owned, at cost								(10)
Investments at fair value								$ (11)
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.50%		5.50%		5.50%
Investment, interest rate								9.12%		9.12%		9.12%
Investment, principal								$ 4,358
Investment owned, at cost								4,286
Investments at fair value								$ 4,280
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.50%		5.50%		5.50%
Investment, interest rate								9.12%		9.12%		9.12%
Investment, principal								$ 449
Investment owned, at cost								432
Investments at fair value								$ 413
Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, interest rate		11.38%		11.38%		11.38%
Investment, principal		$ 200
Investment owned, at cost		192
Investments at fair value		$ 189
Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, interest rate		11.44%		11.44%		11.44%
Investment, principal		$ 1,965
Investment owned, at cost		1,938
Investments at fair value		$ 1,930
Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, interest rate		11.44%		11.44%		11.44%
Investment, principal		$ 2,366
Investment owned, at cost		2,332
Investments at fair value		$ 2,324
Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 3 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, interest rate		11.44%		11.44%		11.44%
Investment, principal		$ 1,988
Investment owned, at cost		1,957
Investments at fair value		$ 1,952
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							5.50%		5.50%		5.50%
Investment, interest rate	[8],[9],[10],[11]							8.62%		8.62%		8.62%
Investment, principal	[8],[9],[10],[12]							$ 10,692
Investment owned, at cost	[8],[9],[10]							10,004
Investments at fair value	[8],[9],[10]							$ 10,209
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[4],[5]	10.70%		10.70%		10.70%
Investment, principal	[1],[4],[5],[7]	$ 130
Investment owned, at cost	[1],[4],[5]	130
Investments at fair value	[1],[4],[5]	$ 130
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[4],[5]	10.70%		10.70%		10.70%
Investment, principal	[1],[4],[5],[7]	$ 129
Investment owned, at cost	[1],[4],[5]	129
Investments at fair value	[1],[4],[5]	$ 129
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[4],[5]	10.70%		10.70%		10.70%
Investment, principal	[1],[4],[5],[7]	$ 1,084
Investment owned, at cost	[1],[4],[5]	1,103
Investments at fair value	[1],[4],[5]	$ 1,084
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[4],[5]	10.70%		10.70%		10.70%
Investment, principal	[1],[4],[5],[7]	$ 9,002
Investment owned, at cost	[1],[4],[5]	9,003
Investments at fair value	[1],[4],[5]	$ 9,002
Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.50%		3.50%		3.50%
Investment, interest rate								6.48%		6.48%		6.48%
Investment, principal								$ 6,451
Investment owned, at cost								6,419
Investments at fair value								$ 6,166
Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.50%		3.50%		3.50%
Investment, interest rate								6.48%		6.48%		6.48%
Investment, principal								$ 2,481
Investment owned, at cost								2,469
Investments at fair value								$ 2,372
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		7.50%	[2],[4],[5],[14]	7.50%	[2],[4],[5],[14]	7.50%	[2],[4],[5],[14]	7.50%	[9],[10],[11],[16]	7.50%	[9],[10],[11],[16]	7.50%	[9],[10],[11],[16]
Investment, principal		$ 2,632	[4],[7],[14]					$ 4,311	[9],[12],[16]
Investment owned, at cost		2,632	[4],[14]					4,311	[9],[16]
Investments at fair value		$ 1,951	[4],[14]					$ 3,132	[9],[16]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		7.75%	[2],[4],[5],[14]	7.75%	[2],[4],[5],[14]	7.75%	[2],[4],[5],[14]	5.13%	[9],[10],[11],[16]	5.13%	[9],[10],[11],[16]	5.13%	[9],[10],[11],[16]
Investment, principal		$ 176	[4],[7],[14]					$ 1,374	[9],[12],[16]
Investment owned, at cost		170	[4],[14]					1,229	[9],[16]
Investments at fair value		$ 138	[4],[14]					$ 1,163	[9],[16]
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11],[16]							7.75%		7.75%		7.75%
Investment, principal	[9],[12],[16]							$ 676
Investment owned, at cost	[9],[16]							648
Investments at fair value	[9],[16]							$ 512
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		7.38%	[2],[4],[5]	7.38%	[2],[4],[5]	7.38%	[2],[4],[5]	7.38%	[9],[10],[11]	7.38%	[9],[10],[11]	7.38%	[9],[10],[11]
Investment, principal		$ 8,420	[4],[7]					$ 8,420	[9],[12]
Investment owned, at cost		8,257	[4]					8,243	[9]
Investments at fair value		$ 7,330	[4]					$ 6,900	[9]
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]
Investment, interest rate		13.69%	[1],[2],[4],[5]	13.69%	[1],[2],[4],[5]	13.69%	[1],[2],[4],[5]	11.62%	[8],[9],[10],[11]	11.62%	[8],[9],[10],[11]	11.62%	[8],[9],[10],[11]
Investment, principal		$ 24,350	[1],[4],[5],[7]					$ 22,537	[8],[9],[10],[12]
Investment owned, at cost		23,525	[1],[4],[5]					21,642	[8],[9],[10]
Investments at fair value		21,506	[1],[4],[5]					20,396	[8],[9],[10]
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, at cost		706	[1],[4]					648	[8],[9]
Investments at fair value		$ 154	[1],[4]					$ 457	[8],[9]
Investment, Identifier [Axis]: Convergeone Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.12%		8.12%		8.12%
Investment, principal								$ 7,373
Investment owned, at cost								7,206
Investments at fair value								$ 5,320
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%	[4],[5]	5.00%	[4],[5]	5.00%	[4],[5]	5.00%	[9],[10]	5.00%	[9],[10]	5.00%	[9],[10]
Investment, interest rate		10.37%	[2],[4],[5]	10.37%	[2],[4],[5]	10.37%	[2],[4],[5]	8.12%	[9],[10],[11]	8.12%	[9],[10],[11]	8.12%	[9],[10],[11]
Investment, principal		$ 17,506	[4],[5],[7]					$ 11,913	[9],[10],[12]
Investment owned, at cost		15,434	[4],[5]					11,697	[9],[10]
Investments at fair value		$ 11,176	[4],[5]					$ 8,596	[9],[10]
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.37%		10.37%		10.37%
Investment, principal		$ 7,315
Investment owned, at cost		7,188
Investments at fair value		$ 4,670
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		417,851	[1],[4]	417,851	[1],[4]	417,851	[1],[4]	417,851	[8],[9]	417,851	[8],[9]	417,851	[8],[9]
Investment owned, at cost		$ 605	[1],[4]					$ 605	[8],[9]
Investments at fair value		$ 894	[1],[4]					$ 894	[8],[9]
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		1,500	[1],[4]	1,500	[1],[4]	1,500	[1],[4]	1,099	[8],[9]	1,099	[8],[9]	1,099	[8],[9]
Investment owned, at cost		$ 1,574	[1],[4]					$ 690	[8],[9]
Investments at fair value		$ 3,299	[1],[4]					$ 2,340	[8],[9]
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%	[1],[3],[4],[5]	5.75%	[1],[3],[4],[5]	5.75%	[1],[3],[4],[5]	4.75%	[8],[9],[10],[13]	4.75%	[8],[9],[10],[13]	4.75%	[8],[9],[10],[13]
Investment, interest rate		14.00%	[1],[2],[3],[4],[5]	14.00%	[1],[2],[3],[4],[5]	14.00%	[1],[2],[3],[4],[5]	11.00%	[8],[9],[10],[11],[13]	11.00%	[8],[9],[10],[11],[13]	11.00%	[8],[9],[10],[11],[13]
Investment, principal		$ 1,250	[1],[3],[4],[5],[7]					$ 916	[8],[9],[10],[12],[13]
Investment owned, at cost		1,226	[1],[3],[4],[5]					898	[8],[9],[10],[13]
Investments at fair value		$ 1,202	[1],[3],[4],[5]					$ 898	[8],[9],[10],[13]
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							5.75%		5.75%		5.75%
Investment, interest rate	[8],[9],[10],[11]							8.88%		8.88%		8.88%
Investment, principal	[8],[9],[10],[12]							$ 13,712
Investment owned, at cost	[8],[9],[10]							13,554
Investments at fair value	[8],[9],[10]							$ 13,583
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.13%		6.13%		6.13%
Investment, interest rate	[1],[2],[4],[5]	11.33%		11.33%		11.33%
Investment, principal	[1],[4],[5],[7]	$ 13,671
Investment owned, at cost	[1],[4],[5]	13,633
Investments at fair value	[1],[4],[5]	$ 13,408
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.13%		6.13%		6.13%
Investment, interest rate	[1],[2],[4],[5]	11.33%		11.33%		11.33%
Investment, principal	[1],[4],[5],[7]	$ 4,903
Investment owned, at cost	[1],[4],[5]	4,853
Investments at fair value	[1],[4],[5]	$ 4,809
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.50%		7.50%		7.50%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(21)
Investments at fair value	[1],[3],[4],[5]	$ (21)
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.50%		7.50%		7.50%
Investment, interest rate	[1],[2],[4],[5]	12.60%		12.60%		12.60%
Investment, principal	[1],[4],[5],[7]	$ 13,157
Investment owned, at cost	[1],[4],[5]	12,843
Investments at fair value	[1],[4],[5]	$ 12,852
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.50%		7.50%		7.50%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(15)
Investments at fair value	[1],[3],[4],[5]	$ (14)
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								7.65%		7.65%		7.65%
Investment, principal								$ 5,375
Investment owned, at cost								5,053
Investments at fair value								$ 5,035
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%		5.00%		5.00%		5.00%
Investment, interest rate		10.24%		10.24%		10.24%		7.65%		7.65%		7.65%
Investment, principal		$ 2,773						$ 2,280
Investment owned, at cost		2,607						2,143
Investments at fair value		$ 2,589						$ 2,136
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%	[4],[5]	5.00%	[4],[5]	5.00%	[4],[5]	5.00%	[9],[10]	5.00%	[9],[10]	5.00%	[9],[10]
Investment, interest rate		10.24%	[2],[4],[5]	10.24%	[2],[4],[5]	10.24%	[2],[4],[5]	7.65%	[9],[10],[11]	7.65%	[9],[10],[11]	7.65%	[9],[10],[11]
Investment, principal		$ 14,787	[4],[5],[7]					$ 10,336	[9],[10],[12]
Investment owned, at cost		14,186	[4],[5]					9,716	[9],[10]
Investments at fair value		$ 13,807	[4],[5]					$ 9,681	[9],[10]
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.24%		10.24%		10.24%
Investment, principal		$ 6,359
Investment owned, at cost		5,983
Investments at fair value		$ 5,937
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[3],[4],[5]	6.00%	[1],[3],[4],[5]	6.00%	[1],[3],[4],[5]	6.00%	[8],[9],[10],[13]	6.00%	[8],[9],[10],[13]	6.00%	[8],[9],[10],[13]
Investment, interest rate	[2],[5]	11.20%		11.20%		11.20%
Investment, principal		$ 533	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		520	[1],[3],[4],[5]					(13)	[8],[9],[10],[13]
Investments at fair value		$ 507	[1],[3],[4],[5]					$ (26)	[8],[9],[10],[13]
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[4],[5]	6.00%	[1],[4],[5]	6.00%	[1],[4],[5]	6.00%	[8],[9],[10]	6.00%	[8],[9],[10]	6.00%	[8],[9],[10]
Investment, interest rate		11.10%	[1],[2],[4],[5]	11.10%	[1],[2],[4],[5]	11.10%	[1],[2],[4],[5]	8.81%	[8],[9],[10],[11]	8.81%	[8],[9],[10],[11]	8.81%	[8],[9],[10],[11]
Investment, principal		$ 18,060	[1],[4],[5],[7]					$ 18,200	[8],[9],[10],[12]
Investment owned, at cost		17,715	[1],[4],[5]					17,790	[8],[9],[10]
Investments at fair value		$ 17,706	[1],[4],[5]					$ 17,843	[8],[9],[10]
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., Biotechnology, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.54%		9.54%		9.54%
Investment, principal		$ 7,760
Investment owned, at cost		7,689
Investments at fair value		$ 7,730
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., Biotechnology, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.25%		4.25%		4.25%
Investment, interest rate		9.79%		9.79%		9.79%
Investment, principal		$ 992
Investment owned, at cost		974
Investments at fair value		$ 987
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.00%		4.00%		4.00%
Investment, interest rate								7.67%		7.67%		7.67%
Investment, principal								$ 5,820
Investment owned, at cost								5,776
Investments at fair value								$ 5,587
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%		4.00%		4.00%		4.00%
Investment, interest rate		9.54%		9.54%		9.54%		7.67%		7.67%		7.67%
Investment, principal		$ 2,848						$ 2,870
Investment owned, at cost		2,827						2,849
Investments at fair value		$ 2,838						$ 2,756
Investment, Identifier [Axis]: DTI Holdco, Inc First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%
Investment, interest rate		9.80%		9.80%		9.80%
Investment, principal		$ 2,978
Investment owned, at cost		2,928
Investments at fair value		$ 2,779
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.75%		4.75%		4.75%
Investment, interest rate								7.33%		7.33%		7.33%
Investment, principal								$ 8,000
Investment owned, at cost								7,849
Investments at fair value								$ 7,616
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.75%		4.75%		4.75%
Investment, interest rate								7.33%		7.33%		7.33%
Investment, principal								$ 3,000
Investment owned, at cost								2,943
Investments at fair value								$ 2,856
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%	[4],[5]	4.75%	[4],[5]	4.75%	[4],[5]	4.75%	[9],[10]	4.75%	[9],[10]	4.75%	[9],[10]
Investment, interest rate		9.80%	[2],[4],[5]	9.80%	[2],[4],[5]	9.80%	[2],[4],[5]	7.33%	[9],[10],[11]	7.33%	[9],[10],[11]	7.33%	[9],[10],[11]
Investment, principal		$ 4,963	[4],[5],[7]					$ 5,000	[9],[10],[12]
Investment owned, at cost		4,879	[4],[5]					4,906	[9],[10]
Investments at fair value		$ 4,632	[4],[5]					$ 4,760	[9],[10]
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%
Investment, interest rate		9.80%		9.80%		9.80%
Investment, principal		$ 7,940
Investment owned, at cost		7,807
Investments at fair value		$ 7,411
Investment, Identifier [Axis]: Dealer Tire, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.25%		4.25%		4.25%
Investment, interest rate								7.37%		7.37%		7.37%
Investment, principal								$ 2,992
Investment owned, at cost								2,935
Investments at fair value								$ 2,924
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.75%		5.75%		5.75%
Investment, interest rate								8.49%		8.49%		8.49%
Investment, principal								$ 6,035
Investment owned, at cost								5,876
Investments at fair value								$ 5,756
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, Internet & Direct Marketing Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10],[16]							5.75%		5.75%		5.75%
Investment, interest rate	[9],[10],[11],[16]							8.49%		8.49%		8.49%
Investment, principal	[9],[10],[12],[16]							$ 4,988
Investment owned, at cost	[9],[10],[16]							4,882
Investments at fair value	[9],[10],[16]							$ 4,757
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		2	[1],[4],[14]	2	[1],[4],[14]	2	[1],[4],[14]	2	[8],[9],[16]	2	[8],[9],[16]	2	[8],[9],[16]
Investment owned, at cost		$ 2	[1],[4],[14]					$ 2	[8],[9],[16]
Investments at fair value		$ 2	[1],[4],[14]					$ 2	[8],[9],[16]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		419	[1],[4],[14]	419	[1],[4],[14]	419	[1],[4],[14]	419	[8],[9],[16]	419	[8],[9],[16]	419	[8],[9],[16]
Investment owned, at cost		$ 419	[1],[4],[14]					$ 419	[8],[9],[16]
Investments at fair value		$ 419	[1],[4],[14]					$ 419	[8],[9],[16]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		3.00%	[1],[2],[3],[4],[5],[14]	3.00%	[1],[2],[3],[4],[5],[14]	3.00%	[1],[2],[3],[4],[5],[14]	10.00%	[8],[9],[10],[11],[13],[16]	10.00%	[8],[9],[10],[11],[13],[16]	10.00%	[8],[9],[10],[11],[13],[16]
Investment, principal		$ 13,043	[1],[3],[4],[7],[14]					$ 4,183	[8],[9],[12],[13],[16]
Investment owned, at cost		13,043	[1],[3],[4],[14]					4,183	[8],[9],[13],[16]
Investments at fair value		$ 13,043	[1],[3],[4],[14]					$ 4,183	[8],[9],[13],[16]
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		31	[1],[4],[14]	31	[1],[4],[14]	31	[1],[4],[14]	31	[8],[9],[16]	31	[8],[9],[16]	31	[8],[9],[16]
Investment owned, at cost		$ 0	[1],[4],[14]					$ 0	[8],[9],[16]
Investments at fair value		$ 0	[1],[4],[14]					$ 0	[8],[9],[16]
Investment, Identifier [Axis]: Delta Topco, Inc., Systems Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							7.25%		7.25%		7.25%
Investment, interest rate	[9],[10],[11]							9.34%		9.34%		9.34%
Investment, principal	[9],[10],[12]							$ 6,680
Investment owned, at cost	[9],[10]							6,647
Investments at fair value	[9],[10]							$ 5,934
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	9.00%		9.00%		9.00%
Investment, interest rate	[1],[2],[4],[5]	14.42%		14.42%		14.42%
Investment, principal	[1],[4],[5],[7]	$ 20,757
Investment owned, at cost	[1],[4],[5]	20,092
Investments at fair value	[1],[4],[5]	20,705
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							9.00%		9.00%		9.00%
Investment, interest rate	[8],[9],[10],[11]							12.67%		12.67%		12.67%
Investment, principal	[8],[9],[10],[12]							$ 24,396
Investment owned, at cost	[8],[9],[10]							23,083
Investments at fair value	[8],[9],[10]							$ 22,993
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							9.00%		9.00%		9.00%
Investment, principal	[8],[9],[10],[12],[13]							$ 0
Investment owned, at cost	[8],[9],[10],[13]							(135)
Investments at fair value	[8],[9],[10],[13]							$ (129)
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal	[1],[4],[7]	641
Investment owned, at cost	[1],[4]	640
Investments at fair value	[1],[4]	$ 611
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		6,397,254	[1],[4]	6,397,254	[1],[4]	6,397,254	[1],[4]	5,403,823	[8],[9]	5,403,823	[8],[9]	5,403,823	[8],[9]
Investment owned, at cost		$ 1,642	[1],[4]					$ 1,405	[8],[9]
Investments at fair value		$ 1,215	[1],[4]					$ 1,297	[8],[9]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[3],[4],[5]	6.75%	[1],[3],[4],[5]	6.75%	[1],[3],[4],[5]	6.50%	[8],[9],[10],[13]	6.50%	[8],[9],[10],[13]	6.50%	[8],[9],[10],[13]
Investment, interest rate		12.09%	[1],[2],[3],[4],[5]	12.09%	[1],[2],[3],[4],[5]	12.09%	[1],[2],[3],[4],[5]	9.41%	[8],[9],[10],[11],[13]	9.41%	[8],[9],[10],[11],[13]	9.41%	[8],[9],[10],[11],[13]
Investment, principal		$ 204	[1],[3],[4],[5],[7]					$ 251	[8],[9],[10],[12],[13]
Investment owned, at cost		184	[1],[3],[4],[5]					228	[8],[9],[10],[13]
Investments at fair value		$ 172	[1],[3],[4],[5]					$ 239	[8],[9],[10],[13]
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.00%	[1],[4],[5]	7.00%	[1],[4],[5]	7.00%	[1],[4],[5]	7.00%	[8],[9],[10]	7.00%	[8],[9],[10]	7.00%	[8],[9],[10]
Investment, interest rate		12.34%	[1],[2],[4],[5]	12.34%	[1],[2],[4],[5]	12.34%	[1],[2],[4],[5]	9.91%	[8],[9],[10],[11]	9.91%	[8],[9],[10],[11]	9.91%	[8],[9],[10],[11]
Investment, principal		$ 12,418	[1],[4],[5],[7]					$ 9,902	[8],[9],[10],[12]
Investment owned, at cost		12,226	[1],[4],[5]					9,599	[8],[9],[10]
Investments at fair value		$ 12,120	[1],[4],[5]					$ 9,793	[8],[9],[10]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%	[4],[5]	5.00%	[4],[5]	5.00%	[4],[5]	5.00%	[9],[10]	5.00%	[9],[10]	5.00%	[9],[10]
Investment, interest rate		10.22%	[2],[4],[5]	10.22%	[2],[4],[5]	10.22%	[2],[4],[5]	8.12%	[9],[10],[11]	8.12%	[9],[10],[11]	8.12%	[9],[10],[11]
Investment, principal		$ 4,769	[4],[5],[7]					$ 19,242	[9],[10],[12]
Investment owned, at cost		4,687	[4],[5]					18,970	[9],[10]
Investments at fair value		$ 4,672	[4],[5]					$ 17,973	[9],[10]
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.22%		10.22%		10.22%
Investment, principal		$ 5,958
Investment owned, at cost		5,869
Investments at fair value		$ 5,838
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.12%		8.12%		8.12%
Investment, principal								$ 6,436
Investment owned, at cost								6,332
Investments at fair value								$ 6,012
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%		5.00%		5.00%		5.00%
Investment, interest rate		10.22%		10.22%		10.22%		8.12%		8.12%		8.12%
Investment, principal		$ 2,528						$ 2,730
Investment owned, at cost		2,502						2,703
Investments at fair value		$ 2,477						$ 2,549
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares														30,031
Investment, principal														$ 0
Investments at fair value														$ 9,267	18,065
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate														5.00%
Investment, principal														$ 0
Investments at fair value														$ 0	0
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate														5.00%
Investment, interest rate														7.26%
Investment, principal														$ 16,074
Investments at fair value														$ 16,074	27,381
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		30,031	[1],[23],[24]	30,031	[1],[23],[24]	30,031	[1],[23],[24]	30,031	[8],[25],[26]	30,031	[8],[25],[26]	30,031	[8],[25],[26]
Investment, principal		$ 0
Investment owned, at cost		15,222	[1],[23],[24]					$ 15,222	[8],[25],[26]
Investments at fair value		$ 2,711	[1],[23],[24]					$ 4,946	[8],[25],[26]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%	[1],[3],[5],[23],[24]	5.00%	[1],[3],[5],[23],[24]	5.00%	[1],[3],[5],[23],[24]	5.00%	[8],[10],[13],[25],[26]	5.00%	[8],[10],[13],[25],[26]	5.00%	[8],[10],[13],[25],[26]
Investment, interest rate	[1],[2],[3],[5],[23],[24]	10.24%		10.24%		10.24%
Investment, principal		$ 3,484	[1],[3],[5],[7],[23],[24]					$ 0	[8],[10],[12],[13],[25],[26]
Investment owned, at cost		3,484	[1],[3],[5],[23],[24]					0	[8],[10],[13],[25],[26]
Investments at fair value		$ 3,484	[1],[3],[5],[23],[24]					$ 0	[8],[10],[13],[25],[26]
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[10],[25],[26]							5.00%		5.00%		5.00%
Investment, interest rate	[8],[10],[11],[25],[26]							8.68%		8.68%		8.68%
Investment, principal	[8],[10],[12],[25],[26]							$ 14,333
Investment owned, at cost	[8],[10],[25],[26]							14,333
Investments at fair value	[8],[10],[25],[26]							14,333
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5],[23],[24]	5.00%		5.00%		5.00%
Investment, interest rate	[1],[2],[5],[23],[24]	10.39%		10.39%		10.39%
Investment, principal	[1],[5],[7],[23],[24]	$ 14,102
Investment owned, at cost	[1],[5],[23],[24]	14,102
Investments at fair value		$ 14,102	[1],[5],[23],[24]					14,333
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[5],[23],[24]	5.00%		5.00%		5.00%
Investment, principal	[1],[3],[5],[7],[23],[24]	$ 0
Investment owned, at cost	[1],[3],[5],[23],[24]	0
Investments at fair value		$ 0	[1],[3],[5],[23],[24]					$ 0
Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.50%		5.50%		5.50%
Investment, interest rate								8.26%		8.26%		8.26%
Investment, principal								$ 4,100
Investment owned, at cost								4,065
Investments at fair value								$ 3,921
Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.50%		5.50%		5.50%
Investment, interest rate								8.26%		8.26%		8.26%
Investment, principal								$ 2,503
Investment owned, at cost								2,478
Investments at fair value								$ 2,394
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		12,500	[1],[4]	12,500	[1],[4]	12,500	[1],[4]	12,500	[8],[9]	12,500	[8],[9]	12,500	[8],[9]
Investment owned, at cost		$ 0	[1],[4]					$ 0	[8],[9]
Investments at fair value		$ 0	[1],[4]					$ 0	[8],[9]
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		488	[1],[4]	488	[1],[4]	488	[1],[4]	488	[8],[9]	488	[8],[9]	488	[8],[9]
Investment owned, at cost		$ 488	[1],[4]					$ 488	[8],[9]
Investments at fair value		$ 1,160	[1],[4]					$ 966	[8],[9]
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.25%		4.25%		4.25%
Investment, interest rate								7.80%		7.80%		7.80%
Investment, principal								$ 4,478
Investment owned, at cost								4,373
Investments at fair value								$ 4,367
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.25%		4.25%		4.25%
Investment, interest rate								7.80%		7.80%		7.80%
Investment, principal								$ 2,488
Investment owned, at cost								2,429
Investments at fair value								$ 2,426
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[8],[9],[10]	7.50%	[8],[9],[10]	7.50%	[8],[9],[10]
Investment, interest rate		13.04%	[1],[2],[4],[5]	13.04%	[1],[2],[4],[5]	13.04%	[1],[2],[4],[5]	11.17%	[8],[9],[10],[11]	11.17%	[8],[9],[10],[11]	11.17%	[8],[9],[10],[11]
Investment, principal		$ 8,974	[1],[4],[5],[7]					$ 8,974	[8],[9],[10],[12]
Investment owned, at cost		8,884	[1],[4],[5]					8,884	[8],[9],[10]
Investments at fair value		$ 7,359	[1],[4],[5]					$ 8,503	[8],[9],[10]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		3.00%	[1],[2],[4],[5],[14]	3.00%	[1],[2],[4],[5],[14]	3.00%	[1],[2],[4],[5],[14]	3.00%	[8],[9],[10],[11],[16]	3.00%	[8],[9],[10],[11],[16]	3.00%	[8],[9],[10],[11],[16]
Investment, principal		$ 10,899	[1],[4],[7],[14]					$ 10,418	[8],[9],[12],[16]
Investment owned, at cost		10,779	[1],[4],[14]					10,275	[8],[9],[16]
Investments at fair value		$ 10,463	[1],[4],[14]					$ 10,231	[8],[9],[16]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		3.00%	[1],[2],[4],[5],[14]	3.00%	[1],[2],[4],[5],[14]	3.00%	[1],[2],[4],[5],[14]	3.00%	[8],[9],[10],[11],[13],[16]	3.00%	[8],[9],[10],[11],[13],[16]	3.00%	[8],[9],[10],[11],[13],[16]
Investment, principal		$ 1,746	[1],[4],[7],[14]					$ 0	[8],[9],[12],[13],[16]
Investment owned, at cost		1,720	[1],[4],[14]					3	[8],[9],[13],[16]
Investments at fair value		$ 1,676	[1],[4],[14]					$ 0	[8],[9],[13],[16]
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[3],[4],[5],[14]	3.00%		3.00%		3.00%
Investment, principal	[1],[3],[4],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[14]	1
Investments at fair value	[1],[3],[4],[14]	$ 0
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[3],[4],[5],[14]	3.00%		3.00%		3.00%
Investment, principal	[1],[3],[4],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[14]	1
Investments at fair value	[1],[3],[4],[14]	$ 0
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[4],[5]	6.75%	[4],[5]	6.75%	[4],[5]	6.75%	[9],[10]	6.75%	[9],[10]	6.75%	[9],[10]
Investment, interest rate		11.94%	[2],[4],[5]	11.94%	[2],[4],[5]	11.94%	[2],[4],[5]	9.87%	[9],[10],[11]	9.87%	[9],[10],[11]	9.87%	[9],[10],[11]
Investment, principal		$ 31,074	[4],[5],[7]					$ 25,061	[9],[10],[12]
Investment owned, at cost		29,063	[4],[5]					24,685	[9],[10]
Investments at fair value		$ 18,664	[4],[5]					$ 21,646	[9],[10]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		9.00%	[1],[2],[3],[4],[5]	9.00%	[1],[2],[3],[4],[5]	9.00%	[1],[2],[3],[4],[5]	9.00%	[8],[9],[10],[11],[27]	9.00%	[8],[9],[10],[11],[27]	9.00%	[8],[9],[10],[11],[27]
Investment, principal		$ 52,658	[1],[3],[4],[7]					$ 27,850	[8],[9],[12],[27]
Investment owned, at cost		52,658	[1],[3],[4]					27,850	[8],[9],[27]
Investments at fair value		$ 52,658	[1],[3],[4]					$ 27,850	[8],[9],[27]
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		2,500	[1],[4],[14]	2,500	[1],[4],[14]	2,500	[1],[4],[14]	2,500	[8],[9],[16],[27]	2,500	[8],[9],[16],[27]	2,500	[8],[9],[16],[27]
Investment owned, at cost		$ 0	[1],[4],[14]					$ 0	[8],[9],[16],[27]
Investments at fair value		3	[1],[4],[14]					3	[8],[9],[16],[27]
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate														9.00%
Investment, principal														$ 0
Investments at fair value														0	7,500
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investments at fair value														0	698
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		54,003,000						48,139
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 28,457						$ 28,973
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.00%	[1],[2],[4],[5],[14]	11.00%	[1],[2],[4],[5],[14]	11.00%	[1],[2],[4],[5],[14]	11.00%	[8],[9],[10],[11],[16]	11.00%	[8],[9],[10],[11],[16]	11.00%	[8],[9],[10],[11],[16]
Investment, principal		$ 11,918	[1],[4],[7],[14]					$ 9,466	[8],[9],[12],[16]
Investment owned, at cost		11,572	[1],[4],[14]					9,071	[8],[9],[16]
Investments at fair value		$ 11,173	[1],[4],[14]					$ 9,008	[8],[9],[16]
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		417,011	[1],[4],[14]	417,011	[1],[4],[14]	417,011	[1],[4],[14]	331,200	[8],[9],[16]	331,200	[8],[9],[16]	331,200	[8],[9],[16]
Investment owned, at cost		$ 427	[1],[4],[14]					$ 405	[8],[9],[16]
Investments at fair value		$ 113	[1],[4],[14]					$ 66	[8],[9],[16]
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		6.00%	[2],[4],[5],[14]	6.00%	[2],[4],[5],[14]	6.00%	[2],[4],[5],[14]	6.00%	[9],[10],[11],[16]	6.00%	[9],[10],[11],[16]	6.00%	[9],[10],[11],[16]
Investment, principal		$ 4,881	[4],[7],[14]					$ 4,881	[9],[12],[16]
Investment owned, at cost		4,456	[4],[14]					4,420	[9],[16]
Investments at fair value		$ 3,595	[4],[14]					$ 3,845	[9],[16]
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[9],[10],[11],[13]							10.60%		10.60%		10.60%
Investment, principal	[8],[9],[10],[12],[13]							$ 1,280
Investment owned, at cost	[8],[9],[10],[13]							1,268
Investments at fair value	[8],[9],[10],[13]							$ 1,262
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[9],[10],[11]							10.67%		10.67%		10.67%
Investment, principal	[8],[9],[10],[12]							$ 25,128
Investment owned, at cost	[8],[9],[10]							24,915
Investments at fair value	[8],[9],[10]							$ 24,851
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.25%		7.25%		7.25%
Investment, interest rate	[1],[2],[3],[4],[5]	12.34%		12.34%		12.34%
Investment, principal	[1],[3],[4],[5],[7]	$ 1,638
Investment owned, at cost	[1],[3],[4],[5]	1,530
Investments at fair value	[1],[3],[4],[5]	$ 1,532
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.25%		7.25%		7.25%
Investment, interest rate	[1],[2],[4],[5]	12.34%		12.34%		12.34%
Investment, principal	[1],[4],[5],[7]	$ 23,774
Investment owned, at cost	[1],[4],[5]	23,080
Investments at fair value	[1],[4],[5]	$ 23,094
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								7.94%		7.94%		7.94%
Investment, principal								$ 7,444
Investment owned, at cost								7,369
Investments at fair value								$ 6,029
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%		5.00%		5.00%		5.00%
Investment, interest rate		10.25%		10.25%		10.25%		7.94%		7.94%		7.94%
Investment, principal		$ 3,940						$ 3,970
Investment owned, at cost		3,901						3,930
Investments at fair value		$ 3,191						$ 3,216
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.00%		5.00%		5.00%
Investment, interest rate	[1],[2],[4],[5]	10.25%		10.25%		10.25%
Investment, principal	[1],[4],[5],[7]	$ 2,463
Investment owned, at cost	[1],[4],[5]	2,039
Investments at fair value	[1],[4],[5]	$ 1,995
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.25%		10.25%		10.25%
Investment, principal		$ 7,388
Investment owned, at cost		7,314
Investments at fair value		$ 5,984
Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.25%		4.25%		4.25%
Investment, interest rate								7.37%		7.37%		7.37%
Investment, principal								$ 1,979
Investment owned, at cost								1,979
Investments at fair value								$ 1,722
Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.25%		4.25%		4.25%
Investment, interest rate								6.81%		6.81%		6.81%
Investment, principal								$ 2,192
Investment owned, at cost								2,165
Investments at fair value								$ 1,912
Investment, Identifier [Axis]: Global Medical Response, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							4.25%		4.25%		4.25%
Investment, interest rate	[9],[10],[11]							7.37%		7.37%		7.37%
Investment, principal	[9],[10],[12]							$ 5,572
Investment owned, at cost	[9],[10]							5,435
Investments at fair value	[9],[10]							$ 4,848
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[4],[5],[14]	2.85%		2.85%		2.85%
Investment, interest rate	[2],[4],[5],[14]	6.05%		6.05%		6.05%
Investment, principal | €	[4],[5],[7],[14]			€ 1,000
Investment owned, at cost	[4],[5],[14]	$ 872
Investments at fair value	[4],[5],[14]	$ 970
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[1],[3],[4],[5]	8.00%	[1],[3],[4],[5]	8.00%	[1],[3],[4],[5]	8.00%	[8],[9],[10],[13]	8.00%	[8],[9],[10],[13]	8.00%	[8],[9],[10],[13]
Investment, principal		$ 0	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		(29)	[1],[3],[4],[5]					(27)	[8],[9],[10],[13]
Investments at fair value		$ (18)	[1],[3],[4],[5]					$ (25)	[8],[9],[10],[13]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[1],[4],[5]	8.00%	[1],[4],[5]	8.00%	[1],[4],[5]	8.00%	[8],[9],[10]	8.00%	[8],[9],[10]	8.00%	[8],[9],[10]
Investment, interest rate		13.39%	[1],[2],[4],[5]	13.39%	[1],[2],[4],[5]	13.39%	[1],[2],[4],[5]	11.04%	[8],[9],[10],[11]	11.04%	[8],[9],[10],[11]	11.04%	[8],[9],[10],[11]
Investment, principal		$ 17,488	[1],[4],[5],[7]					$ 14,311	[8],[9],[10],[12]
Investment owned, at cost		17,308	[1],[4],[5]					14,041	[8],[9],[10]
Investments at fair value		$ 17,314	[1],[4],[5]					$ 14,060	[8],[9],[10]
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[1],[3],[4],[5]	8.00%	[1],[3],[4],[5]	8.00%	[1],[3],[4],[5]	8.00%	[8],[9],[10],[13]	8.00%	[8],[9],[10],[13]	8.00%	[8],[9],[10],[13]
Investment, principal		$ 0	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		(58)	[1],[3],[4],[5]					(54)	[8],[9],[10],[13]
Investments at fair value		$ (35)	[1],[3],[4],[5]					$ (50)	[8],[9],[10],[13]
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%	[4],[5]	5.25%	[4],[5]	5.25%	[4],[5]	5.25%	[9],[10]	5.25%	[9],[10]	5.25%	[9],[10]
Investment, interest rate		10.45%	[2],[4],[5]	10.45%	[2],[4],[5]	10.45%	[2],[4],[5]	8.38%	[9],[10],[11]	8.38%	[9],[10],[11]	8.38%	[9],[10],[11]
Investment, principal		$ 14,383	[4],[5],[7]					$ 9,392	[9],[10],[12]
Investment owned, at cost		13,885	[4],[5]					9,080	[9],[10]
Investments at fair value		$ 12,352	[4],[5]					$ 8,582	[9],[10]
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%
Investment, interest rate		10.45%		10.45%		10.45%
Investment, principal		$ 7,940
Investment owned, at cost		7,742
Investments at fair value		$ 6,818
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								8.38%		8.38%		8.38%
Investment, principal								$ 8,000
Investment owned, at cost								7,774
Investments at fair value								$ 7,310
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.45%		10.45%		10.45%		8.38%		8.38%		8.38%
Investment, principal		$ 3,970						$ 4,000
Investment owned, at cost		3,871						3,887
Investments at fair value		$ 3,409						$ 3,655
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[14]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5],[14]	11.74%		11.74%		11.74%
Investment, principal	[1],[4],[5],[7],[14]	$ 7,448
Investment owned, at cost	[1],[4],[5],[14]	7,279
Investments at fair value	[1],[4],[5],[14]	$ 7,295
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5],[14]	6.50%		6.50%		6.50%
Investment, principal	[1],[3],[4],[5],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[5],[14]	(91)
Investments at fair value	[1],[3],[4],[5],[14]	$ (83)
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[2],[4],[5],[14]	4.46%		4.46%		4.46%
Investment, principal	[4],[7],[14]	$ 6,932
Investment owned, at cost	[4],[14]	5,577
Investments at fair value	[4],[14]	$ 6,001
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[14]	8.25%		8.25%		8.25%
Investment, interest rate	[1],[2],[4],[5],[14]	13.30%		13.30%		13.30%
Investment, principal	[1],[4],[5],[7],[14]	$ 23,975
Investment owned, at cost	[1],[4],[5],[14]	23,274
Investments at fair value	[1],[4],[5],[14]	$ 23,292
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.75%		5.75%		5.75%
Investment, interest rate								9.42%		9.42%		9.42%
Investment, principal								$ 9,500
Investment owned, at cost								9,282
Investments at fair value								$ 8,408
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%		5.75%		5.75%		5.75%		5.75%		5.75%
Investment, interest rate		11.29%		11.29%		11.29%		9.42%		9.42%		9.42%
Investment, principal		$ 2,281						$ 2,375
Investment owned, at cost		2,238						2,320
Investments at fair value		$ 1,810						$ 2,102
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.75%		5.75%		5.75%
Investment, interest rate	[1],[2],[4],[5]	11.29%		11.29%		11.29%
Investment, principal	[1],[4],[5],[7]	$ 45,169
Investment owned, at cost	[1],[4],[5]	43,394
Investments at fair value	[1],[4],[5]	$ 35,834
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%		5.75%		5.75%
Investment, interest rate		11.29%		11.29%		11.29%
Investment, principal		$ 9,125
Investment owned, at cost		8,950
Investments at fair value		$ 7,239
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Products, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							5.75%		5.75%		5.75%
Investment, interest rate	[8],[9],[10],[11]							9.42%		9.42%		9.42%
Investment, principal	[8],[9],[10],[12]							$ 35,625
Investment owned, at cost	[8],[9],[10]							34,806
Investments at fair value	[8],[9],[10]							$ 31,528
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[4],[5]	6.50%	[1],[4],[5]	6.50%	[1],[4],[5]	6.50%	[8],[9],[10]	6.50%	[8],[9],[10]	6.50%	[8],[9],[10]
Investment, interest rate		11.57%	[1],[2],[4],[5]	11.57%	[1],[2],[4],[5]	11.57%	[1],[2],[4],[5]	9.44%	[8],[9],[10],[11]	9.44%	[8],[9],[10],[11]	9.44%	[8],[9],[10],[11]
Investment, principal		$ 40,484	[1],[4],[5],[7]					$ 34,357	[8],[9],[10],[12]
Investment owned, at cost		39,779	[1],[4],[5]					33,612	[8],[9],[10]
Investments at fair value		38,662	[1],[4],[5]					$ 32,639	[8],[9],[10]
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							5.75%		5.75%		5.75%
Investment, interest rate	[8],[9],[10],[11]							9.42%		9.42%		9.42%
Investment, principal	[8],[9],[10],[12]							$ 8,569
Investment owned, at cost	[8],[9],[10]							8,401
Investments at fair value	[8],[9],[10]							$ 8,407
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							8.00%		8.00%		8.00%
Investment, interest rate	[8],[9],[10],[11]							11.67%		11.67%		11.67%
Investment, principal	[8],[9],[10],[12]							$ 22,619
Investment owned, at cost	[8],[9],[10]							22,162
Investments at fair value	[8],[9],[10]							22,275
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		15,302	[1],[4],[7],[15]					13,083	[8],[9],[12],[22]
Investment owned, at cost		15,341	[1],[4],[15]					13,083	[8],[9],[22]
Investments at fair value		$ 14,269	[1],[4],[15]					$ 13,083	[8],[9],[22]
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.75%	[1],[4],[5]	8.75%	[1],[4],[5]	8.75%	[1],[4],[5]	8.75%	[8],[9],[10]	8.75%	[8],[9],[10]	8.75%	[8],[9],[10]
Investment, interest rate		14.14%	[1],[2],[4],[5]	14.14%	[1],[2],[4],[5]	14.14%	[1],[2],[4],[5]	12.45%	[8],[9],[10],[11]	12.45%	[8],[9],[10],[11]	12.45%	[8],[9],[10],[11]
Investment, principal		$ 13,109	[1],[4],[5],[7]					$ 12,161	[8],[9],[10],[12]
Investment owned, at cost		12,939	[1],[4],[5]					11,944	[8],[9],[10]
Investments at fair value		$ 12,617	[1],[4],[5]					$ 11,942	[8],[9],[10]
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								8.80%		8.80%		8.80%
Investment, principal								$ 7,406
Investment owned, at cost								7,293
Investments at fair value								$ 7,286
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.75%		10.75%		10.75%		8.80%		8.80%		8.80%
Investment, principal		$ 3,920						$ 3,950
Investment owned, at cost		3,872						3,890
Investments at fair value		$ 3,925						$ 3,886
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., Pharmaceuticals, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%
Investment, interest rate		10.75%		10.75%		10.75%
Investment, principal		$ 7,350
Investment owned, at cost		7,260
Investments at fair value		$ 7,359
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.00%	[1],[2],[4],[5],[14]	11.00%	[1],[2],[4],[5],[14]	11.00%	[1],[2],[4],[5],[14]	11.00%	[8],[9],[10],[11],[16]	11.00%	[8],[9],[10],[11],[16]	11.00%	[8],[9],[10],[11],[16]
Investment, principal		$ 8,452	[1],[4],[7],[14]					$ 6,817	[8],[9],[12],[16]
Investment owned, at cost		8,185	[1],[4],[14]					6,553	[8],[9],[16]
Investments at fair value		$ 7,730	[1],[4],[14]					$ 6,408	[8],[9],[16]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.00%	[1],[2],[3],[4],[5],[14]	11.00%	[1],[2],[3],[4],[5],[14]	11.00%	[1],[2],[3],[4],[5],[14]	11.00%	[8],[9],[10],[11],[13],[16]	11.00%	[8],[9],[10],[11],[13],[16]	11.00%	[8],[9],[10],[11],[13],[16]
Investment, principal		$ 0	[1],[3],[4],[7],[14]					$ 0	[8],[9],[12],[13],[16]
Investment owned, at cost		0	[1],[3],[4],[14]					0	[8],[9],[13],[16]
Investments at fair value		$ 0	[1],[3],[4],[14]					$ 0	[8],[9],[13],[16]
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[3],[4],[5],[14]	11.00%		11.00%		11.00%
Investment, principal	[1],[3],[4],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[14]	0
Investments at fair value	[1],[3],[4],[14]	$ 0
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		112,990	[1],[4],[14]	112,990	[1],[4],[14]	112,990	[1],[4],[14]	56,999	[8],[9],[16]	56,999	[8],[9],[16]	56,999	[8],[9],[16]
Investment owned, at cost		$ 300	[1],[4],[14]					$ 135	[8],[9],[16]
Investments at fair value		$ 172	[1],[4],[14]					$ 609	[8],[9],[16]
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	1,078,284		1,078,284		1,078,284
Investment owned, at cost	[1],[4]	$ 113
Investments at fair value	[1],[4]	$ 0
Investment, Identifier [Axis]: Integral Development Corporation, Other Diversified Financial Services, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9]							1,078,284		1,078,284		1,078,284
Investment owned, at cost	[8],[9]							$ 113
Investments at fair value	[8],[9]							$ 0
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.50%		7.50%		7.50%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(114)
Investments at fair value	[1],[3],[4],[5]	$ (114)
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	5.00%	[8],[9],[10]	5.00%	[8],[9],[10]	5.00%	[8],[9],[10]
Investment, interest rate		12.72%	[1],[2],[4],[5]	12.72%	[1],[2],[4],[5]	12.72%	[1],[2],[4],[5]	8.55%	[8],[9],[10],[11]	8.55%	[8],[9],[10],[11]	8.55%	[8],[9],[10],[11]
Investment, principal		$ 33,498	[1],[4],[5],[7]					$ 18,660	[8],[9],[10],[12]
Investment owned, at cost		32,494	[1],[4],[5]					18,567	[8],[9],[10]
Investments at fair value		$ 32,493	[1],[4],[5]					$ 18,134	[8],[9],[10]
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							8.50%		8.50%		8.50%
Investment, interest rate	[8],[9],[10],[11]							12.17%		12.17%		12.17%
Investment, principal	[8],[9],[10],[12]							$ 13,674
Investment owned, at cost	[8],[9],[10]							13,514
Investments at fair value	[8],[9],[10]							$ 13,154
Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.75%		4.75%		4.75%
Investment, interest rate								7.89%		7.89%		7.89%
Investment, principal								$ 5,000
Investment owned, at cost								4,624
Investments at fair value								$ 4,610
Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%		4.75%		4.75%		4.75%
Investment, interest rate		9.90%		9.90%		9.90%		7.89%		7.89%		7.89%
Investment, principal		$ 1,985						$ 2,000
Investment owned, at cost		1,852						1,846
Investments at fair value		$ 1,690						$ 1,844
Investment, Identifier [Axis]: Iris Holding, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%
Investment, interest rate		9.90%		9.90%		9.90%
Investment, principal		$ 4,963
Investment owned, at cost		4,638
Investments at fair value		$ 4,226
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[4],[5]	7.25%	[4],[5]	7.25%	[4],[5]	7.25%	[9],[10]	7.25%	[9],[10]	7.25%	[9],[10]
Investment, interest rate		12.42%	[2],[4],[5]	12.42%	[2],[4],[5]	12.42%	[2],[4],[5]	10.33%	[9],[10],[11]	10.33%	[9],[10],[11]	10.33%	[9],[10],[11]
Investment, principal		$ 13,939	[4],[5],[7]					$ 10,247	[9],[10],[12]
Investment owned, at cost		12,601	[4],[5]					10,196	[9],[10]
Investments at fair value		9,252	[4],[5]					$ 7,702	[9],[10]
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, at cost		5,193
Investments at fair value		$ 5,193
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.50%		7.50%		7.50%
Investment, interest rate	[8],[9],[10],[11]							10.62%		10.62%		10.62%
Investment, principal	[8],[9],[10],[12]							$ 36,234
Investment owned, at cost	[8],[9],[10]							35,170
Investments at fair value	[8],[9],[10]							$ 36,392
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.50%		7.50%		7.50%
Investment, interest rate	[1],[2],[4],[5]	12.70%		12.70%		12.70%
Investment, principal	[1],[4],[5],[7]	$ 17,069
Investment owned, at cost	[1],[4],[5]	17,053
Investments at fair value	[1],[4],[5]	$ 16,966
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.50%		7.50%		7.50%
Investment, interest rate	[1],[2],[4],[5]	12.70%		12.70%		12.70%
Investment, principal	[1],[4],[5],[7]	$ 27,360
Investment owned, at cost	[1],[4],[5]	26,872
Investments at fair value	[1],[4],[5]	$ 27,488
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[4],[5]	10.60%		10.60%		10.60%
Investment, principal	[1],[4],[5],[7]	$ 15,150
Investment owned, at cost	[1],[4],[5]	14,331
Investments at fair value	[1],[4],[5]	$ 14,924
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[4],[5]	8.00%	[4],[5]	8.00%	[4],[5]	8.00%	[9],[10]	8.00%	[9],[10]	8.00%	[9],[10]
Investment, interest rate		13.20%	[2],[4],[5]	13.20%	[2],[4],[5]	13.20%	[2],[4],[5]	11.12%	[9],[10],[11]	11.12%	[9],[10],[11]	11.12%	[9],[10],[11]
Investment, principal		$ 666	[4],[5],[7]					$ 528	[9],[10],[12]
Investment owned, at cost		616	[4],[5]					478	[9],[10]
Investments at fair value		$ 652	[4],[5]					$ 481	[9],[10]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[3],[4],[5]	6.50%	[1],[3],[4],[5]	6.50%	[1],[3],[4],[5]	6.50%	[8],[9],[10],[13]	6.50%	[8],[9],[10],[13]	6.50%	[8],[9],[10],[13]
Investment, interest rate		11.84%	[1],[2],[3],[4],[5]	11.84%	[1],[2],[3],[4],[5]	11.84%	[1],[2],[3],[4],[5]	10.17%	[8],[9],[10],[11],[13]	10.17%	[8],[9],[10],[11],[13]	10.17%	[8],[9],[10],[11],[13]
Investment, principal		$ 545	[1],[3],[4],[5],[7]					$ 329	[8],[9],[10],[12],[13]
Investment owned, at cost		517	[1],[3],[4],[5]					311	[8],[9],[10],[13]
Investments at fair value		$ 510	[1],[3],[4],[5]					$ 292	[8],[9],[10],[13]
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[4],[5]	6.50%	[1],[4],[5]	6.50%	[1],[4],[5]	6.50%	[8],[9],[10]	6.50%	[8],[9],[10]	6.50%	[8],[9],[10]
Investment, interest rate		11.84%	[1],[2],[4],[5]	11.84%	[1],[2],[4],[5]	11.84%	[1],[2],[4],[5]	10.17%	[8],[9],[10],[11]	10.17%	[8],[9],[10],[11]	10.17%	[8],[9],[10],[11]
Investment, principal		$ 16,765	[1],[4],[5],[7]					$ 13,623	[8],[9],[10],[12]
Investment owned, at cost		16,636	[1],[4],[5]					13,487	[8],[9],[10]
Investments at fair value		$ 16,511	[1],[4],[5]					$ 13,351	[8],[9],[10]
Investment, Identifier [Axis]: LABL, Inc., Office Services & Supplies, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.20%		10.20%		10.20%
Investment, principal		$ 3,972
Investment owned, at cost		3,817
Investments at fair value		$ 3,940
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[3],[4],[5]	6.00%	[1],[3],[4],[5]	6.00%	[1],[3],[4],[5]	6.00%	[8],[9],[10],[13]	6.00%	[8],[9],[10],[13]	6.00%	[8],[9],[10],[13]
Investment, interest rate	[8],[9],[10],[11],[13]							9.12%		9.12%		9.12%
Investment, principal		$ 0	[1],[3],[4],[5],[7]					$ 1,710	[8],[9],[10],[12],[13]
Investment owned, at cost		(44)	[1],[3],[4],[5]					1,672	[8],[9],[10],[13]
Investments at fair value		$ (146)	[1],[3],[4],[5]					$ 1,651	[8],[9],[10],[13]
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[9],[10],[11]							9.12%		9.12%		9.12%
Investment, principal	[8],[9],[10],[12]							$ 19,236
Investment owned, at cost	[8],[9],[10]							18,894
Investments at fair value	[8],[9],[10]							$ 18,707
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.00%		6.00%		6.00%
Investment, interest rate	[1],[2],[4],[5]	11.20%		11.20%		11.20%
Investment, principal	[1],[4],[5],[7]	$ 2,742
Investment owned, at cost	[1],[4],[5]	2,594
Investments at fair value	[1],[4],[5]	$ 2,592
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.00%		6.00%		6.00%
Investment, interest rate	[1],[2],[4],[5]	11.20%		11.20%		11.20%
Investment, principal	[1],[4],[5],[7]	$ 23,554
Investment owned, at cost	[1],[4],[5]	23,166
Investments at fair value	[1],[4],[5]	$ 22,258
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.50%		3.50%		3.50%
Investment, interest rate		8.72%		8.72%		8.72%
Investment, principal		$ 7,308
Investment owned, at cost		7,246
Investments at fair value		$ 7,037
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[4],[5]	6.75%	[4],[5]	6.75%	[4],[5]	6.75%	[9],[10]	6.75%	[9],[10]	6.75%	[9],[10]
Investment, interest rate		11.97%	[2],[4],[5]	11.97%	[2],[4],[5]	11.97%	[2],[4],[5]	9.87%	[9],[10],[11]	9.87%	[9],[10],[11]	9.87%	[9],[10],[11]
Investment, principal		$ 2,140	[4],[5],[7]					$ 2,140	[9],[10],[12]
Investment owned, at cost		2,101	[4],[5]					2,092	[9],[10]
Investments at fair value		$ 1,834	[4],[5]					$ 1,890	[9],[10]
Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.25%		3.25%		3.25%
Investment, interest rate								6.37%		6.37%		6.37%
Investment, principal								$ 7,366
Investment owned, at cost								7,282
Investments at fair value								$ 6,835
Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.50%		3.50%		3.50%		3.25%		3.25%		3.25%
Investment, interest rate		8.72%		8.72%		8.72%		6.37%		6.37%		6.37%
Investment, principal		$ 1,347						$ 1,358
Investment owned, at cost		1,224						1,192
Investments at fair value		1,297						1,260
Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		11,304,000						10,093
Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal		$ 6,313						$ 6,562
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.75%		5.75%		5.75%
Investment, interest rate								8.23%		8.23%		8.23%
Investment, principal								$ 7,444
Investment owned, at cost								7,318
Investments at fair value								$ 7,323
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%		5.75%		5.75%		5.75%		5.75%		5.75%
Investment, interest rate		11.08%		11.08%		11.08%		8.23%		8.23%		8.23%
Investment, principal		$ 3,940						$ 3,970
Investment owned, at cost		3,883						3,903
Investments at fair value		$ 3,876						$ 3,905
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, Health Care Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.75%		5.75%		5.75%
Investment, interest rate		11.08%		11.08%		11.08%
Investment, principal		$ 7,388
Investment owned, at cost		7,281
Investments at fair value		$ 7,267
Investment, Identifier [Axis]: LaserShip, Inc., Air Freight & Logistics, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.50%		7.50%		7.50%
Investment, interest rate	[8],[9],[10],[11]							10.38%		10.38%		10.38%
Investment, principal	[8],[9],[10],[12]							$ 2,394
Investment owned, at cost	[8],[9],[10]							2,370
Investments at fair value	[8],[9],[10]							$ 1,867
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[4],[5],[14]	9.50%		9.50%		9.50%
Investment, interest rate	[2],[4],[5],[14]	14.61%		14.61%		14.61%
Investment, principal	[4],[5],[7],[14]	$ 26,489
Investment owned, at cost	[4],[5],[14]	24,888
Investments at fair value	[4],[5],[14]	$ 26,985
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		2,000,000	[1],[4]	2,000,000	[1],[4]	2,000,000	[1],[4]	2,000,000	[8],[9]	2,000,000	[8],[9]	2,000,000	[8],[9]
Investment owned, at cost		$ 1,399	[1],[4]					$ 1,399	[8],[9]
Investments at fair value		$ 0	[1],[4]					$ 0	[8],[9]
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.67%		8.67%		8.67%
Investment, principal								$ 7,367
Investment owned, at cost								7,315
Investments at fair value								$ 7,109
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%	[1],[4],[5]	5.00%	[1],[4],[5]	5.00%	[1],[4],[5]	5.00%	[8],[9],[10]	5.00%	[8],[9],[10]	5.00%	[8],[9],[10]
Investment, interest rate		10.50%	[1],[2],[4],[5]	10.50%	[1],[2],[4],[5]	10.50%	[1],[2],[4],[5]	8.67%	[8],[9],[10],[11]	8.67%	[8],[9],[10],[11]	8.67%	[8],[9],[10],[11]
Investment, principal		$ 45,361	[1],[4],[5],[7]					$ 41,008	[8],[9],[10],[12]
Investment owned, at cost		44,783	[1],[4],[5]					40,243	[8],[9],[10]
Investments at fair value		$ 44,227	[1],[4],[5]					$ 39,573	[8],[9],[10]
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.50%		10.50%		10.50%
Investment, principal		$ 11,279
Investment owned, at cost		11,121
Investments at fair value		$ 10,997
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		559	[1],[4]	559	[1],[4]	559	[1],[4]	451	[8],[9]	451	[8],[9]	451	[8],[9]
Investment, principal	[1],[4],[7]
Investment owned, at cost		563	[1],[4]					$ 451	[8],[9]
Investments at fair value		$ 487	[1],[4]					$ 451	[8],[9]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]
Investment, interest rate		13.84%	[1],[2],[4],[5]	13.84%	[1],[2],[4],[5]	13.84%	[1],[2],[4],[5]	11.38%	[8],[9],[10],[11]	11.38%	[8],[9],[10],[11]	11.38%	[8],[9],[10],[11]
Investment, principal		$ 5,403	[1],[4],[5],[7]					$ 4,357	[8],[9],[10],[12]
Investment owned, at cost		5,344	[1],[4],[5]					4,285	[8],[9],[10]
Investments at fair value		$ 5,173	[1],[4],[5]					$ 4,226	[8],[9],[10]
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[3],[4],[5]	8.50%	[1],[3],[4],[5]	8.50%	[1],[3],[4],[5]	8.50%	[8],[9],[10],[13]	8.50%	[8],[9],[10],[13]	8.50%	[8],[9],[10],[13]
Investment, interest rate		13.84%	[1],[2],[3],[4],[5]	13.84%	[1],[2],[3],[4],[5]	13.84%	[1],[2],[3],[4],[5]	11.38%	[8],[9],[10],[11],[13]	11.38%	[8],[9],[10],[11],[13]	11.38%	[8],[9],[10],[11],[13]
Investment, principal		$ 2,939	[1],[3],[4],[5],[7]					$ 2,370	[8],[9],[10],[12],[13]
Investment owned, at cost		2,883	[1],[3],[4],[5]					2,323	[8],[9],[10],[13]
Investments at fair value		$ 2,755	[1],[3],[4],[5]					$ 2,265	[8],[9],[10],[13]
Investment, Identifier [Axis]: LogMeIn, Inc., Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%
Investment, interest rate		9.94%		9.94%		9.94%
Investment, principal		$ 7,800
Investment owned, at cost		7,705
Investments at fair value		$ 4,918
Investment, Identifier [Axis]: LogMeIn, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.75%		4.75%		4.75%
Investment, interest rate								7.80%		7.80%		7.80%
Investment, principal								$ 7,860
Investment owned, at cost								7,751
Investments at fair value								$ 5,494
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[3],[4],[5]	6.00%	[1],[3],[4],[5]	6.00%	[1],[3],[4],[5]	6.00%	[8],[9],[10],[13]	6.00%	[8],[9],[10],[13]	6.00%	[8],[9],[10],[13]
Investment, interest rate	[1],[2],[3],[4],[5]	11.25%		11.25%		11.25%
Investment, principal		$ 250	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		220	[1],[3],[4],[5]					(23)	[8],[9],[10],[13]
Investments at fair value		$ 203	[1],[3],[4],[5]					$ (54)	[8],[9],[10],[13]
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[9],[10],[11]							9.50%		9.50%		9.50%
Investment, principal	[8],[9],[10],[12]							$ 18,390
Investment owned, at cost	[8],[9],[10]							18,088
Investments at fair value	[8],[9],[10]							$ 17,691
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.00%		6.00%		6.00%
Investment, interest rate	[1],[2],[4],[5]	11.20%		11.20%		11.20%
Investment, principal	[1],[4],[5],[7]	$ 20,176
Investment owned, at cost	[1],[4],[5]	19,949
Investments at fair value	[1],[4],[5]	$ 19,648
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.00%		6.00%		6.00%
Investment, interest rate	[1],[2],[4],[5]	11.20%		11.20%		11.20%
Investment, principal	[1],[4],[5],[7]	$ 2,637
Investment owned, at cost	[1],[4],[5]	2,594
Investments at fair value	[1],[4],[5]	$ 2,568
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.50%		7.50%		7.50%
Investment, interest rate	[1],[2],[3],[4],[5]	12.58%		12.58%		12.58%
Investment, principal	[1],[3],[4],[5],[7]	$ 2,118
Investment owned, at cost	[1],[3],[4],[5]	1,853
Investments at fair value	[1],[3],[4],[5]	$ 1,853
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.50%		7.50%		7.50%
Investment, interest rate	[1],[2],[4],[5]	12.74%		12.74%		12.74%
Investment, principal	[1],[4],[5],[7]	$ 40,640
Investment owned, at cost	[1],[4],[5]	39,937
Investments at fair value	[1],[4],[5]	$ 39,937
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[3],[4],[5]	5.50%	[1],[3],[4],[5]	5.50%	[1],[3],[4],[5]	5.50%	[8],[9],[10],[13]	5.50%	[8],[9],[10],[13]	5.50%	[8],[9],[10],[13]
Investment, principal		$ 0	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		(29)	[1],[3],[4],[5]					(13)	[8],[9],[10],[13]
Investments at fair value		$ (62)	[1],[3],[4],[5]					$ (51)	[8],[9],[10],[13]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%
Investment, principal		$ 0
Investment owned, at cost		(3)
Investments at fair value		$ (9)
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%
Investment, interest rate		10.84%		10.84%		10.84%
Investment, principal		$ 8,340
Investment owned, at cost		8,172
Investments at fair value		$ 8,111
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[4],[5]	5.50%	[1],[4],[5]	5.50%	[1],[4],[5]	5.50%	[8],[9],[10]	5.50%	[8],[9],[10]	5.50%	[8],[9],[10]
Investment, interest rate		10.84%	[1],[2],[4],[5]	10.84%	[1],[2],[4],[5]	10.84%	[1],[2],[4],[5]	9.17%	[8],[9],[10],[11]	9.17%	[8],[9],[10],[11]	9.17%	[8],[9],[10],[11]
Investment, principal		$ 12,397	[1],[4],[5],[7]					$ 29,565	[8],[9],[10],[12]
Investment owned, at cost		12,357	[1],[4],[5]					29,128	[8],[9],[10]
Investments at fair value		$ 12,056	[1],[4],[5]					$ 28,734	[8],[9],[10]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[4],[5]	5.50%	[1],[4],[5]	5.50%	[1],[4],[5]	5.50%	[8],[9],[10],[13]	5.50%	[8],[9],[10],[13]	5.50%	[8],[9],[10],[13]
Investment, interest rate	[1],[2],[4],[5]	10.84%		10.84%		10.84%
Investment, principal		$ 21,383	[1],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		21,055	[1],[4],[5]					(12)	[8],[9],[10],[13]
Investments at fair value		$ 20,795	[1],[4],[5]					$ (96)	[8],[9],[10],[13]
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%
Investment, interest rate		10.84%		10.84%		10.84%
Investment, principal		$ 2,217
Investment owned, at cost		2,216
Investments at fair value		$ 2,156
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[1],[2],[3],[4],[5]	10.83%		10.83%		10.83%
Investment, principal	[1],[3],[4],[5],[7]	$ 570
Investment owned, at cost	[1],[3],[4],[5]	559
Investments at fair value	[1],[3],[4],[5]	$ 526
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.50%		5.50%		5.50%
Investment, principal
Investment owned, at cost								(3)
Investments at fair value								$ (10)
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%		5.50%		5.50%		5.50%
Investment, principal		$ 0						$ 0
Investment owned, at cost		(1)						(1)
Investments at fair value		$ (4)						$ (4)
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.50%		5.50%		5.50%
Investment, interest rate								9.17%		9.17%		9.17%
Investment, principal								$ 6,139
Investment owned, at cost								6,104
Investments at fair value								$ 5,966
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%		5.50%		5.50%		5.50%
Investment, interest rate		10.84%		10.84%		10.84%		9.17%		9.17%		9.17%
Investment, principal		$ 1,634						$ 1,647
Investment owned, at cost		1,621						1,632
Investments at fair value		$ 1,589						$ 1,600
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.50%	[1],[2],[4],[5],[14]	11.50%	[1],[2],[4],[5],[14]	11.50%	[1],[2],[4],[5],[14]	11.50%	[8],[9],[10],[11],[16]	11.50%	[8],[9],[10],[11],[16]	11.50%	[8],[9],[10],[11],[16]
Investment, principal		$ 8,568	[1],[4],[7],[14]					$ 17,203	[8],[9],[12],[16]
Investment owned, at cost		8,488	[1],[4],[14]					16,954	[8],[9],[16]
Investments at fair value		$ 8,225	[1],[4],[14]					$ 16,644	[8],[9],[16]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.50%	[1],[2],[4],[5],[14]	11.50%	[1],[2],[4],[5],[14]	11.50%	[1],[2],[4],[5],[14]	11.50%	[8],[9],[10],[11],[13],[16]	11.50%	[8],[9],[10],[11],[13],[16]	11.50%	[8],[9],[10],[11],[13],[16]
Investment, principal		$ 4,284	[1],[4],[7],[14]					$ 0	[8],[9],[12],[13],[16]
Investment owned, at cost		4,244	[1],[4],[14]					0	[8],[9],[13],[16]
Investments at fair value		$ 4,112	[1],[4],[14]					$ 0	[8],[9],[13],[16]
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	11.50%		11.50%		11.50%
Investment, principal	[1],[4],[7],[14]	$ 8,568
Investment owned, at cost	[1],[4],[14]	8,488
Investments at fair value	[1],[4],[14]	$ 8,225
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	11.50%		11.50%		11.50%
Investment, principal	[1],[3],[4],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[14]	0
Investments at fair value	[1],[3],[4],[14]	$ 0
Investment, Identifier [Axis]: McAfee Corp., Systems Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.01%		9.01%		9.01%
Investment, principal		$ 5,955
Investment owned, at cost		5,655
Investments at fair value		$ 5,713
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8.00%	[1],[2],[4],[5],[14]	8.00%	[1],[2],[4],[5],[14]	8.00%	[1],[2],[4],[5],[14]	8.00%	[8],[9],[10],[11],[16]	8.00%	[8],[9],[10],[11],[16]	8.00%	[8],[9],[10],[11],[16]
Investment, principal		$ 9,066	[1],[4],[7],[14]					$ 7,215	[8],[9],[12],[16]
Investment owned, at cost		8,496	[1],[4],[14]					6,650	[8],[9],[16]
Investments at fair value		$ 8,114	[1],[4],[14]					$ 6,440	[8],[9],[16]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		8.00%	[1],[2],[4],[5],[14]	8.00%	[1],[2],[4],[5],[14]	8.00%	[1],[2],[4],[5],[14]	8.00%	[8],[9],[10],[11],[13],[16]	8.00%	[8],[9],[10],[11],[13],[16]	8.00%	[8],[9],[10],[11],[13],[16]
Investment, principal		$ 0	[1],[3],[4],[7],[14]					$ 0	[8],[9],[12],[13],[16]
Investment owned, at cost		1	[1],[3],[4],[14]					1	[8],[9],[13],[16]
Investments at fair value		$ 0	[1],[3],[4],[14]					$ 0	[8],[9],[13],[16]
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	8.00%		8.00%		8.00%
Investment, principal	[1],[3],[4],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[14]	0
Investments at fair value	[1],[3],[4],[14]	$ 0
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9],[16]							209,588		209,588		209,588
Investment owned, at cost	[8],[9],[16]							$ 480
Investments at fair value	[8],[9],[16]							$ 170
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4],[14]	259,877		259,877		259,877
Investment, principal	[1],[4],[7],[14]
Investment owned, at cost	[1],[4],[14]	545
Investments at fair value	[1],[4],[14]	$ 437
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4],[14]	66,817		66,817		66,817
Investment, principal	[1],[4],[7],[14]
Investment owned, at cost	[1],[4],[14]	23
Investments at fair value	[1],[4],[14]	$ 153
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								8.00%		8.00%		8.00%
Investment, principal								$ 0
Investment owned, at cost								(4)
Investments at fair value								$ (12)
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								7.00%		7.00%		7.00%
Investment, interest rate								10.64%		10.64%		10.64%
Investment, principal								$ 4,687
Investment owned, at cost								4,651
Investments at fair value								$ 4,570
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.00%	[1],[3],[4],[5]	7.00%	[1],[3],[4],[5]	7.00%	[1],[3],[4],[5]	8.00%	[8],[9],[10],[13]	8.00%	[8],[9],[10],[13]	8.00%	[8],[9],[10],[13]
Investment, principal		$ 0	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		(51)	[1],[3],[4],[5]					(54)	[8],[9],[10],[13]
Investments at fair value		$ (71)	[1],[3],[4],[5]					$ (100)	[8],[9],[10],[13]
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%		8.00%		8.00%
Investment, principal		$ 0
Investment owned, at cost		(3)
Investments at fair value		$ (7)
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[9],[10],[11]							10.64%		10.64%		10.64%
Investment, principal	[8],[9],[10],[12]							$ 45,665
Investment owned, at cost	[8],[9],[10]							44,689
Investments at fair value	[8],[9],[10]							$ 44,523
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.00%		7.00%		7.00%
Investment, interest rate		12.19%		12.19%		12.19%
Investment, principal		$ 4,669
Investment owned, at cost		4,644
Investments at fair value		$ 4,599
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[4],[5]	12.19%		12.19%		12.19%
Investment, principal	[1],[4],[5],[7]	$ 7,464
Investment owned, at cost	[1],[4],[5]	7,416
Investments at fair value	[1],[4],[5]	$ 7,352
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[4],[5]	12.19%		12.19%		12.19%
Investment, principal	[1],[4],[5],[7]	$ 46,687
Investment owned, at cost	[1],[4],[5]	46,157
Investments at fair value	[1],[4],[5]	$ 45,987
Investment, Identifier [Axis]: Mitchell International Inc, Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		8.94%		8.94%		8.94%
Investment, principal		$ 2,991
Investment owned, at cost		2,845
Investments at fair value		$ 2,931
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[4],[5]	6.75%	[1],[4],[5]	6.75%	[1],[4],[5]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]
Investment, interest rate		11.97%	[1],[2],[4],[5]	11.97%	[1],[2],[4],[5]	11.97%	[1],[2],[4],[5]	9.89%	[8],[9],[10],[11]	9.89%	[8],[9],[10],[11]	9.89%	[8],[9],[10],[11]
Investment, principal		$ 55,297	[1],[4],[5],[7]					$ 46,499	[8],[9],[10],[12]
Investment owned, at cost		54,939	[1],[4],[5]					45,802	[8],[9],[10]
Investments at fair value		$ 54,235	[1],[4],[5]					$ 45,421	[8],[9],[10]
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[2],[4],[5]	6.88%		6.88%		6.88%
Investment, principal	[4],[7]	$ 10,191
Investment owned, at cost	[4]	9,816
Investments at fair value	[4]	$ 8,860
Investment, Identifier [Axis]: NFP Corp., Other Diversified Financial Services, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11]							6.88%		6.88%		6.88%
Investment, principal	[9],[12]							$ 10,191
Investment owned, at cost	[9]							9,773
Investments at fair value	[9]							$ 7,966
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[14]	6.88%		6.88%		6.88%
Investment, interest rate	[1],[2],[4],[5],[14]	12.08%		12.08%		12.08%
Investment, principal	[1],[4],[5],[7],[14]	$ 73,178
Investment owned, at cost	[1],[4],[5],[14]	72,195
Investments at fair value	[1],[4],[5],[14]	$ 69,885
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		487,870		487,870		487,870
Investment, principal | €	[1],[4],[5],[7],[14]			€ 0
Investment owned, at cost	[1],[4],[5],[14]	$ 0
Investments at fair value	[1],[4],[5],[14]	$ 1,161
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		487,870		487,870		487,870
Investment, principal | €	[4],[5],[7],[14]			€ 0
Investment owned, at cost	[4],[5],[14]	$ 0
Investments at fair value	[4],[5],[14]	$ 1,161
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[16]							6.88%		6.88%		6.88%
Investment, interest rate	[8],[9],[10],[11],[16]							9.99%		9.99%		9.99%
Investment, principal	[8],[9],[10],[12],[16]							$ 58,713
Investment owned, at cost	[8],[9],[10],[16]							57,655
Investments at fair value	[8],[9],[10],[16]							$ 56,805
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]
Investment, interest rate		14.04%	[1],[2],[4],[5]	14.04%	[1],[2],[4],[5]	14.04%	[1],[2],[4],[5]	12.17%	[8],[9],[10],[11]	12.17%	[8],[9],[10],[11]	12.17%	[8],[9],[10],[11]
Investment, principal		$ 30,339	[1],[4],[5],[7]					$ 22,560	[8],[9],[10],[12]
Investment owned, at cost		30,002	[1],[4],[5]					22,241	[8],[9],[10]
Investments at fair value		$ 29,125	[1],[4],[5]					$ 21,524	[8],[9],[10]
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10.50%	[1],[4],[5]	10.50%	[1],[4],[5]	10.50%	[1],[4],[5]	10.50%	[8],[9],[10]	10.50%	[8],[9],[10]	10.50%	[8],[9],[10]
Investment, interest rate		16.04%	[1],[2],[4],[5]	16.04%	[1],[2],[4],[5]	16.04%	[1],[2],[4],[5]	14.17%	[8],[9],[10],[11]	14.17%	[8],[9],[10],[11]	14.17%	[8],[9],[10],[11]
Investment, principal		$ 64,606	[1],[4],[5],[7]					$ 50,459	[8],[9],[10],[12]
Investment owned, at cost		64,750	[1],[4],[5]					49,301	[8],[9],[10]
Investments at fair value		$ 63,185	[1],[4],[5]					$ 51,972	[8],[9],[10]
Investment, Identifier [Axis]: Northern Star Industries Inc., Electrical Components & Equipment, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%
Investment, interest rate		10.00%		10.00%		10.00%
Investment, principal		$ 6,633
Investment owned, at cost		6,624
Investments at fair value		$ 6,583
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.75%		4.75%		4.75%
Investment, interest rate								7.87%		7.87%		7.87%
Investment, principal								$ 6,685
Investment owned, at cost								6,673
Investments at fair value								$ 6,484
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.75%		4.75%		4.75%
Investment, interest rate		10.00%		10.00%		10.00%		7.87%		7.87%		7.87%
Investment, principal		$ 5,211						$ 5,252
Investment owned, at cost		5,205						5,243
Investments at fair value		5,172						$ 5,095
Investment, Identifier [Axis]: OCSI Glick JV LLC, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investments at fair value														$ 0	0
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[13],[16],[25],[26],[28],[29]							0.875		0.875		0.875
Investment, principal		0
Investment owned, at cost		0	[3],[14],[23],[24],[30],[31]					$ 0	[13],[16],[25],[26],[28],[29]
Investments at fair value		$ 0	[3],[14],[23],[24],[30],[31]					$ 0	[13],[16],[25],[26],[28],[29]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%	[1],[3],[5],[14],[23],[24],[30]	4.50%	[1],[3],[5],[14],[23],[24],[30]	4.50%	[1],[3],[5],[14],[23],[24],[30]	4.50%	[8],[10],[13],[16],[25],[26],[28]	4.50%	[8],[10],[13],[16],[25],[26],[28]	4.50%	[8],[10],[13],[16],[25],[26],[28]
Investment, interest rate		9.36%	[1],[2],[3],[5],[14],[23],[24],[30]	9.36%	[1],[2],[3],[5],[14],[23],[24],[30]	9.36%	[1],[2],[3],[5],[14],[23],[24],[30]	6.30%	[8],[10],[11],[13],[16],[25],[26],[28]	6.30%	[8],[10],[11],[13],[16],[25],[26],[28]	6.30%	[8],[10],[11],[13],[16],[25],[26],[28]
Investment, principal		$ 58,349	[1],[3],[5],[7],[14],[23],[24],[30]					$ 59,662	[8],[10],[12],[13],[16],[25],[26],[28]
Investment owned, at cost		49,997	[1],[3],[5],[14],[23],[24],[30]					50,194	[8],[10],[13],[16],[25],[26],[28]
Investments at fair value		$ 49,632	[1],[3],[5],[14],[23],[24],[30]					$ 50,283	[8],[10],[13],[16],[25],[26],[28]
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate														4.50%
Investment, interest rate														4.94%
Investment, principal														$ 60,274
Investments at fair value														50,606	55,582
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							4.00%		4.00%		4.00%
Investment, interest rate	[9],[10],[11]							7.12%		7.12%		7.12%
Investment, principal	[9],[10],[12]							$ 3,323
Investment owned, at cost	[9],[10]							3,162
Investments at fair value	[9],[10]							$ 3,207
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.25%		9.25%		9.25%
Investment, principal		$ 11,015
Investment owned, at cost		10,845
Investments at fair value		$ 10,852
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.00%	[1],[4],[5]	7.00%	[1],[4],[5]	7.00%	[1],[4],[5]	7.00%	[8],[9],[10]	7.00%	[8],[9],[10]	7.00%	[8],[9],[10]
Investment, interest rate		12.34%	[1],[2],[4],[5]	12.34%	[1],[2],[4],[5]	12.34%	[1],[2],[4],[5]	10.05%	[8],[9],[10],[11]	10.05%	[8],[9],[10],[11]	10.05%	[8],[9],[10],[11]
Investment, principal		$ 9,323	[1],[4],[5],[7]					$ 7,519	[8],[9],[10],[12]
Investment owned, at cost		9,203	[1],[4],[5]					7,389	[8],[9],[10]
Investments at fair value		$ 9,090	[1],[4],[5]					$ 7,237	[8],[9],[10]
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.00%		4.00%		4.00%
Investment, interest rate								7.12%		7.12%		7.12%
Investment, principal								$ 7,777
Investment owned, at cost								7,741
Investments at fair value								$ 7,505
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%		4.00%		4.00%		4.00%
Investment, interest rate		9.25%		9.25%		9.25%		7.12%		7.12%		7.12%
Investment, principal		$ 3,858						$ 3,888
Investment owned, at cost		3,841						3,871
Investments at fair value		$ 3,802						$ 3,752
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10.00%	[1],[4],[5]	10.00%	[1],[4],[5]	10.00%	[1],[4],[5]	2.00%	[8],[9],[10]	2.00%	[8],[9],[10]	2.00%	[8],[9],[10]
Investment, interest rate		15.50%	[1],[2],[4],[5]	15.50%	[1],[2],[4],[5]	15.50%	[1],[2],[4],[5]	5.08%	[8],[9],[10],[11]	5.08%	[8],[9],[10],[11]	5.08%	[8],[9],[10],[11]
Investment, principal		$ 25,712	[1],[4],[5],[7]					$ 21,557	[8],[9],[10],[12]
Investment owned, at cost		25,603	[1],[4],[5]					21,267	[8],[9],[10]
Investments at fair value		$ 25,712	[1],[4],[5]					$ 21,557	[8],[9],[10]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		10.00%	[1],[3],[4],[5]	10.00%	[1],[3],[4],[5]	10.00%	[1],[3],[4],[5]	2.00%	[8],[9],[10],[13]	2.00%	[8],[9],[10],[13]	2.00%	[8],[9],[10],[13]
Investment, principal		$ 0	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		(13)	[1],[3],[4],[5]					(31)	[8],[9],[10],[13]
Investments at fair value		$ 0	[1],[3],[4],[5]					$ 0	[8],[9],[10],[13]
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	10.00%		10.00%		10.00%
Investment, interest rate	[1],[2],[3],[4],[5]	15.39%		15.39%		15.39%
Investment, principal	[1],[3],[4],[5],[7]	$ 1,210
Investment owned, at cost	[1],[3],[4],[5]	1,192
Investments at fair value	[1],[3],[4],[5]	$ 1,210
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.75%		7.75%		7.75%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(44)
Investments at fair value	[1],[3],[4],[5]	$ (44)
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.75%		7.75%		7.75%
Investment, interest rate	[1],[2],[4],[5]	12.79%		12.79%		12.79%
Investment, principal	[1],[4],[5],[7]	$ 15,231
Investment owned, at cost	[1],[4],[5]	14,876
Investments at fair value	[1],[4],[5]	14,882
Investment, Identifier [Axis]: Other cash accounts
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, at cost		67,467
Investments at fair value		$ 67,467
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		7.75%	[2],[4],[5]	7.75%	[2],[4],[5]	7.75%	[2],[4],[5]	7.75%	[9],[10],[11]	7.75%	[9],[10],[11]	7.75%	[9],[10],[11]
Investment, principal		$ 7,480	[4],[7]					$ 7,776	[9],[12]
Investment owned, at cost		7,514	[4]					7,820	[9]
Investments at fair value		$ 6,090	[4]					$ 5,846	[9]
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							7.00%		7.00%		7.00%
Investment, principal	[8],[9],[10],[12],[13]							$ 0
Investment owned, at cost	[8],[9],[10],[13]							(21)
Investments at fair value	[8],[9],[10],[13]							$ (13)
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[9],[10],[11]							9.28%		9.28%		9.28%
Investment, principal	[8],[9],[10],[12]							$ 26,154
Investment owned, at cost	[8],[9],[10]							25,712
Investments at fair value	[8],[9],[10]							$ 25,893
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[13]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[9],[10],[11],[13]							9.25%		9.25%		9.25%
Investment, principal	[8],[9],[10],[12],[13]							$ 2,228
Investment owned, at cost	[8],[9],[10],[13]							2,186
Investments at fair value	[8],[9],[10],[13]							$ 2,203
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.00%		7.00%		7.00%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(55)
Investments at fair value	[1],[3],[4],[5]	$ (57)
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[4],[5]	12.10%		12.10%		12.10%
Investment, principal	[1],[4],[5],[7]	$ 10,923
Investment owned, at cost	[1],[4],[5]	10,513
Investments at fair value	[1],[4],[5]	$ 10,497
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		100,000	[1],[4]	100,000	[1],[4]	100,000	[1],[4]	80,515	[8],[9]	80,515	[8],[9]	80,515	[8],[9]
Investment owned, at cost		$ 109	[1],[4]					$ 79	[8],[9]
Investments at fair value		$ 221	[1],[4]					$ 89	[8],[9]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[3],[4],[5]	6.50%	[1],[3],[4],[5]	6.50%	[1],[3],[4],[5]	6.75%	[8],[9],[10],[13]	6.75%	[8],[9],[10],[13]	6.75%	[8],[9],[10],[13]
Investment, principal		$ 0	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		(37)	[1],[3],[4],[5]					(34)	[8],[9],[10],[13]
Investments at fair value		$ (26)	[1],[3],[4],[5]					$ (49)	[8],[9],[10],[13]
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[4],[5]	6.50%	[1],[4],[5]	6.50%	[1],[4],[5]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]
Investment, interest rate		11.73%	[1],[2],[4],[5]	11.73%	[1],[2],[4],[5]	11.73%	[1],[2],[4],[5]	10.42%	[8],[9],[10],[11]	10.42%	[8],[9],[10],[11]	10.42%	[8],[9],[10],[11]
Investment, principal		$ 38,521	[1],[4],[5],[7]					$ 33,775	[8],[9],[10],[12]
Investment owned, at cost		38,018	[1],[4],[5]					32,931	[8],[9],[10]
Investments at fair value		$ 38,205	[1],[4],[5]					$ 33,116	[8],[9],[10]
Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.13%		8.13%		8.13%
Investment, principal								$ 4,925
Investment owned, at cost								4,781
Investments at fair value								$ 4,687
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%	[4],[5]	5.00%	[4],[5]	5.00%	[4],[5]	5.00%	[9],[10]	5.00%	[9],[10]	5.00%	[9],[10]
Investment, interest rate		10.20%	[2],[4],[5]	10.20%	[2],[4],[5]	10.20%	[2],[4],[5]	8.13%	[9],[10],[11]	8.13%	[9],[10],[11]	8.13%	[9],[10],[11]
Investment, principal		$ 9,701	[4],[5],[7]					$ 9,850	[9],[10],[12]
Investment owned, at cost		9,535	[4],[5]					9,460	[9],[10]
Investments at fair value		$ 9,458	[4],[5]					$ 9,374	[9],[10]
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.20%		10.20%		10.20%
Investment, principal		$ 9,849
Investment owned, at cost		9,495
Investments at fair value		$ 9,603
Investment, Identifier [Axis]: Peloton Interactive, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.50%		6.50%		6.50%
Investment, interest rate								8.35%		8.35%		8.35%
Investment, principal								$ 5,486
Investment owned, at cost								5,251
Investments at fair value								$ 5,371
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[4],[5]	6.00%	[1],[4],[5]	6.00%	[1],[4],[5]	6.00%	[8],[9],[10]	6.00%	[8],[9],[10]	6.00%	[8],[9],[10]
Investment, interest rate		10.96%	[1],[2],[4],[5]	10.96%	[1],[2],[4],[5]	10.96%	[1],[2],[4],[5]	8.88%	[8],[9],[10],[11]	8.88%	[8],[9],[10],[11]	8.88%	[8],[9],[10],[11]
Investment, principal		$ 22,375	[1],[4],[5],[7]					$ 17,976	[8],[9],[10],[12]
Investment owned, at cost		22,177	[1],[4],[5]					17,690	[8],[9],[10]
Investments at fair value		$ 21,829	[1],[4],[5]					$ 17,537	[8],[9],[10]
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.50%		9.50%		9.50%
Investment, principal		$ 2,422
Investment owned, at cost		2,297
Investments at fair value		$ 2,305
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[4],[5]	7.25%	[1],[4],[5]	7.25%	[1],[4],[5]	7.25%	[8],[9],[10]	7.25%	[8],[9],[10]	7.25%	[8],[9],[10]
Investment, interest rate		12.59%	[1],[2],[4],[5]	12.59%	[1],[2],[4],[5]	12.59%	[1],[2],[4],[5]	10.92%	[8],[9],[10],[11]	10.92%	[8],[9],[10],[11]	10.92%	[8],[9],[10],[11]
Investment, principal		$ 36,499	[1],[4],[5],[7]					$ 28,627	[8],[9],[10],[12]
Investment owned, at cost		35,427	[1],[4],[5]					28,198	[8],[9],[10]
Investments at fair value		$ 32,606	[1],[4],[5]					$ 27,482	[8],[9],[10]
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%		7.25%		7.25%
Investment, interest rate		12.59%		12.59%		12.59%
Investment, principal		$ 4,503
Investment owned, at cost		4,435
Investments at fair value		$ 4,023
Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.50%		9.50%		9.50%
Investment, principal		$ 685
Investment owned, at cost		649
Investments at fair value		$ 652
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								7.25%		7.25%		7.25%
Investment, interest rate								10.92%		10.92%		10.92%
Investment, principal								$ 4,503
Investment owned, at cost								4,435
Investments at fair value								$ 4,323
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%		7.25%		7.25%		7.25%		7.25%		7.25%
Investment, interest rate		12.59%		12.59%		12.59%		10.92%		10.92%		10.92%
Investment, principal		$ 2,842						$ 2,842
Investment owned, at cost		2,799						2,799
Investments at fair value		$ 2,539						$ 2,728
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[1],[3],[4],[5]	8.00%	[1],[3],[4],[5]	8.00%	[1],[3],[4],[5]	8.00%	[8],[9],[10],[13]	8.00%	[8],[9],[10],[13]	8.00%	[8],[9],[10],[13]
Investment, interest rate	[1],[2],[3],[4],[5]	13.04%		13.04%		13.04%
Investment, principal		$ 2,395	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		2,312	[1],[3],[4],[5]					(53)	[8],[9],[10],[13]
Investments at fair value		$ 2,218	[1],[3],[4],[5]					$ (111)	[8],[9],[10],[13]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%		8.00%		8.00%
Investment, interest rate		13.04%		13.04%		13.04%
Investment, principal		$ 254
Investment owned, at cost		236
Investments at fair value		$ 235
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[1],[4],[5]	8.00%	[1],[4],[5]	8.00%	[1],[4],[5]	8.00%	[8],[9],[10]	8.00%	[8],[9],[10]	8.00%	[8],[9],[10]
Investment, interest rate		13.04%	[1],[2],[4],[5]	13.04%	[1],[2],[4],[5]	13.04%	[1],[2],[4],[5]	10.68%	[8],[9],[10],[11]	10.68%	[8],[9],[10],[11]	10.68%	[8],[9],[10],[11]
Investment, principal		$ 67,244	[1],[4],[5],[7]					$ 48,689	[8],[9],[10],[12]
Investment owned, at cost		66,290	[1],[4],[5]					47,951	[8],[9],[10]
Investments at fair value		$ 64,756	[1],[4],[5]					$ 47,155	[8],[9],[10]
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%		8.00%		8.00%
Investment, interest rate		13.04%		13.04%		13.04%
Investment, principal		$ 8,116
Investment owned, at cost		7,831
Investments at fair value		$ 7,815
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								8.00%		8.00%		8.00%
Investment, principal								$ 0
Investment owned, at cost								(6)
Investments at fair value								$ (13)
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%		8.00%		8.00%		8.00%		8.00%		8.00%
Investment, interest rate		13.04%		13.04%		13.04%
Investment, principal		$ 180						$ 0
Investment owned, at cost		169						(5)
Investments at fair value		$ 167						$ (10)
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								8.00%		8.00%		8.00%
Investment, interest rate								10.68%		10.68%		10.68%
Investment, principal								$ 6,796
Investment owned, at cost								6,694
Investments at fair value								$ 6,582
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%		8.00%		8.00%		8.00%		8.00%		8.00%
Investment, interest rate		13.04%		13.04%		13.04%		10.68%		10.68%		10.68%
Investment, principal		$ 5,182						$ 4,465
Investment owned, at cost		5,018						4,398
Investments at fair value		$ 4,990						$ 4,325
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.25%		7.25%		7.25%
Investment, interest rate	[1],[2],[4],[5]	12.42%		12.42%		12.42%
Investment, principal	[1],[4],[5],[7]	$ 24,537
Investment owned, at cost	[1],[4],[5]	24,245
Investments at fair value	[1],[4],[5]	$ 24,047
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.25%		7.25%		7.25%
Investment, interest rate	[1],[2],[4],[5]	12.42%		12.42%		12.42%
Investment, principal	[1],[4],[5],[7]	$ 2,823
Investment owned, at cost	[1],[4],[5]	2,797
Investments at fair value	[1],[4],[5]	$ 2,767
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							8.50%		8.50%		8.50%
Investment, interest rate	[8],[9],[10],[11]							10.01%		10.01%		10.01%
Investment, principal	[8],[9],[10],[12]							$ 23,275
Investment owned, at cost	[8],[9],[10]							22,722
Investments at fair value	[8],[9],[10]							$ 22,810
Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[1],[4],[5]	8.00%	[1],[4],[5]	8.00%	[1],[4],[5]	8.00%	[8],[9],[10]	8.00%	[8],[9],[10]	8.00%	[8],[9],[10]
Investment, interest rate		13.22%	[1],[2],[4],[5]	13.22%	[1],[2],[4],[5]	13.22%	[1],[2],[4],[5]	11.12%	[8],[9],[10],[11]	11.12%	[8],[9],[10],[11]	11.12%	[8],[9],[10],[11]
Investment, principal		$ 6,750	[1],[4],[5],[7]					$ 5,250	[8],[9],[10],[12]
Investment owned, at cost		6,652	[1],[4],[5]					5,168	[8],[9],[10]
Investments at fair value		$ 6,235	[1],[4],[5]					$ 5,047	[8],[9],[10]
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.68%	[1],[4],[5],[14]	5.68%	[1],[4],[5],[14]	5.68%	[1],[4],[5],[14]	6.00%	[8],[9],[10],[16]	6.00%	[8],[9],[10],[16]	6.00%	[8],[9],[10],[16]
Investment, interest rate		10.88%	[1],[2],[4],[5],[14]	10.88%	[1],[2],[4],[5],[14]	10.88%	[1],[2],[4],[5],[14]	8.39%	[8],[9],[10],[11],[16]	8.39%	[8],[9],[10],[11],[16]	8.39%	[8],[9],[10],[11],[16]
Investment, principal | £						£ 4,626	[1],[4],[5],[7],[14]					£ 3,501	[8],[9],[10],[12],[16]
Investment owned, at cost		$ 5,900	[1],[4],[5],[14]					$ 4,646	[8],[9],[10],[16]
Investments at fair value		$ 5,296	[1],[4],[5],[14]					$ 3,367	[8],[9],[10],[16]
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		64,887,669	[1],[4]	64,887,669	[1],[4]	64,887,669	[1],[4]	64,887,669	[8],[9]	64,887,669	[8],[9]	64,887,669	[8],[9]
Investment owned, at cost		$ 375	[1],[4]					$ 375	[8],[9]
Investments at fair value		$ 0	[1],[4]					$ 0	[8],[9]
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Health Care Distributors, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11]							5.25%		5.25%		5.25%
Investment, principal	[9],[12]							$ 1,325
Investment owned, at cost	[9]							1,218
Investments at fair value	[9]							$ 1,097
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							4.25%		4.25%		4.25%
Investment, interest rate	[9],[10],[11]							7.33%		7.33%		7.33%
Investment, principal	[9],[10],[12]							$ 3,400
Investment owned, at cost	[9],[10]							3,202
Investments at fair value	[9],[10]							$ 2,880
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11]							9.25%		9.25%		9.25%
Investment, principal	[9],[12]							$ 4,755
Investment owned, at cost	[9]							4,720
Investments at fair value	[9]							$ 3,109
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.50%	[1],[3],[4],[5]	6.50%	[1],[3],[4],[5]	6.50%	[1],[3],[4],[5]	6.50%	[8],[9],[10],[13]	6.50%	[8],[9],[10],[13]	6.50%	[8],[9],[10],[13]
Investment, principal		$ 0	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		(46)	[1],[3],[4],[5]					(43)	[8],[9],[10],[13]
Investments at fair value		$ (52)	[1],[3],[4],[5]					$ (64)	[8],[9],[10],[13]
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[8],[9],[10]	7.50%	[8],[9],[10]	7.50%	[8],[9],[10]
Investment, interest rate	[1],[2],[4],[5]	11.70%		11.70%		11.70%
Investment, principal		$ 32,329	[1],[4],[5],[7]					$ 24,692	[8],[9],[10],[12]
Investment owned, at cost		32,052	[1],[4],[5]					24,265	[8],[9],[10]
Investments at fair value		$ 31,715	[1],[4],[5]					$ 24,101	[8],[9],[10]
Investment, Identifier [Axis]: Renaissance Holding Corp., Diversified Banks, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							7.00%		7.00%		7.00%
Investment, interest rate	[9],[10],[11]							10.12%		10.12%		10.12%
Investment, principal	[9],[10],[12]							$ 3,542
Investment owned, at cost	[9],[10]							3,515
Investments at fair value	[9],[10]							$ 3,402
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%
Investment, interest rate		9.99%		9.99%		9.99%
Investment, principal		$ 5,000
Investment owned, at cost		4,855
Investments at fair value		$ 4,948
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[4],[5]	7.00%		7.00%		7.00%
Investment, interest rate	[2],[4],[5]	12.19%		12.19%		12.19%
Investment, principal	[4],[5],[7]	$ 1,789
Investment owned, at cost	[4],[5]	1,775
Investments at fair value	[4],[5]	$ 1,764
Investment, Identifier [Axis]: RevSpring, Inc., Commercial Printing, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.00%		4.00%		4.00%
Investment, interest rate		9.50%		9.50%		9.50%
Investment, principal		$ 9,550
Investment owned, at cost		9,536
Investments at fair value		$ 9,208
Investment, Identifier [Axis]: RevSpring, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.00%		4.00%		4.00%
Investment, interest rate								7.67%		7.67%		7.67%
Investment, principal								$ 9,625
Investment owned, at cost								9,607
Investments at fair value								$ 9,304
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[4],[5],[14]	8.25%	[1],[4],[5],[14]	8.25%	[1],[4],[5],[14]	8.25%	[8],[9],[10],[16]	8.25%	[8],[9],[10],[16]	8.25%	[8],[9],[10],[16]
Investment, interest rate		13.75%	[1],[2],[4],[5],[14]	13.75%	[1],[2],[4],[5],[14]	13.75%	[1],[2],[4],[5],[14]	11.92%	[8],[9],[10],[11],[16]	11.92%	[8],[9],[10],[11],[16]	11.92%	[8],[9],[10],[11],[16]
Investment, principal		$ 44,602	[1],[4],[5],[7],[14]					$ 37,656	[8],[9],[10],[12],[16]
Investment owned, at cost		43,077	[1],[4],[5],[14]					35,775	[8],[9],[10],[16]
Investments at fair value		$ 41,815	[1],[4],[5],[14]					$ 36,187	[8],[9],[10],[16]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[4],[5],[14]	8.25%	[1],[4],[5],[14]	8.25%	[1],[4],[5],[14]	8.25%	[8],[9],[10],[13],[16]	8.25%	[8],[9],[10],[13],[16]	8.25%	[8],[9],[10],[13],[16]
Investment, interest rate		13.75%	[1],[2],[4],[5],[14]	13.75%	[1],[2],[4],[5],[14]	13.75%	[1],[2],[4],[5],[14]	11.92%	[8],[9],[10],[11],[13],[16]	11.92%	[8],[9],[10],[11],[13],[16]	11.92%	[8],[9],[10],[11],[13],[16]
Investment, principal		$ 13,495	[1],[4],[5],[7],[14]					$ 11,393	[8],[9],[10],[12],[13],[16]
Investment owned, at cost		13,010	[1],[4],[5],[14]					10,583	[8],[9],[10],[13],[16]
Investments at fair value		$ 12,651	[1],[4],[5],[14]					$ 10,760	[8],[9],[10],[13],[16]
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		204,454	[1],[4],[14]	204,454	[1],[4],[14]	204,454	[1],[4],[14]	164,660	[8],[9],[16]	164,660	[8],[9],[16]	164,660	[8],[9],[16]
Investment owned, at cost		$ 1,202	[1],[4],[14]					$ 1,202	[8],[9],[16]
Investments at fair value		$ 0	[1],[4],[14]					$ 74	[8],[9],[16]
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	1,037		1,037		1,037
Investment owned, at cost	[1],[4]	$ 1,037
Investments at fair value	[1],[4]	$ 1,024
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	8.75%		8.75%		8.75%
Investment, interest rate	[1],[2],[4],[5]	14.00%		14.00%		14.00%
Investment, principal	[1],[4],[5],[7]	$ 8,010
Investment owned, at cost	[1],[4],[5]	7,792
Investments at fair value	[1],[4],[5]	$ 7,770
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	8.75%		8.75%		8.75%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(35)
Investments at fair value	[1],[3],[4],[5]	$ (71)
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								8.06%		8.06%		8.06%
Investment, principal								$ 8,201
Investment owned, at cost								8,194
Investments at fair value								$ 7,176
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%		5.25%		5.25%		5.25%
Investment, interest rate		10.52%		10.52%		10.52%		8.06%		8.06%		8.06%
Investment, principal		$ 6,045						$ 6,094
Investment owned, at cost		6,039						6,082
Investments at fair value		$ 4,272						$ 5,332
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.23%		5.23%		5.23%
Investment, interest rate								8.04%		8.04%		8.04%
Investment, principal								$ 138
Investment owned, at cost								138
Investments at fair value								$ 121
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.23%		5.23%		5.23%		5.23%		5.23%		5.23%
Investment, interest rate		10.50%		10.50%		10.50%		8.04%		8.04%		8.04%
Investment, principal		$ 102						$ 102
Investment owned, at cost		102						102
Investments at fair value		$ 74						$ 90
Investment, Identifier [Axis]: SHO Holding I Corporation, Footwear, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%		5.25%		5.25%
Investment, interest rate		10.52%		10.52%		10.52%
Investment, principal		$ 8,135
Investment owned, at cost		8,132
Investments at fair value		$ 5,749
Investment, Identifier [Axis]: SHO Holding I Corporation, Footwear, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.23%		5.23%		5.23%
Investment, interest rate		10.50%		10.50%		10.50%
Investment, principal		$ 138
Investment owned, at cost		138
Investments at fair value		$ 100
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal & Glass Containers, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9]							415		415		415
Investment owned, at cost	[8],[9]							$ 681
Investments at fair value	[8],[9]							$ 681
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	491		491		491
Investment owned, at cost	[1],[4]	$ 727
Investments at fair value	[1],[4]	$ 0
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	4.75%		4.75%		4.75%
Investment, interest rate	[1],[2],[4],[5]	9.97%		9.97%		9.97%
Investment, principal	[1],[4],[5],[7]	$ 4,463
Investment owned, at cost	[1],[4],[5]	3,780
Investments at fair value	[1],[4],[5]	$ 4,139
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.75%		4.75%		4.75%
Investment, interest rate		9.97%		9.97%		9.97%
Investment, principal		$ 2,985
Investment owned, at cost		2,564
Investments at fair value		$ 2,768
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.00%	[1],[4],[5]	8.00%	[1],[4],[5]	8.00%	[1],[4],[5]	8.00%	[8],[9],[10]	8.00%	[8],[9],[10]	8.00%	[8],[9],[10]
Investment, interest rate		13.22%	[1],[2],[4],[5]	13.22%	[1],[2],[4],[5]	13.22%	[1],[2],[4],[5]	10.74%	[8],[9],[10],[11]	10.74%	[8],[9],[10],[11]	10.74%	[8],[9],[10],[11]
Investment, principal		$ 12,034	[1],[4],[5],[7]					$ 9,109	[8],[9],[10],[12]
Investment owned, at cost		11,220	[1],[4],[5]					8,972	[8],[9],[10]
Investments at fair value		$ 9,387	[1],[4],[5]					$ 8,289	[8],[9],[10]
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.50%		4.50%		4.50%
Investment, interest rate								7.63%		7.63%		7.63%
Investment, principal								$ 7,500
Investment owned, at cost								7,184
Investments at fair value								$ 6,966
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.70%		9.70%		9.70%		7.63%		7.63%		7.63%
Investment, principal		$ 5,227						$ 6,000
Investment owned, at cost		5,023						5,734
Investments at fair value		$ 5,174						$ 5,572
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%
Investment, interest rate		9.70%		9.70%		9.70%
Investment, principal		$ 8,801
Investment owned, at cost		8,426
Investments at fair value		$ 8,710
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							4.50%		4.50%		4.50%
Investment, interest rate	[9],[10],[11]							7.63%		7.63%		7.63%
Investment, principal	[9],[10],[12]							$ 1,500
Investment owned, at cost	[9],[10]							1,410
Investments at fair value	[9],[10]							$ 1,393
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[4],[5]	6.75%	[1],[4],[5]	6.75%	[1],[4],[5]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]
Investment, interest rate		12.29%	[1],[2],[4],[5]	12.29%	[1],[2],[4],[5]	12.29%	[1],[2],[4],[5]	10.42%	[8],[9],[10],[11]	10.42%	[8],[9],[10],[11]	10.42%	[8],[9],[10],[11]
Investment, principal		$ 25,592	[1],[4],[5],[7]					$ 20,766	[8],[9],[10],[12]
Investment owned, at cost		23,832	[1],[4],[5]					19,550	[8],[9],[10]
Investments at fair value		$ 19,514	[1],[4],[5]					$ 18,188	[8],[9],[10]
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.50%		4.50%		4.50%
Investment, interest rate								7.63%		7.63%		7.63%
Investment, principal								$ 2,536
Investment owned, at cost								2,511
Investments at fair value								$ 2,435
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.50%		4.50%		4.50%
Investment, interest rate								7.63%		7.63%		7.63%
Investment, principal								$ 1,691
Investment owned, at cost								1,674
Investments at fair value								$ 1,623
Investment, Identifier [Axis]: Sabert Corporation, Metal & Glass Containers, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							4.50%		4.50%		4.50%
Investment, interest rate	[9],[10],[11]							7.63%		7.63%		7.63%
Investment, principal	[9],[10],[12]							$ 1,691
Investment owned, at cost	[9],[10]							1,610
Investments at fair value	[9],[10]							$ 1,623
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	10.00%		10.00%		10.00%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	(103)
Investments at fair value	[1],[3],[4],[5]	$ (93)
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	10.00%		10.00%		10.00%
Investment, interest rate	[1],[2],[4],[5]	15.24%		15.24%		15.24%
Investment, principal	[1],[4],[5],[7]	$ 25,558
Investment owned, at cost	[1],[4],[5]	24,711
Investments at fair value	[1],[4],[5]	$ 24,791
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	991,019		991,019		991,019
Investment owned, at cost	[1],[4]	$ 327
Investments at fair value	[1],[4]	$ 1,883
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[4],[14]	9,307		9,307		9,307
Investment owned, at cost	[4],[14]	$ 78
Investments at fair value	[4],[14]	52
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, principal														0
Investments at fair value														$ 23,023	37,651
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[13],[16],[25],[26],[28],[29],[32]							0.875		0.875		0.875
Investment, principal		0
Investment owned, at cost		54,791	[3],[14],[23],[24],[30],[31],[33]					$ 49,322	[13],[16],[25],[26],[28],[29],[32]
Investments at fair value		$ 27,973	[3],[14],[23],[24],[30],[31],[33]					$ 20,715	[13],[16],[25],[26],[28],[29],[32]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.00%	[1],[3],[5],[14],[23],[24],[30]	7.00%	[1],[3],[5],[14],[23],[24],[30]	7.00%	[1],[3],[5],[14],[23],[24],[30]	7.00%	[8],[10],[13],[16],[25],[26],[28]	7.00%	[8],[10],[13],[16],[25],[26],[28]	7.00%	[8],[10],[13],[16],[25],[26],[28]
Investment, interest rate		11.86%	[1],[2],[3],[5],[14],[23],[24],[30]	11.86%	[1],[2],[3],[5],[14],[23],[24],[30]	11.86%	[1],[2],[3],[5],[14],[23],[24],[30]	8.80%	[8],[10],[11],[13],[16],[25],[26],[28]	8.80%	[8],[10],[11],[13],[16],[25],[26],[28]	8.80%	[8],[10],[11],[13],[16],[25],[26],[28]
Investment, principal		$ 112,656	[1],[3],[5],[7],[14],[23],[24],[30]					$ 96,250	[8],[10],[12],[13],[16],[25],[26],[28]
Investment owned, at cost		112,656	[1],[3],[5],[14],[23],[24],[30]					96,250	[8],[10],[13],[16],[25],[26],[28]
Investments at fair value		$ 112,656	[1],[3],[5],[14],[23],[24],[30]					$ 96,250	[8],[10],[13],[16],[25],[26],[28]
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate														7.00%
Investment, interest rate														8.00%
Investment, principal														$ 96,250
Investments at fair value														$ 96,250	$ 96,250
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[14]	7.88%		7.88%		7.88%
Investment, interest rate	[1],[4],[5],[14]	12.95%		12.95%		12.95%
Investment, principal	[1],[4],[5],[7],[14]	$ 7,191
Investment owned, at cost	[1],[4],[5],[14]	6,923
Investments at fair value	[1],[4],[5],[14]	$ 6,931
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[14]	7.88%		7.88%		7.88%
Investment, interest rate	[1],[4],[5],[14]	12.88%		12.88%		12.88%
Investment, principal	[1],[4],[5],[7],[14]	$ 2,697
Investment owned, at cost	[1],[4],[5],[14]	2,596
Investments at fair value	[1],[4],[5],[14]	$ 2,599
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5],[14]	7.88%		7.88%		7.88%
Investment, principal	[1],[3],[4],[5],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[5],[14]	0
Investments at fair value	[1],[3],[4],[5],[14]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5],[14]	7.88%		7.88%		7.88%
Investment, principal	[1],[3],[4],[5],[7],[14]	$ 0
Investment owned, at cost	[1],[3],[4],[5],[14]	0
Investments at fair value	[1],[3],[4],[5],[14]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4],[14]	58,210		58,210		58,210
Investment owned, at cost	[1],[4],[14]	$ 182
Investments at fair value	[1],[4],[14]	$ 202
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		345,452	[1],[4]	345,452	[1],[4]	345,452	[1],[4]	345,452	[8],[9]	345,452	[8],[9]	345,452	[8],[9]
Investment owned, at cost		$ 367	[1],[4]					$ 367	[8],[9]
Investments at fair value		$ 0	[1],[4]					$ 0	[8],[9]
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal & Glass Containers, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[8],[9],[10],[11]							5.50%		5.50%		5.50%
Investment, principal	[8],[9],[12]							$ 46,121
Investment owned, at cost	[8],[9]							45,413
Investments at fair value	[8],[9]							$ 45,295
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[4],[17]	14.00%		14.00%		14.00%
Investment, principal	[1],[4],[7],[17]	$ 54,730
Investment owned, at cost	[1],[4],[17]	41,705
Investments at fair value	[1],[4],[17]	$ 25,997
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[4],[17]	14.00%		14.00%		14.00%
Investment, principal	[1],[4],[7],[17]	$ 14,993
Investment owned, at cost	[1],[4],[17]	11,582
Investments at fair value	[1],[4],[17]	$ 13,923
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[3],[4],[5],[17]	14.00%		14.00%		14.00%
Investment, principal	[1],[3],[4],[7],[17]	$ 4,813
Investment owned, at cost	[1],[3],[4],[17]	3,935
Investments at fair value	[1],[3],[4],[17]	$ 4,034
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[1],[4],[5]	7.50%	[8],[9],[10]	7.50%	[8],[9],[10]	7.50%	[8],[9],[10]
Investment, interest rate		12.69%	[1],[2],[4],[5]	12.69%	[1],[2],[4],[5]	12.69%	[1],[2],[4],[5]	10.48%	[8],[9],[10],[11]	10.48%	[8],[9],[10],[11]	10.48%	[8],[9],[10],[11]
Investment, principal		$ 1,095	[1],[4],[5],[7]					$ 3,195	[8],[9],[10],[12]
Investment owned, at cost		1,084	[1],[4],[5]					3,163	[8],[9],[10]
Investments at fair value		$ 1,024	[1],[4],[5]					$ 2,997	[8],[9],[10]
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[4],[5]	5.50%		5.50%		5.50%
Investment, interest rate	[2],[4],[5]	10.69%		10.69%		10.69%
Investment, principal	[4],[5],[7]	$ 1,054
Investment owned, at cost	[4],[5]	1,053
Investments at fair value	[4],[5]	$ 980
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%
Investment, interest rate		10.69%		10.69%		10.69%
Investment, principal		$ 2,328
Investment owned, at cost		2,305
Investments at fair value		$ 2,166
Investment, Identifier [Axis]: Sorenson Communications, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.50%		5.50%		5.50%
Investment, interest rate								9.17%		9.17%		9.17%
Investment, principal								$ 2,553
Investment owned, at cost								2,528
Investments at fair value								$ 2,454
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		66,000	[4],[14]	66,000	[4],[14]	66,000	[4],[14]	50,000	[9],[16]	50,000	[9],[16]	50,000	[9],[16]
Investment owned, at cost		$ 139	[4],[14]					$ 197	[9],[16]
Investments at fair value		$ 24	[4],[14]					$ 79	[9],[16]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.25%	[1],[3],[4],[5]	5.25%	[1],[3],[4],[5]	5.25%	[1],[3],[4],[5]	5.25%	[8],[9],[10],[13]	5.25%	[8],[9],[10],[13]	5.25%	[8],[9],[10],[13]
Investment, interest rate		10.35%	[1],[2],[3],[4],[5]	10.35%	[1],[2],[3],[4],[5]	10.35%	[1],[2],[3],[4],[5]	8.03%	[8],[9],[10],[11],[13]	8.03%	[8],[9],[10],[11],[13]	8.03%	[8],[9],[10],[11],[13]
Investment, principal		$ 907	[1],[3],[4],[5],[7]					$ 866	[8],[9],[10],[12],[13]
Investment owned, at cost		862	[1],[3],[4],[5]					813	[8],[9],[10],[13]
Investments at fair value		$ 837	[1],[3],[4],[5]					$ 796	[8],[9],[10],[13]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%	[1],[4],[5]	5.50%	[1],[4],[5]	5.50%	[1],[4],[5]	5.25%	[8],[9],[10]	5.25%	[8],[9],[10]	5.25%	[8],[9],[10]
Investment, interest rate		10.70%	[1],[2],[4],[5]	10.70%	[1],[2],[4],[5]	10.70%	[1],[2],[4],[5]	8.30%	[8],[9],[10],[11]	8.30%	[8],[9],[10],[11]	8.30%	[8],[9],[10],[11]
Investment, principal		$ 4,500	[1],[4],[5],[7]					$ 4,534	[8],[9],[10],[12]
Investment owned, at cost		4,431	[1],[4],[5]					4,455	[8],[9],[10]
Investments at fair value		$ 4,393	[1],[4],[5]					$ 4,427	[8],[9],[10]
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%
Investment, interest rate		10.70%		10.70%		10.70%
Investment, principal		$ 8,865
Investment owned, at cost		8,729
Investments at fair value		$ 8,655
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.25%		5.25%		5.25%
Investment, interest rate								8.30%		8.30%		8.30%
Investment, principal								$ 8,933
Investment owned, at cost								8,776
Investments at fair value								$ 8,721
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.50%		5.50%		5.50%		5.25%		5.25%		5.25%
Investment, interest rate		10.70%		10.70%		10.70%		8.30%		8.30%		8.30%
Investment, principal		$ 4,925						$ 4,962
Investment owned, at cost		4,849						4,876
Investments at fair value		$ 4,808						$ 4,845
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[14]	8.50%		8.50%		8.50%
Investment, interest rate	[1],[2],[4],[5],[14]	11.97%		11.97%		11.97%
Investment, principal | €	[1],[4],[5],[7],[14]			€ 23,731
Investment owned, at cost	[1],[4],[5],[14]	$ 26,829
Investments at fair value	[1],[4],[5],[14]	$ 25,632
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Other Diversified Financial Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10],[16]							8.50%		8.50%		8.50%
Investment, interest rate	[8],[9],[10],[11],[16]							10.00%		10.00%		10.00%
Investment, principal | £	[8],[9],[10],[12],[16]											£ 16,911
Investment owned, at cost	[8],[9],[10],[16]							$ 19,414
Investments at fair value	[8],[9],[10],[16]							$ 16,360
Investment, Identifier [Axis]: Sunland Asphalt & Construction, LLC, Construction & Engineering, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[9],[10],[11]							8.88%		8.88%		8.88%
Investment, principal	[8],[9],[10],[12]							$ 42,618
Investment owned, at cost	[8],[9],[10]							41,654
Investments at fair value	[8],[9],[10]							$ 41,723
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.75%		7.75%		7.75%
Investment, interest rate	[1],[2],[4],[5]	12.85%		12.85%		12.85%
Investment, principal	[1],[4],[5],[7]	$ 49,645
Investment owned, at cost	[1],[4],[5]	48,611
Investments at fair value	[1],[4],[5]	$ 49,128
Investment, Identifier [Axis]: Supermoose Borrower, LLC, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[9],[10]							3.75%		3.75%		3.75%
Investment, interest rate	[9],[10],[11]							7.42%		7.42%		7.42%
Investment, principal	[9],[10],[12]							$ 3,466
Investment owned, at cost	[9],[10]							3,141
Investments at fair value	[9],[10]							$ 3,056
Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								7.42%		7.42%		7.42%
Investment, principal								$ 7,743
Investment owned, at cost								7,479
Investments at fair value								$ 6,827
Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								7.42%		7.42%		7.42%
Investment, principal								$ 2,820
Investment owned, at cost								2,712
Investments at fair value								$ 2,487
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[34]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[4],[5],[34]	12.18%		12.18%		12.18%
Investment, principal	[1],[4],[5],[7],[34]	$ 1,552
Investment owned, at cost	[1],[4],[5],[34]	1,539
Investments at fair value	[1],[4],[5],[34]	$ 1,471
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5],[34]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[4],[5],[34]	12.18%		12.18%		12.18%
Investment, principal	[1],[4],[5],[7],[34]	$ 32,185
Investment owned, at cost	[1],[4],[5],[34]	31,923
Investments at fair value	[1],[4],[5],[34]	$ 30,495
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5],[34]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[3],[4],[5],[34]	12.18%		12.18%		12.18%
Investment, principal	[1],[3],[4],[5],[7],[34]	$ 2,756
Investment owned, at cost	[1],[3],[4],[5],[34]	2,728
Investments at fair value	[1],[3],[4],[5],[34]	$ 2,593
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5],[34]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[3],[4],[5],[34]	12.18%		12.18%		12.18%
Investment, principal	[1],[3],[4],[5],[7],[34]	$ 1,099
Investment owned, at cost	[1],[3],[4],[5],[34]	1,059
Investments at fair value	[1],[3],[4],[5],[34]	$ 926
Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								6.51%		6.51%		6.51%
Investment, principal								$ 3,377
Investment owned, at cost								3,365
Investments at fair value								$ 3,213
Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								6.51%		6.51%		6.51%
Investment, principal								$ 3,377
Investment owned, at cost								3,365
Investments at fair value								$ 3,213
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Auto Parts & Equipment, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[4],[5]	6.75%	[1],[4],[5]	6.75%	[1],[4],[5]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]
Investment, interest rate		11.94%	[1],[2],[4],[5]	11.94%	[1],[2],[4],[5]	11.94%	[1],[2],[4],[5]	9.81%	[8],[9],[10],[11]	9.81%	[8],[9],[10],[11]	9.81%	[8],[9],[10],[11]
Investment, principal		$ 12,500	[1],[4],[5],[7]					$ 12,500	[8],[9],[10],[12]
Investment owned, at cost		12,480	[1],[4],[5]					12,474	[8],[9],[10]
Investments at fair value		$ 11,681	[1],[4],[5]					$ 11,469	[8],[9],[10]
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate		11.50%	[2],[4],[5],[6],[14]	11.50%	[2],[4],[5],[6],[14]	11.50%	[2],[4],[5],[6],[14]	11.50%	[8],[9],[10],[11],[16]	11.50%	[8],[9],[10],[11],[16]	11.50%	[8],[9],[10],[11],[16]
Investment, principal		$ 4,984	[4],[6],[7],[14]					$ 4,984	[8],[9],[12],[16]
Investment owned, at cost		4,887	[4],[6],[14]					4,866	[8],[9],[16]
Investments at fair value		$ 4,810	[4],[6],[14]					$ 4,872	[8],[9],[16]
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[1],[2],[4],[5],[14]	13.00%		13.00%		13.00%
Investment, principal	[1],[4],[7],[14]	$ 50,419
Investment owned, at cost	[1],[4],[14]	49,787
Investments at fair value	[1],[4],[14]	$ 49,809
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%	[4],[5]	4.50%	[4],[5]	4.50%	[4],[5]	4.50%	[9],[10]	4.50%	[9],[10]	4.50%	[9],[10]
Investment, interest rate		9.84%	[2],[4],[5]	9.84%	[2],[4],[5]	9.84%	[2],[4],[5]	8.15%	[9],[10],[11]	8.15%	[9],[10],[11]	8.15%	[9],[10],[11]
Investment, principal		$ 17,213	[4],[5],[7]					$ 12,032	[9],[10],[12]
Investment owned, at cost		15,952	[4],[5]					10,949	[9],[10]
Investments at fair value		$ 16,141	[4],[5]					$ 10,827	[9],[10]
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%
Investment, interest rate		9.84%		9.84%		9.84%
Investment, principal		$ 8,235
Investment owned, at cost		7,548
Investments at fair value		$ 7,722
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.50%		4.50%		4.50%
Investment, interest rate								8.15%		8.15%		8.15%
Investment, principal								$ 6,256
Investment owned, at cost								5,693
Investments at fair value								$ 5,629
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.84%		9.84%		9.84%		8.15%		8.15%		8.15%
Investment, principal		$ 2,647						$ 2,654
Investment owned, at cost		2,435						2,415
Investments at fair value		$ 2,483						$ 2,388
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[4],[5]	7.50%	[4],[5]	7.50%	[4],[5]	7.50%	[9],[10]	7.50%	[9],[10]	7.50%	[9],[10]
Investment, interest rate		12.69%	[2],[4],[5]	12.69%	[2],[4],[5]	12.69%	[2],[4],[5]	10.62%	[9],[10],[11]	10.62%	[9],[10],[11]	10.62%	[9],[10],[11]
Investment, principal		$ 12,843	[4],[5],[7]					$ 9,448	[9],[10],[12]
Investment owned, at cost		12,589	[4],[5]					9,338	[9],[10]
Investments at fair value		$ 12,168	[4],[5]					$ 8,692	[9],[10]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[3],[4],[5],[14]	6.00%	[1],[3],[4],[5],[14]	6.00%	[1],[3],[4],[5],[14]	6.00%	[8],[9],[10],[13],[16]	6.00%	[8],[9],[10],[13],[16]	6.00%	[8],[9],[10],[13],[16]
Investment, principal		$ 0	[1],[3],[4],[5],[7],[14]					$ 0	[8],[9],[10],[12],[13],[16]
Investment owned, at cost		(31)	[1],[3],[4],[5],[14]					(29)	[8],[9],[10],[13],[16]
Investments at fair value		$ (24)	[1],[3],[4],[5],[14]					$ (28)	[8],[9],[10],[13],[16]
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[4],[5],[14]	6.00%	[1],[4],[5],[14]	6.00%	[1],[4],[5],[14]	6.00%	[8],[9],[10],[16]	6.00%	[8],[9],[10],[16]	6.00%	[8],[9],[10],[16]
Investment, interest rate		11.15%	[1],[2],[4],[5],[14]	11.15%	[1],[2],[4],[5],[14]	11.15%	[1],[2],[4],[5],[14]	8.68%	[8],[9],[10],[11],[16]	8.68%	[8],[9],[10],[11],[16]	8.68%	[8],[9],[10],[11],[16]
Investment, principal		$ 28,826	[1],[4],[5],[7],[14]					$ 23,215	[8],[9],[10],[12],[16]
Investment owned, at cost		28,583	[1],[4],[5],[14]					22,815	[8],[9],[10],[16]
Investments at fair value		$ 28,537	[1],[4],[5],[14]					$ 22,843	[8],[9],[10],[16]
Investment, Identifier [Axis]: Tecta America Corp., Construction & Engineering, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[1],[4],[5]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]	8.50%	[8],[9],[10]
Investment, interest rate		13.72%	[1],[2],[4],[5]	13.72%	[1],[2],[4],[5]	13.72%	[1],[2],[4],[5]	11.62%	[8],[9],[10],[11]	11.62%	[8],[9],[10],[11]	11.62%	[8],[9],[10],[11]
Investment, principal		$ 4,755	[1],[4],[5],[7]					$ 5,203	[8],[9],[10],[12]
Investment owned, at cost		4,677	[1],[4],[5]					5,125	[8],[9],[10]
Investments at fair value		$ 4,529	[1],[4],[5]					$ 5,034	[8],[9],[10]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9.75%	[1],[3],[4],[5]	9.75%	[1],[3],[4],[5]	9.75%	[1],[3],[4],[5]	9.25%	[8],[9],[10],[13]	9.25%	[8],[9],[10],[13]	9.25%	[8],[9],[10],[13]
Investment, interest rate		14.93%	[1],[2],[3],[4],[5]	14.93%	[1],[2],[3],[4],[5]	14.93%	[1],[2],[3],[4],[5]	12.20%	[8],[9],[10],[11],[13]	12.20%	[8],[9],[10],[11],[13]	12.20%	[8],[9],[10],[11],[13]
Investment, principal		$ 1,590	[1],[3],[4],[5],[7]					$ 1,231	[8],[9],[10],[12],[13]
Investment owned, at cost		1,572	[1],[3],[4],[5]					1,210	[8],[9],[10],[13]
Investments at fair value		$ 1,535	[1],[3],[4],[5]					$ 1,187	[8],[9],[10],[13]
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		9.75%	[1],[4],[5]	9.75%	[1],[4],[5]	9.75%	[1],[4],[5]	9.25%	[8],[9],[10]	9.25%	[8],[9],[10]	9.25%	[8],[9],[10]
Investment, interest rate		14.99%	[1],[2],[4],[5]	14.99%	[1],[2],[4],[5]	14.99%	[1],[2],[4],[5]	12.11%	[8],[9],[10],[11]	12.11%	[8],[9],[10],[11]	12.11%	[8],[9],[10],[11]
Investment, principal		$ 23,483	[1],[4],[5],[7]					$ 18,323	[8],[9],[10],[12]
Investment owned, at cost		23,239	[1],[4],[5]					17,956	[8],[9],[10]
Investments at fair value		$ 22,919	[1],[4],[5]					$ 17,865	[8],[9],[10]
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.00%		6.00%		6.00%
Investment, interest rate	[1],[2],[4],[5]	11.09%		11.09%		11.09%
Investment, principal	[1],[4],[5],[7]	$ 19,947
Investment owned, at cost	[1],[4],[5]	18,963
Investments at fair value	[1],[4],[5]	$ 19,000
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9]							668,879		668,879		668,879
Investment, principal	[8],[9],[12]
Investment owned, at cost	[8],[9]							2,028
Investments at fair value	[8],[9]							$ 4,077
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							9.50%		9.50%		9.50%
Investment, interest rate	[8],[9],[10],[11]							13.17%		13.17%		13.17%
Investment, principal	[8],[9],[10],[12]							$ 29,663
Investment owned, at cost	[8],[9],[10]							29,352
Investments at fair value	[8],[9],[10]							$ 29,031
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.30%	[1],[4],[5],[17]	7.30%	[1],[4],[5],[17]	7.30%	[1],[4],[5],[17]	7.30%	[8],[9],[10]	7.30%	[8],[9],[10]	7.30%	[8],[9],[10]
Investment, interest rate	[8],[9],[10],[11]							10.44%		10.44%		10.44%
Investment, principal		$ 19,163	[1],[4],[5],[7],[17]					$ 15,674	[8],[9],[10],[12]
Investment owned, at cost		19,163	[1],[4],[5],[17]					15,605	[8],[9],[10]
Investments at fair value		$ 18,286	[1],[4],[5],[17]					$ 15,682	[8],[9],[10]
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		12.50%	[1],[4],[5],[17]	12.50%	[1],[4],[5],[17]	12.50%	[1],[4],[5],[17]	12.50%	[8],[9],[10]	12.50%	[8],[9],[10]	12.50%	[8],[9],[10]
Investment, interest rate	[8],[9],[10],[11]							16.17%		16.17%		16.17%
Investment, principal		$ 4,641	[1],[4],[5],[7],[17]					$ 3,789	[8],[9],[10],[12]
Investment owned, at cost		4,641	[1],[4],[5],[17]					3,774	[8],[9],[10]
Investments at fair value		$ 4,164	[1],[4],[5],[17]					$ 3,800	[8],[9],[10]
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.00%		7.00%		7.00%
Investment, interest rate	[1],[2],[4],[5]	12.50%		12.50%		12.50%
Investment, principal	[1],[4],[5],[7]	$ 46,832
Investment owned, at cost	[1],[4],[5]	45,609
Investments at fair value	[1],[4],[5]	$ 41,919
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	10,616		10,616		10,616
Investment owned, at cost	[1],[4]	$ 120
Investments at fair value	[1],[4]	$ 55
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	358,299		358,299		358,299
Investment owned, at cost	[1],[4]	$ 2,912
Investments at fair value	[1],[4]	$ 1,526
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	60,862		60,862		60,862
Investment owned, at cost	[1],[4]	$ 1,207
Investments at fair value	[1],[4]	$ 795
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	32,447		32,447		32,447
Investment owned, at cost	[1],[4]	$ 33,353
Investments at fair value	[1],[4]	$ 36,587
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.00%		7.00%		7.00%
Investment, interest rate	[8],[9],[10],[11]							11.17%		11.17%		11.17%
Investment, principal	[8],[9],[10],[12]							$ 37,494
Investment owned, at cost	[8],[9],[10]							36,569
Investments at fair value	[8],[9],[10]							$ 35,807
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9]							8,434		8,434		8,434
Investment owned, at cost	[8],[9]							$ 101
Investments at fair value	[8],[9]							$ 69
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9]							284,650		284,650		284,650
Investment owned, at cost	[8],[9]							$ 2,409
Investments at fair value	[8],[9]							$ 2,320
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9]							48,352		48,352		48,352
Investment owned, at cost	[8],[9]							$ 979
Investments at fair value	[8],[9]							$ 979
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 4
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9],[13]							23,201		23,201		23,201
Investment owned, at cost	[8],[9],[13]							$ 22,986
Investments at fair value	[8],[9],[13]							$ 26,487
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.00%		6.00%		6.00%
Investment, interest rate								9.12%		9.12%		9.12%
Investment, principal								$ 7,285
Investment owned, at cost								7,155
Investments at fair value								$ 7,140
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%		6.00%		6.00%		6.00%
Investment, interest rate		11.20%		11.20%		11.20%		9.12%		9.12%		9.12%
Investment, principal		$ 3,001						$ 3,024
Investment owned, at cost		2,954						2,970
Investments at fair value		$ 2,926						$ 2,963
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%	[1],[4],[5]	6.00%	[1],[4],[5]	6.00%	[1],[4],[5]	6.00%	[8],[9],[10]	6.00%	[8],[9],[10]	6.00%	[8],[9],[10]
Investment, interest rate		11.20%	[1],[2],[4],[5]	11.20%	[1],[2],[4],[5]	11.20%	[1],[2],[4],[5]	9.12%	[8],[9],[10],[11]	9.12%	[8],[9],[10],[11]	9.12%	[8],[9],[10],[11]
Investment, principal		$ 11,701	[1],[4],[5],[7]					$ 6,016	[8],[9],[10],[12]
Investment owned, at cost		11,675	[1],[4],[5]					5,908	[8],[9],[10]
Investments at fair value		$ 11,408	[1],[4],[5]					$ 5,895	[8],[9],[10]
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.00%		6.00%		6.00%
Investment, interest rate		11.20%		11.20%		11.20%
Investment, principal		$ 7,230
Investment owned, at cost		7,116
Investments at fair value		$ 7,050
Investment, Identifier [Axis]: Tribe Buyer LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		4.50%		4.50%		4.50%		4.50%		4.50%		4.50%
Investment, interest rate		9.69%		9.69%		9.69%		7.62%		7.62%		7.62%
Investment, principal		$ 1,570						$ 1,583
Investment owned, at cost		1,570						1,582
Investments at fair value		$ 931						$ 1,266
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[4],[5],[14]	7.45%		7.45%		7.45%
Investment, interest rate	[2],[4],[5],[14]	12.72%		12.72%		12.72%
Investment, principal	[4],[5],[7],[14]	$ 1,000
Investment owned, at cost	[4],[5],[14]	814
Investments at fair value	[4],[5],[14]	$ 929
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[2],[4],[5],[14]	6.50%		6.50%		6.50%
Investment, principal	[4],[7],[14]	$ 4,500
Investment owned, at cost	[4],[14]	4,101
Investments at fair value	[4],[14]	$ 3,189
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[2],[4],[5],[14]	4.75%		4.75%		4.75%
Investment, principal	[4],[7],[14]	$ 300
Investment owned, at cost	[4],[14]	263
Investments at fair value	[4],[14]	$ 249
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11],[16]							6.50%		6.50%		6.50%
Investment, principal	[9],[12],[16]							$ 4,500
Investment owned, at cost	[9],[16]							4,060
Investments at fair value	[9],[16]							$ 3,026
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11],[16]							4.75%		4.75%		4.75%
Investment, principal	[9],[12],[16]							$ 300
Investment owned, at cost	[9],[16]							258
Investments at fair value	[9],[16]							$ 238
Investment, Identifier [Axis]: Veritas US Inc., Application Software, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		5.00%		5.00%		5.00%
Investment, interest rate		10.22%		10.22%		10.22%
Investment, principal		$ 6,322
Investment owned, at cost		6,266
Investments at fair value		$ 5,185
Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								5.00%		5.00%		5.00%
Investment, interest rate								8.67%		8.67%		8.67%
Investment, principal								$ 6,365
Investment owned, at cost								6,290
Investments at fair value								$ 5,087
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	7.25%		7.25%		7.25%
Investment, interest rate	[1],[2],[4],[5]	12.47%		12.47%		12.47%
Investment, principal	[1],[4],[5],[7]	$ 1,540
Investment owned, at cost	[1],[4],[5]	1,239
Investments at fair value	[1],[4],[5]	$ 1,279
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	15.00%		15.00%		15.00%
Investment, interest rate	[1],[2],[4],[5]	21.22%		21.22%		21.22%
Investment, principal	[1],[4],[5]	$ 1,323
Investment owned, at cost	[1],[4],[5]	1,311
Investments at fair value	[1],[4],[5]	$ 1,247
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%	[4],[5]	3.75%	[4],[5]	3.75%	[4],[5]	3.75%	[9],[10]	3.75%	[9],[10]	3.75%	[9],[10]
Investment, interest rate		9.03%	[2],[4],[5]	9.03%	[2],[4],[5]	9.03%	[2],[4],[5]	6.56%	[9],[10],[11]	6.56%	[9],[10],[11]	6.56%	[9],[10],[11]
Investment, principal		$ 11,822	[4],[5]					$ 7,564	[9],[10],[12]
Investment owned, at cost		11,228	[4],[5]					6,989	[9],[10]
Investments at fair value		$ 10,743	[4],[5]					$ 6,795	[9],[10]
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%
Investment, interest rate		9.03%		9.03%		9.03%
Investment, principal		$ 1,970
Investment owned, at cost		1,917
Investments at fair value		$ 1,791
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							7.75%		7.75%		7.75%
Investment, interest rate	[8],[9],[10],[11]							10.56%		10.56%		10.56%
Investment, principal	[8],[9],[10],[12]							$ 6,000
Investment owned, at cost	[8],[9],[10]							5,855
Investments at fair value	[8],[9],[10]							$ 5,070
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.75%		3.75%		3.75%
Investment, interest rate								6.56%		6.56%		6.56%
Investment, principal								$ 1,985
Investment owned, at cost								1,910
Investments at fair value								$ 1,783
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.75%		3.75%		3.75%		3.75%		3.75%		3.75%
Investment, interest rate		9.03%		9.03%		9.03%		6.56%		6.56%		6.56%
Investment, principal		$ 985						$ 993
Investment owned, at cost		959						955
Investments at fair value		$ 895						$ 892
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								7.75%		7.75%		7.75%
Investment, interest rate								10.56%		10.56%		10.56%
Investment, principal								$ 6,000
Investment owned, at cost								5,972
Investments at fair value								$ 5,070
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								7.75%		7.75%		7.75%
Investment, interest rate								10.56%		10.56%		10.56%
Investment, principal								$ 3,000
Investment owned, at cost								2,986
Investments at fair value								$ 2,534
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[8],[9],[10]							6.00%		6.00%		6.00%
Investment, interest rate	[8],[9],[10],[11]							10.19%		10.19%		10.19%
Investment, principal	[8],[9],[10],[12]							$ 40,536
Investment owned, at cost	[8],[9],[10]							39,947
Investments at fair value	[8],[9],[10]							$ 40,131
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	11.38%		11.38%		11.38%
Investment, principal	[1],[4],[5]	$ 35,853
Investment owned, at cost	[1],[4],[5]	35,764
Investments at fair value	[1],[4],[5]	$ 35,495
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	6.50%		6.50%		6.50%
Investment, interest rate	[1],[2],[4],[5]	12.00%		12.00%		12.00%
Investment, principal	[1],[4],[5]	$ 19,306
Investment owned, at cost	[1],[4],[5]	19,258
Investments at fair value	[1],[4],[5]	$ 19,113
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.00%	[1],[4],[5]	7.00%	[1],[4],[5]	7.00%	[1],[4],[5]	7.00%	[8],[9],[10]	7.00%	[8],[9],[10]	7.00%	[8],[9],[10]
Investment, interest rate		12.50%	[1],[2],[4],[5]	12.50%	[1],[2],[4],[5]	12.50%	[1],[2],[4],[5]	10.67%	[8],[9],[10],[11]	10.67%	[8],[9],[10],[11]	10.67%	[8],[9],[10],[11]
Investment, principal		$ 5,000	[1],[4],[5]					$ 5,000	[8],[9],[10],[12]
Investment owned, at cost		4,925	[1],[4],[5]					4,925	[8],[9],[10]
Investments at fair value		$ 4,025	[1],[4],[5]					$ 4,538	[8],[9],[10]
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		15.00%	[1],[4],[5]	15.00%	[1],[4],[5]	15.00%	[1],[4],[5]	15.00%	[8],[9],[10]	15.00%	[8],[9],[10]	15.00%	[8],[9],[10]
Investment, interest rate		21.22%	[1],[2],[4],[5]	21.22%	[1],[2],[4],[5]	21.22%	[1],[2],[4],[5]	19.64%	[8],[9],[10],[11]	19.64%	[8],[9],[10],[11]	19.64%	[8],[9],[10],[11]
Investment, principal		$ 1,565	[1],[4],[5]					$ 2,316	[8],[9],[10],[12]
Investment owned, at cost		1,551	[1],[4],[5]					2,293	[8],[9],[10]
Investments at fair value		$ 1,475	[1],[4],[5]					$ 2,264	[8],[9],[10]
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		4,871	[1],[4]	4,871	[1],[4]	4,871	[1],[4]	3,621	[8],[9]	3,621	[8],[9]	3,621	[8],[9]
Investment owned, at cost		$ 46	[1],[4]					$ 0	[8],[9]
Investments at fair value		$ 136	[1],[4]					$ 192	[8],[9]
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								6.25%		6.25%		6.25%
Investment, interest rate								9.37%		9.37%		9.37%
Investment, principal								$ 7,818
Investment owned, at cost								7,596
Investments at fair value								$ 7,115
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%		6.25%		6.25%		6.25%		6.25%		6.25%
Investment, interest rate		11.45%		11.45%		11.45%		9.37%		9.37%		9.37%
Investment, principal		$ 4,848						$ 4,886
Investment owned, at cost		4,731						4,747
Investments at fair value		$ 4,539						$ 4,447
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		127,452	[1],[4]	127,452	[1],[4]	127,452	[1],[4]	18,032	[8],[9]	18,032	[8],[9]	18,032	[8],[9]
Investment owned, at cost		$ 2,057	[1],[4]					$ 216	[8],[9]
Investments at fair value		$ 1,565	[1],[4]					$ 296	[8],[9]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%	[4],[5]	6.25%	[4],[5]	6.25%	[4],[5]	6.25%	[9],[10]	6.25%	[9],[10]	6.25%	[9],[10]
Investment, interest rate		11.45%	[2],[4],[5]	11.45%	[2],[4],[5]	11.45%	[2],[4],[5]	9.37%	[9],[10],[11]	9.37%	[9],[10],[11]	9.37%	[9],[10],[11]
Investment, principal		$ 24,419	[4],[5]					$ 25,499	[9],[10],[12]
Investment owned, at cost		23,589	[4],[5]					24,632	[9],[10]
Investments at fair value		$ 22,862	[4],[5]					$ 23,204	[9],[10]
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.25%		6.25%		6.25%
Investment, interest rate		11.45%		11.45%		11.45%
Investment, principal		$ 7,757
Investment owned, at cost		7,570
Investments at fair value		$ 7,263
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[8],[9]							109,420		109,420		109,420
Investment owned, at cost	[8],[9]							$ 1,842
Investments at fair value	[8],[9]							$ 1,799
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Alternative Carriers, Fixed Rate Bond
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, interest rate	[9],[10],[11]							4.00%		4.00%		4.00%
Investment, principal	[9],[12]							$ 250
Investment owned, at cost	[9]							212
Investments at fair value	[9]							$ 201
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								3.00%		3.00%		3.00%
Investment, interest rate								6.12%		6.12%		6.12%
Investment, principal								$ 2,155
Investment owned, at cost								2,000
Investments at fair value								$ 1,812
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		8.25%	[1],[4],[5]	8.25%	[1],[4],[5]	8.25%	[1],[4],[5]	8.25%	[8],[9],[10]	8.25%	[8],[9],[10]	8.25%	[8],[9],[10]
Investment, interest rate		13.79%	[1],[2],[4],[5]	13.79%	[1],[2],[4],[5]	13.79%	[1],[2],[4],[5]	11.92%	[8],[9],[10],[11]	11.92%	[8],[9],[10],[11]	11.92%	[8],[9],[10],[11]
Investment, principal		$ 19,578	[1],[4],[5]					$ 19,578	[8],[9],[10],[12]
Investment owned, at cost		19,551	[1],[4],[5]					19,542	[8],[9],[10]
Investments at fair value		$ 13,693	[1],[4],[5]					$ 16,152	[8],[9],[10]
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.50%	[1],[4],[5],[14]	7.50%	[1],[4],[5],[14]	7.50%	[1],[4],[5],[14]	7.50%	[8],[9],[10],[16]	7.50%	[8],[9],[10],[16]	7.50%	[8],[9],[10],[16]
Investment, interest rate		12.46%	[1],[2],[4],[5],[14]	12.46%	[1],[2],[4],[5],[14]	12.46%	[1],[2],[4],[5],[14]	9.72%	[8],[9],[10],[11],[16]	9.72%	[8],[9],[10],[11],[16]	9.72%	[8],[9],[10],[11],[16]
Investment, principal | £						£ 20,000	[1],[4],[5],[14]					£ 18,000	[8],[9],[10],[12],[16]
Investment owned, at cost		$ 25,857	[1],[4],[5],[14]					$ 23,804	[8],[9],[10],[16]
Investments at fair value		$ 23,270	[1],[4],[5],[14]					$ 16,552	[8],[9],[10],[16]
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Delayed Draw Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.50%		3.50%		3.50%
Investment, principal		$ 0
Investment owned, at cost		(13)
Investments at fair value		$ (8)
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.50%		3.50%		3.50%
Investment, interest rate		8.59%		8.59%		8.59%
Investment, principal		$ 1,777
Investment owned, at cost		1,674
Investments at fair value		$ 1,715
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan 1 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.50%		3.50%		3.50%
Investment, interest rate		8.59%		8.59%		8.59%
Investment, principal		$ 4,331
Investment owned, at cost		4,079
Investments at fair value		$ 4,179
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan 2 | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		3.50%		3.50%		3.50%
Investment, principal		$ 0
Investment owned, at cost		(32)
Investments at fair value		$ (19)
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares		21,523	[1],[4]	21,523	[1],[4]	21,523	[1],[4]	18,635	[8],[9]	18,635	[8],[9]	18,635	[8],[9]
Investment owned, at cost		$ 20,789	[1],[4]					$ 18,264	[8],[9]
Investments at fair value		$ 18,821	[1],[4]					$ 16,575	[8],[9]
Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan | SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.50%		4.50%		4.50%
Investment, interest rate								7.62%		7.62%		7.62%
Investment, principal								$ 7,331
Investment owned, at cost								7,258
Investments at fair value								$ 6,859
Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan | OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate								4.50%		4.50%		4.50%
Investment, interest rate								7.62%		7.62%		7.62%
Investment, principal								$ 2,444
Investment owned, at cost								2,419
Investments at fair value								$ 2,286
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		6.75%	[1],[3],[4],[5]	6.75%	[1],[3],[4],[5]	6.75%	[1],[3],[4],[5]	6.75%	[8],[9],[10],[13]	6.75%	[8],[9],[10],[13]	6.75%	[8],[9],[10],[13]
Investment, interest rate	[1],[2],[3],[4],[5]	11.99%		11.99%		11.99%
Investment, principal		$ 377	[1],[3],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		331	[1],[3],[4],[5]					(31)	[8],[9],[10],[13]
Investments at fair value		$ 288	[1],[3],[4],[5]					$ (32)	[8],[9],[10],[13]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[4],[5]	7.25%	[1],[4],[5]	7.25%	[1],[4],[5]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]	6.75%	[8],[9],[10]
Investment, interest rate		8.50%	[1],[2],[4],[5]	8.50%	[1],[2],[4],[5]	8.50%	[1],[2],[4],[5]	9.49%	[8],[9],[10],[11]	9.49%	[8],[9],[10],[11]	9.49%	[8],[9],[10],[11]
Investment, principal		$ 24,188	[1],[4],[5],[7]					$ 19,203	[8],[9],[10],[12]
Investment owned, at cost		23,876	[1],[4],[5]					18,874	[8],[9],[10]
Investments at fair value		$ 23,235	[1],[4],[5]					$ 18,867	[8],[9],[10]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate		7.25%	[1],[4],[5]	7.25%	[1],[4],[5]	7.25%	[1],[4],[5]	6.75%	[8],[9],[10],[13]	6.75%	[8],[9],[10],[13]	6.75%	[8],[9],[10],[13]
Investment, interest rate	[1],[2],[4],[5]	12.38%		12.38%		12.38%
Investment, principal		$ 3,636	[1],[4],[5],[7]					$ 0	[8],[9],[10],[12],[13]
Investment owned, at cost		3,600	[1],[4],[5]					0	[8],[9],[10],[13]
Investments at fair value		$ 3,563	[1],[4],[5]					$ 0	[8],[9],[10],[13]
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	7.25%		7.25%		7.25%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	0
Investments at fair value	[1],[3],[4],[5]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[4],[5]	8.75%		8.75%		8.75%
Investment, interest rate	[1],[2],[4],[5]	11.75%		11.75%		11.75%
Investment, principal	[1],[4],[5],[7]	$ 5,212
Investment owned, at cost	[1],[4],[5]	4,973
Investments at fair value	[1],[4],[5]	$ 5,034
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	8.75%		8.75%		8.75%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	0
Investments at fair value	[1],[3],[4],[5]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment, basis spread, variable rate	[1],[3],[4],[5]	8.75%		8.75%		8.75%
Investment, principal	[1],[3],[4],[5],[7]	$ 0
Investment owned, at cost	[1],[3],[4],[5]	0
Investments at fair value	[1],[3],[4],[5]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, balance (in shares) | shares	[1],[4]	53,700		53,700		53,700
Investment owned, at cost	[1],[4]	$ 175
Investments at fair value	[1],[4]	$ 407

[1] As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

[2] Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

[3] Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

[4] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[5] The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the London Interbank Offered Rate ("LIBOR" or "L"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of June 30, 2023, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 180-day LIBOR at 5.73%, the PRIME at 8.25%, the 30-day SOFR at 5.10%, the 90-day SOFR at 5.24%, the 180-day SOFR at 5.34%, the SONIA at 3.47%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.49% and the 180-day EURIBOR at 2.82%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

[6] This investment represents a participation interest in the underlying securities shown.

[7] Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

[8] As of September 30, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.

[9] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[10] The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR, SOFR, SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 180-day LIBOR at 4.17%, the 360-day LIBOR at 4.78%, the PRIME at 6.25%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55%, the SONIA at 1.69%, the 30-day EURIBOR at 0.69%, the 90-day EURIBOR at 0.99% and the 180-day EURIBOR at 0.38%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

[11] Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

[12] Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

[13] Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

[14] Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of June 30, 2023, qualifying assets represented 73.7% of the Company's total assets and non-qualifying assets represented 26.3% of the Company's total assets.

[15] This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

[16] Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2022, qualifying assets represented 75.7% of the Company's total assets and non-qualifying assets represented 24.3% of the Company's total assets.

[17] This investment was on non-accrual status as of June 30, 2023.

[18] One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.

[19] One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.

[20] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[21] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[22] This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

[23] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[24] Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[25] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[26] Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[27] This investment was renamed during the three months ended March 31, 2022. For periods prior to March 31, 2022, this investment was referenced as Realfi Strategic Capital Funding LLC.

[28] See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

[29] This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.

[30] See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

[31] This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.

[32] Income producing through payment of dividends or distributions.

[33] Income producing through payment of dividends or distributions.

[34] This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

XML

Portfolio Investments - Summarized Balance Sheet Information (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 3,135,619	$ 2,494,111
Cash and cash equivalents	59,704	23,528
Restricted cash	12,956	2,836
Other assets	693	1,665
Total assets	3,335,974	2,646,313
Credit facilities payable	1,135,000	700,000
Due to affiliate	7,724	3,180
Total liabilities	1,826,533	1,400,750
Total liabilities and net assets	3,335,974	2,646,313
Investment owned, at cost	3,296,285	2,617,754
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	329,809	359,625
Cash and cash equivalents	21,906	14,274
Restricted cash	8,715	5,642
Other assets	9,798	5,686
Total assets	370,228	385,227
Credit facilities payable	200,000	230,000
Notes payable at fair value	128,750	110,000
Due to affiliate	9,509	21,539
Total liabilities	338,259	361,539
Members' equity	31,969	23,688
Total liabilities and net assets	370,228	385,227
Investment owned, at cost	348,782	382,673
Net proceeds	128,750	110,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	113,833	133,144
Cash and cash equivalents	8,895	7,021
Restricted cash	1,812	1,788
Other assets	2,284	4,855
Total assets	126,824	146,808
Credit facilities payable	66,082	82,082
Notes payable at fair value	56,723	57,463
Due to affiliate	4,019	7,263
Total liabilities	126,824	146,808
Members' equity	0	0
Total liabilities and net assets	126,824	146,808
Investment owned, at cost	120,172	140,083
Net proceeds	$ 66,684	$ 68,185

XML

Portfolio Investments - Summarized Statement of Operations Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Investment Company, Nonconsolidated Subsidiary [Line Items]
Total investment income	$ 101,900	$ 63,137	$ 277,381	$ 192,376
Interest expense	30,793	11,870	79,316	31,178
Total expenses	54,987	23,517	148,129	78,555
Net investment income before taxes	48,413	40,370	133,277	116,071
Net increase (decrease) in net assets resulting from operations	36,685	(37,834)	71,379	16,015
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	3,576	2,416	10,488	6,796
Fee income	0	47	35	82
Total investment income	3,576	2,463	10,523	6,878
Other expenses	70	59	148	127
Total expenses	3,047	1,613	8,544	4,348
Net investment income before taxes	529	850	1,979	2,530
Net unrealized appreciation (depreciation)	431	(753)	(159)	(2,549)
Realized gain (loss)	(960)	(97)	(1,820)	19
Net increase (decrease) in net assets resulting from operations	0	0	0	0
OCSI Glick JV LLC | Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	1,400	694	4,002	1,742
OCSI Glick JV LLC | Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	1,577	860	4,394	2,479
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	10,312	5,796	29,106	16,664
Fee income	0	32	62	105
Total investment income	10,312	5,828	29,168	16,769
Other expenses	73	77	249	198
Total expenses	8,122	4,230	22,764	11,866
Net investment income before taxes	2,190	1,598	6,404	4,903
Net unrealized appreciation (depreciation)	2,652	(16,411)	4,075	(19,856)
Realized gain (loss)	(2,137)	165	(4,850)	568
Net increase (decrease) in net assets resulting from operations	2,705	(14,648)	5,629	(14,385)
SLF JV I | Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	4,190	1,929	12,004	4,995
SLF JV I | SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	$ 3,859	$ 2,224	$ 10,511	$ 6,673

XML

Fee Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Fee income	$ 1,573	$ 2,275	$ 5,974	$ 5,092
Recurring fee income	$ 200	$ 200	$ 800	$ 700

XML

Share Data and Net Assets - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations		$ 36,685	$ (37,834)	$ 71,379	$ 16,015
Weighted average common shares outstanding - basic (shares)	[1]	77,080,000	61,123,000	70,431,000	60,593,000
Weighted average common shares outstanding - diluted (shares)	[1]	77,080,000	61,123,000	70,431,000	60,593,000
Earnings (loss) per common share - basic (dollars per share)	[1]	$ 0.48	$ (0.62)	$ 1.01	$ 0.26
Earnings (loss) per common share - diluted (dollars per share)	[1]	$ 0.48	$ (0.62)	$ 1.01	$ 0.26

[1] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

XML

Share Data and Net Assets - Schedule of Changes in Net Assets (Details) - USD ($) $ in Thousands					3 Months Ended								9 Months Ended
	Jan. 23, 2023	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023		Mar. 31, 2023	Dec. 31, 2022		Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023		Jun. 30, 2022
Investment Company, Net Assets [Roll Forward]
Beginning of period (shares)								61,125,000					61,125,000
Net assets at beginning of period					$ 1,515,150		$ 1,201,989	$ 1,245,563	[1]	$ 1,330,376	$ 1,325,061	$ 1,312,823	$ 1,245,563	[1]	$ 1,312,823
Net investment income					48,413		45,978	38,808		40,370	40,098	32,295	133,199		112,763
Net unrealized appreciation (depreciation)					(1,039)		(18,279)	(22,982)		(86,755)	(27,038)	(4,586)	(42,300)		(118,400)
Net realized gains (losses)					(10,603)		(6,111)	(3,203)		9,212	1,402	9,321	(19,900)		19,900
(Provision) benefit for taxes on realized and unrealized gains (losses)					(86)		(66)	549		(661)	(21)	2,378	397		1,696
Net increase (decrease) in net assets from stockholder transactions					(42,394)		(42,395)	(58,679)		(30,256)	(29,271)	(27,956)	(143,468)		(87,483)
Issuance of common stock in connection with the OSI2 Merger (shares)	15,860,200
Issuance of common stock in connection with the OSI2 Merger					0		334,034			0			334,034		0
Issuance of common stock in connection with the "at the market" offering					0					1,243	19,379		$ 0		$ 20,622
Issuance of common stock under dividend reinvestment plan (shares)		43,676,000	34,804,000	35,990,000									220,570,000		114,470,000
Issuance of common stock under dividend reinvestment plan		$ 900	$ 800	$ 800	1,123		1,295	1,933		874	766	786	$ 4,351		$ 2,426
Repurchase of common stock under dividend reinvestment plan					$ (1,123)		(1,295)			(874)			$ (2,418)		(874)
End of period (shares)					77,080,000								77,080,000
Net assets at end of period		$ 1,263,529	$ 1,330,376	$ 1,325,061	$ 1,509,441	[1]	$ 1,515,150	$ 1,201,989		$ 1,263,529	$ 1,330,376	$ 1,325,061	$ 1,509,441	[1]	$ 1,263,529
Common Stock
Investment Company, Net Assets [Roll Forward]
Beginning of period (shares)					77,080,000		61,220,000	61,125,000		61,068,000	60,156,000	60,120,000	61,125,000		60,120,000
Net assets at beginning of period					$ 771		$ 612	$ 611		$ 611	$ 602	$ 601	$ 611		$ 601
Issuance of common stock in connection with the OSI2 Merger (shares)							15,860,000
Issuance of common stock in connection with the OSI2 Merger							$ 159
Issuance of common stock in connection with the "at the market" offering (shares)										57,000	877,000
Issuance of common stock in connection with the "at the market" offering										$ 0	$ 9
Issuance of common stock under dividend reinvestment plan (shares)					57,000		68,000	95,000		44,000	35,000	36,000
Issuance of common stock under dividend reinvestment plan					$ 1		$ 1	$ 1		$ 1	$ 0	$ 1
Repurchase of common stock under dividend reinvestment plan (shares)					(57,000)		(68,000)			(44,000)
Repurchase of common stock under dividend reinvestment plan					$ (1)		$ (1)			$ (1)
End of period (shares)		61,125,000	61,068,000	60,156,000	77,080,000		77,080,000	61,220,000		61,125,000	61,068,000	60,156,000	77,080,000		61,125,000
Net assets at end of period		$ 611	$ 611	$ 602	$ 771		$ 771	$ 612		$ 611	$ 611	$ 602	$ 771		$ 611
Additional paid-in-capital
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period					2,163,528		1,829,653	1,827,721		1,826,478	1,806,342	1,805,557	1,827,721		1,805,557
Issuance of common stock in connection with the OSI2 Merger							333,875
Issuance of common stock in connection with the "at the market" offering										1,243	19,370
Issuance of common stock under dividend reinvestment plan					1,122		1,294	1,932		873	766	785
Repurchase of common stock under dividend reinvestment plan					(1,122)		(1,294)			(873)
Net assets at end of period		1,827,721	1,826,478	1,806,342	2,163,528		2,163,528	1,829,653		1,827,721	1,826,478	1,806,342	2,163,528		1,827,721
Accumulated Overdistributed Earnings
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period					(649,149)		(628,276)	(582,769)		(496,713)	(481,883)	(493,335)	(582,769)		(493,335)
Net investment income					48,413		45,978	38,808		40,370	40,098	32,295
Net unrealized appreciation (depreciation)					(1,039)		(18,279)	(22,982)		(86,755)	(27,038)	(4,586)
Net realized gains (losses)					(10,603)		(6,111)	(3,203)		9,212	1,402	9,321
(Provision) benefit for taxes on realized and unrealized gains (losses)					(86)		(66)	549		(661)	(21)	2,378
Net increase (decrease) in net assets from stockholder transactions					(42,394)		(42,395)	(58,679)		(30,256)	(29,271)	(27,956)
Issuance of common stock under dividend reinvestment plan											0
Net assets at end of period		$ (564,803)	$ (496,713)	$ (481,883)	$ (654,858)		$ (649,149)	$ (628,276)		$ (564,803)	$ (496,713)	$ (481,883)	$ (654,858)		$ (564,803)

[1] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.

XML

Share Data and Net Assets - Schedule of Distributions (Details) - USD ($) $ / shares in Units, $ in Thousands							3 Months Ended						9 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022
Investment Company, Changes in Net Assets [Line Items]
Amount per share (dollars per share)				$ 0.495	$ 0.48	$ 0.465	$ 0.55			$ 0.50			$ 2.06	$ 1.44
Distributions to stockholders				$ 29,400	$ 28,500	$ 27,200							$ 139,100	$ 85,100
Issuance of common stock under dividend reinvestment plan (shares)				43,676,000	34,804,000	35,990,000							220,570,000	114,470,000
Issuance of common stock under dividend reinvestment plan				$ 900	$ 800	$ 800	$ 1,123	$ 1,295	$ 1,933	$ 874	$ 766	$ 786	$ 4,351	$ 2,426
Quarterly
Investment Company, Changes in Net Assets [Line Items]
Amount per share (dollars per share)	$ 0.55	$ 0.55	$ 0.54
Distributions to stockholders	$ 41,300	$ 41,100	$ 32,000
Issuance of common stock under dividend reinvestment plan (shares)	57,279,000	68,412,000	53,369,000
Issuance of common stock under dividend reinvestment plan	$ 1,100	$ 1,300	$ 1,100
Special
Investment Company, Changes in Net Assets [Line Items]
Amount per share (dollars per share)			$ 0.42
Distributions to stockholders			$ 24,800
Issuance of common stock under dividend reinvestment plan (shares)			41,510,000
Issuance of common stock under dividend reinvestment plan			$ 800

XML

Share Data and Net Assets - Narrative (Details) - USD ($) $ in Millions							3 Months Ended		9 Months Ended
	Feb. 08, 2023	Jan. 23, 2023	Jun. 30, 2022	Mar. 31, 2022	Feb. 07, 2022	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Investment Company, Changes in Net Assets [Line Items]
Issuance of common stock in connection with the OSI2 Merger (shares)		15,860,200
Issuance of common stock under dividend reinvestment plan (shares)			43,676,000	34,804,000		35,990,000			220,570,000	114,470,000
Aggregate offering price	$ 125.0				$ 125.0
Number of shares issued (in shares)							0		0	2,801,206
Consideration received on transaction										$ 20.6
Common Stock
Investment Company, Changes in Net Assets [Line Items]
Issuance of common stock under dividend reinvestment plan (shares)							0	0	94,879,000	70,794

XML

Borrowings (Details) - USD ($) $ in Thousands					3 Months Ended		5 Months Ended	9 Months Ended
	May 26, 2023	Jan. 23, 2023	May 18, 2021	Feb. 25, 2020	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Line of Credit Facility [Line Items]
Borrowings outstanding					$ 1,135,000		$ 1,135,000	$ 1,135,000		$ 700,000
Interest expense					30,793	$ 11,870		79,316	$ 31,178
Fair Value					$ 1,722,977		$ 1,722,977	$ 1,722,977		$ 1,277,105
Interest rate swap
Line of Credit Facility [Line Items]
Interest rate					2.70%		2.70%	2.70%		2.70%
Floating interest rate					1.658%		1.658%	1.658%		1.658%
Notional amount					$ 350,000		$ 350,000	$ 350,000		$ 350,000
Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Interest rate			2.70%
Notional amount			$ 350,000
Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Interest rate								2.00%
Secured Overnight Financing Rate | Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate								0.11448%
Secured Overnight Financing Rate | Maximum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate								0.26161%
London Interbank Offered Rate (LIBOR) | Interest rate swap | Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate			1.658%
Base Rate
Line of Credit Facility [Line Items]
Interest rate								1.00%
Citibank Facility
Line of Credit Facility [Line Items]
Interest expense					600
2025 Notes
Line of Credit Facility [Line Items]
Principal amount				$ 300,000	300,000		300,000	$ 300,000		300,000
Net proceeds				293,800
Unaccreted discount				2,500	$ 800		$ 800	$ 800		1,200
Underwriting commissions				3,000
Offering costs				$ 700
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)				3.50%	3.50%		3.50%	3.50%
Redemption price				100.00%
2027 Notes
Line of Credit Facility [Line Items]
Principal amount			$ 350,000		$ 350,000		$ 350,000	$ 350,000		350,000
Net proceeds			344,800
Unaccreted discount			1,000		$ 600		$ 600	$ 600		700
Underwriting commissions			3,500
Offering costs			$ 700
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)			2.70%		2.70%		2.70%	2.70%
Redemption price			100.00%
Line of Credit | Revolving Credit Facility | Syndicated Facility
Line of Credit Facility [Line Items]
Borrowing capacity					$ 1,218,000		$ 1,218,000	$ 1,218,000
Accordion feature, increase limit					1,250,000		1,250,000	1,250,000
Borrowing capacity subject to expiration					$ 1,035,000		$ 1,035,000	$ 1,035,000
Debt instrument, covenant, total assets to total indebtedness, ratio, minimum threshold					1.50		1.50	1.50
Debt instrument, covenant, consolidated EBITDA to consolidated interest expense, ratio, minimum threshold					2.25		2.25	2.25
Borrowings outstanding					$ 800,000		$ 800,000	$ 800,000		540,000
Fair value					$ 800,000		$ 800,000	$ 800,000		540,000
Weighted average interest rate					6.584%	2.406%	6.584%	6.584%	2.406%
Interest expense inclusive of fees					$ 14,300	$ 4,800		$ 37,400	$ 12,600
Line of Credit | Revolving Credit Facility | Citibank Facility
Line of Credit Facility [Line Items]
Borrowings outstanding										160,000
Fair value										$ 160,000
Weighted average interest rate					6.762%		6.762%	6.762%		2.563%
Interest expense inclusive of fees					$ 2,400	$ 1,600		$ 8,000	$ 3,500
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility
Line of Credit Facility [Line Items]
Borrowing capacity					400,000		$ 400,000	400,000
Borrowings outstanding					$ 335,000		$ 335,000	$ 335,000
Weighted average interest rate					7.275%		7.275%	7.275%
Interest expense inclusive of fees					$ 4,900		$ 8,000
Unused capacity, commitment fee		0.50%
Commitment fee, unused capacity threshold percentage		30.00%
Fair Value					$ 335,000		$ 335,000	$ 335,000
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility | Secured Overnight Financing Rate | After Reinvestment Period
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate	4.00%
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility | Secured Overnight Financing Rate | Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate	2.50%
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility, Syndicated Loans | Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate	2.00%
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility, All Other Loans | Secured Overnight Financing Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate	2.75%

XML

Borrowings - Components of the Carrying Value of Notes (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022	May 18, 2021	Feb. 25, 2020
Debt Instrument [Line Items]
Unamortized financing costs	$ (3,909)	$ (5,020)
Net carrying value	1,740,066	1,301,043
2025 Notes
Debt Instrument [Line Items]
Principal amount	300,000	300,000		$ 300,000
Unamortized financing costs	(1,200)	(1,800)
Unaccreted discount	(800)	(1,200)		$ (2,500)
Interest rate swap fair value adjustment	0	0
Net carrying value	298,000	297,000
Fair Value	285,700	283,100
2027 Notes
Debt Instrument [Line Items]
Principal amount	350,000	350,000	$ 350,000
Unamortized financing costs	(2,700)	(3,200)
Unaccreted discount	(600)	(700)	$ (1,000)
Interest rate swap fair value adjustment	(39,600)	(42,000)
Net carrying value	307,100	304,100
Fair Value	$ 302,300	$ 294,000

XML

Borrowings - Components of Interest and Other Debt Expenses (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Debt Instrument [Line Items]
Effect of interest rate swap	$ 3.7	$ (0.1)	$ 9.4	$ (1.6)
2025 Notes
Debt Instrument [Line Items]
Coupon interest	2.6	2.6	7.9	7.9
Amortization of financing costs and discount	0.3	0.3	0.9	0.9
Total interest expense	$ 2.9	$ 2.9	$ 8.8	$ 8.8
Coupon interest rate	3.50%	3.50%	3.50%	3.50%
2027 Notes
Debt Instrument [Line Items]
Coupon interest	$ 2.4	$ 2.4	$ 7.1	$ 7.1
Amortization of financing costs and discount	0.2	0.2	0.7	0.7
Total interest expense	$ 6.3	$ 2.5	$ 17.2	$ 6.2
Coupon interest rate	6.912%	2.572%	6.274%	2.069%

XML

Taxable/Distributable Income and Dividend Distributions - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net									$ 523,700
Valuation allowance	$ 6,100						$ 6,100
Deferred tax assets	8,800						8,800
Deferred tax asset, net	2,695						2,695		1,687
(Provision) benefit for taxes on realized and unrealized gains (losses)	(86)	$ (66)	$ 549	$ (661)	$ (21)	$ 2,378	397	$ 1,696
Income tax expense (benefit)	(1,000)						(600)
Deferred taxes	$ (900)						$ (1,030)	$ (984)
Cost of investments									2,654,300
Unrealized appreciation									466,900
Unrealized depreciation									620,000
Unrealized appreciation (depreciation)									153,100
Short-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net									64,500
Long-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net									$ 459,200

XML

Taxable/Distributable Income and Dividend Distributions - Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Net increase (decrease) in net assets resulting from operations	$ 36,685	$ (37,834)	$ 71,379	$ 16,015
Net unrealized (appreciation) depreciation	1,039	86,755	42,300	118,379
Book/tax difference due to organizational costs	0	(21)	0	(65)
Book/tax difference due to capital losses utilized	12,118	(3,736)	20,380	(19,183)
Other book/tax differences	(3,825)	(8,819)	(14,912)	(18,597)
Taxable/Distributable Income	$ 46,017	$ 36,345	$ 119,147	$ 96,549

XML

Taxable/Distributable Income and Dividend Distributions - Components of Accumulated Overdistributed Earnings (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Undistributed ordinary income, net		$ (43,624)
Net realized capital losses		473,274
Unrealized losses, net		153,119
Accumulated overdistributed earnings	$ 654,858	$ 582,769

XML

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (10,603)	$ (6,111)	$ (3,203)	$ 9,212	$ 1,402	$ 9,321	$ (19,900)	$ 19,900
Net unrealized appreciation (depreciation)	(1,039)	$ (18,279)	$ (22,982)	(86,755)	$ (27,038)	$ (4,586)	(42,300)	(118,400)
OSI2 Merger
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)							(20,700)
Investments in debt securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(9,800)			(66,800)			(54,300)	(84,600)
Investments in equity securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(800)			(17,900)			5,100	(23,800)
Exited Investments
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	5,000			(400)			11,800	(9,200)
Foreign currency forward contract
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	$ 4,600			$ (1,600)			$ (4,800)	$ (800)

XML

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Aggregate Net Realized Gains (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (10,603)	$ (6,111)	$ (3,203)	$ 9,212	$ 1,402	$ 9,321	$ (19,900)	$ 19,900
Foreign currency forward contract
Schedule of Investments [Line Items]
Net realized gains (losses)	(6,300)			8,800			(5,500)	12,200
Carvana Co
Schedule of Investments [Line Items]
Net realized gains (losses)							(2,800)
ASP Unifrax Holdings Inc
Schedule of Investments [Line Items]
Net realized gains (losses)							(2,100)
Global Medical Response Inc
Schedule of Investments [Line Items]
Net realized gains (losses)							(1,000)
Other Investments, Net
Schedule of Investments [Line Items]
Net realized gains (losses)								1,800
TigerConnect, Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)								1,800
OmniSYS Acquisition Corporation
Schedule of Investments [Line Items]
Net realized gains (losses)								2,200
First Star Speir Aviation Limited
Schedule of Investments [Line Items]
Net realized gains (losses)								$ 1,900
Radiology Partners Inc
Schedule of Investments [Line Items]
Net realized gains (losses)	(3,800)						(4,200)
WP CPP Holdings LLC
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,300)						(1,300)
Aden & Anais Merger Sub Inc
Schedule of Investments [Line Items]
Net realized gains (losses)	(5,200)						(5,200)
Tersera Therapeutics LLC
Schedule of Investments [Line Items]
Net realized gains (losses)	5,200						5,200
Other, net
Schedule of Investments [Line Items]
Net realized gains (losses)	$ 800			$ 400			$ (3,000)

XML

Related Party Transactions (Details)			3 Months Ended		9 Months Ended
	Mar. 19, 2021 USD ($)	May 03, 2019	Jun. 30, 2023 USD ($) component	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) component	Jun. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)
Related Party Transaction [Line Items]
Base management fee and incentive fee payable			$ 20,072,000		$ 20,072,000		$ 15,940,000
Base management fee rate		1.00%			1.50%
Base management fee, threshold		200.00%
Base management fee			11,983,000	$ 9,819,000	$ 33,383,000	$ 29,853,000
Part I incentive fee			9,590,000	6,497,000	26,300,000	19,658,000
Due to affiliate			7,724,000		$ 7,724,000		3,180,000
Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, termination, notice period					60 days
Administrator expense			400,000	300,000	$ 1,200,000	1,200,000
General and administrative expenses			100,000	100,000	200,000	200,000
Due to affiliate			$ 7,700,000		$ 7,700,000		$ 3,200,000
Oaktree Strategic Income Corporation Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived	$ 6,000,000
Contractual fee waived, period otherwise receivable	2 years
Contractual fee waived, per quarter	$ 750,000
Oaktree Strategic Income II, Inc. Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived	9,000,000
Oaktree Strategic Income II, Inc Merger, Year One
Related Party Transaction [Line Items]
Investment company, contractual fee waived	6,000,000
Contractual fee waived, per quarter	1,500,000
Oaktree Strategic Income II, Inc Merger, Year Two
Related Party Transaction [Line Items]
Investment company, contractual fee waived	3,000,000
Contractual fee waived, per quarter	$ 750,000
Investment Advisory Agreement
Related Party Transaction [Line Items]
Number of components | component			2		2
Related party transaction, termination, notice period					60 days
Base management fee			$ 10,500,000	9,100,000	$ 29,400,000	27,600,000
Management incentive rate					1.50%
Investment Advisory Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Part I incentive fee			$ 9,600,000	6,500,000	$ 26,300,000	19,700,000
Incentive fee expense					$ 9,600,000
Accrued capital gains incentive fees reversed				$ 6,800,000		$ 8,800,000
Investment Advisory Agreement Incentive Rate Pre Incentive Fee Net Investment Income Below Catch Up
Related Party Transaction [Line Items]
Management incentive rate					100.00%
Investment Advisory Agreement Incentive Rate Quarterly Catch Up Threshold
Related Party Transaction [Line Items]
Management incentive rate					1.8182%
Investment Advisory Agreement Cumulative Pre Incentive Fee Net Investment Income
Related Party Transaction [Line Items]
Management incentive rate					17.50%
Investment Advisory Agreement - Incentive Rate, Realized Capital Gains | Affiliated Entity
Related Party Transaction [Line Items]
Management incentive rate					17.50%

XML

Financial Highlights (Details) $ / shares in Units, $ in Thousands							3 Months Ended				9 Months Ended
		Jan. 20, 2023	Jun. 30, 2022 USD ($) $ / shares shares		Mar. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 $ / shares	Jun. 30, 2023 USD ($) $ / shares shares		Jun. 30, 2022 USD ($) $ / shares shares		Jun. 30, 2023 USD ($) $ / shares shares		Jun. 30, 2022 USD ($) $ / shares shares
Investment Company, Financial Highlights [Roll Forward]
Net asset value per share at beginning of period (dollars per share)							$ 19.66		$ 21.79		$ 20.38		$ 21.84
Net investment income per common share - basic and diluted (dollars per share)	[1]						0.63		0.66		1.89		1.86
Net unrealized appreciation (depreciation) (dollars per share)							(0.02)		(1.42)		(0.36)		(1.95)
Net realized gains (losses) (dollars per share)							(0.14)		0.15		(0.28)		0.33
(Provision) benefit for taxes on realized and unrealized gains (losses) (dollars per share)							0		(0.01)		0.01		0.03
Amount per share (dollars per share)			$ (0.495)		$ (0.48)	$ (0.465)	(0.55)		(0.50)		(2.06)		(1.44)
Net asset value per share at end of period (dollars per share)			20.67	[2]	21.79		19.58	[2]	20.67	[2]	19.58	[2]	20.67	[2]
Per share market value at beginning of period (dollars per share)							18.77		22.11		18.00		21.18
Per share market value at end of period (dollars per share)			$ 19.65		$ 22.11		$ 19.43		$ 19.65		$ 19.43		$ 19.65
Total return							6.42%		(8.93%)		19.58%		(0.79%)
Common shares outstanding at beginning of period (shares) | shares							77,080,000		61,068,000		61,125,000		60,120,000
Common shares outstanding at end of period (shares) | shares			61,125,000	[2]	61,068,000		77,080,000	[2]	61,125,000	[2]	77,080,000	[2]	61,125,000	[2]
Net assets at beginning of period | $							$ 1,515,150		$ 1,330,376		$ 1,245,563		$ 1,312,823
Net assets at end of period | $			$ 1,263,529		$ 1,330,376		1,509,441		1,263,529		1,509,441		1,263,529
Average net assets | $							$ 1,526,644		$ 1,306,727		$ 1,407,814		$ 1,323,232
Ratio of net investment income to average net assets							12.72%		12.39%		12.65%		11.39%
Ratio of total expenses to average net assets							14.45%		7.22%		14.07%		7.94%
Ratio of net expenses to average net assets							14.05%		6.99%		13.69%		7.71%
Ratio of portfolio turnover to average investments at fair value							7.48%		4.73%		18.43%		21.44%
Weighted average outstanding debt | $							$ 1,756,758		$ 1,369,615		$ 1,640,062		$ 1,358,150
Average debt per share (dollars per share)							$ 22.79		$ 22.41		$ 23.29		$ 22.41
Asset coverage ratio			187.82%				182.05%		187.82%		182.05%		187.82%
Stock split, conversion ratio		0.0033

[1] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

[2] (1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.

XML

Derivative Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Due from broker	$ 39,990	$ 45,530

XML

Derivative Instruments - Schedule of Foreign Currency Forward Contracts and Interest Rate Swap (Details) € in Thousands, £ in Thousands, $ in Thousands	Jun. 30, 2023 USD ($)	Jun. 30, 2023 EUR (€)	Jun. 30, 2023 GBP (£)	Sep. 30, 2022 USD ($)	Sep. 30, 2022 EUR (€)	Sep. 30, 2022 GBP (£)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	$ 49			$ 6,789
Derivative liability at fair value	39,567			41,969
Foreign currency forward contract
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	49			6,789
Interest rate swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	350,000			350,000
Derivative liability at fair value	39,567			41,969
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022, 1
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased				43,179
Notional Amount to be Sold | €					€ 41,444
Derivative assets at fair value				2,466
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing August 10, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	531
Derivative liability at fair value	482
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing May 11, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	78,866
Notional Amount to be Sold | €		€ 71,658
Derivative assets at fair value	531
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased				43,179
Notional Amount to be Sold | €					€ 41,444
Derivative assets at fair value				2,466
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing May 11, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	71,438
Notional Amount to be Sold | £			£ 56,556
Derivative liability at fair value	$ 482
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 10, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased				45,692
Notional Amount to be Sold | £						£ 37,033
Derivative assets at fair value				4,323
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 19, 2022, 2
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased				45,692
Notional Amount to be Sold | £						£ 37,033
Derivative assets at fair value				$ 4,323

XML

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 274,373	$ 224,239
Debt and Equity Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	247,300	175,200
JV Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 27,100	$ 49,000

XML

Commitments and Contingencies - Schedule of Unfunded Commitments by Investment (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Sep. 30, 2022
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 274,373	$ 224,239
Investment, Identifier [Axis]: 107 Fair Street LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,322	0
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	30,922	0
Investment, Identifier [Axis]: 109 Montgomery Owner LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	477
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,703	0
Investment, Identifier [Axis]: ADC Therapeutics SA
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,020	3,020
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	396	0
Investment, Identifier [Axis]: Accupac, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,500	4,605
Investment, Identifier [Axis]: Acquia Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	596	1,326
Investment, Identifier [Axis]: Apptio, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,885	1,338
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	4,372
Investment, Identifier [Axis]: Assembled Brands Capital LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	7,062	2,008
Investment, Identifier [Axis]: Avalara, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,047	0
Investment, Identifier [Axis]: BAART Programs, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	8,645
Investment, Identifier [Axis]: Berner Food & Beverage, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,314	1,392
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	14,543	11,785
Investment, Identifier [Axis]: CorEvitas, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,251	915
Investment, Identifier [Axis]: Coupa Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,075	0
Investment, Identifier [Axis]: Coyote Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	800	1,333
Investment, Identifier [Axis]: Delta Leasing SPV II LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	18,822	27,187
Investment, Identifier [Axis]: Dialyze Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	3,431
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,156	826
Investment, Identifier [Axis]: Dominion Diagnostics, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	7,664	11,148
Investment, Identifier [Axis]: Establishment Labs Holdings Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,384	5,075
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	20,382	22,150
Investment, Identifier [Axis]: GKD Index Partners, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	320
Investment, Identifier [Axis]: Galileo Parent, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,061	0
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,286	4,293
Investment, Identifier [Axis]: Harrow Health, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,011	0
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,200	4,195
Investment, Identifier [Axis]: Inventus Power, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,792	0
Investment, Identifier [Axis]: Kings Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,771	1,537
Investment, Identifier [Axis]: LSL Holdco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,650	427
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,383	1,115
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,536	1,429
Investment, Identifier [Axis]: MND Holdings III Corp
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	8,470	0
Investment, Identifier [Axis]: MRI Software LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,302	5,196
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	7,139	5,734
Investment, Identifier [Axis]: Mesoblast, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,405	3,553
Investment, Identifier [Axis]: Mindbody, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,762	4,000
Investment, Identifier [Axis]: OCSI Glick JV LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,998	13,998
Investment, Identifier [Axis]: OTG Management, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,190	3,789
Investment, Identifier [Axis]: Oranje Holdco, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,904	0
Investment, Identifier [Axis]: PPW Aero Buyer, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,466	0
Investment, Identifier [Axis]: PRGX Global, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,127	2,518
Investment, Identifier [Axis]: Pluralsight, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,395	3,532
Investment, Identifier [Axis]: Relativity ODA LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,762	2,218
Investment, Identifier [Axis]: RumbleOn, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	4,822
Investment, Identifier [Axis]: SCP Eye Care Services, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,356	0
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,102	0
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,125	35,000
Investment, Identifier [Axis]: Seres Therapeutics, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	8,090	0
Investment, Identifier [Axis]: SiO2 Medical Products, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	10,765	0
Investment, Identifier [Axis]: Spanx, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,185	2,226
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,540	1,527
Investment, Identifier [Axis]: Tahoe Bidco B.V.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,162	1,741
Investment, Identifier [Axis]: Telestream Holdings Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	678	528
Investment, Identifier [Axis]: Thrasio, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,578
Investment, Identifier [Axis]: iCIMs, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	7,704	6,930
Investment, Identifier [Axis]: scPharmaceuticals Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 5,212	$ 0

XML

Merger with OSI2 (Details) $ in Thousands	Jan. 23, 2023 USD ($) shares	Sep. 30, 2022 USD ($)
Business Acquisition [Line Items]
Unrealized appreciation (depreciation)		$ 153,100
Cash paid in lieu of issuing fractional shares	$ 19
OSI2 Merger
Business Acquisition [Line Items]
Conversion ratio (in shares)	0.9115
Number of shares issued (in shares) | shares	15,860,200
Unrealized appreciation (depreciation)	$ (20,700)
Common stock issued by the Company	334,034
Transaction costs	1,932
Consideration paid	335,966
Investments	592,809
Cash and cash equivalents	22,317
Other assets	6,679
Total assets acquired	621,805
Debt	225,000
Other liabilities	60,839
Total liabilities acquired	285,839
Total net assets acquired	$ 335,966

XML

Subsequent Events (Details)	Jul. 28, 2023 $ / shares
Subsequent Event
Subsequent Event [Line Items]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.55

XML

Schedule 12-14 - Schedule of Investments in and Advances to Affiliates (Details) € in Thousands, £ in Thousands, $ in Thousands		9 Months Ended
		Jun. 30, 2023 USD ($) shares		Jun. 30, 2022 USD ($) shares	Jun. 30, 2023 EUR (€) shares		Jun. 30, 2023 GBP (£) shares		Sep. 30, 2022 USD ($) shares		Sep. 30, 2022 EUR (€) shares		Sep. 30, 2022 GBP (£) shares
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		$ 2,494,111
Fair Value, Ending Balance		$ 3,135,619
Investment owned, percent of net assets		207.73%			207.73%		207.73%		200.24%		200.24%		200.24%
Control & Affiliate Investments
Schedule of Investments [Line Items]
Investment owned, balance, principal amount				$ 194,352
Net Realized Gain (Loss)				1,868
Amount of Interest, Fees or Dividends Credited in Income				16,928
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		$ 26,196		289,054
Gross Additions				12,759
Gross Reductions				(55,528)
Fair Value, Ending Balance		23,911		$ 246,285
Investment owned, percent of net assets				19.50%
Control Investments
Schedule of Investments [Line Items]
Investment owned, ownership percentage	[1],[2]								17.20%		17.20%		17.20%
Investment owned, balance, principal amount		188,591		$ 172,598
Net Realized Gain (Loss)		0		1,868
Amount of Interest, Fees or Dividends Credited in Income		18,514		15,743
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		214,165	[1],[2]	270,765
Gross Additions		28,264		1,123
Gross Reductions		(4,233)		(49,030)
Fair Value, Ending Balance		$ 238,196	[3],[4]	$ 222,858
Investment owned, percent of net assets		15.80%	[3],[4]	17.60%	15.80%	[3],[4]	15.80%	[3],[4]
Affiliate Investments
Schedule of Investments [Line Items]
Investment, interest rate	[5]								2.10%		2.10%		2.10%
Investment owned, balance, principal amount		$ 22,304		$ 21,754
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		1,985		1,185
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		26,196	[5]	18,289
Gross Additions		2,607		11,636
Gross Reductions		(4,892)		(6,498)
Fair Value, Ending Balance		$ 23,911	[6]	$ 23,427
Investment owned, percent of net assets		1.60%	[6]	1.90%	1.60%	[6]	1.60%	[6]
Investment, Affiliated Issuer, Control and Affiliate
Schedule of Investments [Line Items]
Investment owned, balance, principal amount		$ 210,895
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		20,499
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		240,361
Gross Additions		30,871
Gross Reductions		(9,125)
Fair Value, Ending Balance		$ 262,107
Investment owned, percent of net assets		17.40%			17.40%		17.40%
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[9],[10],[11],[12]	12.50%			12.50%		12.50%
Investment owned, balance, principal amount	[7],[9],[10],[12],[13]	$ 1,174
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[12]	$ 1,112
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[9],[10],[11]	11.00%			11.00%		11.00%
Investment owned, balance, principal amount	[7],[9],[10],[13]	$ 14,916
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10]	14,489
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.00%		7.00%		7.00%
Investment, interest rate	[14],[15],[16],[17]								9.80%		9.80%		9.80%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 389
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	727
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								7.00%		7.00%		7.00%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	$ 0
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[9],[10],[11],[12]	12.00%			12.00%		12.00%
Investment owned, balance, principal amount	[7],[9],[10],[12],[13]	$ 3,710
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[12]	$ 3,645
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20],[21]	14.25%			14.25%		14.25%
Investment owned, balance, principal amount	[7],[10],[13],[20],[21]	$ 21,434
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20],[21]	21,434
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment owned, balance, principal amount		5,576	[7],[10],[13],[20]						$ 33,997	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	34,891
Fair Value, Ending Balance	[7],[10],[20]	5,464
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								6.25%		6.25%		6.25%
Investment, interest rate	[14],[15],[16],[17]								9.80%		9.80%		9.80%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 14,685
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 14,431
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	12.00%			12.00%		12.00%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 3,520
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 3,455
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	12.00%			12.00%		12.00%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 18,271
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 17,935
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	11.66%			11.66%		11.66%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 1,000
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 982
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[10],[20]		7.50%	[7],[10],[20]	7.50%	[7],[10],[20]	7.50%	[14],[15],[16],[22]	7.50%	[14],[15],[16],[22]	7.50%	[14],[15],[16],[22]
Investment, interest rate		12.89%	[7],[8],[10],[11],[20]		12.89%	[7],[8],[10],[11],[20]	12.89%	[7],[8],[10],[11],[20]	11.20%	[14],[15],[16],[17],[22]	11.20%	[14],[15],[16],[17],[22]	11.20%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 6,589	[7],[10],[11],[13],[20]						$ 6,589	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	6,262
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 6,267
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[9],[10],[20]		7.50%	[7],[9],[10],[20]	7.50%	[7],[9],[10],[20]	7.50%	[14],[15],[16],[19],[22]	7.50%	[14],[15],[16],[19],[22]	7.50%	[14],[15],[16],[19],[22]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13],[20]						$ 0	[14],[15],[16],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19],[22]	(37)
Fair Value, Ending Balance	[7],[9],[10],[11],[20]	$ (38)
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		28,948	[7],[10],[20]		28,948	[7],[10],[20]	28,948	[7],[10],[20]	28,948	[14],[15],[22]	28,948	[14],[15],[22]	28,948	[14],[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 73
Fair Value, Ending Balance	[7],[10],[20]	$ 18
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[10],[11],[20]		7.25%	[7],[10],[11],[20]	7.25%	[7],[10],[11],[20]	7.25%	[14],[15],[16],[22]	7.25%	[14],[15],[16],[22]	7.25%	[14],[15],[16],[22]
Investment, interest rate		10.67%	[7],[8],[10],[11],[20]		10.67%	[7],[8],[10],[11],[20]	10.67%	[7],[8],[10],[11],[20]	7.94%	[14],[15],[16],[17],[22]	7.94%	[14],[15],[16],[17],[22]	7.94%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount | €					€ 29,985	[7],[10],[11],[13],[20]					€ 24,838	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	$ 22,143
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 32,128
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		17,870	[7],[10]		17,870	[7],[10]	17,870	[7],[10]	14,410	[14],[15]	14,410	[14],[15]	14,410	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 1,291
Fair Value, Ending Balance	[7],[10]	$ 2,578
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.75%	[7],[10],[11]		7.75%	[7],[10],[11]	7.75%	[7],[10],[11]	7.75%	[14],[15],[16]	7.75%	[14],[15],[16]	7.75%	[14],[15],[16]
Investment, interest rate		12.95%	[7],[8],[10],[11]		12.95%	[7],[8],[10],[11]	12.95%	[7],[8],[10],[11]	10.88%	[14],[15],[16],[17]	10.88%	[14],[15],[16],[17]	10.88%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 17,873	[7],[10],[11],[13]						$ 14,414	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	13,910
Fair Value, Ending Balance	[7],[10],[11]	17,533
Investment, Identifier [Axis]: APX Group Inc., Electrical Components & Equipment, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17],[22]								5.75%		5.75%		5.75%
Investment owned, balance, principal amount	[15],[18],[22]								$ 2,075
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	1,645
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17]								7.50%		7.50%		7.50%
Investment owned, balance, principal amount	[15],[18]								$ 5,500
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	3,641
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17]								5.25%		5.25%		5.25%
Investment owned, balance, principal amount	[15],[18]								$ 2,500
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 1,926
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11],[20]	6.00%			6.00%		6.00%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11],[20]	$ (20)
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[20]	6.00%			6.00%		6.00%
Investment, interest rate	[7],[8],[10],[11],[20]	11.31%			11.31%		11.31%
Investment owned, balance, principal amount	[7],[10],[11],[13],[20]	$ 3,284
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	3,120
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment owned, balance, principal amount	[7],[10],[13],[20],[21]	11,683
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20],[21]	$ 11,274
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.75%	[7],[10]		7.75%	[7],[10]	7.75%	[7],[10]	7.75%	[15],[16]	7.75%	[15],[16]	7.75%	[15],[16]
Investment, interest rate		12.94%	[7],[8],[10],[11]		12.94%	[7],[8],[10],[11]	12.94%	[7],[8],[10],[11]	10.82%	[15],[16],[17]	10.82%	[15],[16],[17]	10.82%	[15],[16],[17]
Investment owned, balance, principal amount		$ 20,000	[7],[10],[11],[13]						$ 20,000	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	19,075
Fair Value, Ending Balance	[7],[10],[11]	$ 18,883
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[9],[10],[11]	10.86%			10.86%		10.86%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 2,033
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 2,027
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[10],[11]	10.86%			10.86%		10.86%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 20,286
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 20,246
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[9],[10],[11]
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	(8)
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								5.50%		5.50%		5.50%
Investment, interest rate	[14],[15],[16],[17],[19]								9.14%		9.14%		9.14%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 500
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	495
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								5.50%		5.50%		5.50%
Investment, interest rate	[14],[15],[16],[17]								9.12%		9.12%		9.12%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 15,976
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	15,944
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								5.50%		5.50%		5.50%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	$ (6)
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.00%	[7],[9],[10]		7.00%	[7],[9],[10]	7.00%	[7],[9],[10]	7.00%	[14],[15],[16],[19]	7.00%	[14],[15],[16],[19]	7.00%	[14],[15],[16],[19]
Investment, interest rate		12.05%	[7],[8],[9],[10],[11]		12.05%	[7],[8],[9],[10],[11]	12.05%	[7],[8],[9],[10],[11]	10.64%	[14],[15],[16],[17],[19]	10.64%	[14],[15],[16],[17],[19]	10.64%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 2,113	[7],[9],[10],[11],[13]						$ 914	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	898
Fair Value, Ending Balance	[7],[9],[10],[11]	2,102
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.00%		7.00%		7.00%
Investment, interest rate	[14],[15],[16],[17]								9.63%		9.63%		9.63%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 27,349
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 27,158
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[10],[11]	12.34%			12.34%		12.34%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 6,400
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 6,374
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[10],[11]	12.34%			12.34%		12.34%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 25,332
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	25,230
Investment, Identifier [Axis]: Aden & Anais Merger Sub, Inc., Apparel, Accessories & Luxury Goods, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15]								51,645		51,645		51,645
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 0
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		5,715	[7],[10]		5,715	[7],[10]	5,715	[7],[10]	5,715	[14],[15]	5,715	[14],[15]	5,715	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 0
Fair Value, Ending Balance	[7],[10]	0
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								8.50%		8.50%		8.50%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 23,338
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 22,141
Investment, Identifier [Axis]: All Web Leads, Inc., First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[23]	8.50%			8.50%		8.50%
Investment owned, balance, principal amount	[7],[10],[11],[13],[23]	$ 23,562
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[23]	$ 16,880
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate		5.50%	[8],[10],[11],[20]		5.50%	[8],[10],[11],[20]	5.50%	[8],[10],[11],[20]	5.50%	[15],[16],[17],[22]	5.50%	[15],[16],[17],[22]	5.50%	[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 4,050	[10],[13],[20]						$ 4,050	[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	3,057
Fair Value, Ending Balance	[10],[20]	$ 2,900
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	8.00%			8.00%		8.00%
Investment, interest rate	[7],[8],[10],[11]	13.34%			13.34%		13.34%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 8,794
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 8,011
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	166,414			166,414		166,414
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 518
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[10],[11]		7.50%	[7],[10],[11]	7.50%	[7],[10],[11]	7.50%	[14],[15],[16]	7.50%	[14],[15],[16]	7.50%	[14],[15],[16]
Investment, interest rate		12.89%	[7],[8],[10],[11]		12.89%	[7],[8],[10],[11]	12.89%	[7],[8],[10],[11]	11.20%	[14],[15],[16],[17]	11.20%	[14],[15],[16],[17]	11.20%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 17,280	[7],[10],[11],[13]						$ 13,134	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	13,068
Fair Value, Ending Balance	[7],[10],[11]	16,503
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate	[14],[15],[16],[17],[22]								10.00%		10.00%		10.00%
Investment owned, balance, principal amount	[14],[15],[18],[22]								$ 24,043
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 23,923
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		824,197	[10],[20]		824,197	[10],[20]	824,197	[10],[20]	587,930	[15],[22]	587,930	[15],[22]	587,930	[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	$ 3,974
Fair Value, Ending Balance	[10],[20]	$ 6,379
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		141,640	[7],[10],[20],[24]		141,640	[7],[10],[20],[24]	141,640	[7],[10],[20],[24]	124,780	[14],[15],[22],[25]	124,780	[14],[15],[22],[25]	124,780	[14],[15],[22],[25]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22],[25]	$ 212
Fair Value, Ending Balance	[7],[10],[20],[24]	$ 339
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	8.50%			8.50%		8.50%
Investment owned, balance, principal amount	[7],[10],[13],[20]	$ 28,464
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 27,682
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	8.50%			8.50%		8.50%
Investment owned, balance, principal amount	[7],[10],[13],[20]	$ 2,121
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 2,063
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 3
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	8.50%			8.50%		8.50%
Investment owned, balance, principal amount	[7],[10],[13],[20]	$ 27,692
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 26,930
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 4
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	8.50%			8.50%		8.50%
Investment owned, balance, principal amount	[7],[10],[13],[20]	$ 2,064
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	2,007
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate	[14],[15],[16],[17],[22]								10.00%		10.00%		10.00%
Investment owned, balance, principal amount	[14],[15],[18],[22]								$ 23,522
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 23,404
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.75%	[7],[10],[11]		8.75%	[7],[10],[11]	8.75%	[7],[10],[11]	8.75%	[14],[15],[16]	8.75%	[14],[15],[16]	8.75%	[14],[15],[16]
Investment, interest rate		13.99%	[7],[8],[10],[11]		13.99%	[7],[8],[10],[11]	13.99%	[7],[8],[10],[11]	12.30%	[14],[15],[16],[17]	12.30%	[14],[15],[16],[17]	12.30%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 17,048	[7],[10],[11],[13]						$ 14,760	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	13,284
Fair Value, Ending Balance	[7],[10],[11]	$ 12,616
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.25%	[10],[11]		6.25%	[10],[11]	6.25%	[10],[11]	6.25%	[15],[16]	6.25%	[15],[16]	6.25%	[15],[16]
Investment, interest rate		11.49%	[8],[10],[11]		11.49%	[8],[10],[11]	11.49%	[8],[10],[11]	9.03%	[15],[16],[17]	9.03%	[15],[16],[17]	9.03%	[15],[16],[17]
Investment owned, balance, principal amount		$ 19,163	[10],[11],[13]						$ 9,895	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	9,293
Fair Value, Ending Balance	[10],[11]	16,718
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[22]								4.25%		4.25%		4.25%
Investment, interest rate	[14],[15],[16],[17],[22]								7.92%		7.92%		7.92%
Investment owned, balance, principal amount	[14],[15],[16],[18],[22]								$ 15,220
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	$ 14,687
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[7],[10],[11],[20]		8.00%	[7],[10],[11],[20]	8.00%	[7],[10],[11],[20]	8.00%	[14],[15],[16],[22]	8.00%	[14],[15],[16],[22]	8.00%	[14],[15],[16],[22]
Investment, interest rate		13.39%	[7],[8],[10],[11],[20]		13.39%	[7],[8],[10],[11],[20]	13.39%	[7],[8],[10],[11],[20]	11.67%	[14],[15],[16],[17],[22]	11.67%	[14],[15],[16],[17],[22]	11.67%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 12,500	[7],[10],[11],[13],[20]						$ 12,500	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	11,958
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 11,865
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[10],[11]	3.75%			3.75%		3.75%
Investment, interest rate	[8],[10],[11]	9.25%			9.25%		9.25%
Investment owned, balance, principal amount	[10],[11],[13]	$ 3,710
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[11]	2,863
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Products, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								3.75%		3.75%		3.75%
Investment, interest rate	[15],[16],[17]								7.42%		7.42%		7.42%
Investment owned, balance, principal amount	[15],[16],[18]								$ 2,736
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	2,189
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Research & Consulting Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								8.00%		8.00%		8.00%
Investment, interest rate	[14],[15],[16],[17]								10.78%		10.78%		10.78%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 4,346
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 3,813
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.00%	[7],[9],[10],[11]		5.00%	[7],[9],[10],[11]	5.00%	[7],[9],[10],[11]	6.00%	[14],[15],[16],[19]	6.00%	[14],[15],[16],[19]	6.00%	[14],[15],[16],[19]
Investment, interest rate		10.20%	[7],[8],[9],[10],[11]		10.20%	[7],[8],[9],[10],[11]	10.20%	[7],[8],[9],[10],[11]	8.46%	[14],[15],[16],[17],[19]	8.46%	[14],[15],[16],[17],[19]	8.46%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 808	[7],[9],[10],[11],[13]						$ 892	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	846
Fair Value, Ending Balance	[7],[9],[10],[11]	808
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								6.00%		6.00%		6.00%
Investment, interest rate	[14],[15],[16],[17]								8.46%		8.46%		8.46%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 34,458
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 33,738
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.00%			5.00%		5.00%
Investment, interest rate	[7],[8],[10],[11]	10.20%			10.20%		10.20%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 9,280
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 9,280
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.00%			5.00%		5.00%
Investment, interest rate	[7],[8],[10],[11]	10.20%			10.20%		10.20%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 32,308
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 32,308
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[10],[11],[20]		7.25%	[7],[10],[11],[20]	7.25%	[7],[10],[11],[20]	7.00%	[14],[15],[16],[22]	7.00%	[14],[15],[16],[22]	7.00%	[14],[15],[16],[22]
Investment, interest rate		10.07%	[7],[8],[10],[11],[20]		10.07%	[7],[8],[10],[11],[20]	10.07%	[7],[8],[10],[11],[20]	8.00%	[14],[15],[16],[17],[22]	8.00%	[14],[15],[16],[17],[22]	8.00%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount | €					€ 3,017	[7],[10],[11],[13],[20]					€ 1,964	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	$ 1,927
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 3,321
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[10],[11],[20]		6.00%	[7],[10],[11],[20]	6.00%	[7],[10],[11],[20]	7.00%	[14],[15],[16],[22]	7.00%	[14],[15],[16],[22]	7.00%	[14],[15],[16],[22]
Investment, interest rate		11.25%	[7],[8],[10],[11],[20]		11.25%	[7],[8],[10],[11],[20]	11.25%	[7],[8],[10],[11],[20]	9.19%	[14],[15],[16],[17],[22]	9.19%	[14],[15],[16],[17],[22]	9.19%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 10,519	[7],[10],[11],[13],[20]										£ 18,636	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	20,826
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 10,614
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[10],[11],[20]		7.25%	[7],[10],[11],[20]	7.25%	[7],[10],[11],[20]	5.75%	[14],[15],[16],[22]	5.75%	[14],[15],[16],[22]	5.75%	[14],[15],[16],[22]
Investment, interest rate		12.18%	[7],[8],[10],[11],[20]		12.18%	[7],[8],[10],[11],[20]	12.18%	[7],[8],[10],[11],[20]	8.81%	[14],[15],[16],[17],[22]	8.81%	[14],[15],[16],[17],[22]	8.81%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount							£ 4,949	[7],[10],[11],[13],[20]	$ 10,519	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	$ 10,328
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 6,348
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[10],[11],[20]		7.25%	[7],[10],[11],[20]	7.25%	[7],[10],[11],[20]	5.75%	[14],[15],[16],[19],[22]	5.75%	[14],[15],[16],[19],[22]	5.75%	[14],[15],[16],[19],[22]
Investment, interest rate	[7],[8],[10],[11],[20]	12.45%			12.45%		12.45%
Investment owned, balance, principal amount | £							£ 23,675	[7],[10],[11],[13],[20]					£ 0	[14],[15],[16],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19],[22]	$ 0
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 30,370
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[20]	5.75%			5.75%		5.75%
Investment, interest rate	[7],[8],[10],[11],[20]	8.57%			8.57%		8.57%
Investment owned, balance, principal amount | €	[7],[10],[11],[13],[20]				€ 3,649
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 4,027
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,783,332		1,609,201	1,783,332		1,783,332
Investment owned, balance, principal amount		$ 0		$ 0
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		370		587
Gross Additions		40		0
Gross Reductions		(410)		(24)
Fair Value, Ending Balance		$ 0		$ 563
Investment owned, percent of net assets		0.00%		0.00%	0.00%		0.00%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%		6.75%	6.75%		6.75%
Investment, interest rate		12.29%		9.00%	12.29%		12.29%
Investment owned, balance, principal amount		$ 22,304		$ 21,754
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		1,985		1,185
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		24,225		15,712
Gross Additions		2,378		11,585
Gross Reductions		(4,417)		(6,037)
Fair Value, Ending Balance		$ 22,186		$ 21,260
Investment owned, percent of net assets		1.50%		1.70%	1.50%		1.50%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,129,453		1,019,169	1,129,453		1,129,453
Investment owned, balance, principal amount		$ 0		$ 0
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		1,223		1,152
Gross Additions		189		51
Gross Reductions		0		0
Fair Value, Ending Balance		$ 1,412		$ 1,203
Investment owned, percent of net assets		0.10%		0.10%	0.10%		0.10%
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,783,332	[6],[7]		1,783,332	[6],[7]	1,783,332	[6],[7]	1,609,201	[5],[14]	1,609,201	[5],[14]	1,609,201	[5],[14]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[5],[14]	$ 370
Fair Value, Ending Balance	[6],[7]	$ 0
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[6],[7],[9],[11]		6.75%	[6],[7],[9],[11]	6.75%	[6],[7],[9],[11]	6.75%	[5],[14],[16],[19]	6.75%	[5],[14],[16],[19]	6.75%	[5],[14],[16],[19]
Investment, interest rate		12.29%	[6],[7],[8],[9],[11]		12.29%	[6],[7],[8],[9],[11]	12.29%	[6],[7],[8],[9],[11]	10.42%	[5],[14],[16],[17],[19]	10.42%	[5],[14],[16],[17],[19]	10.42%	[5],[14],[16],[17],[19]
Investment owned, balance, principal amount		$ 22,304	[6],[7],[9],[11],[13]						$ 24,490	[5],[14],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[5],[14],[16],[19]	24,225
Fair Value, Ending Balance	[6],[7],[9],[11]	$ 22,186
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,129,453	[6],[7]		1,129,453	[6],[7]	1,129,453	[6],[7]	1,019,169	[5],[14]	1,019,169	[5],[14]	1,019,169	[5],[14]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[5],[14]	$ 1,223
Fair Value, Ending Balance	[6],[7]	$ 1,412
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		78,045	[6],[7]		78,045	[6],[7]	78,045	[6],[7]	70,425	[5],[14]	70,425	[5],[14]	70,425	[5],[14]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[5],[14]	$ 0
Fair Value, Ending Balance	[6],[7]	$ 0
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		78,045		70,425	78,045		78,045
Investment owned, balance, principal amount		$ 0		$ 0
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0		0
Gross Additions		0		0
Gross Reductions		0		0
Fair Value, Ending Balance		$ 0		$ 0
Investment owned, percent of net assets		0.00%		0.00%	0.00%		0.00%
Investment, Identifier [Axis]: Associated Asphalt Partners, LLC, Construction Materials, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								5.25%		5.25%		5.25%
Investment, interest rate	[15],[16],[17]								8.06%		8.06%		8.06%
Investment owned, balance, principal amount	[15],[16],[18]								$ 2,501
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 1,934
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[10],[11]		5.25%	[10],[11]	5.25%	[10],[11]	5.25%	[15],[16]	5.25%	[15],[16]	5.25%	[15],[16]
Investment, interest rate		10.44%	[8],[10],[11]		10.44%	[8],[10],[11]	10.44%	[8],[10],[11]	8.37%	[15],[16],[17]	8.37%	[15],[16],[17]	8.37%	[15],[16],[17]
Investment owned, balance, principal amount		$ 8,490	[10],[11],[13]						$ 5,640	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	4,822
Fair Value, Ending Balance	[10],[11]	$ 5,983
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate		11.00%	[7],[8],[10],[11],[20],[23]		11.00%	[7],[8],[10],[11],[20],[23]	11.00%	[7],[8],[10],[11],[20],[23]	11.00%	[14],[15],[16],[17],[22]	11.00%	[14],[15],[16],[17],[22]	11.00%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 1,338	[7],[10],[13],[20],[23]						$ 13,346	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	12,812
Fair Value, Ending Balance	[7],[10],[20],[23]	$ 1,257
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20],[23]	11.00%			11.00%		11.00%
Investment owned, balance, principal amount		$ 1,338	[7],[10],[13],[20],[23]						$ 8,309	[14],[15],[18],[22],[26]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22],[26]	8,309
Fair Value, Ending Balance	[7],[10],[20],[23]	$ 1,257
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20],[23]	11.00%			11.00%		11.00%
Investment owned, balance, principal amount	[7],[10],[13],[20],[23]	$ 5,350
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20],[23]	5,029
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15],[22]								328,149		328,149		328,149
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 16
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		10,634			10,634		10,634
Investment owned, balance, principal amount	[7],[10],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 0
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10],[20]	10,634			10,634		10,634
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 0
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[10],[11],[20]		6.00%	[7],[10],[11],[20]	6.00%	[7],[10],[11],[20]	6.00%	[14],[15],[16],[22]	6.00%	[14],[15],[16],[22]	6.00%	[14],[15],[16],[22]
Investment, interest rate		11.27%	[7],[8],[10],[11],[20]		11.27%	[7],[8],[10],[11],[20]	11.27%	[7],[8],[10],[11],[20]	8.78%	[14],[15],[16],[17],[22]	8.78%	[14],[15],[16],[17],[22]	8.78%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 29,509	[7],[10],[11],[13],[20]						$ 22,425	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	21,326
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 28,299
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.25%			7.25%		7.25%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (101)
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.25%			7.25%		7.25%
Investment, interest rate	[7],[8],[10],[11]	12.49%			12.49%		12.49%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 50,470
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	49,461
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								5.00%		5.00%		5.00%
Investment, interest rate	[14],[15],[16],[17],[19]								8.12%		8.12%		8.12%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 2,546
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	$ 2,395
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.00%			5.00%		5.00%
Investment, interest rate	[7],[8],[10],[11]	10.50%			10.50%		10.50%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 3,258
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 3,173
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.00%			5.00%		5.00%
Investment, interest rate	[7],[8],[10],[11]	10.50%			10.50%		10.50%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 1,264
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 1,232
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[10],[11]		8.50%	[7],[10],[11]	8.50%	[7],[10],[11]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]
Investment, interest rate		14.00%	[7],[8],[10],[11]		14.00%	[7],[8],[10],[11]	14.00%	[7],[8],[10],[11]	11.62%	[14],[15],[16],[17]	11.62%	[14],[15],[16],[17]	11.62%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 8,920	[7],[10],[11],[13]						$ 7,166	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	6,915
Fair Value, Ending Balance	[7],[10],[11]	$ 8,661
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[10],[11]		8.50%	[7],[10],[11]	8.50%	[7],[10],[11]	8.50%	[14],[15],[16],[19]	8.50%	[14],[15],[16],[19]	8.50%	[14],[15],[16],[19]
Investment, interest rate		14.00%	[7],[8],[10],[11]		14.00%	[7],[8],[10],[11]	14.00%	[7],[8],[10],[11]	11.62%	[14],[15],[16],[17],[19]	11.62%	[14],[15],[16],[17],[19]	11.62%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 2,091	[7],[10],[11],[13]						$ 4,227	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	3,839
Fair Value, Ending Balance	[7],[10],[11]	$ 2,030
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	8.50%			8.50%		8.50%
Investment, interest rate	[7],[8],[10],[11]	14.00%			14.00%		14.00%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 4,361
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 4,235
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	4.50%			4.50%		4.50%
Investment, interest rate	[7],[8],[9],[10],[11]	12.50%			12.50%		12.50%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 2,528
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 2,482
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[10],[11]	10.70%			10.70%		10.70%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 40,764
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	40,316
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								4.50%		4.50%		4.50%
Investment, interest rate	[14],[15],[16],[17],[19]								10.75%		10.75%		10.75%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 1,702
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	1,617
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								5.50%		5.50%		5.50%
Investment, interest rate	[14],[15],[16],[17]								8.31%		8.31%		8.31%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 33,078
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	32,053
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment owned, balance, principal amount	[14],[15],[18],[19],[22],[26]								$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[19],[22],[26]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate		8.00%	[7],[8],[10],[11],[20]		8.00%	[7],[8],[10],[11],[20]	8.00%	[7],[8],[10],[11],[20]	10.25%	[14],[15],[16],[17],[22]	10.25%	[14],[15],[16],[17],[22]	10.25%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 6,719	[7],[10],[13],[20]						$ 5,322	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	5,114
Fair Value, Ending Balance	[7],[10],[20]	6,282
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate	[14],[15],[16],[17],[19],[22]								10.25%		10.25%		10.25%
Investment owned, balance, principal amount		3,210	[7],[10],[13],[20],[21]						$ 0	[14],[15],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[19],[22]	0
Fair Value, Ending Balance	[7],[10],[20],[21]	$ 3,130
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	8.00%			8.00%		8.00%
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[13],[20]						$ 2,353	[14],[15],[18],[22],[26]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22],[26]	2,353
Fair Value, Ending Balance	[7],[9],[10],[20]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	8.00%			8.00%		8.00%
Investment owned, balance, principal amount	[7],[9],[10],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[20]	0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5
Schedule of Investments [Line Items]
Investment owned, balance, principal amount	[7],[9],[10],[13],[20],[21]	0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[20],[21]	0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6
Schedule of Investments [Line Items]
Investment owned, balance, principal amount	[7],[9],[10],[13],[20],[21]	0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[20],[21]	$ 0
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		26,131	[7],[10],[20]		26,131	[7],[10],[20]	26,131	[7],[10],[20]	21,177	[14],[15],[22]	21,177	[14],[15],[22]	21,177	[14],[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 98
Fair Value, Ending Balance	[7],[10],[20]	$ 34
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.00%	[10],[11]		7.00%	[10],[11]	7.00%	[10],[11]	7.00%	[15],[16]	7.00%	[15],[16]	7.00%	[15],[16]
Investment, interest rate		12.25%	[8],[10],[11]		12.25%	[8],[10],[11]	12.25%	[8],[10],[11]	9.50%	[15],[16],[17]	9.50%	[15],[16],[17]	9.50%	[15],[16],[17]
Investment owned, balance, principal amount		$ 30,625	[10],[11],[13]						$ 30,625	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	29,017
Fair Value, Ending Balance	[10],[11]	$ 29,385
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		394,297	[7],[10]		394,297	[7],[10]	394,297	[7],[10]	298,460	[14],[15]	298,460	[14],[15]	298,460	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 349
Fair Value, Ending Balance	[7],[10]	$ 355
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		9.00%	[7],[8],[10],[11]		9.00%	[7],[8],[10],[11]	9.00%	[7],[8],[10],[11]	9.00%	[14],[15],[16],[17]	9.00%	[14],[15],[16],[17]	9.00%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 4,994	[7],[10],[13]						$ 3,979	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	3,960
Fair Value, Ending Balance	[7],[10]	$ 4,969
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,708,618	[7],[10]		1,708,618	[7],[10]	1,708,618	[7],[10]	1,293,324	[14],[15]	1,293,324	[14],[15]	1,293,324	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 1,280
Fair Value, Ending Balance	[7],[10]	$ 2,085
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		394,297	[7],[10]		394,297	[7],[10]	394,297	[7],[10]	298,460	[14],[15]	298,460	[14],[15]	298,460	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 295
Fair Value, Ending Balance	[7],[10]	$ 481
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares				829
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				0
Gross Additions				0
Gross Reductions				0
Fair Value, Ending Balance				$ 0
Investment owned, percent of net assets				0.00%
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		829	[3],[4],[7]		829	[3],[4],[7]	829	[3],[4],[7]	829	[1],[2],[14]	829	[1],[2],[14]	829	[1],[2],[14]
Investment owned, balance, principal amount		$ 0
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[14]	0
Gross Additions		0
Gross Reductions		0
Fair Value, Ending Balance	[3],[4],[7]	$ 0
Investment owned, percent of net assets		0.00%			0.00%		0.00%
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		34,984,460	[3],[4],[7]		34,984,460	[3],[4],[7]	34,984,460	[3],[4],[7]	34,984,460	[1],[2],[14]	34,984,460	[1],[2],[14]	34,984,460	[1],[2],[14]
Investment owned, balance, principal amount		$ 0
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[14]	27,638
Gross Additions		0
Gross Reductions		0
Fair Value, Ending Balance	[3],[4],[7]	$ 27,638
Investment owned, percent of net assets		1.80%			1.80%		1.80%
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares				34,984,460
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				27,638
Gross Additions				0
Gross Reductions				0
Fair Value, Ending Balance				$ 27,638
Investment owned, percent of net assets				2.20%
Investment, Identifier [Axis]: CCO Holdings LLC, Cable & Satellite, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17],[22]								4.50%		4.50%		4.50%
Investment owned, balance, principal amount	[15],[18],[22]								$ 2,097
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	$ 1,603
Investment, Identifier [Axis]: CITGO Holding, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17]								9.25%		9.25%		9.25%
Investment owned, balance, principal amount	[15],[18]								$ 7,857
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	7,807
Investment, Identifier [Axis]: CITGO Petroleum Corp., Oil & Gas Refining & Marketing, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								6.25%		6.25%		6.25%
Investment, interest rate	[15],[16],[17]								9.37%		9.37%		9.37%
Investment owned, balance, principal amount	[15],[16],[18]								$ 795
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 797
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[23]	7.75%			7.75%		7.75%
Investment owned, balance, principal amount	[7],[10],[11],[13],[23]	$ 727
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[23]	325
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								6.50%		6.50%		6.50%
Investment, interest rate	[14],[15],[16],[17]								9.31%		9.31%		9.31%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 14,294
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 13,143
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	11.91%			11.91%		11.91%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 13
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 13
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	11.91%			11.91%		11.91%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 3,031
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 3,031
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	11.91%			11.91%		11.91%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 1,557
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 1,557
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	11.91%			11.91%		11.91%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 1,024
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 1,024
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,080,399	[6],[7]		1,080,399	[6],[7]	1,080,399	[6],[7]	1,080,399	[5],[14]	1,080,399	[5],[14]	1,080,399	[5],[14]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[5],[14]	$ 378
Fair Value, Ending Balance	[6],[7]	$ 313
Investment, Identifier [Axis]: Caregiver Services, Inc., Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,080,399		1,080,399	1,080,399		1,080,399
Investment owned, balance, principal amount		$ 0		$ 0
Net Realized Gain (Loss)		0		0
Amount of Interest, Fees or Dividends Credited in Income		0		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		378		838
Gross Additions		0		0
Gross Reductions		(65)		(437)
Fair Value, Ending Balance		$ 313		$ 401
Investment owned, percent of net assets		0.00%		0.00%	0.00%		0.00%
Investment, Identifier [Axis]: Carvana Co., Automotive Retail, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17],[22]								5.63%		5.63%		5.63%
Investment owned, balance, principal amount	[15],[18],[22]								$ 6,700
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	$ 4,724
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								5.50%		5.50%		5.50%
Investment, interest rate	[14],[15],[16],[17]								8.62%		8.62%		8.62%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 10,692
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 10,209
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[10],[11]	10.70%			10.70%		10.70%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 130
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 130
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[10],[11]	10.70%			10.70%		10.70%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 129
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 129
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[10],[11]	10.70%			10.70%		10.70%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 1,084
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 1,084
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[10],[11]	10.70%			10.70%		10.70%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 9,002
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 9,002
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate		7.50%	[8],[10],[11],[20]		7.50%	[8],[10],[11],[20]	7.50%	[8],[10],[11],[20]	7.50%	[15],[16],[17],[22]	7.50%	[15],[16],[17],[22]	7.50%	[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 2,632	[10],[13],[20]						$ 4,311	[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	3,132
Fair Value, Ending Balance	[10],[20]	$ 1,951
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate		7.75%	[8],[10],[11],[20]		7.75%	[8],[10],[11],[20]	7.75%	[8],[10],[11],[20]	5.13%	[15],[16],[17],[22]	5.13%	[15],[16],[17],[22]	5.13%	[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 176	[10],[13],[20]						$ 1,374	[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	1,163
Fair Value, Ending Balance	[10],[20]	138
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 3
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17],[22]								7.75%		7.75%		7.75%
Investment owned, balance, principal amount	[15],[18],[22]								$ 676
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	$ 512
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate		7.38%	[8],[10],[11]		7.38%	[8],[10],[11]	7.38%	[8],[10],[11]	7.38%	[15],[16],[17]	7.38%	[15],[16],[17]	7.38%	[15],[16],[17]
Investment owned, balance, principal amount		$ 8,420	[10],[13]						$ 8,420	[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	6,900
Fair Value, Ending Balance	[10]	$ 7,330
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[10],[11]		8.50%	[7],[10],[11]	8.50%	[7],[10],[11]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]
Investment, interest rate		13.69%	[7],[8],[10],[11]		13.69%	[7],[8],[10],[11]	13.69%	[7],[8],[10],[11]	11.62%	[14],[15],[16],[17]	11.62%	[14],[15],[16],[17]	11.62%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 24,350	[7],[10],[11],[13]						$ 22,537	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	20,396
Fair Value, Ending Balance	[7],[10],[11]	21,506
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	457
Fair Value, Ending Balance	[7],[10]	$ 154
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.00%	[10],[11]		5.00%	[10],[11]	5.00%	[10],[11]	5.00%	[15],[16]	5.00%	[15],[16]	5.00%	[15],[16]
Investment, interest rate		10.37%	[8],[10],[11]		10.37%	[8],[10],[11]	10.37%	[8],[10],[11]	8.12%	[15],[16],[17]	8.12%	[15],[16],[17]	8.12%	[15],[16],[17]
Investment owned, balance, principal amount		$ 17,506	[10],[11],[13]						$ 11,913	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	8,596
Fair Value, Ending Balance	[10],[11]	$ 11,176
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		417,851	[7],[10]		417,851	[7],[10]	417,851	[7],[10]	417,851	[14],[15]	417,851	[14],[15]	417,851	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 894
Fair Value, Ending Balance	[7],[10]	$ 894
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		1,500	[7],[10]		1,500	[7],[10]	1,500	[7],[10]	1,099	[14],[15]	1,099	[14],[15]	1,099	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 2,340
Fair Value, Ending Balance	[7],[10]	$ 3,299
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.75%	[7],[9],[10],[11]		5.75%	[7],[9],[10],[11]	5.75%	[7],[9],[10],[11]	4.75%	[14],[15],[16],[19]	4.75%	[14],[15],[16],[19]	4.75%	[14],[15],[16],[19]
Investment, interest rate		14.00%	[7],[8],[9],[10],[11]		14.00%	[7],[8],[9],[10],[11]	14.00%	[7],[8],[9],[10],[11]	11.00%	[14],[15],[16],[17],[19]	11.00%	[14],[15],[16],[17],[19]	11.00%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 1,250	[7],[9],[10],[11],[13]						$ 916	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	898
Fair Value, Ending Balance	[7],[9],[10],[11]	1,202
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								5.75%		5.75%		5.75%
Investment, interest rate	[14],[15],[16],[17]								8.88%		8.88%		8.88%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 13,712
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 13,583
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.13%			6.13%		6.13%
Investment, interest rate	[7],[8],[10],[11]	11.33%			11.33%		11.33%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 13,671
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 13,408
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.13%			6.13%		6.13%
Investment, interest rate	[7],[8],[10],[11]	11.33%			11.33%		11.33%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 4,903
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 4,809
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.50%			7.50%		7.50%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (21)
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.50%			7.50%		7.50%
Investment, interest rate	[7],[8],[10],[11]	12.60%			12.60%		12.60%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 13,157
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 12,852
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.50%			7.50%		7.50%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (14)
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.00%	[10],[11]		5.00%	[10],[11]	5.00%	[10],[11]	5.00%	[15],[16]	5.00%	[15],[16]	5.00%	[15],[16]
Investment, interest rate		10.24%	[8],[10],[11]		10.24%	[8],[10],[11]	10.24%	[8],[10],[11]	7.65%	[15],[16],[17]	7.65%	[15],[16],[17]	7.65%	[15],[16],[17]
Investment owned, balance, principal amount		$ 14,787	[10],[11],[13]						$ 10,336	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	9,681
Fair Value, Ending Balance	[10],[11]	$ 13,807
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[9],[10],[11]		6.00%	[7],[9],[10],[11]	6.00%	[7],[9],[10],[11]	6.00%	[14],[15],[16],[19]	6.00%	[14],[15],[16],[19]	6.00%	[14],[15],[16],[19]
Investment, interest rate	[8],[11]	11.20%			11.20%		11.20%
Investment owned, balance, principal amount		$ 533	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(26)
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 507
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[10],[11]		6.00%	[7],[10],[11]	6.00%	[7],[10],[11]	6.00%	[14],[15],[16]	6.00%	[14],[15],[16]	6.00%	[14],[15],[16]
Investment, interest rate		11.10%	[7],[8],[10],[11]		11.10%	[7],[8],[10],[11]	11.10%	[7],[8],[10],[11]	8.81%	[14],[15],[16],[17]	8.81%	[14],[15],[16],[17]	8.81%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 18,060	[7],[10],[11],[13]						$ 18,200	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	17,843
Fair Value, Ending Balance	[7],[10],[11]	$ 17,706
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.75%	[10],[11]		4.75%	[10],[11]	4.75%	[10],[11]	4.75%	[15],[16]	4.75%	[15],[16]	4.75%	[15],[16]
Investment, interest rate		9.80%	[8],[10],[11]		9.80%	[8],[10],[11]	9.80%	[8],[10],[11]	7.33%	[15],[16],[17]	7.33%	[15],[16],[17]	7.33%	[15],[16],[17]
Investment owned, balance, principal amount		$ 4,963	[10],[11],[13]						$ 5,000	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	4,760
Fair Value, Ending Balance	[10],[11]	4,632
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, Internet & Direct Marketing Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16],[22]								5.75%		5.75%		5.75%
Investment, interest rate	[15],[16],[17],[22]								8.49%		8.49%		8.49%
Investment owned, balance, principal amount	[15],[16],[18],[22]								$ 4,988
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16],[22]	$ 4,757
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		2	[7],[10],[20]		2	[7],[10],[20]	2	[7],[10],[20]	2	[14],[15],[22]	2	[14],[15],[22]	2	[14],[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 2
Fair Value, Ending Balance	[7],[10],[20]	$ 2
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		419	[7],[10],[20]		419	[7],[10],[20]	419	[7],[10],[20]	419	[14],[15],[22]	419	[14],[15],[22]	419	[14],[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 419
Fair Value, Ending Balance	[7],[10],[20]	$ 419
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		3.00%	[7],[8],[9],[10],[11],[20]		3.00%	[7],[8],[9],[10],[11],[20]	3.00%	[7],[8],[9],[10],[11],[20]	10.00%	[14],[15],[16],[17],[19],[22]	10.00%	[14],[15],[16],[17],[19],[22]	10.00%	[14],[15],[16],[17],[19],[22]
Investment owned, balance, principal amount		$ 13,043	[7],[9],[10],[13],[20]						$ 4,183	[14],[15],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[19],[22]	4,183
Fair Value, Ending Balance	[7],[9],[10],[20]	$ 13,043
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		31	[7],[10],[20]		31	[7],[10],[20]	31	[7],[10],[20]	31	[14],[15],[22]	31	[14],[15],[22]	31	[14],[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 0
Fair Value, Ending Balance	[7],[10],[20]	0
Investment, Identifier [Axis]: Delta Topco, Inc., Systems Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								7.25%		7.25%		7.25%
Investment, interest rate	[15],[16],[17]								9.34%		9.34%		9.34%
Investment owned, balance, principal amount	[15],[16],[18]								$ 6,680
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 5,934
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	9.00%			9.00%		9.00%
Investment, interest rate	[7],[8],[10],[11]	14.42%			14.42%		14.42%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 20,757
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	20,705
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								9.00%		9.00%		9.00%
Investment, interest rate	[14],[15],[16],[17]								12.67%		12.67%		12.67%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 24,396
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	22,993
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								9.00%		9.00%		9.00%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(129)
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan
Schedule of Investments [Line Items]
Investment owned, balance, principal amount	[7],[10],[13]	641
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 611
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		6,397,254	[7],[10]		6,397,254	[7],[10]	6,397,254	[7],[10]	5,403,823	[14],[15]	5,403,823	[14],[15]	5,403,823	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 1,297
Fair Value, Ending Balance	[7],[10]	$ 1,215
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[9],[10],[11]		6.75%	[7],[9],[10],[11]	6.75%	[7],[9],[10],[11]	6.50%	[14],[15],[16],[19]	6.50%	[14],[15],[16],[19]	6.50%	[14],[15],[16],[19]
Investment, interest rate		12.09%	[7],[8],[9],[10],[11]		12.09%	[7],[8],[9],[10],[11]	12.09%	[7],[8],[9],[10],[11]	9.41%	[14],[15],[16],[17],[19]	9.41%	[14],[15],[16],[17],[19]	9.41%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 204	[7],[9],[10],[11],[13]						$ 251	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	239
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 172
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.00%	[7],[10],[11]		7.00%	[7],[10],[11]	7.00%	[7],[10],[11]	7.00%	[14],[15],[16]	7.00%	[14],[15],[16]	7.00%	[14],[15],[16]
Investment, interest rate		12.34%	[7],[8],[10],[11]		12.34%	[7],[8],[10],[11]	12.34%	[7],[8],[10],[11]	9.91%	[14],[15],[16],[17]	9.91%	[14],[15],[16],[17]	9.91%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 12,418	[7],[10],[11],[13]						$ 9,902	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	9,793
Fair Value, Ending Balance	[7],[10],[11]	$ 12,120
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.00%	[10],[11]		5.00%	[10],[11]	5.00%	[10],[11]	5.00%	[15],[16]	5.00%	[15],[16]	5.00%	[15],[16]
Investment, interest rate		10.22%	[8],[10],[11]		10.22%	[8],[10],[11]	10.22%	[8],[10],[11]	8.12%	[15],[16],[17]	8.12%	[15],[16],[17]	8.12%	[15],[16],[17]
Investment owned, balance, principal amount		$ 4,769	[10],[11],[13]						$ 19,242	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	17,973
Fair Value, Ending Balance	[10],[11]	$ 4,672
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares				30,031
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				3,308
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				18,065
Gross Additions				0
Gross Reductions				(8,798)
Fair Value, Ending Balance				$ 9,267
Investment owned, percent of net assets				0.70%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate				5.00%
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				42
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				0
Gross Additions				0
Gross Reductions				0
Fair Value, Ending Balance				$ 0
Investment owned, percent of net assets				0.00%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate				5.00%
Investment, interest rate				7.26%
Investment owned, balance, principal amount				$ 16,074
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				1,078
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				27,381
Gross Additions				0
Gross Reductions				(11,307)
Fair Value, Ending Balance				$ 16,074
Investment owned, percent of net assets				1.30%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		30,031	[3],[4],[7]		30,031	[3],[4],[7]	30,031	[3],[4],[7]	30,031	[1],[2],[14]	30,031	[1],[2],[14]	30,031	[1],[2],[14]
Investment owned, balance, principal amount		$ 0
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[14]	4,946
Gross Additions		0
Gross Reductions		(2,235)
Fair Value, Ending Balance	[3],[4],[7]	$ 2,711
Investment owned, percent of net assets		0.20%			0.20%		0.20%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.00%	[3],[4],[7],[9],[11]		5.00%	[3],[4],[7],[9],[11]	5.00%	[3],[4],[7],[9],[11]	5.00%	[1],[2],[14],[16],[19]	5.00%	[1],[2],[14],[16],[19]	5.00%	[1],[2],[14],[16],[19]
Investment, interest rate	[3],[4],[7],[8],[9],[11]	10.24%			10.24%		10.24%
Investment owned, balance, principal amount		$ 3,484	[3],[4],[7],[9],[11],[13]						$ 0	[1],[2],[14],[16],[18],[19]
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		136
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[14],[16],[19]	0
Gross Additions		3,484
Gross Reductions		0
Fair Value, Ending Balance	[3],[4],[7],[9],[11]	$ 3,484
Investment owned, percent of net assets		0.20%			0.20%		0.20%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[1],[2],[14],[16]								5.00%		5.00%		5.00%
Investment, interest rate	[1],[2],[14],[16],[17]								8.68%		8.68%		8.68%
Investment owned, balance, principal amount	[1],[2],[14],[16],[18]								$ 14,333
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[14],[16]	$ 14,333
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[3],[4],[7],[11]	5.00%			5.00%		5.00%
Investment, interest rate	[3],[4],[7],[8],[11]	10.39%			10.39%		10.39%
Investment owned, balance, principal amount	[3],[4],[7],[11],[13]	$ 14,102
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		1,070
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		14,333
Gross Additions		0
Gross Reductions		(231)
Fair Value, Ending Balance	[3],[4],[7],[11]	$ 14,102
Investment owned, percent of net assets		0.90%			0.90%		0.90%
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[3],[4],[7],[11]	5.00%			5.00%		5.00%
Investment owned, balance, principal amount	[3],[4],[7],[9],[11],[13]	$ 0
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance		0
Gross Additions		0
Gross Reductions		0
Fair Value, Ending Balance	[3],[4],[7],[9],[11]	$ 0
Investment owned, percent of net assets		0.00%			0.00%		0.00%
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		12,500	[7],[10]		12,500	[7],[10]	12,500	[7],[10]	12,500	[14],[15]	12,500	[14],[15]	12,500	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 0
Fair Value, Ending Balance	[7],[10]	$ 0
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		488	[7],[10]		488	[7],[10]	488	[7],[10]	488	[14],[15]	488	[14],[15]	488	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 966
Fair Value, Ending Balance	[7],[10]	$ 1,160
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[10],[11]		7.50%	[7],[10],[11]	7.50%	[7],[10],[11]	7.50%	[14],[15],[16]	7.50%	[14],[15],[16]	7.50%	[14],[15],[16]
Investment, interest rate		13.04%	[7],[8],[10],[11]		13.04%	[7],[8],[10],[11]	13.04%	[7],[8],[10],[11]	11.17%	[14],[15],[16],[17]	11.17%	[14],[15],[16],[17]	11.17%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 8,974	[7],[10],[11],[13]						$ 8,974	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	8,503
Fair Value, Ending Balance	[7],[10],[11]	$ 7,359
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate		3.00%	[7],[8],[10],[11],[20]		3.00%	[7],[8],[10],[11],[20]	3.00%	[7],[8],[10],[11],[20]	3.00%	[14],[15],[16],[17],[22]	3.00%	[14],[15],[16],[17],[22]	3.00%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 10,899	[7],[10],[13],[20]						$ 10,418	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	10,231
Fair Value, Ending Balance	[7],[10],[20]	$ 10,463
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate		3.00%	[7],[8],[10],[11],[20]		3.00%	[7],[8],[10],[11],[20]	3.00%	[7],[8],[10],[11],[20]	3.00%	[14],[15],[16],[17],[19],[22]	3.00%	[14],[15],[16],[17],[19],[22]	3.00%	[14],[15],[16],[17],[19],[22]
Investment owned, balance, principal amount		$ 1,746	[7],[10],[13],[20]						$ 0	[14],[15],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[19],[22]	0
Fair Value, Ending Balance	[7],[10],[20]	$ 1,676
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[9],[10],[11],[20]	3.00%			3.00%		3.00%
Investment owned, balance, principal amount	[7],[9],[10],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[20]	$ 0
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[9],[10],[11],[20]	3.00%			3.00%		3.00%
Investment owned, balance, principal amount	[7],[9],[10],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[20]	$ 0
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[10],[11]		6.75%	[10],[11]	6.75%	[10],[11]	6.75%	[15],[16]	6.75%	[15],[16]	6.75%	[15],[16]
Investment, interest rate		11.94%	[8],[10],[11]		11.94%	[8],[10],[11]	11.94%	[8],[10],[11]	9.87%	[15],[16],[17]	9.87%	[15],[16],[17]	9.87%	[15],[16],[17]
Investment owned, balance, principal amount		$ 31,074	[10],[11],[13]						$ 25,061	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	21,646
Fair Value, Ending Balance	[10],[11]	$ 18,664
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		9.00%	[7],[8],[9],[10],[11]		9.00%	[7],[8],[9],[10],[11]	9.00%	[7],[8],[9],[10],[11]	9.00%	[14],[15],[16],[17],[27]	9.00%	[14],[15],[16],[17],[27]	9.00%	[14],[15],[16],[17],[27]
Investment owned, balance, principal amount		$ 52,658	[7],[9],[10],[13]						$ 27,850	[14],[15],[18],[27]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[27]	27,850
Fair Value, Ending Balance	[7],[9],[10]	$ 52,658
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		2,500	[7],[10],[20]		2,500	[7],[10],[20]	2,500	[7],[10],[20]	2,500	[14],[15],[22],[27]	2,500	[14],[15],[22],[27]	2,500	[14],[15],[22],[27]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22],[27]	$ 3
Fair Value, Ending Balance	[7],[10],[20]	$ 3
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate				9.00%
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)				7,500
Amount of Interest, Fees or Dividends Credited in Income				0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				7,500
Gross Additions				0
Gross Reductions				(7,500)
Fair Value, Ending Balance				$ 0
Investment owned, percent of net assets				0.00%
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Membership Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage				100.00%
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)				(5,632)
Amount of Interest, Fees or Dividends Credited in Income				158
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				698
Gross Additions				0
Gross Reductions				(698)
Fair Value, Ending Balance				$ 0
Investment owned, percent of net assets				0.00%
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate		11.00%	[7],[8],[10],[11],[20]		11.00%	[7],[8],[10],[11],[20]	11.00%	[7],[8],[10],[11],[20]	11.00%	[14],[15],[16],[17],[22]	11.00%	[14],[15],[16],[17],[22]	11.00%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 11,918	[7],[10],[13],[20]						$ 9,466	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	9,008
Fair Value, Ending Balance	[7],[10],[20]	$ 11,173
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		417,011	[7],[10],[20]		417,011	[7],[10],[20]	417,011	[7],[10],[20]	331,200	[14],[15],[22]	331,200	[14],[15],[22]	331,200	[14],[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 66
Fair Value, Ending Balance	[7],[10],[20]	$ 113
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate		6.00%	[8],[10],[11],[20]		6.00%	[8],[10],[11],[20]	6.00%	[8],[10],[11],[20]	6.00%	[15],[16],[17],[22]	6.00%	[15],[16],[17],[22]	6.00%	[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 4,881	[10],[13],[20]						$ 4,881	[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	3,845
Fair Value, Ending Balance	[10],[20]	3,595
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								7.00%		7.00%		7.00%
Investment, interest rate	[14],[15],[16],[17],[19]								10.60%		10.60%		10.60%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 1,280
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	1,262
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.00%		7.00%		7.00%
Investment, interest rate	[14],[15],[16],[17]								10.67%		10.67%		10.67%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 25,128
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 24,851
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.25%			7.25%		7.25%
Investment, interest rate	[7],[8],[9],[10],[11]	12.34%			12.34%		12.34%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 1,638
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 1,532
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.25%			7.25%		7.25%
Investment, interest rate	[7],[8],[10],[11]	12.34%			12.34%		12.34%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 23,774
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 23,094
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.00%			5.00%		5.00%
Investment, interest rate	[7],[8],[10],[11]	10.25%			10.25%		10.25%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 2,463
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	1,995
Investment, Identifier [Axis]: Global Medical Response, Inc., Health Care Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								4.25%		4.25%		4.25%
Investment, interest rate	[15],[16],[17]								7.37%		7.37%		7.37%
Investment owned, balance, principal amount	[15],[16],[18]								$ 5,572
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 4,848
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[10],[11],[20]	2.85%			2.85%		2.85%
Investment, interest rate	[8],[10],[11],[20]	6.05%			6.05%		6.05%
Investment owned, balance, principal amount | €	[10],[11],[13],[20]				€ 1,000
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[11],[20]	$ 970
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[7],[9],[10],[11]		8.00%	[7],[9],[10],[11]	8.00%	[7],[9],[10],[11]	8.00%	[14],[15],[16],[19]	8.00%	[14],[15],[16],[19]	8.00%	[14],[15],[16],[19]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(25)
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (18)
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[7],[10],[11]		8.00%	[7],[10],[11]	8.00%	[7],[10],[11]	8.00%	[14],[15],[16]	8.00%	[14],[15],[16]	8.00%	[14],[15],[16]
Investment, interest rate		13.39%	[7],[8],[10],[11]		13.39%	[7],[8],[10],[11]	13.39%	[7],[8],[10],[11]	11.04%	[14],[15],[16],[17]	11.04%	[14],[15],[16],[17]	11.04%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 17,488	[7],[10],[11],[13]						$ 14,311	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	14,060
Fair Value, Ending Balance	[7],[10],[11]	$ 17,314
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[7],[9],[10],[11]		8.00%	[7],[9],[10],[11]	8.00%	[7],[9],[10],[11]	8.00%	[14],[15],[16],[19]	8.00%	[14],[15],[16],[19]	8.00%	[14],[15],[16],[19]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(50)
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (35)
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[10],[11]		5.25%	[10],[11]	5.25%	[10],[11]	5.25%	[15],[16]	5.25%	[15],[16]	5.25%	[15],[16]
Investment, interest rate		10.45%	[8],[10],[11]		10.45%	[8],[10],[11]	10.45%	[8],[10],[11]	8.38%	[15],[16],[17]	8.38%	[15],[16],[17]	8.38%	[15],[16],[17]
Investment owned, balance, principal amount		$ 14,383	[10],[11],[13]						$ 9,392	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	8,582
Fair Value, Ending Balance	[10],[11]	$ 12,352
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[20]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11],[20]	11.74%			11.74%		11.74%
Investment owned, balance, principal amount	[7],[10],[11],[13],[20]	$ 7,448
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 7,295
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11],[20]	6.50%			6.50%		6.50%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11],[20]	$ (83)
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes
Schedule of Investments [Line Items]
Investment, interest rate	[8],[10],[11],[20]	4.46%			4.46%		4.46%
Investment owned, balance, principal amount	[10],[13],[20]	$ 6,932
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[20]	$ 6,001
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[20]	8.25%			8.25%		8.25%
Investment, interest rate	[7],[8],[10],[11],[20]	13.30%			13.30%		13.30%
Investment owned, balance, principal amount	[7],[10],[11],[13],[20]	$ 23,975
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 23,292
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.75%			5.75%		5.75%
Investment, interest rate	[7],[8],[10],[11]	11.29%			11.29%		11.29%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 45,169
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	35,834
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Products, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								5.75%		5.75%		5.75%
Investment, interest rate	[14],[15],[16],[17]								9.42%		9.42%		9.42%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 35,625
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 31,528
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[10],[11]		6.50%	[7],[10],[11]	6.50%	[7],[10],[11]	6.50%	[14],[15],[16]	6.50%	[14],[15],[16]	6.50%	[14],[15],[16]
Investment, interest rate		11.57%	[7],[8],[10],[11]		11.57%	[7],[8],[10],[11]	11.57%	[7],[8],[10],[11]	9.44%	[14],[15],[16],[17]	9.44%	[14],[15],[16],[17]	9.44%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 40,484	[7],[10],[11],[13]						$ 34,357	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	32,639
Fair Value, Ending Balance	[7],[10],[11]	38,662
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								5.75%		5.75%		5.75%
Investment, interest rate	[14],[15],[16],[17]								9.42%		9.42%		9.42%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 8,569
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	8,407
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								8.00%		8.00%		8.00%
Investment, interest rate	[14],[15],[16],[17]								11.67%		11.67%		11.67%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 22,619
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	22,275
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment owned, balance, principal amount		15,302	[7],[10],[13],[21]						$ 13,083	[14],[15],[18],[26]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[26]	13,083
Fair Value, Ending Balance	[7],[10],[21]	$ 14,269
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.75%	[7],[10],[11]		8.75%	[7],[10],[11]	8.75%	[7],[10],[11]	8.75%	[14],[15],[16]	8.75%	[14],[15],[16]	8.75%	[14],[15],[16]
Investment, interest rate		14.14%	[7],[8],[10],[11]		14.14%	[7],[8],[10],[11]	14.14%	[7],[8],[10],[11]	12.45%	[14],[15],[16],[17]	12.45%	[14],[15],[16],[17]	12.45%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 13,109	[7],[10],[11],[13]						$ 12,161	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	11,942
Fair Value, Ending Balance	[7],[10],[11]	$ 12,617
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate		11.00%	[7],[8],[10],[11],[20]		11.00%	[7],[8],[10],[11],[20]	11.00%	[7],[8],[10],[11],[20]	11.00%	[14],[15],[16],[17],[22]	11.00%	[14],[15],[16],[17],[22]	11.00%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 8,452	[7],[10],[13],[20]						$ 6,817	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	6,408
Fair Value, Ending Balance	[7],[10],[20]	$ 7,730
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate		11.00%	[7],[8],[9],[10],[11],[20]		11.00%	[7],[8],[9],[10],[11],[20]	11.00%	[7],[8],[9],[10],[11],[20]	11.00%	[14],[15],[16],[17],[19],[22]	11.00%	[14],[15],[16],[17],[19],[22]	11.00%	[14],[15],[16],[17],[19],[22]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[13],[20]						$ 0	[14],[15],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[19],[22]	0
Fair Value, Ending Balance	[7],[9],[10],[20]	$ 0
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[9],[10],[11],[20]	11.00%			11.00%		11.00%
Investment owned, balance, principal amount	[7],[9],[10],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[20]	$ 0
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		112,990	[7],[10],[20]		112,990	[7],[10],[20]	112,990	[7],[10],[20]	56,999	[14],[15],[22]	56,999	[14],[15],[22]	56,999	[14],[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 609
Fair Value, Ending Balance	[7],[10],[20]	$ 172
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	1,078,284			1,078,284		1,078,284
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 0
Investment, Identifier [Axis]: Integral Development Corporation, Other Diversified Financial Services, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15]								1,078,284		1,078,284		1,078,284
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 0
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.50%			7.50%		7.50%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (114)
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[10],[11]		7.50%	[7],[10],[11]	7.50%	[7],[10],[11]	5.00%	[14],[15],[16]	5.00%	[14],[15],[16]	5.00%	[14],[15],[16]
Investment, interest rate		12.72%	[7],[8],[10],[11]		12.72%	[7],[8],[10],[11]	12.72%	[7],[8],[10],[11]	8.55%	[14],[15],[16],[17]	8.55%	[14],[15],[16],[17]	8.55%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 33,498	[7],[10],[11],[13]						$ 18,660	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	18,134
Fair Value, Ending Balance	[7],[10],[11]	32,493
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								8.50%		8.50%		8.50%
Investment, interest rate	[14],[15],[16],[17]								12.17%		12.17%		12.17%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 13,674
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 13,154
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[10],[11]		7.25%	[10],[11]	7.25%	[10],[11]	7.25%	[15],[16]	7.25%	[15],[16]	7.25%	[15],[16]
Investment, interest rate		12.42%	[8],[10],[11]		12.42%	[8],[10],[11]	12.42%	[8],[10],[11]	10.33%	[15],[16],[17]	10.33%	[15],[16],[17]	10.33%	[15],[16],[17]
Investment owned, balance, principal amount		$ 13,939	[10],[11],[13]						$ 10,247	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	7,702
Fair Value, Ending Balance	[10],[11]	9,252
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		5,193
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.50%		7.50%		7.50%
Investment, interest rate	[14],[15],[16],[17]								10.62%		10.62%		10.62%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 36,234
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 36,392
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.50%			7.50%		7.50%
Investment, interest rate	[7],[8],[10],[11]	12.70%			12.70%		12.70%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 17,069
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 16,966
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.50%			7.50%		7.50%
Investment, interest rate	[7],[8],[10],[11]	12.70%			12.70%		12.70%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 27,360
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 27,488
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[10],[11]	10.60%			10.60%		10.60%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 15,150
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 14,924
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[10],[11]		8.00%	[10],[11]	8.00%	[10],[11]	8.00%	[15],[16]	8.00%	[15],[16]	8.00%	[15],[16]
Investment, interest rate		13.20%	[8],[10],[11]		13.20%	[8],[10],[11]	13.20%	[8],[10],[11]	11.12%	[15],[16],[17]	11.12%	[15],[16],[17]	11.12%	[15],[16],[17]
Investment owned, balance, principal amount		$ 666	[10],[11],[13]						$ 528	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	481
Fair Value, Ending Balance	[10],[11]	$ 652
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[9],[10],[11]		6.50%	[7],[9],[10],[11]	6.50%	[7],[9],[10],[11]	6.50%	[14],[15],[16],[19]	6.50%	[14],[15],[16],[19]	6.50%	[14],[15],[16],[19]
Investment, interest rate		11.84%	[7],[8],[9],[10],[11]		11.84%	[7],[8],[9],[10],[11]	11.84%	[7],[8],[9],[10],[11]	10.17%	[14],[15],[16],[17],[19]	10.17%	[14],[15],[16],[17],[19]	10.17%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 545	[7],[9],[10],[11],[13]						$ 329	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	292
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 510
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[10],[11]		6.50%	[7],[10],[11]	6.50%	[7],[10],[11]	6.50%	[14],[15],[16]	6.50%	[14],[15],[16]	6.50%	[14],[15],[16]
Investment, interest rate		11.84%	[7],[8],[10],[11]		11.84%	[7],[8],[10],[11]	11.84%	[7],[8],[10],[11]	10.17%	[14],[15],[16],[17]	10.17%	[14],[15],[16],[17]	10.17%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 16,765	[7],[10],[11],[13]						$ 13,623	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	13,351
Fair Value, Ending Balance	[7],[10],[11]	$ 16,511
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[9],[10],[11]		6.00%	[7],[9],[10],[11]	6.00%	[7],[9],[10],[11]	6.00%	[14],[15],[16],[19]	6.00%	[14],[15],[16],[19]	6.00%	[14],[15],[16],[19]
Investment, interest rate	[14],[15],[16],[17],[19]								9.12%		9.12%		9.12%
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13]						$ 1,710	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	1,651
Fair Value, Ending Balance	[7],[9],[10],[11]	(146)
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								6.00%		6.00%		6.00%
Investment, interest rate	[14],[15],[16],[17]								9.12%		9.12%		9.12%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 19,236
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 18,707
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.00%			6.00%		6.00%
Investment, interest rate	[7],[8],[10],[11]	11.20%			11.20%		11.20%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 2,742
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 2,592
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.00%			6.00%		6.00%
Investment, interest rate	[7],[8],[10],[11]	11.20%			11.20%		11.20%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 23,554
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 22,258
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[10],[11]		6.75%	[10],[11]	6.75%	[10],[11]	6.75%	[15],[16]	6.75%	[15],[16]	6.75%	[15],[16]
Investment, interest rate		11.97%	[8],[10],[11]		11.97%	[8],[10],[11]	11.97%	[8],[10],[11]	9.87%	[15],[16],[17]	9.87%	[15],[16],[17]	9.87%	[15],[16],[17]
Investment owned, balance, principal amount		$ 2,140	[10],[11],[13]						$ 2,140	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	1,890
Fair Value, Ending Balance	[10],[11]	1,834
Investment, Identifier [Axis]: LaserShip, Inc., Air Freight & Logistics, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.50%		7.50%		7.50%
Investment, interest rate	[14],[15],[16],[17]								10.38%		10.38%		10.38%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 2,394
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 1,867
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[10],[11],[20]	9.50%			9.50%		9.50%
Investment, interest rate	[8],[10],[11],[20]	14.61%			14.61%		14.61%
Investment owned, balance, principal amount	[10],[11],[13],[20]	$ 26,489
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[11],[20]	$ 26,985
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		2,000,000	[7],[10]		2,000,000	[7],[10]	2,000,000	[7],[10]	2,000,000	[14],[15]	2,000,000	[14],[15]	2,000,000	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 0
Fair Value, Ending Balance	[7],[10]	$ 0
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.00%	[7],[10],[11]		5.00%	[7],[10],[11]	5.00%	[7],[10],[11]	5.00%	[14],[15],[16]	5.00%	[14],[15],[16]	5.00%	[14],[15],[16]
Investment, interest rate		10.50%	[7],[8],[10],[11]		10.50%	[7],[8],[10],[11]	10.50%	[7],[8],[10],[11]	8.67%	[14],[15],[16],[17]	8.67%	[14],[15],[16],[17]	8.67%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 45,361	[7],[10],[11],[13]						$ 41,008	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	39,573
Fair Value, Ending Balance	[7],[10],[11]	$ 44,227
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		559	[7],[10]		559	[7],[10]	559	[7],[10]	451	[14],[15]	451	[14],[15]	451	[14],[15]
Investment owned, balance, principal amount	[7],[10],[13]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	451
Fair Value, Ending Balance	[7],[10]	$ 487
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[10],[11]		8.50%	[7],[10],[11]	8.50%	[7],[10],[11]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]
Investment, interest rate		13.84%	[7],[8],[10],[11]		13.84%	[7],[8],[10],[11]	13.84%	[7],[8],[10],[11]	11.38%	[14],[15],[16],[17]	11.38%	[14],[15],[16],[17]	11.38%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 5,403	[7],[10],[11],[13]						$ 4,357	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	4,226
Fair Value, Ending Balance	[7],[10],[11]	$ 5,173
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[9],[10],[11]		8.50%	[7],[9],[10],[11]	8.50%	[7],[9],[10],[11]	8.50%	[14],[15],[16],[19]	8.50%	[14],[15],[16],[19]	8.50%	[14],[15],[16],[19]
Investment, interest rate		13.84%	[7],[8],[9],[10],[11]		13.84%	[7],[8],[9],[10],[11]	13.84%	[7],[8],[9],[10],[11]	11.38%	[14],[15],[16],[17],[19]	11.38%	[14],[15],[16],[17],[19]	11.38%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 2,939	[7],[9],[10],[11],[13]						$ 2,370	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	2,265
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 2,755
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[9],[10],[11]		6.00%	[7],[9],[10],[11]	6.00%	[7],[9],[10],[11]	6.00%	[14],[15],[16],[19]	6.00%	[14],[15],[16],[19]	6.00%	[14],[15],[16],[19]
Investment, interest rate	[7],[8],[9],[10],[11]	11.25%			11.25%		11.25%
Investment owned, balance, principal amount		$ 250	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(54)
Fair Value, Ending Balance	[7],[9],[10],[11]	203
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								6.00%		6.00%		6.00%
Investment, interest rate	[14],[15],[16],[17]								9.50%		9.50%		9.50%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 18,390
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 17,691
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.00%			6.00%		6.00%
Investment, interest rate	[7],[8],[10],[11]	11.20%			11.20%		11.20%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 20,176
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 19,648
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.00%			6.00%		6.00%
Investment, interest rate	[7],[8],[10],[11]	11.20%			11.20%		11.20%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 2,637
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 2,568
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.50%			7.50%		7.50%
Investment, interest rate	[7],[8],[9],[10],[11]	12.58%			12.58%		12.58%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 2,118
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 1,853
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.50%			7.50%		7.50%
Investment, interest rate	[7],[8],[10],[11]	12.74%			12.74%		12.74%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 40,640
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 39,937
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[9],[10],[11]		5.50%	[7],[9],[10],[11]	5.50%	[7],[9],[10],[11]	5.50%	[14],[15],[16],[19]	5.50%	[14],[15],[16],[19]	5.50%	[14],[15],[16],[19]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(51)
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (62)
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[10],[11]		5.50%	[7],[10],[11]	5.50%	[7],[10],[11]	5.50%	[14],[15],[16]	5.50%	[14],[15],[16]	5.50%	[14],[15],[16]
Investment, interest rate		10.84%	[7],[8],[10],[11]		10.84%	[7],[8],[10],[11]	10.84%	[7],[8],[10],[11]	9.17%	[14],[15],[16],[17]	9.17%	[14],[15],[16],[17]	9.17%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 12,397	[7],[10],[11],[13]						$ 29,565	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	28,734
Fair Value, Ending Balance	[7],[10],[11]	$ 12,056
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[10],[11]		5.50%	[7],[10],[11]	5.50%	[7],[10],[11]	5.50%	[14],[15],[16],[19]	5.50%	[14],[15],[16],[19]	5.50%	[14],[15],[16],[19]
Investment, interest rate	[7],[8],[10],[11]	10.84%			10.84%		10.84%
Investment owned, balance, principal amount		$ 21,383	[7],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(96)
Fair Value, Ending Balance	[7],[10],[11]	$ 20,795
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[7],[8],[9],[10],[11]	10.83%			10.83%		10.83%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 570
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 526
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate		11.50%	[7],[8],[10],[11],[20]		11.50%	[7],[8],[10],[11],[20]	11.50%	[7],[8],[10],[11],[20]	11.50%	[14],[15],[16],[17],[22]	11.50%	[14],[15],[16],[17],[22]	11.50%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 8,568	[7],[10],[13],[20]						$ 17,203	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	16,644
Fair Value, Ending Balance	[7],[10],[20]	$ 8,225
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate		11.50%	[7],[8],[10],[11],[20]		11.50%	[7],[8],[10],[11],[20]	11.50%	[7],[8],[10],[11],[20]	11.50%	[14],[15],[16],[17],[19],[22]	11.50%	[14],[15],[16],[17],[19],[22]	11.50%	[14],[15],[16],[17],[19],[22]
Investment owned, balance, principal amount		$ 4,284	[7],[10],[13],[20]						$ 0	[14],[15],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[19],[22]	0
Fair Value, Ending Balance	[7],[10],[20]	$ 4,112
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	11.50%			11.50%		11.50%
Investment owned, balance, principal amount	[7],[10],[13],[20]	$ 8,568
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 8,225
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	11.50%			11.50%		11.50%
Investment owned, balance, principal amount	[7],[9],[10],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[20]	$ 0
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate		8.00%	[7],[8],[10],[11],[20]		8.00%	[7],[8],[10],[11],[20]	8.00%	[7],[8],[10],[11],[20]	8.00%	[14],[15],[16],[17],[22]	8.00%	[14],[15],[16],[17],[22]	8.00%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 9,066	[7],[10],[13],[20]						$ 7,215	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	6,440
Fair Value, Ending Balance	[7],[10],[20]	$ 8,114
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate		8.00%	[7],[8],[10],[11],[20]		8.00%	[7],[8],[10],[11],[20]	8.00%	[7],[8],[10],[11],[20]	8.00%	[14],[15],[16],[17],[19],[22]	8.00%	[14],[15],[16],[17],[19],[22]	8.00%	[14],[15],[16],[17],[19],[22]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[13],[20]						$ 0	[14],[15],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[19],[22]	0
Fair Value, Ending Balance	[7],[9],[10],[20]	$ 0
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	8.00%			8.00%		8.00%
Investment owned, balance, principal amount	[7],[9],[10],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[20]	0
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15],[22]								209,588		209,588		209,588
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 170
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10],[20]	259,877			259,877		259,877
Investment owned, balance, principal amount	[7],[10],[13],[20]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 437
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10],[20]	66,817			66,817		66,817
Investment owned, balance, principal amount	[7],[10],[13],[20]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 153
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.00%	[7],[9],[10],[11]		7.00%	[7],[9],[10],[11]	7.00%	[7],[9],[10],[11]	8.00%	[14],[15],[16],[19]	8.00%	[14],[15],[16],[19]	8.00%	[14],[15],[16],[19]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(100)
Fair Value, Ending Balance	[7],[9],[10],[11]	(71)
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.00%		7.00%		7.00%
Investment, interest rate	[14],[15],[16],[17]								10.64%		10.64%		10.64%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 45,665
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 44,523
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[10],[11]	12.19%			12.19%		12.19%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 7,464
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 7,352
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[10],[11]	12.19%			12.19%		12.19%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 46,687
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 45,987
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[10],[11]		6.75%	[7],[10],[11]	6.75%	[7],[10],[11]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]
Investment, interest rate		11.97%	[7],[8],[10],[11]		11.97%	[7],[8],[10],[11]	11.97%	[7],[8],[10],[11]	9.89%	[14],[15],[16],[17]	9.89%	[14],[15],[16],[17]	9.89%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 55,297	[7],[10],[11],[13]						$ 46,499	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	45,421
Fair Value, Ending Balance	[7],[10],[11]	$ 54,235
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[8],[10],[11]	6.88%			6.88%		6.88%
Investment owned, balance, principal amount	[10],[13]	$ 10,191
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10]	8,860
Investment, Identifier [Axis]: NFP Corp., Other Diversified Financial Services, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17]								6.88%		6.88%		6.88%
Investment owned, balance, principal amount	[15],[18]								$ 10,191
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 7,966
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[20]	6.88%			6.88%		6.88%
Investment, interest rate	[7],[8],[10],[11],[20]	12.08%			12.08%		12.08%
Investment owned, balance, principal amount	[7],[10],[11],[13],[20]	$ 73,178
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 69,885
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		487,870			487,870		487,870
Investment owned, balance, principal amount | €	[7],[10],[11],[13],[20]				€ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 1,161
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		487,870			487,870		487,870
Investment owned, balance, principal amount | €	[10],[11],[13],[20]				€ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[11],[20]	$ 1,161
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[22]								6.88%		6.88%		6.88%
Investment, interest rate	[14],[15],[16],[17],[22]								9.99%		9.99%		9.99%
Investment owned, balance, principal amount	[14],[15],[16],[18],[22]								$ 58,713
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	$ 56,805
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[10],[11]		8.50%	[7],[10],[11]	8.50%	[7],[10],[11]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]
Investment, interest rate		14.04%	[7],[8],[10],[11]		14.04%	[7],[8],[10],[11]	14.04%	[7],[8],[10],[11]	12.17%	[14],[15],[16],[17]	12.17%	[14],[15],[16],[17]	12.17%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 30,339	[7],[10],[11],[13]						$ 22,560	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	21,524
Fair Value, Ending Balance	[7],[10],[11]	$ 29,125
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10.50%	[7],[10],[11]		10.50%	[7],[10],[11]	10.50%	[7],[10],[11]	10.50%	[14],[15],[16]	10.50%	[14],[15],[16]	10.50%	[14],[15],[16]
Investment, interest rate		16.04%	[7],[8],[10],[11]		16.04%	[7],[8],[10],[11]	16.04%	[7],[8],[10],[11]	14.17%	[14],[15],[16],[17]	14.17%	[14],[15],[16],[17]	14.17%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 64,606	[7],[10],[11],[13]						$ 50,459	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	51,972
Fair Value, Ending Balance	[7],[10],[11]	$ 63,185
Investment, Identifier [Axis]: OCSI Glick JV LLC, Membership Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage				87.50%
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				0
Gross Additions				0
Gross Reductions				0
Fair Value, Ending Balance				$ 0
Investment owned, percent of net assets				0.00%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[1],[2],[19],[22],[28],[29]								0.875		0.875		0.875
Investment owned, ownership percentage	[3],[4],[9],[20],[30],[31]	87.50%			87.50%		87.50%
Investment owned, balance, principal amount		$ 0
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[19],[22],[28],[29]	0
Gross Additions		0
Gross Reductions		0
Fair Value, Ending Balance	[3],[4],[9],[20],[30],[31]	$ 0
Investment owned, percent of net assets		0.00%			0.00%		0.00%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.50%	[3],[4],[7],[9],[11],[20],[30]		4.50%	[3],[4],[7],[9],[11],[20],[30]	4.50%	[3],[4],[7],[9],[11],[20],[30]	4.50%	[1],[2],[14],[16],[19],[22],[28]	4.50%	[1],[2],[14],[16],[19],[22],[28]	4.50%	[1],[2],[14],[16],[19],[22],[28]
Investment, interest rate		9.36%	[3],[4],[7],[8],[9],[11],[20],[30]		9.36%	[3],[4],[7],[8],[9],[11],[20],[30]	9.36%	[3],[4],[7],[8],[9],[11],[20],[30]	6.30%	[1],[2],[14],[16],[17],[19],[22],[28]	6.30%	[1],[2],[14],[16],[17],[19],[22],[28]	6.30%	[1],[2],[14],[16],[17],[19],[22],[28]
Investment owned, balance, principal amount		$ 58,349	[3],[4],[7],[9],[11],[13],[20],[30]						$ 59,662	[1],[2],[14],[16],[18],[19],[22],[28]
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		4,961
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[14],[16],[19],[22],[28]	50,283
Gross Additions		1,116
Gross Reductions		(1,767)
Fair Value, Ending Balance	[3],[4],[7],[9],[11],[20],[30]	$ 49,632
Investment owned, percent of net assets		3.30%			3.30%		3.30%
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt
Schedule of Investments [Line Items]
Investment, basis spread, variable rate				4.50%
Investment, interest rate				4.94%
Investment owned, balance, principal amount				$ 60,274
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				3,292
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				55,582
Gross Additions				1,123
Gross Reductions				(6,099)
Fair Value, Ending Balance				$ 50,606
Investment owned, percent of net assets				4.00%
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								4.00%		4.00%		4.00%
Investment, interest rate	[15],[16],[17]								7.12%		7.12%		7.12%
Investment owned, balance, principal amount	[15],[16],[18]								$ 3,323
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 3,207
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.00%	[7],[10],[11]		7.00%	[7],[10],[11]	7.00%	[7],[10],[11]	7.00%	[14],[15],[16]	7.00%	[14],[15],[16]	7.00%	[14],[15],[16]
Investment, interest rate		12.34%	[7],[8],[10],[11]		12.34%	[7],[8],[10],[11]	12.34%	[7],[8],[10],[11]	10.05%	[14],[15],[16],[17]	10.05%	[14],[15],[16],[17]	10.05%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 9,323	[7],[10],[11],[13]						$ 7,519	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	7,237
Fair Value, Ending Balance	[7],[10],[11]	$ 9,090
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10.00%	[7],[10],[11]		10.00%	[7],[10],[11]	10.00%	[7],[10],[11]	2.00%	[14],[15],[16]	2.00%	[14],[15],[16]	2.00%	[14],[15],[16]
Investment, interest rate		15.50%	[7],[8],[10],[11]		15.50%	[7],[8],[10],[11]	15.50%	[7],[8],[10],[11]	5.08%	[14],[15],[16],[17]	5.08%	[14],[15],[16],[17]	5.08%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 25,712	[7],[10],[11],[13]						$ 21,557	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	21,557
Fair Value, Ending Balance	[7],[10],[11]	$ 25,712
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		10.00%	[7],[9],[10],[11]		10.00%	[7],[9],[10],[11]	10.00%	[7],[9],[10],[11]	2.00%	[14],[15],[16],[19]	2.00%	[14],[15],[16],[19]	2.00%	[14],[15],[16],[19]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	0
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 0
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	10.00%			10.00%		10.00%
Investment, interest rate	[7],[8],[9],[10],[11]	15.39%			15.39%		15.39%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 1,210
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 1,210
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.75%			7.75%		7.75%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (44)
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.75%			7.75%		7.75%
Investment, interest rate	[7],[8],[10],[11]	12.79%			12.79%		12.79%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 15,231
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	14,882
Investment, Identifier [Axis]: Other cash accounts
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance		$ 67,467
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate		7.75%	[8],[10],[11]		7.75%	[8],[10],[11]	7.75%	[8],[10],[11]	7.75%	[15],[16],[17]	7.75%	[15],[16],[17]	7.75%	[15],[16],[17]
Investment owned, balance, principal amount		$ 7,480	[10],[13]						$ 7,776	[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	5,846
Fair Value, Ending Balance	[10]	6,090
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								7.00%		7.00%		7.00%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(13)
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.00%		7.00%		7.00%
Investment, interest rate	[14],[15],[16],[17]								9.28%		9.28%		9.28%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 26,154
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	25,893
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[19]								7.00%		7.00%		7.00%
Investment, interest rate	[14],[15],[16],[17],[19]								9.25%		9.25%		9.25%
Investment owned, balance, principal amount	[14],[15],[16],[18],[19]								$ 2,228
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	$ 2,203
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.00%			7.00%		7.00%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (57)
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[10],[11]	12.10%			12.10%		12.10%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 10,923
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 10,497
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		100,000	[7],[10]		100,000	[7],[10]	100,000	[7],[10]	80,515	[14],[15]	80,515	[14],[15]	80,515	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 89
Fair Value, Ending Balance	[7],[10]	$ 221
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[9],[10],[11]		6.50%	[7],[9],[10],[11]	6.50%	[7],[9],[10],[11]	6.75%	[14],[15],[16],[19]	6.75%	[14],[15],[16],[19]	6.75%	[14],[15],[16],[19]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(49)
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (26)
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[10],[11]		6.50%	[7],[10],[11]	6.50%	[7],[10],[11]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]
Investment, interest rate		11.73%	[7],[8],[10],[11]		11.73%	[7],[8],[10],[11]	11.73%	[7],[8],[10],[11]	10.42%	[14],[15],[16],[17]	10.42%	[14],[15],[16],[17]	10.42%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 38,521	[7],[10],[11],[13]						$ 33,775	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	33,116
Fair Value, Ending Balance	[7],[10],[11]	$ 38,205
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.00%	[10],[11]		5.00%	[10],[11]	5.00%	[10],[11]	5.00%	[15],[16]	5.00%	[15],[16]	5.00%	[15],[16]
Investment, interest rate		10.20%	[8],[10],[11]		10.20%	[8],[10],[11]	10.20%	[8],[10],[11]	8.13%	[15],[16],[17]	8.13%	[15],[16],[17]	8.13%	[15],[16],[17]
Investment owned, balance, principal amount		$ 9,701	[10],[11],[13]						$ 9,850	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	9,374
Fair Value, Ending Balance	[10],[11]	$ 9,458
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[10],[11]		6.00%	[7],[10],[11]	6.00%	[7],[10],[11]	6.00%	[14],[15],[16]	6.00%	[14],[15],[16]	6.00%	[14],[15],[16]
Investment, interest rate		10.96%	[7],[8],[10],[11]		10.96%	[7],[8],[10],[11]	10.96%	[7],[8],[10],[11]	8.88%	[14],[15],[16],[17]	8.88%	[14],[15],[16],[17]	8.88%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 22,375	[7],[10],[11],[13]						$ 17,976	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	17,537
Fair Value, Ending Balance	[7],[10],[11]	$ 21,829
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[10],[11]		7.25%	[7],[10],[11]	7.25%	[7],[10],[11]	7.25%	[14],[15],[16]	7.25%	[14],[15],[16]	7.25%	[14],[15],[16]
Investment, interest rate		12.59%	[7],[8],[10],[11]		12.59%	[7],[8],[10],[11]	12.59%	[7],[8],[10],[11]	10.92%	[14],[15],[16],[17]	10.92%	[14],[15],[16],[17]	10.92%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 36,499	[7],[10],[11],[13]						$ 28,627	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	27,482
Fair Value, Ending Balance	[7],[10],[11]	$ 32,606
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[7],[9],[10],[11]		8.00%	[7],[9],[10],[11]	8.00%	[7],[9],[10],[11]	8.00%	[14],[15],[16],[19]	8.00%	[14],[15],[16],[19]	8.00%	[14],[15],[16],[19]
Investment, interest rate	[7],[8],[9],[10],[11]	13.04%			13.04%		13.04%
Investment owned, balance, principal amount		$ 2,395	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(111)
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 2,218
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[7],[10],[11]		8.00%	[7],[10],[11]	8.00%	[7],[10],[11]	8.00%	[14],[15],[16]	8.00%	[14],[15],[16]	8.00%	[14],[15],[16]
Investment, interest rate		13.04%	[7],[8],[10],[11]		13.04%	[7],[8],[10],[11]	13.04%	[7],[8],[10],[11]	10.68%	[14],[15],[16],[17]	10.68%	[14],[15],[16],[17]	10.68%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 67,244	[7],[10],[11],[13]						$ 48,689	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	47,155
Fair Value, Ending Balance	[7],[10],[11]	$ 64,756
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.25%			7.25%		7.25%
Investment, interest rate	[7],[8],[10],[11]	12.42%			12.42%		12.42%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 24,537
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 24,047
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.25%			7.25%		7.25%
Investment, interest rate	[7],[8],[10],[11]	12.42%			12.42%		12.42%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 2,823
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	2,767
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								8.50%		8.50%		8.50%
Investment, interest rate	[14],[15],[16],[17]								10.01%		10.01%		10.01%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 23,275
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 22,810
Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[7],[10],[11]		8.00%	[7],[10],[11]	8.00%	[7],[10],[11]	8.00%	[14],[15],[16]	8.00%	[14],[15],[16]	8.00%	[14],[15],[16]
Investment, interest rate		13.22%	[7],[8],[10],[11]		13.22%	[7],[8],[10],[11]	13.22%	[7],[8],[10],[11]	11.12%	[14],[15],[16],[17]	11.12%	[14],[15],[16],[17]	11.12%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 6,750	[7],[10],[11],[13]						$ 5,250	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	5,047
Fair Value, Ending Balance	[7],[10],[11]	$ 6,235
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.68%	[7],[10],[11],[20]		5.68%	[7],[10],[11],[20]	5.68%	[7],[10],[11],[20]	6.00%	[14],[15],[16],[22]	6.00%	[14],[15],[16],[22]	6.00%	[14],[15],[16],[22]
Investment, interest rate		10.88%	[7],[8],[10],[11],[20]		10.88%	[7],[8],[10],[11],[20]	10.88%	[7],[8],[10],[11],[20]	8.39%	[14],[15],[16],[17],[22]	8.39%	[14],[15],[16],[17],[22]	8.39%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount | £							£ 4,626	[7],[10],[11],[13],[20]					£ 3,501	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	$ 3,367
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 5,296
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		64,887,669	[7],[10]		64,887,669	[7],[10]	64,887,669	[7],[10]	64,887,669	[14],[15]	64,887,669	[14],[15]	64,887,669	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 0
Fair Value, Ending Balance	[7],[10]	0
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Health Care Distributors, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17]								5.25%		5.25%		5.25%
Investment owned, balance, principal amount	[15],[18]								$ 1,325
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	1,097
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								4.25%		4.25%		4.25%
Investment, interest rate	[15],[16],[17]								7.33%		7.33%		7.33%
Investment owned, balance, principal amount	[15],[16],[18]								$ 3,400
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	2,880
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17]								9.25%		9.25%		9.25%
Investment owned, balance, principal amount	[15],[18]								$ 4,755
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 3,109
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.50%	[7],[9],[10],[11]		6.50%	[7],[9],[10],[11]	6.50%	[7],[9],[10],[11]	6.50%	[14],[15],[16],[19]	6.50%	[14],[15],[16],[19]	6.50%	[14],[15],[16],[19]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(64)
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (52)
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[10],[11]		7.50%	[7],[10],[11]	7.50%	[7],[10],[11]	7.50%	[14],[15],[16]	7.50%	[14],[15],[16]	7.50%	[14],[15],[16]
Investment, interest rate	[7],[8],[10],[11]	11.70%			11.70%		11.70%
Investment owned, balance, principal amount		$ 32,329	[7],[10],[11],[13]						$ 24,692	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	24,101
Fair Value, Ending Balance	[7],[10],[11]	31,715
Investment, Identifier [Axis]: Renaissance Holding Corp., Diversified Banks, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								7.00%		7.00%		7.00%
Investment, interest rate	[15],[16],[17]								10.12%		10.12%		10.12%
Investment owned, balance, principal amount	[15],[16],[18]								$ 3,542
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 3,402
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[10],[11]	7.00%			7.00%		7.00%
Investment, interest rate	[8],[10],[11]	12.19%			12.19%		12.19%
Investment owned, balance, principal amount	[10],[11],[13]	$ 1,789
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[11]	$ 1,764
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[7],[10],[11],[20]		8.25%	[7],[10],[11],[20]	8.25%	[7],[10],[11],[20]	8.25%	[14],[15],[16],[22]	8.25%	[14],[15],[16],[22]	8.25%	[14],[15],[16],[22]
Investment, interest rate		13.75%	[7],[8],[10],[11],[20]		13.75%	[7],[8],[10],[11],[20]	13.75%	[7],[8],[10],[11],[20]	11.92%	[14],[15],[16],[17],[22]	11.92%	[14],[15],[16],[17],[22]	11.92%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 44,602	[7],[10],[11],[13],[20]						$ 37,656	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	36,187
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 41,815
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[7],[10],[11],[20]		8.25%	[7],[10],[11],[20]	8.25%	[7],[10],[11],[20]	8.25%	[14],[15],[16],[19],[22]	8.25%	[14],[15],[16],[19],[22]	8.25%	[14],[15],[16],[19],[22]
Investment, interest rate		13.75%	[7],[8],[10],[11],[20]		13.75%	[7],[8],[10],[11],[20]	13.75%	[7],[8],[10],[11],[20]	11.92%	[14],[15],[16],[17],[19],[22]	11.92%	[14],[15],[16],[17],[19],[22]	11.92%	[14],[15],[16],[17],[19],[22]
Investment owned, balance, principal amount		$ 13,495	[7],[10],[11],[13],[20]						$ 11,393	[14],[15],[16],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19],[22]	10,760
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 12,651
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		204,454	[7],[10],[20]		204,454	[7],[10],[20]	204,454	[7],[10],[20]	164,660	[14],[15],[22]	164,660	[14],[15],[22]	164,660	[14],[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	$ 74
Fair Value, Ending Balance	[7],[10],[20]	$ 0
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	1,037			1,037		1,037
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 1,024
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	8.75%			8.75%		8.75%
Investment, interest rate	[7],[8],[10],[11]	14.00%			14.00%		14.00%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 8,010
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 7,770
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	8.75%			8.75%		8.75%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	(71)
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal & Glass Containers, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15]								415		415		415
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 681
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	491			491		491
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 0
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	4.75%			4.75%		4.75%
Investment, interest rate	[7],[8],[10],[11]	9.97%			9.97%		9.97%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 4,463
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 4,139
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.00%	[7],[10],[11]		8.00%	[7],[10],[11]	8.00%	[7],[10],[11]	8.00%	[14],[15],[16]	8.00%	[14],[15],[16]	8.00%	[14],[15],[16]
Investment, interest rate		13.22%	[7],[8],[10],[11]		13.22%	[7],[8],[10],[11]	13.22%	[7],[8],[10],[11]	10.74%	[14],[15],[16],[17]	10.74%	[14],[15],[16],[17]	10.74%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 12,034	[7],[10],[11],[13]						$ 9,109	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	8,289
Fair Value, Ending Balance	[7],[10],[11]	9,387
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								4.50%		4.50%		4.50%
Investment, interest rate	[15],[16],[17]								7.63%		7.63%		7.63%
Investment owned, balance, principal amount	[15],[16],[18]								$ 1,500
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 1,393
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[10],[11]		6.75%	[7],[10],[11]	6.75%	[7],[10],[11]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]
Investment, interest rate		12.29%	[7],[8],[10],[11]		12.29%	[7],[8],[10],[11]	12.29%	[7],[8],[10],[11]	10.42%	[14],[15],[16],[17]	10.42%	[14],[15],[16],[17]	10.42%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 25,592	[7],[10],[11],[13]						$ 20,766	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	18,188
Fair Value, Ending Balance	[7],[10],[11]	19,514
Investment, Identifier [Axis]: Sabert Corporation, Metal & Glass Containers, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								4.50%		4.50%		4.50%
Investment, interest rate	[15],[16],[17]								7.63%		7.63%		7.63%
Investment owned, balance, principal amount	[15],[16],[18]								$ 1,691
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 1,623
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	10.00%			10.00%		10.00%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ (93)
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	10.00%			10.00%		10.00%
Investment, interest rate	[7],[8],[10],[11]	15.24%			15.24%		15.24%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 25,558
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 24,791
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	991,019			991,019		991,019
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 1,883
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[10],[20]	9,307			9,307		9,307
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[20]	$ 52
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Membership Interest
Schedule of Investments [Line Items]
Investment owned, ownership percentage				87.50%
Investment owned, balance, principal amount				$ 0
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				2,026
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				37,651
Gross Additions				0
Gross Reductions				(14,628)
Fair Value, Ending Balance				$ 23,023
Investment owned, percent of net assets				1.80%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[1],[2],[19],[22],[28],[29],[32]								0.875		0.875		0.875
Investment owned, ownership percentage	[3],[4],[9],[20],[30],[31],[33]	87.50%			87.50%		87.50%
Investment owned, balance, principal amount		$ 0
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		3,150
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[19],[22],[28],[29],[32]	20,715
Gross Additions		7,258
Gross Reductions		0
Fair Value, Ending Balance	[3],[4],[9],[20],[30],[31],[33]	$ 27,973
Investment owned, percent of net assets		1.90%			1.90%		1.90%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.00%	[3],[4],[7],[9],[11],[20],[30]		7.00%	[3],[4],[7],[9],[11],[20],[30]	7.00%	[3],[4],[7],[9],[11],[20],[30]	7.00%	[1],[2],[14],[16],[19],[22],[28]	7.00%	[1],[2],[14],[16],[19],[22],[28]	7.00%	[1],[2],[14],[16],[19],[22],[28]
Investment, interest rate		11.86%	[3],[4],[7],[8],[9],[11],[20],[30]		11.86%	[3],[4],[7],[8],[9],[11],[20],[30]	11.86%	[3],[4],[7],[8],[9],[11],[20],[30]	8.80%	[1],[2],[14],[16],[17],[19],[22],[28]	8.80%	[1],[2],[14],[16],[17],[19],[22],[28]	8.80%	[1],[2],[14],[16],[17],[19],[22],[28]
Investment owned, balance, principal amount		$ 112,656	[3],[4],[7],[9],[11],[13],[20],[30]						$ 96,250	[1],[2],[14],[16],[18],[19],[22],[28]
Net Realized Gain (Loss)		0
Amount of Interest, Fees or Dividends Credited in Income		9,197
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[1],[2],[14],[16],[19],[22],[28]	96,250
Gross Additions		16,406
Gross Reductions		0
Fair Value, Ending Balance	[3],[4],[7],[9],[11],[20],[30]	$ 112,656
Investment owned, percent of net assets		7.50%			7.50%		7.50%
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt
Schedule of Investments [Line Items]
Investment, basis spread, variable rate				7.00%
Investment, interest rate				8.00%
Investment owned, balance, principal amount				$ 96,250
Net Realized Gain (Loss)				0
Amount of Interest, Fees or Dividends Credited in Income				5,839
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance				96,250
Gross Additions				0
Gross Reductions				0
Fair Value, Ending Balance				$ 96,250
Investment owned, percent of net assets				7.60%
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[20]	7.88%			7.88%		7.88%
Investment, interest rate	[7],[10],[11],[20]	12.95%			12.95%		12.95%
Investment owned, balance, principal amount	[7],[10],[11],[13],[20]	$ 7,191
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 6,931
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[20]	7.88%			7.88%		7.88%
Investment, interest rate	[7],[10],[11],[20]	12.88%			12.88%		12.88%
Investment owned, balance, principal amount	[7],[10],[11],[13],[20]	$ 2,697
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 2,599
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11],[20]	7.88%			7.88%		7.88%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11],[20]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11],[20]	7.88%			7.88%		7.88%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13],[20]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11],[20]	$ 0
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10],[20]	58,210			58,210		58,210
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 202
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		345,452	[7],[10]		345,452	[7],[10]	345,452	[7],[10]	345,452	[14],[15]	345,452	[14],[15]	345,452	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 0
Fair Value, Ending Balance	[7],[10]	0
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal & Glass Containers, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate	[14],[15],[16],[17]								5.50%		5.50%		5.50%
Investment owned, balance, principal amount	[14],[15],[18]								$ 46,121
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 45,295
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, interest rate	[7],[10],[23]	14.00%			14.00%		14.00%
Investment owned, balance, principal amount	[7],[10],[13],[23]	$ 54,730
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[23]	$ 25,997
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, interest rate	[7],[10],[23]	14.00%			14.00%		14.00%
Investment owned, balance, principal amount	[7],[10],[13],[23]	$ 14,993
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[23]	$ 13,923
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[9],[10],[11],[23]	14.00%			14.00%		14.00%
Investment owned, balance, principal amount	[7],[9],[10],[13],[23]	$ 4,813
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[23]	$ 4,034
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[10],[11]		7.50%	[7],[10],[11]	7.50%	[7],[10],[11]	7.50%	[14],[15],[16]	7.50%	[14],[15],[16]	7.50%	[14],[15],[16]
Investment, interest rate		12.69%	[7],[8],[10],[11]		12.69%	[7],[8],[10],[11]	12.69%	[7],[8],[10],[11]	10.48%	[14],[15],[16],[17]	10.48%	[14],[15],[16],[17]	10.48%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 1,095	[7],[10],[11],[13]						$ 3,195	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	2,997
Fair Value, Ending Balance	[7],[10],[11]	$ 1,024
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[10],[11]	5.50%			5.50%		5.50%
Investment, interest rate	[8],[10],[11]	10.69%			10.69%		10.69%
Investment owned, balance, principal amount	[10],[11],[13]	$ 1,054
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[11]	$ 980
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		66,000	[10],[20]		66,000	[10],[20]	66,000	[10],[20]	50,000	[15],[22]	50,000	[15],[22]	50,000	[15],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	$ 79
Fair Value, Ending Balance	[10],[20]	$ 24
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.25%	[7],[9],[10],[11]		5.25%	[7],[9],[10],[11]	5.25%	[7],[9],[10],[11]	5.25%	[14],[15],[16],[19]	5.25%	[14],[15],[16],[19]	5.25%	[14],[15],[16],[19]
Investment, interest rate		10.35%	[7],[8],[9],[10],[11]		10.35%	[7],[8],[9],[10],[11]	10.35%	[7],[8],[9],[10],[11]	8.03%	[14],[15],[16],[17],[19]	8.03%	[14],[15],[16],[17],[19]	8.03%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 907	[7],[9],[10],[11],[13]						$ 866	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	796
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 837
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		5.50%	[7],[10],[11]		5.50%	[7],[10],[11]	5.50%	[7],[10],[11]	5.25%	[14],[15],[16]	5.25%	[14],[15],[16]	5.25%	[14],[15],[16]
Investment, interest rate		10.70%	[7],[8],[10],[11]		10.70%	[7],[8],[10],[11]	10.70%	[7],[8],[10],[11]	8.30%	[14],[15],[16],[17]	8.30%	[14],[15],[16],[17]	8.30%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 4,500	[7],[10],[11],[13]						$ 4,534	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	4,427
Fair Value, Ending Balance	[7],[10],[11]	$ 4,393
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[20]	8.50%			8.50%		8.50%
Investment, interest rate	[7],[8],[10],[11],[20]	11.97%			11.97%		11.97%
Investment owned, balance, principal amount | €	[7],[10],[11],[13],[20]				€ 23,731
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 25,632
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Other Diversified Financial Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16],[22]								8.50%		8.50%		8.50%
Investment, interest rate	[14],[15],[16],[17],[22]								10.00%		10.00%		10.00%
Investment owned, balance, principal amount | £	[14],[15],[16],[18],[22]												£ 16,911
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	16,360
Investment, Identifier [Axis]: Sunland Asphalt & Construction, LLC, Construction & Engineering, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								6.00%		6.00%		6.00%
Investment, interest rate	[14],[15],[16],[17]								8.88%		8.88%		8.88%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 42,618
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 41,723
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.75%			7.75%		7.75%
Investment, interest rate	[7],[8],[10],[11]	12.85%			12.85%		12.85%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 49,645
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	49,128
Investment, Identifier [Axis]: Supermoose Borrower, LLC, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[15],[16]								3.75%		3.75%		3.75%
Investment, interest rate	[15],[16],[17]								7.42%		7.42%		7.42%
Investment owned, balance, principal amount	[15],[16],[18]								$ 3,466
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	$ 3,056
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[34]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[10],[11],[34]	12.18%			12.18%		12.18%
Investment owned, balance, principal amount	[7],[10],[11],[13],[34]	$ 1,552
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[34]	$ 1,471
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11],[34]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[10],[11],[34]	12.18%			12.18%		12.18%
Investment owned, balance, principal amount	[7],[10],[11],[13],[34]	$ 32,185
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11],[34]	$ 30,495
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11],[34]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[9],[10],[11],[34]	12.18%			12.18%		12.18%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13],[34]	$ 2,756
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11],[34]	$ 2,593
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11],[34]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[9],[10],[11],[34]	12.18%			12.18%		12.18%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13],[34]	$ 1,099
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11],[34]	$ 926
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Auto Parts & Equipment, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[10],[11]		6.75%	[7],[10],[11]	6.75%	[7],[10],[11]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]
Investment, interest rate		11.94%	[7],[8],[10],[11]		11.94%	[7],[8],[10],[11]	11.94%	[7],[8],[10],[11]	9.81%	[14],[15],[16],[17]	9.81%	[14],[15],[16],[17]	9.81%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 12,500	[7],[10],[11],[13]						$ 12,500	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	11,469
Fair Value, Ending Balance	[7],[10],[11]	$ 11,681
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt
Schedule of Investments [Line Items]
Investment, interest rate		11.50%	[8],[10],[11],[12],[20]		11.50%	[8],[10],[11],[12],[20]	11.50%	[8],[10],[11],[12],[20]	11.50%	[14],[15],[16],[17],[22]	11.50%	[14],[15],[16],[17],[22]	11.50%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 4,984	[10],[12],[13],[20]						$ 4,984	[14],[15],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[22]	4,872
Fair Value, Ending Balance	[10],[12],[20]	$ 4,810
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, interest rate	[7],[8],[10],[11],[20]	13.00%			13.00%		13.00%
Investment owned, balance, principal amount	[7],[10],[13],[20]	$ 50,419
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[20]	$ 49,809
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		4.50%	[10],[11]		4.50%	[10],[11]	4.50%	[10],[11]	4.50%	[15],[16]	4.50%	[15],[16]	4.50%	[15],[16]
Investment, interest rate		9.84%	[8],[10],[11]		9.84%	[8],[10],[11]	9.84%	[8],[10],[11]	8.15%	[15],[16],[17]	8.15%	[15],[16],[17]	8.15%	[15],[16],[17]
Investment owned, balance, principal amount		$ 17,213	[10],[11],[13]						$ 12,032	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	10,827
Fair Value, Ending Balance	[10],[11]	$ 16,141
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[10],[11]		7.50%	[10],[11]	7.50%	[10],[11]	7.50%	[15],[16]	7.50%	[15],[16]	7.50%	[15],[16]
Investment, interest rate		12.69%	[8],[10],[11]		12.69%	[8],[10],[11]	12.69%	[8],[10],[11]	10.62%	[15],[16],[17]	10.62%	[15],[16],[17]	10.62%	[15],[16],[17]
Investment owned, balance, principal amount		$ 12,843	[10],[11],[13]						$ 9,448	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	8,692
Fair Value, Ending Balance	[10],[11]	$ 12,168
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[9],[10],[11],[20]		6.00%	[7],[9],[10],[11],[20]	6.00%	[7],[9],[10],[11],[20]	6.00%	[14],[15],[16],[19],[22]	6.00%	[14],[15],[16],[19],[22]	6.00%	[14],[15],[16],[19],[22]
Investment owned, balance, principal amount		$ 0	[7],[9],[10],[11],[13],[20]						$ 0	[14],[15],[16],[18],[19],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19],[22]	(28)
Fair Value, Ending Balance	[7],[9],[10],[11],[20]	$ (24)
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[10],[11],[20]		6.00%	[7],[10],[11],[20]	6.00%	[7],[10],[11],[20]	6.00%	[14],[15],[16],[22]	6.00%	[14],[15],[16],[22]	6.00%	[14],[15],[16],[22]
Investment, interest rate		11.15%	[7],[8],[10],[11],[20]		11.15%	[7],[8],[10],[11],[20]	11.15%	[7],[8],[10],[11],[20]	8.68%	[14],[15],[16],[17],[22]	8.68%	[14],[15],[16],[17],[22]	8.68%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount		$ 28,826	[7],[10],[11],[13],[20]						$ 23,215	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	22,843
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 28,537
Investment, Identifier [Axis]: Tecta America Corp., Construction & Engineering, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.50%	[7],[10],[11]		8.50%	[7],[10],[11]	8.50%	[7],[10],[11]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]	8.50%	[14],[15],[16]
Investment, interest rate		13.72%	[7],[8],[10],[11]		13.72%	[7],[8],[10],[11]	13.72%	[7],[8],[10],[11]	11.62%	[14],[15],[16],[17]	11.62%	[14],[15],[16],[17]	11.62%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 4,755	[7],[10],[11],[13]						$ 5,203	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	5,034
Fair Value, Ending Balance	[7],[10],[11]	$ 4,529
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.75%	[7],[9],[10],[11]		9.75%	[7],[9],[10],[11]	9.75%	[7],[9],[10],[11]	9.25%	[14],[15],[16],[19]	9.25%	[14],[15],[16],[19]	9.25%	[14],[15],[16],[19]
Investment, interest rate		14.93%	[7],[8],[9],[10],[11]		14.93%	[7],[8],[9],[10],[11]	14.93%	[7],[8],[9],[10],[11]	12.20%	[14],[15],[16],[17],[19]	12.20%	[14],[15],[16],[17],[19]	12.20%	[14],[15],[16],[17],[19]
Investment owned, balance, principal amount		$ 1,590	[7],[9],[10],[11],[13]						$ 1,231	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	1,187
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 1,535
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		9.75%	[7],[10],[11]		9.75%	[7],[10],[11]	9.75%	[7],[10],[11]	9.25%	[14],[15],[16]	9.25%	[14],[15],[16]	9.25%	[14],[15],[16]
Investment, interest rate		14.99%	[7],[8],[10],[11]		14.99%	[7],[8],[10],[11]	14.99%	[7],[8],[10],[11]	12.11%	[14],[15],[16],[17]	12.11%	[14],[15],[16],[17]	12.11%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 23,483	[7],[10],[11],[13]						$ 18,323	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	17,865
Fair Value, Ending Balance	[7],[10],[11]	$ 22,919
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.00%			6.00%		6.00%
Investment, interest rate	[7],[8],[10],[11]	11.09%			11.09%		11.09%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 19,947
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	19,000
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15]								668,879		668,879		668,879
Investment owned, balance, principal amount	[14],[15],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	4,077
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								9.50%		9.50%		9.50%
Investment, interest rate	[14],[15],[16],[17]								13.17%		13.17%		13.17%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 29,663
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 29,031
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.30%	[7],[10],[11],[23]		7.30%	[7],[10],[11],[23]	7.30%	[7],[10],[11],[23]	7.30%	[14],[15],[16]	7.30%	[14],[15],[16]	7.30%	[14],[15],[16]
Investment, interest rate	[14],[15],[16],[17]								10.44%		10.44%		10.44%
Investment owned, balance, principal amount		$ 19,163	[7],[10],[11],[13],[23]						$ 15,674	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	15,682
Fair Value, Ending Balance	[7],[10],[11],[23]	$ 18,286
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		12.50%	[7],[10],[11],[23]		12.50%	[7],[10],[11],[23]	12.50%	[7],[10],[11],[23]	12.50%	[14],[15],[16]	12.50%	[14],[15],[16]	12.50%	[14],[15],[16]
Investment, interest rate	[14],[15],[16],[17]								16.17%		16.17%		16.17%
Investment owned, balance, principal amount		$ 4,641	[7],[10],[11],[13],[23]						$ 3,789	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	3,800
Fair Value, Ending Balance	[7],[10],[11],[23]	$ 4,164
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.00%			7.00%		7.00%
Investment, interest rate	[7],[8],[10],[11]	12.50%			12.50%		12.50%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 46,832
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 41,919
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	10,616			10,616		10,616
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 55
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	358,299			358,299		358,299
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 1,526
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	60,862			60,862		60,862
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 795
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	32,447			32,447		32,447
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 36,587
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.00%		7.00%		7.00%
Investment, interest rate	[14],[15],[16],[17]								11.17%		11.17%		11.17%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 37,494
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	35,807
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 1
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15]								8,434		8,434		8,434
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	69
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 2
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15]								284,650		284,650		284,650
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	2,320
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 3
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15]								48,352		48,352		48,352
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	979
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 4
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15],[19]								23,201		23,201		23,201
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[19]	$ 26,487
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.00%	[7],[10],[11]		6.00%	[7],[10],[11]	6.00%	[7],[10],[11]	6.00%	[14],[15],[16]	6.00%	[14],[15],[16]	6.00%	[14],[15],[16]
Investment, interest rate		11.20%	[7],[8],[10],[11]		11.20%	[7],[8],[10],[11]	11.20%	[7],[8],[10],[11]	9.12%	[14],[15],[16],[17]	9.12%	[14],[15],[16],[17]	9.12%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 11,701	[7],[10],[11],[13]						$ 6,016	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	5,895
Fair Value, Ending Balance	[7],[10],[11]	$ 11,408
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[10],[11],[20]	7.45%			7.45%		7.45%
Investment, interest rate	[8],[10],[11],[20]	12.72%			12.72%		12.72%
Investment owned, balance, principal amount	[10],[11],[13],[20]	$ 1,000
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[11],[20]	$ 929
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate	[8],[10],[11],[20]	6.50%			6.50%		6.50%
Investment owned, balance, principal amount	[10],[13],[20]	$ 4,500
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[20]	$ 3,189
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate	[8],[10],[11],[20]	4.75%			4.75%		4.75%
Investment owned, balance, principal amount	[10],[13],[20]	$ 300
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[10],[20]	249
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 1
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17],[22]								6.50%		6.50%		6.50%
Investment owned, balance, principal amount	[15],[18],[22]								$ 4,500
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	3,026
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 2
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17],[22]								4.75%		4.75%		4.75%
Investment owned, balance, principal amount	[15],[18],[22]								$ 300
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[22]	$ 238
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	7.25%			7.25%		7.25%
Investment, interest rate	[7],[8],[10],[11]	12.47%			12.47%		12.47%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 1,540
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 1,279
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	15.00%			15.00%		15.00%
Investment, interest rate	[7],[8],[10],[11]	21.22%			21.22%		21.22%
Investment owned, balance, principal amount	[7],[10],[11]	$ 1,323
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 1,247
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		3.75%	[10],[11]		3.75%	[10],[11]	3.75%	[10],[11]	3.75%	[15],[16]	3.75%	[15],[16]	3.75%	[15],[16]
Investment, interest rate		9.03%	[8],[10],[11]		9.03%	[8],[10],[11]	9.03%	[8],[10],[11]	6.56%	[15],[16],[17]	6.56%	[15],[16],[17]	6.56%	[15],[16],[17]
Investment owned, balance, principal amount		$ 11,822	[10],[11]						$ 7,564	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	6,795
Fair Value, Ending Balance	[10],[11]	10,743
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								7.75%		7.75%		7.75%
Investment, interest rate	[14],[15],[16],[17]								10.56%		10.56%		10.56%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 6,000
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	5,070
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[14],[15],[16]								6.00%		6.00%		6.00%
Investment, interest rate	[14],[15],[16],[17]								10.19%		10.19%		10.19%
Investment owned, balance, principal amount	[14],[15],[16],[18]								$ 40,536
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	$ 40,131
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	11.38%			11.38%		11.38%
Investment owned, balance, principal amount	[7],[10],[11]	$ 35,853
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 35,495
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	6.50%			6.50%		6.50%
Investment, interest rate	[7],[8],[10],[11]	12.00%			12.00%		12.00%
Investment owned, balance, principal amount	[7],[10],[11]	$ 19,306
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 19,113
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.00%	[7],[10],[11]		7.00%	[7],[10],[11]	7.00%	[7],[10],[11]	7.00%	[14],[15],[16]	7.00%	[14],[15],[16]	7.00%	[14],[15],[16]
Investment, interest rate		12.50%	[7],[8],[10],[11]		12.50%	[7],[8],[10],[11]	12.50%	[7],[8],[10],[11]	10.67%	[14],[15],[16],[17]	10.67%	[14],[15],[16],[17]	10.67%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 5,000	[7],[10],[11]						$ 5,000	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	4,538
Fair Value, Ending Balance	[7],[10],[11]	$ 4,025
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		15.00%	[7],[10],[11]		15.00%	[7],[10],[11]	15.00%	[7],[10],[11]	15.00%	[14],[15],[16]	15.00%	[14],[15],[16]	15.00%	[14],[15],[16]
Investment, interest rate		21.22%	[7],[8],[10],[11]		21.22%	[7],[8],[10],[11]	21.22%	[7],[8],[10],[11]	19.64%	[14],[15],[16],[17]	19.64%	[14],[15],[16],[17]	19.64%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 1,565	[7],[10],[11]						$ 2,316	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	2,264
Fair Value, Ending Balance	[7],[10],[11]	$ 1,475
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		4,871	[7],[10]		4,871	[7],[10]	4,871	[7],[10]	3,621	[14],[15]	3,621	[14],[15]	3,621	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 192
Fair Value, Ending Balance	[7],[10]	$ 136
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		127,452	[7],[10]		127,452	[7],[10]	127,452	[7],[10]	18,032	[14],[15]	18,032	[14],[15]	18,032	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 296
Fair Value, Ending Balance	[7],[10]	$ 1,565
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.25%	[10],[11]		6.25%	[10],[11]	6.25%	[10],[11]	6.25%	[15],[16]	6.25%	[15],[16]	6.25%	[15],[16]
Investment, interest rate		11.45%	[8],[10],[11]		11.45%	[8],[10],[11]	11.45%	[8],[10],[11]	9.37%	[15],[16],[17]	9.37%	[15],[16],[17]	9.37%	[15],[16],[17]
Investment owned, balance, principal amount		$ 24,419	[10],[11]						$ 25,499	[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15],[16]	23,204
Fair Value, Ending Balance	[10],[11]	22,862
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[14],[15]								109,420		109,420		109,420
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	1,799
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Alternative Carriers, Fixed Rate Bond
Schedule of Investments [Line Items]
Investment, interest rate	[15],[16],[17]								4.00%		4.00%		4.00%
Investment owned, balance, principal amount	[15],[18]								$ 250
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[15]	$ 201
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		8.25%	[7],[10],[11]		8.25%	[7],[10],[11]	8.25%	[7],[10],[11]	8.25%	[14],[15],[16]	8.25%	[14],[15],[16]	8.25%	[14],[15],[16]
Investment, interest rate		13.79%	[7],[8],[10],[11]		13.79%	[7],[8],[10],[11]	13.79%	[7],[8],[10],[11]	11.92%	[14],[15],[16],[17]	11.92%	[14],[15],[16],[17]	11.92%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 19,578	[7],[10],[11]						$ 19,578	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	16,152
Fair Value, Ending Balance	[7],[10],[11]	$ 13,693
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.50%	[7],[10],[11],[20]		7.50%	[7],[10],[11],[20]	7.50%	[7],[10],[11],[20]	7.50%	[14],[15],[16],[22]	7.50%	[14],[15],[16],[22]	7.50%	[14],[15],[16],[22]
Investment, interest rate		12.46%	[7],[8],[10],[11],[20]		12.46%	[7],[8],[10],[11],[20]	12.46%	[7],[8],[10],[11],[20]	9.72%	[14],[15],[16],[17],[22]	9.72%	[14],[15],[16],[17],[22]	9.72%	[14],[15],[16],[17],[22]
Investment owned, balance, principal amount | £							£ 20,000	[7],[10],[11],[20]					£ 18,000	[14],[15],[16],[18],[22]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[22]	$ 16,552
Fair Value, Ending Balance	[7],[10],[11],[20]	$ 23,270
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares		21,523	[7],[10]		21,523	[7],[10]	21,523	[7],[10]	18,635	[14],[15]	18,635	[14],[15]	18,635	[14],[15]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15]	$ 16,575
Fair Value, Ending Balance	[7],[10]	$ 18,821
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		6.75%	[7],[9],[10],[11]		6.75%	[7],[9],[10],[11]	6.75%	[7],[9],[10],[11]	6.75%	[14],[15],[16],[19]	6.75%	[14],[15],[16],[19]	6.75%	[14],[15],[16],[19]
Investment, interest rate	[7],[8],[9],[10],[11]	11.99%			11.99%		11.99%
Investment owned, balance, principal amount		$ 377	[7],[9],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	(32)
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 288
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[10],[11]		7.25%	[7],[10],[11]	7.25%	[7],[10],[11]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]	6.75%	[14],[15],[16]
Investment, interest rate		8.50%	[7],[8],[10],[11]		8.50%	[7],[8],[10],[11]	8.50%	[7],[8],[10],[11]	9.49%	[14],[15],[16],[17]	9.49%	[14],[15],[16],[17]	9.49%	[14],[15],[16],[17]
Investment owned, balance, principal amount		$ 24,188	[7],[10],[11],[13]						$ 19,203	[14],[15],[16],[18]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16]	18,867
Fair Value, Ending Balance	[7],[10],[11]	$ 23,235
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate		7.25%	[7],[10],[11]		7.25%	[7],[10],[11]	7.25%	[7],[10],[11]	6.75%	[14],[15],[16],[19]	6.75%	[14],[15],[16],[19]	6.75%	[14],[15],[16],[19]
Investment, interest rate	[7],[8],[10],[11]	12.38%			12.38%		12.38%
Investment owned, balance, principal amount		$ 3,636	[7],[10],[11],[13]						$ 0	[14],[15],[16],[18],[19]
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Beginning Balance	[14],[15],[16],[19]	0
Fair Value, Ending Balance	[7],[10],[11]	$ 3,563
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	7.25%			7.25%		7.25%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[10],[11]	8.75%			8.75%		8.75%
Investment, interest rate	[7],[8],[10],[11]	11.75%			11.75%		11.75%
Investment owned, balance, principal amount	[7],[10],[11],[13]	$ 5,212
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10],[11]	$ 5,034
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	8.75%			8.75%		8.75%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3
Schedule of Investments [Line Items]
Investment, basis spread, variable rate	[7],[9],[10],[11]	8.75%			8.75%		8.75%
Investment owned, balance, principal amount	[7],[9],[10],[11],[13]	$ 0
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[9],[10],[11]	$ 0
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants
Schedule of Investments [Line Items]
Investment owned, balance (in shares) | shares	[7],[10]	53,700			53,700		53,700
Investments in and Advances to Affiliates, at Fair Value [Roll Forward]
Fair Value, Ending Balance	[7],[10]	$ 407

[1] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[2] Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[3] As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.

[4] Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.

[5] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[6] Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

[7] As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").

[8] Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

[9] Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

[10] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[11] The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the London Interbank Offered Rate ("LIBOR" or "L"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of June 30, 2023, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 180-day LIBOR at 5.73%, the PRIME at 8.25%, the 30-day SOFR at 5.10%, the 90-day SOFR at 5.24%, the 180-day SOFR at 5.34%, the SONIA at 3.47%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.49% and the 180-day EURIBOR at 2.82%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

[12] This investment represents a participation interest in the underlying securities shown.

[13] Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

[14] As of September 30, 2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.

[15] Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

[16] The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR, SOFR, SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 180-day LIBOR at 4.17%, the 360-day LIBOR at 4.78%, the PRIME at 6.25%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55%, the SONIA at 1.69%, the 30-day EURIBOR at 0.69%, the 90-day EURIBOR at 0.99% and the 180-day EURIBOR at 0.38%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

[17] Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

[18] Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

[19] Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

[20] Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of June 30, 2023, qualifying assets represented 73.7% of the Company's total assets and non-qualifying assets represented 26.3% of the Company's total assets.

[21] This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

[22] Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2022, qualifying assets represented 75.7% of the Company's total assets and non-qualifying assets represented 24.3% of the Company's total assets.

[23] This investment was on non-accrual status as of June 30, 2023.

[24] One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.

[25] One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.

[26] This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

[27] This investment was renamed during the three months ended March 31, 2022. For periods prior to March 31, 2022, this investment was referenced as Realfi Strategic Capital Funding LLC.

[28] See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

[29] This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.

[30] See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.

[31] This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.

[32] Income producing through payment of dividends or distributions.

[33] Income producing through payment of dividends or distributions.

[34] This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

XML

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	$ 26,364,000
SLF JV I, LLC [Member]
Investment Owned, Cost	us-gaap_InvestmentOwnedAtCost	54,800,000
Investment Owned, Cost	us-gaap_InvestmentOwnedAtCost	49,300,000
Investment Owned, Fair Value	us-gaap_InvestmentOwnedAtFairValue	28,000,000
Investment Owned, Fair Value	us-gaap_InvestmentOwnedAtFairValue	20,700,000
Dividend Income, Operating	us-gaap_DividendIncomeOperating	1,100,000
Dividend Income, Operating	us-gaap_DividendIncomeOperating	3,200,000
Dividend Income, Operating	us-gaap_DividendIncomeOperating	900,000
Dividend Income, Operating	us-gaap_DividendIncomeOperating	$ 2,000,000
SLF JV I Notes [Member]
Investment, Interest Rate, Floor	us-gaap_InvestmentInterestRateFloor	1.00%
Investment, Basis Spread, Variable Rate	us-gaap_InvestmentBasisSpreadVariableRate	7.00%
Investment Owned, Cost	us-gaap_InvestmentOwnedAtCost	$ 96,300,000
Investment Owned, Cost	us-gaap_InvestmentOwnedAtCost	112,700,000
Investment Owned, Fair Value	us-gaap_InvestmentOwnedAtFairValue	112,700,000
Investment Owned, Fair Value	us-gaap_InvestmentOwnedAtFairValue	96,300,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	3,400,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	9,200,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	1,900,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	$ 5,800,000
Glick JV Notes [Member]
Investment, Basis Spread, Variable Rate	us-gaap_InvestmentBasisSpreadVariableRate	4.50%
Interest Income, Operating	us-gaap_InterestIncomeOperating	$ 1,800,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	5,000,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	1,200,000
Interest Income, Operating	us-gaap_InterestIncomeOperating	3,300,000
SLF JV I [Member] | SLF JV I, LLC [Member]
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	3,300,000
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	8,800,000
Investment Company, Financial Support To Investee During Period	ocsl_InvestmentCompanyFinancialSupportToInvesteeDuringPeriod	5,500,000
SLF JV I [Member] | SLF JV I Notes [Member]
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	9,800,000
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	26,200,000
Investment Company, Financial Support To Investee During Period	ocsl_InvestmentCompanyFinancialSupportToInvesteeDuringPeriod	16,400,000
OCSI Glick JV LLC [Member] | Glick JV Notes [Member]
Investment Owned, Cost	us-gaap_InvestmentOwnedAtCost	50,300,000
Investment Owned, Fair Value	us-gaap_InvestmentOwnedAtFairValue	50,300,000
Investment Company, Financial Commitment To Investee, Aggregate Amount	ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount	78,800,000
Investment Company, Financial Commitment To Investee, Aggregate Amount	ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount	78,800,000
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	12,400,000
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	$ 12,400,000
Investment Owned, Ownership Percentage	ocsl_InvestmentOwnedOwnershipPercentage	87.50%
Investment Owned, Ownership Percentage	ocsl_InvestmentOwnedOwnershipPercentage	12.50%
OCSI Glick JV LLC [Member] | Glick JV LLC [Member]
Investment Owned, Cost	us-gaap_InvestmentOwnedAtCost	$ 49,600,000
Investment Owned, Fair Value	us-gaap_InvestmentOwnedAtFairValue	49,600,000
Investment Company, Financial Commitment To Investee, Aggregate Amount	ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount	8,700,000
Investment Company, Financial Commitment To Investee, Aggregate Amount	ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount	8,700,000
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	1,600,000
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount	us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	$ 1,600,000
Investment Owned, Ownership Percentage	ocsl_InvestmentOwnedOwnershipPercentage	87.50%
Investment Owned, Ownership Percentage	ocsl_InvestmentOwnedOwnershipPercentage	12.50%